<SEC-DOCUMENT>0001628280-19-006439.txt : 20190509
<SEC-HEADER>0001628280-19-006439.hdr.sgml : 20190509
<ACCEPTANCE-DATETIME>20190509161627
ACCESSION NUMBER:		0001628280-19-006439
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		71
CONFORMED PERIOD OF REPORT:	20190331
FILED AS OF DATE:		20190509
DATE AS OF CHANGE:		20190509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cerecor Inc.
		CENTRAL INDEX KEY:			0001534120
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				450705648
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37590
		FILM NUMBER:		19810751

	BUSINESS ADDRESS:	
		STREET 1:		540 GAITHER ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		410-522-8707

	MAIL ADDRESS:	
		STREET 1:		540 GAITHER ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cerc10-q20190331.htm
<DESCRIPTION>10-Q
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s2C4CABE8487D59E3BE8182765AEC3E3C"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:3px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, DC 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:22.77777777777778%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 10&#8209;Q</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:9%;"></td><td style="width:91%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">for the quarterly period ended March&#160;31, 2019</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OR</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#9744;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">COMMISSION FILE NUMBER: 001-37590</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">CERECOR INC.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State of incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">45-0705648</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(I.R.S. Employer Identification No.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">540 Gaither Road, Suite 400</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Rockville, Maryland 20850</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(410)&#160;522&#8209;8707</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant&#8217;s telephone number,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">including area code)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.29629629629629%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:31%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Title of each class</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Trading Symbol</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name of each exchange on which registered</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock, $0.001 par value</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERC</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nasdaq Capital Market</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:16px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254; </font><font style="font-family:inherit;font-size:10pt;">No&#160;&#9744;&#160;</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S&#8209;T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254; </font><font style="font-family:inherit;font-size:10pt;">No&#160;&#9744;</font></div><div style="line-height:120%;padding-bottom:4px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non&#8209;accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b&#8209;2 of the Exchange Act.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:28%;"></td><td style="width:41%;"></td><td style="width:31%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Large accelerated filer </font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accelerated filer </font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-accelerated filer </font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Smaller reporting company </font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company </font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b&#8209;2 of the Exchange Act).&#160;Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#32;&#160;No&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of May&#160;3, 2019, the registrant had 42,753,659 shares of common stock outstanding.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:3px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="s31A117BED97D572C8808BF6FCEDA8807"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CERECOR INC.</font></div><div style="line-height:120%;text-align:center;text-indent:84px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">FORM 10-Q</font></div><div style="line-height:120%;text-align:center;text-indent:84px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">For the Quarter Ended </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:center;text-indent:84px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">TABLE OF CONTENTS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:40px;text-align:left;padding-left:48px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:90.1535682023487%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:8%;"></td><td style="width:8%;"></td><td style="width:3%;"></td><td style="width:71%;"></td><td style="width:4%;"></td><td style="width:6%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Page</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s177E3C7D1B545598B3D3B87ACED0EC0F"><font style="font-family:inherit;font-size:10pt;">PART I.&#160;</font></a></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s177E3C7D1B545598B3D3B87ACED0EC0F"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FINANCIAL INFORMATION&#160;</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sCA805EF127235B228510C9D38546057E"><font style="font-family:inherit;font-size:10pt;">Item 1.</font></a><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s55E7B188C54C5E2DA3FB52E3F260AAE9"><font style="font-family:inherit;font-size:10pt;">Financial Statements</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s38C39C0B0061503AADC637216E5AA3E5"><font style="font-family:inherit;font-size:10pt;">Condensed Consolidated Balance Sheets as of March 31, 2019 (Unaudited) and December 31, 2018</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s38C39C0B0061503AADC637216E5AA3E5"> 3</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">b)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD1B425E0458F51299116EBD1B43D3369"><font style="font-family:inherit;font-size:10pt;">Condensed Consolidated Statements of Operations (Unaudited) for the Three Months Ended March 31, 2019 and 2018</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sD1B425E0458F51299116EBD1B43D3369"> 4</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">c)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s9BCC7761DB205FC29AAF8DE2286D7C80"><font style="font-family:inherit;font-size:10pt;">Condensed Consolidated Statements of Cash Flows (Unaudited) for the Three Months Ended March 31, 2019 and 2018</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s9BCC7761DB205FC29AAF8DE2286D7C80"> 5</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">d)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><a style="font-family:inherit;font-size:10pt;" href="#se6832e9d5b124e13ae36b6eacef646b3"><font style="font-family:inherit;font-size:10pt;">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity (Unaudited) for the Three Months Ended March 31, 2019 and 2018</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">e)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE6AB2EF935A25488B8B0A864010C409F"><font style="font-family:inherit;font-size:10pt;">Notes to Unaudited Financial Statements</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sE6AB2EF935A25488B8B0A864010C409F"> 8</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s91F11461F91A5BE08668A9F04FF1545C"><font style="font-family:inherit;font-size:10pt;">Item 2.</font></a></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s91F11461F91A5BE08668A9F04FF1545C"><font style="font-family:inherit;font-size:10pt;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#160;</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s91F11461F91A5BE08668A9F04FF1545C"> 29</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s2E7BEF4EBAC55F469D386635BDA73BFB"><font style="font-family:inherit;font-size:10pt;">Item 3.</font></a></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s2E7BEF4EBAC55F469D386635BDA73BFB"><font style="font-family:inherit;font-size:10pt;">Quantitative and Qualitative Disclosures About Market Risk</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s2E7BEF4EBAC55F469D386635BDA73BFB"> 38</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sAF86CF04441F5B3E9052884047823CE7"><font style="font-family:inherit;font-size:10pt;">Item 4.</font></a></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sAF86CF04441F5B3E9052884047823CE7"><font style="font-family:inherit;font-size:10pt;">Controls and Procedures</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sAF86CF04441F5B3E9052884047823CE7"> 38</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s2C214970BE5652999AC0D2388CDE331F"><font style="font-family:inherit;font-size:10pt;">PART II.&#160;</font></a></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s2C214970BE5652999AC0D2388CDE331F"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OTHER INFORMATION</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sBB102D22F9F85C1B8650298D29C45002"><font style="font-family:inherit;font-size:10pt;">Item 1.</font></a></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sBB102D22F9F85C1B8650298D29C45002"><font style="font-family:inherit;font-size:10pt;">Legal Proceedings</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sBB102D22F9F85C1B8650298D29C45002"> 39</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sFE58560E55865F97992A956CAD85F5E2"><font style="font-family:inherit;font-size:10pt;">Item 1A.</font></a></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sFE58560E55865F97992A956CAD85F5E2"><font style="font-family:inherit;font-size:10pt;">Risk Factors</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sFE58560E55865F97992A956CAD85F5E2"> 39</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s7D620DDC35EC594BB9E726099BA00A11"><font style="font-family:inherit;font-size:10pt;">Item 6.</font></a></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s7D620DDC35EC594BB9E726099BA00A11"><font style="font-family:inherit;font-size:10pt;">Exhibits</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s7D620DDC35EC594BB9E726099BA00A11"> 40</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s32F9A55443DA52A6833C08F97DC01684"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s32F9A55443DA52A6833C08F97DC01684"> 41</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:40px;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s177E3C7D1B545598B3D3B87ACED0EC0F"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART I - FINANCIAL INFORMATION</font></div><div><a name="sCA805EF127235B228510C9D38546057E"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1.&#160;&#160;Financial Statements.</font></div><div><a name="s38C39C0B0061503AADC637216E5AA3E5"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERECOR&#160;INC. and SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Balance Sheets</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(unaudited)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,121,388</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,646,301</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,718,396</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,157,555</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other receivables</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,531,025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,469,011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,046,982</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,110,780</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,248,465</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,529,516</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash, current portion</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,846</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,730</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,744,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,931,893</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,477,067</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">586,512</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangibles assets, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,160,621</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,239,468</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,411,123</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,411,123</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash, net of current portion</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,118</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,870,031</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,250,721</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities and stockholders&#8217; equity</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,249,470</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,446,141</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,815,097</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,731,373</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,814,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,032,258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, current portion</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,050,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,050,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration, current portion</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,205,647</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,956,807</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,134,864</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,216,579</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, net of current portion</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,303,540</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,327,882</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration, net of current portion</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,796,641</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,093,757</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liability, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,179</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,189,277</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">385,517</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,749,501</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,342,973</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders&#8217; equity:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock&#8212;$0.001 par value; 200,000,000 shares authorized at March&#160;31, 2019 and December 31, 2018; 42,753,659 and 40,804,189 shares issued and outstanding at March&#160;31, 2019 and December 31, 2018, respectively </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,754</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,804</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock&#8212;$0.001 par value; 5,000,000 shares authorized at March 31, 2019 and December 31, 2018; 2,857,143 shares issued and outstanding at March&#160;31, 2019 and December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,857</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,857</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional paid-in capital</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,747,037</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119,082,157</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated deficit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(105,672,118</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98,218,070</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stockholders&#8217; equity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,120,530</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,907,748</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders&#8217; equity</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,870,031</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,250,721</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes to the condensed consolidated financial statements.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;3</font></div></div><hr style="page-break-after:always"><div><a name="sD1B425E0458F51299116EBD1B43D3369"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERECOR&#160;INC. and SUBSIDIARIES&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statements of Operations (Unaudited)</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,411,443</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,260,119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales force revenue </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222,656</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,411,443</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,482,775</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of product sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,947,892</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">863,624</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,401,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,649,778</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,716,983</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,918,916</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,108,902</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,524,816</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,078,847</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,017,408</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262,769</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,434,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,237,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from operations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,022,772</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,754,536</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (expense) income: </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of warrant liability and unit purchase option liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47,577</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,251</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (expense) income, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,400</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,655</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(207,941</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(264,918</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(104,998</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss before taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,287,690</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,859,534</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166,358</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,313</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,454,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,882,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss per share of common stock, basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.13</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss per share of preferred stock, basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.67</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes to the condensed consolidated unaudited financial statements.</font></div><div style="line-height:120%;padding-bottom:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;4</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s9BCC7761DB205FC29AAF8DE2286D7C80"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERECOR&#160;INC. and SUBSIDIARIES</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statements of Cash Flows (Unaudited)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,454,048</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,882,847</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Adjustments to reconcile net loss provided by (used in) to net cash used in operating activities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,098,478</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,023,040</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">596,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">242,824</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Deferred taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,941</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,913</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of inventory fair value associated with acquisition of TRx and Avadel</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45,450</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-cash interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">105,451</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in fair value of warrant liability and unit purchase option liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,577</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23,251</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in fair value of contingent consideration and long-term royalty obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">180,402</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">262,769</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,412</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Changes in assets and liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">439,159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">104,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other receivables</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(62,014</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">371,663</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventory, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41,195</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(554,445</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses and other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">281,051</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(71,085</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Escrowed cash receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,065</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(196,671</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,866,960</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income taxes payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(217,608</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,074,278</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">160,627</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash used in operating activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,121,552</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(280,423</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Investing activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition of business</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchase of property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(165,969</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19,224</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash used in investing activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(165,969</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19,225</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Financing activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Proceeds from exercise of stock options and warrants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94,177</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">363,390</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Proceeds from underwritten public offering, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,975,960</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payment of contingent consideration </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(228,678</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payment of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(24,342</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash provided by financing activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,817,117</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">363,390</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Increase in cash, cash equivalents and restricted cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,529,596</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">63,742</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, cash equivalents, and restricted cash at beginning of period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,746,756</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,605,499</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, cash equivalents, and restricted cash at end of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,276,352</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,669,241</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Supplemental disclosures of cash flow information</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash paid for interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">262,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">44,003</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash paid for taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">378,025</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Supplemental disclosures of non-cash activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Leased asset obtained in exchange for new operating lease liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">743,025</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Debt assumed in Avadel Pediatric Products acquisition</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,075,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows:</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;5</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,121,388</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,523,927</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted cash, current</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77,846</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,955</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted cash, non-current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77,118</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">131,359</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total cash, cash equivalents and restricted cash</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,276,352</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,669,241</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes to the condensed consolidated financial statements.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;6</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="se6832e9d5b124e13ae36b6eacef646b3"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERECOR&#160;INC. and SUBSIDIARIES</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.80555555555556%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:24%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="29" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Stockholders&#8217;&#160;Equity</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Additional</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Common&#160;stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Preferred Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">paid&#8209;in</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Contingently issuable stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accumulated</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">stockholders&#8217;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">capital</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">deficit</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">equity </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended March 31, 2018: </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance, December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,266,989</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,268</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83,338,136</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,655,464</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(58,165,260</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,859,608</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise of stock options and warrants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">143,346</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">363,247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">363,390</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock-based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">242,824</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">242,824</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,882,847</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,882,847</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,410,335</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,411</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83,944,207</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,655,464</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(62,048,107</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,582,975</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.80555555555556%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:24%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended March 31, 2019:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,804,189</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,804</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,857,143</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,857</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">119,082,157</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(98,218,070</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,907,748</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Issuance of shares of common stock in underwritten public offering, net of offering costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,818,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,818</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,974,142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,975,960</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise of stock options and warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,288</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94,146</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94,177</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">596,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">596,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted Stock Units vested during period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">101</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(101</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,454,048</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,454,048</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42,753,659</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42,754</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,857,143</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,857</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">128,747,037</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(105,672,118</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23,120,530</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes to the condensed consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;7</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sE6AB2EF935A25488B8B0A864010C409F"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERECOR&#160;INC. and SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Notes to Unaudited Condensed Consolidated Financial Statements</font><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s81C0E7442DCE5EB4AAD7AB3D9E6702BD"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1. Business</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cerecor Inc. (the "Company" or &#8220;Cerecor&#8221;) is a fully integrated biopharmaceutical company with commercial operations and research and development capabilities.  The Company is building a pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases.  The Company's neurology pipeline is led by CERC-301, which recently received positive interim results from the Phase I safety study of Neurogenic Orthostatic Hypotension ("nOH").  The Company is also developing </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;other neurological compounds, </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;of which is in preclinical testing and the other is in the clinical ready stage.  The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802, and CERC-803.  All </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;of these compounds are therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation ("CDGs") by means of substrate replacement therapy.  The U.S. Food and Drug Administration ("FDA") has granted Rare Pediatric Disease designation ("RPDD") and Orphan Drug Designation ("ODD") to all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;compounds.  Under the FDA&#8217;s Rare Pediatric Disease Priority Review Voucher ("PRV") program, upon the approval of a new drug application ("NDA") for the treatment of a rare pediatric disease, the sponsor of such application would be eligible for a PRV that can be used to obtain priority review for a subsequent new drug application or biologics license application.  The PRV may be sold or transferred an unlimited number of times.  The Company plans to leverage the 505(b)(2) NDA pathway for all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;compounds to accelerate development and approval.  The Company is also in the process of developing </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;other preclinical pediatric orphan rare disease compound. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also has a diverse portfolio of marketed products.  Our marketed products are led by our prescribed dietary supplements and prescribed drugs.  Our prescribed dietary supplements include Poly-Vi-Flor and Tri-Vi-Flor, which are prescription vitamin and fluoride supplements used in infants and children to treat or prevent deficiency of essential vitamins and fluoride.  The Company also markets a number of prescription drugs that treat a range of pediatric diseases, disorders and conditions.  Cerecor's prescription drugs include Millipred&#174;, Ulesfia&#174;, Karbinal&#8482; ER, AcipHex&#174; Sprinkle&#8482;, and Cefaclor for Oral Suspension. Finally, the Company has </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;marketed medical device, Flexichamber&#8482;. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cerecor was incorporated in 2011, commenced operations in the second quarter of 2011 and completed an initial public offering in October 2015. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 17, 2017, the Company acquired TRx Pharmaceuticals, LLC (&#8220;TRx&#8221;) and its wholly-owned subsidiaries (see "TRx Acquisition" in Note 5 below for a description of this transaction).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2018, Cerecor acquired all rights to Avadel Pharmaceuticals PLC&#8217;s (&#8220;Avadel&#8221;) marketed pediatric products (the &#8220;Acquired Products&#8221;) in exchange for Cerecor assuming certain financial obligations of Avadel (see "Avadel Pediatric Products Acquisition" in Note 5 below for a description of this transaction).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 25, 2018, the Company acquired Ichorion Therapeutics, Inc., a privately-held biopharmaceutical company focused on developing treatments and increasing awareness of inherited metabolic disorders known as CDGs (see "Ichorion Asset Acquisition" in Note 5 below for a description of this transaction).</font></div><div style="line-height:120%;text-align:justify;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidity</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In order to meet its cash flow needs, the Company applies a disciplined decision-making methodology as it evaluates the optimal allocation of the Company's resources between investing in the Company's current commercial product line, the Company's development portfolio and acquisitions or in-licensing of new assets.  For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, Cerecor generated </font><font style="font-family:inherit;font-size:10pt;">a net loss</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">$7.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">negative</font><font style="font-family:inherit;font-size:10pt;">&#32;cash flow from operations of </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;">.  As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, Cerecor had an accumulated deficit of </font><font style="font-family:inherit;font-size:10pt;">$105.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and a balance of </font><font style="font-family:inherit;font-size:10pt;">$16.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash and cash equivalents.  During the first quarter of 2019, the Company closed an underwritten public offering of common stock for </font><font style="font-family:inherit;font-size:10pt;">1,818,182</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock of the Company, at a price to the public of </font><font style="font-family:inherit;font-size:10pt;">$5.50</font><font style="font-family:inherit;font-size:10pt;">&#32;per share ("public price"). Armistice Capital Master Fund Ltd. ("Armistice"), our largest stockholder, participated in the offering by purchasing </font><font style="font-family:inherit;font-size:10pt;">363,637</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock of the Company from the underwriter at the public price.  Cerecor director Steven J. Boyd is Armistice's Chief Investment Officer.  The net proceeds of the offering were approximately </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(see "Common Stock Offering" in Note 9 below for description of the transaction).  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company plans to use cash and the anticipated cash flows from the Company's existing product sales to offset costs related to its neurology programs, pediatric rare disease programs, business development, costs associated with its organizational </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;8</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">infrastructure, and debt principal and interest payments.  Cerecor expects to continue to incur significant expenses and operating losses for the immediate future as it continues to invest in the Company's pipeline assets.  Our ability to achieve and maintain profitability in the future is dependent on, among other things, the development, regulatory approval, and commercialization of our new product candidates and achieving a level of revenues from our existing product sales adequate to support our cost structure, which includes significant investment in our pipeline assets. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company believes it will require additional financing to continue to execute its clinical development strategy and fund future operations. The Company plans to meet its capital requirements through operating cash flows from product sales and some combination of equity or debt financings, collaborations, out-licensing arrangements, strategic alliances, federal and private grants, marketing, distribution, or licensing arrangements, or the sale of current or future assets.  If the Company is not able to secure adequate additional funding, the Company may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs. If the Company raises additional funds through collaborations, strategic alliances, or licensing arrangements with third parties, the Company may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our plan to aggressively develop our pipeline will require substantial cash inflows in excess of what the Company expects our current commercial operations to generate.&#160; However, the Company expects that our existing cash and cash equivalents, together with anticipated revenue, will enable us to fund our operating expenses, capital expenditure requirements, and other non-operating cash payments, such as fixed quarterly payments on our outstanding debt balances, through at least May 2020. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s5C9E8607733A515DA7BEA6CE75197AC0"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Basis of Presentation and Significant Accounting Policies </font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;).   Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows. The condensed consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;has been derived from audited financial statements at that date. The interim results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosure normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (&#8220;SEC&#8221;). Certain prior period amounts have been reclassified to conform to the current year presentation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company believes that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;audited consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassification</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2018, the Company concluded that going forward it would include change in fair value of contingent consideration within its own stand-alone line in operating expenses in the Company's statements of operations.  The Company has reclassified </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;from other expenses to operating expenses in the March 31, 2018 statement of operations to conform with current period presentation.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant Accounting Policies </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended March 31, 2019, there have been no significant changes to the Company&#8217;s summary of significant accounting policies contained in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on March 18, 2019 and amended on April 23, 2019, except for the recently adopted accounting standards described below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following significant accounting policy was updated in 2019 to reflect changes upon our adoption of ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">&#32;(Topic 842) ("ASU 2016-02").</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;9</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines if an arrangement is a lease at inception.  If an arrangement contains a lease, the Company performs a lease classification test to determine if the lease is an operating lease or a finance lease.  The Company has identified </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;operating lease for its corporate headquarters. Right-of-use ("ROU") assets represent the right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.  Operating lease liabilities are recognized on the commencement date of the lease based on the present value of the future lease payments over the lease term and are included in other long-term liabilities on our condensed consolidated balance sheet.  Right-of-use assets are valued at the initial measurement of the lease liability, plus any indirect costs or rent prepayments, and reduced by any lease incentives and any deferred lease payments.  Operating right-of-use assets are recorded in property and equipment, net on the condensed consolidated balance sheet and are amortized over the lease term.  To determine the present value of lease payments on lease commencement, we use the implicit rate when readily determinable, however as most leases do not provide an implicit rate, we use our incremental borrowing rate based on information available at commencement date. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Furthermore, the Company has elected the practical expedient to account for the lease and non-lease components as a single lease component for the leased property asset class.  Lease expense is recognized on a straight-line basis over the life of the lease and is included within general and administrative expenses. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adoption of ASC 842</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">&#32;(Topic 842) ("ASU 2016-02"). This guidance revises existing practice related to accounting for leases under ASC No. 840,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">&#160;(&#8220;ASC 840&#8221;) for both lessees and lessors. The new guidance in ASU 2016-02 requires lessees to recognize a right-of-use asset and a lease liability for nearly all leases (other than leases that meet the definition of a short-term lease). The lease liability will be equal to the present value of lease payments and the right-of-use asset will be based on the lease liability, subject to adjustment such as for initial direct costs. For income statement purposes, the new standard retains a dual model similar to ASC 840, requiring leases to be classified as either operating leases or finance leases. For lessees, operating leases will result in straight-line expense (similar to current accounting by lessees for operating leases under ASC 840) while finance leases will result in a front-loaded expense pattern (similar to current accounting by lessees for capital leases under ASC 840). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted the standard using the simplified transition method on its effective date of January 1, 2019 and therefore did not adjust prior comparative periods as permitted by the codification improvements issued by FASB in July 2018.  Additionally, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allows the Company to carryforward the historical lease classification.  As a result of the standard, the Company recorded a lease liability of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and a right-of-use asset of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, which is equal to the initial measurement of the lease liability reduced by the unamortized balance of lease incentive received and deferred rent.  There was no material impact to our condensed consolidated income statement (see Note 12 below for more information). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Adopted Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532&#160;Disclosure Update and&#160;Simplification, to eliminate or modify certain disclosure rules that are redundant, outdated, or duplicative of GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of stockholders' equity are expanded for interim financial statements. An analysis of the changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement.  The Company has provided this disclosure beginning in the first quarter of 2019.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sd8a4773c250842fc93c608e6d984027d"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3. Revenue from Contracts with Customers </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#ff0000;"></font><font style="font-family:inherit;font-size:10pt;">The Company generates substantially all of its revenue from sales of prescription pharmaceutical products to its customers.  The following table presents net revenues disaggregated by type (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.07407407407408%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prescribed dietary supplements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prescription drugs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,620</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,029</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales force revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,411</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,483</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;10</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the pharmaceutical industry, the Company sells its prescription pharmaceutical products (which include prescribed dietary supplements and prescription drugs) in the United States primarily through wholesale distributors and a specialty contracted pharmacy.  Wholesale distributors account for substantially all of the Company&#8217;s net product revenues and trade receivables. In addition, the Company earns revenue from sales of its prescription pharmaceutical products directly to retail pharmacies. &#160;&#160;For the three months ended March 31, 2019, the Company&#8217;s three largest customers accounted for approximately </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">33%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of the Company's total net product revenues from sale of prescription pharmaceutical products. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s10E932CB30D655A19F0B6FD2FB1DE0B9"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4. Net Loss Per Share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The Company computes earnings per sh</font><font style="font-family:inherit;font-size:10pt;">are ("EPS") using the two-class method.  The two-class method of computing EPS is an earnings allocation formula that determines EPS for common stock and any participating securities according to dividends declared and participation rights in undistributed earnings.  The Company has two classes of stock outstanding, common stock and preferred stock.  The preferred stock was issued in the fourth quarter of 2018 upon Armistice exercising preferred stock warrants to acquire an aggregate of </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the Series B Convertible Preferred Stock ("convertible preferred stock").  The convertible preferred stock has the same rights and preferences as common stock other than being non-voting and convertible to shares of common stock on a 1-to-</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">&#32;ratio.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the two-class method, the convertible preferred stock is considered a separate class of stock for EPS purposes and therefore basic and diluted EPS is provided below for both common stock and preferred stock.  EPS for common stock and EPS for preferred stock is computed by dividing the sum of distributed earnings and undistributed earnings for each class of stock by the weighted average number of shares outstanding for each class of stock for the period.  In applying the two-class method, undistributed earnings are allocated to common stock and preferred stock based on the weighted average shares outstanding during the period, which assumes the convertible preferred stock has been converted to common stock.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Diluted net (loss) income per share includes the potential dilutive effect of common stock equivalents as if such securities were converted or exercised during the period, when the effect is dilutive.  Common stock equivalents include: (i) outstanding stock options and restricted stock units, which are included under the "treasury stock method" when dilutive, (ii) common stock to be issued upon the assumed conversion of the Company's unit purchase option shares, which are included under the "if-converted method" when dilutive; (iii) prior to issuance, the contingently issuable shares in the TRx acquisition, if contingencies would have been satisfied if the end of the contingency period were as of the balance sheet date under the "if-converted method" when dilutive; and (iv) common stock to be issued upon the exercise of outstanding warrants, which are included under the "treasury stock method" when dilutive.  Because the impact of these items is generally anti-dilutive during periods of net loss, there is no difference between basic and diluted loss per common share for periods with net losses.  </font><font style="font-family:inherit;font-size:10pt;">In periods of net loss, losses are allocated</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">to the participating security only if the security has not only the right to participate in earnings, but also a contractual obligation to share in the Company's losses.</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted net loss per share of common stock and preferred stock for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, which includes both classes of participating securities:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.25925925925925%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Preferred stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Preferred stock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net&#160;loss&#160;per&#160;share,&#160;basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator: </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allocation of undistributed net loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,537,787</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,916,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,882,847</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,284,168</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,857,143</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,316,246</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and diluted net loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.13</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.67</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following outstanding securities at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;have been excluded from the computation of diluted weighted shares outstanding, as they could have been anti-dilutive:&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;11</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:70%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,345,305</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,909,384</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrants on common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,024,708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,986,659</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Underwriters' unit purchase option</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sD59449C4CDA657F2AC9400BDCF73449B"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5. Acquisitions </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Ichorion Asset Acquisition </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September&#160;24, 2018, the Company entered into, and subsequently consummated the transactions contemplated by, an agreement and plan of merger (the "Merger Agreement") by and among the Company and&#160;Ichorion Therapeutics,&#160;Inc., a Delaware corporation (the &#8220;Ichorion Asset Acquisition&#8221;), with Ichorion surviving as a wholly owned subsidiary of the Company.&#160; The consideration for the Ichorion Asset Acquisition consisted of approximately&#160;</font><font style="font-family:inherit;font-size:10pt;">5.8 million</font><font style="font-family:inherit;font-size:10pt;">&#160;shares of the Company&#8217;s common stock, par value&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.001</font><font style="font-family:inherit;font-size:10pt;">&#160;per share, as adjusted for Estimated Working Capital as defined in the Merger Agreement.&#160; The shares of common stock issued as part of the acquisition may not be resold until January 2020.  Consideration for the Ichorion Asset Acquisition includes certain development milestones worth up to an additional&#160;</font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;">, payable either in shares of the Company's common stock or in cash, at the election of the Company.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the common stock shares transferred at closing was approximately&#160;</font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;">&#160;based on the Company's stock price close on September 24, 2018 and offset by an estimated discount for lack of marketability calculated using guideline public company volatility for comparable companies. The assets acquired consisted primarily of&#160;</font><font style="font-family:inherit;font-size:10pt;">$18.7 million</font><font style="font-family:inherit;font-size:10pt;">&#160;of IPR&amp;D,&#160;</font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of cash and&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#160;assembled workforce. The Company recorded this transaction as an asset purchase as opposed to a business combination as management concluded that substantially all of the value received was related to one group of similar identifiable assets, which was the IPR&amp;D for the&#160;</font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#160;preclinical therapies for inherited metabolic disorders known as CDGs (CERC-801, CERC-802, and CERC-803). The Company has considered these assets similar due to similarities in the risks for development, compound type, stage of development, regulatory pathway, patient population and economics of commercialization.&#160; The fair value of the IPR&amp;D was immediately recognized as Acquired In-Process Research and Development expense as the IPR&amp;D asset has no other alternate use due to the stage of development.&#160; The&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.2</font><font style="font-family:inherit;font-size:10pt;">&#32;million&#160;of transaction costs incurred were recorded to acquired IPR&amp;D expense. The assembled workforce asset recorded to intangible assets will be amortized over an estimated useful life of&#160;</font><font style="font-family:inherit;font-size:10pt;">two years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contingent consideration of up to an additional </font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;">&#32;relates to </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;future development milestones.  The first milestone is the first product being approved for marketing by the FDA on or prior to December 31, 2021.  If this milestone is met, the Company is required to make a milestone payment of </font><font style="font-family:inherit;font-size:10pt;">$6 million</font><font style="font-family:inherit;font-size:10pt;">.  The second milestone is the second product being approved for marketing by the FDA on or prior to December 31, 2021.  If this milestone is met, the Company is required to make a milestone payment of </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;">.  The third milestone is a protide molecule being approved by the FDA on or prior to December 31, 2023.  If this milestone is met, the Company is required to make a milestone payment of </font><font style="font-family:inherit;font-size:10pt;">$4 million</font><font style="font-family:inherit;font-size:10pt;">.  All milestones are payable in either shares of the Company's common stock or cash, at the election of the Company. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contingent consideration related to the development milestones will be recognized if and when such milestones are probable and can be reasonably estimated.  As of March 31, 2019, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;contingent consideration related to the development milestone has been recognized.  The Company will continue to monitor the development milestones at each reporting period. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Avadel Pediatric Products Acquisition</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2018, the Company entered into an Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Avadel US Holdings, Inc., Avadel Pharmaceuticals (USA), Inc., Avadel Pediatrics, Inc., Avadel Therapeutics, LLC and Avadel Pharmaceuticals PLC (collectively, the &#8220;Sellers&#8221;) to purchase and acquire all rights to the Sellers&#8217; pediatric products. Total consideration transferred to the Sellers consisted of: (1) a cash payment of&#160;</font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;dollar, (2) the Company's assumption of existing seller debt due in January 2021 with a fair value of&#160;</font><font style="font-family:inherit;font-size:10pt;">$15.1 million</font><font style="font-family:inherit;font-size:10pt;">,&#160;and (3) contingent consideration relating to royalty obligations through February 2026 with a fair value at acquisition date of approximately&#160;</font><font style="font-family:inherit;font-size:10pt;">$7.9 million</font><font style="font-family:inherit;font-size:10pt;">. As a result of the Avadel pediatric products acquisition, the Company recorded goodwill of&#160;</font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;">, which is deductible over&#160;</font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">&#32;years for income tax purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The transaction was accounted for as a business combination under the acquisition method of accounting. Accordingly, the tangible and identifiable intangible assets acquired and liabilities assumed were recorded at fair value as of the date of acquisition, </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;12</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">with the remaining purchase price recorded as goodwill. The goodwill recognized is attributable primarily to strategic opportunities related to an expanded commercial footprint and diversified pediatric product portfolio that is expected to provide revenue and cost synergies. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the second quarter of 2018, the Company identified and recorded measurement period adjustments to the preliminary purchase price allocation. These adjustments are reflected in the tables below. The measurement period adjustments were the result of additional analysis performed and information identified during the second quarter of 2018 based on facts and circumstances that existed as of the purchase date. There were no additional measurement adjustments recorded in 2018.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition and as adjusted for measurement period adjustments identified during the second quarter of 2018: &#160; &#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (as adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,549,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,831,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">718,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">570,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">570,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,453,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,838,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,291,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(362,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(362,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of debt assumed</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,272,303</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197,303</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,075,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,875,165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44,835</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,920,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net liabilities assumed</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,145,468</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367,468</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,778,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consideration exchanged</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(240,999</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,386,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(608,467</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,778,001</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price allocation related to the acquisition of Avadel's pediatric products was finalized in 2018.  The fair values of intangible assets, including marketing rights, licenses, and developed technology, were determined using variations of the income approach. Varying discount rates were also applied to the projected net cash flows. The Company believes the assumptions are representative of those a market participant would use in estimating fair value.  The fair value of intangible assets, both as of the date of acquisition and as adjusted by measurement period adjustments identified during the second quarter of 2018, includes the following: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:39%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:14%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (as adjusted)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Product Marketing Rights - Karbinal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,221,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,200,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Product Marketing Rights - AcipHex</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,520,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">283,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,803,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Product Marketing Rights - Cefaclor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,291,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,320,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,611,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Developed Technology - Flexichamber</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,131,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,677,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired IPR&amp;D - LiquiTime formulations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">290,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(290,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indefinite</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,453,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,838,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,291,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">TRx Acquisition&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 17, 2017, the Company entered into, and consummated the transactions contemplated by, an equity interest purchase agreement (the &#8220;TRx Purchase Agreement&#8221;) by and among the Company, TRx, Fremantle Corporation, and LRS International LLC, the selling members of TRx (collectively, the &#8220;TRx Sellers&#8221;), which provided for the purchase of all of the equity and ownership interests of TRx by the Company (the "TRx Acquisition").  The consideration for the TRx Acquisition consisted of </font><font style="font-family:inherit;font-size:10pt;">$18.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash, </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;13</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">as adjusted for estimated working capital, estimated cash on hand, estimated indebtedness and estimated transaction expenses, as well as </font><font style="font-family:inherit;font-size:10pt;">7,534,884</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the Company&#8217;s common stock having an aggregate value on the closing date of </font><font style="font-family:inherit;font-size:10pt;">$8.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(the "Equity Consideration") and certain potential contingent payments.  Upon closing, the Company issued </font><font style="font-family:inherit;font-size:10pt;">5,184,920</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of its common stock to the TRx Sellers.&#160; Pursuant to the TRx Purchase Agreement, the issuance of the remaining </font><font style="font-family:inherit;font-size:10pt;">2,349,968</font><font style="font-family:inherit;font-size:10pt;">&#32;shares was subject to the Company's stockholder approval.  In May 2018, stockholder approval was obtained and the remaining shares were issued to the TRx Sellers.  The contingent shares were initially recorded to contingently issuable shares, which is recorded within stockholder's equity and were reclassed to common stock and additional paid in capital upon issuance, on the consolidating balance sheet date. As a result of the TRx Acquisition, the Company has currently recorded goodwill of </font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was deductible for income taxes. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the third quarter of 2018, the Company identified and recorded measurement period adjustments to our preliminary purchase price allocation that was disclosed in prior periods. These adjustments are reflected in the tables below. The measurement period adjustments were the result of an arbitration ruling discussed in further detail in Note 13, the facts and circumstances of which existed as of the acquisition date.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary acquisition-date fair value of the consideration transferred at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2017 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17, 2017 (as adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,900,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,900,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock (including contingently issuable shares)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,514,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,514,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,576,633</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,366,633</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total consideration transferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,991,052</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,781,052</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The TRx Acquisition was accounted for as a business combination under the acquisition method of accounting. Accordingly, the tangible and identifiable intangible assets acquired and liabilities assumed were recorded at fair value as of the date of acquisition, with the remaining purchase price recorded as goodwill. The goodwill recognized is attributable primarily to strategic opportunities related to leveraging TRx&#8217;s research and development, intellectual property, and processes.  </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;14</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2017 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17, 2017 (as adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,068</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,068</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,872,545</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,872,545</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,281</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,281</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other receivables</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,764,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,764,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable Intangible Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Metafolin</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,465,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,987,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PAI sales and marketing agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,334,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,553,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Millipred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,714,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,056,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Ulesfia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">555,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(555,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets acquired</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,581,671</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,292,515</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,874,186</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of liabilities assumed:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192,706</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192,706</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,850,422</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,764,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,614,937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">839,773</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,840</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">918,613</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities assumed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,882,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,843,355</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,726,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,698,770</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449,160</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,147,930</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of consideration transferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,991,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,781,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,292,282</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,659,160</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,633,122</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price allocation related to the acquisition of TRx was finalized in 2018.  The fair values of intangible assets, including marketing rights, licenses and developed technology, were determined using variations of the income approach, specifically the multi-period excess earnings method. Varying discount rates were also applied to the projected net cash flows. The Company believes the assumptions are representative of those a market participant would use in estimating fair value. The final fair value of intangible assets both as disclosed in prior periods and as adjusted by measurement period adjustments identified during the third quarter of 2018 includes the following: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:39%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:14%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17,<br>2017 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17, 2017 (as adjusted)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Metafolin</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,465,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,987,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PAI sales and marketing agreement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,334,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,553,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Millipred</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,714,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,056,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Ulesfia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">555,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(555,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,068,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,528,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,596,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company received written notice to terminate the PAI sales and marketing agreement in the second quarter of 2018.  As a result, the Company reassessed the fair value of the PAI sales and marketing agreement on that date (a level III non-recurring fair value measurement) and concluded due to the absence of future cash flows beyond the date of termination that the fair value was </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;">.  An </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;15</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">impairment charge was recognized in the second quarter of 2018 in the amount of </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;">, representing the remaining net book value of the PAI sales and marketing agreement intangible asset. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Pro Forma Impact of Business Combinations</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following supplemental unaudited pro forma information presents Cerecor&#8217;s financial results as if the acquisition of the Avadel pediatric products, which was completed on February 16, 2018, had occurred on January 1, 2018:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.48148148148148%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,187,775</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,928,446</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Basic and diluted net loss per share of common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Basic and diluted net loss per share of preferred stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The above unaudited pro forma information was determined based on the historical GAAP results of Cerecor and Avadel's pediatric products.  The unaudited pro forma consolidated results are provided for informational purposes only and are not necessarily indicative of what Cerecor&#8217;s consolidated results of operations would have been had the acquisition of Avadel's pediatric products been completed on the date indicated or what the consolidated results of operations will be in the future.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="sFEAD9862329C5D92A9D9C46D59102169"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6. Fair Value Measurements </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC No. 820, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;">&#32;(&#8220;ASC 820&#8221;), defines fair value as the price that would be received to sell an asset, or paid to transfer a liability, in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value standard also establishes a three&#8209;level hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level&#160;1&#8212;inputs to the valuation methodology are quoted prices (unadjusted) for an identical asset or liability in an active market.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level&#160;2&#8212;inputs to the valuation methodology include quoted prices for a similar asset or liability in an active market or model&#8209;derived valuations in which all significant inputs are observable for substantially the full term of the asset or liability.&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level&#160;3&#8212;inputs to the valuation methodology are unobservable and significant to the fair value measurement of the asset or liability.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents, for each of the fair value hierarchy levels required under ASC 820, the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis:</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;16</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:55%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;prices&#160;in</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant&#160;other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">active&#160;markets&#160;for</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">observable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">unobservable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">identical&#160;assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in money market funds*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,965,626</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,002,288</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrant liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unit purchase option liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,993</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:55%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;prices&#160;in</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant&#160;other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">active&#160;markets&#160;for</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">observable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">unobservable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">identical&#160;assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in money market funds*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,324,932</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,050,564</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrant liability**</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,950</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unit purchase option liability**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,216</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Investments in money market funds are reflected in cash and cash equivalents on the accompanying condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**Warrant liability and unit purchase option liability are reflected in accrued expenses and other current liabilities on the accompanying condensed consolidated balance sheets. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of  </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s financial instruments included cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses and other current liabilities, short term and long-term debt, warrant liability, the underwriters' unit purchase option liability, and contingent consideration.  The carrying amounts reported in the accompanying condensed consolidated financial statements for cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses, and other current liabilities approximate their respective fair values because of the short-term nature of these accounts. The estimated fair value of the Company&#8217;s long-term debt of </font><font style="font-family:inherit;font-size:10pt;">$14.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of March 31, 2019 was based on current interest rates for similar types of borrowings and is in Level 2 of the fair value hierarchy.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Level&#160;3 Valuation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">The tables presented below are a summary of changes in the fair value of the Company&#8217;s Level&#160;3 valuations for the warrant liability, unit purchase option liability, and contingent consideration for the three months ended March 31, 2019 and 2018:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.62962962962963%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Warrant</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unit purchase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">option&#160;liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,950</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,216</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,050,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,060,730</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228,678</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228,678</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227,979</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,750</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,993</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,002,288</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,060,031</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;17</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.07407407407408%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Warrant liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unit purchase option liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Royalty Obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,991</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,576,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,611,809</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance of contingent consideration and royalty</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,875,165</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">240,744</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,115,909</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,846</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286,020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,590</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,837</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,651,081</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">304,230</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,013,738</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2014, the Company issued warrants to purchase </font><font style="font-family:inherit;font-size:10pt;">625,208</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of convertible preferred stock. Upon the closing of our initial public offering ("IPO") in October 2015 these warrants became warrants to purchase </font><font style="font-family:inherit;font-size:10pt;">22,328</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock, in accordance with their terms.   The warrants expire in October 2020. The warrants represent a freestanding financial instrument that is indexed to an obligation, which the Company refers to as the warrant liability.  The warrant liability is marked-to-market each reporting period with the change in fair value recorded to other income, net in the accompanying statements of operations until the warrants are exercised, expire or other facts and circumstances lead the warrant liability to be reclassified to stockholders&#8217; equity. The fair value of the warrant liability is estimated using a Black-Scholes option-pricing model. The significant assumptions used in preparing the option pricing model for valuing the warrant liability as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, include (i)&#160;volatility of </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">, (ii)&#160;risk free interest rate of </font><font style="font-family:inherit;font-size:10pt;">2.33%</font><font style="font-family:inherit;font-size:10pt;">, (iii)&#160;strike price </font><font style="font-family:inherit;font-size:10pt;">$8.40</font><font style="font-family:inherit;font-size:10pt;">, (iv)&#160;fair value of common stock </font><font style="font-family:inherit;font-size:10pt;">$5.84</font><font style="font-family:inherit;font-size:10pt;">, and (v)&#160;expected life of </font><font style="font-family:inherit;font-size:10pt;">1.60 years</font><font style="font-family:inherit;font-size:10pt;">&#160;years.</font></div><div style="line-height:120%;text-align:justify;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The underwriters&#8217; unit purchase option (the &#8220;UPO&#8221;) was issued to the underwriters of the Company's IPO in 2015 and provides the underwriters the option to purchase up to a total of </font><font style="font-family:inherit;font-size:10pt;">40,000</font><font style="font-family:inherit;font-size:10pt;">&#32;units. The units underlying the UPO will be, immediately upon exercise, separated into shares of common stock, underwriters&#8217; Class A warrants, and underwriters&#8217; Class B warrants (such warrants together referred to as the Underwriters&#8217; Warrants).  The Underwriters&#8217; Warrants were warrants to purchase shares of common stock.  The Class B warrants expired in April 2017 and the Class A warrants expired in October 2018, while the UPO expires in October 2020. The Company classifies the UPO as a liability, as it is a freestanding marked-to-market derivative instrument that is precluded from being classified in stockholders&#8217; equity.  The UPO liability is marked-to-market each reporting period with the change in fair value recorded to other income, net in the accompanying statements of operations until the UPO is exercised, expires or other facts and circumstances lead the UPO to be reclassified to stockholders&#8217; equity. The fair value of the UPO liability is estimated using a Black-Scholes option-pricing model. The significant assumptions used in preparing the simulation model for valuing the UPO as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, include (i)&#160;volatility of </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">, (ii)&#160;risk free interest rate of </font><font style="font-family:inherit;font-size:10pt;">2.33%</font><font style="font-family:inherit;font-size:10pt;">, (iii)&#160;unit strike price </font><font style="font-family:inherit;font-size:10pt;">$7.47</font><font style="font-family:inherit;font-size:10pt;">, (iv) fair value of underlying equity </font><font style="font-family:inherit;font-size:10pt;">$5.84</font><font style="font-family:inherit;font-size:10pt;">, and (v)&#160;expected life of </font><font style="font-family:inherit;font-size:10pt;">1.6 years</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's business acquisitions of Avadel's pediatric products and TRx (see Note 5) involve the potential for future payment of consideration that is contingent upon the achievement of operation and commercial milestones and royalty payments on future product sales.  The fair value of contingent consideration was determined at the acquisition date utilizing unobservable inputs such as the estimated amount and timing of projected cash flows, the probability of success (achievement of the contingent event), and the risk-adjusted discount rate used to present value the probability-weighted cash flows.  Subsequent to the acquisition date, at each reporting period, the contingent consideration liabilities are remeasured at the current fair value with changes recorded in the condensed consolidated statement of operations.    </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the acquisition of Avadel's pediatric products, the Company will pay a </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">&#32;annual royalty on net sales of the acquired Avadel pediatric products through February 2026, up to an aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;">.  The fair value of the future royalty is the expected future value of the contingent payments discounted to a present value.  The estimated fair value of the royalty payments as of March 31, 2019 was </font><font style="font-family:inherit;font-size:10pt;">$7.7 million</font><font style="font-family:inherit;font-size:10pt;">.  The significant assumptions used in estimating the fair value of the royalty payment as of March 31, 2019 include (i) the expected net sales of the acquired Avadel pediatric products for that are subject to the </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">&#32;royalty based on the Company's net sales forecast and (ii) the risk-adjusted discount rate of  </font><font style="font-family:inherit;font-size:10pt;">8.4%</font><font style="font-family:inherit;font-size:10pt;">, which is comprised of the risk-free interest rate of </font><font style="font-family:inherit;font-size:10pt;">2.3%</font><font style="font-family:inherit;font-size:10pt;">&#32;and a counterparty risk of </font><font style="font-family:inherit;font-size:10pt;">6.1%</font><font style="font-family:inherit;font-size:10pt;">&#32;utilized to discount the expected royalty payments.  The liability is reduced by periodic payments. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, as part of the initial purchase price allocation for the acquisition of Avadel's pediatric products performed during the first quarter of 2018, contingent consideration of </font><font style="font-family:inherit;font-size:10pt;">$240,744</font><font style="font-family:inherit;font-size:10pt;">&#32;was assigned to future royalty obligations for the use of the Sellers' LiquiTime process technology.  In the second quarter of 2018, we identified measurement period adjustments which included the adjustment of the fair value of the LiquiTime intangible asset down to </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consideration for the TRx acquisition includes certain potential contingent payments.  First, pursuant to the TRx Purchase Agreement, the Company would have been required to pay </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to the Sellers if the gross profit related to TRx products equaled or exceeded </font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in 2018.  The Company did not achieve this contingent event in 2018 and therefore </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;value was assigned to the contingent payout as of December 31, 2018.  Additionally, the Company is required to pay </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;upon the transfer of the Ulesfia </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;18</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NDA to the Company ("NDA Transfer Milestone").  Finally, the Company will pay </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;upon FDA approval of a new dosage of Ulesfia ("FDA Approval Milestone").  The main inputs utilized to determine the fair value of each milestone is the probability of the milestone's success, the expected time to successfully reach the milestone, and the risk-adjusted discount rate.  The estimated fair value of the NDA Transfer Milestone as of March 31, 2019 was </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and the significant assumptions used in estimating the fair value include (i) probability of milestone success of </font><font style="font-family:inherit;font-size:10pt;">45.0%</font><font style="font-family:inherit;font-size:10pt;">, (ii) expected time to milestone of </font><font style="font-family:inherit;font-size:10pt;">0.2 years</font><font style="font-family:inherit;font-size:10pt;">, and (iii) risk-adjusted discount rate of  </font><font style="font-family:inherit;font-size:10pt;">8.5%</font><font style="font-family:inherit;font-size:10pt;">, which is comprised of the risk-free rate of </font><font style="font-family:inherit;font-size:10pt;">2.4%</font><font style="font-family:inherit;font-size:10pt;">&#32;and a counterparty risk of </font><font style="font-family:inherit;font-size:10pt;">6.1%</font><font style="font-family:inherit;font-size:10pt;">.  The estimated fair value of the FDA Approval Milestone as of March 31, 2019 was </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">.  The significant assumptions used in estimating the fair value of the FDA Approval Milestone as of March 31, 2019 include (i) probability of milestone success at </font><font style="font-family:inherit;font-size:10pt;">22.5%</font><font style="font-family:inherit;font-size:10pt;">, (ii) expected time to milestone of </font><font style="font-family:inherit;font-size:10pt;">1.3 years</font><font style="font-family:inherit;font-size:10pt;">, and (iii) risk-adjusted discount rate of </font><font style="font-family:inherit;font-size:10pt;">8.4%</font><font style="font-family:inherit;font-size:10pt;">, which is comprised of the risk-free rate of </font><font style="font-family:inherit;font-size:10pt;">2.3%</font><font style="font-family:inherit;font-size:10pt;">&#32;and a counterparty risk of </font><font style="font-family:inherit;font-size:10pt;">6.1%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;">&#32;other changes in valuation techniques or inputs occurred during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;">&#32;transfers of assets between Level&#160;1 and Level&#160;2 of the fair value measurement hierarchy occurred during the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s79B8FE429C7D5119ACA9C1FD01C006CC"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">7. Accrued Expenses and Other Current Liabilities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities as of March 31, 2019 and December 31, 2018 consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.07407407407408%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales returns and allowances</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,249,977</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,972,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicaid rebates</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,758,384</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,237,269</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum sales commitments, royalties payable, and purchase obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,808,083</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,662,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation and benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,679,572</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,953,065</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,123,051</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278,132</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">938,437</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,112,378</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187,465</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235,721</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,128</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279,397</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accrued expenses and other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,815,097</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,731,373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s78D980963A7B511BB20F020A8F4F4589"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8. Deerfield Obligation </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In relation to the Company's acquisition of Avadel's pediatric products on February 16, 2018, the Company assumed an obligation that Avadel had to Deerfield CSF (the "Deerfield Obligation").  Beginning in July 2018 through October 2020, the Company is required to pay a quarterly payment of&#160;</font><font style="font-family:inherit;font-size:10pt;">$262,500</font><font style="font-family:inherit;font-size:10pt;">&#160;to Deerfield. In January 2021, a balloon payment of&#160;</font><font style="font-family:inherit;font-size:10pt;">$15,250,000</font><font style="font-family:inherit;font-size:10pt;">&#160;is due.  The difference between the gross value and fair value of these payments will be recorded as interest expense in the Company's condensed consolidated statements of operations through January 2021 using the effective interest method.  Interest expense for the three months ended March 31, 2019 was </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and is included in interest expense, net on the accompanying condensed consolidated statements of operations. The amounts due within the next year are included in current portion of long-term debt on the Company's condensed consolidated balance sheets.  The amounts due in greater than one year are included in long-term debt, net of current portion, on the Company's condensed consolidated balance sheets.  The Deerfield Obligation was </font><font style="font-family:inherit;font-size:10pt;">$15.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of March 31, 2019, of which </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;is recorded as a current liability. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4B1CA939EBAF5A62B1B38F7A2ACA7EFF"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9. Capital Structure </font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">According to the Company's amended and restated certificate of incorporation, the Company is authorized to issue </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;classes of stock, common stock and preferred stock.  At March 31, 2019, the total number of shares of capital stock the Company was authorized to issue was </font><font style="font-family:inherit;font-size:10pt;">205,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;of which </font><font style="font-family:inherit;font-size:10pt;">200,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;was common stock and </font><font style="font-family:inherit;font-size:10pt;">5,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;was</font><font style="font-family:inherit;font-size:10pt;color:#ee2724;">&#32;</font><font style="font-family:inherit;font-size:10pt;">preferred stock.  All shares of common and</font><font style="font-family:inherit;font-size:10pt;color:#ee2724;">&#32;</font><font style="font-family:inherit;font-size:10pt;">preferred stock have a par value of </font><font style="font-family:inherit;font-size:10pt;">$0.001</font><font style="font-family:inherit;font-size:10pt;">&#32;per share. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 26, 2018, the Company filed a Certificate of Designation of Preferences of Series B Non-Voting Convertible Preferred Stock ("Series B Convertible Preferred Stock" or "convertible preferred stock") of Cerecor Inc. (the &#8220;Certificate of Designation of the Series B Preferred Stock&#8221;) classifying and designating the rights, preferences and privileges of the Series B Convertible Preferred Stock.  The Certificate of Designation of the Series B Convertible Preferred Stock authorized </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of convertible preferred stock.  The Series B Convertible Preferred Stock converts to shares of common stock on a 1-for-</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">&#32;ratio and has the same rights, preferences, and privileges as common stock other than it holds no voting rights.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;19</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Preferred Stock </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">December 2018 Armistice Private Placement</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 27, 2018, the Company entered into a series of transactions as part of a private placement with Armistice in order to generate cash to continue to develop our pipeline assets and for general corporate purposes.  The transactions are considered one transaction for accounting purposes.  As part of the transaction, the Company exchanged common stock warrants issued on April 27, 2017 to Armistice for the  purchase up to </font><font style="font-family:inherit;font-size:10pt;">14,285,714</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the Company&#8217;s common stock at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$0.40</font><font style="font-family:inherit;font-size:10pt;">&#32;per share (the "original warrants") for like-kind warrants to purchase up to </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the Company's newly designated Series B Convertible Preferred Stock with an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$2.00</font><font style="font-family:inherit;font-size:10pt;">&#32;per share (the "exchanged warrants").  Armistice immediately exercised the exchanged warrants and acquired an aggregate of </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the convertible preferred stock.  Net proceeds of the transaction were approximately </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended December 31, 2018. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In order to provide Armistice an incentive to exercise the exchanged warrants, the Company also entered into a securities purchase agreement with Armistice pursuant to which the Company issued warrants for </font><font style="font-family:inherit;font-size:10pt;">4,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock of the Company with a term of </font><font style="font-family:inherit;font-size:10pt;">5.5 years</font><font style="font-family:inherit;font-size:10pt;">&#32;and an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$12.50</font><font style="font-family:inherit;font-size:10pt;">&#32;per share (the "incentive warrants").  For accounting purposes, the Company calculated the fair value of the incentive warrants of </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;">, which was considered a deemed distribution to Armistice for the year ended December 31, 2018. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Voting</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the Company's convertible preferred stock are not entitled to vote. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Dividends</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The holders of convertible preferred stock are entitled to receive dividends, if any, as may be declared from time to time by the board of directors out of legally available funds.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidation</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event of the Company&#8217;s liquidation, dissolution or winding up, holders of the Company&#8217;s convertible preferred stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all debts and other liabilities.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rights and Preferences</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each share of convertible preferred stock converts to shares of common stock on a 1-for-</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">&#32;ratio.  There are no other preemptive or subscription rights and there are </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;redemption or sinking fund provisions applicable to the Company&#8217;s common stock.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Common Stock Offering</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 8, 2019, the Company closed on an underwritten public offering of common stock for </font><font style="font-family:inherit;font-size:10pt;">1,818,182</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock of the Company, at a price to the public of </font><font style="font-family:inherit;font-size:10pt;">$5.50</font><font style="font-family:inherit;font-size:10pt;">&#32;per share.  Armistice participated in the offering by purchasing </font><font style="font-family:inherit;font-size:10pt;">363,637</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock of the Company from the underwriter at the public price.  The gross proceeds to the Company, before deducting underwriting discounts and commissions and offering expenses, were approximately </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;">.  The net proceeds were approximately </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">December 2018 Armistice Private Placement</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">As discussed in detail above, on December 27, 2018 the Company exchanged previously outstanding warrants for like-kind warrants for </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the Company's convertible preferred stock with an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$2.00</font><font style="font-family:inherit;font-size:10pt;">&#32;per share.  Armistice immediately exercised these warrants for </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of convertible preferred stock for net proceeds to the Company of </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;">.  The convertible preferred stock converts to common stock on a 1-for-</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">&#32;ratio (or to </font><font style="font-family:inherit;font-size:10pt;">14,285,714</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock in total).  Additionally, on December 27, 2018, in order to provide Armistice an incentive to exercise the exchanged warrants, the Company entered into a securities purchase agreement with Armistice pursuant to which the Company issued warrants for </font><font style="font-family:inherit;font-size:10pt;">4,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;20</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">stock of the Company with a term of </font><font style="font-family:inherit;font-size:10pt;">5.5 years</font><font style="font-family:inherit;font-size:10pt;">&#32;and an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$12.50</font><font style="font-family:inherit;font-size:10pt;">&#32;per share (the "incentive warrants").  See "December 2018 Armistice Private Placement" above for more details. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">August 2018 Armistice Private Placement</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August&#160;17, 2018, the Company entered into a securities purchase agreement with Armistice, pursuant to which the Company sold </font><font style="font-family:inherit;font-size:10pt;">1,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the Company&#8217;s common stock, </font><font style="font-family:inherit;font-size:10pt;">$0.001</font><font style="font-family:inherit;font-size:10pt;">&#32;par value per share for a purchase price of </font><font style="font-family:inherit;font-size:10pt;">$3.91</font><font style="font-family:inherit;font-size:10pt;">&#32;per share, which was the closing price of shares of the Common Stock on August&#160;16, 2018. Net proceeds of this securities purchase agreement were approximately </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Ichorion Asset Acquisition</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 25, 2018, under the terms of the Ichorion Asset Acquisition noted above in Note 5, the Company issued </font><font style="font-family:inherit;font-size:10pt;">5.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;common stock shares upon closing.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingently Issuable Shares</font></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the terms of TRx acquisition noted above in Note 5, the Company was required to issue common stock having an aggregate value as calculated in the TRx Purchase Agreement on the Closing Date of </font><font style="font-family:inherit;font-size:10pt;">$8.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(the &#8220;Equity Consideration&#8221;). &#160;Upon closing, the Company issued </font><font style="font-family:inherit;font-size:10pt;">5,184,920</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of its common stock.&#160; Pursuant to the TRx Purchase Agreement, the issuance of the remaining </font><font style="font-family:inherit;font-size:10pt;">2,349,968</font><font style="font-family:inherit;font-size:10pt;">&#32;shares as a part of the Equity Consideration was subject to stockholder approval at the Company's 2018 Annual Stockholder's Meeting.  This approval was obtained in May 2018 and the remaining shares were issued to the TRx Sellers. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Voting</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock is entitled to </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;vote for each share held of record on all matters submitted to a vote of the stockholders, including the election of directors, and does not have cumulative voting rights. Accordingly, the holders of a majority of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing for election.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Dividends</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The holders of common stock are entitled to receive dividends, if any, as may be declared from time to time by the board of directors out of legally available funds.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidation</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event of the Company&#8217;s liquidation, dissolution or winding up, holders of the Company&#8217;s common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all debts and other liabilities.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rights and Preferences</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the Company&#8217;s common stock have </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;preemptive, conversion or subscription rights, and there are </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;redemption or sinking fund provisions applicable to the Company&#8217;s common stock.</font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock Warrants</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the following common stock warrants were outstanding:&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number&#160;of&#160;shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise&#160;price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Expiration</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">underlying&#160;warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">per&#160;share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">date</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,328*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 2020</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,380*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.68</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 2022</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,000,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 2024</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,024,708</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Accounted for as a liability instrument (see Note 6)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;21</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div><a name="sFED54476DC3756D299BE89F57D64D693"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;10. Stock-Based Compensation </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2016 Equity Incentive Plan</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 5, 2016, the Company&#8217;s board of directors adopted the 2016 Equity Incentive Plan (the &#8220;2016 Plan&#8221;) as the successor to the 2015 Omnibus Plan (the &#8220;2015 Plan&#8221;). The 2016 Plan was approved by the Company&#8217;s stockholders and became effective on May 18, 2016 (the &#8220;2016 Plan Effective Date&#8221;).</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon the 2016 Plan Effective Date, the 2016 Plan reserved and authorized up to </font><font style="font-family:inherit;font-size:10pt;">600,000</font><font style="font-family:inherit;font-size:10pt;">&#32;additional shares of common stock for issuance, as well as </font><font style="font-family:inherit;font-size:10pt;">464,476</font><font style="font-family:inherit;font-size:10pt;">&#32;unallocated shares remaining available for grant of new awards under the 2015 Plan. An Amended and Restated 2016 Equity Incentive Plan (the "2016 Amended Plan") was approved by the Company's stockholders in May 2018, which increased the share reserve by an additional&#160;</font><font style="font-family:inherit;font-size:10pt;">1.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;shares. During the term of the 2016 Amended Plan, the share reserve will automatically increase on the first trading day in January of each calendar year, by an amount equal to </font><font style="font-family:inherit;font-size:10pt;">4%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the total number of outstanding shares of common stock of the Company on the last trading day in December of the prior calendar year. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">2.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;shares available for future issuance under the 2016 Amended Plan.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Option grants to employees and directors typically expire after </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;">&#32;years. Employee options with service based vesting conditions typically vest over </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;or </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;">&#32;years.  Options granted to directors typically vest over </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;years.  Directors may also elect to receive stock options in lieu of cash board compensation, which vest immediately.  For stock options granted to employees and non-employee directors, the estimated grant date fair market value of the Company&#8217;s stock-based awards is amortized ratably over the individuals&#8217; service periods, which is the period in which the awards vest.   Stock-based compensation expense includes expense related to stock options, restricted stock unit awards, and ESPP shares. The amount of stock-based compensation expense recognized for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;was as follows:&#160;</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87.03703703703704%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:70%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,376</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">489,953</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,382</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,364</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,945</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stock-based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">596,693</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock options with service-based vesting conditions</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">The Company has granted awards that contain service-based vesting conditions. The compensation cost for these options is recognized on a straight-line basis over the vesting periods.  A summary of option activity for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.22222222222221%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options&#160;Outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant date fair value of options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average remaining contractual term (in years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,746,597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.79</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,379</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.78</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334,624</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31,288</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,383</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,297</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,845,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.61</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,269,081</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.56</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.76</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&#8217;s common stock for those stock options that had exercise prices lower than the fair value of the Company&#8217;s common stock. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the aggregate intrinsic value of options outstanding and currently exercisable was </font><font style="font-family:inherit;font-size:10pt;">$8.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$4.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The total intrinsic value of options exercised during the three months ended March 31, 2019 was&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">.  The total grant date fair value of shares which vested during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#160;was&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">.  The </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;22</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">per&#8209;share weighted&#8209;average grant date fair value of the options granted during the&#160;</font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;was estimated at&#160;</font><font style="font-family:inherit;font-size:10pt;">$2.49</font><font style="font-family:inherit;font-size:10pt;">. There were&#160;</font><font style="font-family:inherit;font-size:10pt;">302,901</font><font style="font-family:inherit;font-size:10pt;">&#160;options that vested during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;with a weighted average grant date fair value of&#160;</font><font style="font-family:inherit;font-size:10pt;">$2.09</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2019, there was </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of total unrecognized compensation cost related to unvested service-based vesting conditions awards.  The unrecognized compensation cost is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">2.9</font><font style="font-family:inherit;font-size:10pt;">&#32;years. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock options with market-based vesting conditions</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2018,&#160;the Company granted awards that vest upon the Company's common stock closing at or above </font><font style="font-family:inherit;font-size:10pt;">$12.50</font><font style="font-family:inherit;font-size:10pt;">&#32;per share for </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;consecutive days.  A summary of option activity with market-based vesting conditions for the three months ended March 31, 2019 is as follows: </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:85%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options&#160;Outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average remaining contractual term (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate intrinsic value (1)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">800,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) The aggregate intrinsic value in the above table represents the total pre-tax amount that a participant would receive if the option had been exercised on the last day of the respective fiscal period. Options with a market value less than its exercise value are not included in the intrinsic value amount.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2019, there was </font><font style="font-family:inherit;font-size:10pt;">$805,068</font><font style="font-family:inherit;font-size:10pt;">&#32;of total unrecognized compensation cost related to unvested market-based vesting conditions awards. This compensation cost is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">1.8</font><font style="font-family:inherit;font-size:10pt;">&#32;years.</font></div><div style="line-height:120%;text-align:justify;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-based compensation assumptions</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows the assumptions used to compute stock-based compensation expense for stock options with service-based vesting conditions granted to employees and members of the board of directors under the Black-Scholes valuation model for the three months ended March 31, 2019.  There were no stock options granted with market-based vesting conditions for the three months ended March 31, 2019. </font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:65.55555555555556%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:77%;"></td><td style="width:5%;"></td><td style="width:18%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Service-based options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0 - 6.25 </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.23 - 2.59%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Units</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2018, the Company granted restricted stock units ("RSU") to certain employees.  The Company measures the fair value of the restricted units using the stock price at the date of the grant. The restricted shares vest annually over a </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;">-year period beginning on the first anniversary of the award. A summary of RSU grants activity for the three months ended March 31, 2019 is as follows:</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;23</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:69.62962962962963%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">RSUs outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average grant date fair value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested RSUs at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested RSUs at March 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The stock compensation expense related to RSUs for the three months ended March 31, 2019 was&#160;</font><font style="font-family:inherit;font-size:10pt;">$118,656</font><font style="font-family:inherit;font-size:10pt;">. At March 31, 2019, there was&#160;</font><font style="font-family:inherit;font-size:10pt;">$1,433,329</font><font style="font-family:inherit;font-size:10pt;">&#32;of total unrecognized compensation cost related to the RSU grants.  The compensation cost is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">3.0</font><font style="font-family:inherit;font-size:10pt;">&#32;years. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Employee Stock Purchase Plan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 5, 2016, the Company&#8217;s board of directors approved the 2016 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was approved by the Company&#8217;s stockholders and became effective on May 18, 2016 (the &#8220;ESPP Effective Date&#8221;).</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the ESPP, eligible employees can purchase common stock through accumulated payroll deductions at such times as are established by the administrator. The ESPP is administered by the compensation committee of the Company&#8217;s board of directors. Under the ESPP, eligible employees may purchase stock at </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the lower of the fair market value of a share of the Company&#8217;s common stock (i) on the first day of an offering period or (ii) on the purchase date. Eligible employees may contribute up to </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">&#32;of their earnings during the offering period. The Company&#8217;s board of directors may establish a maximum number of shares of the Company&#8217;s common stock that may be purchased by any participant, or all participants in the aggregate, during each offering or offering period. Under the ESPP, a participant may not accrue rights to purchase more than </font><font style="font-family:inherit;font-size:10pt;">$25,000</font><font style="font-family:inherit;font-size:10pt;">&#32;of the fair market value of the Company&#8217;s common stock for each calendar year in which such right is outstanding.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon the ESPP Effective Date, the Company reserved and authorized up to </font><font style="font-family:inherit;font-size:10pt;">500,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock for issuance under the ESPP. On January 1 of each calendar year, the aggregate number of shares that may be issued under the ESPP shall automatically increase by a number equal to the lesser of (i) </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the total number of shares of the Company&#8217;s capital stock outstanding on December 31 of the preceding calendar year, and (ii) </font><font style="font-family:inherit;font-size:10pt;">500,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the Company&#8217;s common stock, or (iii) a number of shares of the Company&#8217;s common stock as determined by the Company&#8217;s board of directors or compensation committee. The number of shares increased by </font><font style="font-family:inherit;font-size:10pt;">408,042</font><font style="font-family:inherit;font-size:10pt;">&#32;on January 1, 2019.  As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1,192,025</font><font style="font-family:inherit;font-size:10pt;">&#32;shares remained available for issuance.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the guidance in ASC 718-50, the ability to purchase shares of the Company&#8217;s common stock at the lower of the offering date price or the purchase date price represents an option and, therefore, the ESPP is a compensatory plan under this guidance. Accordingly, stock-based compensation expense is determined based on the option&#8217;s grant-date fair value and is recognized over the requisite service period of the option. The Company used the Black-Scholes valuation model and recognized stock-based compensation expense of </font><font style="font-family:inherit;font-size:10pt;">$35,298</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, which is included in the table above with stock-based compensation from stock options.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Subsequent Equity Grants</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 1, 2019, the Company granted </font><font style="font-family:inherit;font-size:10pt;">1.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;options with service-based vesting conditions at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$6.22</font><font style="font-family:inherit;font-size:10pt;">&#32;per share to its employees as part of its annual stock option award.  One-quarter of the shares subject to the stock option will vest on the first anniversary of the grant date and the remaining three-quarters of the shares will vest in equal monthly installments over the following </font><font style="font-family:inherit;font-size:10pt;">36 months</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furthermore, on April 15, 2019, the Company granted </font><font style="font-family:inherit;font-size:10pt;">300,000</font><font style="font-family:inherit;font-size:10pt;">&#32;options with service-based vesting conditions at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$5.17</font><font style="font-family:inherit;font-size:10pt;">&#32;to its newly appointed Executive Chairman of the Board.  One-third of the shares subject to the stock option will vest on the first anniversary of the date of grant and the remaining two-thirds of the shares will vest in equal monthly installments over the following </font><font style="font-family:inherit;font-size:10pt;">24 months</font><font style="font-family:inherit;font-size:10pt;">, based on continuous service. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, the Company agreed to grant the Executive Chairman of the Board an option to purchase </font><font style="font-family:inherit;font-size:10pt;">300,000</font><font style="font-family:inherit;font-size:10pt;">&#32;additional shares of Company common stock with market-based vesting conditions.  The exercise price will equal the market value on the date of the grant with one-third of the shares vesting upon the Company's common stock closing at or above </font><font style="font-family:inherit;font-size:10pt;">$8.00</font><font style="font-family:inherit;font-size:10pt;">&#32;per share for </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;consecutive days, one-third of the shares vesting upon the Company's stock closing at or above </font><font style="font-family:inherit;font-size:10pt;">$10.50</font><font style="font-family:inherit;font-size:10pt;">&#32;per share for </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;consecutive days, and one-t</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;24</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">hird of these shares vesting upon the Company's stock closing at or above </font><font style="font-family:inherit;font-size:10pt;">$13.00</font><font style="font-family:inherit;font-size:10pt;">&#32;per share for </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;consecutive days. The Company also agreed to grant the Executive Chairman of the Board </font><font style="font-family:inherit;font-size:10pt;">250,000</font><font style="font-family:inherit;font-size:10pt;">&#32;RSUs, of which </font><font style="font-family:inherit;font-size:10pt;">50,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares will vest immediately on the grant date and the remainder will vest in </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;equal annual increments based on continued service.  These </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;equity awards will be granted upon the Company having an adequate share reserve available for future issuance under the 2016 Amended Plan as a result of either an increase to the total share reserve subject to shareholder approval or as a result of an increase to the existing available share reserve due to future forfeitures and expirations. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s5C6DF3CB06C85E7E8D954C6209CC587D"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11. Income Taxes </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision for income taxes was </font><font style="font-family:inherit;font-size:10pt;">$166,358</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended March 31, 2019 and is comprised of several components including current year state income tax related to one of the Company's wholly owned subsidiaries and current year amortization of tax-deductible goodwill that gives rise to indefinite lived deferred tax liability impacting the amount of valuation allowance required.  Additionally, discrete to the quarter, the Company recorded interest and penalties on the outstanding taxes payable to the IRS and various state authorities.</font></div><div><a name="s90CBC0F627E0558DAE9360BBAB1E8BB6"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12. Leases</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Corporate Headquarter Lease</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">The Company identified </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;operating lease for its corporate headquarters located in Rockville, Maryland.  The annual base rent for the office space is </font><font style="font-family:inherit;font-size:10pt;">$161,671</font><font style="font-family:inherit;font-size:10pt;">, subject to annual </font><font style="font-family:inherit;font-size:10pt;">2.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;increases over the term of the lease.  The lease provides for a rent abatement for a period of </font><font style="font-family:inherit;font-size:10pt;">12 months</font><font style="font-family:inherit;font-size:10pt;">&#32;following the Company's date of occupancy.  The lease has an initial term of </font><font style="font-family:inherit;font-size:10pt;">10 years</font><font style="font-family:inherit;font-size:10pt;">&#32;from the date the Company makes its first annual fixed rent payment, which is expected to occur in January 2020. The Company has the option to extend the lease </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#160;times, each for a period of </font><font style="font-family:inherit;font-size:10pt;">five years</font><font style="font-family:inherit;font-size:10pt;">, and may terminate the lease as of the sixth anniversary of the first annual fixed rent payment, upon the payment of a termination fee.  As of the lease commencement date, it is not reasonably certain that the Company will exercise the renewal periods or early terminate the lease and therefore the end date of the lease for accounting purposes is January 31, 2030.  The remaining term of the lease at March 31, 2019 is </font><font style="font-family:inherit;font-size:10pt;">10.83 years</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplemental balance sheet information related to the lease is as follows: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment, net </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737,658</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,189,277</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The operating lease right-of-use asset is included in property and equipment and the lease liability is included in other long-term liabilities in our condensed consolidated balance sheets.  In order to determine the present value of lease payments, the Company utilized a discount rate of </font><font style="font-family:inherit;font-size:10pt;">7.7%</font><font style="font-family:inherit;font-size:10pt;">.  This rate was determined based on available information of the rate of interest the Company would pay to borrow on a collateralized basis at an amount equal to the lease payments in a similar economic environment over a similar term on the transition date. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of lease expense for the three months ended March 31, 2019 and 2018 were as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,606</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,559</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Includes short-term leases, which are immaterial. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because the corporate headquarter lease provides for a </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;">-month lease abatement, the cash paid for amounts included in the measurement of lease liabilities is </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended March 31, 2019. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows a maturity analysis of the operating lease liability as of March 31, 2019: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;25</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.14814814814815%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:22%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Undiscounted Cash Flows</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 1, 2019 through December 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">155,815</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173,748</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">178,092</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,183,290</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,860,455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less implied interest </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(671,178</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,189,277</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sBFED24B154BB5598A7EB105BB0F42CA7"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13. Commitments and Contingencies </font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Litigation</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is party in various contractual disputes, litigation, and potential claims arising in the ordinary course of business.  The Company does not believe that the resolution of these matters will have a material adverse effect on our financial position or results of operations except as otherwise disclosed in this document. See below for further discussion of the Lachlan legal arbitration.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Purchase obligations</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has unconditional purchase obligations as a result of recent acquisitions that include agreements to purchase goods that are enforceable and legally binding and that specify all significant terms including: fixed or minimum quantities to be purchased; fixed, minimum or variable price provisions; and the approximate timing of the transaction. Purchase obligations exclude agreements that are cancelable at any time without penalty. The unconditional purchase obligations outstanding as of March 31, 2019 include the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lachlan Pharmaceuticals Minimum Obligations and Indemnity Receivable</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As discussed in Note 5, in November 2017, the Company acquired TRx and its wholly-owned subsidiaries, including Zylera.  The previous owners of TRx beneficially own more than </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">&#32;of our outstanding common stock.  Zylera, which is now our wholly owned subsidiary, entered into an agreement with Lachlan Pharmaceuticals, an Irish company controlled by the previous owners of TRx (&#8220;Lachlan&#8221;), effective December 18, 2015 (the "Lachlan Agreement"). Pursuant to the Lachlan Agreement, Lachlan named Zylera as its exclusive distributor of Ulesfia in the United States and agreed to supply Ulesfia to Zylera exclusively for marketing and sale in the United States.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Lachlan Agreement requires Zylera to purchase a minimum of </font><font style="font-family:inherit;font-size:10pt;">20,000</font><font style="font-family:inherit;font-size:10pt;">&#32;units per year, or approximately </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;worth of product, from Lachlan, unless and until there has been a &#8220;Market Change&#8221; involving a new successful competitive product. Zylera must pay Lachlan </font><font style="font-family:inherit;font-size:10pt;">$58.84</font><font style="font-family:inherit;font-size:10pt;">&#32;per unit and handling fees that are equal to </font><font style="font-family:inherit;font-size:10pt;">$4.03</font><font style="font-family:inherit;font-size:10pt;">&#32;per unit of fully packaged Ulesfia in 2019 and escalate at a rate of </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">&#32;annually.  The Lachlan Agreement also requires that Zylera make certain cumulative net sales milestone payments and royalty payments to Lachlan with a </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;annual minimum payment unless and until there has been a &#8220;Market Change&#8221; involving a new successful competitive product.  Lachlan is obligated to pay identical amounts to an unrelated third party from which it obtained rights to Ulesfia, with the payments ultimately flowing to Summers Laboratories, Inc. ("Summers Labs").  Because of the dispute described below, the Company has not made any payments to Lachlan under the Lachlan Agreement subsequent to the acquisition date.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 10, 2016, Zylera informed Lachlan that a Market Change had occurred due to the introduction of Arbor Pharmaceuticals' lice product, Sklice&#174;.&#160; On June 5, 2017, Lachlan and Zylera entered into joint legal representation along with other unrelated third parties in negotiation and arbitration of a dispute with Summers Labs regarding the existence of a Market Change and the concomitant obligations of the parties. The arbitration panel issued an interim ruling on October 23, 2018 that no Market Change had occurred up to and including the date of the hearing.  The arbitration panel issued a second interim ruling on December 26, 2018.  The second interim award rejected Summers Labs' request to accelerate future minimum royalties, however, it ruled in favor of Summers Labs that it is owed reimbursement for all reasonable costs and expenses, including legal fees, by Shionogi, as well as </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;26</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">interest, as stipulated in the contract.  The arbitration panel issued a final award on March 1, 2019 that dictated the final amount of reimbursable costs and interest as contemplated in the second interim ruling.  The final award has no direct bearing on the Company as the Company was not a named defendant to the original claim by Summers Labs and a federal court denied Zylera's ability to be a counterclaimant in the matter.  Furthermore, the Company is not subject to the guarantee or interest provisions identified in the second ruling as these elements of the contractual relationship were not passed down to the Company&#8217;s agreement with Lachlan.  However, the Company has interpreted this ruling's impact on the Lachlan Agreement to mean that the minimum purchase obligation and minimum royalty provisions of the contract are active and due for any prior periods as well as going forward for any future periods.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recognized an&#160;</font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;liability for these minimum obligations in accrued liabilities as of March 31, 2019. Under the terms of the TRx Purchase Agreement, the former TRx owners are required to indemnify the Company for&#160;</font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#160;of all pre-acquisition losses related this arbitration, including legal costs, and possible minimum payments in excess of&#160;</font><font style="font-family:inherit;font-size:10pt;">$1 million</font><font style="font-family:inherit;font-size:10pt;">. Furthermore, the former TRx owners are required to indemnify the Company for&#160;</font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">&#160;of post-acquisition Ulesfia losses, which would include losses resulting from having to fund these minimum obligations. The Company has recorded an indemnity receivable of </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in other receivables as of March 31, 2019, which the Company believes is fully collectible.  For the three months ended March 31, 2019, minimum obligations net of amounts recorded within the indemnity receivable of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#160;has been recorded in cost of product sales.  If the Company fails to make these minimum obligations timely then the Lachlan Agreement may be terminated by Lachlan, in which case the Company would no longer be able to sell the Ulesfia product, but it would also not be subject to future minimum obligations.  Lachlan has not requested payment for the minimum obligations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company expects a successful competitive product will enter the market in early 2021 and therefore the future minimum purchase obligations and royalty payments are expected only through 2020.  As of March 31, 2019, future minimum purchase obligations and future minimum royalty payments to Lachlan are as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q2 2019 - Q4 2019*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2020*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum Purchase Obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">942,994</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,265,378</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,208,372</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum Royalties</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,250,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,250,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,192,994</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,265,378</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,458,372</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Per the TRx Purchase Agreement, the previous owners of TRx are required to indemnify the Company for </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">&#32;of post-acquisition Ulesfia losses, which include the future minimum purchase obligations and future minimum royalties disclosed above. Thus, the Company's future net payouts related to the Ulesfia product should be significantly reduced as a result of the indemnification.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Karbinal Royalty Make-Whole Provision</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As discussed in Note 5, on February 16, 2018, in connection with the acquisition of Avadel's pediatric products, the Company entered into a supply and distribution agreement with TRIS Pharma (the "Karbinal Agreement").  As part of this agreement, the Company has an annual minimum sales commitment, which is based on a commercial year that spans from August 1 through July 31, of </font><font style="font-family:inherit;font-size:10pt;">70,000</font><font style="font-family:inherit;font-size:10pt;">&#32;units through 2033.  The Company is required to pay TRIS a royalty make-whole payment of </font><font style="font-family:inherit;font-size:10pt;">$30</font><font style="font-family:inherit;font-size:10pt;">&#32;for each unit under the </font><font style="font-family:inherit;font-size:10pt;">70,000</font><font style="font-family:inherit;font-size:10pt;">&#32;units annual minimum sales commitment through 2033.  The annual payment is due in August of each year.  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to TRIS in August 2018 related to the make-whole payment for the commercial year ended July 31, 2018.  As of March 31, 2019, the Company has accrued </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in accrued expenses and other current liabilities related to the Karbinal royalty make whole for the commercial year ending July 31, 2019.  For the three months ended March 31, 2019, the make-whole provision of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;has been recorded in cost of product sales.  The future royalty make-whole payments are unknown as the amount owed to TRIS is dependent on the number of units sold.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Possible future milestone proceeds for out-licensed compound</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, the Company sold its worldwide rights to CERC-501 to Janssen Pharmaceuticals, Inc. (&#8220;Janssen&#8221;) in exchange for initial gross proceeds of </font><font style="font-family:inherit;font-size:10pt;">$25 million</font><font style="font-family:inherit;font-size:10pt;">.  There is a potential future </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;">&#32;regulatory milestone payment to the </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;27</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Company. The terms of the agreement provide that Janssen will assume ongoing clinical trials and be responsible for any new development and commercialization of CERC-501. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;28</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s91F11461F91A5BE08668A9F04FF1545C"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></div><div style="line-height:120%;text-align:center;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">This Quarterly Report on Form 10-Q and the information incorporated herein by reference contain forward-looking statements that involve a number of risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements can be identified by the use of forward-looking words such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;plans,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;continue,&#8221; &#8220;seeks,&#8221; &#8220;aims,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; &#8220;pro forma,&#8221; &#8220;anticipates,&#8221; &#8220;potential&#8221; or other similar words (including their use in the negative), or by discussions of future matters such as the development of product candidates or products, technology enhancements, possible changes in legislation, and other statements that are not historical. Although our forward-looking statements reflect the good faith judgment of our management, these statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from results and outcomes discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those below and elsewhere in this Quarterly Report on Form 10-Q, particularly in Part II &#8211; Item 1A, &#8220;Risk Factors,&#8221; as well as in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">March&#160;18, 2019</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, as amended on April 23, 2019 and in our other filings with the SEC. Statements made herein are as of the date of the filing of this Quarterly Report on Form 10-Q with the SEC and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited financial statements and related notes that appear in Item 1 of this Quarterly Report on Form 10-Q and with our audited financial statements and related notes for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;appearing in our Annual Report on Form 10-K filed with the SEC on </font><font style="font-family:inherit;font-size:10pt;">March&#160;18, 2019</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">as amended on April 23, 2019. &#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Overview</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cerecor Inc. (the "Company" or &#8220;Cerecor&#8221;) is a fully integrated biopharmaceutical company with commercial operations and research and development capabilities.  The Company is building a pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases.  The Company's neurology pipeline is led by CERC-301, which recently received positive interim results from the Phase I safety study of Neurogenic Orthostatic Hypotension ("nOH").  The Company is also developing </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;">&#32;other neurological compounds, one of which is in preclinical testing and the other is in clinical ready stage.  The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802, and CERC-803. All </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">&#32;of these compounds are therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation ("CDGs") by means of substrate replacement therapy.  The U.S. Food and Drug Administration ("FDA") has granted Rare Pediatric Disease designation ("RPDD") and Orphan Drug Designation ("ODD") to all </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">&#32;compounds.  Under the FDA&#8217;s Rare Pediatric Disease Priority Review Voucher ("PRV") program, upon the approval of a new drug application ("NDA") for the treatment of a rare pediatric disease, the sponsor of such application would be eligible for a PRV that can be used to obtain priority review for a subsequent new drug application or biologics license application.  The PRV may be sold or transferred an unlimited number of times.  The Company plans to leverage the 505(b)(2) NDA pathway for all </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">&#32;compounds to accelerate development and approval.  The Company is also in the process of developing </font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">&#32;other preclinical pediatric orphan rare disease compound. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also has a diverse portfolio of marketed products.  Our marketed products are led by our prescribed dietary supplements and prescribed drugs.  Our prescribed dietary supplements include Poly-Vi-Flor and Tri-Vi-Flor, which are prescription vitamin and fluoride supplements used in infants and children to treat or prevent deficiency of essential vitamins and fluoride.  The Company also markets a number of prescription drugs that treat a range of pediatric diseases, disorders and conditions.  Cerecor's prescription drugs include Millipred&#174;, Ulesfia&#174;, Karbinal&#8482; ER, AcipHex&#174; Sprinkle&#8482;, and Cefaclor for Oral Suspension. Finally, the Company has </font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">&#32;marketed medical device, Flexichamber&#8482;. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Developments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Executive Leadership Changes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2019, the Company announced changes to its executive leadership team.  Effective April 15, 2019, Dr. Simon Pedder, Ph.D., was appointed Executive Chairman of the Board.  Additionally, Patrick Crutcher was promoted to Chief Strategy Officer.  Peter Greenleaf resigned from his position as Chief Executive Officer role and remains on the Board of Directors.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development Updates </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;29</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2019, the Company received positive interim results from the Phase 1 study of CERC-301 for the treatment of Neurogenic Orthostatic Hypotension in Parkinson&#8217;s disease patients. All doses showed clinically meaningful increases in blood pressure over placebo, within the six-hour post-dose timepoints.  The purpose of the Phase 1 study is to evaluate the single-dose safety, tolerability and pharmacokinetics of CERC-301 in the relevant patient population, as well as explore the effects on blood pressure in nOH patients during an orthostatic challenge at escalating dose levels.   The interim results demonstrate a rapid, robust increase in systolic blood pressure (SBP) from baseline to six hours.  This early and sustained effect could differentiate CERC-301 from existing nOH treatments. Additionally, all doses tested were safe and well tolerated with no serious adverse events reported.  Additionally, in early 2019, a patent was issued for CERC-301, which provides Cerecor with intellectual property rights to CERC-301 until 2035</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The FDA granted ODD to CERC-801, CERC-802, and CERC-803 in early 2019. There are numerous benefits associated with receipt of ODD, which include 7-year marketing exclusivity (upon approval) in the United States, tax credits (up to 25% of clinical development costs) and waiver of Prescription Drug User Fee Act application fees (filing fees). Additionally, CERC-801, CERC-802, and CERC-803 were granted RPDD in 2018.  RPDD provides eligibility for receipt of a PRV upon approval of an NDA.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In early 2019, the Company received a may proceed letter related to an Investigational New Drug ("IND") application previously submitted to the FDA for CERC-801.  Additionally, the FDA designated Fast Track Designation for CERC-801. Fast Track Designation is granted to drugs being developed for the treatment of serious or life-threatening diseases or conditions where there is an unmet medical need. The purpose of the Fast Track Designation provision is to help facilitate development and expedite the review of drugs to treat serious and life-threatening conditions so that an approved product can reach the market expeditiously.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furthermore, in April 2019, the Company announced positive Phase 1 safety data for CERC-801 in healthy volunteers.  The single-center, US-based safety, tolerability and pharmacokinetic study was an open-label, randomized, single-dose, four-way crossover study in 16 healthy adult volunteers. CERC-801 was shown to be safe and well-tolerated at the studied doses, with no serious adverse events. CERC&#8209;801 related adverse events were mild and transient.  Cerecor seeks to leverage existing clinical and nonclinical data in conjunction with sponsor-initiated studies, such as this Phase 1 study, to accelerate development and approval of CERC-801 via the 505(b)(2) pathway.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;"><img src="rdmilestonechart10q1a01.jpg" alt="rdmilestonechart10q1a01.jpg" style="height:322px;width:652px;"></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Financing</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2019, the Company closed on an underwritten public offering of common stock for 1,818,182 shares of common stock of the Company, at a price to the public of $5.50 per share ("public price").  Armistice Capital Master Fund Ltd. ("Armistice"), our largest stockholder, participated in the offering by purchasing 363,637 shares of common stock of the Company from the underwriter at the public price.  Cerecor director Steven J. Boyd is Armistice's Chief Investment Officer.  The gross proceeds to the Company, before deducting underwriting discounts and commissions and offering expenses, were approximately $10.0 million.  The net proceeds were approximately $9.0 million. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;30</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Our Strategy</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our strategy for increasing shareholder value includes: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Advancing our pipeline of compounds through development and to regulatory approval; </font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuing targeted, differentiated preclinical and clinical stage product candidates; </font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquiring or licensing rights to clinically meaningful and differentiated products that are already on the market for pediatric use or in late-stage development for pediatric indications; and</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Growing sales of the existing commercial products in our portfolio, including by identifying and investing in growth opportunities such as new indications and new geographic markets.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Product Pipeline Assets </font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:9px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes key information about our product candidates and further detail regarding each product candidate follows:</font></div><div style="line-height:120%;padding-bottom:9px;text-align:center;"><img src="pipelinechart10q1a01.jpg" alt="pipelinechart10q1a01.jpg" style="height:366px;width:650px;"></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Results of Operations</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Comparison of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Three Months Ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#32;and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2018</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">The following table summarizes our revenue for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales force revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product revenue, net&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;31</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net product revenue increased $1.2 million for the three months ended March 31, 2019 as compared to the same period in 2018.  The increase was due to favorable product mix and unit growth driven by the sales force expansion as well as due to a full quarter of sales of products that were acquired during the prior year quarter.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sales force revenue</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the acquisition of TRx in November 2017, the Company acquired a sales and marketing agreement with Pharmaceutical Associates, Inc. ("PAI") under which the Company received a monthly marketing fee to promote, market and sell certain products on behalf of PAI.  The Company was also entitled to a share of PAI's profits.  For the three months ended March 31, 2018, sales force revenue was </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">.  The PAI contract was canceled during the second quarter of 2018 and therefore there is no sales force revenue for the three months ended March 31, 2019. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of product sales</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of product sales was </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, compared to </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">.  The increase of $1.0 million for the three months ended March 31, 2019 compared to the same period in 2018 is driven by the increase in net product revenue as well as Lachlan Pharmaceuticals' minimum purchase and royalty obligations that arose during the third quarter of 2018 as further discussed in Note 13 to the accompanying unaudited financial statements appearing above.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Research and Development Expenses</font></div><div style="line-height:120%;text-align:justify;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our research and development expenses for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preclinical expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">879</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Clinical expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,590</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CMC expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Internal expenses not allocated to programs:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Salaries, benefits and related costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">240</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,401</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,650</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses increased </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the same period in 2018.  The overall increase is driven by an increase in research and development activities during the current year as the Company continues to develop its pipeline of assets.  Clinical expenses increased </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;primarily due to increased activities related to the CERC-301 clinical study in nOH during the first quarter of 2019 and activities related to CERC-801, CERC-802, and CERC-803, which were acquired as part of the Ichorion Acquisition in September 2018.  Chemistry, Manufacturing, and Controls ("CMC") expenses increased </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended March 31, 2019 compared to the same period in 2018 due to additional spending on manufacturing to support clinical development.  Salaries, benefits, and related costs increased by </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the same period in 2018 due to an increase in headcount and salary-related costs. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">General and Administrative Expenses</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our general and administrative expenses for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">:&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;32</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Salaries, benefits, and related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,230</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">617</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal, consulting, and other professional expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">469</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,717</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,919</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative expenses decreased $0.2 million for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;as compared to the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">.  The overall decrease was driven by a $1.1 million decrease in legal, consulting, and other professional expenses, partially offset by a $0.6 million increase in salaries, benefits, and related costs and a $0.3 million increase in stock-based compensation expense.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal, consulting, and other professional expenses decreased $1.1 million as compared to the same period in 2018 mainly due to a substantial decrease in consulting fees.  The consulting costs incurred in the prior year were related to the integration of the acquisitions of TRx and Avadel's pediatric products.  The Company has since increased corporate headcount and therefore utilizes less consulting services to meet accounting and reporting requirements.  Additionally, $0.4 million of litigation fees incurred in the three months ended March 31, 2018 relate to arbitration and legal costs related to Lachlan Pharmaceuticals (explained further in Note 13 to the accompanying unaudited financial statements appearing above).  Under the terms of the TRx Purchase Agreement, the former TRx owners are required to indemnify the Company for&#160;100%&#160;of all pre-acquisition losses related this arbitration, including legal costs, and possible minimum payments in excess of&#160;$1.0 million.  The $1.0 million threshold was met in the third quarter of 2018 and therefore the minimal legal costs related to Lachlan Pharmaceuticals incurred in the three months ended March 31, 2019 were offset by a corresponding  receivable instead of general and administrative expenses.  Salaries, benefits, and related costs </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;by </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;due to an increase in headcount and salary-related costs.  Stock-based compensation expense increased for the three months ended March 31, 2019 as compared to the same period in 2018 due to equity awards granted to a senior executive who joined the Company in late March 2018. Due to the timing of the grant, minimal expense was recognized for the three months ended March 31, 2018, however a full quarter of expense was recognized for the three months ended March 31, 2019. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sales and Marketing Expenses</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our sales and marketing expenses for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Salaries, benefits, and related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,838</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">952</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Logistics, insurance, and other commercial operations expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Advertising and marketing expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">815</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,109</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,524</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing expenses increased </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended March 31, 2019 as compared to the same period in 2018.  Salaries, benefits and related costs increased </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as a result of increasing sales and sales support personnel needed to maintain and grow our commercial sales activities in connection with the acquisition of TRx and Avadel's pediatric products.  Logistics, insurance, and other commercial operations expenses increased largely due to an increase of FDA fees incurred for the three months ended March 31, 2019.  Advertising and marketing expenses increased </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;due to an increased focus on advertising and marketing initiatives during the current quarter to support the portfolio of pediatric drugs. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amortization Expense</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our amortization expense for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;33</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,079</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense relates to the acquisition of intangible assets as part of the acquisition of TRx in November 2017 and Avadel's pediatric products in February 2018. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Change in fair value of contingent consideration</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognized a loss on the change in fair value of contingent consideration of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended March 31, 2019 as compared to a loss of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the same period in 2018. The contingent consideration is related to the potential for future payment of consideration that is contingent upon the achievement of operation and commercial milestones and royalty payments on future product sales as part of the Company's acquisitions of Avadel's pediatric products and TRx. The fair value of contingent consideration was determined at the acquisition date.  Subsequent to the acquisition date, at each reporting period, the contingent consideration liability is remeasured at the current fair value with changes recorded in operating expenses in the condensed consolidated statement of operations. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other expense, net</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our other expense, net for the three months ended March 31, 2019 and 2018:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of warrant liability and unit purchase option liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (expense) income, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(208</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(265</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(104</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other expense, net increased $0.2 million for the three months ended March 31, 2019 as compared to the same period in 2018, which was primarily driven by a $0.1 million increase in interest expense. The interest expense recognized relates to interest for the Deerfield Obligation, as defined below, assumed as part of the acquisition of Avadel's pediatric products, which took place on February 16, 2018.  Due to the timing of the acquisition, approximately 1.5 months of interest was incurred for the three months ended March 31, 2018 as compared to a full quarter in the current year. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income tax expense</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision for income taxes was $0.2 million for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and includes estimated cash taxes and additionally, discrete to the quarter, interest and penalties on the outstanding taxes payable to the IRS and various state authorities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liquidity, Capital Resources and Expenditure Requirements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In order to meet its cash flow needs, the Company applies a disciplined decision-making methodology as it evaluates the optimal allocation of the Company's resources between investing in the Company's current commercial product line, the Company's development portfolio and acquisitions, or in-licensing of new assets.  For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, Cerecor generated </font><font style="font-family:inherit;font-size:10pt;">a net loss</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">$7.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">negative</font><font style="font-family:inherit;font-size:10pt;">&#32;cash flow from operations of </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;">.  As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, Cerecor had an accumulated deficit of </font><font style="font-family:inherit;font-size:10pt;">$105.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and a balance of </font><font style="font-family:inherit;font-size:10pt;">$16.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash and cash equivalents.  During the first quarter of 2019, the Company closed an underwritten public offering of common stock for </font><font style="font-family:inherit;font-size:10pt;">1,818,182</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock of the Company, at a price to the public of </font><font style="font-family:inherit;font-size:10pt;">$5.50</font><font style="font-family:inherit;font-size:10pt;">&#32;per share ("public price"). Armistice, our largest stockholder, participated in the offering by purchasing </font><font style="font-family:inherit;font-size:10pt;">363,637</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock of the Company from the underwriter at the public price.  Cerecor director Steven J. Boyd is Armistice's Chief Investment Officer.  The net proceeds of the offering were approximately </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(see "Common Stock Offering" in Note 9 below for description of the transaction).  </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;34</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company plans to use cash and the anticipated cash flows from the Company's existing product sales to offset costs related to its neurology programs, pediatric rare disease programs, business development, costs associated with its organizational infrastructure, and debt principal and interest payments.  Cerecor expects to continue to incur significant expenses and operating losses for the immediate future as it continues to invest in the Company's pipeline assets.  Our ability to achieve and maintain profitability in the future is dependent on, among other things, the development, regulatory approval, and commercialization of our new product candidates and achieving a level of revenues from our existing product sales adequate to support our cost structure, which includes significant investment in our pipeline assets. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company believes it will require additional financing to continue to execute its clinical development strategy and fund future operations. The Company plans to meet its capital requirements through operating cash flows from product sales and some combination of equity or debt financings, collaborations, out-licensing arrangements, strategic alliances, federal and private grants, marketing, distribution, or licensing arrangements or the sale of current or future assets.  If the Company is not able to secure adequate additional funding, the Company may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs. If the Company raises additional funds through collaborations, strategic alliances, or licensing arrangements with third parties, the Company may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our plan to aggressively develop our pipeline will require substantial cash inflows in excess of what the Company expects our current commercial operations to generate.&#160; However, the Company expects that our existing cash and cash equivalents, together with anticipated revenue, will enable us to fund our operating expenses, capital expenditure requirements, and other non-operating cash payments, such as fixed quarterly payments on our outstanding debt balances, through at least May 2020. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Uses of Liquidity</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses cash and the anticipated positive net cash flows from the Company's existing product sales to fund research and development expenses related to its neurology and pediatric rare disease pipelines, business development, costs associated with its organizational infrastructure, and debt principal and interest payments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Ichorion Asset Acquisition</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September&#160;24, 2018, the Company entered into a merger agreement in which we acquired Ichorion Therapeutics,&#160;Inc. The consideration for the Ichorion acquisition at closing consisted of 5.8 million shares of the Company&#8217;s Common Stock, par value $0.001 per share, as adjusted for estimated working capital.&#160; The shares are subject to a lockup through December 31, 2019.  Consideration for the Merger included certain development milestones worth up to an additional $15 million, payable either in shares of Company common stock or in cash, at the election of the Company. There will be future cash outflow for research and development costs associated with the development of the assets acquired as part of the Ichorion acquisition (CERC-801, CERC-802, CERC-803 and CERC-913). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deerfield Debt Obligation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">In relation to the Company's acquisition of Avadel's pediatric products on February 16, 2018, the Company assumed an obligation that Avadel had to Deerfield (the "Deerfield Obligation").  Beginning in July 2018 through October 2020, the Company will pay a quarterly payment of $262,500 to Deerfield. In January 2021, a balloon payment of $15,250,000 is due.  The Deerfield Obligation was </font><font style="font-family:inherit;font-size:10pt;">$15.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of March 31, 2019, of which </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;is recorded as a current liability. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash Flows</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes our cash flows for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">:&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;35</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:82.03703703703704%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by (used in):</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investing activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(166</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financing activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,817</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net increase (decrease) in cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,530</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">64</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net cash used in operating activities</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash </font><font style="font-family:inherit;font-size:10pt;">used in</font><font style="font-family:inherit;font-size:10pt;">&#32;operating activities was </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and consisted primarily of </font><font style="font-family:inherit;font-size:10pt;">a net loss</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">$7.5 million</font><font style="font-family:inherit;font-size:10pt;">, offset by depreciation and amortization of </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">, non-cash stock-based compensation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">,  and changes in working capital, primarily, an increase in accrued expenses of </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, largely related to the Lachlan minimum obligations as discussed in Note 13 to the accompanying unaudited financial statements appearing above.  The net loss for the three months ended March 31, 2019 was driven by increased research and development activities incurred as the Company continues to fund its pipeline of development assets and also by increased sales and marketing expenses incurred to support commercial sales activities.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in operating activities was $0.3 million for the three months ended March 31, 2018 and consisted primarily of a net loss of $3.9 million, adjusted for non-cash stock-based compensation expense of $0.2 million, depreciation and amortization of $1.0 million, and changes in working capital, primarily driven by a change in accounts payable of $1.9 million and other receivables of $0.4 million, offset by a change in inventory of $0.6 million. </font></div><div style="line-height:120%;text-align:justify;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net cash used in investing activities</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash </font><font style="font-family:inherit;font-size:10pt;">used in</font><font style="font-family:inherit;font-size:10pt;">&#32;investing activities was </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, an increase of approximately $0.2 million over the three months ended March 31, 2018. The increase was primarily driven by the purchase of property and equipment in connection with the Company occupying its new corporate headquarters during the first quarter of 2019. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in investing activities was $19,225 for the three months ended March 31, 2018 and primarily consisted of purchases of property and equipment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net cash provided by financing activities</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash </font><font style="font-family:inherit;font-size:10pt;">provided by</font><font style="font-family:inherit;font-size:10pt;">&#32;financing activities was </font><font style="font-family:inherit;font-size:10pt;">$8.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and consisted primarily of net proceeds of approximately </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;from the underwritten public offering of common stock for 1,818,182 shares of common stock of the Company, at a price to the public of $5.50 per share.  The increase was partially offset by </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;payment of contingent consideration related to the Avadel acquisition. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash </font><font style="font-family:inherit;font-size:10pt;">provided by</font><font style="font-family:inherit;font-size:10pt;">&#32;financing activities was </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and consisted of proceeds from option and warrant exercises. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Critical Accounting Policies, Estimates, and Assumptions</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with GAAP.&#160;In preparing the financial statements in conformity with GAAP, the Company makes estimates and assumptions that have an impact on assets, liabilities, revenue and expenses reported.  These estimates can also affect supplemental information disclosed by us, including information about contingencies, risk, and financial condition.  In our unaudited condensed consolidated financial statements, estimates are used for, but not limited to, revenue recognition, cost of product sales, stock-based compensation, fair value measurements (including those relating to contingent consideration), cash flows used in management's going concern assessment, income taxes, goodwill, and other intangible assets, and clinical trial accruals.  The Company believes, given current facts and circumstances, our estimates and assumptions are reasonable, adhere to GAAP and are consistently applied. Inherent in the nature of an estimate or assumption is the fact that actual results may differ from estimates, and estimates may vary as new facts and circumstances arise.  Our most critical accounting estimates and assumptions are included in our Annual Report on Form 10-K for the year ended December&#160;31, 2018 filed with the SEC on </font><font style="font-family:inherit;font-size:10pt;">March&#160;18, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and amended on April 23, 2019. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;36</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Off&#8209;Balance Sheet Arrangements</font></div><div style="line-height:120%;text-indent:84px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not have any off&#8209;balance sheet arrangements, as defined by applicable SEC rules and regulations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;"></font><font style="font-family:inherit;font-size:10pt;">See Item 1 of Part I, &#8220;Notes to Unaudited Financial Statements,&#8221; </font><font style="font-family:inherit;font-size:10pt;">Note 2</font><font style="font-family:inherit;font-size:10pt;">, of this Quarterly Report on Form 10-Q.</font></div><div style="line-height:120%;text-indent:132px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">JOBS Act</font></div><div style="line-height:120%;text-indent:84px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The JOBS Act contains provisions that, among other things, reduce reporting requirements for an &#8220;emerging growth company.&#8221; As an emerging growth company, we have elected to not take advantage of the extended transition period afforded by the JOBS Act for the implementation of new or revised accounting standards and, as a result, will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non&#8209;emerging growth companies.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;37</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s2E7BEF4EBAC55F469D386635BDA73BFB"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</font></div><div style="line-height:120%;text-indent:84px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a smaller reporting company, we are not required to provide the information required by this Item.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="sAF86CF04441F5B3E9052884047823CE7"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 4. Controls and Procedures.</font></div><div style="line-height:120%;text-indent:84px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Evaluation of Disclosure Controls and Procedures</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As required by Rule&#160;13a-15(b)&#160;and Rule&#160;15d-15(b)&#160;of the Exchange Act, our management, including our principal executive officer and our principal financial officer, conducted an evaluation as of the end of the period covered by this Quarterly Report on Form&#160;10-Q of the effectiveness of the design and operation of our disclosure controls and procedures. In designing and evaluating our disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Changes in Internal Control Over Financial Reporting</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There were no changes in our internal control over financial reporting identified in management&#8217;s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Attestation Report of Registered Public Accounting Firm</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Quarterly Report on Form 10-Q does not include an attestation report of our independent registered public accounting firm due to an exemption established by the JOBS Act for emerging growth companies.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;38</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s2C214970BE5652999AC0D2388CDE331F"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART II &#8211; OTHER INFORMATION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sBB102D22F9F85C1B8650298D29C45002"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1. Legal Proceedings.</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Lachlan Pharmaceuticals</font></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2017, the Company acquired TRx and its wholly-owned subsidiaries, including Zylera.  The previous owners of TRx beneficially own more than&#160;10%&#160;of our outstanding common stock.  Zylera, which is our wholly owned subsidiary, entered into the First Amended and Restated Distribution Agreement with</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Lachlan, effective December 18, 2015. Pursuant to the Lachlan Agreement, Lachlan named Zylera as its exclusive distributor of Ulesfia in the United States and agreed to supply Ulesfia to Zylera exclusively for marketing and sale in the United States.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Zylera is obligated to purchase a minimum of&#160;20,000&#160;units per year, or approximately&#160;$1.2 million&#160;worth of product, from Lachlan, subject to certain termination rights. Zylera must pay Lachlan&#160;$58.84&#160;per unit and handling fees that are equal to&#160;$3.66&#160;per unit of fully packaged Ulesfia in 2018, and escalate at a rate of&#160;10%&#160;annually, as well as reimburse Lachlan for all product liability insurance fees incurred by Lachlan. The Lachlan Agreement also requires that Zylera make certain cumulative net sales milestone payments and royalty payments to Lachlan with a&#160;$3 million&#160;annual minimum payment unless and until there has been a &#8220;Market Change&#8221; involving a new successful competitive product. Lachlan is obligated to pay identical amounts to an unrelated third party from which it obtained rights to Ulesfia, with the payments ultimately flowing to Summers Laboratories, Inc. (&#8220;Summers Labs&#8221;). Because of the dispute described below, the Company has not made any payments to Lachlan under the Lachlan Agreement subsequent to the acquisition date.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 10, 2016, Zylera informed Lachlan that a Market Change had occurred due to the introduction of Arbor Pharmaceuticals' lice product, Sklice&#174;.&#160; On June 5, 2017, Lachlan and Zylera entered into joint legal representation along with other unrelated third parties in negotiation and arbitration of a dispute with Summers Labs regarding the existence of a Market Change and the concomitant obligations of the parties. The arbitration panel issued an interim ruling on October 23, 2018 that no Market Change had occurred up to and including the date of the hearing.  The arbitration panel issued a second interim ruling on December 26, 2018.  The second interim award rejected Summers Labs' request to accelerate future minimum royalties, however, it ruled in favor of Summers Labs that it is owed reimbursement for all reasonable costs and expenses, including legal fees, by Shionogi, as well as interest, as stipulated in the contract.  The arbitration panel issued a final award on March 1, 2019 that dictated the final amount of reimbursable costs and interest as contemplated in the second interim ruling.  The final award has no direct bearing on the Company as the Company was not a named defendant to the original claim by Summers Labs and a federal court denied Zylera's ability to be a counterclaimant in the matter.  Furthermore, the Company is not subject to the guarantee or interest provisions identified in the second ruling as these elements of the contractual relationship were not passed down to the Company&#8217;s agreement with Lachlan.  However, the Company has interpreted this ruling's impact on the Lachlan Agreement to mean the minimum purchase obligation and minimum royalty provisions of the contract are active and due for any prior periods as well as going forward for any future periods.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recognized an&#160;$8.7 million liability for these minimum obligations in accrued liabilities as of March 31, 2019. Under the terms of the TRx Purchase Agreement, the former TRx owners are required to indemnify the Company for&#160;100%&#160;of all pre-acquisition losses related this arbitration, including legal costs, and possible minimum payments in excess of&#160;$1 million. Furthermore, the former TRx owners are required to indemnify the Company for&#160;50%&#160;of post-acquisition Ulesfia losses, which would include losses resulting from having to fund these minimum obligations. The Company has recorded an indemnity receivable of $5.2 million in other receivables as of March 31, 2019, which the Company believes is fully collectible.  For the three months ended March 31, 2019, minimum obligations net of amounts recorded within the indemnity receivable of $0.6 million&#160;has been recorded in cost of product sales.  If the Company fails to make these minimum obligations timely then the Lachlan Agreement may be terminated by Lachlan, in which case the Company would no longer be able to sell the Ulesfia product, but it would also not be subject to future minimum obligations.  Lachlan has not requested payment for the minimum obligations. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sFE58560E55865F97992A956CAD85F5E2"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1A. Risk Factors.</font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, &#8220;Item 1A. Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on </font><font style="font-family:inherit;font-size:10pt;">March&#160;18, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and amended on April 23, 2019, which could materially affect our business, financial condition, or future results. Our risk factors as of the date of this Quarterly Report on Form 10-Q have not changed materially from those described in our Annual Report on Form 10-K, as amended. However, the risks described in our Annual Report on Form 10-K are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or future results of operations and the trading price of our common stock.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;39</font></div></div><hr style="page-break-after:always"><div><a name="s7D620DDC35EC594BB9E726099BA00A11"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 6.&#160;&#160;Exhibits. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.55555555555556%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:88%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description of Exhibit</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="q12019cercex-311.htm"><font style="font-family:inherit;font-size:10pt;">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.1*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="q12019cercex-321.htm"><font style="font-family:inherit;font-size:10pt;">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. </font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.INS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Instance Document.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.SCH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Schema Document.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.CAL</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Calculation Linkbase Document.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.DEF</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Definition Linkbase Document.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.LAB</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Label Linkbase Document.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.PRE</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Presentation Linkbase Document.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;&#160;&#160;This certification is being furnished solely to accompany this Quarterly Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;40</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s32F9A55443DA52A6833C08F97DC01684"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s31A117BED97D572C8808BF6FCEDA8807"><font style="font-family:inherit;font-size:10pt;">Table of Contents</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:6%;"></td><td style="width:40%;"></td><td style="width:13%;"></td><td style="width:41%;"></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cerecor Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: May 9, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Joseph M. Miller</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Joseph M. Miller</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(on behalf of the registrant and as the registrant&#8217;s principal executive officer, principal financial officer and principal accounting officer)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;41</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>q12019cercex-311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sBE30985648B556BF88A57E6E9CDF2864"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:13px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit&#160;31.1</font></div><div style="line-height:120%;text-align:center;text-indent:84px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;text-align:center;text-indent:84px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I,&#160;Joseph M. Miller, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this Quarterly Report on Form&#160;10-Q of Cerecor&#160;Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.51219512195122%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:6%;"></td><td style="width:40%;"></td><td style="width:13%;"></td><td style="width:41%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: May 9, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Joseph M. Miller</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Joseph M. Miller</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant&#8217;s principal executive officer, principal financial officer and principal accounting officer)</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>q12019cercex-321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sFCD99D572AB250A5933C955DBD31611A"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 32.1</font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AND PRINCIPAL FINANCIAL OFFICER</font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PURSUANT TO</font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">18 U.S.C. SECTION 1350,</font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AS ADOPTED PURSUANT TO</font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;padding-top:16px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Quarterly Report of Cerecor Inc. (the &#8220;Registrant&#8221;) on Form 10-Q for the period ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Joseph M. Miller, Chief Financial Officer of the Registrant, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></div></td></tr></table><div style="line-height:120%;text-indent:84px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:6%;"></td><td style="width:40%;"></td><td style="width:13%;"></td><td style="width:41%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: May 9, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Joseph M. Miller</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Joseph M. Miller</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant&#8217;s principal executive officer, principal financial officer and principal accounting officer)</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The foregoing certifications are not deemed filed with the Securities and Exchange Commission for purposes of section&#160;18 of the Securities Exchange Act of 1934, as amended (Exchange Act), and are not to be incorporated by reference into any filing of</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cerecor Inc.</font><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>4
<FILENAME>cerc-20190331.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:CC5C72674CA5516BA967D17444DEFF3A,x:9a84bf414c5f4924a99ecb5e92b5d7f8-->
<xbrli:xbrl xmlns:acec="http://fasb.org/dis/acec/2018-01-31" xmlns:ap="http://fasb.org/dis/ap/2018-01-31" xmlns:aro="http://fasb.org/dis/aro/2018-01-31" xmlns:bc="http://fasb.org/dis/bc/2018-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2018-01-31" xmlns:cc="http://fasb.org/dis/cc/2018-01-31" xmlns:cce="http://fasb.org/dis/cce/2018-01-31" xmlns:cerc="http://www.cerecor.com/20190331" xmlns:codification-part="http://fasb.org/codification-part/2018-01-31" xmlns:com="http://fasb.org/stm/com/2018-01-31" xmlns:con="http://fasb.org/dis/con/2018-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2018-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2018-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2018-01-31" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2018-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2018-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2017-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2017-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2017-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2017-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2018-01-31" xmlns:debt="http://fasb.org/dis/debt/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2018-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2018-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2018-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:diha="http://fasb.org/dis/diha/2018-01-31" xmlns:disops="http://fasb.org/dis/disops/2018-01-31" xmlns:dr="http://fasb.org/dis/dr/2018-01-31" xmlns:edco="http://fasb.org/dis/edco/2018-01-31" xmlns:ei="http://fasb.org/dis/ei/2018-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2018-01-31" xmlns:eps="http://fasb.org/dis/eps/2018-01-31" xmlns:equity="http://fasb.org/dis/equity/2018-01-31" xmlns:ero="http://fasb.org/dis/ero/2018-01-31" xmlns:eui="http://fasb.org/dis/eui/2018-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2018-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2018-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2018-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2018-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2018-01-31" xmlns:foct="http://fasb.org/dis/foct/2018-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2018-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2018-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2018-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2018-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2018-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2018-01-31" xmlns:guar="http://fasb.org/dis/guar/2018-01-31" xmlns:hco="http://fasb.org/dis/hco/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2018-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2018-01-31" xmlns:ides="http://fasb.org/dis/ides/2018-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2018-01-31" xmlns:inv="http://fasb.org/dis/inv/2018-01-31" xmlns:invco="http://fasb.org/dis/invco/2018-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:ir="http://fasb.org/dis/ir/2018-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:lea="http://fasb.org/dis/lea/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:ni="http://fasb.org/dis/ni/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:nt="http://fasb.org/dis/nt/2018-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2018-01-31" xmlns:oi="http://fasb.org/dis/oi/2018-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2018-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2018-01-31" xmlns:pay="http://fasb.org/dis/pay/2018-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2018-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2018-01-31" xmlns:rd="http://fasb.org/dis/rd/2018-01-31" xmlns:re="http://fasb.org/dis/re/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:regop="http://fasb.org/dis/regop/2018-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2018-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2018-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2018-01-31" xmlns:ru="http://fasb.org/dis/ru/2018-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2018-01-31" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2018-01-31" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2018-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2018-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2018-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2018-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2018-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2018-01-31" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2018-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2018-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2018-01-31" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2018-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2018-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2018-01-31" xmlns:se="http://fasb.org/dis/se/2018-01-31" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2018-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2018-01-31" xmlns:sec-re="http://fasb.org/dis/sec-re/2018-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2018-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2018-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2018-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2018-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2018-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2018-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2018-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2018-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2018-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2018-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2018-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:soc="http://fasb.org/stm/soc/2018-01-31" xmlns:soi="http://fasb.org/stm/soi/2018-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2018-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2018-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2018-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2018-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2018-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2018-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2018-01-31" xmlns:spc="http://fasb.org/stm/spc/2018-01-31" xmlns:sr="http://fasb.org/dis/sr/2018-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:srt-all="http://fasb.org/srt-all/2018-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2018-01-31" xmlns:srt-std="http://fasb.org/srt-std/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2018-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:te="http://fasb.org/dis/te/2018-01-31" xmlns:tin-part="http://fasb.org/tin-part/2018-01-31" xmlns:ts="http://fasb.org/dis/ts/2018-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2018-01-31" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2018-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2018-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2018-01-31" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
	<link:schemaRef xlink:href="cerc-20190331.xsd" xlink:type="simple" />
	<xbrli:context id="FD2019Q1YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2019Q2May3">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-05-03</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_SalesForceRevenueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:SalesForceRevenueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_srt_ProductOrServiceAxis_cerc_SalesForceRevenueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:SalesForceRevenueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_SalesRevenueProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:SalesRevenueProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_srt_ProductOrServiceAxis_cerc_SalesRevenueProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:SalesRevenueProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_cerc_ContingentlyIssuableCommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cerc:ContingentlyIssuableCommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_cerc_ContingentlyIssuableCommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cerc:ContingentlyIssuableCommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_cerc_ContingentlyIssuableCommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cerc:ContingentlyIssuableCommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_cerc_ContingentlyIssuableCommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cerc:ContingentlyIssuableCommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_cerc_UnderwrittenPublicOfferingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_CounterpartyNameAxis_cerc_ArmisticeMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_cerc_UnderwrittenPublicOfferingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cerc:ArmisticeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:PreclinicalPediatricOrphanRareDiseaseCompoundMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_cerc_UnderwrittenPublicOfferingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_ThreePreclinicalTherapiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:ThreePreclinicalTherapiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:NeurologicalClinicalAndPreclinicalStageCompoundsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2019Q1Jan1_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_us-gaap_AccountingStandardsUpdate201602Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_srt_ProductOrServiceAxis_cerc_PrescribedDietarySupplementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:PrescribedDietarySupplementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_PrescriptionDrugsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:PrescriptionDrugsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_srt_ProductOrServiceAxis_cerc_PrescriptionDrugsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:PrescriptionDrugsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_PrescribedDietarySupplementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:PrescribedDietarySupplementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_MajorCustomersAxis_cerc_MajorCustomerNumberThreeMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cerc:MajorCustomerNumberThreeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_MajorCustomersAxis_cerc_MajorCustomerNumberOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cerc:MajorCustomerNumberOneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_MajorCustomersAxis_cerc_MajorCustomerNumberTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cerc:MajorCustomerNumberTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4QTD_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_WarrantCommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cerc:WarrantCommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_RestrictedStockAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cerc:RestrictedStockAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cerc:EmployeeConsultantsAndDirectorsStockOptionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_UnderwritersUnitPurchaseOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cerc:UnderwritersUnitPurchaseOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_UnderwritersUnitPurchaseOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cerc:UnderwritersUnitPurchaseOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_RestrictedStockAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cerc:RestrictedStockAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cerc:EmployeeConsultantsAndDirectorsStockOptionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_WarrantCommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cerc:WarrantCommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_UlesfiaMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:UlesfiaMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-18</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:PAISalesAndMarketingAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Nov18-Sep30_srt_ProductOrServiceAxis_cerc_MillipredMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:MillipredMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-18</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MetafolinMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:MetafolinMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Nov18-Sep30_srt_ProductOrServiceAxis_cerc_UlesfiaMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:UlesfiaMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-18</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MillipredMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:MillipredMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_UlesfiaMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:UlesfiaMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MetafolinMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:MetafolinMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MillipredMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:MillipredMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:PAISalesAndMarketingAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-17</xbrli:startDate>
			<xbrli:endDate>2017-11-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:PAISalesAndMarketingAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-18</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-17</xbrli:startDate>
			<xbrli:endDate>2017-11-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Nov18-Sep30_srt_ProductOrServiceAxis_cerc_MetafolinMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:MetafolinMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-18</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MillipredMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:MillipredMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-17</xbrli:startDate>
			<xbrli:endDate>2017-11-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MetafolinMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:MetafolinMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-17</xbrli:startDate>
			<xbrli:endDate>2017-11-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:PAISalesAndMarketingAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-17</xbrli:startDate>
			<xbrli:endDate>2017-11-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_FlexichamberMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:FlexichamberMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_LiquiTimeProcessMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:LiquiTimeProcessMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_KarbinalMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:KarbinalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_KarbinalMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:KarbinalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_AcipHexMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:AcipHexMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_LiquiTimeProcessMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:LiquiTimeProcessMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_CefaclorMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:CefaclorMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Feb16-16_srt_ProductOrServiceAxis_cerc_AcipHexMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:AcipHexMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-02-16</xbrli:startDate>
			<xbrli:endDate>2018-02-16</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Feb16-16_srt_ProductOrServiceAxis_cerc_CefaclorMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:CefaclorMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-02-16</xbrli:startDate>
			<xbrli:endDate>2018-02-16</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Feb16-16_srt_ProductOrServiceAxis_cerc_KarbinalMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:KarbinalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-02-16</xbrli:startDate>
			<xbrli:endDate>2018-02-16</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_AcipHexMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:AcipHexMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_KarbinalMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:KarbinalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_FlexichamberMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:FlexichamberMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_CefaclorMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:CefaclorMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_LiquiTimeProcessMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:LiquiTimeProcessMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_AcipHexMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:AcipHexMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Feb16-16_srt_ProductOrServiceAxis_cerc_FlexichamberMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:FlexichamberMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-02-16</xbrli:startDate>
			<xbrli:endDate>2018-02-16</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_FlexichamberMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:FlexichamberMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_CefaclorMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cerc:CefaclorMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AcquiredProductMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Sep2424_cerc_AssetAcquisitionAxis_cerc_IchorionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AssembledWorkforceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:AssetAcquisitionAxis">cerc:IchorionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AssembledWorkforceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-09-24</xbrli:startDate>
			<xbrli:endDate>2018-09-24</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Sep2424_cerc_AssetAcquisitionAxis_cerc_IchorionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:AssetAcquisitionAxis">cerc:IchorionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-09-24</xbrli:startDate>
			<xbrli:endDate>2018-09-24</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q3Sep24_cerc_AssetAcquisitionAxis_cerc_IchorionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:AssetAcquisitionAxis">cerc:IchorionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q3Sep24">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2023Q4Purchase-Dec31_cerc_AssetAcquisitionAxis_cerc_IchorionMember_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:AssetAcquisitionAxis">cerc:IchorionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneThreeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-09-24</xbrli:startDate>
			<xbrli:endDate>2023-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Feb16-16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-02-16</xbrli:startDate>
			<xbrli:endDate>2018-02-16</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q3Sep24_cerc_AssetAcquisitionAxis_cerc_IchorionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AssembledWorkforceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:AssetAcquisitionAxis">cerc:IchorionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:AssembledWorkforceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2021Q4Purchase-Dec31_cerc_AssetAcquisitionAxis_cerc_IchorionMember_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:AssetAcquisitionAxis">cerc:IchorionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-09-24</xbrli:startDate>
			<xbrli:endDate>2021-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2021Q4Purchase-Dec31_cerc_AssetAcquisitionAxis_cerc_IchorionMember_cerc_MilestoneAxis_cerc_MilestoneOneMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:AssetAcquisitionAxis">cerc:IchorionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneOneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-09-24</xbrli:startDate>
			<xbrli:endDate>2021-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q2_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cerc:PAISalesAndMarketingAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q1Mar31-31_cerc_AssetAcquisitionAxis_cerc_IchorionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:AssetAcquisitionAxis">cerc:IchorionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-03-31</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Feb16-16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-02-16</xbrli:startDate>
			<xbrli:endDate>2018-02-16</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_RoyaltyPayableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:RoyaltyPayableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_RoyaltyPayableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:RoyaltyPayableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:ContingentConsiderationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:ContingentConsiderationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_RoyaltyPayableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:RoyaltyPayableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:ContingentConsiderationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:ContingentConsiderationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:ContingentConsiderationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:ContingentConsiderationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:ContingentConsiderationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:ContingentConsiderationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cerc:MeasurementInputProbabilityOfMilestoneSuccessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_cerc_MilestoneAxis_cerc_MilestoneOneMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneOneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_cerc_MilestoneAxis_cerc_MilestoneOneMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneOneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputCounterpartyCreditRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCounterpartyCreditRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_cerc_MilestoneAxis_cerc_MilestoneOneMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneOneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneThreeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cerc:MeasurementInputProbabilityOfMilestoneSuccessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneThreeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputCounterpartyCreditRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCounterpartyCreditRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q3OCT31_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-10-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputCounterpartyCreditRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneThreeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCounterpartyCreditRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:AvadelMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Nov17-17_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneThreeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneThreeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cerc:CommonStockWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneThreeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:EquityUnitPurchaseOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneThreeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_RoyaltyPayableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:RoyaltyPayableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cerc:WarrantLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:MilestoneAxis">cerc:MilestoneTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cerc:TRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2021Q1Jan31_us-gaap_DebtInstrumentAxis_cerc_DeerfieldObligationMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cerc:DeerfieldObligationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2021-01-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_DebtInstrumentAxis_cerc_DeerfieldObligationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cerc:DeerfieldObligationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2020Q4Jul2018-Oct2020_us-gaap_DebtInstrumentAxis_cerc_DeerfieldObligationMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cerc:DeerfieldObligationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2020-10-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_DebtInstrumentAxis_cerc_DeerfieldObligationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cerc:DeerfieldObligationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Sep25-25_cerc_AssetAcquisitionAxis_cerc_IchorionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cerc:AssetAcquisitionAxis">cerc:IchorionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-09-25</xbrli:startDate>
			<xbrli:endDate>2018-09-25</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q1Mar8-8_us-gaap_SubsidiarySaleOfStockAxis_cerc_BoughtDealMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:BoughtDealMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-03-08</xbrli:startDate>
			<xbrli:endDate>2019-03-08</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Dec27_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Dec27_us-gaap_ClassOfWarrantOrRightAxis_cerc_IncentiveWarrantsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cerc:IncentiveWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q4Dec27-27_us-gaap_ClassOfWarrantOrRightAxis_cerc_IncentiveWarrantsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cerc:IncentiveWarrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-12-27</xbrli:startDate>
			<xbrli:endDate>2018-12-27</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q4Dec27-27_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-12-27</xbrli:startDate>
			<xbrli:endDate>2018-12-27</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q3Aug17">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-08-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Aug17_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-08-17</xbrli:startDate>
			<xbrli:endDate>2018-08-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q3Aug17_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-08-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2019Q1Mar8_us-gaap_SubsidiarySaleOfStockAxis_cerc_BoughtDealMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:BoughtDealMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-08</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q1Mar8-8_srt_CounterpartyNameAxis_cerc_ArmisticeMember_us-gaap_SubsidiarySaleOfStockAxis_cerc_BoughtDealMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cerc:ArmisticeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:BoughtDealMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-03-08</xbrli:startDate>
			<xbrli:endDate>2019-03-08</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Aug17_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-08-17</xbrli:startDate>
			<xbrli:endDate>2018-08-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4QTD_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_WarrantCommonStockMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cerc:WarrantCommonStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsExpirationMay2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cerc:CommonStockWarrantsExpirationMay2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsExpirationDateJune2024Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cerc:CommonStockWarrantsExpirationDateJune2024Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsExpirationOctober2020Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cerc:CommonStockWarrantsExpirationOctober2020Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:StockOptionsWithMarketBasedVestingConditionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:StockOptionsWithMarketBasedVestingConditionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:StockOptionsWithMarketBasedVestingConditionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:StockOptionsWithMarketBasedVestingConditionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:StockOptionsWithMarketBasedVestingConditionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-15</xbrli:startDate>
			<xbrli:endDate>2019-04-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_us-gaap_PlanNameAxis_cerc_The2016PlanMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:EmployeeConsultantsAndDirectorsStockOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cerc:The2016PlanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">cerc:EmployeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-15</xbrli:startDate>
			<xbrli:endDate>2019-04-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_us-gaap_PlanNameAxis_cerc_The2016PlanMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:EmployeeConsultantsAndDirectorsStockOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cerc:The2016PlanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">cerc:EmployeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:StockOptionsWithMarketBasedVestingConditionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-15</xbrli:startDate>
			<xbrli:endDate>2019-04-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-15</xbrli:startDate>
			<xbrli:endDate>2019-04-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Apr5_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-04-05</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2Apr5_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-04-05</xbrli:startDate>
			<xbrli:endDate>2016-04-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q2May1-31_us-gaap_PlanNameAxis_cerc_The2016PlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cerc:The2016PlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-05-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:StockOptionsWithMarketBasedVestingConditionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-15</xbrli:startDate>
			<xbrli:endDate>2019-04-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Jan1_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-01-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr1-1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">cerc:EmployeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-01</xbrli:startDate>
			<xbrli:endDate>2019-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_PlanNameAxis_cerc_The2016PlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cerc:The2016PlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:StockOptionsWithMarketBasedVestingConditionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-15</xbrli:startDate>
			<xbrli:endDate>2019-04-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2May18_us-gaap_PlanNameAxis_cerc_The2015PlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cerc:The2015PlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-18</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2MAY18_us-gaap_PlanNameAxis_cerc_The2016PlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cerc:The2016PlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-05-18</xbrli:startDate>
			<xbrli:endDate>2016-05-18</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_us-gaap_PlanNameAxis_cerc_The2016PlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:EmployeeConsultantsAndDirectorsStockOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cerc:The2016PlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cerc:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_us-gaap_PlanNameAxis_cerc_The2016PlanMember_us-gaap_TitleOfIndividualAxis_us-gaap_DirectorMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:EmployeeConsultantsAndDirectorsStockOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cerc:The2016PlanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr1-1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">cerc:EmployeeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-01</xbrli:startDate>
			<xbrli:endDate>2019-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-15</xbrli:startDate>
			<xbrli:endDate>2019-04-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-15</xbrli:startDate>
			<xbrli:endDate>2019-04-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2019Q2Apr1-1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cerc:ServiceBasedOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">cerc:EmployeeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-01</xbrli:startDate>
			<xbrli:endDate>2019-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_ZyleraMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">cerc:ZyleraMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:UlesfiaSupplyAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-01</xbrli:startDate>
			<xbrli:endDate>2017-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_LachlanPharmaceuticalsMember_srt_RangeAxis_srt_MinimumMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">cerc:LachlanPharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:UlesfiaSupplyAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-01</xbrli:startDate>
			<xbrli:endDate>2017-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_LachlanPharmaceuticalsMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">cerc:LachlanPharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:UlesfiaSupplyAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-01</xbrli:startDate>
			<xbrli:endDate>2017-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:UlesfiaSupplyAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Feb16-16_srt_CounterpartyNameAxis_cerc_TRISPharmaMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_KarbinalAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cerc:TRISPharmaMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:KarbinalAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-02-16</xbrli:startDate>
			<xbrli:endDate>2018-02-16</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3August_srt_ProductOrServiceAxis_us-gaap_LicenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-08-01</xbrli:startDate>
			<xbrli:endDate>2017-08-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_srt_CounterpartyNameAxis_cerc_TRISPharmaMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_KarbinalAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cerc:TRISPharmaMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:KarbinalAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_dei_LegalEntityAxis_cerc_ZyleraMember_srt_CounterpartyNameAxis_cerc_LachlanPharmaceuticalsMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">cerc:ZyleraMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cerc:LachlanPharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:UlesfiaSupplyAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q4Oct31">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-10-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_ZyleraMember_srt_CounterpartyNameAxis_cerc_LachlanPharmaceuticalsMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">cerc:ZyleraMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cerc:LachlanPharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:UlesfiaSupplyAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-01</xbrli:startDate>
			<xbrli:endDate>2017-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:UlesfiaSupplyAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3August">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-08-01</xbrli:startDate>
			<xbrli:endDate>2017-08-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Aug1-31_srt_CounterpartyNameAxis_cerc_TRISPharmaMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_KarbinalAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001534120</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cerc:TRISPharmaMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cerc:KarbinalAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-08-01</xbrli:startDate>
			<xbrli:endDate>2018-08-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:unit id="Vote">
		<xbrli:measure>cerc:Vote</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="contract">
		<xbrli:measure>cerc:contract</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="therapy">
		<xbrli:measure>cerc:therapy</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="class_of_stock">
		<xbrli:measure>cerc:class_of_stock</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="renewal_option">
		<xbrli:measure>cerc:renewal_option</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="installment">
		<xbrli:measure>cerc:installment</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="day">
		<xbrli:measure>cerc:day</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="product">
		<xbrli:measure>cerc:product</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit>
	<xbrli:unit id="milestone">
		<xbrli:measure>cerc:milestone</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="award">
		<xbrli:measure>cerc:award</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="unit">
		<xbrli:measure>cerc:unit</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="USD_PER_unit">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>cerc:unit</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit>
	<cerc:AccruedGeneralAndAdministrativeExpenses contextRef="FI2018Q4" decimals="0" id="Fact-96C87EE6A62B4B6914D18ECF51D35075" unitRef="usd">235721</cerc:AccruedGeneralAndAdministrativeExpenses>
	<cerc:AccruedGeneralAndAdministrativeExpenses contextRef="FI2019Q1" decimals="0" id="Fact-1A452B1C8FC20F1672848ECF51C4BE83" unitRef="usd">187465</cerc:AccruedGeneralAndAdministrativeExpenses>
	<cerc:AccruedLiabilitiesAndOtherCurrentLiabilities contextRef="FI2018Q4" decimals="0" id="Fact-1BAD4CDC8DAAEE6148018ECF52138647" unitRef="usd">19731373</cerc:AccruedLiabilitiesAndOtherCurrentLiabilities>
	<cerc:AccruedLiabilitiesAndOtherCurrentLiabilities contextRef="FI2019Q1" decimals="0" id="Fact-5659448FF09C7E0295A28ECF51DC27E6" unitRef="usd">21815097</cerc:AccruedLiabilitiesAndOtherCurrentLiabilities>
	<cerc:AccruedMedicaidRebates contextRef="FI2018Q4" decimals="0" id="Fact-75614E1B470DDB5973CD941DA6A93EDE" unitRef="usd">2237269</cerc:AccruedMedicaidRebates>
	<cerc:AccruedMedicaidRebates contextRef="FI2019Q1" decimals="0" id="Fact-3142F2D6CB3AE639A55B941DBEC8EAD2" unitRef="usd">2758384</cerc:AccruedMedicaidRebates>
	<cerc:AccruedResearchAndDevelopmentExpenses contextRef="FI2018Q4" decimals="0" id="Fact-7C3A180D790698E031578ED0B56A0051" unitRef="usd">278132</cerc:AccruedResearchAndDevelopmentExpenses>
	<cerc:AccruedResearchAndDevelopmentExpenses contextRef="FI2019Q1" decimals="0" id="Fact-9C29D8B98378C61E51128ED0B4216201" unitRef="usd">1123051</cerc:AccruedResearchAndDevelopmentExpenses>
	<cerc:AccruedSalesReturnsAndAllowances contextRef="FI2018Q4" decimals="0" id="Fact-7558224A1E482332BE0A8ECF520A2987" unitRef="usd">3972510</cerc:AccruedSalesReturnsAndAllowances>
	<cerc:AccruedSalesReturnsAndAllowances contextRef="FI2019Q1" decimals="0" id="Fact-699FD3DAD9297C9A94F08ECF51F1768A" unitRef="usd">4249977</cerc:AccruedSalesReturnsAndAllowances>
	<cerc:AmortizationOfInventoryFairValueAdjustment contextRef="FD2018Q1YTD" decimals="0" id="Fact-40778DB4BA816D8516728DD4EC89EA5E" unitRef="usd">45450</cerc:AmortizationOfInventoryFairValueAdjustment>
	<cerc:AmortizationOfInventoryFairValueAdjustment contextRef="FD2019Q1YTD" decimals="0" id="Fact-221C635E15523B087BEF8DD4EC9952F6" unitRef="usd">22603</cerc:AmortizationOfInventoryFairValueAdjustment>
	<cerc:AssetAcquisitionContingentConsiderationLiability contextRef="I2018Q3Sep24_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="-6" id="Fact-2D0124FCD3516EF618258E8689E820EA" unitRef="usd">15000000</cerc:AssetAcquisitionContingentConsiderationLiability>
	<cerc:AssetAcquisitionNumberOfContingentConsiderationMilestones contextRef="D2018Q3Sep2424_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="INF" id="Fact-C441D175561B715BB69F93D08A010D74" unitRef="milestone">3</cerc:AssetAcquisitionNumberOfContingentConsiderationMilestones>
	<cerc:AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="I2018Q3Sep24_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="-5" id="Fact-FEC103EB0E7896A9D59D8E86DE62D205" unitRef="usd">1600000</cerc:AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
	<cerc:AssetAcquisitionResearchAndDevelopmentInProcess contextRef="I2018Q3Sep24_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="-5" id="Fact-27B3ADC7AC9EABFAA68F8E86C6C65EE4" unitRef="usd">18700000</cerc:AssetAcquisitionResearchAndDevelopmentInProcess>
	<cerc:AssetAcquisitionResearchAndDevelopmentInProcess contextRef="I2018Q3Sep24_cerc_AssetAcquisitionAxis_cerc_IchorionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AssembledWorkforceMember" decimals="-5" id="Fact-2AE2AF5DBA10CE7638C08E86FD558659" unitRef="usd">200000</cerc:AssetAcquisitionResearchAndDevelopmentInProcess>
	<cerc:AssetAcquisitionsTransactionCosts contextRef="I2018Q3Sep24_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="-5" id="Fact-B5D5363EAA170A28808A8E87478245F5" unitRef="usd">200000</cerc:AssetAcquisitionsTransactionCosts>
	<cerc:BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares contextRef="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="INF" id="Fact-1369006BD1ABFF0387BD8E8E50F227DF" unitRef="shares">2349968</cerc:BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares>
	<cerc:BusinessAcquisitionGoodwillTaxDeductiblePeriod contextRef="D2018Q1Feb16-16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" id="Fact-327D293D90A6967E6F218E88957FC885">P15Y</cerc:BusinessAcquisitionGoodwillTaxDeductiblePeriod>
	<cerc:BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted contextRef="FD2018Q1YTD_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="2" id="Fact-548C1A16730F7E06A04A8DD4ECA8D438" unitRef="usdPerShare">-0.16</cerc:BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted>
	<cerc:BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted contextRef="FD2018Q1YTD_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember" decimals="2" id="Fact-A801A87D3C6EB00F663D93DD5781714A" unitRef="usdPerShare">0.00</cerc:BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted>
	<cerc:BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued contextRef="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="INF" id="Fact-9B395598E452CAEBBEDF8E8E1451FB48" unitRef="shares">5184920</cerc:BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued>
	<cerc:BusinessCombinationContingentConsiderationExpectedTimeToMilestone contextRef="FD2019Q1YTD_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" id="Fact-CD28B26684ECCDBDDC4A940829AE6957">P1Y3M18D</cerc:BusinessCombinationContingentConsiderationExpectedTimeToMilestone>
	<cerc:BusinessCombinationContingentConsiderationExpectedTimeToMilestone contextRef="FD2019Q1YTD_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" id="Fact-60B4421ED3C1CEC381DE9405F1382116">P0Y2M12D</cerc:BusinessCombinationContingentConsiderationExpectedTimeToMilestone>
	<cerc:BusinessCombinationGrossProfit contextRef="FD2018Q4YTD_cerc_MilestoneAxis_cerc_MilestoneOneMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-89E496A7162893300BA594039DB4483A" unitRef="usd">12600000</cerc:BusinessCombinationGrossProfit>
	<cerc:BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-DB2554EF238E6CA936838E933A51145C" unitRef="usd">2764515</cerc:BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-92CED5BD891FA7D2981E8E938E5E3084" unitRef="usd">0</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-DB34263255DE6B77EC378E91D6078669" unitRef="usd">0</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-0471C06FF35123FE8C938E9395B3AE42" unitRef="usd">3764515</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses contextRef="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-C7B5E8A309E18D6CE5B28E8AC7EB259E" unitRef="usd">362000</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-49F62DEDA182C04D35228E9378ED54E3" unitRef="usd">4292515</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-EA09923CD6DABECE15C38E9007709DAF" unitRef="usd">-1210000</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability contextRef="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-C311FFCD39651E2EB70B8E8AD56D11B4" unitRef="usd">44835</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-32FC2A4B70123B3E96918E939D0FE0B4" unitRef="usd">78840</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-B2B66A3C506E3B8D88B58E93A4C894F8" unitRef="usd">3843355</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt contextRef="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-D4C417FEA57AF7A568EC8E8ACE9E8F9A" unitRef="usd">-197303</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-07F7E33DA5F45E99EC898E93ADAD40E7" unitRef="usd">449160</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities contextRef="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-EDC0668197F886F369CC8E8ADAA1AD04" unitRef="usd">367468</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-A8D4E18CB7A27CBAC7F58E932FBF2822" unitRef="usd">0</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets>
	<cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets contextRef="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-AA1CF0A207B9493D83F08E8ABA6D9D09" unitRef="usd">570000</cerc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets>
	<cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-4281D06E4CABA52436B78E9392502549" unitRef="usd">4850422</cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities>
	<cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-EB30E93286F730B3987B8E9397A976C1" unitRef="usd">8614937</cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities>
	<cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities contextRef="I2018Q1Feb16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-9B8E7DDCF85066B773478E8AC5498A52" unitRef="usd">0</cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities>
	<cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-D568A8A884A58F32A3638E8AC9E046B3" unitRef="usd">362000</cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities>
	<cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-BAFE48BBBBB3E462DC128E93363C70BD" unitRef="usd">0</cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables>
	<cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-D6C43050403857897C6E8E933CA03184" unitRef="usd">2764515</cerc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables>
	<cerc:CapitalStockSharesAuthorized contextRef="FI2019Q1" decimals="INF" id="Fact-A8D6D38F4BCF4D37B09E8ED7AA00B53E" unitRef="shares">205000000</cerc:CapitalStockSharesAuthorized>
	<cerc:ClassOfWarrantOrRightDistributionAdjustment contextRef="D2018Q4Dec27-27_us-gaap_ClassOfWarrantOrRightAxis_cerc_IncentiveWarrantsMember" decimals="-5" id="Fact-9527FB0DEBA8D7BAEC30942A2B3B1B82" unitRef="usd">1700000</cerc:ClassOfWarrantOrRightDistributionAdjustment>
	<cerc:FairValueAdjustmentOfWarrantsAndInvestorRightsObligation contextRef="FD2018Q1YTD" decimals="0" id="Fact-CDF32C53E898B97B3CA98DD4ECA8B314" unitRef="usd">23251</cerc:FairValueAdjustmentOfWarrantsAndInvestorRightsObligation>
	<cerc:FairValueAdjustmentOfWarrantsAndInvestorRightsObligation contextRef="FD2019Q1YTD" decimals="0" id="Fact-6BC95A199FB6C3F0F5C78DD4EC9957B2" unitRef="usd">47577</cerc:FairValueAdjustmentOfWarrantsAndInvestorRightsObligation>
	<cerc:FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration contextRef="FD2018Q1YTD" decimals="0" id="Fact-BDF818670BB538BCF61A8DD4ECA82EAA" unitRef="usd">23251</cerc:FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration>
	<cerc:FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration contextRef="FD2019Q1YTD" decimals="0" id="Fact-D6AEE53FA83B93B76DD18DD4ECB81E07" unitRef="usd">47577</cerc:FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration>
	<cerc:FairValueMeasurementsChangesInValuationTechniquesNumber contextRef="FD2018Q1YTD" decimals="INF" id="Fact-403874433276CDE494AC8DD4ECB84950" unitRef="class_of_stock">0</cerc:FairValueMeasurementsChangesInValuationTechniquesNumber>
	<cerc:LesseeOperatingLeaseNumberOfContracts contextRef="FD2019Q1YTD" decimals="INF" id="Fact-FBF63B14948E0593B48793A13F13C0F4" unitRef="contract">1</cerc:LesseeOperatingLeaseNumberOfContracts>
	<cerc:LesseeOperatingLeaseNumberOfRenewalOptions contextRef="FD2019Q1YTD" decimals="INF" id="Fact-436623F1FB699A734E7C9512FB18FC01" unitRef="renewal_option">2</cerc:LesseeOperatingLeaseNumberOfRenewalOptions>
	<cerc:LesseeOperatingLeaseRemainingLeaseTeam contextRef="FD2019Q1YTD" id="Fact-062EB1800670348FFDEF9515378CC88E">P10Y9M29D</cerc:LesseeOperatingLeaseRemainingLeaseTeam>
	<cerc:LesseeOperatingLeaseRentAbatement contextRef="FD2019Q1YTD" id="Fact-7BF4223BC2DBEF8E1159951918A6C92A">P12M</cerc:LesseeOperatingLeaseRentAbatement>
	<cerc:LicenseAgreementAccruedMakeWholePayment contextRef="FD2019Q1YTD_srt_CounterpartyNameAxis_cerc_TRISPharmaMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_KarbinalAgreementMember" decimals="-5" id="Fact-2C91D6BFA7F66881C573953B24CB0204" unitRef="usd">1100000</cerc:LicenseAgreementAccruedMakeWholePayment>
	<cerc:LicenseAgreementIndemnificationOfPostacquisitionLossesPercent contextRef="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_LachlanPharmaceuticalsMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="2" id="Fact-34E8CB7610B9FC3993AC954877D53C7D" unitRef="number">0.50</cerc:LicenseAgreementIndemnificationOfPostacquisitionLossesPercent>
	<cerc:LicenseAgreementIndemnificationOfPostacquisitionLossesPercent contextRef="FD2019Q1YTD_dei_LegalEntityAxis_cerc_ZyleraMember_srt_CounterpartyNameAxis_cerc_LachlanPharmaceuticalsMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="2" id="Fact-57C929FABF5209B84C94952F22CC99F1" unitRef="number">0.50</cerc:LicenseAgreementIndemnificationOfPostacquisitionLossesPercent>
	<cerc:LicenseAgreementIndemnificationOfPreacquisitionLossesPercent contextRef="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_LachlanPharmaceuticalsMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="INF" id="Fact-6658CE0923A84CF4D8989547B895353F" unitRef="number">1</cerc:LicenseAgreementIndemnificationOfPreacquisitionLossesPercent>
	<cerc:LicenseAgreementIndemnityReceivable contextRef="FI2019Q1_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="-5" id="Fact-714961C91A32A7B5A77B9548C72FCFEE" unitRef="usd">5200000</cerc:LicenseAgreementIndemnityReceivable>
	<cerc:LicenseAgreementMakeWholePayment contextRef="D2018Q3Aug1-31_srt_CounterpartyNameAxis_cerc_TRISPharmaMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_KarbinalAgreementMember" decimals="INF" id="Fact-9E3340C78370E2C445C0953ACAC7B9FB" unitRef="usd">900000.0</cerc:LicenseAgreementMakeWholePayment>
	<cerc:LicenseAgreementMakeWholePayment contextRef="FD2019Q1YTD_srt_CounterpartyNameAxis_cerc_TRISPharmaMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_KarbinalAgreementMember" decimals="INF" id="Fact-500D049E8CA646F2D8E0953BC34C6618" unitRef="usd">432960</cerc:LicenseAgreementMakeWholePayment>
	<cerc:LicenseAgreementMakeWholePaymentPerUnit contextRef="D2018Q1Feb16-16_srt_CounterpartyNameAxis_cerc_TRISPharmaMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_KarbinalAgreementMember" decimals="INF" id="Fact-7B4C616A34575BCBCF0C8EEA46298E99" unitRef="USD_PER_unit">30</cerc:LicenseAgreementMakeWholePaymentPerUnit>
	<cerc:LicenseAgreementMinimumRoyalty contextRef="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_ZyleraMember_srt_CounterpartyNameAxis_cerc_LachlanPharmaceuticalsMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="-5" id="Fact-C1D0EB2073708A48AC438EE9494B37A6" unitRef="usd">3000000</cerc:LicenseAgreementMinimumRoyalty>
	<cerc:LicenseAgreementPricePerUnit contextRef="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_ZyleraMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="INF" id="Fact-E41D2068D50AABA7ABA78EE8FAE8DB95" unitRef="USD_PER_unit">58.84</cerc:LicenseAgreementPricePerUnit>
	<cerc:LicenseAgreementProductRoyaltyNet contextRef="D2018Q1Feb16-16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="2" id="Fact-73B1BB3ABA873A27C29D93FFA9263A8B" unitRef="number">0.15</cerc:LicenseAgreementProductRoyaltyNet>
	<cerc:LicenseAgreementRoyaltyObligation contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="-5" id="Fact-6915B48558783434E5AE93FFD2A6D71E" unitRef="usd">12500000</cerc:LicenseAgreementRoyaltyObligation>
	<cerc:LicenseAgreementRoyaltyObligationFairValueDisclosure contextRef="FI2019Q1_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="-5" id="Fact-6560B9A30035DC788CA5940008892FE0" unitRef="usd">7700000</cerc:LicenseAgreementRoyaltyObligationFairValueDisclosure>
	<cerc:LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments contextRef="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_LachlanPharmaceuticalsMember_srt_RangeAxis_srt_MinimumMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="-6" id="Fact-BBAB46A358380DCAE147954840025F1F" unitRef="usd">1000000</cerc:LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments>
	<cerc:LicenseObligationCurrent contextRef="FI2019Q1_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="-5" id="Fact-CDCE7AC9FA33541BFB62954731DB4D9C" unitRef="usd">8700000</cerc:LicenseObligationCurrent>
	<cerc:LicenseObligationNoncurrent contextRef="FI2018Q4" decimals="0" id="Fact-132C01169553BA052CC08DD4EC999738" unitRef="usd">1250000</cerc:LicenseObligationNoncurrent>
	<cerc:LicenseObligationNoncurrent contextRef="FI2019Q1" decimals="0" id="Fact-6B707BC5CC7D22D3E44D8DD4ECA84415" unitRef="usd">1250000</cerc:LicenseObligationNoncurrent>
	<cerc:ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent contextRef="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_ZyleraMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="2" id="Fact-82D016407CEA3C9AE4058EE93218E2A4" unitRef="number">0.10</cerc:ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent>
	<cerc:ManagementAndHandlingFeeRelatedPartyPricePerUnit contextRef="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_ZyleraMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="INF" id="Fact-0C4A8430C5CBA8CD0CF18EE91B26B753" unitRef="USD_PER_unit">4.03</cerc:ManagementAndHandlingFeeRelatedPartyPricePerUnit>
	<cerc:MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent contextRef="FI2018Q4" decimals="0" id="Fact-C8909807A4F014A4ED4E8ED068DB6409" unitRef="usd">9662901</cerc:MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent>
	<cerc:MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent contextRef="FI2019Q1" decimals="0" id="Fact-E245E518049307EDE08C8ED067C3F590" unitRef="usd">10808083</cerc:MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent>
	<cerc:NetIncomeLossBeforeTaxes contextRef="FD2018Q1YTD" decimals="0" id="Fact-F8834EE74DC90BDC0C558DD4ECB8F848" unitRef="usd">-3859534</cerc:NetIncomeLossBeforeTaxes>
	<cerc:NetIncomeLossBeforeTaxes contextRef="FD2019Q1YTD" decimals="0" id="Fact-EEEED8076759AB78B0CC8DD4ECB8A8CB" unitRef="usd">-7287690</cerc:NetIncomeLossBeforeTaxes>
	<cerc:NumberOfClassOfStockAuthorized contextRef="FI2019Q1" decimals="INF" id="Fact-1F424A9139249248E2E692E8606B8D57" unitRef="class_of_stock">2</cerc:NumberOfClassOfStockAuthorized>
	<cerc:NumberOfMarketedMedicalDevices contextRef="FD2019Q1YTD" decimals="INF" id="Fact-8571B0081D18EFEBEE7D8E507F772443" unitRef="product">1</cerc:NumberOfMarketedMedicalDevices>
	<cerc:NumberOfPreclinicalTherapies contextRef="D2018Q3Sep2424_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="INF" id="Fact-B9D34789E1EDD9F7CE5F8E872043EBFE" unitRef="therapy">3</cerc:NumberOfPreclinicalTherapies>
	<cerc:NumberOfPreemptiveConversionOrSubscriptionRights contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="INF" id="Fact-08392EF095CA8027D98B8EDF39280829" unitRef="class_of_stock">0</cerc:NumberOfPreemptiveConversionOrSubscriptionRights>
	<cerc:NumberOfProductsInDevelopment contextRef="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember" decimals="INF" id="Fact-65ED47F7281BF4B9383A8E4EA9C2C234" unitRef="product">2</cerc:NumberOfProductsInDevelopment>
	<cerc:NumberOfProductsInDevelopment contextRef="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember" decimals="INF" id="Fact-666675A8855A766A2A068E502913DBD9" unitRef="product">1</cerc:NumberOfProductsInDevelopment>
	<cerc:NumberOfProductsInDevelopment contextRef="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_ThreePreclinicalTherapiesMember" decimals="INF" id="Fact-A91849F2DD8D687C579A8E4FA573DCA0" unitRef="product">3</cerc:NumberOfProductsInDevelopment>
	<cerc:NumberOfRedemptionOrSinkingFundProvisions contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="INF" id="Fact-6030E108274B96D0590E942C69914660" unitRef="class_of_stock">0</cerc:NumberOfRedemptionOrSinkingFundProvisions>
	<cerc:NumberofVotesPerShare contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="INF" id="Fact-697B40F49BE7705ED2448EDEE54A8C72" unitRef="Vote">1</cerc:NumberofVotesPerShare>
	<cerc:OperatingLeasesRentExpenseAnnualIncreasePercent contextRef="FD2019Q1YTD" decimals="3" id="Fact-A246F01A387310FEBC4B951780C4AE23" unitRef="number">0.025</cerc:OperatingLeasesRentExpenseAnnualIncreasePercent>
	<cerc:PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities contextRef="D2019Q1Mar31-31_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="INF" id="Fact-C0A8190AF6CDD95A979293D16CB7DC67" unitRef="usd">0</cerc:PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities>
	<cerc:PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities contextRef="D2021Q4Purchase-Dec31_cerc_AssetAcquisitionAxis_cerc_IchorionMember_cerc_MilestoneAxis_cerc_MilestoneOneMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="-6" id="Fact-29A38DD683B32FBC588293D0B61CDD0B" unitRef="usd">6000000</cerc:PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities>
	<cerc:PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities contextRef="D2021Q4Purchase-Dec31_cerc_AssetAcquisitionAxis_cerc_IchorionMember_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="-6" id="Fact-DEC112B82F72F492944493D0D6208FFE" unitRef="usd">5000000</cerc:PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities>
	<cerc:PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities contextRef="D2023Q4Purchase-Dec31_cerc_AssetAcquisitionAxis_cerc_IchorionMember_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="-6" id="Fact-0EAFA7EB456B3795B52A93D19328AF7A" unitRef="usd">4000000</cerc:PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities>
	<cerc:PotentialFutureRegulatoryMilestone contextRef="D2017Q3August" decimals="-6" id="Fact-D9CD88DE7D25B624C77F991942B26345" unitRef="usd">20000000</cerc:PotentialFutureRegulatoryMilestone>
	<cerc:RoyaltyObligationMeasurementInput contextRef="FI2019Q1_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputCounterpartyCreditRiskMember" decimals="3" id="Fact-D1F10E6C8C40810C32BA9402E5DD12B2" unitRef="number">0.061</cerc:RoyaltyObligationMeasurementInput>
	<cerc:RoyaltyObligationMeasurementInput contextRef="FI2019Q1_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember" decimals="3" id="Fact-665FEB7DDA4951FDBB639402690BBDD2" unitRef="number">0.084</cerc:RoyaltyObligationMeasurementInput>
	<cerc:RoyaltyObligationMeasurementInput contextRef="FI2019Q1_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember" decimals="3" id="Fact-4D03A12FDE36FCDA844C9402B3B51BC2" unitRef="number">0.023</cerc:RoyaltyObligationMeasurementInput>
	<cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear contextRef="I2016Q2Apr5_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember" decimals="INF" id="Fact-D814C98636E71623C1FA8DD4EC9963E1" unitRef="number">0.01</cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear>
	<cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease contextRef="D2016Q2MAY18_us-gaap_PlanNameAxis_cerc_The2016PlanMember" decimals="INF" id="Fact-A63323B58F33B13632088DD4ECA88FC2" unitRef="shares">600000</cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease>
	<cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease contextRef="D2018Q2May1-31_us-gaap_PlanNameAxis_cerc_The2016PlanMember" decimals="INF" id="Fact-BED5015728C5BBDEE8828EE1891C7059" unitRef="shares">1400000.0</cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease>
	<cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="0" id="Fact-71B2F25B12536C004F249450B5736863" unitRef="usd">11297</cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue>
	<cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="0" id="Fact-8386918F22613D94C1678DD4ECA8CD33" unitRef="usd">334624</cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue>
	<cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent contextRef="FD2019Q1YTD" decimals="2" id="Fact-D44206784CC0090192438DD4ECB88C2C" unitRef="number">0.04</cerc:ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent>
	<cerc:ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum contextRef="D2016Q2Apr5_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember" decimals="INF" id="Fact-DC4892772BAC6F7B0A718DD4ECA88FB1" unitRef="usd">25000</cerc:ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum>
	<cerc:SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember" decimals="INF" id="Fact-36759E29EFF0BD7AD2B99500A2A00625" unitRef="award">2</cerc:SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent contextRef="D2019Q2Apr1-1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember" decimals="2" id="Fact-EE56132165DB8A66A86994EDA747F956" unitRef="number">0.25</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent contextRef="D2019Q2Apr1-1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" decimals="2" id="Fact-EFD79F4E9FA39161749594EF05AFB63C" unitRef="number">0.75</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember" decimals="2" id="Fact-45D13FF717A88C9A6C6A94F31FE06F18" unitRef="number">0.33</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" decimals="2" id="Fact-2D5FA037E92CC515BE4894F337B14BDF" unitRef="number">0.67</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember" decimals="INF" id="Fact-CF03CB2C80BAE695777B94FF15C950BE" unitRef="installment">3</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember" decimals="INF" id="Fact-CD271A0505786CCB3BBC94F82620B041" unitRef="day">3</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" decimals="INF" id="Fact-8590949756CA1B75624294F84E20AB10" unitRef="day">3</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" decimals="INF" id="Fact-21C62AC976A7D152E5D394F83DF29D40" unitRef="day">3</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="INF" id="Fact-0DDF65DF201EEFC1046A94D7EBB97954" unitRef="day">3</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember" decimals="2" id="Fact-201A2995335D2B9388B994F63E1D41CC" unitRef="usdPerShare">8.00</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" decimals="2" id="Fact-C51B35F45C3E4DCD697B94F66B4E3AC9" unitRef="usdPerShare">13.00</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" decimals="2" id="Fact-94A4A88B428CEE2E1A4F94F65074837D" unitRef="usdPerShare">10.50</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor>
	<cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="2" id="Fact-85800AF63CD37A4EE13B94D62FACF866" unitRef="usdPerShare">12.50</cerc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor>
	<cerc:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised contextRef="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-C1AEA76FF00EFF42099590591230820E" unitRef="shares">143346</cerc:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised>
	<cerc:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-73DFBE7B0BC5637C6643905A95C3D541" unitRef="shares">31288</cerc:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised>
	<cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised contextRef="FD2018Q1YTD" decimals="0" id="Fact-147E39E3AD24A6EFC9DA90591FF864F4" unitRef="usd">363390</cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
	<cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised contextRef="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-85BC74D1D780584561A490591BF1FB33" unitRef="usd">363247</cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
	<cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised contextRef="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-021E5D671DDE749152BD905915073726" unitRef="usd">143</cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
	<cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised contextRef="FD2019Q1YTD" decimals="0" id="Fact-EA94E72FEC728D36730C905AA2F32472" unitRef="usd">94177</cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
	<cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-3C99A9461D4E1CDD0286905A9ED89A81" unitRef="usd">94146</cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
	<cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-F759ADD9BDECADE0A7D6905A97E54E4A" unitRef="usd">31</cerc:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
	<cerc:StockholdersEquityNotePreferredStockConversionRatio contextRef="D2018Q4Dec27-27_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="INF" id="Fact-210F3480FCDC2091B6DB94321C7503DD" unitRef="number">5</cerc:StockholdersEquityNotePreferredStockConversionRatio>
	<cerc:StockholdersEquityNotePreferredStockConversionRatio contextRef="FD2018Q4QTD_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="INF" id="Fact-1AC77109ECFA2A7580D593BAEC4DD280" unitRef="number">5</cerc:StockholdersEquityNotePreferredStockConversionRatio>
	<cerc:StockholdersEquityNotePreferredStockConversionRatio contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="INF" id="Fact-F6A0F5BBC7075D28B696942B8863C493" unitRef="number">5</cerc:StockholdersEquityNotePreferredStockConversionRatio>
	<dei:AmendmentFlag contextRef="FD2019Q1YTD" id="Fact-E9E3B12A1A126A97FBD28DD4EC994B0D">false</dei:AmendmentFlag>
	<dei:CurrentFiscalYearEndDate contextRef="FD2019Q1YTD" id="Fact-46155CA2FF20EFED3EF38DD4ECA81C0D">--12-31</dei:CurrentFiscalYearEndDate>
	<dei:DocumentFiscalPeriodFocus contextRef="FD2019Q1YTD" id="Fact-3DC5DFF3A7A01837D14A8DD4ECA8CDDB">Q1</dei:DocumentFiscalPeriodFocus>
	<dei:DocumentFiscalYearFocus contextRef="FD2019Q1YTD" id="Fact-7BC0B984FB2FB83027348DD4EC99B355">2019</dei:DocumentFiscalYearFocus>
	<dei:DocumentPeriodEndDate contextRef="FD2019Q1YTD" id="Fact-FE78A144A9BA2A52A9E68DD4EC993804">2019-03-31</dei:DocumentPeriodEndDate>
	<dei:DocumentType contextRef="FD2019Q1YTD" id="Fact-C351D6DAED987D3301D48DD4EC994416">10-Q</dei:DocumentType>
	<dei:EntityCentralIndexKey contextRef="FD2019Q1YTD" id="Fact-F528078814486CC59BC48DD4EC998D0E">0001534120</dei:EntityCentralIndexKey>
	<dei:EntityCommonStockSharesOutstanding contextRef="I2019Q2May3" decimals="INF" id="Fact-87A68A455C2223AE9AF48DD4ECA891FF" unitRef="shares">42753659</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityEmergingGrowthCompany contextRef="FD2019Q1YTD" id="Fact-9B6FB7300F276396763190302997B9AD">true</dei:EntityEmergingGrowthCompany>
	<dei:EntityExTransitionPeriod contextRef="FD2019Q1YTD" id="Fact-90F2DE1DBA685A4FC4A390302ADC35AD">true</dei:EntityExTransitionPeriod>
	<dei:EntityFilerCategory contextRef="FD2019Q1YTD" id="Fact-6F37A1E0D37F447B8A038DD4EC9955BB">Non-accelerated Filer</dei:EntityFilerCategory>
	<dei:EntityRegistrantName contextRef="FD2019Q1YTD" id="Fact-92672A4712EBDC74BD268DD4EC99CBB0">Cerecor Inc.</dei:EntityRegistrantName>
	<dei:EntitySmallBusiness contextRef="FD2019Q1YTD" id="Fact-4EE036AE0A9F02C9CF5C90302A37CE6F">true</dei:EntitySmallBusiness>
	<us-gaap:AccountsPayableCurrent contextRef="FI2018Q4" decimals="0" id="Fact-8F254522B495301EA3258DD4ECB8EC06" unitRef="usd">1446141</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent contextRef="FI2019Q1" decimals="0" id="Fact-1A892B49E718F521341A8DD4EC99041E" unitRef="usd">1249470</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms contextRef="FI2018Q4" decimals="0" id="Fact-F656B70C6E4E026542C78DD4ECA85364" unitRef="usd">5469011</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
	<us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms contextRef="FI2019Q1" decimals="0" id="Fact-5218FA7A2E508DFCB43A8DD4ECB80EEE" unitRef="usd">5531025</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
	<us-gaap:AccountsReceivableNet contextRef="FI2018Q4" decimals="0" id="Fact-768455815E9DA16089678DD4ECA8BECB" unitRef="usd">3157555</us-gaap:AccountsReceivableNet>
	<us-gaap:AccountsReceivableNet contextRef="FI2019Q1" decimals="0" id="Fact-5E1DAC5BE01DAA11B9C18DD4EC998FE9" unitRef="usd">2718396</us-gaap:AccountsReceivableNet>
	<us-gaap:AccruedIncomeTaxesCurrent contextRef="FI2018Q4" decimals="0" id="Fact-16F8AD5887E03F421F8F8DD4EC99DD28" unitRef="usd">2032258</us-gaap:AccruedIncomeTaxesCurrent>
	<us-gaap:AccruedIncomeTaxesCurrent contextRef="FI2019Q1" decimals="0" id="Fact-D3B2E12903C146C3AD1A8DD4ECA8EA10" unitRef="usd">1814650</us-gaap:AccruedIncomeTaxesCurrent>
	<us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="FI2018Q4" decimals="0" id="Fact-5E2A2A97C564B7B6EC2B8DD4ECA8AC77" unitRef="usd">19731373</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
	<us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="FI2019Q1" decimals="0" id="Fact-3816AC4C14C4FBC880158DD4ECA8906F" unitRef="usd">21815097</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
	<us-gaap:AccruedMarketingCostsCurrent contextRef="FI2018Q4" decimals="0" id="Fact-1B73B69070A2BD8BA976941EB1750EC8" unitRef="usd">1112378</us-gaap:AccruedMarketingCostsCurrent>
	<us-gaap:AccruedMarketingCostsCurrent contextRef="FI2019Q1" decimals="0" id="Fact-3DAC6213B72225E83E73941EC6B8824F" unitRef="usd">938437</us-gaap:AccruedMarketingCostsCurrent>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MetafolinMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" id="Fact-C19CBE11A253A954268B8E987AC37A00">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MillipredMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" id="Fact-2187E407F62171FD048A8E989B90FDC7">P4Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember" id="Fact-8D99639E3184BE3CBED28E988B2AFD6A">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2018Q1Feb16-16_srt_ProductOrServiceAxis_cerc_AcipHexMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" id="Fact-10D0E13BAA9DBB6632FF8E8C294F9630">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2018Q1Feb16-16_srt_ProductOrServiceAxis_cerc_CefaclorMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" id="Fact-FE29184961583E1ABD978E8C37C8781B">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2018Q1Feb16-16_srt_ProductOrServiceAxis_cerc_FlexichamberMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" id="Fact-629E3D6C76B53187B6D18E8C474844B6">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2018Q1Feb16-16_srt_ProductOrServiceAxis_cerc_KarbinalMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" id="Fact-8EE404D6128426147A308E8C1B596D42">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AdditionalPaidInCapital contextRef="FI2018Q4" decimals="0" id="Fact-EECB2B21C5C0E8FB17248DD4ECA87E3C" unitRef="usd">119082157</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital contextRef="FI2019Q1" decimals="0" id="Fact-D941A5EAC598A04DF2BC8DD4EC891154" unitRef="usd">128747037</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="FD2018Q1YTD" decimals="0" id="Fact-4EAE12D3798C8699F0F2905976F31E7A" unitRef="usd">242824</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-B7097125B7B9443B72CD905972F54F5D" unitRef="usd">242824</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="FD2019Q1YTD" decimals="0" id="Fact-956C148892007ED5B50A905AAB863445" unitRef="usd">596693</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-FBFB35CF58E5A5C2D153905AA77EF721" unitRef="usd">596693</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q1YTD" decimals="0" id="Fact-2E055EF5ED8A9FB9822E8DD4ECB8F066" unitRef="usd">242824</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" decimals="0" id="Fact-DC93112D6066E4A8FB418DD4ECB8EC95" unitRef="usd">207382</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" decimals="0" id="Fact-E24466B25281B1337F3C8DD4EC99AFEB" unitRef="usd">11497</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember" decimals="0" id="Fact-100820719261DB0BC7E98DD4ECA8ECA3" unitRef="usd">23945</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2019Q1YTD" decimals="0" id="Fact-0FEE80C0DE3599045BD08DD4ECB894E5" unitRef="usd">596693</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="0" id="Fact-5C73B79C4A2E6CE8E2348EE629A89DFD" unitRef="usd">118656</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2019Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" decimals="0" id="Fact-FCB36ADDD57BC265234F8DD4ECA848A6" unitRef="usd">489953</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2019Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" decimals="0" id="Fact-141EDA4F77A710832C5A8DD4ECB8F485" unitRef="usd">57376</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2019Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember" decimals="0" id="Fact-C0E11A4A73FB680A60878DD4ECB88D82" unitRef="usd">49364</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2019Q1YTD_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember" decimals="0" id="Fact-84A09CF0A9B41D3389768DD4ECA89E35" unitRef="usd">35298</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2018Q1YTD" decimals="0" id="Fact-2A99147EDDB2294BD4928DD4ECA860B1" unitRef="usd">1017408</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2019Q1YTD" decimals="0" id="Fact-1E542FADCD3BF6A6F6C78DD4ECA8B89B" unitRef="usd">1078847</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2018Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember" decimals="0" id="Fact-09B937AF4FB83E72DD468DD4EC996EFC" unitRef="shares">3909384</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2018Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_RestrictedStockAwardsMember" decimals="0" id="Fact-2425D381D523869ADAC98E6A6E574FBA" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2018Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_UnderwritersUnitPurchaseOptionMember" decimals="0" id="Fact-DED811885DF976FCC5898DD4ECB8E651" unitRef="shares">40000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2018Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_WarrantCommonStockMember" decimals="0" id="Fact-306B9CA92229CF6FA45C8DD4ECA844D8" unitRef="shares">18986659</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2019Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember" decimals="0" id="Fact-DE08F4A8E7F4F370942A8DD4ECB826FA" unitRef="shares">4345305</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2019Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_RestrictedStockAwardsMember" decimals="0" id="Fact-B405CF0337B4F2950CF98E6A5D118E56" unitRef="shares">345000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2019Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_UnderwritersUnitPurchaseOptionMember" decimals="0" id="Fact-38F0E9EB746A77CE78D18DD4ECA89E23" unitRef="shares">40000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2019Q1YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_WarrantCommonStockMember" decimals="0" id="Fact-AE447B2AFDA82FACE79C8DD4ECA80940" unitRef="shares">4024708</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:Assets contextRef="FI2018Q4" decimals="0" id="Fact-141F02DADFE1A72A762E8DD4ECB802E0" unitRef="usd">70250721</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2019Q1" decimals="0" id="Fact-AB7A12EFCF92642FA6C08DD4ECB81CD0" unitRef="usd">74870031</us-gaap:Assets>
	<us-gaap:AssetsCurrent contextRef="FI2018Q4" decimals="0" id="Fact-EA9910A418791B4950DE8DD4ECA8EF48" unitRef="usd">21931893</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent contextRef="FI2019Q1" decimals="0" id="Fact-71E83A79B01F5D3AFADE8DD4ECA80948" unitRef="usd">26744102</us-gaap:AssetsCurrent>
	<us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-235A52C3DE6BDEDD592B8ED99D709BE8" unitRef="usd">8100000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
	<us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="INF" id="Fact-9012AA860C797A3B94518E8D8B592E30" unitRef="shares">7534884</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
	<us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-5022521D651AF8A8648F8E8EA7F1F564" unitRef="usd">8700000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
	<us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="FD2018Q1YTD_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-7DA34EE91F441B98047D8DD4ECA80AD9" unitRef="usd">-4928446</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
	<us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="FD2018Q1YTD_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-B93355ED95EA5F9402048DD4ECA8E76F" unitRef="usd">6187775</us-gaap:BusinessAcquisitionsProFormaRevenue>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-DFA88AE465419B97BD478E93B2CBB64C" unitRef="usd">29991052</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-EC95DC215AA9C80300E98E93B98E8233" unitRef="usd">28781052</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2018Q1Feb16-16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-54F0F9A27668ADE3E2238E8ADC37CC93" unitRef="usd">241000</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2018Q1Feb16-16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-F4A3852657742906FA618E8AE04166AD" unitRef="usd">1</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="D2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-1B4D2E8C265C16AE0C9E8E8FFDE6AFA8" unitRef="usd">8514419</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
	<us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-2BC6C0B26C3A72C73DC58E8DBE2FB32B" unitRef="usd">8500000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
	<us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-B591DF4D54800D7B3C5D8E9002535384" unitRef="usd">8514419</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="FD2018Q1YTD" decimals="0" id="Fact-2ECD97E4772492A779C48DD4ECB8EED7" unitRef="usd">262769</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="FD2019Q1YTD" decimals="0" id="Fact-322B3BF956063356A83E8DD4EC99AA29" unitRef="usd">180402</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q4_cerc_MilestoneAxis_cerc_MilestoneOneMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="INF" id="Fact-1D11F747AE87D8B175BC94044912875A" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-5303D3ADC92312C5B4A494070AD3A4B8" unitRef="usd">400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-CFA5F65AB16469273E929404FA9AFBFE" unitRef="usd">900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2017Q4Nov17-17_cerc_MilestoneAxis_cerc_MilestoneOneMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-A5DBB745D19DCC8393EE940369ACA2AF" unitRef="usd">3000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2017Q4Nov17-17_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-47B8667F10FB2CB8C2AC9404B85359A3" unitRef="usd">2000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2017Q4Nov17-17_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-6C6B4309E63EBD1DB5EA94047F5B75AA" unitRef="usd">2000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-A9FFFE641ADD6ADC8D358E9004D8AF9D" unitRef="usd">2576633</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-4DCBB28908ECBF319A728E900989CCDE" unitRef="usd">1366633</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="-5" id="Fact-4F0EED5596011F48929F8E882AF48E2B" unitRef="usd">7900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="FI2018Q4" decimals="0" id="Fact-21B99B35D0164E97994A8DD4ECA82DCA" unitRef="usd">1956807</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="FI2019Q1" decimals="0" id="Fact-463CE44445A78C581BB98DD4ECB84397" unitRef="usd">2205647</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember" decimals="3" id="Fact-06C0E8217C2A8F1E53B694074B8F11B1" unitRef="number">0.225</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputCounterpartyCreditRiskMember" decimals="3" id="Fact-941B1A0FC1A6BD37839E9408D46A58D9" unitRef="number">0.061</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember" decimals="3" id="Fact-08E3B61B6ACA199A47BC94085FE9B89B" unitRef="number">0.084</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneThreeMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember" decimals="3" id="Fact-8F115E9238E7BC8CF48E94087FCD9BCF" unitRef="number">0.023</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember" decimals="3" id="Fact-3CD7BC8DB156B5542D8594054053E545" unitRef="number">0.450</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputCounterpartyCreditRiskMember" decimals="3" id="Fact-14A4B2A67977F76502E09406C46349EE" unitRef="number">0.061</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember" decimals="3" id="Fact-4BCFC4C5D0FE1D7CA5CE9406567BABD4" unitRef="number">0.085</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="FI2019Q1_cerc_MilestoneAxis_cerc_MilestoneTwoMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember" decimals="3" id="Fact-E37A14227A032E01EB0F94068C13246C" unitRef="number">0.024</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2018Q4" decimals="0" id="Fact-86AFF83C2025FB3E14568DD4ECA89B48" unitRef="usd">7093757</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2019Q1" decimals="0" id="Fact-6D9EA2F25F03455E7FA48DD4ECA8E5F1" unitRef="usd">6796641</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-B5BBC6DBA409BD04C9108E93B72929B4" unitRef="usd">-1210000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred contextRef="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-82BC7F720F369594DBF58E8ADE34B156" unitRef="usd">-240999</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="D2018Q3Nov18-Sep30_srt_ProductOrServiceAxis_cerc_MetafolinMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-D8E43E413D4F26EB11F98E934A5CA88C" unitRef="usd">1522000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="D2018Q3Nov18-Sep30_srt_ProductOrServiceAxis_cerc_MillipredMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-2F83242173C6BF06A3FE8E935F8683BC" unitRef="usd">342000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="D2018Q3Nov18-Sep30_srt_ProductOrServiceAxis_cerc_UlesfiaMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-ECDA392D565A4C6E00268E936B666179" unitRef="usd">-555000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-88EFE216719300DA49CF8E98B05AC628" unitRef="usd">1528000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember" decimals="0" id="Fact-7C0F35080B755AF473818E9355B89F1A" unitRef="usd">219000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_AcipHexMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-3B40563E84D4F5727C908E8C22B05104" unitRef="usd">283000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_CefaclorMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-F276E3F4CC5560F910B48E8C31417327" unitRef="usd">1320000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_FlexichamberMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="0" id="Fact-3ECBFF31E79F01DDC5588E8C3FE81B4E" unitRef="usd">546000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_KarbinalMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-D2623B25CFB880E730208E8C14473A67" unitRef="usd">-21000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="FD2018Q2QTD_srt_ProductOrServiceAxis_cerc_LiquiTimeProcessMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="0" id="Fact-F6C2C63EA4BAD9F810438E8C4FBF2C44" unitRef="usd">-290000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-4C39C419D571DC2B33D68E8C5A968A83" unitRef="usd">1838000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-FA78B537D013919E202F8E91DF64CB75" unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
	<us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory contextRef="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-C5E0369F91B5D19215B08E8AB397E604" unitRef="usd">-1831000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-0815FB03D6D22C81F62F8E937512E923" unitRef="usd">21581671</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-64DD174731EF81EDE0288E937B26CDC2" unitRef="usd">25874186</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-1DE34D48382A188CD6478E91CBF79F55" unitRef="usd">11068</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-AD3B45356F9A08109C2D8E91D0B41648" unitRef="usd">11068</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability contextRef="I2018Q1Feb16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-47E9381B31A75586F08E8E8AD261806F" unitRef="usd">7875165</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-4033D85E04C417E55B9C8E8AD75B897A" unitRef="usd">7920000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-792CD0C9268F32B464E78E932B8DB722" unitRef="usd">134281</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-0C81CB419D93CFFA4C5C8E93332F8BE1" unitRef="usd">134281</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets contextRef="I2018Q1Feb16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-9211587B2251A0C08F078E8AB7A7AEEC" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-E17B0B1B3FD4B8AE75238E8ABD2EC75E" unitRef="usd">570000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-C5B9AF2CDB9025E1EF778E91D27AA541" unitRef="usd">2872545</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-A68DB79A91ACA8CED5868E91D81B1B08" unitRef="usd">2872545</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-0BBA5FEAB1F036BDC20A8E938AC341D0" unitRef="usd">192706</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-4CB22387F0CE4A98C00F8E93903918D2" unitRef="usd">192706</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-E8DD29497FF04D7D2AB38E939A03C18D" unitRef="usd">839773</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-E8D6E3DB3EE893908B928E939F239E92" unitRef="usd">918613</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MetafolinMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-1B3F0BF76255D22594178E934519F2B9" unitRef="usd">10465000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MetafolinMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-26589834BF22C1EB23388E934E38C714" unitRef="usd">11987000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MillipredMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-21AC78FEA0B4385A1A6B8E935B3D6D76" unitRef="usd">4714000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_MillipredMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-94678ABB9635BFA99F088E9363509E6A" unitRef="usd">5056000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_UlesfiaMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-FEE3D29A1646F3847ACE8E9366F5C438" unitRef="usd">555000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_srt_ProductOrServiceAxis_cerc_UlesfiaMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-389E54241A82505CE9178E93701CFE75" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-563AE1A38E8A0D0075638E98AD950A06" unitRef="usd">18068000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember" decimals="0" id="Fact-21FBA02D13096331D79C8E9352056649" unitRef="usd">2334000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-3F73FA703A14F66B0F228E98B2289240" unitRef="usd">19596000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember" decimals="0" id="Fact-72F17A7C368727D5F4C68E935893D4AA" unitRef="usd">2553000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_AcipHexMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-5B5037FB9BF10CEFEA758E8C1E675D53" unitRef="usd">2520000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_AcipHexMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-E6AD38688C96EB8FF6D38E8C2630593B" unitRef="usd">2803000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_CefaclorMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-DE5A7B7F05371C8D59A88E8C2CE40CC9" unitRef="usd">6291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_CefaclorMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-E278AD8A97BC02F18A2D8E8C34BB3AAB" unitRef="usd">7611000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_FlexichamberMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="0" id="Fact-01EC08614388C64C35988E8C3B56DD26" unitRef="usd">1131000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_FlexichamberMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="0" id="Fact-5144843BE4CE44F8A3B38E8C4380877B" unitRef="usd">1677000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_KarbinalMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-BFF519AEB1B01D77FA098E8C0FCCFEA5" unitRef="usd">6221000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_KarbinalMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AcquiredProductMarketingMember" decimals="0" id="Fact-69C7ABA04422577E1E1A8E8C17BB4ADE" unitRef="usd">6200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_LiquiTimeProcessMember_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="0" id="Fact-40B12BF2B5057FAC8A2E8E8C4B1DB257" unitRef="usd">290000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_ProductOrServiceAxis_cerc_LiquiTimeProcessMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="0" id="Fact-45D8637785D4FED84F1A8E8C5378FCE4" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-51CBA043C2E2F4BF95EF8E8C57B24616" unitRef="usd">16453000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-F0525F6A1CC55D9619248E8C5C6E5C83" unitRef="usd">18291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-9BBAEA63CE3AD1B293E28E91DAF65361" unitRef="usd">495777</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-0F163DFAFA83068FF45F8E91E1EA4B44" unitRef="usd">495777</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="I2018Q1Feb16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-BD9EFBEF19528BD784798E8AAF43D7F2" unitRef="usd">2549000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-480CADB87521683F492A8E8AB5E24B38" unitRef="usd">718000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-F12FDC9EED78E26195398E93A19E40B8" unitRef="usd">5882901</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-E67E17FFB4B8D84D9C3E8E93A67FF0E3" unitRef="usd">9726256</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-BD7B670EBF08283174538E93A8E567D0" unitRef="usd">15698770</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-BC4ABF0149EC1D0B73938E93AFC4E3B3" unitRef="usd">16147930</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="I2018Q1Feb16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-C45D57F1C2EBE2C7769B8E8AD990CBF6" unitRef="usd">-4145468</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-5E43BEA0BAC0FDAB37B68E8ADB324E25" unitRef="usd">-3778000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt contextRef="FI2018Q1" decimals="0" id="Fact-61B349A0408C29E866EA8DD4EC894E4C" unitRef="usd">15075000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt contextRef="FI2019Q1" decimals="0" id="Fact-5FD8171D527B960697B290447168866D" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt contextRef="I2018Q1Feb16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-B9588871A75767C804B78E8ACBD7D685" unitRef="usd">15272303</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="-5" id="Fact-78DCAC8454CCF17679488E880B875558" unitRef="usd">15100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-885F07C9793C220136108E8AD0639915" unitRef="usd">15075000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2018Q1" decimals="0" id="Fact-6E826A53FE695B8930B58DD4EC99C3EF" unitRef="usd">2523927</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2018Q4" decimals="0" id="Fact-E6BB5AD6F3FCE5D5F8B48DD4ECA804BF" unitRef="usd">10646301</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2019Q1" decimals="0" id="Fact-A0D8BA4FFCB6006BC9008DD4ECA83589" unitRef="usd">16121388</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2019Q1" decimals="-5" id="Fact-1F73146BD9D3300580318DD4EC89862C" unitRef="usd">16100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-F425AFF578392408EEC48EBF76057917" unitRef="usd">7324932</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-B5ECCB5FB8BC6624BDA78EBEABF6B5C0" unitRef="usd">13965626</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="FI2017Q4" decimals="0" id="Fact-8DE690CED2D53AA6C6DF8DD4EC8975BC" unitRef="usd">2605499</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
	<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="FI2018Q1" decimals="0" id="Fact-CBFE49C1AC88E7CEBA858DD4ECA8FA00" unitRef="usd">2669241</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
	<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="FI2018Q4" decimals="0" id="Fact-2636777E6C97E5FCDCDE8DD4EC899901" unitRef="usd">10746756</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
	<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="FI2019Q1" decimals="0" id="Fact-F7B1E7D4938D567843FF8DD4EC8983E2" unitRef="usd">16276352</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
	<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="FD2018Q1YTD" decimals="0" id="Fact-9475D7833022E36B8CAB8DD4EC899F93" unitRef="usd">63742</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
	<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="FD2019Q1YTD" decimals="0" id="Fact-5A00C1CE826FB690E7928DD4EC89A854" unitRef="usd">5529596</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
	<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="FI2017Q4_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="INF" id="Fact-489A6DD950281ECD20369428817E967F" unitRef="usdPerShare">0.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
	<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="FI2019Q1_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsExpirationDateJune2024Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="2" id="Fact-7A6D29987A7BE1FD69258EDBF822E458" unitRef="usdPerShare">12.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
	<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="FI2019Q1_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsExpirationMay2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="2" id="Fact-590CF64BB32D0AE986D58EDBB3DC7F38" unitRef="usdPerShare">8.68</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
	<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="FI2019Q1_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsExpirationOctober2020Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="2" id="Fact-D1ACF54A22CB00A8CE038EDB59CDD5CE" unitRef="usdPerShare">8.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
	<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="I2018Q4Dec27_us-gaap_ClassOfWarrantOrRightAxis_cerc_IncentiveWarrantsMember" decimals="INF" id="Fact-7C465835DA590DBE4B9F94332FE71946" unitRef="usdPerShare">12.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="FI2014Q4_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="INF" id="Fact-9B69ACBCFA186254C9BF93F87DDA573B" unitRef="shares">625208</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="FI2015Q4_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsMember" decimals="INF" id="Fact-030030FB3AD38CF9DF638EBCDDA617C7" unitRef="shares">40000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="FI2017Q4_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="INF" id="Fact-7149671B626FA5D05FF9943241DE7230" unitRef="shares">14285714</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="FI2019Q1_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cerc_WarrantCommonStockMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="INF" id="Fact-D1E90C3AD6165DF724758EDCD56F76CE" unitRef="shares">4024708</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="FI2019Q1_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsExpirationDateJune2024Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="INF" id="Fact-AF41D1CE8BA856969FC48EDC9A0F281F" unitRef="shares">4000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="FI2019Q1_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsExpirationMay2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="INF" id="Fact-A0B2394C927F52F764098DD4EC99BC7D" unitRef="shares">2380</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="FI2019Q1_us-gaap_ClassOfWarrantOrRightAxis_cerc_CommonStockWarrantsExpirationOctober2020Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" decimals="INF" id="Fact-66577F2CCB3114DDC2EE8DD4ECA8E4F0" unitRef="shares">22328</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="I2015Q3OCT31_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-02EBC6996739F661701E93F8A44493CE" unitRef="shares">22328</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
	<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="I2018Q4Dec27_us-gaap_ClassOfWarrantOrRightAxis_cerc_IncentiveWarrantsMember" decimals="INF" id="Fact-E9F03731A881EBE28C9494298E130839" unitRef="shares">4000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
	<us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="I2016Q2Apr5_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember" decimals="INF" id="Fact-A45DBC2BE09CEAA4E5AB8DD4ECB8C0D5" unitRef="shares">500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2018Q4" decimals="INF" id="Fact-00AE7123ABE62E1EEDDC8DD4ECB81F50" unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2019Q1" decimals="INF" id="Fact-9D2A15093B4F75A76B5B8DD4ECB83BEF" unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="I2018Q3Aug17" decimals="INF" id="Fact-400CB7802FF5A201E9508EDE43AAA118" unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="I2018Q3Sep24" decimals="INF" id="Fact-82F345E8B139B8E05DEC8E8671A3D842" unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2018Q4" decimals="INF" id="Fact-E769843B3D717C101E3C8DD4EC897916" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2019Q1" decimals="INF" id="Fact-00F823558BD6FED89BC28DD4ECB8E9A2" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued contextRef="FI2018Q4" decimals="INF" id="Fact-0482311A6D1A14E2A3218DD4ECB8BD3D" unitRef="shares">40804189</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued contextRef="FI2019Q1" decimals="INF" id="Fact-8BDC9391B597E8C946078DD4ECB83EAB" unitRef="shares">42753659</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding contextRef="FI2018Q4" decimals="INF" id="Fact-155AEDCC3584CAC6A4E58DD4ECB8866B" unitRef="shares">40804189</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding contextRef="FI2019Q1" decimals="INF" id="Fact-803E30DA795660EAFA258DD4ECA83178" unitRef="shares">42753659</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockValue contextRef="FI2018Q4" decimals="0" id="Fact-68857C397C0680B823C88DD4ECA86C69" unitRef="usd">40804</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue contextRef="FI2019Q1" decimals="0" id="Fact-1C9AD806B4412A3C6C578DD4ECA838C8" unitRef="usd">42754</us-gaap:CommonStockValue>
	<us-gaap:ConcentrationRiskPercentage1 contextRef="FD2019Q1YTD_srt_MajorCustomersAxis_cerc_MajorCustomerNumberOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" decimals="2" id="Fact-AE21777D5F3251F51D5F93AD2793F20A" unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
	<us-gaap:ConcentrationRiskPercentage1 contextRef="FD2019Q1YTD_srt_MajorCustomersAxis_cerc_MajorCustomerNumberThreeMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" decimals="2" id="Fact-3A8EA31FF41AEB3F0EE393AD279A0830" unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
	<us-gaap:ConcentrationRiskPercentage1 contextRef="FD2019Q1YTD_srt_MajorCustomersAxis_cerc_MajorCustomerNumberTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" decimals="2" id="Fact-B697F458727346BC248F93AD278F65D0" unitRef="number">0.33</us-gaap:ConcentrationRiskPercentage1>
	<us-gaap:ContractualObligation contextRef="FI2019Q1" decimals="0" id="Fact-F1677297D7437CD0AAB595304BF2B7A4" unitRef="usd">7458372</us-gaap:ContractualObligation>
	<us-gaap:ContractualObligationDueInFourthYear contextRef="FI2019Q1" decimals="0" id="Fact-E3DBD5719408E5C54CAC95304AE63D5C" unitRef="usd">0</us-gaap:ContractualObligationDueInFourthYear>
	<us-gaap:ContractualObligationDueInSecondYear contextRef="FI2019Q1" decimals="0" id="Fact-412C6AB4A4F85373E748953048A8941C" unitRef="usd">4265378</us-gaap:ContractualObligationDueInSecondYear>
	<us-gaap:ContractualObligationDueInThirdYear contextRef="FI2019Q1" decimals="0" id="Fact-5E40BA86F94B45AC611D953049A8E943" unitRef="usd">0</us-gaap:ContractualObligationDueInThirdYear>
	<us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear contextRef="FI2019Q1" decimals="0" id="Fact-57F56EE336785A204FE99533110BE9DD" unitRef="usd">3192994</us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear>
	<us-gaap:CostOfGoodsAndServicesSold contextRef="FD2018Q1YTD" decimals="0" id="Fact-262342469CC8E0BE7D2C8DD4ECA816DA" unitRef="usd">863624</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:CostOfGoodsAndServicesSold contextRef="FD2019Q1YTD" decimals="0" id="Fact-B0F73BAED2CB978220CD8DD4ECA8C02C" unitRef="usd">1947892</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:CostOfGoodsAndServicesSold contextRef="FD2019Q1YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="-5" id="Fact-F3646360609AD2C2971D954926DDECDF" unitRef="usd">600000</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2019Q1_us-gaap_DebtInstrumentAxis_cerc_DeerfieldObligationMember" decimals="-5" id="Fact-C2B1383D3272D58A15658ED3D50A3EAC" unitRef="usd">15400000</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentPeriodicPayment contextRef="D2020Q4Jul2018-Oct2020_us-gaap_DebtInstrumentAxis_cerc_DeerfieldObligationMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="INF" id="Fact-79D17D1AB43061D1F1098ED33D153B9D" unitRef="usd">262500</us-gaap:DebtInstrumentPeriodicPayment>
	<us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid contextRef="I2021Q1Jan31_us-gaap_DebtInstrumentAxis_cerc_DeerfieldObligationMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="INF" id="Fact-841CDCD3035C1F025DD68ED396B95ED8" unitRef="usd">15250000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2018Q1YTD" decimals="0" id="Fact-EBD8D2120CDB9E7E60BF8DD4ECA894A7" unitRef="usd">15913</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2019Q1YTD" decimals="0" id="Fact-BC6AFCB88F153924903E8DD4EC996F5B" unitRef="usd">5941</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="FI2018Q4" decimals="0" id="Fact-5088077921823D373B438DD4EC9910A9" unitRef="usd">69238</us-gaap:DeferredIncomeTaxLiabilitiesNet>
	<us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="FI2019Q1" decimals="0" id="Fact-03D002ACC743E63B87178DD4ECB8D7B1" unitRef="usd">75179</us-gaap:DeferredIncomeTaxLiabilitiesNet>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2018Q1YTD" decimals="0" id="Fact-BCFFE08842CE2D7CDDDF8DD4ECA8A9AA" unitRef="usd">1023040</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2019Q1YTD" decimals="0" id="Fact-E371049F91A72FD5064A8DD4EC8943E7" unitRef="usd">1098478</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:EarningsPerShareBasicAndDiluted contextRef="FD2018Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="2" id="Fact-378EF05C3663816C2A57903E27D18882" unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted contextRef="FD2018Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember" decimals="2" id="Fact-F50A77149ACC38B7B8E4903E27D6E5AE" unitRef="usdPerShare">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="2" id="Fact-26A77EE28B1597762F26903E27CC1C20" unitRef="usdPerShare">-0.13</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember" decimals="2" id="Fact-1091640832A2ED76AD9B903E27DB99A7" unitRef="usdPerShare">-0.67</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2018Q4" decimals="0" id="Fact-9E610AF6D460FEC6BDB28ECF522262B9" unitRef="usd">1953065</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2019Q1" decimals="0" id="Fact-85E1DD6E89EE73EBE7DA8ECF51E67A75" unitRef="usd">1679572</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" id="Fact-091F52DAD700412F5B0D94CDBE2A6BA5">P2Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" id="Fact-EF24881172A4669E106D8DD4ECB84ACC">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" id="Fact-6A25F59E0EF6D6189CAA8EE68F7A9558">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="FI2019Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="0" id="Fact-AD868D20BC408C146E4E8EE66B08E01E" unitRef="usd">1433329</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="-5" id="Fact-D4540BFA1C52E0353AEB94CD47C8D3DD" unitRef="usd">3100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="0" id="Fact-8F34A5D388DDEB61AC608DD4ECB8626F" unitRef="usd">805068</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
	<us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount contextRef="FI2018Q1" decimals="INF" id="Fact-92C325DB66DEC45E31608DD4EC894BFA" unitRef="usd">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
	<us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount contextRef="FI2019Q1" decimals="INF" id="Fact-22EA3BF71050FF2DB93D8DD4EC997244" unitRef="usd">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
	<us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount contextRef="FI2018Q1" decimals="INF" id="Fact-81BF65F79EB6574498438DD4ECB8BA84" unitRef="usd">0</us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-73E3ED9397A7BD560D0C8EBF4E61C35E" unitRef="usd">9050564</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-550144A385A0D70B41898EBF5622F914" unitRef="usd">7216</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-4B55708F460C491396298EBF521BABC6" unitRef="usd">2950</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-F3AFBE096C444A5EE6D38EBEF23808E1" unitRef="usd">9002288</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-5762899A72C921D7B96F8EBEF99AEE1B" unitRef="usd">39993</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-12BC3CC1F0B1F06AE2AA8EBEF5F3DFA7" unitRef="usd">17750</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2018Q1YTD" decimals="0" id="Fact-FC3918C259A0B77C8D8E903B273512FE" unitRef="usd">-262769</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="0" id="Fact-6680DE4AB498FF34D1418EC6277BB1FE" unitRef="usd">-286020</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember" decimals="0" id="Fact-3F21E0D78711E24F81A98EC608C31E5F" unitRef="usd">-199283</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember" decimals="0" id="Fact-E9B295A3DA0B9D81A0948EC60549C8DA" unitRef="usd">-15846</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_RoyaltyPayableMember" decimals="0" id="Fact-4C9C1ACBD175E551E47A8EC623694304" unitRef="usd">-63486</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-D5C869C91628F62E1DAC8EC600C753B5" unitRef="usd">-7405</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2019Q1YTD" decimals="0" id="Fact-6257F9E2D3E4100768BC903B03B43CDF" unitRef="usd">-180402</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="0" id="Fact-FB9D7A9459819D972F838EC178A2BE8A" unitRef="usd">-227979</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember" decimals="0" id="Fact-9CF5046DFBDAB5592DDE8EC174E33D9C" unitRef="usd">-180402</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember" decimals="0" id="Fact-E96B4FD990468345B3238EC17127AC5A" unitRef="usd">-32777</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-D468E59140533FE252828EC16C9D8E8D" unitRef="usd">-14800</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues contextRef="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="0" id="Fact-DF8FCE232937B46AE5EE8EC5BB8C615C" unitRef="usd">8115909</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues contextRef="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember" decimals="0" id="Fact-A8A4AE804A38AAB5F0918EC507CB4200" unitRef="usd">7875165</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues contextRef="FD2018Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_RoyaltyPayableMember" decimals="0" id="Fact-66B2DF25FE7AB3DC28C68EC52231E0FB" unitRef="usd">240744</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues contextRef="FD2018Q2QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_RoyaltyPayableMember" decimals="INF" id="Fact-066367455B70E2190F81940B32B0E821" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="0" id="Fact-4C8974868E9DB63EC08A8EC1A72D4440" unitRef="usd">228678</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2019Q1YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember" decimals="0" id="Fact-EEC42A4F0EC29AFF58678EC1A2F6A7A6" unitRef="usd">228678</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="0" id="Fact-E12A670CA67B990AB3F38EC3F5F78C39" unitRef="usd">2611809</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember" decimals="0" id="Fact-CD57A009BA2835830B4F8EC3A7D0AD02" unitRef="usd">2576633</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember" decimals="0" id="Fact-78B5E8E1CE1AC516CED58EC3A454EDE8" unitRef="usd">26991</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_RoyaltyPayableMember" decimals="0" id="Fact-D04C8F225D1FEDE7250E8EC3AADE15F0" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-7ACC46142A9104CF294B8EC39F99B9FD" unitRef="usd">8185</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="0" id="Fact-D9CD85EDB40317B00A7F8EC6ABFE6E68" unitRef="usd">11013738</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember" decimals="0" id="Fact-865A26B0C80CDBB800EB8EC6A0C50789" unitRef="usd">10651081</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember" decimals="0" id="Fact-548C2093EAA90BA69B578EC69CFB1658" unitRef="usd">42837</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_RoyaltyPayableMember" decimals="0" id="Fact-25B6EA379471237DB1EE8EC6A423E765" unitRef="usd">304230</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-6F26D6A1E894111B0A028EC69869D9EA" unitRef="usd">15590</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="0" id="Fact-A25D0DA4C8A1FD5DAAAF8EC0D44EE24B" unitRef="usd">9060730</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember" decimals="0" id="Fact-656CC612095C09EFB1018EC0D1851044" unitRef="usd">9050564</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember" decimals="0" id="Fact-9DB322302CFD2E2276188EC0CE957B7F" unitRef="usd">7216</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-38B23ED94EE0C1D559E38EC0CA0B6EBC" unitRef="usd">2950</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="0" id="Fact-0B9DFEEC2068A068B7BA8EC115386BB8" unitRef="usd">9060031</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_ContingentConsiderationMember" decimals="0" id="Fact-3D577D2A9C2FFEF742128EC1128351B0" unitRef="usd">9002288</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember" decimals="0" id="Fact-0AB4C6DA36557B8F77A08EC10F627617" unitRef="usd">39993</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="0" id="Fact-F5D8EC40F52C0CFB19C68EC10B51A71D" unitRef="usd">17750</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="D2018Q3Sep2424_cerc_AssetAcquisitionAxis_cerc_IchorionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_AssembledWorkforceMember" id="Fact-68CC8BCB6D8316F96C468E877100AD53">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure contextRef="FI2018Q2_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cerc_PAISalesAndMarketingAgreementMember" decimals="INF" id="Fact-016D29206333830E9B5092E18F5DDAA2" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="FD2018Q1YTD" decimals="0" id="Fact-FF86697419C424F527138DD4ECA88804" unitRef="usd">2918916</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="FD2019Q1YTD" decimals="0" id="Fact-09C5DBEDD5432021D3D78DD4ECA879AC" unitRef="usd">2716983</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:Goodwill contextRef="FI2018Q4" decimals="0" id="Fact-3C6D6105FC6BD28495548DD4ECB8DC98" unitRef="usd">16411123</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2019Q1" decimals="0" id="Fact-6D32435B0186E258A0AD8DD4ECA8B740" unitRef="usd">16411123</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-F36AFA80D5D66BDD39AB8E93BC810367" unitRef="usd">14292282</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-4341506159EBB63941128E8E7C4866CA" unitRef="usd">12600000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-ADAC47CB2179A6FE45128E93C24932A3" unitRef="usd">12633122</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2018Q1Feb16_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-A5E0EEE7B9ED0BEA97F28E8AE272A64D" unitRef="usd">4386468</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="-5" id="Fact-B7E1D79CF435A94B9B2A8E88402E8C2A" unitRef="usd">3800000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2018Q1Feb16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-A0B1290B09C400FA24978E8AE82259F6" unitRef="usd">3778001</us-gaap:Goodwill>
	<us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="D2018Q3Nov18-Sep30_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-382F3A6086D0EC8DA7E58E93C042EDCA" unitRef="usd">-1659160</us-gaap:GoodwillPurchaseAccountingAdjustments>
	<us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="FD2018Q2QTD_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-FA2264B3C071CB216B828E8AE5C17437" unitRef="usd">-608467</us-gaap:GoodwillPurchaseAccountingAdjustments>
	<us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="FD2018Q2QTD" decimals="-5" id="Fact-DCC03B12A25C0988993092E3D56D394B" unitRef="usd">1900000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2018Q1YTD" decimals="0" id="Fact-90CE364DFA3FD79BCE818DD4EC9973A5" unitRef="usd">23313</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2019Q1YTD" decimals="0" id="Fact-367B2BFE7A284D5CA1CD8DD4ECA88DDF" unitRef="usd">166358</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxesPaid contextRef="FD2018Q1YTD" decimals="0" id="Fact-5C8F425E34D5C83A2B108DD4EC891B96" unitRef="usd">0</us-gaap:IncomeTaxesPaid>
	<us-gaap:IncomeTaxesPaid contextRef="FD2019Q1YTD" decimals="0" id="Fact-750646A90377FA0FD5158DD4EC99CD5D" unitRef="usd">378025</us-gaap:IncomeTaxesPaid>
	<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="FD2018Q1YTD" decimals="0" id="Fact-B0428D6E31F6208EB23E8DD4ECA86A5E" unitRef="usd">1866960</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="FD2019Q1YTD" decimals="0" id="Fact-BF0EE42794FCEDAF42A28DD4EC89C22E" unitRef="usd">-196671</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2018Q1YTD" decimals="0" id="Fact-9ECD961973A76CB4E0EF8DD4EC89B096" unitRef="usd">-104671</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2019Q1YTD" decimals="0" id="Fact-37C311120064806381A78DD4EC990C71" unitRef="usd">-439159</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="FD2018Q1YTD" decimals="0" id="Fact-969501633E3A8994AA6F8DD4EC893C05" unitRef="usd">7400</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
	<us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="FD2019Q1YTD" decimals="0" id="Fact-00BB8BA636B226ECE03A8DD4EC99005D" unitRef="usd">-217608</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
	<us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="FD2018Q1YTD" decimals="0" id="Fact-D1445807F14250D4DA518DD4EC895C46" unitRef="usd">2065</us-gaap:IncreaseDecreaseInDepositOtherAssets>
	<us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="FD2019Q1YTD" decimals="0" id="Fact-6DB6F226E598271579CE8DD4EC899DD4" unitRef="usd">0</us-gaap:IncreaseDecreaseInDepositOtherAssets>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2018Q1YTD" decimals="0" id="Fact-EED47C935BBFA92B2A0B8DD4EC99D86F" unitRef="usd">554445</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2019Q1YTD" decimals="0" id="Fact-7038BFC4B7AE7052ADFF8DD4ECA82CF7" unitRef="usd">-41195</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="FD2018Q1YTD" decimals="0" id="Fact-0AEA1CF3AF29890A31458DD4EC8940E4" unitRef="usd">160627</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="FD2019Q1YTD" decimals="0" id="Fact-FC63BFE8865AC79430DA8DD4EC992447" unitRef="usd">2074278</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInOtherReceivables contextRef="FD2018Q1YTD" decimals="0" id="Fact-9A1437DB3B1D738CA1AC8DD4EC9937E0" unitRef="usd">-371663</us-gaap:IncreaseDecreaseInOtherReceivables>
	<us-gaap:IncreaseDecreaseInOtherReceivables contextRef="FD2019Q1YTD" decimals="0" id="Fact-F83EF3F9C367C57DDF428DD4EC99C83F" unitRef="usd">62014</us-gaap:IncreaseDecreaseInOtherReceivables>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="FD2018Q1YTD" decimals="0" id="Fact-691955FCB8D37136133B8DD4EC999C96" unitRef="usd">71085</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="FD2019Q1YTD" decimals="0" id="Fact-371C9BEF5D2F22B6965B8DD4EC8971A9" unitRef="usd">-281051</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2018Q4" decimals="0" id="Fact-49AA97FFD1F9D642FC7B8DD4ECA8F55A" unitRef="usd">31239468</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2019Q1" decimals="0" id="Fact-BA84BC0F641532FB79D18DD4ECA80AC2" unitRef="usd">30160621</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="FD2018Q1YTD" decimals="0" id="Fact-B3837FBF27751A8C46558DD4ECA8482E" unitRef="usd">-100402</us-gaap:InterestIncomeExpenseNonoperatingNet>
	<us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="FD2019Q1YTD" decimals="0" id="Fact-1005E9338C2677D006198DD4ECA83905" unitRef="usd">-207941</us-gaap:InterestIncomeExpenseNonoperatingNet>
	<us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="FD2019Q1YTD_us-gaap_DebtInstrumentAxis_cerc_DeerfieldObligationMember" decimals="-5" id="Fact-C0E3F343DE554220A3958ED3BA58CCE4" unitRef="usd">200000</us-gaap:InterestIncomeExpenseNonoperatingNet>
	<us-gaap:InterestPaidNet contextRef="FD2018Q1YTD" decimals="0" id="Fact-C1A136F1B521699755AD8DD4EC99E151" unitRef="usd">44003</us-gaap:InterestPaidNet>
	<us-gaap:InterestPaidNet contextRef="FD2019Q1YTD" decimals="0" id="Fact-3328ECFE1C568DFA6CAB8DD4ECA86679" unitRef="usd">262500</us-gaap:InterestPaidNet>
	<us-gaap:InventoryNet contextRef="FI2018Q4" decimals="0" id="Fact-D1FD0E4C8ADA2ECCC7878DD4ECA86ED3" unitRef="usd">1110780</us-gaap:InventoryNet>
	<us-gaap:InventoryNet contextRef="FI2019Q1" decimals="0" id="Fact-D441A422090735A913998DD4ECA84334" unitRef="usd">1046982</us-gaap:InventoryNet>
	<us-gaap:LesseeOperatingLeaseDiscountRate contextRef="FI2019Q1" decimals="3" id="Fact-BA0C5DCBDE0AD2BED81D951CC2F64171" unitRef="number">0.077</us-gaap:LesseeOperatingLeaseDiscountRate>
	<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="FI2019Q1" decimals="0" id="Fact-BF473D772A780FCCACB3952748079C76" unitRef="usd">1860455</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
	<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="FI2019Q1" decimals="0" id="Fact-88FDA86434D3E521A9F495273313B171" unitRef="usd">1183290</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
	<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="FI2019Q1" decimals="0" id="Fact-3E9830F357729A907E2195167274EDF5" unitRef="usd">161671</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
	<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="FI2019Q1" decimals="0" id="Fact-3DCFB880820B1D22D93C95271F79E14D" unitRef="usd">178092</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
	<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="FI2019Q1" decimals="0" id="Fact-84B90B29BDB56FB8B2F195270C12B4DB" unitRef="usd">173748</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
	<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="FI2019Q1" decimals="0" id="Fact-89DDB1C21C9859E088169526F4D6AB8E" unitRef="usd">169510</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
	<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="FI2019Q1" decimals="0" id="Fact-BBF4CA9F2FD34333C4729526D9CFAFE2" unitRef="usd">155815</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
	<us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="FI2019Q1" decimals="0" id="Fact-16C2EB5CC58DC2358C729526C0FB4F39" unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
	<us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="FI2019Q1" decimals="0" id="Fact-0688F9947F7F8C83084195276ABBC887" unitRef="usd">671178</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
	<us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="FI2019Q1" id="Fact-4AA15DD3604F9BD91EDA9514272F8AD0">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
	<us-gaap:LesseeOperatingLeaseTermOfContract contextRef="FI2019Q1" id="Fact-09B1AD2C309D84B8100995114F5ACD15">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
	<us-gaap:Liabilities contextRef="FI2018Q4" decimals="0" id="Fact-A818B485E8FA935EE6C68DD4ECA85CC8" unitRef="usd">49342973</us-gaap:Liabilities>
	<us-gaap:Liabilities contextRef="FI2019Q1" decimals="0" id="Fact-74D7D28F5EF58ADC2CFB8DD4ECA86E17" unitRef="usd">51749501</us-gaap:Liabilities>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2018Q4" decimals="0" id="Fact-88DFB6AF4BF2CE10BD5F8DD4ECA8B891" unitRef="usd">70250721</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2019Q1" decimals="0" id="Fact-BD877D91C5D828B6D2918DD4ECA80AAF" unitRef="usd">74870031</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesCurrent contextRef="FI2018Q4" decimals="0" id="Fact-EC87059A0E15FEF55B938DD4EC99EDFC" unitRef="usd">26216579</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="FI2019Q1" decimals="0" id="Fact-265ADA1692305E4293408DD4ECA85CF3" unitRef="usd">28134864</us-gaap:LiabilitiesCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2018Q4" decimals="0" id="Fact-9DBC6784BF438F026A388DD4ECA8DB03" unitRef="usd">1050000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2019Q1" decimals="0" id="Fact-0094EA2D4AB787D850E18DD4ECA89B5A" unitRef="usd">1050000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2019Q1_us-gaap_DebtInstrumentAxis_cerc_DeerfieldObligationMember" decimals="-5" id="Fact-EEBF0783E101D16DA9828ED3FA87905A" unitRef="usd">1100000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtFairValue contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" decimals="-5" id="Fact-3C47AD4D4136D79EF1818EBC3D5FB1DB" unitRef="usd">14900000</us-gaap:LongTermDebtFairValue>
	<us-gaap:LongTermDebtNoncurrent contextRef="FI2018Q4" decimals="0" id="Fact-00CA55250EC9E8FB8DD88DD4ECA88D33" unitRef="usd">14327882</us-gaap:LongTermDebtNoncurrent>
	<us-gaap:LongTermDebtNoncurrent contextRef="FI2019Q1" decimals="0" id="Fact-FFAD341D74CEC05E46F08DD4EC89D690" unitRef="usd">14303540</us-gaap:LongTermDebtNoncurrent>
	<us-gaap:LongTermPurchaseCommitmentAmount contextRef="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_ZyleraMember_srt_CounterpartyNameAxis_cerc_LachlanPharmaceuticalsMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="-5" id="Fact-5C235D40649729326F2F8EE8DAD05DF4" unitRef="usd">1200000</us-gaap:LongTermPurchaseCommitmentAmount>
	<us-gaap:LongTermPurchaseCommitmentMinimumQuantityRequired contextRef="D2017Q4Nov1-30_dei_LegalEntityAxis_cerc_ZyleraMember_srt_CounterpartyNameAxis_cerc_LachlanPharmaceuticalsMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_UlesfiaSupplyAgreementMember" decimals="INF" id="Fact-90136939127098C419DA8EE8B5F1D506" unitRef="unit">20000</us-gaap:LongTermPurchaseCommitmentMinimumQuantityRequired>
	<us-gaap:LongTermPurchaseCommitmentMinimumQuantityRequired contextRef="D2018Q1Feb16-16_srt_CounterpartyNameAxis_cerc_TRISPharmaMember_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_cerc_KarbinalAgreementMember" decimals="INF" id="Fact-80B5BC9D2597E0C5C5858EEA66828401" unitRef="unit">70000</us-gaap:LongTermPurchaseCommitmentMinimumQuantityRequired>
	<us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners contextRef="I2017Q4Oct31" decimals="2" id="Fact-DEE7C5D6EB0C4035B6EC8EE8781D6AE0" unitRef="number">0.10</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2018Q1YTD" decimals="0" id="Fact-10BB6A71CBBF911D0C568DD4EC99EC1A" unitRef="usd">363390</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2019Q1YTD" decimals="0" id="Fact-616317240A07E2361E2E8DD4EC89405F" unitRef="usd">8817117</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2018Q1YTD" decimals="0" id="Fact-5C88935FD7353E509EDF8DD4EC89BFB3" unitRef="usd">-19225</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2019Q1YTD" decimals="0" id="Fact-F5C31D112E13DA37E4BC8DD4EC89182C" unitRef="usd">-165969</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2018Q1YTD" decimals="0" id="Fact-34DD823A7D4DCB9696508DD4EC891905" unitRef="usd">-280423</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2019Q1YTD" decimals="-5" id="Fact-C43487225C25E68E02608DD4EC896E25" unitRef="usd">-3100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2019Q1YTD" decimals="0" id="Fact-3C4795DF057DA51D453E8DD4EC8963F3" unitRef="usd">-3121552</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q1YTD" decimals="0" id="Fact-2DA7D5F4988ECAF95A358DD4EC991CE2" unitRef="usd">-3882847</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="0" id="Fact-AFDE10AF5FA2B28B42D69313D7DA74E9" unitRef="usd">-3882847</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2019Q1YTD" decimals="-5" id="Fact-9C5F14A51AF5A32B085A8DD4ECB836BE" unitRef="usd">-7500000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2019Q1YTD" decimals="0" id="Fact-6065B4719C65AD49C91D8DD4ECB8F00D" unitRef="usd">-7454048</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="0" id="Fact-B39138C20DA62089A67A9313CBCF1BA1" unitRef="usd">-7454048</us-gaap:NetIncomeLoss>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2018Q1YTD" decimals="0" id="Fact-F10BC4ACCEB10E03F1648DD4EC99BB00" unitRef="usd">-104998</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2019Q1YTD" decimals="0" id="Fact-B4355FD365E966FC622A8DD4ECA8AB4B" unitRef="usd">-264918</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:OperatingExpenses contextRef="FD2018Q1YTD" decimals="0" id="Fact-0BB642C3E0F6EB390E0F8DD4ECB8008D" unitRef="usd">8237311</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses contextRef="FD2019Q1YTD" decimals="0" id="Fact-F3B26CEA5AC7B29DDA9F8DD4ECA87AF4" unitRef="usd">12434215</us-gaap:OperatingExpenses>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1YTD" decimals="0" id="Fact-6FA2492F2FA5D63AA6248DD4ECA83519" unitRef="usd">-3754536</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2019Q1YTD" decimals="0" id="Fact-66C5D11B6D7E9D6770B08DD4ECA8C9A8" unitRef="usd">-7022772</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingLeaseCost contextRef="FD2019Q1YTD" decimals="0" id="Fact-24DA1A2D98907BC01D44952367E9552E" unitRef="usd">54606</us-gaap:OperatingLeaseCost>
	<us-gaap:OperatingLeaseLiability contextRef="FI2019Q1" decimals="0" id="Fact-91EA94EF46CFC13DC089952191041584" unitRef="usd">1189277</us-gaap:OperatingLeaseLiability>
	<us-gaap:OperatingLeaseLiability contextRef="I2019Q1Jan1_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_us-gaap_AccountingStandardsUpdate201602Member" decimals="-5" id="Fact-59ECCE5EECDA7CCD0B2A93A38D5E3237" unitRef="usd">1200000</us-gaap:OperatingLeaseLiability>
	<us-gaap:OperatingLeasePayments contextRef="FD2019Q1YTD" decimals="0" id="Fact-07CF24A518A51D5F655C951A763A1025" unitRef="usd">0</us-gaap:OperatingLeasePayments>
	<us-gaap:OperatingLeaseRightOfUseAsset contextRef="FI2019Q1" decimals="0" id="Fact-49753DDE6DA4DF6BFAE893A468FFCF1B" unitRef="usd">737658</us-gaap:OperatingLeaseRightOfUseAsset>
	<us-gaap:OperatingLeaseRightOfUseAsset contextRef="I2019Q1Jan1_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_us-gaap_AccountingStandardsUpdate201602Member" decimals="-5" id="Fact-2D732418704B4DC9444598DE92F15C44" unitRef="usd">700000</us-gaap:OperatingLeaseRightOfUseAsset>
	<us-gaap:OperatingLeasesRentExpenseNet contextRef="FD2018Q1YTD" decimals="0" id="Fact-BA418A0AA4276F34830C9524691DDAC0" unitRef="usd">47559</us-gaap:OperatingLeasesRentExpenseNet>
	<us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent contextRef="FI2018Q4" decimals="0" id="Fact-58F6F8E2E5C8989CDB448ECF51B588A4" unitRef="usd">279397</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
	<us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent contextRef="FI2019Q1" decimals="0" id="Fact-08CBC307A6BE855AEAED8ECF5201298B" unitRef="usd">70128</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
	<us-gaap:OtherCommitment contextRef="FI2019Q1" decimals="0" id="Fact-60286334D01C295EE6F1953047F03131" unitRef="usd">5250000</us-gaap:OtherCommitment>
	<us-gaap:OtherCommitmentDueInFourthYear contextRef="FI2019Q1" decimals="0" id="Fact-209E64FC33EF3BE04CA6953046C4612B" unitRef="usd">0</us-gaap:OtherCommitmentDueInFourthYear>
	<us-gaap:OtherCommitmentDueInSecondYear contextRef="FI2019Q1" decimals="0" id="Fact-AB9A846C64C3C8A72E8C95304483CC2F" unitRef="usd">3000000</us-gaap:OtherCommitmentDueInSecondYear>
	<us-gaap:OtherCommitmentDueInThirdYear contextRef="FI2019Q1" decimals="0" id="Fact-862A9DD8F273059970E9953045A1F012" unitRef="usd">0</us-gaap:OtherCommitmentDueInThirdYear>
	<us-gaap:OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear contextRef="FI2019Q1" decimals="0" id="Fact-C3348D72B025C64DA2EF95327F8CC00B" unitRef="usd">2250000</us-gaap:OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear>
	<us-gaap:OtherIncome contextRef="FD2018Q1YTD" decimals="0" id="Fact-E5EB7FEED30509F134858DD4ECB87795" unitRef="usd">18655</us-gaap:OtherIncome>
	<us-gaap:OtherIncome contextRef="FD2019Q1YTD" decimals="0" id="Fact-EB3C91FEEC3ECC1365768DD4EC8926CB" unitRef="usd">-9400</us-gaap:OtherIncome>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2018Q4" decimals="0" id="Fact-3898F7F726CBE24F36608DD4ECA8528A" unitRef="usd">385517</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2019Q1" decimals="0" id="Fact-F0BAE0403193E78AB8E38DD4EC99EF3B" unitRef="usd">1189277</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="FD2018Q1YTD" decimals="0" id="Fact-B1F6E59D73570BF05D2898D157369D66" unitRef="usd">0</us-gaap:OtherOperatingActivitiesCashFlowStatement>
	<us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="FD2019Q1YTD" decimals="0" id="Fact-4B9D3083EB3883EC30D8930406B71E5F" unitRef="usd">21412</us-gaap:OtherOperatingActivitiesCashFlowStatement>
	<us-gaap:PaidInKindInterest contextRef="FD2018Q1YTD" decimals="0" id="Fact-4A623227014E12DA3E628DD4ECB8F620" unitRef="usd">105451</us-gaap:PaidInKindInterest>
	<us-gaap:PaidInKindInterest contextRef="FD2019Q1YTD" decimals="0" id="Fact-FBCA2FFCE27FF397745D8DD4EC992BEC" unitRef="usd">0</us-gaap:PaidInKindInterest>
	<us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="FD2018Q1YTD" decimals="0" id="Fact-7A0ECBBCA670153B38698DD4ECA876D4" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
	<us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="FD2019Q1YTD" decimals="0" id="Fact-12E7C7EA3034477FCF748DD4EC892089" unitRef="usd">228678</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2017Q4Nov17-17_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-332C7776F2278230CD1A8E8FF7E6B7BE" unitRef="usd">18900000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="-5" id="Fact-EDFABC9C545C6C09D1798E8D551E9185" unitRef="usd">18900000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2017Q4Nov17-17_us-gaap_BusinessAcquisitionAxis_cerc_TRxMember" decimals="0" id="Fact-821D8C42BB51F7D61E568E8FFBD51688" unitRef="usd">18900000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2018Q1Feb16-16_us-gaap_BusinessAcquisitionAxis_cerc_AvadelMember" decimals="0" id="Fact-FE0D27BAB51406439A6893D2CC9076E2" unitRef="usd">1</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2018Q1YTD" decimals="0" id="Fact-5735C9C8A918F9E2384B8DD4EC996680" unitRef="usd">1</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2019Q1YTD" decimals="0" id="Fact-91682AB3D67E8AFBF1558DD4ECA852E8" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2018Q1YTD" decimals="0" id="Fact-E7DEEB19C69388BA26C38DD4EC99CCF8" unitRef="usd">19224</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2019Q1YTD" decimals="0" id="Fact-E1EA970D9663A43E535A8DD4EC89FCE4" unitRef="usd">165969</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="FI2018Q4" decimals="INF" id="Fact-01EE8ACE41C569EF9DF18DD4ECA80C3E" unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="FI2019Q1" decimals="INF" id="Fact-17DAD4594DE57B0FC60A8DD4EC891553" unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="I2018Q4Dec27_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="INF" id="Fact-1D548A4D26FFA940C8F994311098A101" unitRef="usdPerShare">2.00</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesAuthorized contextRef="FI2018Q4" decimals="INF" id="Fact-5B8DC4BA60D2304E07678DD4ECB88BB7" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized contextRef="FI2018Q4_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="INF" id="Fact-946BEB039BF5326FE3EB93BA7E6E8D1F" unitRef="shares">2857143</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized contextRef="FI2019Q1" decimals="INF" id="Fact-71D1D9A4E50A10EADD488DD4ECB88A12" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized contextRef="I2018Q4Dec27_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="INF" id="Fact-7A8288D3CEF9B57ACACD94289E5CC8E5" unitRef="shares">2857143</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesIssued contextRef="FI2018Q4" decimals="INF" id="Fact-00EB5F5F85DD5E4D41FE8DD4EC89F402" unitRef="shares">2857143</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesIssued contextRef="FI2019Q1" decimals="INF" id="Fact-65A750C1A0138F1ED67D8DD4ECA8BD45" unitRef="shares">2857143</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesOutstanding contextRef="FI2018Q4" decimals="INF" id="Fact-F0D521773729EF49C14A8DD4EC89425A" unitRef="shares">2857143</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:PreferredStockSharesOutstanding contextRef="FI2019Q1" decimals="INF" id="Fact-E1281FEA570B8BEB352D8DD4ECB8BFBA" unitRef="shares">2857143</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:PreferredStockValue contextRef="FI2018Q4" decimals="0" id="Fact-BC56D00AB1C3C3B24BE58DD4ECA814EA" unitRef="usd">2857</us-gaap:PreferredStockValue>
	<us-gaap:PreferredStockValue contextRef="FI2019Q1" decimals="0" id="Fact-13CDC4C327949F72C2B38DD4ECA89900" unitRef="usd">2857</us-gaap:PreferredStockValue>
	<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="FI2018Q4" decimals="0" id="Fact-ECA73906D48E02EF77338DD4ECB80596" unitRef="usd">1529516</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
	<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="FI2019Q1" decimals="0" id="Fact-E70AB7D2A24805A770F78DD4ECA86BDB" unitRef="usd">1248465</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
	<us-gaap:PriorPeriodReclassificationAdjustment contextRef="FD2018Q1YTD" decimals="-5" id="Fact-B8157AAC3B0764F123AF8E55968B90AC" unitRef="usd">300000</us-gaap:PriorPeriodReclassificationAdjustment>
	<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="D2019Q1Mar8-8_us-gaap_SubsidiarySaleOfStockAxis_cerc_BoughtDealMember" decimals="-5" id="Fact-0BB50602D5899E7DA72C942F91FAA8A8" unitRef="usd">10000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="FD2018Q1YTD" decimals="0" id="Fact-17A9BCB772F9537FAFEE8DD4EC8939E3" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="FD2019Q1YTD" decimals="0" id="Fact-A55306BACD5FD00E94BE8DD4ECA88E56" unitRef="usd">8975960</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="D2018Q3Aug17_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="-5" id="Fact-BABE7A6FE84DDF02F81E8EDE96AF6313" unitRef="usd">3900000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
	<us-gaap:ProceedsFromStockPlans contextRef="FD2018Q1YTD" decimals="0" id="Fact-C3287908BFCAEFF574C68DD4ECA8C640" unitRef="usd">363390</us-gaap:ProceedsFromStockPlans>
	<us-gaap:ProceedsFromStockPlans contextRef="FD2019Q1YTD" decimals="0" id="Fact-3960A4220C91BD7591608DD4ECA8F447" unitRef="usd">94177</us-gaap:ProceedsFromStockPlans>
	<us-gaap:ProceedsFromWarrantExercises contextRef="FD2018Q4QTD_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="-5" id="Fact-A8E8A84F9C161C6F7B86943179E4063C" unitRef="usd">5700000</us-gaap:ProceedsFromWarrantExercises>
	<us-gaap:ProceedsFromWarrantExercises contextRef="FD2018Q4YTD_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="-5" id="Fact-2B1EC438372945E0D18594291A29AC1E" unitRef="usd">5700000</us-gaap:ProceedsFromWarrantExercises>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2018Q4" decimals="0" id="Fact-9992671761D9E05703B98DD4EC99C185" unitRef="usd">586512</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2019Q1" decimals="0" id="Fact-6D2B3CE06C1092C681D78DD4ECA8020D" unitRef="usd">1477067</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PurchaseObligation contextRef="FI2019Q1" decimals="0" id="Fact-F26C23CB79A79201EC67953043CBFCA0" unitRef="usd">2208372</us-gaap:PurchaseObligation>
	<us-gaap:PurchaseObligationDueInFourthYear contextRef="FI2019Q1" decimals="0" id="Fact-9E08EFDE79B2E131E81A953042A73E74" unitRef="usd">0</us-gaap:PurchaseObligationDueInFourthYear>
	<us-gaap:PurchaseObligationDueInSecondYear contextRef="FI2019Q1" decimals="0" id="Fact-19A12B9384819ABEF9D595304072AB93" unitRef="usd">1265378</us-gaap:PurchaseObligationDueInSecondYear>
	<us-gaap:PurchaseObligationDueInThirdYear contextRef="FI2019Q1" decimals="0" id="Fact-76EC8D3EFA57EED7E632953041818E8F" unitRef="usd">0</us-gaap:PurchaseObligationDueInThirdYear>
	<us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear contextRef="FI2019Q1" decimals="0" id="Fact-54C8277F573E5D41CFF79531D5FC32D6" unitRef="usd">942994</us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2018Q1YTD" decimals="0" id="Fact-DDBA30131727418257A8930709BDCB2A" unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2019Q1YTD" decimals="0" id="Fact-A5768E56570CC3FB5D179306EA2A952A" unitRef="usd">24342</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="FD2018Q1YTD" decimals="0" id="Fact-6BF5C662FC22930B53678DD4EC99B128" unitRef="usd">1649778</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="FD2019Q1YTD" decimals="0" id="Fact-0B6D2F19EA31F796519B8DD4ECA89196" unitRef="usd">3401189</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="FI2018Q1" decimals="0" id="Fact-50AAB6283CD7CD5A9F668DD4EC9924C6" unitRef="usd">13955</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
	<us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="FI2018Q4" decimals="0" id="Fact-8E55FB938245A71144AE8DD4ECA865D8" unitRef="usd">18730</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
	<us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="FI2019Q1" decimals="0" id="Fact-19E2D7A6D28FA7E63D9D8DD4EC99EBDD" unitRef="usd">77846</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
	<us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="FI2018Q1" decimals="0" id="Fact-FDAB9ACE16BB9108792D8DD4EC99AF65" unitRef="usd">131359</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
	<us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="FI2018Q4" decimals="0" id="Fact-62A71BDB5BEB0975F5718DD4ECA8B879" unitRef="usd">81725</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
	<us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="FI2019Q1" decimals="0" id="Fact-DCAF4D47A249789334D18DD4EC99BCB0" unitRef="usd">77118</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2018Q4" decimals="0" id="Fact-E002CEDF9F59ABCFFABF8DD4EC895C52" unitRef="usd">-98218070</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2019Q1" decimals="0" id="Fact-79ED113C7736EF6254828DD4EC89C23A" unitRef="usd">-105672118</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2019Q1" decimals="-5" id="Fact-2A80FBA92C283BC381208DD4ECB858AA" unitRef="usd">-105700000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="D2017Q3August_srt_ProductOrServiceAxis_us-gaap_LicenseMember" decimals="-6" id="Fact-77FB82F967CC83CB1EB9991902BD4D3D" unitRef="usd">25000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q1YTD" decimals="-3" id="Fact-C81A96F6C4E0D2EEFCB293ABC613281D" unitRef="usd">4483000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q1YTD" decimals="0" id="Fact-BCC1C3F30ACDC5E1C3AC8DD4ECA8F071" unitRef="usd">4482775</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q1YTD_srt_ProductOrServiceAxis_cerc_PrescribedDietarySupplementsMember" decimals="-3" id="Fact-ED8698D1431DBCD1541593ABC1FB585B" unitRef="usd">2231000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q1YTD_srt_ProductOrServiceAxis_cerc_PrescriptionDrugsMember" decimals="-3" id="Fact-2810212A7F837849361193ABC36CAF30" unitRef="usd">2029000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q1YTD_srt_ProductOrServiceAxis_cerc_SalesForceRevenueMember" decimals="0" id="Fact-E4EB903484F47901ED318DD4ECA810B2" unitRef="usd">222656</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q1YTD_srt_ProductOrServiceAxis_cerc_SalesForceRevenueMember" decimals="-3" id="Fact-3EB75377359FB4F1EDA093ABC4B1853D" unitRef="usd">223000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q1YTD_srt_ProductOrServiceAxis_cerc_SalesRevenueProductMember" decimals="0" id="Fact-7AB5FD7FFB33587D6D2B8E3237D9D4F9" unitRef="usd">4260119</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2019Q1YTD" decimals="0" id="Fact-A2DE935C7325716654E38DD4EC898D54" unitRef="usd">5411443</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2019Q1YTD" decimals="-3" id="Fact-5AF08B1A0B338F8E508F93AB1C020F11" unitRef="usd">5411000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_PrescribedDietarySupplementsMember" decimals="-3" id="Fact-40C8D231C414A3457B7F93AB1C0A3883" unitRef="usd">1791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_PrescriptionDrugsMember" decimals="-3" id="Fact-B1CC5E83E4AC682C907893AB1C100C3F" unitRef="usd">3620000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_SalesForceRevenueMember" decimals="0" id="Fact-2DE0D649D2DF1B0A76558DD4ECA8D8E7" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_SalesForceRevenueMember" decimals="-3" id="Fact-AD30B04C0E00BBCFC35B93AB1C163B30" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2019Q1YTD_srt_ProductOrServiceAxis_cerc_SalesRevenueProductMember" decimals="0" id="Fact-7904B67C3971178C50E68DD4EC8979D1" unitRef="usd">5411443</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="FD2019Q1YTD" decimals="0" id="Fact-7A9BF9100E62EFDB654292FDF59CD13C" unitRef="usd">743025</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
	<us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="D2019Q1Mar8-8_us-gaap_SubsidiarySaleOfStockAxis_cerc_BoughtDealMember" decimals="-5" id="Fact-B0A1D3848AF4AA5BA79D942E2330D8A5" unitRef="usd">9000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
	<us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_cerc_UnderwrittenPublicOfferingMember" decimals="-5" id="Fact-11A3DBC1FF7F0DF477E59397355662E2" unitRef="usd">9000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
	<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="D2019Q1Mar8-8_srt_CounterpartyNameAxis_cerc_ArmisticeMember_us-gaap_SubsidiarySaleOfStockAxis_cerc_BoughtDealMember" decimals="INF" id="Fact-80F2779E824D311DEC3A942CE9CB3D0C" unitRef="shares">363637</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
	<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="D2019Q1Mar8-8_us-gaap_SubsidiarySaleOfStockAxis_cerc_BoughtDealMember" decimals="INF" id="Fact-98376DA4BFAD13ED21B0942B10D741A8" unitRef="shares">1818182</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
	<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="FD2019Q1YTD_srt_CounterpartyNameAxis_cerc_ArmisticeMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_cerc_UnderwrittenPublicOfferingMember" decimals="INF" id="Fact-997541D821057E793D05939568F1BAD7" unitRef="shares">363637</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
	<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_cerc_UnderwrittenPublicOfferingMember" decimals="INF" id="Fact-C03721BCD7A050B973BE938E29B884CF" unitRef="shares">1818182</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
	<us-gaap:SaleOfStockPricePerShare contextRef="FI2019Q1_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_cerc_UnderwrittenPublicOfferingMember" decimals="2" id="Fact-26BFF4C391324F1F6A1293949D6CF98D" unitRef="usdPerShare">5.50</us-gaap:SaleOfStockPricePerShare>
	<us-gaap:SaleOfStockPricePerShare contextRef="I2018Q3Aug17_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="2" id="Fact-2E8AC1228DBEC7C6F2148EDE75F2D9E7" unitRef="usdPerShare">3.91</us-gaap:SaleOfStockPricePerShare>
	<us-gaap:SaleOfStockPricePerShare contextRef="I2019Q1Mar8_us-gaap_SubsidiarySaleOfStockAxis_cerc_BoughtDealMember" decimals="INF" id="Fact-BFA1297CC893CF3702FF942CAD96ECE6" unitRef="usdPerShare">5.50</us-gaap:SaleOfStockPricePerShare>
	<us-gaap:SellingAndMarketingExpense contextRef="FD2018Q1YTD" decimals="0" id="Fact-A2554565E7AEDEF8D9588DD4ECA8C0B8" unitRef="usd">1524816</us-gaap:SellingAndMarketingExpense>
	<us-gaap:SellingAndMarketingExpense contextRef="FD2019Q1YTD" decimals="0" id="Fact-9D14E7FCEA1BE5EA55BC8DD4EC89D936" unitRef="usd">3108902</us-gaap:SellingAndMarketingExpense>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q1YTD" decimals="0" id="Fact-1B7AE79EDFDCEFE72D608DD4ECB82B26" unitRef="usd">242824</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2019Q1YTD" decimals="0" id="Fact-9735A07A4EEF0DB51B708DD4EC894068" unitRef="usd">596693</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="D2019Q2Apr1-1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember" id="Fact-ADCBFC53541AA99720C594EC0D20EB71">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember" id="Fact-5204CC00BA6684F73D1F94F0FC095DEF">P24M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" id="Fact-5AA670A6B1047101E39A94E1160EC7F9">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2019Q1YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_us-gaap_PlanNameAxis_cerc_The2016PlanMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember" id="Fact-211FB35FAEAB479F2FF58DD4ECB8A540">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2019Q1YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_us-gaap_PlanNameAxis_cerc_The2016PlanMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember" id="Fact-5D654226ABDB485C1CFC95658CD5B3EC">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_us-gaap_PlanNameAxis_cerc_The2016PlanMember_us-gaap_TitleOfIndividualAxis_us-gaap_DirectorMember" id="Fact-DDC95816BF15C0378B2A8DD4ECB8A157">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember" decimals="INF" id="Fact-AEFA9EEC2FE1CF6694C294FBB6339235" unitRef="shares">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-F9D2E06FE73F72421A718DD4ECA811AE" unitRef="shares">445000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2019Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-A7CB809E27220FFA94DF8DD4ECA8D64C" unitRef="shares">345000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-88ED242EED44971D14688DD4ECA8322D" unitRef="usdPerShare">4.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2019Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-AACEC1AC1F6B11E5AD718EE5E0205C9C" unitRef="usdPerShare">4.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember" decimals="INF" id="Fact-18E4EE888CE4207B271194FD2F086FC9" unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-ACDF7027937CA23D51DD8DD4ECA81499" unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-D3DF1371C7C9D24ACE0D8EE5C9393D74" unitRef="usdPerShare">4.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="INF" id="Fact-3AD4142E30DA053038258DD4EC897006" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="2" id="Fact-88474CFD6421D068F42594DBCEAFA9F5" unitRef="number">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="FD2019Q1YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="4" id="Fact-7E1F841036102CD6579F8DD4EC992F52" unitRef="number">0.0259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="FD2019Q1YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="4" id="Fact-F399A1A556794A095CCA8DD4EC893789" unitRef="number">0.0223</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate contextRef="I2016Q2Apr5_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember" decimals="INF" id="Fact-E5762FCD1BB971D53CA18DD4ECB8826E" unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="FI2019Q1_us-gaap_PlanNameAxis_cerc_The2016PlanMember" decimals="-5" id="Fact-A4EE1650ED8A03C3C81E8EE2160D8DFF" unitRef="shares">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="FI2019Q1_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember" decimals="INF" id="Fact-0D8AA024F752F194116C8DD4EC89A9D0" unitRef="shares">1192025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="I2016Q2May18_us-gaap_PlanNameAxis_cerc_The2015PlanMember" decimals="INF" id="Fact-1A0558C116FB446F56728DD4ECA842A0" unitRef="shares">464476</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="INF" id="Fact-821043EE1DD6BE58E2D78DD4EC999AC2" unitRef="shares">2269081</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="INF" id="Fact-F9C0B6F789FB1822F8338DD4ECA8B509" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="2" id="Fact-6C90E4F06326728F417C8DD4ECB8C2BF" unitRef="usdPerShare">4.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="-5" id="Fact-0BE91CF12D04C696036594CBEBE2DFAD" unitRef="usd">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="INF" id="Fact-05D97C96D1ECBEFA58808DD4ECA87EE9" unitRef="shares">4383</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="D2019Q2Apr1-1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember" decimals="INF" id="Fact-F0AC46D35629ACCC573494E7DC33F0FB" unitRef="shares">1800000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember" decimals="INF" id="Fact-AD7B14277E0C07455ED594EFDA83DEE3" unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember" decimals="INF" id="Fact-42A76D2F17018E57695C94F6E17A17FF" unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="INF" id="Fact-AD6DA7B1A45ECB51F64E8DD4EC99698B" unitRef="shares">134379</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="INF" id="Fact-83BD53775AC6B2B5F8A78DD4ECA81BD5" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="2" id="Fact-E1550613D4249740A3D28DD4EC89CB7D" unitRef="usdPerShare">2.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2018Q4_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="INF" id="Fact-E603AAA08E479B9301EA8DD4ECA85FE4" unitRef="shares">3746597</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2018Q4_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="INF" id="Fact-E2C1C95B414B69DC6EA38DD4ECA85E63" unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="INF" id="Fact-559C2980314C32AC7A318DD4ECA82677" unitRef="shares">3845305</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="INF" id="Fact-DF2A9AB469A406F1F4118DD4ECA82A67" unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2018Q4_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="2" id="Fact-6F8E1BA86BE4DF2771948DD4ECA80578" unitRef="usdPerShare">4.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2018Q4_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="2" id="Fact-A26A0A8295DEEBE8C3508EE4C6C09C5E" unitRef="usdPerShare">4.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="2" id="Fact-573280EDADD652AFFE538DD4ECA8767E" unitRef="usdPerShare">4.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="2" id="Fact-788456BAAA3FADFEE2728DD4ECA8D521" unitRef="usdPerShare">4.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="-5" id="Fact-A479E72721BC150EFF2694CAACDB7D2A" unitRef="usd">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="-5" id="Fact-7C355F5F715953B7BEA68EE2BB034DDE" unitRef="usd">8100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="FI2019Q1_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" decimals="0" id="Fact-63A14DD2C2263F547F938DD4ECA8E125" unitRef="usd">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease contextRef="D2017Q1Jan1_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember" decimals="INF" id="Fact-E3FDC59D4C3004FE97C68DD4ECB8FC6C" unitRef="shares">408042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="2" id="Fact-7B238ADF5F9CC68DA6AF8DD4ECA86AE5" unitRef="usdPerShare">3.01</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="2" id="Fact-3DA2A5D088A61C9EA3368DD4ECA8D530" unitRef="usdPerShare">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="D2019Q2Apr1-1_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_cerc_EmployeeMember" decimals="2" id="Fact-05A5362849934A7A1CD594E873E2E74F" unitRef="usdPerShare">6.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="D2019Q2Apr15-15_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TitleOfIndividualAxis_us-gaap_BoardOfDirectorsChairmanMember" decimals="2" id="Fact-5FD9F1A4212FAABAF57B94F0B8646C77" unitRef="usdPerShare">5.17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="2" id="Fact-73B1A72FAC920EEE744A8DD4EC999996" unitRef="usdPerShare">4.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" id="Fact-63DF78F1E04BBEEB34508DD4EC99EC03" unitRef="usdPerShare" xsi:nil="true" />
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_us-gaap_PlanNameAxis_cerc_The2016PlanMember" id="Fact-F1CD8CC6104FA88C1DCC8DD4ECB825C4">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="FD2019Q1YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" id="Fact-F200B06FB844190BFBC88DD4EC991607">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="FD2019Q1YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" id="Fact-AF0D8564C8F081FAF5D98DD4ECA8203D">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" id="Fact-C4EF10BCAB95B37E72518DD4ECA82CB1">P6Y9M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" id="Fact-99EF316799C47ACA31C78DD4ECA89130">P7Y9M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" id="Fact-F5A58D49E3339F3CF33E8EE4C8CBAD6F">P9Y2M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" id="Fact-A8F5E69E971CB3A264728DD4ECA838D4">P7Y7M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_StockOptionsWithMarketBasedVestingConditionsMember" id="Fact-30C5C8F07097B98B99258DD4EC895550">P8Y11M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="-5" id="Fact-E45CCEBF1D28B43E0B6E8EE41773B46F" unitRef="usd">600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="INF" id="Fact-FE0E1D75C28839370C148DD4ECB82316" unitRef="shares">302901</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="2" id="Fact-EF8FE97B3E231ED2BBC58DD4EC99B432" unitRef="usdPerShare">2.09</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="D2016Q2Apr5_us-gaap_SubsidiarySaleOfStockAxis_cerc_EmployeeStockPurchasePlanESPPMember" decimals="INF" id="Fact-B962702BCA357151C8DC8DD4ECA84C8C" unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
	<us-gaap:SharesOutstanding contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-3AD1C6F122126D78A1689056A0F209AA" unitRef="shares">31266989</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="INF" id="Fact-1913CFDAA4676266A49C9056A506C93E" unitRef="shares">0</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-0F9683D6133949FE91219056FE95CA02" unitRef="shares">31410335</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="INF" id="Fact-70F5DDD7D55584E5757B905702AC5A00" unitRef="shares">0</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-CA5E28DDE4A1A2A7BEFB9057430CA46F" unitRef="shares">40804189</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="INF" id="Fact-DA276A2E15E8AC907F27905746E8585D" unitRef="shares">2857143</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-637AD7228AC5C155B56D9057963743CD" unitRef="shares">42753659</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="INF" id="Fact-3622214DA92CAB333AC490579A1A71BD" unitRef="shares">2857143</us-gaap:SharesOutstanding>
	<us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="D2018Q3Sep2424_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="-5" id="Fact-4BD26C3B9842B58ADFA48E8638D37919" unitRef="shares">5800000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
	<us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="D2018Q3Sep25-25_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="-5" id="Fact-9EF4CA4C6B060E6693D08ED939886BBB" unitRef="shares">5800000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
	<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="D2018Q3Aug17_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember" decimals="INF" id="Fact-AD83D400C87764CEAEFA8EDE1E82B84A" unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
	<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-5C8340DB918365CD9CBD905BD5E65CB9" unitRef="shares">1818182</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
	<us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-1AAFB99EA53DF032B51E931AC0E17F03" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2019Q1YTD_us-gaap_AwardTypeAxis_cerc_ServiceBasedOptionsMember" decimals="INF" id="Fact-5FC49E901D000F0E8D528DD4ECA8D1B1" unitRef="shares">31288</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="D2018Q3Sep2424_cerc_AssetAcquisitionAxis_cerc_IchorionMember" decimals="-6" id="Fact-D6D509AF928BA6301FA48E86AB0CB5B4" unitRef="usd">20000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="FD2019Q1YTD" decimals="0" id="Fact-782D71AA323185ABC646905BE32D09DC" unitRef="usd">8975960</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-CE72EA08BF0B8E073BB6905BDE1B3DE4" unitRef="usd">8974142</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-35C6CA262B3524137AED905BD7ED8F6C" unitRef="usd">1818</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="FD2019Q1YTD" decimals="0" id="Fact-C0B776AD36AD017FEAC9931D797D7313" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
	<us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-787FAE3DBFA7434D15E1931D4FE5CB32" unitRef="usd">-101</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
	<us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="FD2019Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-FAAAC57157997BD9B0F6931D14F3B573" unitRef="usd">101</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4" decimals="0" id="Fact-5840C5FAB0F90D5E704B9056B4B143E7" unitRef="usd">27859608</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_cerc_ContingentlyIssuableCommonStockMember" decimals="0" id="Fact-E5E23BA5EC15166B37529056B05C7662" unitRef="usd">2655464</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-0DBECB1CF460B97068229056AE1EC705" unitRef="usd">83338136</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-43A7DEB3C15A63ACA5D59056A2EE9C7E" unitRef="usd">31268</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="0" id="Fact-678306999A07285624CE9056AAF7B863" unitRef="usd">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="0" id="Fact-D83173F2E4321BB4162D9056B28FA3C2" unitRef="usd">-58165260</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q1" decimals="0" id="Fact-B4DE2740F9A4EF11FE6390571103ABD1" unitRef="usd">24582975</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_cerc_ContingentlyIssuableCommonStockMember" decimals="0" id="Fact-D3AEA8991EF0FD16422190570CC59E1E" unitRef="usd">2655464</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-376E613897C23FB5147290570A9EB938" unitRef="usd">83944207</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-D35FD22307618146CACB90570086E449" unitRef="usd">31411</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="0" id="Fact-A83636AE4E817C9841399057078F8322" unitRef="usd">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="0" id="Fact-F8BC9C426ABD3A766D3890570EDF647E" unitRef="usd">-62048107</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4" decimals="0" id="Fact-DAFF149EC904F1FC3B158DD4EC8984C7" unitRef="usd">20907748</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_cerc_ContingentlyIssuableCommonStockMember" decimals="0" id="Fact-F6907D943BF7A865196690574F15EC5B" unitRef="usd">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-C65F984999C3E9DEDF9090574D1F45E3" unitRef="usd">119082157</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-165A6D80F9921F12D5C1905744F911B1" unitRef="usd">40804</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="0" id="Fact-F3333095A6B45850C08590574A508B58" unitRef="usd">2857</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="0" id="Fact-681173156E7FB3C9A645905751297FC4" unitRef="usd">-98218070</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2019Q1" decimals="0" id="Fact-84119856563C7B51B9458DD4ECA838B5" unitRef="usd">23120530</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_cerc_ContingentlyIssuableCommonStockMember" decimals="0" id="Fact-21049E7EF1EBB8939CE99057A2E664BE" unitRef="usd">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact-870818D7CFDF0B8CFB6E9057A0F7420F" unitRef="usd">128747037</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-457DF0147AB7C03E8A189057982BA577" unitRef="usd">42754</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember" decimals="0" id="Fact-3739559ECEBAE084DEB790579E4CADD9" unitRef="usd">2857</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="0" id="Fact-0DD8E88BEFB902C02C5A9057A4E0B2DC" unitRef="usd">-105672118</us-gaap:StockholdersEquity>
	<us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="FD2018Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-ECDEB6BA3EE78F4760DC8E6C4ECA73DB" unitRef="usd">-3882847</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
	<us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="FD2018Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember" decimals="0" id="Fact-1F5AAFAC3F726074A1288E6C4ED1D72C" unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
	<us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-40862A15AE3FC62C78EB8E6C4ED98CC5" unitRef="usd">-5537787</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
	<us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember" decimals="0" id="Fact-9498E05145E0A9C868948E6C4EC557A8" unitRef="usd">-1916261</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
	<us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember" decimals="2" id="Fact-0EA79BA7A6050DD8840B8DD4EC994FDA" unitRef="usdPerShare">7.47</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
	<us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember" decimals="2" id="Fact-E68C1073F8B65D84971E8DD4ECA88C86" unitRef="number">0.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
	<us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember" decimals="4" id="Fact-4E86AFDA8E714877D27A8DD4ECA81DFC" unitRef="number">0.0233</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
	<us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember" decimals="2" id="Fact-296D4360C881C23FF4618DD4ECA8E0E9" unitRef="usdPerShare">5.84</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
	<us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember" decimals="2" id="Fact-7BF81B537006EFC035FD8DD4EC89DBEB" unitRef="usdPerShare">8.40</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
	<us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember" decimals="2" id="Fact-5645F5F87EB858E1BEBE8DD4ECA85FA9" unitRef="number">0.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
	<us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember" decimals="4" id="Fact-CC2214F065EA5DFA8E298DD4ECB8C2E3" unitRef="number">0.0233</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
	<us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember" decimals="2" id="Fact-BD1B5195194050EA0FE28DD4EC9926AA" unitRef="usdPerShare">5.84</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
	<us-gaap:WarrantsAndRightsOutstandingTerm contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_EquityUnitPurchaseOptionMember" id="Fact-B55F2E7F6C51167E070D93FC8847ACFE">P1Y7M6D</us-gaap:WarrantsAndRightsOutstandingTerm>
	<us-gaap:WarrantsAndRightsOutstandingTerm contextRef="FI2019Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByLiabilityClassAxis_cerc_WarrantLiabilityMember" id="Fact-1B70879845192653D2E78DD4EC9906A0">P1Y7M6D</us-gaap:WarrantsAndRightsOutstandingTerm>
	<us-gaap:WarrantsAndRightsOutstandingTerm contextRef="I2018Q4Dec27_us-gaap_ClassOfWarrantOrRightAxis_cerc_IncentiveWarrantsMember" id="Fact-854326633FD0E7172B889429CCCDE986">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="FD2018Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-BB66987ACFEADAE135668E6C6E084BC2" unitRef="shares">31316246</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="FD2018Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember" decimals="0" id="Fact-A96CE4DE042FB233A92B8E6C6E5A0A35" unitRef="shares">0</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-C1F2B133364D8DD6CEC98E6C6E127750" unitRef="shares">41284168</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="FD2019Q1YTD_us-gaap_StatementClassOfStockAxis_us-gaap_PreferredStockMember" decimals="0" id="Fact-1E5A4F7B6FA308EB64B68E6C6E32E9B3" unitRef="shares">2857143</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<cerc:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="FD2019Q1YTD" id="Fact-CFB951BF6F9B398FD3FF951EBDD60965">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Supplemental balance sheet information related to the lease is as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:72%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Property and equipment, net &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;737,658&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other long-term liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,189,277&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</cerc:AssetsAndLiabilitiesLesseeTableTextBlock>
	<cerc:BusinessCombinationsAndAssetAcquisitionsTextBlock contextRef="FD2019Q1YTD" id="Fact-25290BA29D6FAF5BDB4D8DD4ECA8F41C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Acquisitions &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Ichorion Asset Acquisition &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On September&amp;#160;24, 2018, the Company entered into, and subsequently consummated the transactions contemplated by, an agreement and plan of merger (the "Merger Agreement") by and among the Company and&amp;#160;Ichorion Therapeutics,&amp;#160;Inc., a Delaware corporation (the &amp;#8220;Ichorion Asset Acquisition&amp;#8221;), with Ichorion surviving as a wholly owned subsidiary of the Company.&amp;#160; The consideration for the Ichorion Asset Acquisition consisted of approximately&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;shares of the Company&amp;#8217;s common stock, par value&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.001&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;per share, as adjusted for Estimated Working Capital as defined in the Merger Agreement.&amp;#160; The shares of common stock issued as part of the acquisition may not be resold until January 2020.  Consideration for the Ichorion Asset Acquisition includes certain development milestones worth up to an additional&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, payable either in shares of the Company's common stock or in cash, at the election of the Company.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The fair value of the common stock shares transferred at closing was approximately&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$20 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;based on the Company's stock price close on September 24, 2018 and offset by an estimated discount for lack of marketability calculated using guideline public company volatility for comparable companies. The assets acquired consisted primarily of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$18.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of IPR&amp;amp;D,&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of cash and&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;assembled workforce. The Company recorded this transaction as an asset purchase as opposed to a business combination as management concluded that substantially all of the value received was related to one group of similar identifiable assets, which was the IPR&amp;amp;D for the&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;preclinical therapies for inherited metabolic disorders known as CDGs (CERC-801, CERC-802, and CERC-803). The Company has considered these assets similar due to similarities in the risks for development, compound type, stage of development, regulatory pathway, patient population and economics of commercialization.&amp;#160; The fair value of the IPR&amp;amp;D was immediately recognized as Acquired In-Process Research and Development expense as the IPR&amp;amp;D asset has no other alternate use due to the stage of development.&amp;#160; The&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million&amp;#160;of transaction costs incurred were recorded to acquired IPR&amp;amp;D expense. The assembled workforce asset recorded to intangible assets will be amortized over an estimated useful life of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The contingent consideration of up to an additional &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; relates to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; future development milestones.  The first milestone is the first product being approved for marketing by the FDA on or prior to December 31, 2021.  If this milestone is met, the Company is required to make a milestone payment of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The second milestone is the second product being approved for marketing by the FDA on or prior to December 31, 2021.  If this milestone is met, the Company is required to make a milestone payment of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The third milestone is a protide molecule being approved by the FDA on or prior to December 31, 2023.  If this milestone is met, the Company is required to make a milestone payment of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  All milestones are payable in either shares of the Company's common stock or cash, at the election of the Company. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The contingent consideration related to the development milestones will be recognized if and when such milestones are probable and can be reasonably estimated.  As of March 31, 2019, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; contingent consideration related to the development milestone has been recognized.  The Company will continue to monitor the development milestones at each reporting period. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Avadel Pediatric Products Acquisition&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On February 16, 2018, the Company entered into an Asset Purchase Agreement (the &amp;#8220;Purchase Agreement&amp;#8221;) with Avadel US Holdings, Inc., Avadel Pharmaceuticals (USA), Inc., Avadel Pediatrics, Inc., Avadel Therapeutics, LLC and Avadel Pharmaceuticals PLC (collectively, the &amp;#8220;Sellers&amp;#8221;) to purchase and acquire all rights to the Sellers&amp;#8217; pediatric products. Total consideration transferred to the Sellers consisted of: (1) a cash payment of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; dollar, (2) the Company's assumption of existing seller debt due in January 2021 with a fair value of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;,&amp;#160;and (3) contingent consideration relating to royalty obligations through February 2026 with a fair value at acquisition date of approximately&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. As a result of the Avadel pediatric products acquisition, the Company recorded goodwill of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which is deductible over&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years for income tax purposes.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The transaction was accounted for as a business combination under the acquisition method of accounting. Accordingly, the tangible and identifiable intangible assets acquired and liabilities assumed were recorded at fair value as of the date of acquisition, with the remaining purchase price recorded as goodwill. The goodwill recognized is attributable primarily to strategic opportunities related to an expanded commercial footprint and diversified pediatric product portfolio that is expected to provide revenue and cost synergies. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the second quarter of 2018, the Company identified and recorded measurement period adjustments to the preliminary purchase price allocation. These adjustments are reflected in the tables below. The measurement period adjustments were the result of additional analysis performed and information identified during the second quarter of 2018 based on facts and circumstances that existed as of the purchase date. There were no additional measurement adjustments recorded in 2018.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition and as adjusted for measurement period adjustments identified during the second quarter of 2018: &amp;#160; &amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At February 16,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At February 16,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,549,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,831,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;718,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prepaid assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;570,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;570,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,453,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,838,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,291,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(362,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(362,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of debt assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(15,272,303&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;197,303&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(15,075,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(7,875,165&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(44,835&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(7,920,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total net liabilities assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,145,468&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;367,468&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,778,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Consideration exchanged&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;241,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(240,999&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,386,468&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(608,467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,778,001&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The purchase price allocation related to the acquisition of Avadel's pediatric products was finalized in 2018.  The fair values of intangible assets, including marketing rights, licenses, and developed technology, were determined using variations of the income approach. Varying discount rates were also applied to the projected net cash flows. The Company believes the assumptions are representative of those a market participant would use in estimating fair value.  The fair value of intangible assets, both as of the date of acquisition and as adjusted by measurement period adjustments identified during the second quarter of 2018, includes the following: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:39%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At February 16,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At February 16,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Useful Life&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired Product Marketing Rights - Karbinal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,221,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(21,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,200,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired Product Marketing Rights - AcipHex&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,520,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;283,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,803,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired Product Marketing Rights - Cefaclor&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,291,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,320,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,611,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired Developed Technology - Flexichamber&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,131,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;546,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,677,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired IPR&amp;amp;D - LiquiTime formulations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;290,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(290,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Indefinite&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,453,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,838,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,291,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;TRx Acquisition&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On November 17, 2017, the Company entered into, and consummated the transactions contemplated by, an equity interest purchase agreement (the &amp;#8220;TRx Purchase Agreement&amp;#8221;) by and among the Company, TRx, Fremantle Corporation, and LRS International LLC, the selling members of TRx (collectively, the &amp;#8220;TRx Sellers&amp;#8221;), which provided for the purchase of all of the equity and ownership interests of TRx by the Company (the "TRx Acquisition").  The consideration for the TRx Acquisition consisted of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$18.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in cash, as adjusted for estimated working capital, estimated cash on hand, estimated indebtedness and estimated transaction expenses, as well as &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,534,884&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the Company&amp;#8217;s common stock having an aggregate value on the closing date of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (the "Equity Consideration") and certain potential contingent payments.  Upon closing, the Company issued &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,184,920&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of its common stock to the TRx Sellers.&amp;#160; Pursuant to the TRx Purchase Agreement, the issuance of the remaining &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,349,968&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares was subject to the Company's stockholder approval.  In May 2018, stockholder approval was obtained and the remaining shares were issued to the TRx Sellers.  The contingent shares were initially recorded to contingently issuable shares, which is recorded within stockholder's equity and were reclassed to common stock and additional paid in capital upon issuance, on the consolidating balance sheet date. As a result of the TRx Acquisition, the Company has currently recorded goodwill of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, of which &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was deductible for income taxes. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the third quarter of 2018, the Company identified and recorded measurement period adjustments to our preliminary purchase price allocation that was disclosed in prior periods. These adjustments are reflected in the tables below. The measurement period adjustments were the result of an arbitration ruling discussed in further detail in Note 13, the facts and circumstances of which existed as of the acquisition date.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the preliminary acquisition-date fair value of the consideration transferred at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17, 2017 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,900,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,900,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Common stock (including contingently issuable shares)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,514,419&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,514,419&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,576,633&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,210,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,366,633&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total consideration transferred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,991,052&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,210,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,781,052&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The TRx Acquisition was accounted for as a business combination under the acquisition method of accounting. Accordingly, the tangible and identifiable intangible assets acquired and liabilities assumed were recorded at fair value as of the date of acquisition, with the remaining purchase price recorded as goodwill. The goodwill recognized is attributable primarily to strategic opportunities related to leveraging TRx&amp;#8217;s research and development, intellectual property, and processes.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17, 2017 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of assets acquired:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,068&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,068&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,872,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,872,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;495,777&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;495,777&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prepaid expenses and other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134,281&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134,281&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other receivables&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,764,515&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,764,515&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Identifiable Intangible Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Metafolin&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,465,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,522,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,987,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;PAI sales and marketing agreement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,334,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;219,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,553,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Millipred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,714,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;342,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,056,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Ulesfia&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;555,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(555,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21,581,671&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,292,515&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,874,186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of liabilities assumed:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts payable &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;192,706&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;192,706&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued expenses and other current liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,850,422&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,764,515&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,614,937&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred tax liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;839,773&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78,840&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;918,613&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total liabilities assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,882,901&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,843,355&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,726,256&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total identifiable net assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,698,770&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;449,160&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,147,930&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of consideration transferred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,991,052&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,210,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,781,052&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,292,282&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,659,160&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,633,122&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The purchase price allocation related to the acquisition of TRx was finalized in 2018.  The fair values of intangible assets, including marketing rights, licenses and developed technology, were determined using variations of the income approach, specifically the multi-period excess earnings method. Varying discount rates were also applied to the projected net cash flows. The Company believes the assumptions are representative of those a market participant would use in estimating fair value. The final fair value of intangible assets both as disclosed in prior periods and as adjusted by measurement period adjustments identified during the third quarter of 2018 includes the following: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:39%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17,&lt;br clear="none"/&gt;2017 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17, 2017 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Useful Life&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Metafolin&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,465,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,522,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,987,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;PAI sales and marketing agreement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,334,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;219,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,553,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Millipred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,714,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;342,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,056,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Ulesfia&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;555,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(555,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,068,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,528,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,596,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company received written notice to terminate the PAI sales and marketing agreement in the second quarter of 2018.  As a result, the Company reassessed the fair value of the PAI sales and marketing agreement on that date (a level III non-recurring fair value measurement) and concluded due to the absence of future cash flows beyond the date of termination that the fair value was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  An impairment charge was recognized in the second quarter of 2018 in the amount of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, representing the remaining net book value of the PAI sales and marketing agreement intangible asset. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Pro Forma Impact of Business Combinations&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following supplemental unaudited pro forma information presents Cerecor&amp;#8217;s financial results as if the acquisition of the Avadel pediatric products, which was completed on February 16, 2018, had occurred on January 1, 2018:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.48148148148148%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:77%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total revenues, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,187,775&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,928,446&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic and diluted net loss per share of common stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.16&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic and diluted net loss per share of preferred stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The above unaudited pro forma information was determined based on the historical GAAP results of Cerecor and Avadel's pediatric products.  The unaudited pro forma consolidated results are provided for informational purposes only and are not necessarily indicative of what Cerecor&amp;#8217;s consolidated results of operations would have been had the acquisition of Avadel's pediatric products been completed on the date indicated or what the consolidated results of operations will be in the future.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</cerc:BusinessCombinationsAndAssetAcquisitionsTextBlock>
	<cerc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock contextRef="FD2019Q1YTD" id="Fact-C9BDC42F677ACF94B9DA8DD4ECA83B64">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued expenses and other current liabilities as of March 31, 2019 and December 31, 2018 consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.07407407407408%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:68%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;As of&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales returns and allowances&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,249,977&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,972,510&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medicaid rebates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,758,384&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,237,269&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Minimum sales commitments, royalties payable, and purchase obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,808,083&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,662,901&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Compensation and benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,679,572&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,953,065&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,123,051&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;278,132&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales and marketing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;938,437&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,112,378&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;General and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;187,465&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;235,721&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;70,128&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;279,397&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total accrued expenses and other current liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21,815,097&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,731,373&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</cerc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock>
	<cerc:ScheduleOfFairValueOfConsiderationTransferredTableTextBlock contextRef="FD2019Q1YTD" id="Fact-E98F588E122A78C6708B8DD4ECA8F257">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the preliminary acquisition-date fair value of the consideration transferred at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17, 2017 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,900,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,900,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Common stock (including contingently issuable shares)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,514,419&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,514,419&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,576,633&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,210,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,366,633&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total consideration transferred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,991,052&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,210,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,781,052&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</cerc:ScheduleOfFairValueOfConsiderationTransferredTableTextBlock>
	<cerc:StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock contextRef="FD2019Q1YTD" id="Fact-8760D5E17FE4D4F56C6A8DD4ECA8BF4B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Capital Structure &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;According to the Company's amended and restated certificate of incorporation, the Company is authorized to issue &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; classes of stock, common stock and preferred stock.  At March 31, 2019, the total number of shares of capital stock the Company was authorized to issue was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;205,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of which &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was common stock and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#ee2724;"&gt; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;preferred stock.  All shares of common and&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#ee2724;"&gt; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;preferred stock have a par value of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.001&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 26, 2018, the Company filed a Certificate of Designation of Preferences of Series B Non-Voting Convertible Preferred Stock ("Series B Convertible Preferred Stock" or "convertible preferred stock") of Cerecor Inc. (the &amp;#8220;Certificate of Designation of the Series B Preferred Stock&amp;#8221;) classifying and designating the rights, preferences and privileges of the Series B Convertible Preferred Stock.  The Certificate of Designation of the Series B Convertible Preferred Stock authorized &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,857,143&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of convertible preferred stock.  The Series B Convertible Preferred Stock converts to shares of common stock on a 1-for-&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; ratio and has the same rights, preferences, and privileges as common stock other than it holds no voting rights.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Convertible Preferred Stock &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;December 2018 Armistice Private Placement&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 27, 2018, the Company entered into a series of transactions as part of a private placement with Armistice in order to generate cash to continue to develop our pipeline assets and for general corporate purposes.  The transactions are considered one transaction for accounting purposes.  As part of the transaction, the Company exchanged common stock warrants issued on April 27, 2017 to Armistice for the  purchase up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,285,714&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the Company&amp;#8217;s common stock at an exercise price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.40&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share (the "original warrants") for like-kind warrants to purchase up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,857,143&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the Company's newly designated Series B Convertible Preferred Stock with an exercise price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share (the "exchanged warrants").  Armistice immediately exercised the exchanged warrants and acquired an aggregate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,857,143&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the convertible preferred stock.  Net proceeds of the transaction were approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the year ended December 31, 2018. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In order to provide Armistice an incentive to exercise the exchanged warrants, the Company also entered into a securities purchase agreement with Armistice pursuant to which the Company issued warrants for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock of the Company with a term of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.5 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and an exercise price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share (the "incentive warrants").  For accounting purposes, the Company calculated the fair value of the incentive warrants of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which was considered a deemed distribution to Armistice for the year ended December 31, 2018. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Voting&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Holders of the Company's convertible preferred stock are not entitled to vote. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Dividends&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The holders of convertible preferred stock are entitled to receive dividends, if any, as may be declared from time to time by the board of directors out of legally available funds.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:132px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Liquidation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the event of the Company&amp;#8217;s liquidation, dissolution or winding up, holders of the Company&amp;#8217;s convertible preferred stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all debts and other liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:132px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Rights and Preferences&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Each share of convertible preferred stock converts to shares of common stock on a 1-for-&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; ratio.  There are no other preemptive or subscription rights and there are &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; redemption or sinking fund provisions applicable to the Company&amp;#8217;s common stock.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Common Stock&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Common Stock Offering&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On March 8, 2019, the Company closed on an underwritten public offering of common stock for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,818,182&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock of the Company, at a price to the public of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share.  Armistice participated in the offering by purchasing &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;363,637&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock of the Company from the underwriter at the public price.  The gross proceeds to the Company, before deducting underwriting discounts and commissions and offering expenses, were approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$10.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The net proceeds were approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;December 2018 Armistice Private Placement&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As discussed in detail above, on December 27, 2018 the Company exchanged previously outstanding warrants for like-kind warrants for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,857,143&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the Company's convertible preferred stock with an exercise price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share.  Armistice immediately exercised these warrants for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,857,143&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of convertible preferred stock for net proceeds to the Company of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The convertible preferred stock converts to common stock on a 1-for-&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; ratio (or to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,285,714&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock in total).  Additionally, on December 27, 2018, in order to provide Armistice an incentive to exercise the exchanged warrants, the Company entered into a securities purchase agreement with Armistice pursuant to which the Company issued warrants for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock of the Company with a term of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.5 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and an exercise price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share (the "incentive warrants").  See "December 2018 Armistice Private Placement" above for more details. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;August 2018 Armistice Private Placement&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On August&amp;#160;17, 2018, the Company entered into a securities purchase agreement with Armistice, pursuant to which the Company sold &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the Company&amp;#8217;s common stock, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.001&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; par value per share for a purchase price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.91&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share, which was the closing price of shares of the Common Stock on August&amp;#160;16, 2018. Net proceeds of this securities purchase agreement were approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Ichorion Asset Acquisition&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On September 25, 2018, under the terms of the Ichorion Asset Acquisition noted above in Note 5, the Company issued &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; common stock shares upon closing.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Contingently Issuable Shares&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Under the terms of TRx acquisition noted above in Note 5, the Company was required to issue common stock having an aggregate value as calculated in the TRx Purchase Agreement on the Closing Date of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (the &amp;#8220;Equity Consideration&amp;#8221;). &amp;#160;Upon closing, the Company issued &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,184,920&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of its common stock.&amp;#160; Pursuant to the TRx Purchase Agreement, the issuance of the remaining &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,349,968&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares as a part of the Equity Consideration was subject to stockholder approval at the Company's 2018 Annual Stockholder's Meeting.  This approval was obtained in May 2018 and the remaining shares were issued to the TRx Sellers. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Voting&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Common stock is entitled to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; vote for each share held of record on all matters submitted to a vote of the stockholders, including the election of directors, and does not have cumulative voting rights. Accordingly, the holders of a majority of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing for election.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:132px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Dividends&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The holders of common stock are entitled to receive dividends, if any, as may be declared from time to time by the board of directors out of legally available funds.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:132px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Liquidation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the event of the Company&amp;#8217;s liquidation, dissolution or winding up, holders of the Company&amp;#8217;s common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all debts and other liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:132px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Rights and Preferences&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Holders of the Company&amp;#8217;s common stock have &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; preemptive, conversion or subscription rights, and there are &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; redemption or sinking fund provisions applicable to the Company&amp;#8217;s common stock.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Common Stock Warrants&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the following common stock warrants were outstanding:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:68%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Number&amp;#160;of&amp;#160;shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Exercise&amp;#160;price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Expiration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;underlying&amp;#160;warrants&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;per&amp;#160;share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;date&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22,328*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.40&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;October 2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,380*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.68&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May 2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,000,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.50&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 2024&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,024,708&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;*Accounted for as a liability instrument (see Note 6)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</cerc:StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock>
	<us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="FD2019Q1YTD" id="Fact-906248DE922789F544A68DD4ECA8942A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accrued Expenses and Other Current Liabilities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued expenses and other current liabilities as of March 31, 2019 and December 31, 2018 consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.07407407407408%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:68%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;As of&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales returns and allowances&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,249,977&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,972,510&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medicaid rebates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,758,384&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,237,269&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Minimum sales commitments, royalties payable, and purchase obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,808,083&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,662,901&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Compensation and benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,679,572&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,953,065&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,123,051&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;278,132&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales and marketing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;938,437&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,112,378&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;General and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;187,465&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;235,721&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;70,128&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;279,397&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total accrued expenses and other current liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21,815,097&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,731,373&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
	<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="FD2019Q1YTD" id="Fact-D5A0E4A833A55FF3949B8DD4EC998E76">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Basis of Presentation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&amp;#8220;GAAP&amp;#8221;).   Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) and Accounting Standards Updates (&amp;#8220;ASU&amp;#8221;) of the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly the Company&amp;#8217;s financial position, results of operations, and cash flows. The condensed consolidated balance sheet at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; has been derived from audited financial statements at that date. The interim results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosure normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;). Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company believes that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; audited consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
	<us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="FD2019Q1YTD" id="Fact-2D361586098065C8D1E88DD4EC992A09">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Basis of Presentation and Significant Accounting Policies &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Basis of Presentation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&amp;#8220;GAAP&amp;#8221;).   Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) and Accounting Standards Updates (&amp;#8220;ASU&amp;#8221;) of the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly the Company&amp;#8217;s financial position, results of operations, and cash flows. The condensed consolidated balance sheet at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; has been derived from audited financial statements at that date. The interim results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosure normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;). Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company believes that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; audited consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Reclassification&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the fourth quarter of 2018, the Company concluded that going forward it would include change in fair value of contingent consideration within its own stand-alone line in operating expenses in the Company's statements of operations.  The Company has reclassified &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; from other expenses to operating expenses in the March 31, 2018 statement of operations to conform with current period presentation.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Significant Accounting Policies &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the three months ended March 31, 2019, there have been no significant changes to the Company&amp;#8217;s summary of significant accounting policies contained in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on March 18, 2019 and amended on April 23, 2019, except for the recently adopted accounting standards described below.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following significant accounting policy was updated in 2019 to reflect changes upon our adoption of ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (Topic 842) ("ASU 2016-02").&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Leases&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company determines if an arrangement is a lease at inception.  If an arrangement contains a lease, the Company performs a lease classification test to determine if the lease is an operating lease or a finance lease.  The Company has identified &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; operating lease for its corporate headquarters. Right-of-use ("ROU") assets represent the right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.  Operating lease liabilities are recognized on the commencement date of the lease based on the present value of the future lease payments over the lease term and are included in other long-term liabilities on our condensed consolidated balance sheet.  Right-of-use assets are valued at the initial measurement of the lease liability, plus any indirect costs or rent prepayments, and reduced by any lease incentives and any deferred lease payments.  Operating right-of-use assets are recorded in property and equipment, net on the condensed consolidated balance sheet and are amortized over the lease term.  To determine the present value of lease payments on lease commencement, we use the implicit rate when readily determinable, however as most leases do not provide an implicit rate, we use our incremental borrowing rate based on information available at commencement date. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Furthermore, the Company has elected the practical expedient to account for the lease and non-lease components as a single lease component for the leased property asset class.  Lease expense is recognized on a straight-line basis over the life of the lease and is included within general and administrative expenses. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Adoption of ASC 842&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In February 2016, FASB issued ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (Topic 842) ("ASU 2016-02"). This guidance revises existing practice related to accounting for leases under ASC No. 840,&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;(&amp;#8220;ASC 840&amp;#8221;) for both lessees and lessors. The new guidance in ASU 2016-02 requires lessees to recognize a right-of-use asset and a lease liability for nearly all leases (other than leases that meet the definition of a short-term lease). The lease liability will be equal to the present value of lease payments and the right-of-use asset will be based on the lease liability, subject to adjustment such as for initial direct costs. For income statement purposes, the new standard retains a dual model similar to ASC 840, requiring leases to be classified as either operating leases or finance leases. For lessees, operating leases will result in straight-line expense (similar to current accounting by lessees for operating leases under ASC 840) while finance leases will result in a front-loaded expense pattern (similar to current accounting by lessees for capital leases under ASC 840). &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company adopted the standard using the simplified transition method on its effective date of January 1, 2019 and therefore did not adjust prior comparative periods as permitted by the codification improvements issued by FASB in July 2018.  Additionally, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allows the Company to carryforward the historical lease classification.  As a result of the standard, the Company recorded a lease liability of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and a right-of-use asset of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which is equal to the initial measurement of the lease liability reduced by the unamortized balance of lease incentive received and deferred rent.  There was no material impact to our condensed consolidated income statement (see Note 12 below for more information). &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Other Adopted Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532&amp;#160;Disclosure Update and&amp;#160;Simplification, to eliminate or modify certain disclosure rules that are redundant, outdated, or duplicative of GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of stockholders' equity are expanded for interim financial statements. An analysis of the changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement.  The Company has provided this disclosure beginning in the first quarter of 2019.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
	<us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="FD2019Q1YTD" id="Fact-5AA8A7C0D80129E1759F8DD4ECB891B5">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following supplemental unaudited pro forma information presents Cerecor&amp;#8217;s financial results as if the acquisition of the Avadel pediatric products, which was completed on February 16, 2018, had occurred on January 1, 2018:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.48148148148148%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:77%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total revenues, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,187,775&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,928,446&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic and diluted net loss per share of common stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.16&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic and diluted net loss per share of preferred stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="FD2019Q1YTD" id="Fact-32F6668061725B80C64D8DD4ECA89E83">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Commitments and Contingencies &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Litigation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is party in various contractual disputes, litigation, and potential claims arising in the ordinary course of business.  The Company does not believe that the resolution of these matters will have a material adverse effect on our financial position or results of operations except as otherwise disclosed in this document. See below for further discussion of the Lachlan legal arbitration.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Purchase obligations&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has unconditional purchase obligations as a result of recent acquisitions that include agreements to purchase goods that are enforceable and legally binding and that specify all significant terms including: fixed or minimum quantities to be purchased; fixed, minimum or variable price provisions; and the approximate timing of the transaction. Purchase obligations exclude agreements that are cancelable at any time without penalty. The unconditional purchase obligations outstanding as of March 31, 2019 include the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Lachlan Pharmaceuticals Minimum Obligations and Indemnity Receivable&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As discussed in Note 5, in November 2017, the Company acquired TRx and its wholly-owned subsidiaries, including Zylera.  The previous owners of TRx beneficially own more than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of our outstanding common stock.  Zylera, which is now our wholly owned subsidiary, entered into an agreement with Lachlan Pharmaceuticals, an Irish company controlled by the previous owners of TRx (&amp;#8220;Lachlan&amp;#8221;), effective December 18, 2015 (the "Lachlan Agreement"). Pursuant to the Lachlan Agreement, Lachlan named Zylera as its exclusive distributor of Ulesfia in the United States and agreed to supply Ulesfia to Zylera exclusively for marketing and sale in the United States.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Lachlan Agreement requires Zylera to purchase a minimum of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; units per year, or approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; worth of product, from Lachlan, unless and until there has been a &amp;#8220;Market Change&amp;#8221; involving a new successful competitive product. Zylera must pay Lachlan &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$58.84&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per unit and handling fees that are equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.03&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per unit of fully packaged Ulesfia in 2019 and escalate at a rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; annually.  The Lachlan Agreement also requires that Zylera make certain cumulative net sales milestone payments and royalty payments to Lachlan with a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; annual minimum payment unless and until there has been a &amp;#8220;Market Change&amp;#8221; involving a new successful competitive product.  Lachlan is obligated to pay identical amounts to an unrelated third party from which it obtained rights to Ulesfia, with the payments ultimately flowing to Summers Laboratories, Inc. ("Summers Labs").  Because of the dispute described below, the Company has not made any payments to Lachlan under the Lachlan Agreement subsequent to the acquisition date.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 10, 2016, Zylera informed Lachlan that a Market Change had occurred due to the introduction of Arbor Pharmaceuticals' lice product, Sklice&amp;#174;.&amp;#160; On June 5, 2017, Lachlan and Zylera entered into joint legal representation along with other unrelated third parties in negotiation and arbitration of a dispute with Summers Labs regarding the existence of a Market Change and the concomitant obligations of the parties. The arbitration panel issued an interim ruling on October 23, 2018 that no Market Change had occurred up to and including the date of the hearing.  The arbitration panel issued a second interim ruling on December 26, 2018.  The second interim award rejected Summers Labs' request to accelerate future minimum royalties, however, it ruled in favor of Summers Labs that it is owed reimbursement for all reasonable costs and expenses, including legal fees, by Shionogi, as well as interest, as stipulated in the contract.  The arbitration panel issued a final award on March 1, 2019 that dictated the final amount of reimbursable costs and interest as contemplated in the second interim ruling.  The final award has no direct bearing on the Company as the Company was not a named defendant to the original claim by Summers Labs and a federal court denied Zylera's ability to be a counterclaimant in the matter.  Furthermore, the Company is not subject to the guarantee or interest provisions identified in the second ruling as these elements of the contractual relationship were not passed down to the Company&amp;#8217;s agreement with Lachlan.  However, the Company has interpreted this ruling's impact on the Lachlan Agreement to mean that the minimum purchase obligation and minimum royalty provisions of the contract are active and due for any prior periods as well as going forward for any future periods.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has recognized an&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; liability for these minimum obligations in accrued liabilities as of March 31, 2019. Under the terms of the TRx Purchase Agreement, the former TRx owners are required to indemnify the Company for&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of all pre-acquisition losses related this arbitration, including legal costs, and possible minimum payments in excess of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Furthermore, the former TRx owners are required to indemnify the Company for&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of post-acquisition Ulesfia losses, which would include losses resulting from having to fund these minimum obligations. The Company has recorded an indemnity receivable of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in other receivables as of March 31, 2019, which the Company believes is fully collectible.  For the three months ended March 31, 2019, minimum obligations net of amounts recorded within the indemnity receivable of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;has been recorded in cost of product sales.  If the Company fails to make these minimum obligations timely then the Lachlan Agreement may be terminated by Lachlan, in which case the Company would no longer be able to sell the Ulesfia product, but it would also not be subject to future minimum obligations.  Lachlan has not requested payment for the minimum obligations. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company expects a successful competitive product will enter the market in early 2021 and therefore the future minimum purchase obligations and royalty payments are expected only through 2020.  As of March 31, 2019, future minimum purchase obligations and future minimum royalty payments to Lachlan are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="18" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:30%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Q2 2019 - Q4 2019*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2020*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Minimum Purchase Obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;942,994&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,265,378&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,208,372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Minimum Royalties&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,250,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,000,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,250,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,192,994&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,265,378&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,458,372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;*Per the TRx Purchase Agreement, the previous owners of TRx are required to indemnify the Company for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of post-acquisition Ulesfia losses, which include the future minimum purchase obligations and future minimum royalties disclosed above. Thus, the Company's future net payouts related to the Ulesfia product should be significantly reduced as a result of the indemnification.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Karbinal Royalty Make-Whole Provision&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As discussed in Note 5, on February 16, 2018, in connection with the acquisition of Avadel's pediatric products, the Company entered into a supply and distribution agreement with TRIS Pharma (the "Karbinal Agreement").  As part of this agreement, the Company has an annual minimum sales commitment, which is based on a commercial year that spans from August 1 through July 31, of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;70,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; units through 2033.  The Company is required to pay TRIS a royalty make-whole payment of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$30&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for each unit under the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;70,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; units annual minimum sales commitment through 2033.  The annual payment is due in August of each year.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company paid &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to TRIS in August 2018 related to the make-whole payment for the commercial year ended July 31, 2018.  As of March 31, 2019, the Company has accrued &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in accrued expenses and other current liabilities related to the Karbinal royalty make whole for the commercial year ending July 31, 2019.  For the three months ended March 31, 2019, the make-whole provision of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; has been recorded in cost of product sales.  The future royalty make-whole payments are unknown as the amount owed to TRIS is dependent on the number of units sold.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Possible future milestone proceeds for out-licensed compound&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2017, the Company sold its worldwide rights to CERC-501 to Janssen Pharmaceuticals, Inc. (&amp;#8220;Janssen&amp;#8221;) in exchange for initial gross proceeds of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$25 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  There is a potential future &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$20 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; regulatory milestone payment to the Company. The terms of the agreement provide that Janssen will assume ongoing clinical trials and be responsible for any new development and commercialization of CERC-501.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:DebtDisclosureTextBlock contextRef="FD2019Q1YTD" id="Fact-182BD643C492BC5086638DD4EC996470">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Deerfield Obligation &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In relation to the Company's acquisition of Avadel's pediatric products on February 16, 2018, the Company assumed an obligation that Avadel had to Deerfield CSF (the "Deerfield Obligation").  Beginning in July 2018 through October 2020, the Company is required to pay a quarterly payment of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$262,500&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;to Deerfield. In January 2021, a balloon payment of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15,250,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;is due.  The difference between the gross value and fair value of these payments will be recorded as interest expense in the Company's condensed consolidated statements of operations through January 2021 using the effective interest method.  Interest expense for the three months ended March 31, 2019 was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and is included in interest expense, net on the accompanying condensed consolidated statements of operations. The amounts due within the next year are included in current portion of long-term debt on the Company's condensed consolidated balance sheets.  The amounts due in greater than one year are included in long-term debt, net of current portion, on the Company's condensed consolidated balance sheets.  The Deerfield Obligation was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; as of March 31, 2019, of which &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; is recorded as a current liability.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
	<us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="FD2019Q1YTD" id="Fact-A3054468862E485D5E2393AA6A5BC0F9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company generates substantially all of its revenue from sales of prescription pharmaceutical products to its customers.  The following table presents net revenues disaggregated by type (in thousands):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.07407407407408%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:68%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prescribed dietary supplements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,791&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,231&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prescription drugs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,620&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,029&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales force revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,411&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,483&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
	<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="FD2019Q1YTD" id="Fact-E5923BAF8960952AD4BA8DD4ECB87A5A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt; 10. Stock-Based Compensation &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;2016 Equity Incentive Plan&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On April 5, 2016, the Company&amp;#8217;s board of directors adopted the 2016 Equity Incentive Plan (the &amp;#8220;2016 Plan&amp;#8221;) as the successor to the 2015 Omnibus Plan (the &amp;#8220;2015 Plan&amp;#8221;). The 2016 Plan was approved by the Company&amp;#8217;s stockholders and became effective on May 18, 2016 (the &amp;#8220;2016 Plan Effective Date&amp;#8221;).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Upon the 2016 Plan Effective Date, the 2016 Plan reserved and authorized up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;600,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; additional shares of common stock for issuance, as well as &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;464,476&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; unallocated shares remaining available for grant of new awards under the 2015 Plan. An Amended and Restated 2016 Equity Incentive Plan (the "2016 Amended Plan") was approved by the Company's stockholders in May 2018, which increased the share reserve by an additional&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares. During the term of the 2016 Amended Plan, the share reserve will automatically increase on the first trading day in January of each calendar year, by an amount equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the total number of outstanding shares of common stock of the Company on the last trading day in December of the prior calendar year. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, there were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares available for future issuance under the 2016 Amended Plan.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Option grants to employees and directors typically expire after &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ten&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years. Employee options with service based vesting conditions typically vest over &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; or &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;four&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years.  Options granted to directors typically vest over &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years.  Directors may also elect to receive stock options in lieu of cash board compensation, which vest immediately.  For stock options granted to employees and non-employee directors, the estimated grant date fair market value of the Company&amp;#8217;s stock-based awards is amortized ratably over the individuals&amp;#8217; service periods, which is the period in which the awards vest.   Stock-based compensation expense includes expense related to stock options, restricted stock unit awards, and ESPP shares. The amount of stock-based compensation expense recognized for the three months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87.03703703703704%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;57,376&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,497&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;General and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;489,953&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;207,382&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales and marketing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,364&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,945&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total stock-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;596,693&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;242,824&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Stock options with service-based vesting conditions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has granted awards that contain service-based vesting conditions. The compensation cost for these options is recognized on a straight-line basis over the vesting periods.  A summary of option activity for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended March 31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.22222222222221%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Options&amp;#160;Outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Number of shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average exercise price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Grant date fair value of options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average remaining contractual term (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,746,597&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.16&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.79&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134,379&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.78&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;334,624&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(31,288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,297&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at March&amp;#160;31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,845,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercisable at March&amp;#160;31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,269,081&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.56&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6.76&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:84px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&amp;#8217;s common stock for those stock options that had exercise prices lower than the fair value of the Company&amp;#8217;s common stock. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the aggregate intrinsic value of options outstanding and currently exercisable was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.  The total intrinsic value of options exercised during the three months ended March 31, 2019 was&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The total grant date fair value of shares which vested during the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended March 31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;was&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The per&amp;#8209;share weighted&amp;#8209;average grant date fair value of the options granted during the&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended March 31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was estimated at&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.49&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. There were&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;302,901&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;options that vested during the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended March 31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; with a weighted average grant date fair value of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.09&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At March 31, 2019, there was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of total unrecognized compensation cost related to unvested service-based vesting conditions awards.  The unrecognized compensation cost is expected to be recognized over a weighted-average period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.9&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Stock options with market-based vesting conditions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During 2018,&amp;#160;the Company granted awards that vest upon the Company's common stock closing at or above &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; consecutive days.  A summary of option activity with market-based vesting conditions for the three months ended March 31, 2019 is as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:85%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Options&amp;#160;Outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Number of shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average exercise price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average remaining contractual term (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Aggregate intrinsic value (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;500,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at March 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;500,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.99&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;800,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercisable at March 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;padding-left:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1) The aggregate intrinsic value in the above table represents the total pre-tax amount that a participant would receive if the option had been exercised on the last day of the respective fiscal period. Options with a market value less than its exercise value are not included in the intrinsic value amount.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At March 31, 2019, there was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$805,068&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of total unrecognized compensation cost related to unvested market-based vesting conditions awards. This compensation cost is expected to be recognized over a weighted-average period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.8&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Stock-based compensation assumptions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table shows the assumptions used to compute stock-based compensation expense for stock options with service-based vesting conditions granted to employees and members of the board of directors under the Black-Scholes valuation model for the three months ended March 31, 2019.  There were no stock options granted with market-based vesting conditions for the three months ended March 31, 2019. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:65.55555555555556%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="3" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:77%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:5%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Service-based options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected dividend yield&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected volatility&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected life (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.0 - 6.25 &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.23 - 2.59%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Restricted Stock Units&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During 2018, the Company granted restricted stock units ("RSU") to certain employees.  The Company measures the fair value of the restricted units using the stock price at the date of the grant. The restricted shares vest annually over a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;four&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;-year period beginning on the first anniversary of the award. A summary of RSU grants activity for the three months ended March 31, 2019 is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:69.62962962962963%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;RSUs outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Number of shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average grant date fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested RSUs at December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;445,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.27&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(100,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested RSUs at March 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;345,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.27&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The stock compensation expense related to RSUs for the three months ended March 31, 2019 was&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$118,656&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. At March 31, 2019, there was&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1,433,329&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of total unrecognized compensation cost related to the RSU grants.  The compensation cost is expected to be recognized over a weighted-average period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.0&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Employee Stock Purchase Plan&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On April 5, 2016, the Company&amp;#8217;s board of directors approved the 2016 Employee Stock Purchase Plan (the &amp;#8220;ESPP&amp;#8221;). The ESPP was approved by the Company&amp;#8217;s stockholders and became effective on May 18, 2016 (the &amp;#8220;ESPP Effective Date&amp;#8221;).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Under the ESPP, eligible employees can purchase common stock through accumulated payroll deductions at such times as are established by the administrator. The ESPP is administered by the compensation committee of the Company&amp;#8217;s board of directors. Under the ESPP, eligible employees may purchase stock at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;85%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the lower of the fair market value of a share of the Company&amp;#8217;s common stock (i) on the first day of an offering period or (ii) on the purchase date. Eligible employees may contribute up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of their earnings during the offering period. The Company&amp;#8217;s board of directors may establish a maximum number of shares of the Company&amp;#8217;s common stock that may be purchased by any participant, or all participants in the aggregate, during each offering or offering period. Under the ESPP, a participant may not accrue rights to purchase more than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$25,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the fair market value of the Company&amp;#8217;s common stock for each calendar year in which such right is outstanding.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Upon the ESPP Effective Date, the Company reserved and authorized up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;500,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock for issuance under the ESPP. On January 1 of each calendar year, the aggregate number of shares that may be issued under the ESPP shall automatically increase by a number equal to the lesser of (i) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the total number of shares of the Company&amp;#8217;s capital stock outstanding on December 31 of the preceding calendar year, and (ii) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;500,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the Company&amp;#8217;s common stock, or (iii) a number of shares of the Company&amp;#8217;s common stock as determined by the Company&amp;#8217;s board of directors or compensation committee. The number of shares increased by &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;408,042&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; on January 1, 2019.  As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,192,025&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares remained available for issuance.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In accordance with the guidance in ASC 718-50, the ability to purchase shares of the Company&amp;#8217;s common stock at the lower of the offering date price or the purchase date price represents an option and, therefore, the ESPP is a compensatory plan under this guidance. Accordingly, stock-based compensation expense is determined based on the option&amp;#8217;s grant-date fair value and is recognized over the requisite service period of the option. The Company used the Black-Scholes valuation model and recognized stock-based compensation expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$35,298&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended March 31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which is included in the table above with stock-based compensation from stock options.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Subsequent Equity Grants&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On April 1, 2019, the Company granted &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; options with service-based vesting conditions at an exercise price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$6.22&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share to its employees as part of its annual stock option award.  One-quarter of the shares subject to the stock option will vest on the first anniversary of the grant date and the remaining three-quarters of the shares will vest in equal monthly installments over the following &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36 months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Furthermore, on April 15, 2019, the Company granted &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;300,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; options with service-based vesting conditions at an exercise price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.17&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to its newly appointed Executive Chairman of the Board.  One-third of the shares subject to the stock option will vest on the first anniversary of the date of grant and the remaining two-thirds of the shares will vest in equal monthly installments over the following &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24 months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, based on continuous service. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Additionally, the Company agreed to grant the Executive Chairman of the Board an option to purchase &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;300,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; additional shares of Company common stock with market-based vesting conditions.  The exercise price will equal the market value on the date of the grant with one-third of the shares vesting upon the Company's common stock closing at or above &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; consecutive days, one-third of the shares vesting upon the Company's stock closing at or above &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$10.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; consecutive days, and one-third of these shares vesting upon the Company's stock closing at or above &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$13.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; consecutive days. The Company also agreed to grant the Executive Chairman of the Board &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;250,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; RSUs, of which &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;50,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares will vest immediately on the grant date and the remainder will vest in &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; equal annual increments based on continued service.  These &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; equity awards will be granted upon the Company having an adequate share reserve available for future issuance under the 2016 Amended Plan as a result of either an increase to the total share reserve subject to shareholder approval or as a result of an increase to the existing available share reserve due to future forfeitures and expirations.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef="FD2019Q1YTD" id="Fact-F20E2B8F73847997C9A18DD4ECB887F9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net Loss Per Share&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"&gt;The Company computes earnings per sh&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;are ("EPS") using the two-class method.  The two-class method of computing EPS is an earnings allocation formula that determines EPS for common stock and any participating securities according to dividends declared and participation rights in undistributed earnings.  The Company has two classes of stock outstanding, common stock and preferred stock.  The preferred stock was issued in the fourth quarter of 2018 upon Armistice exercising preferred stock warrants to acquire an aggregate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,857,143&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the Series B Convertible Preferred Stock ("convertible preferred stock").  The convertible preferred stock has the same rights and preferences as common stock other than being non-voting and convertible to shares of common stock on a 1-to-&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; ratio.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Under the two-class method, the convertible preferred stock is considered a separate class of stock for EPS purposes and therefore basic and diluted EPS is provided below for both common stock and preferred stock.  EPS for common stock and EPS for preferred stock is computed by dividing the sum of distributed earnings and undistributed earnings for each class of stock by the weighted average number of shares outstanding for each class of stock for the period.  In applying the two-class method, undistributed earnings are allocated to common stock and preferred stock based on the weighted average shares outstanding during the period, which assumes the convertible preferred stock has been converted to common stock.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"&gt;Diluted net (loss) income per share includes the potential dilutive effect of common stock equivalents as if such securities were converted or exercised during the period, when the effect is dilutive.  Common stock equivalents include: (i) outstanding stock options and restricted stock units, which are included under the "treasury stock method" when dilutive, (ii) common stock to be issued upon the assumed conversion of the Company's unit purchase option shares, which are included under the "if-converted method" when dilutive; (iii) prior to issuance, the contingently issuable shares in the TRx acquisition, if contingencies would have been satisfied if the end of the contingency period were as of the balance sheet date under the "if-converted method" when dilutive; and (iv) common stock to be issued upon the exercise of outstanding warrants, which are included under the "treasury stock method" when dilutive.  Because the impact of these items is generally anti-dilutive during periods of net loss, there is no difference between basic and diluted loss per common share for periods with net losses.  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In periods of net loss, losses are allocated&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"&gt;to the participating security only if the security has not only the right to participate in earnings, but also a contractual obligation to share in the Company's losses.&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the computation of basic and diluted net loss per share of common stock and preferred stock for the three months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which includes both classes of participating securities:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.25925925925925%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Common stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Preferred stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Common stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Preferred stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&amp;#160;loss&amp;#160;per&amp;#160;share,&amp;#160;basic and diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Numerator: &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allocation of undistributed net loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,537,787&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,916,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,882,847&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Denominator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,284,168&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,857,143&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,316,246&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Basic and diluted net loss per share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.67&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following outstanding securities at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; have been excluded from the computation of diluted weighted shares outstanding, as they could have been anti-dilutive:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,345,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,909,384&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Warrants on common stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,024,708&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,986,659&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Restricted Stock Units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;345,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Underwriters' unit purchase option&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
	<us-gaap:FairValueDisclosuresTextBlock contextRef="FD2019Q1YTD" id="Fact-EC6096D27C2DDAA243A48DD4ECA8121F">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair Value Measurements &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASC No. 820, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements and Disclosures&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (&amp;#8220;ASC 820&amp;#8221;), defines fair value as the price that would be received to sell an asset, or paid to transfer a liability, in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value standard also establishes a three&amp;#8209;level hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows:&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:13px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:48px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Level&amp;#160;1&amp;#8212;inputs to the valuation methodology are quoted prices (unadjusted) for an identical asset or liability in an active market.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:justify;padding-left:60px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:48px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Level&amp;#160;2&amp;#8212;inputs to the valuation methodology include quoted prices for a similar asset or liability in an active market or model&amp;#8209;derived valuations in which all significant inputs are observable for substantially the full term of the asset or liability.&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:13px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:48px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Level&amp;#160;3&amp;#8212;inputs to the valuation methodology are unobservable and significant to the fair value measurement of the asset or liability.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table presents, for each of the fair value hierarchy levels required under ASC 820, the Company&amp;#8217;s assets and liabilities that are measured at fair value on a recurring basis:&lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:55%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&amp;#160;Using&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;prices&amp;#160;in&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&amp;#160;other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;active&amp;#160;markets&amp;#160;for&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;observable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;unobservable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;identical&amp;#160;assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;inputs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;inputs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Investments in money market funds*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,965,626&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,002,288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Warrant liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unit purchase option liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,993&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:55%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&amp;#160;Using&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;prices&amp;#160;in&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&amp;#160;other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;active&amp;#160;markets&amp;#160;for&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;observable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;unobservable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;identical&amp;#160;assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;inputs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;inputs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Investments in money market funds*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,324,932&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,050,564&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Warrant liability**&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,950&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unit purchase option liability**&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;*Investments in money market funds are reflected in cash and cash equivalents on the accompanying condensed consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;**Warrant liability and unit purchase option liability are reflected in accrued expenses and other current liabilities on the accompanying condensed consolidated balance sheets. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company&amp;#8217;s financial instruments included cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses and other current liabilities, short term and long-term debt, warrant liability, the underwriters' unit purchase option liability, and contingent consideration.  The carrying amounts reported in the accompanying condensed consolidated financial statements for cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses, and other current liabilities approximate their respective fair values because of the short-term nature of these accounts. The estimated fair value of the Company&amp;#8217;s long-term debt of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$14.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; as of March 31, 2019 was based on current interest rates for similar types of borrowings and is in Level 2 of the fair value hierarchy.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Level&amp;#160;3 Valuation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The tables presented below are a summary of changes in the fair value of the Company&amp;#8217;s Level&amp;#160;3 valuations for the warrant liability, unit purchase option liability, and contingent consideration for the three months ended March 31, 2019 and 2018:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.62962962962963%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Warrant&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unit purchase&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Contingent&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;option&amp;#160;liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,950&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,050,564&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,060,730&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Payment of contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(228,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(228,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,800&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;32,777&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;180,402&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;227,979&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at March 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,993&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,002,288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,060,031&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.07407407407408%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Warrant liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unit purchase option liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Royalty Obligation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,185&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,991&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,576,633&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,611,809&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Issuance of contingent consideration and royalty&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,875,165&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;240,744&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,115,909&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,405&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,846&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;199,283&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;63,486&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;286,020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at March 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,590&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,837&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,651,081&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;304,230&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,013,738&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In 2014, the Company issued warrants to purchase &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;625,208&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of convertible preferred stock. Upon the closing of our initial public offering ("IPO") in October 2015 these warrants became warrants to purchase &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22,328&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock, in accordance with their terms.   The warrants expire in October 2020. The warrants represent a freestanding financial instrument that is indexed to an obligation, which the Company refers to as the warrant liability.  The warrant liability is marked-to-market each reporting period with the change in fair value recorded to other income, net in the accompanying statements of operations until the warrants are exercised, expire or other facts and circumstances lead the warrant liability to be reclassified to stockholders&amp;#8217; equity. The fair value of the warrant liability is estimated using a Black-Scholes option-pricing model. The significant assumptions used in preparing the option pricing model for valuing the warrant liability as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, include (i)&amp;#160;volatility of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, (ii)&amp;#160;risk free interest rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.33%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, (iii)&amp;#160;strike price &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.40&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, (iv)&amp;#160;fair value of common stock &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.84&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and (v)&amp;#160;expected life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.60 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;years.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:132px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The underwriters&amp;#8217; unit purchase option (the &amp;#8220;UPO&amp;#8221;) was issued to the underwriters of the Company's IPO in 2015 and provides the underwriters the option to purchase up to a total of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; units. The units underlying the UPO will be, immediately upon exercise, separated into shares of common stock, underwriters&amp;#8217; Class A warrants, and underwriters&amp;#8217; Class B warrants (such warrants together referred to as the Underwriters&amp;#8217; Warrants).  The Underwriters&amp;#8217; Warrants were warrants to purchase shares of common stock.  The Class B warrants expired in April 2017 and the Class A warrants expired in October 2018, while the UPO expires in October 2020. The Company classifies the UPO as a liability, as it is a freestanding marked-to-market derivative instrument that is precluded from being classified in stockholders&amp;#8217; equity.  The UPO liability is marked-to-market each reporting period with the change in fair value recorded to other income, net in the accompanying statements of operations until the UPO is exercised, expires or other facts and circumstances lead the UPO to be reclassified to stockholders&amp;#8217; equity. The fair value of the UPO liability is estimated using a Black-Scholes option-pricing model. The significant assumptions used in preparing the simulation model for valuing the UPO as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, include (i)&amp;#160;volatility of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, (ii)&amp;#160;risk free interest rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.33%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, (iii)&amp;#160;unit strike price &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.47&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, (iv) fair value of underlying equity &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.84&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and (v)&amp;#160;expected life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.6 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's business acquisitions of Avadel's pediatric products and TRx (see Note 5) involve the potential for future payment of consideration that is contingent upon the achievement of operation and commercial milestones and royalty payments on future product sales.  The fair value of contingent consideration was determined at the acquisition date utilizing unobservable inputs such as the estimated amount and timing of projected cash flows, the probability of success (achievement of the contingent event), and the risk-adjusted discount rate used to present value the probability-weighted cash flows.  Subsequent to the acquisition date, at each reporting period, the contingent consideration liabilities are remeasured at the current fair value with changes recorded in the condensed consolidated statement of operations.    &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As part of the acquisition of Avadel's pediatric products, the Company will pay a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; annual royalty on net sales of the acquired Avadel pediatric products through February 2026, up to an aggregate amount of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The fair value of the future royalty is the expected future value of the contingent payments discounted to a present value.  The estimated fair value of the royalty payments as of March 31, 2019 was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The significant assumptions used in estimating the fair value of the royalty payment as of March 31, 2019 include (i) the expected net sales of the acquired Avadel pediatric products for that are subject to the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; royalty based on the Company's net sales forecast and (ii) the risk-adjusted discount rate of  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.4%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which is comprised of the risk-free interest rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.3%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and a counterparty risk of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6.1%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; utilized to discount the expected royalty payments.  The liability is reduced by periodic payments. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Additionally, as part of the initial purchase price allocation for the acquisition of Avadel's pediatric products performed during the first quarter of 2018, contingent consideration of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$240,744&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was assigned to future royalty obligations for the use of the Sellers' LiquiTime process technology.  In the second quarter of 2018, we identified measurement period adjustments which included the adjustment of the fair value of the LiquiTime intangible asset down to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consideration for the TRx acquisition includes certain potential contingent payments.  First, pursuant to the TRx Purchase Agreement, the Company would have been required to pay &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to the Sellers if the gross profit related to TRx products equaled or exceeded &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in 2018.  The Company did not achieve this contingent event in 2018 and therefore &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; value was assigned to the contingent payout as of December 31, 2018.  Additionally, the Company is required to pay &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; upon the transfer of the Ulesfia NDA to the Company ("NDA Transfer Milestone").  Finally, the Company will pay &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; upon FDA approval of a new dosage of Ulesfia ("FDA Approval Milestone").  The main inputs utilized to determine the fair value of each milestone is the probability of the milestone's success, the expected time to successfully reach the milestone, and the risk-adjusted discount rate.  The estimated fair value of the NDA Transfer Milestone as of March 31, 2019 was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and the significant assumptions used in estimating the fair value include (i) probability of milestone success of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45.0%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, (ii) expected time to milestone of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.2 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and (iii) risk-adjusted discount rate of  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which is comprised of the risk-free rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.4%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and a counterparty risk of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6.1%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The estimated fair value of the FDA Approval Milestone as of March 31, 2019 was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The significant assumptions used in estimating the fair value of the FDA Approval Milestone as of March 31, 2019 include (i) probability of milestone success at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22.5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, (ii) expected time to milestone of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.3 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and (iii) risk-adjusted discount rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.4%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which is comprised of the risk-free rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.3%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and a counterparty risk of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6.1%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;No&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; other changes in valuation techniques or inputs occurred during the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended March 31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;No&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; transfers of assets between Level&amp;#160;1 and Level&amp;#160;2 of the fair value measurement hierarchy occurred during the three months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="FD2019Q1YTD" id="Fact-BC79691C014963CA7AAD8DD4EC99DA54">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The tables presented below are a summary of changes in the fair value of the Company&amp;#8217;s Level&amp;#160;3 valuations for the warrant liability, unit purchase option liability, and contingent consideration for the three months ended March 31, 2019 and 2018:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.62962962962963%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Warrant&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unit purchase&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Contingent&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;option&amp;#160;liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,950&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,050,564&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,060,730&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Payment of contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(228,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(228,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,800&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;32,777&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;180,402&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;227,979&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at March 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,993&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,002,288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,060,031&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.07407407407408%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Warrant liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unit purchase option liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Royalty Obligation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,185&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,991&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,576,633&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,611,809&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Issuance of contingent consideration and royalty&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,875,165&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;240,744&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,115,909&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,405&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,846&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;199,283&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;63,486&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;286,020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at March 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,590&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,837&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,651,081&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;304,230&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,013,738&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef="FD2019Q1YTD" id="Fact-DD662940A182E038ACA08DD4ECA864B4">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Income Taxes &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The provision for income taxes was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$166,358&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the three months ended March 31, 2019 and is comprised of several components including current year state income tax related to one of the Company's wholly owned subsidiaries and current year amortization of tax-deductible goodwill that gives rise to indefinite lived deferred tax liability impacting the amount of valuation allowance required.  Additionally, discrete to the quarter, the Company recorded interest and penalties on the outstanding taxes payable to the IRS and various state authorities.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:LeaseCostTableTextBlock contextRef="FD2019Q1YTD" id="Fact-672983949F5F9D91AC39952287396539">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The components of lease expense for the three months ended March 31, 2019 and 2018 were as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:72%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Operating lease cost*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;54,606&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;47,559&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;*Includes short-term leases, which are immaterial. &lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
	<us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="FD2019Q1YTD" id="Fact-7C9B7E0864C1024844FA9525C1CCCE1A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;he following table shows a maturity analysis of the operating lease liability as of March 31, 2019: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.14814814814815%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Undiscounted Cash Flows&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;April 1, 2019 through December 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;155,815&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;169,510&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;173,748&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;178,092&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,183,290&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total lease payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,860,455&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less implied interest &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(671,178&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,189,277&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
	<us-gaap:LesseeOperatingLeasesTextBlock contextRef="FD2019Q1YTD" id="Fact-2C9379463BA53C04F330950E4EE24F5B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt; Leases&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Corporate Headquarter Lease&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company identified &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; operating lease for its corporate headquarters located in Rockville, Maryland.  The annual base rent for the office space is &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$161,671&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, subject to annual &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; increases over the term of the lease.  The lease provides for a rent abatement for a period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12 months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; following the Company's date of occupancy.  The lease has an initial term of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; from the date the Company makes its first annual fixed rent payment, which is expected to occur in January 2020. The Company has the option to extend the lease &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;times, each for a period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;five years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and may terminate the lease as of the sixth anniversary of the first annual fixed rent payment, upon the payment of a termination fee.  As of the lease commencement date, it is not reasonably certain that the Company will exercise the renewal periods or early terminate the lease and therefore the end date of the lease for accounting purposes is January 31, 2030.  The remaining term of the lease at March 31, 2019 is &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.83 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Supplemental balance sheet information related to the lease is as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:72%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Property and equipment, net &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;737,658&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other long-term liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,189,277&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The operating lease right-of-use asset is included in property and equipment and the lease liability is included in other long-term liabilities in our condensed consolidated balance sheets.  In order to determine the present value of lease payments, the Company utilized a discount rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.7%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  This rate was determined based on available information of the rate of interest the Company would pay to borrow on a collateralized basis at an amount equal to the lease payments in a similar economic environment over a similar term on the transition date. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The components of lease expense for the three months ended March 31, 2019 and 2018 were as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:72%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Operating lease cost*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;54,606&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;47,559&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;*Includes short-term leases, which are immaterial. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Because the corporate headquarter lease provides for a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;-month lease abatement, the cash paid for amounts included in the measurement of lease liabilities is &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the three months ended March 31, 2019. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table shows a maturity analysis of the operating lease liability as of March 31, 2019: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.14814814814815%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Undiscounted Cash Flows&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;April 1, 2019 through December 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;155,815&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;169,510&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;173,748&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;178,092&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,183,290&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total lease payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,860,455&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less implied interest &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(671,178&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,189,277&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
	<us-gaap:LongTermPurchaseCommitmentTextBlock contextRef="FD2019Q1YTD" id="Fact-57E74BC3B3BFC3BD237D952C16BE2C87">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of March 31, 2019, future minimum purchase obligations and future minimum royalty payments to Lachlan are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="18" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:30%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Q2 2019 - Q4 2019*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2020*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Minimum Purchase Obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;942,994&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,265,378&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,208,372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Minimum Royalties&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,250,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,000,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,250,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,192,994&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,265,378&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,458,372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LongTermPurchaseCommitmentTextBlock>
	<us-gaap:NatureOfOperations contextRef="FD2019Q1YTD" id="Fact-BDC6C249DF0E77CBA2C28DD4EC89449C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;1. Business&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cerecor Inc. (the "Company" or &amp;#8220;Cerecor&amp;#8221;) is a fully integrated biopharmaceutical company with commercial operations and research and development capabilities.  The Company is building a pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases.  The Company's neurology pipeline is led by CERC-301, which recently received positive interim results from the Phase I safety study of Neurogenic Orthostatic Hypotension ("nOH").  The Company is also developing &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; other neurological compounds, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of which is in preclinical testing and the other is in the clinical ready stage.  The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802, and CERC-803.  All &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of these compounds are therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation ("CDGs") by means of substrate replacement therapy.  The U.S. Food and Drug Administration ("FDA") has granted Rare Pediatric Disease designation ("RPDD") and Orphan Drug Designation ("ODD") to all &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; compounds.  Under the FDA&amp;#8217;s Rare Pediatric Disease Priority Review Voucher ("PRV") program, upon the approval of a new drug application ("NDA") for the treatment of a rare pediatric disease, the sponsor of such application would be eligible for a PRV that can be used to obtain priority review for a subsequent new drug application or biologics license application.  The PRV may be sold or transferred an unlimited number of times.  The Company plans to leverage the 505(b)(2) NDA pathway for all &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; compounds to accelerate development and approval.  The Company is also in the process of developing &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; other preclinical pediatric orphan rare disease compound. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company also has a diverse portfolio of marketed products.  Our marketed products are led by our prescribed dietary supplements and prescribed drugs.  Our prescribed dietary supplements include Poly-Vi-Flor and Tri-Vi-Flor, which are prescription vitamin and fluoride supplements used in infants and children to treat or prevent deficiency of essential vitamins and fluoride.  The Company also markets a number of prescription drugs that treat a range of pediatric diseases, disorders and conditions.  Cerecor's prescription drugs include Millipred&amp;#174;, Ulesfia&amp;#174;, Karbinal&amp;#8482; ER, AcipHex&amp;#174; Sprinkle&amp;#8482;, and Cefaclor for Oral Suspension. Finally, the Company has &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; marketed medical device, Flexichamber&amp;#8482;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cerecor was incorporated in 2011, commenced operations in the second quarter of 2011 and completed an initial public offering in October 2015. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On November 17, 2017, the Company acquired TRx Pharmaceuticals, LLC (&amp;#8220;TRx&amp;#8221;) and its wholly-owned subsidiaries (see "TRx Acquisition" in Note 5 below for a description of this transaction).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On February 16, 2018, Cerecor acquired all rights to Avadel Pharmaceuticals PLC&amp;#8217;s (&amp;#8220;Avadel&amp;#8221;) marketed pediatric products (the &amp;#8220;Acquired Products&amp;#8221;) in exchange for Cerecor assuming certain financial obligations of Avadel (see "Avadel Pediatric Products Acquisition" in Note 5 below for a description of this transaction).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On September 25, 2018, the Company acquired Ichorion Therapeutics, Inc., a privately-held biopharmaceutical company focused on developing treatments and increasing awareness of inherited metabolic disorders known as CDGs (see "Ichorion Asset Acquisition" in Note 5 below for a description of this transaction).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:132px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Liquidity&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In order to meet its cash flow needs, the Company applies a disciplined decision-making methodology as it evaluates the optimal allocation of the Company's resources between investing in the Company's current commercial product line, the Company's development portfolio and acquisitions or in-licensing of new assets.  For the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended March 31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, Cerecor generated &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;a net loss&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;negative&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; cash flow from operations of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, Cerecor had an accumulated deficit of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$105.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and a balance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$16.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in cash and cash equivalents.  During the first quarter of 2019, the Company closed an underwritten public offering of common stock for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,818,182&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock of the Company, at a price to the public of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share ("public price"). Armistice Capital Master Fund Ltd. ("Armistice"), our largest stockholder, participated in the offering by purchasing &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;363,637&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock of the Company from the underwriter at the public price.  Cerecor director Steven J. Boyd is Armistice's Chief Investment Officer.  The net proceeds of the offering were approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (see "Common Stock Offering" in Note 9 below for description of the transaction).  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company plans to use cash and the anticipated cash flows from the Company's existing product sales to offset costs related to its neurology programs, pediatric rare disease programs, business development, costs associated with its organizational infrastructure, and debt principal and interest payments.  Cerecor expects to continue to incur significant expenses and operating losses for the immediate future as it continues to invest in the Company's pipeline assets.  Our ability to achieve and maintain profitability in the future is dependent on, among other things, the development, regulatory approval, and commercialization of our new product candidates and achieving a level of revenues from our existing product sales adequate to support our cost structure, which includes significant investment in our pipeline assets. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company believes it will require additional financing to continue to execute its clinical development strategy and fund future operations. The Company plans to meet its capital requirements through operating cash flows from product sales and some combination of equity or debt financings, collaborations, out-licensing arrangements, strategic alliances, federal and private grants, marketing, distribution, or licensing arrangements, or the sale of current or future assets.  If the Company is not able to secure adequate additional funding, the Company may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs. If the Company raises additional funds through collaborations, strategic alliances, or licensing arrangements with third parties, the Company may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Our plan to aggressively develop our pipeline will require substantial cash inflows in excess of what the Company expects our current commercial operations to generate.&amp;#160; However, the Company expects that our existing cash and cash equivalents, together with anticipated revenue, will enable us to fund our operating expenses, capital expenditure requirements, and other non-operating cash payments, such as fixed quarterly payments on our outstanding debt balances, through at least May 2020.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="FD2019Q1YTD" id="Fact-1AB506D100DD4976BF438DD4EC999F60">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Significant Accounting Policies &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the three months ended March 31, 2019, there have been no significant changes to the Company&amp;#8217;s summary of significant accounting policies contained in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on March 18, 2019 and amended on April 23, 2019, except for the recently adopted accounting standards described below.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following significant accounting policy was updated in 2019 to reflect changes upon our adoption of ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (Topic 842) ("ASU 2016-02").&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Leases&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company determines if an arrangement is a lease at inception.  If an arrangement contains a lease, the Company performs a lease classification test to determine if the lease is an operating lease or a finance lease.  The Company has identified &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; operating lease for its corporate headquarters. Right-of-use ("ROU") assets represent the right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.  Operating lease liabilities are recognized on the commencement date of the lease based on the present value of the future lease payments over the lease term and are included in other long-term liabilities on our condensed consolidated balance sheet.  Right-of-use assets are valued at the initial measurement of the lease liability, plus any indirect costs or rent prepayments, and reduced by any lease incentives and any deferred lease payments.  Operating right-of-use assets are recorded in property and equipment, net on the condensed consolidated balance sheet and are amortized over the lease term.  To determine the present value of lease payments on lease commencement, we use the implicit rate when readily determinable, however as most leases do not provide an implicit rate, we use our incremental borrowing rate based on information available at commencement date. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Furthermore, the Company has elected the practical expedient to account for the lease and non-lease components as a single lease component for the leased property asset class.  Lease expense is recognized on a straight-line basis over the life of the lease and is included within general and administrative expenses. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Adoption of ASC 842&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In February 2016, FASB issued ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (Topic 842) ("ASU 2016-02"). This guidance revises existing practice related to accounting for leases under ASC No. 840,&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;(&amp;#8220;ASC 840&amp;#8221;) for both lessees and lessors. The new guidance in ASU 2016-02 requires lessees to recognize a right-of-use asset and a lease liability for nearly all leases (other than leases that meet the definition of a short-term lease). The lease liability will be equal to the present value of lease payments and the right-of-use asset will be based on the lease liability, subject to adjustment such as for initial direct costs. For income statement purposes, the new standard retains a dual model similar to ASC 840, requiring leases to be classified as either operating leases or finance leases. For lessees, operating leases will result in straight-line expense (similar to current accounting by lessees for operating leases under ASC 840) while finance leases will result in a front-loaded expense pattern (similar to current accounting by lessees for capital leases under ASC 840). &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company adopted the standard using the simplified transition method on its effective date of January 1, 2019 and therefore did not adjust prior comparative periods as permitted by the codification improvements issued by FASB in July 2018.  Additionally, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allows the Company to carryforward the historical lease classification.  As a result of the standard, the Company recorded a lease liability of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and a right-of-use asset of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which is equal to the initial measurement of the lease liability reduced by the unamortized balance of lease incentive received and deferred rent.  There was no material impact to our condensed consolidated income statement (see Note 12 below for more information). &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Other Adopted Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532&amp;#160;Disclosure Update and&amp;#160;Simplification, to eliminate or modify certain disclosure rules that are redundant, outdated, or duplicative of GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of stockholders' equity are expanded for interim financial statements. An analysis of the changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement.  The Company has provided this disclosure beginning in the first quarter of 2019.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="FD2019Q1YTD" id="Fact-D421647195253D55B9128DD4EC99A8ED">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;A summary of RSU grants activity for the three months ended March 31, 2019 is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:69.62962962962963%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;RSUs outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Number of shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average grant date fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested RSUs at December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;445,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.27&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(100,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested RSUs at March 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;345,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.27&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
	<us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="FD2019Q1YTD" id="Fact-FA4470C74F73D415E6828DD4ECA8BD45">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Reclassification&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the fourth quarter of 2018, the Company concluded that going forward it would include change in fair value of contingent consideration within its own stand-alone line in operating expenses in the Company's statements of operations.  The Company has reclassified &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; from other expenses to operating expenses in the March 31, 2018 statement of operations to conform with current period presentation.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
	<us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="FD2019Q1YTD" id="Fact-2F3B617FC14DAA41D19A93A940999AD9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Revenue from Contracts with Customers &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#ff0000;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company generates substantially all of its revenue from sales of prescription pharmaceutical products to its customers.  The following table presents net revenues disaggregated by type (in thousands):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.07407407407408%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:68%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prescribed dietary supplements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,791&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,231&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prescription drugs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,620&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,029&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales force revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,411&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,483&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As is typical in the pharmaceutical industry, the Company sells its prescription pharmaceutical products (which include prescribed dietary supplements and prescription drugs) in the United States primarily through wholesale distributors and a specialty contracted pharmacy.  Wholesale distributors account for substantially all of the Company&amp;#8217;s net product revenues and trade receivables. In addition, the Company earns revenue from sales of its prescription pharmaceutical products directly to retail pharmacies. &amp;#160;&amp;#160;For the three months ended March 31, 2019, the Company&amp;#8217;s three largest customers accounted for approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, of the Company's total net product revenues from sale of prescription pharmaceutical products.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
	<us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="FD2019Q1YTD" id="Fact-0DB0C12D3C57701FF20F8DD4ECA8955B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following outstanding securities at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; have been excluded from the computation of diluted weighted shares outstanding, as they could have been anti-dilutive:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,345,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,909,384&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Warrants on common stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,024,708&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,986,659&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Restricted Stock Units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;345,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Underwriters' unit purchase option&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="FD2019Q1YTD" id="Fact-366D3538D8D28FA1CCBF8DD4ECB86501">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the computation of basic and diluted net loss per share of common stock and preferred stock for the three months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which includes both classes of participating securities:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.25925925925925%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Common stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Preferred stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Common stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Preferred stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&amp;#160;loss&amp;#160;per&amp;#160;share,&amp;#160;basic and diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Numerator: &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allocation of undistributed net loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,537,787&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,916,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,882,847&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Denominator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,284,168&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,857,143&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,316,246&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Basic and diluted net loss per share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.67&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="FD2019Q1YTD" id="Fact-3E38C23005D463F6D3618DD4ECA8550E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The amount of stock-based compensation expense recognized for the three months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87.03703703703704%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;57,376&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,497&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;General and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;489,953&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;207,382&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales and marketing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,364&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,945&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total stock-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;596,693&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;242,824&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
	<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="FD2019Q1YTD" id="Fact-F9C1DD9B996DDAF5F60F8EBAACB7D9D3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table presents, for each of the fair value hierarchy levels required under ASC 820, the Company&amp;#8217;s assets and liabilities that are measured at fair value on a recurring basis:&lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:55%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&amp;#160;Using&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;prices&amp;#160;in&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&amp;#160;other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;active&amp;#160;markets&amp;#160;for&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;observable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;unobservable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;identical&amp;#160;assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;inputs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;inputs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Investments in money market funds*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,965,626&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,002,288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Warrant liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unit purchase option liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,993&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:55%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&amp;#160;Using&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;prices&amp;#160;in&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&amp;#160;other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;active&amp;#160;markets&amp;#160;for&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;observable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;unobservable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;identical&amp;#160;assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;inputs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;inputs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Investments in money market funds*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,324,932&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,050,564&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Warrant liability**&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,950&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unit purchase option liability**&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;*Investments in money market funds are reflected in cash and cash equivalents on the accompanying condensed consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;**Warrant liability and unit purchase option liability are reflected in accrued expenses and other current liabilities on the accompanying condensed consolidated balance sheets. &lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
	<us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock contextRef="FD2019Q1YTD" id="Fact-E4236061AC1418B6C2B88E7CF421C867">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The final fair value of intangible assets both as disclosed in prior periods and as adjusted by measurement period adjustments identified during the third quarter of 2018 includes the following: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:39%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17,&lt;br clear="none"/&gt;2017 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17, 2017 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Useful Life&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Metafolin&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,465,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,522,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,987,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;PAI sales and marketing agreement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,334,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;219,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,553,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Millipred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,714,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;342,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,056,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Ulesfia&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;555,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(555,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,068,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,528,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,596,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The fair value of intangible assets, both as of the date of acquisition and as adjusted by measurement period adjustments identified during the second quarter of 2018, includes the following: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:39%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At February 16,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At February 16,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Useful Life&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired Product Marketing Rights - Karbinal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,221,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(21,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,200,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired Product Marketing Rights - AcipHex&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,520,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;283,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,803,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired Product Marketing Rights - Cefaclor&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,291,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,320,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,611,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired Developed Technology - Flexichamber&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,131,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;546,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,677,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired IPR&amp;amp;D - LiquiTime formulations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;290,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(290,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Indefinite&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,453,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,838,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,291,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
	<us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="FD2019Q1YTD" id="Fact-A5CBEC0D9A5A5BB58D148E830C80772A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At November 17, 2017 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of assets acquired:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,068&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,068&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,872,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,872,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;495,777&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;495,777&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prepaid expenses and other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134,281&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134,281&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other receivables&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,764,515&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,764,515&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Identifiable Intangible Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Metafolin&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,465,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,522,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,987,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;PAI sales and marketing agreement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,334,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;219,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,553,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Millipred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,714,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;342,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,056,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired product marketing rights - Ulesfia&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;555,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(555,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21,581,671&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,292,515&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,874,186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of liabilities assumed:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts payable &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;192,706&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;192,706&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued expenses and other current liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,850,422&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,764,515&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,614,937&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred tax liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;839,773&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78,840&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;918,613&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total liabilities assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,882,901&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,843,355&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,726,256&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total identifiable net assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,698,770&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;449,160&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,147,930&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of consideration transferred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,991,052&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,210,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,781,052&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,292,282&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,659,160&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,633,122&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition and as adjusted for measurement period adjustments identified during the second quarter of 2018: &amp;#160; &amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At February 16,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018 (preliminary)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Measurement Period Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;At February 16,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018 (as adjusted)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,549,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,831,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;718,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prepaid assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;570,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;570,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,453,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,838,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,291,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(362,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(362,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of debt assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(15,272,303&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;197,303&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(15,075,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair value of contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(7,875,165&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(44,835&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(7,920,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total net liabilities assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,145,468&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;367,468&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,778,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Consideration exchanged&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;241,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(240,999&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,386,468&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(608,467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,778,001&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
	<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="FD2019Q1YTD" id="Fact-683EBD86766A44D286A58DD4EC89A0A5">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;A summary of option activity with market-based vesting conditions for the three months ended March 31, 2019 is as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:85%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Options&amp;#160;Outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Number of shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average exercise price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average remaining contractual term (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Aggregate intrinsic value (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;500,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at March 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;500,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.99&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;800,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercisable at March 31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;padding-left:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1) The aggregate intrinsic value in the above table represents the total pre-tax amount that a participant would receive if the option had been exercised on the last day of the respective fiscal period. Options with a market value less than its exercise value are not included in the intrinsic value amount.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;A summary of option activity for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended March 31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.22222222222221%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Options&amp;#160;Outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Number of shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average exercise price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Grant date fair value of options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted average remaining contractual term (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,746,597&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.16&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.79&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134,379&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.78&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;334,624&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(31,288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,297&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at March&amp;#160;31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,845,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercisable at March&amp;#160;31, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,269,081&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.56&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6.76&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
	<us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="FD2019Q1YTD" id="Fact-692C05554BFD5A08750F8DD4ECB80834">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table shows the assumptions used to compute stock-based compensation expense for stock options with service-based vesting conditions granted to employees and members of the board of directors under the Black-Scholes valuation model for the three months ended March 31, 2019.  There were no stock options granted with market-based vesting conditions for the three months ended March 31, 2019. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:65.55555555555556%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="3" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:77%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:5%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Service-based options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected dividend yield&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected volatility&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected life (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.0 - 6.25 &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.23 - 2.59%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
	<us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="FD2019Q1YTD" id="Fact-926C071956A96430812D8DD4ECB806C7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the following common stock warrants were outstanding:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:68%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Number&amp;#160;of&amp;#160;shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Exercise&amp;#160;price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Expiration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;underlying&amp;#160;warrants&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;per&amp;#160;share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;date&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22,328*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.40&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;October 2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,380*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.68&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May 2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,000,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.50&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 2024&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,024,708&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;*Accounted for as a liability instrument (see Note 6)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
	<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
	</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cerc-20190331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cerecor.com/20190331" xmlns:cerc="http://www.cerecor.com/20190331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cerc-20190331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cerc-20190331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cerc-20190331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cerc-20190331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="AccruedExpensesAndOtherCurrentLiabilities" roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilities">
        <link:definition>2107100 - Disclosure - Accrued Expenses And Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesAndOtherCurrentLiabilitiesDetails" roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails">
        <link:definition>2407402 - Disclosure - Accrued Expenses And Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesAndOtherCurrentLiabilitiesTables" roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables">
        <link:definition>2307301 - Disclosure - Accrued Expenses And Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.cerecor.com/role/Acquisitions">
        <link:definition>2105100 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.cerecor.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2405402 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsProFormaInformationDetails" roleURI="http://www.cerecor.com/role/AcquisitionsProFormaInformationDetails">
        <link:definition>2405406 - Disclosure - Acquisitions - Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfAllocationOfPurchasePriceDetails">
        <link:definition>2405403 - Disclosure - Acquisitions - Schedule of Allocation of Purchase Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsScheduleOfConsiderationTransferredDetails" roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfConsiderationTransferredDetails">
        <link:definition>2405405 - Disclosure - Acquisitions - Schedule of Consideration Transferred (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails">
        <link:definition>2405404 - Disclosure - Acquisitions - Schedule of Intangible Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.cerecor.com/role/AcquisitionsTables">
        <link:definition>2305301 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSignificantAccountingPolicies" roleURI="http://www.cerecor.com/role/BasisOfPresentationAndSignificantAccountingPolicies">
        <link:definition>2102100 - Disclosure - Basis of Presentation and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Business" roleURI="http://www.cerecor.com/role/Business">
        <link:definition>2101100 - Disclosure - Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessDetails" roleURI="http://www.cerecor.com/role/BusinessDetails">
        <link:definition>2401401 - Disclosure - Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructure" roleURI="http://www.cerecor.com/role/CapitalStructure">
        <link:definition>2109100 - Disclosure - Capital Structure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureCommonStockDetails" roleURI="http://www.cerecor.com/role/CapitalStructureCommonStockDetails">
        <link:definition>2409402 - Disclosure - Capital Structure - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureTables" roleURI="http://www.cerecor.com/role/CapitalStructureTables">
        <link:definition>2309301 - Disclosure - Capital Structure (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureWarrantsDetails" roleURI="http://www.cerecor.com/role/CapitalStructureWarrantsDetails">
        <link:definition>2409403 - Disclosure - Capital Structure - Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingencies" roleURI="http://www.cerecor.com/role/CommitmentsAndContingencies">
        <link:definition>2113100 - Disclosure - Commitments And Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesDetails" roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesDetails">
        <link:definition>2413402 - Disclosure - Commitments And Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesMinimumFutureObligationsDetails" roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetails">
        <link:definition>2413403 - Disclosure - Commitments And Contingencies - Minimum Future Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesMinimumFutureObligationsDetailsCalc2" roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetailsCalc2">
        <link:definition>2413403 - Disclosure - Commitments And Contingencies - Minimum Future Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesTables" roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesTables">
        <link:definition>2313301 - Disclosure - Commitments And Contingencies - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001000 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>1003000 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfOperations" roleURI="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfOperations">
        <link:definition>1002000 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfChangesInStockholdersEquity" roleURI="http://www.cerecor.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity">
        <link:definition>1004000 - Statement - Consolidated Statements of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeerfieldObligation" roleURI="http://www.cerecor.com/role/DeerfieldObligation">
        <link:definition>2108100 - Disclosure - Deerfield Obligation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeerfieldObligationNarrativeDetails" roleURI="http://www.cerecor.com/role/DeerfieldObligationNarrativeDetails">
        <link:definition>2408401 - Disclosure - Deerfield Obligation  - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DocumentAndEntityInformation" roleURI="http://www.cerecor.com/role/DocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.cerecor.com/role/FairValueMeasurements">
        <link:definition>2106100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.cerecor.com/role/FairValueMeasurementsDetails">
        <link:definition>2406402 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.cerecor.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2406403 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsRollforwardDetails" roleURI="http://www.cerecor.com/role/FairValueMeasurementsRollforwardDetails">
        <link:definition>2406404 - Disclosure - Fair Value Measurements - Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.cerecor.com/role/FairValueMeasurementsTables">
        <link:definition>2306301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cerecor.com/role/IncomeTaxes">
        <link:definition>2111100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.cerecor.com/role/IncomeTaxesDetails">
        <link:definition>2411401 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cerecor.com/role/Leases">
        <link:definition>2112100 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAssetsAndLiabilitiesDetails" roleURI="http://www.cerecor.com/role/LeasesAssetsAndLiabilitiesDetails">
        <link:definition>2412403 - Disclosure - Leases - Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://www.cerecor.com/role/LeasesLeaseCostDetails">
        <link:definition>2412404 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturityDetails" roleURI="http://www.cerecor.com/role/LeasesLeaseMaturityDetails">
        <link:definition>2412405 - Disclosure - Leases - Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturityDetailsCalc2" roleURI="http://www.cerecor.com/role/LeasesLeaseMaturityDetailsCalc2">
        <link:definition>2412405 - Disclosure - Leases - Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.cerecor.com/role/LeasesNarrativeDetails">
        <link:definition>2412402 - Disclosure - Leases  - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cerecor.com/role/LeasesTables">
        <link:definition>2312301 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.cerecor.com/role/NetLossPerShare">
        <link:definition>2104100 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAntiDilutiveSecuritiesDetails" roleURI="http://www.cerecor.com/role/NetLossPerShareAntiDilutiveSecuritiesDetails">
        <link:definition>2404404 - Disclosure - Net Loss Per Share  - Anti-dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareNarrativeDetails" roleURI="http://www.cerecor.com/role/NetLossPerShareNarrativeDetails">
        <link:definition>2404402 - Disclosure - Net Loss Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareOfCommonStockBasicAndDilutedTables" roleURI="http://www.cerecor.com/role/NetLossPerShareOfCommonStockBasicAndDilutedTables">
        <link:definition>2304301 - Disclosure - Net Loss Per Share Of Common Stock, Basic And Diluted (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleOfEarningsPerShareDetails" roleURI="http://www.cerecor.com/role/NetLossPerShareScheduleOfEarningsPerShareDetails">
        <link:definition>2404403 - Disclosure - Net Loss Per Share  - Schedule of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueFromContractsWithCustomers" roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomers">
        <link:definition>2103100 - Disclosure - Revenue from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueFromContractsWithCustomersDetails" roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomersDetails">
        <link:definition>2403402 - Disclosure - Revenue from Contracts with Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueFromContractsWithCustomersTables" roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomersTables">
        <link:definition>2303301 - Disclosure - Revenue from Contracts with Customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://www.cerecor.com/role/SignificantAccountingPoliciesDetails">
        <link:definition>2402402 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.cerecor.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.cerecor.com/role/StockBasedCompensation">
        <link:definition>2110100 - Disclosure - Stock Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationDetails" roleURI="http://www.cerecor.com/role/StockBasedCompensationDetails">
        <link:definition>2410402 - Disclosure - Stock Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.cerecor.com/role/StockBasedCompensationTables">
        <link:definition>2310301 - Disclosure - Stock Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="cerc_AccruedGeneralAndAdministrativeExpenses" name="AccruedGeneralAndAdministrativeExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cerc_AccruedLiabilitiesAndOtherCurrentLiabilities" name="AccruedLiabilitiesAndOtherCurrentLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cerc_AccruedMedicaidRebates" name="AccruedMedicaidRebates" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cerc_AccruedResearchAndDevelopmentExpenses" name="AccruedResearchAndDevelopmentExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cerc_AccruedSalesReturnsAndAllowances" name="AccruedSalesReturnsAndAllowances" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cerc_AcipHexMember" name="AcipHexMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_AcquiredProductMarketingMember" name="AcquiredProductMarketingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_AmortizationOfInventoryFairValueAdjustment" name="AmortizationOfInventoryFairValueAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_ArmisticeMember" name="ArmisticeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_AssembledWorkforceMember" name="AssembledWorkforceMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_AssetAcquisitionAxis" name="AssetAcquisitionAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_AssetAcquisitionContingentConsiderationLiability" name="AssetAcquisitionContingentConsiderationLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cerc_AssetAcquisitionDomain" name="AssetAcquisitionDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones" name="AssetAcquisitionNumberOfContingentConsiderationMilestones" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" name="AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cerc_AssetAcquisitionResearchAndDevelopmentInProcess" name="AssetAcquisitionResearchAndDevelopmentInProcess" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cerc_AssetAcquisitionsTransactionCosts" name="AssetAcquisitionsTransactionCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cerc_AssetsAndLiabilitiesLesseeTableTextBlock" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_AvadelMember" name="AvadelMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_BoughtDealMember" name="BoughtDealMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares" name="BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod" name="BusinessAcquisitionGoodwillTaxDeductiblePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted" name="BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued" name="BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone" name="BusinessCombinationContingentConsiderationExpectedTimeToMilestone" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationGrossProfit" name="BusinessCombinationGrossProfit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables" name="BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock" name="BusinessCombinationsAndAssetAcquisitionsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract" name="BusinessCombinationsandAssetAcquisitionsAbstractAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_CapitalStockSharesAuthorized" name="CapitalStockSharesAuthorized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cerc_CefaclorMember" name="CefaclorMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_ClassOfWarrantOrRightDistributionAdjustment" name="ClassOfWarrantOrRightDistributionAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_CommonStockWarrantsExpirationDateJune2024Member" name="CommonStockWarrantsExpirationDateJune2024Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_CommonStockWarrantsExpirationMay2022Member" name="CommonStockWarrantsExpirationMay2022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_CommonStockWarrantsExpirationOctober2020Member" name="CommonStockWarrantsExpirationOctober2020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_CommonStockWarrantsMember" name="CommonStockWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_ContingentConsiderationMember" name="ContingentConsiderationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_ContingentlyIssuableCommonStockMember" name="ContingentlyIssuableCommonStockMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_DeerfieldObligationMember" name="DeerfieldObligationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_EmployeeConsultantsAndDirectorsStockOptionsMember" name="EmployeeConsultantsAndDirectorsStockOptionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_EmployeeMember" name="EmployeeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_EmployeeStockPurchasePlanESPPMember" name="EmployeeStockPurchasePlanESPPMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_EquityUnitPurchaseOptionMember" name="EquityUnitPurchaseOptionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation" name="FairValueAdjustmentOfWarrantsAndInvestorRightsObligation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration" name="FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_FairValueMeasurementsChangesInValuationTechniquesNumber" name="FairValueMeasurementsChangesInValuationTechniquesNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_FlexichamberMember" name="FlexichamberMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_IchorionMember" name="IchorionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_IncentiveWarrantsMember" name="IncentiveWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_KarbinalAgreementMember" name="KarbinalAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_KarbinalMember" name="KarbinalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_LachlanPharmaceuticalsMember" name="LachlanPharmaceuticalsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LesseeOperatingLeaseNumberOfContracts" name="LesseeOperatingLeaseNumberOfContracts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LesseeOperatingLeaseNumberOfRenewalOptions" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LesseeOperatingLeaseRemainingLeaseTeam" name="LesseeOperatingLeaseRemainingLeaseTeam" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LesseeOperatingLeaseRentAbatement" name="LesseeOperatingLeaseRentAbatement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseAgreementAccruedMakeWholePayment" name="LicenseAgreementAccruedMakeWholePayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent" name="LicenseAgreementIndemnificationOfPostacquisitionLossesPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent" name="LicenseAgreementIndemnificationOfPreacquisitionLossesPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseAgreementIndemnityReceivable" name="LicenseAgreementIndemnityReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cerc_LicenseAgreementMakeWholePayment" name="LicenseAgreementMakeWholePayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseAgreementMakeWholePaymentPerUnit" name="LicenseAgreementMakeWholePaymentPerUnit" nillable="true" substitutionGroup="xbrli:item" type="us-types:perUnitItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseAgreementMinimumRoyalty" name="LicenseAgreementMinimumRoyalty" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseAgreementPricePerUnit" name="LicenseAgreementPricePerUnit" nillable="true" substitutionGroup="xbrli:item" type="us-types:perUnitItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseAgreementProductRoyaltyNet" name="LicenseAgreementProductRoyaltyNet" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseAgreementRoyaltyObligation" name="LicenseAgreementRoyaltyObligation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure" name="LicenseAgreementRoyaltyObligationFairValueDisclosure" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments" name="LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cerc_LicenseObligationCurrent" name="LicenseObligationCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cerc_LicenseObligationNoncurrent" name="LicenseObligationNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cerc_LiquiTimeProcessMember" name="LiquiTimeProcessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MajorCustomerNumberOneMember" name="MajorCustomerNumberOneMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MajorCustomerNumberThreeMember" name="MajorCustomerNumberThreeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MajorCustomerNumberTwoMember" name="MajorCustomerNumberTwoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent" name="ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit" name="ManagementAndHandlingFeeRelatedPartyPricePerUnit" nillable="true" substitutionGroup="xbrli:item" type="us-types:perUnitItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MeasurementInputProbabilityOfMilestoneSuccessMember" name="MeasurementInputProbabilityOfMilestoneSuccessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MetafolinMember" name="MetafolinMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MilestoneAxis" name="MilestoneAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MilestoneDomain" name="MilestoneDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MilestoneOneMember" name="MilestoneOneMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MilestoneThreeMember" name="MilestoneThreeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MilestoneTwoMember" name="MilestoneTwoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_MillipredMember" name="MillipredMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent" name="MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cerc_NetIncomeLossBeforeTaxes" name="NetIncomeLossBeforeTaxes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember" name="NeurologicalClinicalAndPreclinicalStageCompoundsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_NumberOfClassOfStockAuthorized" name="NumberOfClassOfStockAuthorized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="cerc_NumberOfMarketedMedicalDevices" name="NumberOfMarketedMedicalDevices" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_NumberOfPreclinicalTherapies" name="NumberOfPreclinicalTherapies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_NumberOfPreemptiveConversionOrSubscriptionRights" name="NumberOfPreemptiveConversionOrSubscriptionRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_NumberOfProductsInDevelopment" name="NumberOfProductsInDevelopment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_NumberOfRedemptionOrSinkingFundProvisions" name="NumberOfRedemptionOrSinkingFundProvisions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_NumberofVotesPerShare" name="NumberofVotesPerShare" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_OperatingLeasesRentExpenseAnnualIncreasePercent" name="OperatingLeasesRentExpenseAnnualIncreasePercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_PAISalesAndMarketingAgreementMember" name="PAISalesAndMarketingAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities" name="PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cerc_PotentialFutureRegulatoryMilestone" name="PotentialFutureRegulatoryMilestone" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember" name="PreclinicalPediatricOrphanRareDiseaseCompoundMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_PrescribedDietarySupplementsMember" name="PrescribedDietarySupplementsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_PrescriptionDrugsMember" name="PrescriptionDrugsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_RestrictedStockAwardsMember" name="RestrictedStockAwardsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_RoyaltyObligationMeasurementInput" name="RoyaltyObligationMeasurementInput" nillable="true" substitutionGroup="xbrli:item" type="xbrli:decimalItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cerc_RoyaltyPayableMember" name="RoyaltyPayableMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_SalesForceRevenueMember" name="SalesForceRevenueMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_SalesRevenueProductMember" name="SalesRevenueProductMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock" name="ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock" name="ScheduleOfFairValueOfConsiderationTransferredTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_ScheduleOfSignificantAccountingLineItems" name="ScheduleOfSignificantAccountingLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_ScheduleOfSignificantAccountingPoliciesTable" name="ScheduleOfSignificantAccountingPoliciesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_ServiceBasedOptionsMember" name="ServiceBasedOptionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum" name="ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards" name="SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent" name="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" name="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" name="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_StockOptionsWithMarketBasedVestingConditionsMember" name="StockOptionsWithMarketBasedVestingConditionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock" name="StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_StockholdersEquityNotePreferredStockConversionRatio" name="StockholdersEquityNotePreferredStockConversionRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_TRISPharmaMember" name="TRISPharmaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_TRxMember" name="TRxMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_TemporaryEquityAndEquityDisclosureAbstract" name="TemporaryEquityAndEquityDisclosureAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_The2015PlanMember" name="The2015PlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_The2016PlanMember" name="The2016PlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_ThreePreclinicalTherapiesMember" name="ThreePreclinicalTherapiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_UlesfiaMember" name="UlesfiaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_UlesfiaSupplyAgreementMember" name="UlesfiaSupplyAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_UnderwritersUnitPurchaseOptionMember" name="UnderwritersUnitPurchaseOptionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_UnderwrittenPublicOfferingMember" name="UnderwrittenPublicOfferingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_WarrantCommonStockMember" name="WarrantCommonStockMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cerc_WarrantLiabilityMember" name="WarrantLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cerc_ZyleraMember" name="ZyleraMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>cerc-20190331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="cerc-20190331.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="cerc-20190331.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="cerc-20190331.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/Acquisitions" xlink:href="cerc-20190331.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsNarrativeDetails" xlink:href="cerc-20190331.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsProFormaInformationDetails" xlink:href="cerc-20190331.xsd#AcquisitionsProFormaInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" xlink:href="cerc-20190331.xsd#AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfConsiderationTransferredDetails" xlink:href="cerc-20190331.xsd#AcquisitionsScheduleOfConsiderationTransferredDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" xlink:href="cerc-20190331.xsd#AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsTables" xlink:href="cerc-20190331.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:href="cerc-20190331.xsd#BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/Business" xlink:href="cerc-20190331.xsd#Business" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/BusinessDetails" xlink:href="cerc-20190331.xsd#BusinessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructure" xlink:href="cerc-20190331.xsd#CapitalStructure" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructureCommonStockDetails" xlink:href="cerc-20190331.xsd#CapitalStructureCommonStockDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructureTables" xlink:href="cerc-20190331.xsd#CapitalStructureTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructureWarrantsDetails" xlink:href="cerc-20190331.xsd#CapitalStructureWarrantsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingencies" xlink:href="cerc-20190331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesDetails" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetails" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesMinimumFutureObligationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetailsCalc2" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesMinimumFutureObligationsDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesTables" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cerc-20190331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cerc-20190331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="cerc-20190331.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="cerc-20190331.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="cerc-20190331.xsd#ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/DeerfieldObligation" xlink:href="cerc-20190331.xsd#DeerfieldObligation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/DeerfieldObligationNarrativeDetails" xlink:href="cerc-20190331.xsd#DeerfieldObligationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/DocumentAndEntityInformation" xlink:href="cerc-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurements" xlink:href="cerc-20190331.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsDetails" xlink:href="cerc-20190331.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="cerc-20190331.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsRollforwardDetails" xlink:href="cerc-20190331.xsd#FairValueMeasurementsRollforwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsTables" xlink:href="cerc-20190331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/IncomeTaxes" xlink:href="cerc-20190331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/IncomeTaxesDetails" xlink:href="cerc-20190331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/Leases" xlink:href="cerc-20190331.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesAssetsAndLiabilitiesDetails" xlink:href="cerc-20190331.xsd#LeasesAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesLeaseCostDetails" xlink:href="cerc-20190331.xsd#LeasesLeaseCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesLeaseMaturityDetails" xlink:href="cerc-20190331.xsd#LeasesLeaseMaturityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesLeaseMaturityDetailsCalc2" xlink:href="cerc-20190331.xsd#LeasesLeaseMaturityDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesNarrativeDetails" xlink:href="cerc-20190331.xsd#LeasesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesTables" xlink:href="cerc-20190331.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShare" xlink:href="cerc-20190331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareAntiDilutiveSecuritiesDetails" xlink:href="cerc-20190331.xsd#NetLossPerShareAntiDilutiveSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareNarrativeDetails" xlink:href="cerc-20190331.xsd#NetLossPerShareNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareOfCommonStockBasicAndDilutedTables" xlink:href="cerc-20190331.xsd#NetLossPerShareOfCommonStockBasicAndDilutedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareScheduleOfEarningsPerShareDetails" xlink:href="cerc-20190331.xsd#NetLossPerShareScheduleOfEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomers" xlink:href="cerc-20190331.xsd#RevenueFromContractsWithCustomers" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomersDetails" xlink:href="cerc-20190331.xsd#RevenueFromContractsWithCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomersTables" xlink:href="cerc-20190331.xsd#RevenueFromContractsWithCustomersTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/SignificantAccountingPoliciesDetails" xlink:href="cerc-20190331.xsd#SignificantAccountingPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/SignificantAccountingPoliciesPolicies" xlink:href="cerc-20190331.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/StockBasedCompensation" xlink:href="cerc-20190331.xsd#StockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/StockBasedCompensationDetails" xlink:href="cerc-20190331.xsd#StockBasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/StockBasedCompensationTables" xlink:href="cerc-20190331.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedLiabilitiesAndOtherCurrentLiabilities" xlink:label="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_7a07cb88-ea08-29ef-5873-7ce076336367" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedSalesReturnsAndAllowances" xlink:label="loc_cerc_AccruedSalesReturnsAndAllowances_717d0dcb-ca0c-5eb6-f039-7ce076ec0628" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_7a07cb88-ea08-29ef-5873-7ce076336367" xlink:to="loc_cerc_AccruedSalesReturnsAndAllowances_717d0dcb-ca0c-5eb6-f039-7ce076ec0628" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedMedicaidRebates" xlink:label="loc_cerc_AccruedMedicaidRebates_01D451E75CF9ED1254C877918E713F23" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_7a07cb88-ea08-29ef-5873-7ce076336367" xlink:to="loc_cerc_AccruedMedicaidRebates_01D451E75CF9ED1254C877918E713F23" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent" xlink:label="loc_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_C7236539E7096D9505C3D13D8B62B6AF" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_7a07cb88-ea08-29ef-5873-7ce076336367" xlink:to="loc_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_C7236539E7096D9505C3D13D8B62B6AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_7a07cb88-ea08-29ef-5873-7ce076336367" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedResearchAndDevelopmentExpenses" xlink:label="loc_cerc_AccruedResearchAndDevelopmentExpenses_e9cb32c2-8de5-591b-1acf-7ce077814dc7" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_7a07cb88-ea08-29ef-5873-7ce076336367" xlink:to="loc_cerc_AccruedResearchAndDevelopmentExpenses_e9cb32c2-8de5-591b-1acf-7ce077814dc7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_ba219a34-af19-ad7c-f6cf-d5a32a7f2e7f" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_7a07cb88-ea08-29ef-5873-7ce076336367" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_ba219a34-af19-ad7c-f6cf-d5a32a7f2e7f" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedGeneralAndAdministrativeExpenses" xlink:label="loc_cerc_AccruedGeneralAndAdministrativeExpenses_f1c78e05-a839-5e24-2bb5-7ce0766e1b77" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_7a07cb88-ea08-29ef-5873-7ce076336367" xlink:to="loc_cerc_AccruedGeneralAndAdministrativeExpenses_f1c78e05-a839-5e24-2bb5-7ce0766e1b77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_3053b5f7-7eba-7a4e-1b48-16e69b0c3bbd" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_7a07cb88-ea08-29ef-5873-7ce076336367" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_3053b5f7-7eba-7a4e-1b48-16e69b0c3bbd" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/Acquisitions" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/AcquisitionsProFormaInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_c544afc8-6a4c-664e-94aa-7ce076ad6820" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_ff988676-4696-7200-7c21-8a1cd7902137" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_c544afc8-6a4c-664e-94aa-7ce076ad6820" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_ff988676-4696-7200-7c21-8a1cd7902137" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_b65b737f-9f4d-f3bb-4218-7ce0778b871b" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_c544afc8-6a4c-664e-94aa-7ce076ad6820" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_b65b737f-9f4d-f3bb-4218-7ce0778b871b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_cd315daa-56f2-d93e-e28d-c8585547d519" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_c544afc8-6a4c-664e-94aa-7ce076ad6820" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_cd315daa-56f2-d93e-e28d-c8585547d519" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_028dd478-2b6d-5ba1-9bb0-7ce07709f6a6" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_c544afc8-6a4c-664e-94aa-7ce076ad6820" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_028dd478-2b6d-5ba1-9bb0-7ce07709f6a6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_4d5e1f10-5527-34bc-0a51-7ce0775b0603" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_c544afc8-6a4c-664e-94aa-7ce076ad6820" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_4d5e1f10-5527-34bc-0a51-7ce0775b0603" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_f634189a-5572-d8a8-1efb-7ce0765b587c" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_c544afc8-6a4c-664e-94aa-7ce076ad6820" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_f634189a-5572-d8a8-1efb-7ce0765b587c" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_BF39E778302ADFFB77F3EC49EF55DBE3" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables" xlink:label="loc_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_ACB036F3AE91AF9997DEEC48D221505D" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_BF39E778302ADFFB77F3EC49EF55DBE3" xlink:to="loc_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_ACB036F3AE91AF9997DEEC48D221505D" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_BF39E778302ADFFB77F3EC49EF55DBE3" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_cd315daa-56f2-d93e-e28d-c8585547d519" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9ad6eb0b-0be8-3959-8888-f510808da951" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9ad6eb0b-0be8-3959-8888-f510808da951" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4969e367-c531-0df1-f44b-bfbc106efa7e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4969e367-c531-0df1-f44b-bfbc106efa7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_588b212f-0609-2b89-932f-cbe7e57377ff" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_588b212f-0609-2b89-932f-cbe7e57377ff" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_960d2d5c-c02c-a785-79db-7ce07651b2e2" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_960d2d5c-c02c-a785-79db-7ce07651b2e2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_87ec0825-6387-9442-2e70-bdbd3f856519" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_87ec0825-6387-9442-2e70-bdbd3f856519" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_30afdeef-aa84-8083-d81b-2bbd33114cc0" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_30afdeef-aa84-8083-d81b-2bbd33114cc0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_395f9bb0-2492-f247-ce6b-39e67453292c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_395f9bb0-2492-f247-ce6b-39e67453292c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8ce68675-8129-3ab4-cbd9-33127f150e28" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8ce68675-8129-3ab4-cbd9-33127f150e28" xlink:type="arc" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9ad6eb0b-0be8-3959-8888-f510808da951" xlink:type="arc" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4969e367-c531-0df1-f44b-bfbc106efa7e" xlink:type="arc" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_588b212f-0609-2b89-932f-cbe7e57377ff" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:label="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_3B21C44D37FE8F9E66D2EC3E05A9D65C" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_3B21C44D37FE8F9E66D2EC3E05A9D65C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fbe331bf-e36a-7435-2eec-e3249b6c0997" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fbe331bf-e36a-7435-2eec-e3249b6c0997" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:to="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_960d2d5c-c02c-a785-79db-7ce07651b2e2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ca5b5f1d-dfc3-4674-aee8-5c9edec064b4" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ca5b5f1d-dfc3-4674-aee8-5c9edec064b4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_D7BD8B67E3B71388A4A6EC50D33ABF28" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_D7BD8B67E3B71388A4A6EC50D33ABF28" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_028dd478-2b6d-5ba1-9bb0-7ce07709f6a6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_ACA087B9691E4871C299EC4B431F0D0B" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_D7BD8B67E3B71388A4A6EC50D33ABF28" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_ACA087B9691E4871C299EC4B431F0D0B" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cerecor.com/role/AcquisitionsScheduleOfConsiderationTransferredDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/AcquisitionsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/Business" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/BusinessDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CapitalStructure" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CapitalStructureCommonStockDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CapitalStructureTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CapitalStructureWarrantsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_f8d2a779-bbbb-3bcc-a820-19aabbbb8c52" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_b8d3de81-d375-f882-3336-669bbb0e1cbf" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_f8d2a779-bbbb-3bcc-a820-19aabbbb8c52" xlink:to="loc_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_b8d3de81-d375-f882-3336-669bbb0e1cbf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_fd38d852-e235-3c2d-5dfe-8b5d6311a727" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_f8d2a779-bbbb-3bcc-a820-19aabbbb8c52" xlink:to="loc_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_fd38d852-e235-3c2d-5dfe-8b5d6311a727" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_4534d2fe-37ac-e651-3737-accd5c658da4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_88f9dced-4ae9-a7b4-5bbb-4e138bdeec2a" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligationDueInSecondYear_4534d2fe-37ac-e651-3737-accd5c658da4" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_88f9dced-4ae9-a7b4-5bbb-4e138bdeec2a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaap_OtherCommitmentDueInSecondYear_0a55f62b-dd36-df29-dde0-6b43aadaa50d" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligationDueInSecondYear_4534d2fe-37ac-e651-3737-accd5c658da4" xlink:to="loc_us-gaap_OtherCommitmentDueInSecondYear_0a55f62b-dd36-df29-dde0-6b43aadaa50d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_ed1eea2b-a48a-4242-eb9b-b8e39209496a" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_f6b6b6cf-d833-15d8-b984-3052c3d8f47b" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligationDueInThirdYear_ed1eea2b-a48a-4242-eb9b-b8e39209496a" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_f6b6b6cf-d833-15d8-b984-3052c3d8f47b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaap_OtherCommitmentDueInThirdYear_1e3f4530-c8c6-e204-389d-78ee78e5bc31" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligationDueInThirdYear_ed1eea2b-a48a-4242-eb9b-b8e39209496a" xlink:to="loc_us-gaap_OtherCommitmentDueInThirdYear_1e3f4530-c8c6-e204-389d-78ee78e5bc31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_2a22a63a-481e-0a6f-f006-7a54404f656a" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_c587ed4b-1c17-dd3d-2c54-f43bb99e468b" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligationDueInFourthYear_2a22a63a-481e-0a6f-f006-7a54404f656a" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_c587ed4b-1c17-dd3d-2c54-f43bb99e468b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFourthYear_348c6de2-f0e3-1a42-8cc3-6adc90f4f37d" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligationDueInFourthYear_2a22a63a-481e-0a6f-f006-7a54404f656a" xlink:to="loc_us-gaap_OtherCommitmentDueInFourthYear_348c6de2-f0e3-1a42-8cc3-6adc90f4f37d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_969c363d-ca7d-3828-00db-919559604b29" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:to="loc_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_b8d3de81-d375-f882-3336-669bbb0e1cbf" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_88f9dced-4ae9-a7b4-5bbb-4e138bdeec2a" xlink:type="arc" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_f6b6b6cf-d833-15d8-b984-3052c3d8f47b" xlink:type="arc" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_c587ed4b-1c17-dd3d-2c54-f43bb99e468b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:to="loc_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_fd38d852-e235-3c2d-5dfe-8b5d6311a727" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:to="loc_us-gaap_OtherCommitmentDueInSecondYear_0a55f62b-dd36-df29-dde0-6b43aadaa50d" xlink:type="arc" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:to="loc_us-gaap_OtherCommitmentDueInThirdYear_1e3f4530-c8c6-e204-389d-78ee78e5bc31" xlink:type="arc" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:to="loc_us-gaap_OtherCommitmentDueInFourthYear_348c6de2-f0e3-1a42-8cc3-6adc90f4f37d" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetailsCalc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_B9ADDFB14FD41858DF919539DD0FDFAF_969c363d-ca7d-3828-00db-919559604b29" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B9ADDFB14FD41858DF919539DD0FDFAF_f8d2a779-bbbb-3bcc-a820-19aabbbb8c52" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_B9ADDFB14FD41858DF919539DD0FDFAF_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B9ADDFB14FD41858DF919539DD0FDFAF_f8d2a779-bbbb-3bcc-a820-19aabbbb8c52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_B9ADDFB14FD41858DF919539DD0FDFAF_4534d2fe-37ac-e651-3737-accd5c658da4" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_B9ADDFB14FD41858DF919539DD0FDFAF_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_B9ADDFB14FD41858DF919539DD0FDFAF_4534d2fe-37ac-e651-3737-accd5c658da4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_B9ADDFB14FD41858DF919539DD0FDFAF_ed1eea2b-a48a-4242-eb9b-b8e39209496a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_B9ADDFB14FD41858DF919539DD0FDFAF_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_B9ADDFB14FD41858DF919539DD0FDFAF_ed1eea2b-a48a-4242-eb9b-b8e39209496a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_B9ADDFB14FD41858DF919539DD0FDFAF_2a22a63a-481e-0a6f-f006-7a54404f656a" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_B9ADDFB14FD41858DF919539DD0FDFAF_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_B9ADDFB14FD41858DF919539DD0FDFAF_2a22a63a-481e-0a6f-f006-7a54404f656a" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_76017261-aa07-deb3-a119-3ccb7898c700" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_AccountsReceivableNet_76017261-aa07-deb3-a119-3ccb7898c700" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_7815dc53-65a7-4398-d380-4a8829de68fd" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_7815dc53-65a7-4398-d380-4a8829de68fd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0e2b0aef-f283-e3cd-a77b-e835b6efc171" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0e2b0aef-f283-e3cd-a77b-e835b6efc171" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_9b51435d-78b0-60ad-5d83-343c76eab3d9" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_9b51435d-78b0-60ad-5d83-343c76eab3d9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af012273-e8ee-655c-daa2-86b96989d377" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af012273-e8ee-655c-daa2-86b96989d377" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_c2c48170-d0ff-2c37-effc-ff5f53e30dcb" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccountsPayableCurrent_c2c48170-d0ff-2c37-effc-ff5f53e30dcb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_da0b2890-b4bd-c1c0-fffc-f41c168eaec4" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_da0b2890-b4bd-c1c0-fffc-f41c168eaec4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_0d8925ae-714a-26e4-aa69-2d9eac65a5c6" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_LongTermDebtCurrent_0d8925ae-714a-26e4-aa69-2d9eac65a5c6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_d1997c77-9fc6-cbee-b2e4-9f642058c98e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_d1997c77-9fc6-cbee-b2e4-9f642058c98e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4d10fc1d-2b1e-a08d-3574-d1bbfff59d2f" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4d10fc1d-2b1e-a08d-3574-d1bbfff59d2f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1c24f6a3-e8ba-9221-ee1e-4678b4a6cab8" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1c24f6a3-e8ba-9221-ee1e-4678b4a6cab8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d3ba3006-9df7-8186-2eb2-dc5094562cfe" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d3ba3006-9df7-8186-2eb2-dc5094562cfe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseObligationNoncurrent" xlink:label="loc_cerc_LicenseObligationNoncurrent_cc1ca9b1-cf54-de45-5318-7ce077365cfe" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_cerc_LicenseObligationNoncurrent_cc1ca9b1-cf54-de45-5318-7ce077365cfe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fcfc6b17-bfc5-2ebc-3fc1-751aa446a572" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fcfc6b17-bfc5-2ebc-3fc1-751aa446a572" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_6dca832a-861c-478d-b1a0-396533beb40d" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_AdditionalPaidInCapital_6dca832a-861c-478d-b1a0-396533beb40d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_ea289a9d-deba-2cde-21e4-3d0ae7a1f011" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_PreferredStockValue_ea289a9d-deba-2cde-21e4-3d0ae7a1f011" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ce4b89e-fa52-7101-5bea-622168a4559a" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ce4b89e-fa52-7101-5bea-622168a4559a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_9b51435d-78b0-60ad-5d83-343c76eab3d9" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ce4b89e-fa52-7101-5bea-622168a4559a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_9b51435d-78b0-60ad-5d83-343c76eab3d9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0e2b0aef-f283-e3cd-a77b-e835b6efc171" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ce4b89e-fa52-7101-5bea-622168a4559a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0e2b0aef-f283-e3cd-a77b-e835b6efc171" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="loc_us-gaap_ProceedsFromStockPlans_89070439-f162-e2de-a2eb-96e6bf6232c9" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromStockPlans_89070439-f162-e2de-a2eb-96e6bf6232c9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6ec8bc8e-bcd9-36ad-d8ae-2c2fa1dfd920" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6ec8bc8e-bcd9-36ad-d8ae-2c2fa1dfd920" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cfa1e746-5920-c3b5-33ed-a7dee018f26c" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cfa1e746-5920-c3b5-33ed-a7dee018f26c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8ca40fc7-564f-832a-56a7-2cfd188fe573" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8ca40fc7-564f-832a-56a7-2cfd188fe573" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6d89f221-3ede-36b2-fcad-4a4ce1606f6a" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6d89f221-3ede-36b2-fcad-4a4ce1606f6a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_80abba07-181c-6ed2-349d-9d7dfc078eab" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_80abba07-181c-6ed2-349d-9d7dfc078eab" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_90cbc3ab-f555-6407-b3b4-b2bfa84c9f18" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_ShareBasedCompensation_90cbc3ab-f555-6407-b3b4-b2bfa84c9f18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AmortizationOfInventoryFairValueAdjustment" xlink:label="loc_cerc_AmortizationOfInventoryFairValueAdjustment_6f1cd759-026d-5573-6262-7ce0775dc1cf" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_cerc_AmortizationOfInventoryFairValueAdjustment_6f1cd759-026d-5573-6262-7ce0775dc1cf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="loc_us-gaap_PaidInKindInterest_74538844-e2fb-8444-e093-2ede9444fc66" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_PaidInKindInterest_74538844-e2fb-8444-e093-2ede9444fc66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_c14a9ac3-04f1-504d-4cf1-cf62b3c1adf2" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_c14a9ac3-04f1-504d-4cf1-cf62b3c1adf2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation" xlink:label="loc_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_fce222d7-1a86-edbc-a843-7ce07630c4f3" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_fce222d7-1a86-edbc-a843-7ce07630c4f3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9dbcf839-4ba1-0e2b-8942-4c8a9981ac5b" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9dbcf839-4ba1-0e2b-8942-4c8a9981ac5b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_5c03a9d6-b8ac-bbf3-746c-c7ea8b29c405" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_5c03a9d6-b8ac-bbf3-746c-c7ea8b29c405" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_334f1d33-7cae-7fd2-9d83-bb387fc2f3dd" xlink:type="locator" />
    <link:calculationArc order="12" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_334f1d33-7cae-7fd2-9d83-bb387fc2f3dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0e4168a9-901d-abb5-15c0-3622e9e2c070" xlink:type="locator" />
    <link:calculationArc order="13" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0e4168a9-901d-abb5-15c0-3622e9e2c070" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_5e1e9e85-84f2-b25a-e88c-265f39456f6f" xlink:type="locator" />
    <link:calculationArc order="14" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_5e1e9e85-84f2-b25a-e88c-265f39456f6f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0a39d2ee-656d-ead5-a676-41794b4da8f4" xlink:type="locator" />
    <link:calculationArc order="15" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0a39d2ee-656d-ead5-a676-41794b4da8f4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e69a15cf-ab4b-cbea-dc70-0b76971b08a1" xlink:type="locator" />
    <link:calculationArc order="16" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e69a15cf-ab4b-cbea-dc70-0b76971b08a1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_c7f00aa8-2173-59e9-a1bf-8080d168d3b9" xlink:type="locator" />
    <link:calculationArc order="17" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_c7f00aa8-2173-59e9-a1bf-8080d168d3b9" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NetIncomeLossBeforeTaxes" xlink:label="loc_cerc_NetIncomeLossBeforeTaxes_b2c72b6a-403e-1b4d-eb20-7ce076e99295" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:to="loc_cerc_NetIncomeLossBeforeTaxes_b2c72b6a-403e-1b4d-eb20-7ce076e99295" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_NetIncomeLossBeforeTaxes_b2c72b6a-403e-1b4d-eb20-7ce076e99295" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration" xlink:label="loc_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_99f98c20-01d8-acdc-0ef8-7ce076b9c4b5" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:to="loc_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_99f98c20-01d8-acdc-0ef8-7ce076b9c4b5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_b28ba7ff-6f6a-a222-c7cf-0da1704e7466" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_b28ba7ff-6f6a-a222-c7cf-0da1704e7466" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome_bb610d99-851f-be70-f405-1d0649f0a727" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:to="loc_us-gaap_OtherIncome_bb610d99-851f-be70-f405-1d0649f0a727" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cerc_NetIncomeLossBeforeTaxes_b2c72b6a-403e-1b4d-eb20-7ce076e99295" xlink:to="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1c604cfe-da19-5194-72b6-98be0130cfb7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1c604cfe-da19-5194-72b6-98be0130cfb7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1c65a201-fd8e-32d7-dad9-c6d1d5719594" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1c65a201-fd8e-32d7-dad9-c6d1d5719594" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_11c9d7e5-c56e-e78a-ae7b-17989a817204" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_11c9d7e5-c56e-e78a-ae7b-17989a817204" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a698662c-5d68-9b87-98fe-02485cda58f8" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a698662c-5d68-9b87-98fe-02485cda58f8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_334a0036-49ae-85df-fa8d-a7de18d975ef" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_SellingAndMarketingExpense_334a0036-49ae-85df-fa8d-a7de18d975ef" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_afd0f625-a29a-3806-bad0-ad0ca19e7015" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_afd0f625-a29a-3806-bad0-ad0ca19e7015" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a8656384-f7ca-f6e9-7877-ac1b97f5601a" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a8656384-f7ca-f6e9-7877-ac1b97f5601a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cerecor.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/DeerfieldObligation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/DeerfieldObligationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsRollforwardDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/IncomeTaxesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/Leases" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/LeasesAssetsAndLiabilitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/LeasesLeaseCostDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/LeasesLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d0e3c4ab-df94-52c6-3761-ce2ed0f2f507" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d0e3c4ab-df94-52c6-3761-ce2ed0f2f507" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e0f20176-305e-e29f-ab09-584aea596901" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e0f20176-305e-e29f-ab09-584aea596901" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8e35e675-3955-0e95-1b9c-d08dd410962e" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8e35e675-3955-0e95-1b9c-d08dd410962e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_852d78fc-d4b9-e5fb-fd5a-9da7d3d49669" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_852d78fc-d4b9-e5fb-fd5a-9da7d3d49669" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7a6864a2-d55e-24e7-17f1-75d5cad038ee" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7a6864a2-d55e-24e7-17f1-75d5cad038ee" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a8c7556a-9f4c-b4fb-2e42-b21cf84287a7" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a8c7556a-9f4c-b4fb-2e42-b21cf84287a7" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cerecor.com/role/LeasesLeaseMaturityDetailsCalc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97F90460C6D551C597BF9527F0AB7841_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_97F90460C6D551C597BF9527F0AB7841_dba432e7-eec4-e0dc-718d-f46fe263fe47" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97F90460C6D551C597BF9527F0AB7841_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_97F90460C6D551C597BF9527F0AB7841_dba432e7-eec4-e0dc-718d-f46fe263fe47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_97F90460C6D551C597BF9527F0AB7841_41784c6f-4555-af92-3354-8f8701c77f60" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97F90460C6D551C597BF9527F0AB7841_4d26bd18-43c4-5981-04d4-83d0e9328a1d" xlink:to="loc_us-gaap_OperatingLeaseLiability_97F90460C6D551C597BF9527F0AB7841_41784c6f-4555-af92-3354-8f8701c77f60" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cerecor.com/role/LeasesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/LeasesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/NetLossPerShare" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/NetLossPerShareAntiDilutiveSecuritiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/NetLossPerShareNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/NetLossPerShareOfCommonStockBasicAndDilutedTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/NetLossPerShareScheduleOfEarningsPerShareDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/RevenueFromContractsWithCustomers" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/RevenueFromContractsWithCustomersDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/RevenueFromContractsWithCustomersTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/StockBasedCompensation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/StockBasedCompensationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cerecor.com/role/StockBasedCompensationTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cerc-20190331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="cerc-20190331.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="cerc-20190331.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="cerc-20190331.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/Acquisitions" xlink:href="cerc-20190331.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsNarrativeDetails" xlink:href="cerc-20190331.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsProFormaInformationDetails" xlink:href="cerc-20190331.xsd#AcquisitionsProFormaInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" xlink:href="cerc-20190331.xsd#AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfConsiderationTransferredDetails" xlink:href="cerc-20190331.xsd#AcquisitionsScheduleOfConsiderationTransferredDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" xlink:href="cerc-20190331.xsd#AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsTables" xlink:href="cerc-20190331.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:href="cerc-20190331.xsd#BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/Business" xlink:href="cerc-20190331.xsd#Business" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/BusinessDetails" xlink:href="cerc-20190331.xsd#BusinessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructure" xlink:href="cerc-20190331.xsd#CapitalStructure" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructureCommonStockDetails" xlink:href="cerc-20190331.xsd#CapitalStructureCommonStockDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructureTables" xlink:href="cerc-20190331.xsd#CapitalStructureTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructureWarrantsDetails" xlink:href="cerc-20190331.xsd#CapitalStructureWarrantsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingencies" xlink:href="cerc-20190331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesDetails" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetails" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesMinimumFutureObligationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesTables" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cerc-20190331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cerc-20190331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="cerc-20190331.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="cerc-20190331.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="cerc-20190331.xsd#ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/DeerfieldObligation" xlink:href="cerc-20190331.xsd#DeerfieldObligation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/DeerfieldObligationNarrativeDetails" xlink:href="cerc-20190331.xsd#DeerfieldObligationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/DocumentAndEntityInformation" xlink:href="cerc-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurements" xlink:href="cerc-20190331.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsDetails" xlink:href="cerc-20190331.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="cerc-20190331.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsRollforwardDetails" xlink:href="cerc-20190331.xsd#FairValueMeasurementsRollforwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsTables" xlink:href="cerc-20190331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/IncomeTaxes" xlink:href="cerc-20190331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/IncomeTaxesDetails" xlink:href="cerc-20190331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/Leases" xlink:href="cerc-20190331.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesAssetsAndLiabilitiesDetails" xlink:href="cerc-20190331.xsd#LeasesAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesLeaseCostDetails" xlink:href="cerc-20190331.xsd#LeasesLeaseCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesLeaseMaturityDetails" xlink:href="cerc-20190331.xsd#LeasesLeaseMaturityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesNarrativeDetails" xlink:href="cerc-20190331.xsd#LeasesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesTables" xlink:href="cerc-20190331.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShare" xlink:href="cerc-20190331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareAntiDilutiveSecuritiesDetails" xlink:href="cerc-20190331.xsd#NetLossPerShareAntiDilutiveSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareNarrativeDetails" xlink:href="cerc-20190331.xsd#NetLossPerShareNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareOfCommonStockBasicAndDilutedTables" xlink:href="cerc-20190331.xsd#NetLossPerShareOfCommonStockBasicAndDilutedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareScheduleOfEarningsPerShareDetails" xlink:href="cerc-20190331.xsd#NetLossPerShareScheduleOfEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomers" xlink:href="cerc-20190331.xsd#RevenueFromContractsWithCustomers" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomersDetails" xlink:href="cerc-20190331.xsd#RevenueFromContractsWithCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomersTables" xlink:href="cerc-20190331.xsd#RevenueFromContractsWithCustomersTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/SignificantAccountingPoliciesDetails" xlink:href="cerc-20190331.xsd#SignificantAccountingPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/SignificantAccountingPoliciesPolicies" xlink:href="cerc-20190331.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/StockBasedCompensation" xlink:href="cerc-20190331.xsd#StockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/StockBasedCompensationDetails" xlink:href="cerc-20190331.xsd#StockBasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/StockBasedCompensationTables" xlink:href="cerc-20190331.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/Acquisitions" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneAxis" xlink:label="loc_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneDomain" xlink:label="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:to="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E_default" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneDomain" xlink:label="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:to="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneOneMember" xlink:label="loc_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:to="loc_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneTwoMember" xlink:label="loc_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:to="loc_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneThreeMember" xlink:label="loc_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:to="loc_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:to="loc_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionAxis" xlink:label="loc_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionDomain" xlink:label="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:to="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521_default" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionDomain" xlink:label="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:to="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_IchorionMember" xlink:label="loc_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:to="loc_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_CDBC0A9E34660D7DCF409459811E6EC6" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_CDBC0A9E34660D7DCF409459811E6EC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_59DE8011A44AE47258D29459811E277F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_CDBC0A9E34660D7DCF409459811E6EC6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_59DE8011A44AE47258D29459811E277F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_59DE8011A44AE47258D29459811E277F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_CDBC0A9E34660D7DCF409459811E6EC6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_59DE8011A44AE47258D29459811E277F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_59DE8011A44AE47258D29459811E277F" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B3113B9D4B324C325C649459811E2C66" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B3113B9D4B324C325C649459811E2C66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07EE80919C21DEBAB3839459811EB2D4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B3113B9D4B324C325C649459811E2C66" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07EE80919C21DEBAB3839459811EB2D4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07EE80919C21DEBAB3839459811EB2D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B3113B9D4B324C325C649459811E2C66" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07EE80919C21DEBAB3839459811EB2D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_A0AA1291D3AB32F83A499459811F8128" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07EE80919C21DEBAB3839459811EB2D4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_A0AA1291D3AB32F83A499459811F8128" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_F90570639BF3F0D8CD279459811F6E91" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_dei_LegalEntityAxis_F90570639BF3F0D8CD279459811F6E91" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_D1FFD1F2E559259EF26E9459811F5868_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_F90570639BF3F0D8CD279459811F6E91" xlink:to="loc_dei_EntityDomain_D1FFD1F2E559259EF26E9459811F5868_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_D1FFD1F2E559259EF26E9459811F5868" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_F90570639BF3F0D8CD279459811F6E91" xlink:to="loc_dei_EntityDomain_D1FFD1F2E559259EF26E9459811F5868" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_5936FE2380378E846C329459811FE5DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_D1FFD1F2E559259EF26E9459811F5868" xlink:to="loc_cerc_TRxMember_5936FE2380378E846C329459811FE5DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A2A2AFC63805BB3EC530945981207AD6" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A2A2AFC63805BB3EC530945981207AD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A2A2AFC63805BB3EC530945981207AD6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A2A2AFC63805BB3EC530945981207AD6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssembledWorkforceMember" xlink:label="loc_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF" xlink:to="loc_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PAISalesAndMarketingAgreementMember" xlink:label="loc_cerc_PAISalesAndMarketingAgreementMember_E1F812401C2B2FA72007945981205457" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF" xlink:to="loc_cerc_PAISalesAndMarketingAgreementMember_E1F812401C2B2FA72007945981205457" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_D942C80DB99A15F837C09459812036B2" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_D942C80DB99A15F837C09459812036B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D942C80DB99A15F837C09459812036B2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D942C80DB99A15F837C09459812036B2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AvadelMember" xlink:label="loc_cerc_AvadelMember_6BD94B63D471A35A9064945981217667" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E" xlink:to="loc_cerc_AvadelMember_6BD94B63D471A35A9064945981217667" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_1E0B73C19D0CF0D9AD82945981214F62" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E" xlink:to="loc_cerc_TRxMember_1E0B73C19D0CF0D9AD82945981214F62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionContingentConsiderationLiability" xlink:label="loc_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionResearchAndDevelopmentInProcess" xlink:label="loc_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfPreclinicalTherapies" xlink:label="loc_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionsTransactionCosts" xlink:label="loc_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones" xlink:label="loc_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities" xlink:label="loc_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B655D23B8FC24C10898794598123D549" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B655D23B8FC24C10898794598123D549" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod" xlink:label="loc_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued" xlink:label="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares" xlink:label="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/AcquisitionsProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BA61696FB4D5B704341B98A29C6546F3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BA61696FB4D5B704341B98A29C6546F3" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_E83B9C61F2420E81110E98A29C65D8CE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BA61696FB4D5B704341B98A29C6546F3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_E83B9C61F2420E81110E98A29C65D8CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_E83B9C61F2420E81110E98A29C65D8CE" xlink:to="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_E83B9C61F2420E81110E98A29C65D8CE" xlink:to="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC" xlink:to="loc_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_08337DA35D76E005C5FB98A29C66A137" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC" xlink:to="loc_us-gaap_PreferredStockMember_08337DA35D76E005C5FB98A29C66A137" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_CA58A6ABBBFB2EEE536F98A29C66DA33" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BA61696FB4D5B704341B98A29C6546F3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_CA58A6ABBBFB2EEE536F98A29C66DA33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2C00268DBB384E0B1F4A98A29C669489_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_CA58A6ABBBFB2EEE536F98A29C66DA33" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2C00268DBB384E0B1F4A98A29C669489_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2C00268DBB384E0B1F4A98A29C669489" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_CA58A6ABBBFB2EEE536F98A29C66DA33" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2C00268DBB384E0B1F4A98A29C669489" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_EE8CFA7AE73B321EAA8598A29C668158" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2C00268DBB384E0B1F4A98A29C669489" xlink:to="loc_cerc_TRxMember_EE8CFA7AE73B321EAA8598A29C668158" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted" xlink:label="loc_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:to="loc_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_073A0F47EC8AF36F08719030688C384D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:to="loc_srt_RestatementAxis_073A0F47EC8AF36F08719030688C384D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_402F289736B160DA1D449030688DC264_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_073A0F47EC8AF36F08719030688C384D" xlink:to="loc_srt_RestatementDomain_402F289736B160DA1D449030688DC264_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_402F289736B160DA1D449030688DC264" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_073A0F47EC8AF36F08719030688C384D" xlink:to="loc_srt_RestatementDomain_402F289736B160DA1D449030688DC264" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_B134973455FAB516DAF79030688DFD33" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_402F289736B160DA1D449030688DC264" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_B134973455FAB516DAF79030688DFD33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_79AE043A5C322EBAC8589030688DC601" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:to="loc_srt_ProductOrServiceAxis_79AE043A5C322EBAC8589030688DC601" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_79AE043A5C322EBAC8589030688DC601" xlink:to="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_79AE043A5C322EBAC8589030688DC601" xlink:to="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MetafolinMember" xlink:label="loc_cerc_MetafolinMember_AFE6E9449BBA1D8664009030688EF4F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:to="loc_cerc_MetafolinMember_AFE6E9449BBA1D8664009030688EF4F7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MillipredMember" xlink:label="loc_cerc_MillipredMember_AB0060EC7F63A0E7D2189030688E88DE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:to="loc_cerc_MillipredMember_AB0060EC7F63A0E7D2189030688E88DE" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaMember" xlink:label="loc_cerc_UlesfiaMember_87A7B1B6F66AB5E252F09030688EAAC7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:to="loc_cerc_UlesfiaMember_87A7B1B6F66AB5E252F09030688EAAC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FBD20FB1F64C46A96A4A9030688EEB50" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FBD20FB1F64C46A96A4A9030688EEB50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FBD20FB1F64C46A96A4A9030688EEB50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FBD20FB1F64C46A96A4A9030688EEB50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AcquiredProductMarketingMember" xlink:label="loc_cerc_AcquiredProductMarketingMember_241CC1EFA3F85FA71B249030688FE68D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4" xlink:to="loc_cerc_AcquiredProductMarketingMember_241CC1EFA3F85FA71B249030688FE68D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PAISalesAndMarketingAgreementMember" xlink:label="loc_cerc_PAISalesAndMarketingAgreementMember_A987B876764000A21D7A9030688F8631" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4" xlink:to="loc_cerc_PAISalesAndMarketingAgreementMember_A987B876764000A21D7A9030688F8631" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_C068876274B241FF251A9030688FD049" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_C068876274B241FF251A9030688FD049" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C068876274B241FF251A9030688FD049" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C068876274B241FF251A9030688FD049" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AvadelMember" xlink:label="loc_cerc_AvadelMember_06E4086A29461AC1DBBA90306890648D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72" xlink:to="loc_cerc_AvadelMember_06E4086A29461AC1DBBA90306890648D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_2D0BF963FD87C8E6D8EC90306890E9C8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72" xlink:to="loc_cerc_TRxMember_2D0BF963FD87C8E6D8EC90306890E9C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:label="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7590632D72724B7D5A739030689199AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7590632D72724B7D5A739030689199AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B32C0811B2A1F249E64E90306892F7A4" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B32C0811B2A1F249E64E90306892F7A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_E1BAC71F3C68B32E836F903068939B97" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_Goodwill_E1BAC71F3C68B32E836F903068939B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables" xlink:label="loc_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_9AB1FC0A4121FC6D3A11903068946BD1" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_9AB1FC0A4121FC6D3A11903068946BD1" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/AcquisitionsScheduleOfConsiderationTransferredDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_82BFCDD9A7FDBB281D3D90306878BFAE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_82BFCDD9A7FDBB281D3D90306878BFAE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_12B4E0407CA35B1535E190306878AF3E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_82BFCDD9A7FDBB281D3D90306878BFAE" xlink:to="loc_srt_RestatementAxis_12B4E0407CA35B1535E190306878AF3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1563CA83A0427040320790306879E02D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_12B4E0407CA35B1535E190306878AF3E" xlink:to="loc_srt_RestatementDomain_1563CA83A0427040320790306879E02D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1563CA83A0427040320790306879E02D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_12B4E0407CA35B1535E190306878AF3E" xlink:to="loc_srt_RestatementDomain_1563CA83A0427040320790306879E02D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_DFE58D6B934244A71EFA9030687926E5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_1563CA83A0427040320790306879E02D" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_DFE58D6B934244A71EFA9030687926E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_294229ECB1F5983B47BE90306879F713" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_82BFCDD9A7FDBB281D3D90306878BFAE" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_294229ECB1F5983B47BE90306879F713" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_574BCE616ABE6DD6B6A090306879A95C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_294229ECB1F5983B47BE90306879F713" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_574BCE616ABE6DD6B6A090306879A95C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_574BCE616ABE6DD6B6A090306879A95C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_294229ECB1F5983B47BE90306879F713" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_574BCE616ABE6DD6B6A090306879A95C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_3FFD9CDBC0DC3760159B903068794202" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_574BCE616ABE6DD6B6A090306879A95C" xlink:to="loc_cerc_TRxMember_3FFD9CDBC0DC3760159B903068794202" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_F7FED8506B883BD4310F9030687AC39D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_F7FED8506B883BD4310F9030687AC39D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_F085FB78FAF711B145EA9030687A491A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_F085FB78FAF711B145EA9030687A491A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3EEB4CD9C493290CFF5D9030687AB316" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3EEB4CD9C493290CFF5D9030687AB316" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_312A4B5BC575EF4381FA9030687A212D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_312A4B5BC575EF4381FA9030687A212D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_3B2526A1BE0ED2E1668E9030687BBEB7" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_3B2526A1BE0ED2E1668E9030687BBEB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_3DD976E879F7336CA28B9030687B7A06" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_3DD976E879F7336CA28B9030687B7A06" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="loc_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:to="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:to="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="loc_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:to="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:to="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_KarbinalMember" xlink:label="loc_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AcipHexMember" xlink:label="loc_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CefaclorMember" xlink:label="loc_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FlexichamberMember" xlink:label="loc_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LiquiTimeProcessMember" xlink:label="loc_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MetafolinMember" xlink:label="loc_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MillipredMember" xlink:label="loc_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaMember" xlink:label="loc_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AcquiredProductMarketingMember" xlink:label="loc_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:to="loc_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PAISalesAndMarketingAgreementMember" xlink:label="loc_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:to="loc_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AvadelMember" xlink:label="loc_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:to="loc_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:to="loc_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/AcquisitionsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/Business" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/BusinessDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_44C5F40655B0FF5E466D9395AAC143F1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="loc_srt_CounterpartyNameAxis_44C5F40655B0FF5E466D9395AAC143F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_F184027F69FBCA3F6B659395AAC2F44A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_44C5F40655B0FF5E466D9395AAC143F1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_F184027F69FBCA3F6B659395AAC2F44A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_F184027F69FBCA3F6B659395AAC2F44A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_44C5F40655B0FF5E466D9395AAC143F1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_F184027F69FBCA3F6B659395AAC2F44A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ArmisticeMember" xlink:label="loc_cerc_ArmisticeMember_B413260CBFA8E7B7230B9396382A3016" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_F184027F69FBCA3F6B659395AAC2F44A" xlink:to="loc_cerc_ArmisticeMember_B413260CBFA8E7B7230B9396382A3016" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1A262348EBD3FF933B019391E5E80411" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1A262348EBD3FF933B019391E5E80411" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_DC2BED3759578F4EADC49391E702F3FD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1A262348EBD3FF933B019391E5E80411" xlink:to="loc_us-gaap_ClassOfStockDomain_DC2BED3759578F4EADC49391E702F3FD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_DC2BED3759578F4EADC49391E702F3FD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1A262348EBD3FF933B019391E5E80411" xlink:to="loc_us-gaap_ClassOfStockDomain_DC2BED3759578F4EADC49391E702F3FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_8A7D593CAA6CC7F328D793928E863DDE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_DC2BED3759578F4EADC49391E702F3FD" xlink:to="loc_us-gaap_CommonStockMember_8A7D593CAA6CC7F328D793928E863DDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_821D9455DE92D9CAD111938EEBFF1AEB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_821D9455DE92D9CAD111938EEBFF1AEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_574F997BBD7FC64AC146938EED568A9D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_821D9455DE92D9CAD111938EEBFF1AEB" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_574F997BBD7FC64AC146938EED568A9D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_574F997BBD7FC64AC146938EED568A9D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_821D9455DE92D9CAD111938EEBFF1AEB" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_574F997BBD7FC64AC146938EED568A9D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UnderwrittenPublicOfferingMember" xlink:label="loc_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_574F997BBD7FC64AC146938EED568A9D" xlink:to="loc_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_0FDA8B7963B9F8EABFE4938D569B1779" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="loc_srt_ProductOrServiceAxis_0FDA8B7963B9F8EABFE4938D569B1779" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0FDA8B7963B9F8EABFE4938D569B1779" xlink:to="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0FDA8B7963B9F8EABFE4938D569B1779" xlink:to="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember" xlink:label="loc_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:to="loc_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ThreePreclinicalTherapiesMember" xlink:label="loc_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:to="loc_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember" xlink:label="loc_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:to="loc_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfProductsInDevelopment" xlink:label="loc_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfMarketedMedicalDevices" xlink:label="loc_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_608BECF7A79498605D98938D56A4E0BF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_NetIncomeLoss_608BECF7A79498605D98938D56A4E0BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_00FB1A64D93159B516CE938D56A4B13E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_00FB1A64D93159B516CE938D56A4B13E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23B4F31C7CCAA430EB7F938D56A404CE" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23B4F31C7CCAA430EB7F938D56A404CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_D99131D39339231BC89B938E29A851E5" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_D99131D39339231BC89B938E29A851E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_19B9499565A8B4393E9693949D2C45E9" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_19B9499565A8B4393E9693949D2C45E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1F4BBCAECF94BA7A605D93973549B42D" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1F4BBCAECF94BA7A605D93973549B42D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CapitalStructure" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CapitalStructureCommonStockDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_7C9D724EAF71BE03414F943A18C7650B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_7C9D724EAF71BE03414F943A18C7650B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_F1209FEFB3B349401ADE943A18C86AFB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_7C9D724EAF71BE03414F943A18C7650B" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_F1209FEFB3B349401ADE943A18C86AFB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_F1209FEFB3B349401ADE943A18C86AFB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_7C9D724EAF71BE03414F943A18C7650B" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_F1209FEFB3B349401ADE943A18C86AFB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_IncentiveWarrantsMember" xlink:label="loc_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_F1209FEFB3B349401ADE943A18C86AFB" xlink:to="loc_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionAxis" xlink:label="loc_cerc_AssetAcquisitionAxis_C87B9AA568D5BA9C5DB9943A18C8C199" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_cerc_AssetAcquisitionAxis_C87B9AA568D5BA9C5DB9943A18C8C199" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionDomain" xlink:label="loc_cerc_AssetAcquisitionDomain_6398F032556F352A3568943A18C8DB92_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cerc_AssetAcquisitionAxis_C87B9AA568D5BA9C5DB9943A18C8C199" xlink:to="loc_cerc_AssetAcquisitionDomain_6398F032556F352A3568943A18C8DB92_default" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionDomain" xlink:label="loc_cerc_AssetAcquisitionDomain_6398F032556F352A3568943A18C8DB92" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cerc_AssetAcquisitionAxis_C87B9AA568D5BA9C5DB9943A18C8C199" xlink:to="loc_cerc_AssetAcquisitionDomain_6398F032556F352A3568943A18C8DB92" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_IchorionMember" xlink:label="loc_cerc_IchorionMember_9E0B7A31F2ACC9B7A2B5943A18C8E958" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_AssetAcquisitionDomain_6398F032556F352A3568943A18C8DB92" xlink:to="loc_cerc_IchorionMember_9E0B7A31F2ACC9B7A2B5943A18C8E958" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_67527210B93ADCE4CC30943A18C95A9C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_67527210B93ADCE4CC30943A18C95A9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85A7346B98469B3B9230943A18C9E81C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_67527210B93ADCE4CC30943A18C95A9C" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85A7346B98469B3B9230943A18C9E81C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85A7346B98469B3B9230943A18C9E81C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_67527210B93ADCE4CC30943A18C95A9C" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85A7346B98469B3B9230943A18C9E81C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_64E0AEC67B0E4CFF9D11943A18C97147" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85A7346B98469B3B9230943A18C9E81C" xlink:to="loc_cerc_TRxMember_64E0AEC67B0E4CFF9D11943A18C97147" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_C7D0B66643787B5FFB70943A18C9F05E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_C7D0B66643787B5FFB70943A18C9F05E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_C7D0B66643787B5FFB70943A18C9F05E" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_C7D0B66643787B5FFB70943A18C9F05E" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_A419F90876B442246DC2943A18CAAFE5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC" xlink:to="loc_us-gaap_PrivatePlacementMember_A419F90876B442246DC2943A18CAAFE5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BoughtDealMember" xlink:label="loc_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC" xlink:to="loc_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_FAA4D3DC6E020D486E40943A18CBBF94" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_StatementClassOfStockAxis_FAA4D3DC6E020D486E40943A18CBBF94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_FAA4D3DC6E020D486E40943A18CBBF94" xlink:to="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_FAA4D3DC6E020D486E40943A18CBBF94" xlink:to="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF" xlink:to="loc_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_6DC8CF1C9C603465E5A0943A18CC0769" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_6DC8CF1C9C603465E5A0943A18CC0769" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_E207E809817E5CAFC264943A18CC7E09" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_srt_CounterpartyNameAxis_E207E809817E5CAFC264943A18CC7E09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_88E573070421AF38632F943A18CD8038_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_E207E809817E5CAFC264943A18CC7E09" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_88E573070421AF38632F943A18CD8038_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_88E573070421AF38632F943A18CD8038" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_E207E809817E5CAFC264943A18CC7E09" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_88E573070421AF38632F943A18CD8038" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ArmisticeMember" xlink:label="loc_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_88E573070421AF38632F943A18CD8038" xlink:to="loc_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_24E0615264588E9F5F42943A18CD028F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_24E0615264588E9F5F42943A18CD028F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_24E0615264588E9F5F42943A18CD028F" xlink:to="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_24E0615264588E9F5F42943A18CD028F" xlink:to="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_4FDDB6BBA72A77D20CBC943A18CE811F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E" xlink:to="loc_us-gaap_CommonStockMember_4FDDB6BBA72A77D20CBC943A18CE811F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_EE238AC287BCA45AFC71943A18CEACC9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E" xlink:to="loc_us-gaap_PreferredStockMember_EE238AC287BCA45AFC71943A18CEACC9" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfClassOfStockAuthorized" xlink:label="loc_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CapitalStockSharesAuthorized" xlink:label="loc_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_220670A8B0D230BEB1D1943A18CF00BA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_220670A8B0D230BEB1D1943A18CF00BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_89B199669F6F0BAF87E2943A18CF6C4A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_89B199669F6F0BAF87E2943A18CF6C4A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_12F3ED2E2D4A42BCD411943A18CF3679" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_12F3ED2E2D4A42BCD411943A18CF3679" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockholdersEquityNotePreferredStockConversionRatio" xlink:label="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_1AEA700707FD1A513FB4943A18CF6AD3" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_1AEA700707FD1A513FB4943A18CF6AD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_39987C8974205D238B57943A18D3FE4F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_39987C8974205D238B57943A18D3FE4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_C7245AEF2B737BFDFA41943A18D0D062" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_C7245AEF2B737BFDFA41943A18D0D062" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_B94AE574D37062B05FB1943A18D363CB" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_B94AE574D37062B05FB1943A18D363CB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ClassOfWarrantOrRightDistributionAdjustment" xlink:label="loc_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1050A64C836506E44132943A18D1F16D" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1050A64C836506E44132943A18D1F16D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7B5D8026752B6BDAA9BA943A18D237C4" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7B5D8026752B6BDAA9BA943A18D237C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_B3CA95D249980B24CD37943A18D23289" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_B3CA95D249980B24CD37943A18D23289" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued" xlink:label="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_59A27697CBE08EE77290943A18D3C49D" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_59A27697CBE08EE77290943A18D3C49D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares" xlink:label="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_F47BE69A78EDDD45DA26943A18D4F959" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_F47BE69A78EDDD45DA26943A18D4F959" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberofVotesPerShare" xlink:label="loc_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfPreemptiveConversionOrSubscriptionRights" xlink:label="loc_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfRedemptionOrSinkingFundProvisions" xlink:label="loc_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CapitalStructureTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CapitalStructureWarrantsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantCommonStockMember" xlink:label="loc_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:to="loc_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0D34FAD49AFFDAF4B9FC943A18BA910F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0D34FAD49AFFDAF4B9FC943A18BA910F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0D34FAD49AFFDAF4B9FC943A18BA910F" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0D34FAD49AFFDAF4B9FC943A18BA910F" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsExpirationOctober2020Member" xlink:label="loc_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:to="loc_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsExpirationMay2022Member" xlink:label="loc_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:to="loc_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsExpirationDateJune2024Member" xlink:label="loc_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:to="loc_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_50F6BC3F66896724729A943A18BB6C93" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_50F6BC3F66896724729A943A18BB6C93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_F68D0EAFD79475567EFD943A18BCD5CC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_50F6BC3F66896724729A943A18BB6C93" xlink:to="loc_us-gaap_ClassOfStockDomain_F68D0EAFD79475567EFD943A18BCD5CC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_F68D0EAFD79475567EFD943A18BCD5CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_50F6BC3F66896724729A943A18BB6C93" xlink:to="loc_us-gaap_ClassOfStockDomain_F68D0EAFD79475567EFD943A18BCD5CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_3C761958C634E4707CF8943A18BC38D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_F68D0EAFD79475567EFD943A18BCD5CC" xlink:to="loc_us-gaap_CommonClassAMember_3C761958C634E4707CF8943A18BC38D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5626324DD30A8ED38607943A18BCC20C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5626324DD30A8ED38607943A18BCC20C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_88C06D3F9B38CFA87B57943A18BDD4BA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_88C06D3F9B38CFA87B57943A18BDD4BA" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_5D0D735576B0ADDC6A4C98E52540687C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_srt_ProductOrServiceAxis_5D0D735576B0ADDC6A4C98E52540687C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_F1CAAF5780C5AC34017298E52540380D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5D0D735576B0ADDC6A4C98E52540687C" xlink:to="loc_srt_ProductsAndServicesDomain_F1CAAF5780C5AC34017298E52540380D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_F1CAAF5780C5AC34017298E52540380D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5D0D735576B0ADDC6A4C98E52540687C" xlink:to="loc_srt_ProductsAndServicesDomain_F1CAAF5780C5AC34017298E52540380D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicenseMember" xlink:label="loc_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_F1CAAF5780C5AC34017298E52540380D" xlink:to="loc_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:to="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:to="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:to="loc_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:to="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:to="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ZyleraMember" xlink:label="loc_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:to="loc_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LachlanPharmaceuticalsMember" xlink:label="loc_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:to="loc_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LachlanPharmaceuticalsMember" xlink:label="loc_cerc_LachlanPharmaceuticalsMember_317265BF02A12276768D98E52543CB34" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:to="loc_cerc_LachlanPharmaceuticalsMember_317265BF02A12276768D98E52543CB34" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRISPharmaMember" xlink:label="loc_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:to="loc_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaSupplyAgreementMember" xlink:label="loc_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:to="loc_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_KarbinalAgreementMember" xlink:label="loc_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:to="loc_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementPricePerUnit" xlink:label="loc_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit" xlink:label="loc_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent" xlink:label="loc_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementMinimumRoyalty" xlink:label="loc_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseObligationCurrent" xlink:label="loc_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent" xlink:label="loc_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments" xlink:label="loc_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent" xlink:label="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnityReceivable" xlink:label="loc_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementMakeWholePaymentPerUnit" xlink:label="loc_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementMakeWholePayment" xlink:label="loc_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementAccruedMakeWholePayment" xlink:label="loc_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PotentialFutureRegulatoryMilestone" xlink:label="loc_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22B9DAC2C52F1F7BBB6D953C84144CBA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22B9DAC2C52F1F7BBB6D953C84144CBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_60072EA41CD7BF314E8D953C8415EE57_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22B9DAC2C52F1F7BBB6D953C84144CBA" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_60072EA41CD7BF314E8D953C8415EE57_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_60072EA41CD7BF314E8D953C8415EE57" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22B9DAC2C52F1F7BBB6D953C84144CBA" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_60072EA41CD7BF314E8D953C8415EE57" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaSupplyAgreementMember" xlink:label="loc_cerc_UlesfiaSupplyAgreementMember_7C1DB368D54C2C9A321B953C84FB06F8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_60072EA41CD7BF314E8D953C8415EE57" xlink:to="loc_cerc_UlesfiaSupplyAgreementMember_7C1DB368D54C2C9A321B953C84FB06F8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_BC7989E2BDE85D2BFE10953C83ABE7CA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:to="loc_dei_LegalEntityAxis_BC7989E2BDE85D2BFE10953C83ABE7CA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_D82910056F05A931F474953C83AD4F64_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_BC7989E2BDE85D2BFE10953C83ABE7CA" xlink:to="loc_dei_EntityDomain_D82910056F05A931F474953C83AD4F64_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_D82910056F05A931F474953C83AD4F64" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_BC7989E2BDE85D2BFE10953C83ABE7CA" xlink:to="loc_dei_EntityDomain_D82910056F05A931F474953C83AD4F64" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ZyleraMember" xlink:label="loc_cerc_ZyleraMember_272C4D00B584F56323C3953C84823FCA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_D82910056F05A931F474953C83AD4F64" xlink:to="loc_cerc_ZyleraMember_272C4D00B584F56323C3953C84823FCA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_B42DD77E50F20A4B1CE5953C8347D72A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:to="loc_srt_CounterpartyNameAxis_B42DD77E50F20A4B1CE5953C8347D72A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_B2F36A2E5E8A5E512C73953C83487AC5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_B42DD77E50F20A4B1CE5953C8347D72A" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_B2F36A2E5E8A5E512C73953C83487AC5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_B2F36A2E5E8A5E512C73953C83487AC5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_B42DD77E50F20A4B1CE5953C8347D72A" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_B2F36A2E5E8A5E512C73953C83487AC5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LachlanPharmaceuticalsMember" xlink:label="loc_cerc_LachlanPharmaceuticalsMember_DCED22FD863FB45DCC8A953C84BD32CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_B2F36A2E5E8A5E512C73953C83487AC5" xlink:to="loc_cerc_LachlanPharmaceuticalsMember_DCED22FD863FB45DCC8A953C84BD32CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent" xlink:label="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_01EC2CA3586136595CFF953C830C999C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_01EC2CA3586136595CFF953C830C999C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_E02048AFA7564DBD25A1903F2C02E7C4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:to="loc_srt_ProductOrServiceAxis_E02048AFA7564DBD25A1903F2C02E7C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_E02048AFA7564DBD25A1903F2C02E7C4" xlink:to="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_E02048AFA7564DBD25A1903F2C02E7C4" xlink:to="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SalesRevenueProductMember" xlink:label="loc_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276" xlink:to="loc_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SalesForceRevenueMember" xlink:label="loc_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276" xlink:to="loc_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_41897C8363407D3B5DB6903F2C0363FE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_41897C8363407D3B5DB6903F2C0363FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_41897C8363407D3B5DB6903F2C0363FE" xlink:to="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_41897C8363407D3B5DB6903F2C0363FE" xlink:to="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_A350D176C5AD4B6509D39040DE383CBE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2" xlink:to="loc_us-gaap_CommonStockMember_A350D176C5AD4B6509D39040DE383CBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_D36700AAD2E24AE43AC290410F203E73" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2" xlink:to="loc_us-gaap_PreferredStockMember_D36700AAD2E24AE43AC290410F203E73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0F9641CEEF5C11F36E3C903F2C04B266" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0F9641CEEF5C11F36E3C903F2C04B266" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_BD895CD0E645821BD276903F2C056694" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_BD895CD0E645821BD276903F2C056694" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration" xlink:label="loc_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:to="loc_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:to="loc_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NetIncomeLossBeforeTaxes" xlink:label="loc_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1F57291F56C0F4C2C9E9903F2C06924E" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_NetIncomeLoss_1F57291F56C0F4C2C9E9903F2C06924E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_BAD670DCA65BC5F5921498A29CF820A0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_4531D2E65A50B2D90A6C98A29CF6DADE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_BAD670DCA65BC5F5921498A29CF820A0" xlink:to="loc_us-gaap_StatementTable_4531D2E65A50B2D90A6C98A29CF6DADE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4CCB05080D3EBD8A7D6B98A29CF6AE6F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4531D2E65A50B2D90A6C98A29CF6DADE" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4CCB05080D3EBD8A7D6B98A29CF6AE6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4CCB05080D3EBD8A7D6B98A29CF6AE6F" xlink:to="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4CCB05080D3EBD8A7D6B98A29CF6AE6F" xlink:to="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_69B5534FFE1E3817E83898A29CF795C1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_us-gaap_CommonStockMember_69B5534FFE1E3817E83898A29CF795C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_4011B4FCFF6FEA38050D98A29CF75DEF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_us-gaap_PreferredStockMember_4011B4FCFF6FEA38050D98A29CF75DEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ContingentlyIssuableCommonStockMember" xlink:label="loc_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_BAD670DCA65BC5F5921498A29CF820A0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:label="loc_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:label="loc_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_D975E771AE7AADEFD56D98A29CFA8421" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_NetIncomeLoss_D975E771AE7AADEFD56D98A29CFA8421" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/DeerfieldObligation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/DeerfieldObligationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_79887956E5A29DBE086A901F19C0015D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:to="loc_us-gaap_StatementScenarioAxis_79887956E5A29DBE086A901F19C0015D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_ACE81B3FE8C9621C1998901F19C08CBA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_79887956E5A29DBE086A901F19C0015D" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_ACE81B3FE8C9621C1998901F19C08CBA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_ACE81B3FE8C9621C1998901F19C08CBA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_79887956E5A29DBE086A901F19C0015D" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_ACE81B3FE8C9621C1998901F19C08CBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_20EE7E231717C56B4DFE901F19C000A6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_ACE81B3FE8C9621C1998901F19C08CBA" xlink:to="loc_us-gaap_ScenarioForecastMember_20EE7E231717C56B4DFE901F19C000A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:to="loc_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_DeerfieldObligationMember" xlink:label="loc_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:to="loc_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_40A1690949CC2D721BB1901F19C211B1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_40A1690949CC2D721BB1901F19C211B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_02AC9EA405B6D44B41FD901F19C22DB6" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_LongTermDebtCurrent_02AC9EA405B6D44B41FD901F19C22DB6" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ContingentConsiderationMember" xlink:label="loc_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:to="loc_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantLiabilityMember" xlink:label="loc_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:to="loc_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EquityUnitPurchaseOptionMember" xlink:label="loc_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:to="loc_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsMember" xlink:label="loc_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:to="loc_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneAxis" xlink:label="loc_cerc_MilestoneAxis_A59CFCB5E283330B274C940BF7469C9E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_cerc_MilestoneAxis_A59CFCB5E283330B274C940BF7469C9E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneDomain" xlink:label="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cerc_MilestoneAxis_A59CFCB5E283330B274C940BF7469C9E" xlink:to="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355_default" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneDomain" xlink:label="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cerc_MilestoneAxis_A59CFCB5E283330B274C940BF7469C9E" xlink:to="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneOneMember" xlink:label="loc_cerc_MilestoneOneMember_3C2FC422771035AF7C2A940BF872F038" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:to="loc_cerc_MilestoneOneMember_3C2FC422771035AF7C2A940BF872F038" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneTwoMember" xlink:label="loc_cerc_MilestoneTwoMember_5ECD4BC71983EF5ED3B7940BF88B4925" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:to="loc_cerc_MilestoneTwoMember_5ECD4BC71983EF5ED3B7940BF88B4925" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneThreeMember" xlink:label="loc_cerc_MilestoneThreeMember_26339E4CE1DC4DB74EAC940BF8A20F3C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:to="loc_cerc_MilestoneThreeMember_26339E4CE1DC4DB74EAC940BF8A20F3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_A1ABC281E21636564E3A940BF71D6BBE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_A1ABC281E21636564E3A940BF71D6BBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A1ABC281E21636564E3A940BF71D6BBE" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A1ABC281E21636564E3A940BF71D6BBE" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AvadelMember" xlink:label="loc_cerc_AvadelMember_C487F23506A45A5578FB940BF80150DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D" xlink:to="loc_cerc_AvadelMember_C487F23506A45A5578FB940BF80150DF" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_E6C39861F85EE6295404940BF85CE606" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D" xlink:to="loc_cerc_TRxMember_E6C39861F85EE6295404940BF85CE606" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_C2C2114A3BCF6A4149D6940BF6EC6B00" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_C2C2114A3BCF6A4149D6940BF6EC6B00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_C2C2114A3BCF6A4149D6940BF6EC6B00" xlink:to="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_C2C2114A3BCF6A4149D6940BF6EC6B00" xlink:to="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_65A4DA7B768F93C3AC6F940BF791576B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5" xlink:to="loc_us-gaap_PreferredStockMember_65A4DA7B768F93C3AC6F940BF791576B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_755DCD9CE143CE9515E2940BF7A4AFF4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5" xlink:to="loc_us-gaap_CommonStockMember_755DCD9CE143CE9515E2940BF7A4AFF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_50D9C57F621EC51498CC940BF6CB0FDA" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_StatementClassOfStockAxis_50D9C57F621EC51498CC940BF6CB0FDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_4D82D62E3752AF166E36940BF6CC4230_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_50D9C57F621EC51498CC940BF6CB0FDA" xlink:to="loc_us-gaap_ClassOfStockDomain_4D82D62E3752AF166E36940BF6CC4230_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_4D82D62E3752AF166E36940BF6CC4230" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_50D9C57F621EC51498CC940BF6CB0FDA" xlink:to="loc_us-gaap_ClassOfStockDomain_4D82D62E3752AF166E36940BF6CC4230" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_125872BC06F71F4F9C1E940BF77D3A5A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4D82D62E3752AF166E36940BF6CC4230" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_125872BC06F71F4F9C1E940BF77D3A5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputCounterpartyCreditRiskMember" xlink:label="loc_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MeasurementInputProbabilityOfMilestoneSuccessMember" xlink:label="loc_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_9BABA54B06DAA71E5A4693BC7AD90B75" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_9BABA54B06DAA71E5A4693BC7AD90B75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_9BABA54B06DAA71E5A4693BC7AD90B75" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_9BABA54B06DAA71E5A4693BC7AD90B75" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantLiabilityMember" xlink:label="loc_cerc_WarrantLiabilityMember_233BAA2C5184A18F83EC93BC7AD9063A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:to="loc_cerc_WarrantLiabilityMember_233BAA2C5184A18F83EC93BC7AD9063A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EquityUnitPurchaseOptionMember" xlink:label="loc_cerc_EquityUnitPurchaseOptionMember_58EA8E600686CD42EB2993BC7AD91D6E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:to="loc_cerc_EquityUnitPurchaseOptionMember_58EA8E600686CD42EB2993BC7AD91D6E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RoyaltyPayableMember" xlink:label="loc_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:to="loc_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3004948436AC7FCDBFD893BC7AD95938" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3004948436AC7FCDBFD893BC7AD95938" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3004948436AC7FCDBFD893BC7AD95938" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3004948436AC7FCDBFD893BC7AD95938" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_E7C29485905D21BF435D93BC7ADA4921" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_E7C29485905D21BF435D93BC7ADA4921" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementProductRoyaltyNet" xlink:label="loc_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementRoyaltyObligation" xlink:label="loc_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure" xlink:label="loc_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RoyaltyObligationMeasurementInput" xlink:label="loc_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0CC9A5073579FCF28B91940BF691AA76" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0CC9A5073579FCF28B91940BF691AA76" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationGrossProfit" xlink:label="loc_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone" xlink:label="loc_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueMeasurementsChangesInValuationTechniquesNumber" xlink:label="loc_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsRollforwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2038F42D27F11F2A0849945980B93298" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2038F42D27F11F2A0849945980B93298" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_E1EED7DE84640E8F4BD1945980B656ED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_E1EED7DE84640E8F4BD1945980B656ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_E1EED7DE84640E8F4BD1945980B656ED" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_E1EED7DE84640E8F4BD1945980B656ED" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantLiabilityMember" xlink:label="loc_cerc_WarrantLiabilityMember_044F31ED3BF97D68FE2D945980B77713" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:to="loc_cerc_WarrantLiabilityMember_044F31ED3BF97D68FE2D945980B77713" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EquityUnitPurchaseOptionMember" xlink:label="loc_cerc_EquityUnitPurchaseOptionMember_422430C4D3D3BA3FC323945980B7ABBD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:to="loc_cerc_EquityUnitPurchaseOptionMember_422430C4D3D3BA3FC323945980B7ABBD" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ContingentConsiderationMember" xlink:label="loc_cerc_ContingentConsiderationMember_C5BD62E64EE46C674779945980B797F5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:to="loc_cerc_ContingentConsiderationMember_C5BD62E64EE46C674779945980B797F5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RoyaltyPayableMember" xlink:label="loc_cerc_RoyaltyPayableMember_F5B64E21EFF547E1D12A945980B8E521" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:to="loc_cerc_RoyaltyPayableMember_F5B64E21EFF547E1D12A945980B8E521" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25738FF376E03FA28AEC945980B88CF2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25738FF376E03FA28AEC945980B88CF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_A285B54CF38BA9947B8D945980B87FE4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25738FF376E03FA28AEC945980B88CF2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_A285B54CF38BA9947B8D945980B87FE4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_A285B54CF38BA9947B8D945980B87FE4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25738FF376E03FA28AEC945980B88CF2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_A285B54CF38BA9947B8D945980B87FE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_2BE57425CAD50909F16F945980B88031" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_A285B54CF38BA9947B8D945980B87FE4" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_2BE57425CAD50909F16F945980B88031" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78D8C7933779A8944941945980B8994D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78D8C7933779A8944941945980B8994D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_F8E7B325B86D6462BDB1945980B8E568_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78D8C7933779A8944941945980B8994D" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_F8E7B325B86D6462BDB1945980B8E568_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_F8E7B325B86D6462BDB1945980B8E568" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78D8C7933779A8944941945980B8994D" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_F8E7B325B86D6462BDB1945980B8E568" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8290E75AD4B20BC061AE945980B9290D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_F8E7B325B86D6462BDB1945980B8E568" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8290E75AD4B20BC061AE945980B9290D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2038F42D27F11F2A0849945980B93298" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_552A90A587FC0B7B1B6E945980BA4AB9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_552A90A587FC0B7B1B6E945980BA4AB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2333FEF03FEF6DCA9610945980BA8F61" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2333FEF03FEF6DCA9610945980BA8F61" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/IncomeTaxesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/Leases" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/LeasesAssetsAndLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/LeasesLeaseCostDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/LeasesLeaseMaturityDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/LeasesNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/LeasesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/NetLossPerShare" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/NetLossPerShareAntiDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22C5FCE90C6EEFB79AF094C84E70B201" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1B366B4C212232B1AEB294C84E6F5DC6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22C5FCE90C6EEFB79AF094C84E70B201" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1B366B4C212232B1AEB294C84E6F5DC6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_D37D4F103DDB12E0A3AF94C84E6F2042" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1B366B4C212232B1AEB294C84E6F5DC6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_D37D4F103DDB12E0A3AF94C84E6F2042" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_D37D4F103DDB12E0A3AF94C84E6F2042" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_D37D4F103DDB12E0A3AF94C84E6F2042" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeConsultantsAndDirectorsStockOptionsMember" xlink:label="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_B9AE5686E43456EB96CD94C84E70D233" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:to="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_B9AE5686E43456EB96CD94C84E70D233" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantCommonStockMember" xlink:label="loc_cerc_WarrantCommonStockMember_196E1F42F7EA9090AB4594C84E700002" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:to="loc_cerc_WarrantCommonStockMember_196E1F42F7EA9090AB4594C84E700002" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RestrictedStockAwardsMember" xlink:label="loc_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:to="loc_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UnderwritersUnitPurchaseOptionMember" xlink:label="loc_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:to="loc_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22C5FCE90C6EEFB79AF094C84E70B201" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/NetLossPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:to="loc_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:to="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:to="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:to="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:to="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:to="loc_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:to="loc_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockholdersEquityNotePreferredStockConversionRatio" xlink:label="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:to="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/NetLossPerShareOfCommonStockBasicAndDilutedTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/NetLossPerShareScheduleOfEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_15B9C56483FD4BC5568594C84E749830" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:to="loc_us-gaap_StatementClassOfStockAxis_15B9C56483FD4BC5568594C84E749830" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_15B9C56483FD4BC5568594C84E749830" xlink:to="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_15B9C56483FD4BC5568594C84E749830" xlink:to="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_19B4CBAE0838944FFAEA94C84E7530F6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447" xlink:to="loc_us-gaap_CommonStockMember_19B4CBAE0838944FFAEA94C84E7530F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_8C1EDB12FC68CC3A577894C84E75DB90" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447" xlink:to="loc_us-gaap_PreferredStockMember_8C1EDB12FC68CC3A577894C84E75DB90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_D6B6C2B268ACFD847EDF94C84E76A922" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_D6B6C2B268ACFD847EDF94C84E76A922" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/RevenueFromContractsWithCustomers" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/RevenueFromContractsWithCustomersDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:to="loc_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_AF40D29485EABA1FF0FB93AADE3B0DE5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="loc_srt_ProductOrServiceAxis_AF40D29485EABA1FF0FB93AADE3B0DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_AF40D29485EABA1FF0FB93AADE3B0DE5" xlink:to="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_AF40D29485EABA1FF0FB93AADE3B0DE5" xlink:to="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PrescribedDietarySupplementsMember" xlink:label="loc_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:to="loc_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PrescriptionDrugsMember" xlink:label="loc_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:to="loc_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SalesForceRevenueMember" xlink:label="loc_cerc_SalesForceRevenueMember_3C10058939522B19AF0193AB9A4FD2EC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:to="loc_cerc_SalesForceRevenueMember_3C10058939522B19AF0193AB9A4FD2EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="loc_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:to="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:to="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MajorCustomerNumberOneMember" xlink:label="loc_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:to="loc_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MajorCustomerNumberTwoMember" xlink:label="loc_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:to="loc_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MajorCustomerNumberThreeMember" xlink:label="loc_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:to="loc_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F8C4B57E4BAF9BD5B25593AB1BF2026A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F8C4B57E4BAF9BD5B25593AB1BF2026A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/RevenueFromContractsWithCustomersTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfSignificantAccountingLineItems" xlink:label="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfSignificantAccountingPoliciesTable" xlink:label="loc_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="loc_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseNumberOfContracts" xlink:label="loc_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="loc_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_644A2F836FB46EE54A3598DEC4F786A7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="loc_us-gaap_OperatingLeaseLiability_644A2F836FB46EE54A3598DEC4F786A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/StockBasedCompensation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cerecor.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:to="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:to="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:to="loc_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeMember" xlink:label="loc_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:to="loc_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:to="loc_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="loc_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:to="loc_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9A639D12F5A57EFFA24694C84D0F195B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9A639D12F5A57EFFA24694C84D0F195B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0DC61D8DE0A7C3C2415994C84D0F5807_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9A639D12F5A57EFFA24694C84D0F195B" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0DC61D8DE0A7C3C2415994C84D0F5807_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0DC61D8DE0A7C3C2415994C84D0F5807" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9A639D12F5A57EFFA24694C84D0F195B" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0DC61D8DE0A7C3C2415994C84D0F5807" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeStockPurchasePlanESPPMember" xlink:label="loc_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0DC61D8DE0A7C3C2415994C84D0F5807" xlink:to="loc_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:to="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:to="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_The2016PlanMember" xlink:label="loc_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:to="loc_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_The2015PlanMember" xlink:label="loc_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:to="loc_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C04072106B1A5F94CD1D94C84D116CF1" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_srt_RangeAxis_C04072106B1A5F94CD1D94C84D116CF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_C04072106B1A5F94CD1D94C84D116CF1" xlink:to="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_C04072106B1A5F94CD1D94C84D116CF1" xlink:to="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_9DB815BD17B152D47EED94C84D11CADA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD" xlink:to="loc_srt_MinimumMember_9DB815BD17B152D47EED94C84D11CADA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD" xlink:to="loc_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ServiceBasedOptionsMember" xlink:label="loc_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:to="loc_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockOptionsWithMarketBasedVestingConditionsMember" xlink:label="loc_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:to="loc_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:to="loc_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeConsultantsAndDirectorsStockOptionsMember" xlink:label="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:to="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:type="locator" />
    <link:definitionArc order="26" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1" xlink:type="locator" />
    <link:definitionArc order="27" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445" xlink:type="locator" />
    <link:definitionArc order="28" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum" xlink:label="loc_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:type="locator" />
    <link:definitionArc order="29" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446" xlink:type="locator" />
    <link:definitionArc order="30" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:type="locator" />
    <link:definitionArc order="31" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0" xlink:type="locator" />
    <link:definitionArc order="32" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB" xlink:type="locator" />
    <link:definitionArc order="33" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:type="locator" />
    <link:definitionArc order="34" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards" xlink:label="loc_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:type="locator" />
    <link:definitionArc order="35" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cerecor.com/role/StockBasedCompensationTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>cerc-20190331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_LeasesAbstract_A02521393C89E2AD3756950E4EB765D8_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract_A02521393C89E2AD3756950E4EB765D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_A02521393C89E2AD3756950E4EB765D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract_A02521393C89E2AD3756950E4EB765D8" xlink:to="lab_us-gaap_LeasesAbstract_A02521393C89E2AD3756950E4EB765D8" xlink:type="arc" />
    <link:label id="lab_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E_terseLabel_en-US" xlink:label="lab_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:label id="lab_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E_label_en-US" xlink:label="lab_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E_documentation_en-US" xlink:label="lab_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:label="loc_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E" xlink:to="lab_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_38DCF2BBFECAE8C433D2952287216F52_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_38DCF2BBFECAE8C433D2952287216F52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_38DCF2BBFECAE8C433D2952287216F52_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_38DCF2BBFECAE8C433D2952287216F52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_38DCF2BBFECAE8C433D2952287216F52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock_38DCF2BBFECAE8C433D2952287216F52" xlink:to="lab_us-gaap_LeaseCostTableTextBlock_38DCF2BBFECAE8C433D2952287216F52" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0E80E6A713DA2BFBBCC09525C1C36BA7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0E80E6A713DA2BFBBCC09525C1C36BA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0E80E6A713DA2BFBBCC09525C1C36BA7_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0E80E6A713DA2BFBBCC09525C1C36BA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0E80E6A713DA2BFBBCC09525C1C36BA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0E80E6A713DA2BFBBCC09525C1C36BA7" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0E80E6A713DA2BFBBCC09525C1C36BA7" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9D1780696C526CB4857F9526C0DC70CB_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9D1780696C526CB4857F9526C0DC70CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">April 1, 2019 through December 31, 2019</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9D1780696C526CB4857F9526C0DC70CB_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9D1780696C526CB4857F9526C0DC70CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9D1780696C526CB4857F9526C0DC70CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9D1780696C526CB4857F9526C0DC70CB" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9D1780696C526CB4857F9526C0DC70CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6D6E658443A315C88B0F9526D9C598E8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6D6E658443A315C88B0F9526D9C598E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6D6E658443A315C88B0F9526D9C598E8_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6D6E658443A315C88B0F9526D9C598E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6D6E658443A315C88B0F9526D9C598E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6D6E658443A315C88B0F9526D9C598E8" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6D6E658443A315C88B0F9526D9C598E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D09AF55AE300D483332B9526F4CB2324_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D09AF55AE300D483332B9526F4CB2324" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D09AF55AE300D483332B9526F4CB2324_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D09AF55AE300D483332B9526F4CB2324" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D09AF55AE300D483332B9526F4CB2324" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D09AF55AE300D483332B9526F4CB2324" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D09AF55AE300D483332B9526F4CB2324" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_293D8971F5400655CF6995270C091F6A_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_293D8971F5400655CF6995270C091F6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_293D8971F5400655CF6995270C091F6A_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_293D8971F5400655CF6995270C091F6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_293D8971F5400655CF6995270C091F6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_293D8971F5400655CF6995270C091F6A" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_293D8971F5400655CF6995270C091F6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15E7521FA5894C1894B295271F6FAAB2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15E7521FA5894C1894B295271F6FAAB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15E7521FA5894C1894B295271F6FAAB2_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15E7521FA5894C1894B295271F6FAAB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15E7521FA5894C1894B295271F6FAAB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15E7521FA5894C1894B295271F6FAAB2" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15E7521FA5894C1894B295271F6FAAB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_F7E3FBB33A688E6317E7952732FB2545_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_F7E3FBB33A688E6317E7952732FB2545" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_F7E3FBB33A688E6317E7952732FB2545_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_F7E3FBB33A688E6317E7952732FB2545" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_F7E3FBB33A688E6317E7952732FB2545" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_F7E3FBB33A688E6317E7952732FB2545" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_F7E3FBB33A688E6317E7952732FB2545" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B54EA29E60CC3ED62308952747F44526_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B54EA29E60CC3ED62308952747F44526" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B54EA29E60CC3ED62308952747F44526_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B54EA29E60CC3ED62308952747F44526" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B54EA29E60CC3ED62308952747F44526" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B54EA29E60CC3ED62308952747F44526" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B54EA29E60CC3ED62308952747F44526" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D87179C80E427CBE200995276AA28089_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D87179C80E427CBE200995276AA28089" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less implied interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D87179C80E427CBE200995276AA28089_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D87179C80E427CBE200995276AA28089" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D87179C80E427CBE200995276AA28089" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D87179C80E427CBE200995276AA28089" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D87179C80E427CBE200995276AA28089" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_9A87B7A3496848C199269527A2190551_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_9A87B7A3496848C199269527A2190551" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_9A87B7A3496848C199269527A2190551_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_9A87B7A3496848C199269527A2190551" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_9A87B7A3496848C199269527A2190551" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_9A87B7A3496848C199269527A2190551" xlink:to="lab_us-gaap_OperatingLeaseLiability_9A87B7A3496848C199269527A2190551" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_DC21EBE6939D53147CF693BC7AF84438_label_en-US" xlink:label="lab_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_DC21EBE6939D53147CF693BC7AF84438" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations and Asset Acquisitions [Abstract] [Abstract]</link:label>
    <link:label id="lab_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_DC21EBE6939D53147CF693BC7AF84438_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_DC21EBE6939D53147CF693BC7AF84438" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combinations and Asset Acquisitions [Abstract] [Abstract]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract" xlink:label="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_DC21EBE6939D53147CF693BC7AF84438" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_DC21EBE6939D53147CF693BC7AF84438" xlink:to="lab_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_DC21EBE6939D53147CF693BC7AF84438" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:type="arc" />
    <link:label id="lab_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928_label_en-US" xlink:label="lab_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:to="lab_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:type="arc" />
    <link:label id="lab_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1_label_en-US" xlink:label="lab_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:to="lab_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:type="arc" />
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E" xlink:to="lab_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E" xlink:type="arc" />
    <link:label id="lab_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:to="lab_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:type="arc" />
    <link:label id="lab_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="lab_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:type="arc" />
    <link:label id="lab_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC_terseLabel_en-US" xlink:label="lab_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Karbinal</link:label>
    <link:label id="lab_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC_label_en-US" xlink:label="lab_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Karbinal [Member]</link:label>
    <link:label id="lab_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC_documentation_en-US" xlink:label="lab_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Karbinal [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_KarbinalMember" xlink:label="loc_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:to="lab_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:type="arc" />
    <link:label id="lab_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364_terseLabel_en-US" xlink:label="lab_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AcipHex</link:label>
    <link:label id="lab_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364_label_en-US" xlink:label="lab_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AcipHex [Member]</link:label>
    <link:label id="lab_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364_documentation_en-US" xlink:label="lab_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AcipHex [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AcipHexMember" xlink:label="loc_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:to="lab_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:type="arc" />
    <link:label id="lab_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091_terseLabel_en-US" xlink:label="lab_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cefaclor</link:label>
    <link:label id="lab_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091_label_en-US" xlink:label="lab_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cefaclor [Member]</link:label>
    <link:label id="lab_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091_documentation_en-US" xlink:label="lab_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cefaclor [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CefaclorMember" xlink:label="loc_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:to="lab_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:type="arc" />
    <link:label id="lab_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B_terseLabel_en-US" xlink:label="lab_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Flexichamber</link:label>
    <link:label id="lab_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B_label_en-US" xlink:label="lab_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Flexichamber [Member]</link:label>
    <link:label id="lab_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B_documentation_en-US" xlink:label="lab_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Flexichamber [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FlexichamberMember" xlink:label="loc_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:to="lab_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:type="arc" />
    <link:label id="lab_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726_terseLabel_en-US" xlink:label="lab_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LiquiTime Process</link:label>
    <link:label id="lab_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726_label_en-US" xlink:label="lab_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">LiquiTime Process [Member]</link:label>
    <link:label id="lab_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726_documentation_en-US" xlink:label="lab_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">LiquiTime Process [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LiquiTimeProcessMember" xlink:label="loc_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:to="lab_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:type="arc" />
    <link:label id="lab_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A_terseLabel_en-US" xlink:label="lab_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Metafolin</link:label>
    <link:label id="lab_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A_label_en-US" xlink:label="lab_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Metafolin [Member]</link:label>
    <link:label id="lab_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A_documentation_en-US" xlink:label="lab_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Metafolin [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MetafolinMember" xlink:label="loc_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:to="lab_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:type="arc" />
    <link:label id="lab_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB_terseLabel_en-US" xlink:label="lab_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Millipred</link:label>
    <link:label id="lab_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB_label_en-US" xlink:label="lab_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Millipred [Member]</link:label>
    <link:label id="lab_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB_documentation_en-US" xlink:label="lab_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Millipred [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MillipredMember" xlink:label="loc_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:to="lab_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:type="arc" />
    <link:label id="lab_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A_terseLabel_en-US" xlink:label="lab_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ulesfia</link:label>
    <link:label id="lab_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A_label_en-US" xlink:label="lab_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ulesfia [Member]</link:label>
    <link:label id="lab_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A_documentation_en-US" xlink:label="lab_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ulesfia [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaMember" xlink:label="loc_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:to="lab_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:type="arc" />
    <link:label id="lab_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E_terseLabel_en-US" xlink:label="lab_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired product marketing rights</link:label>
    <link:label id="lab_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E_label_en-US" xlink:label="lab_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Product Marketing [Member]</link:label>
    <link:label id="lab_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E_documentation_en-US" xlink:label="lab_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquired Product Marketing [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AcquiredProductMarketingMember" xlink:label="loc_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:to="lab_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired Developed Technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0" xlink:type="arc" />
    <link:label id="lab_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080_terseLabel_en-US" xlink:label="lab_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PAI sales and marketing agreement</link:label>
    <link:label id="lab_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080_label_en-US" xlink:label="lab_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PAI Sales And Marketing Agreement [Member]</link:label>
    <link:label id="lab_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080_documentation_en-US" xlink:label="lab_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PAI Sales And Marketing Agreement [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PAISalesAndMarketingAgreementMember" xlink:label="loc_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:to="lab_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:type="arc" />
    <link:label id="lab_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790_terseLabel_en-US" xlink:label="lab_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Avadel</link:label>
    <link:label id="lab_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790_label_en-US" xlink:label="lab_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Avadel [Member]</link:label>
    <link:label id="lab_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790_documentation_en-US" xlink:label="lab_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Avadel [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AvadelMember" xlink:label="loc_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:to="lab_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:type="arc" />
    <link:label id="lab_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B_terseLabel_en-US" xlink:label="lab_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TRx</link:label>
    <link:label id="lab_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B_label_en-US" xlink:label="lab_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TRx [Member]</link:label>
    <link:label id="lab_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B_documentation_en-US" xlink:label="lab_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">TRx [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:to="lab_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Identifiable Intangible Assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired finite-lived intangible assets, weighted average useful life (in years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_35697E54D365FBDAF7C99392C4149ADA_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_35697E54D365FBDAF7C99392C4149ADA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_35697E54D365FBDAF7C99392C4149ADA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35697E54D365FBDAF7C99392C4149ADA" xlink:to="lab_us-gaap_EarningsPerShareAbstract_35697E54D365FBDAF7C99392C4149ADA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7FDFA6C23AEFC8B988F49392C4145FCE_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7FDFA6C23AEFC8B988F49392C4145FCE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of the computation of basic and diluted net loss per share of Common Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7FDFA6C23AEFC8B988F49392C4145FCE_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7FDFA6C23AEFC8B988F49392C4145FCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7FDFA6C23AEFC8B988F49392C4145FCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7FDFA6C23AEFC8B988F49392C4145FCE" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7FDFA6C23AEFC8B988F49392C4145FCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_588EFD44D86F23E8998F9392C414A1C8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_588EFD44D86F23E8998F9392C414A1C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of anti-dilutive securities excluded from computation of diluted weighted shares outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_588EFD44D86F23E8998F9392C414A1C8_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_588EFD44D86F23E8998F9392C414A1C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_588EFD44D86F23E8998F9392C414A1C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_588EFD44D86F23E8998F9392C414A1C8" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_588EFD44D86F23E8998F9392C414A1C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C62E32B42AA1F8BA7FE298E52540E8B3_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C62E32B42AA1F8BA7FE298E52540E8B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C62E32B42AA1F8BA7FE298E52540E8B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C62E32B42AA1F8BA7FE298E52540E8B3" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C62E32B42AA1F8BA7FE298E52540E8B3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="lab_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:type="arc" />
    <link:label id="lab_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License</link:label>
    <link:label id="lab_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42_label_en-US" xlink:label="lab_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicenseMember" xlink:label="loc_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42" xlink:to="lab_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42" xlink:type="arc" />
    <link:label id="lab_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C_terseLabel_en-US" xlink:label="lab_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C_label_en-US" xlink:label="lab_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:to="lab_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:type="arc" />
    <link:label id="lab_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D_terseLabel_en-US" xlink:label="lab_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D_label_en-US" xlink:label="lab_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:to="lab_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:type="arc" />
    <link:label id="lab_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13_terseLabel_en-US" xlink:label="lab_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13_label_en-US" xlink:label="lab_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13" xlink:to="lab_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13" xlink:type="arc" />
    <link:label id="lab_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20_label_en-US" xlink:label="lab_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:to="lab_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:type="arc" />
    <link:label id="lab_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4_terseLabel_en-US" xlink:label="lab_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4_label_en-US" xlink:label="lab_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:to="lab_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:type="arc" />
    <link:label id="lab_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111_terseLabel_en-US" xlink:label="lab_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zylera</link:label>
    <link:label id="lab_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111_label_en-US" xlink:label="lab_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zylera [Member]</link:label>
    <link:label id="lab_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111_documentation_en-US" xlink:label="lab_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zylera [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ZyleraMember" xlink:label="loc_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:to="lab_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:type="arc" />
    <link:label id="lab_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B_terseLabel_en-US" xlink:label="lab_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lachlan Pharmaceuticals</link:label>
    <link:label id="lab_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B_label_en-US" xlink:label="lab_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lachlan Pharmaceuticals [Member]</link:label>
    <link:label id="lab_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B_documentation_en-US" xlink:label="lab_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lachlan Pharmaceuticals [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LachlanPharmaceuticalsMember" xlink:label="loc_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:to="lab_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:type="arc" />
    <link:label id="lab_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:to="lab_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:type="arc" />
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:type="arc" />
    <link:label id="lab_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8_terseLabel_en-US" xlink:label="lab_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TRIS Pharma</link:label>
    <link:label id="lab_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8_label_en-US" xlink:label="lab_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TRIS Pharma [Member]</link:label>
    <link:label id="lab_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8_documentation_en-US" xlink:label="lab_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">TRIS Pharma [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRISPharmaMember" xlink:label="loc_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:to="lab_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:type="arc" />
    <link:label id="lab_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1_terseLabel_en-US" xlink:label="lab_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ulesfia Supply Agreement</link:label>
    <link:label id="lab_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1_label_en-US" xlink:label="lab_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ulesfia Supply Agreement [Member]</link:label>
    <link:label id="lab_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1_documentation_en-US" xlink:label="lab_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ulesfia Supply Agreement [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaSupplyAgreementMember" xlink:label="loc_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:to="lab_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:type="arc" />
    <link:label id="lab_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D_terseLabel_en-US" xlink:label="lab_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Karbinal Agreement</link:label>
    <link:label id="lab_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D_label_en-US" xlink:label="lab_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Karbinal Agreement [Member]</link:label>
    <link:label id="lab_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D_documentation_en-US" xlink:label="lab_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Karbinal Agreement [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_KarbinalAgreementMember" xlink:label="loc_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:to="lab_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="lab_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interest ownership percentage by Noncontrolling Owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum quantity required</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment, Minimum Quantity Required</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term purchase commitment</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price (in dollars per unit)</link:label>
    <link:label id="lab_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC_label_en-US" xlink:label="lab_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Price Per Unit</link:label>
    <link:label id="lab_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Price Per Unit</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementPricePerUnit" xlink:label="loc_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:to="lab_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:type="arc" />
    <link:label id="lab_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8_terseLabel_en-US" xlink:label="lab_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Management and handling fee (in dollars per unit)</link:label>
    <link:label id="lab_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8_label_en-US" xlink:label="lab_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management And Handling Fee, Related Party, Price Per Unit</link:label>
    <link:label id="lab_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8_documentation_en-US" xlink:label="lab_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Management And Handling Fee, Related Party, Price Per Unit</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit" xlink:label="loc_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:to="lab_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:type="arc" />
    <link:label id="lab_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623_terseLabel_en-US" xlink:label="lab_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Management and handling fee annual price increase</link:label>
    <link:label id="lab_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623_label_en-US" xlink:label="lab_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management And Handling Fee, Related Party, Annual Price Increase, Percent</link:label>
    <link:label id="lab_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623_documentation_en-US" xlink:label="lab_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Management And Handling Fee, Related Party, Annual Price Increase, Percent</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent" xlink:label="loc_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:to="lab_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum royalty</link:label>
    <link:label id="lab_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51_label_en-US" xlink:label="lab_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Minimum Royalty</link:label>
    <link:label id="lab_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Minimum Royalty</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementMinimumRoyalty" xlink:label="loc_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:to="lab_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F_terseLabel_en-US" xlink:label="lab_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License obligation current</link:label>
    <link:label id="lab_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F_label_en-US" xlink:label="lab_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Obligation, Current</link:label>
    <link:label id="lab_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F_documentation_en-US" xlink:label="lab_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Obligation, Current</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseObligationCurrent" xlink:label="loc_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:to="lab_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indemnification of pre-acquisition losses</link:label>
    <link:label id="lab_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A_label_en-US" xlink:label="lab_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Indemnification Of Pre-acquisition Losses, Percent</link:label>
    <link:label id="lab_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Indemnification Of Pre-acquisition Losses, Percent</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent" xlink:label="loc_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:to="lab_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Threshold indemnification of legal costs and possible minimum payments</link:label>
    <link:label id="lab_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4_label_en-US" xlink:label="lab_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Threshold Indemnification Of Legal Costs And Possible Minimum Payments</link:label>
    <link:label id="lab_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Threshold Indemnification Of Legal Costs And Possible Minimum Payments</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments" xlink:label="loc_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:to="lab_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indemnification of post-acquisition losses</link:label>
    <link:label id="lab_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5_label_en-US" xlink:label="lab_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Indemnification Of Post-acquisition Losses, Percent</link:label>
    <link:label id="lab_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Indemnification Of Post-acquisition Losses, Percent</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent" xlink:label="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:to="lab_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indemnity receivable</link:label>
    <link:label id="lab_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81_label_en-US" xlink:label="lab_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Indemnity Receivable</link:label>
    <link:label id="lab_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Indemnity Receivable</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnityReceivable" xlink:label="loc_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:to="lab_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of product sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Make whole payment (in dollars per unit)</link:label>
    <link:label id="lab_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608_label_en-US" xlink:label="lab_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Make Whole Payment Per Unit</link:label>
    <link:label id="lab_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Make Whole Payment Per Unit</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementMakeWholePaymentPerUnit" xlink:label="loc_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:to="lab_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Make whole payment</link:label>
    <link:label id="lab_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43_label_en-US" xlink:label="lab_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Make Whole Payment</link:label>
    <link:label id="lab_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Make Whole Payment</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementMakeWholePayment" xlink:label="loc_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:to="lab_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued make whole payment</link:label>
    <link:label id="lab_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D_label_en-US" xlink:label="lab_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Accrued Make Whole Payment</link:label>
    <link:label id="lab_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Accrued Make Whole Payment</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementAccruedMakeWholePayment" xlink:label="loc_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:to="lab_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8" xlink:type="arc" />
    <link:label id="lab_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD_terseLabel_en-US" xlink:label="lab_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential future regulatory milestone</link:label>
    <link:label id="lab_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD_label_en-US" xlink:label="lab_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Future Regulatory Milestone</link:label>
    <link:label id="lab_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD_documentation_en-US" xlink:label="lab_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Future Regulatory Milestone</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PotentialFutureRegulatoryMilestone" xlink:label="loc_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:to="lab_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:to="lab_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:to="lab_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC" xlink:to="lab_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:to="lab_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B" xlink:to="lab_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:type="arc" />
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F" xlink:to="lab_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Anti-dilutive securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5" xlink:type="arc" />
    <link:label id="lab_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589_terseLabel_en-US" xlink:label="lab_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock conversion ratio</link:label>
    <link:label id="lab_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589_label_en-US" xlink:label="lab_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Preferred Stock, Conversion Ratio</link:label>
    <link:label id="lab_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589_documentation_en-US" xlink:label="lab_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Preferred Stock, Conversion Ratio</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockholdersEquityNotePreferredStockConversionRatio" xlink:label="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:to="lab_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_CE4A086B78149E65B1E093BC7B333B64_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_CE4A086B78149E65B1E093BC7B333B64" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_CE4A086B78149E65B1E093BC7B333B64_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_CE4A086B78149E65B1E093BC7B333B64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_CE4A086B78149E65B1E093BC7B333B64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_CE4A086B78149E65B1E093BC7B333B64" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_CE4A086B78149E65B1E093BC7B333B64" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_9D66899C31C0CF2C8D8E93BC7B346FA0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_9D66899C31C0CF2C8D8E93BC7B346FA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_9D66899C31C0CF2C8D8E93BC7B346FA0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_9D66899C31C0CF2C8D8E93BC7B346FA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_9D66899C31C0CF2C8D8E93BC7B346FA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_9D66899C31C0CF2C8D8E93BC7B346FA0" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_9D66899C31C0CF2C8D8E93BC7B346FA0" xlink:type="arc" />
    <link:label id="lab_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5_terseLabel_en-US" xlink:label="lab_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value of Consideration Transferred</link:label>
    <link:label id="lab_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5_label_en-US" xlink:label="lab_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Fair Value Of Consideration Transferred [Table Text Block]</link:label>
    <link:label id="lab_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5_documentation_en-US" xlink:label="lab_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Fair Value Of Consideration Transferred [Table Text Block]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock" xlink:label="loc_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5" xlink:to="lab_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_29429767FD538B56312993BC7B34B856_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_29429767FD538B56312993BC7B34B856" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_29429767FD538B56312993BC7B34B856_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_29429767FD538B56312993BC7B34B856" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_29429767FD538B56312993BC7B34B856" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_29429767FD538B56312993BC7B34B856" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_29429767FD538B56312993BC7B34B856" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7" xlink:to="lab_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total revenues, net</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869_terseLabel_en-US" xlink:label="lab_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted net loss per share (in dollars per share)</link:label>
    <link:label id="lab_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869_label_en-US" xlink:label="lab_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869_documentation_en-US" xlink:label="lab_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted" xlink:label="loc_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:to="lab_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_C2E8C436F6817976424698A29CEFF78D_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_C2E8C436F6817976424698A29CEFF78D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_C2E8C436F6817976424698A29CEFF78D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C2E8C436F6817976424698A29CEFF78D" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_C2E8C436F6817976424698A29CEFF78D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5BE16A491CBAA476E5C498A29CEF07C8_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5BE16A491CBAA476E5C498A29CEF07C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5BE16A491CBAA476E5C498A29CEF07C8_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5BE16A491CBAA476E5C498A29CEF07C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5BE16A491CBAA476E5C498A29CEF07C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5BE16A491CBAA476E5C498A29CEF07C8" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5BE16A491CBAA476E5C498A29CEF07C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60368AA67DCEC69DFE2398A29CEFB715_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60368AA67DCEC69DFE2398A29CEFB715" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60368AA67DCEC69DFE2398A29CEFB715_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60368AA67DCEC69DFE2398A29CEFB715" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60368AA67DCEC69DFE2398A29CEFB715" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60368AA67DCEC69DFE2398A29CEFB715" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60368AA67DCEC69DFE2398A29CEFB715" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_FB7AB0BCF6B32312E30098A29CF0E8C5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_FB7AB0BCF6B32312E30098A29CF0E8C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies and Recent Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_FB7AB0BCF6B32312E30098A29CF0E8C5_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_FB7AB0BCF6B32312E30098A29CF0E8C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_FB7AB0BCF6B32312E30098A29CF0E8C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_FB7AB0BCF6B32312E30098A29CF0E8C5" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_FB7AB0BCF6B32312E30098A29CF0E8C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_4A5EFC24DEB17D0475848E796B5AF2E2_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_4A5EFC24DEB17D0475848E796B5AF2E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4A5EFC24DEB17D0475848E796B5AF2E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4A5EFC24DEB17D0475848E796B5AF2E2" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_4A5EFC24DEB17D0475848E796B5AF2E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:type="arc" />
    <link:label id="lab_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F_terseLabel_en-US" xlink:label="lab_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F_label_en-US" xlink:label="lab_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F_documentation_en-US" xlink:label="lab_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ContingentConsiderationMember" xlink:label="loc_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:to="lab_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:type="arc" />
    <link:label id="lab_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621_verboseLabel_en-US" xlink:label="lab_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Warrant liability</link:label>
    <link:label id="lab_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621_label_en-US" xlink:label="lab_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability [Member]</link:label>
    <link:label id="lab_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621_documentation_en-US" xlink:label="lab_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liabilities relate to warrants to purchase convertible preferred stock.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantLiabilityMember" xlink:label="loc_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:to="lab_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:type="arc" />
    <link:label id="lab_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321_terseLabel_en-US" xlink:label="lab_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unit purchase option liability</link:label>
    <link:label id="lab_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321_label_en-US" xlink:label="lab_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Unit Purchase Option [Member]</link:label>
    <link:label id="lab_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321_documentation_en-US" xlink:label="lab_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to the Equity unit purchase option liability.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EquityUnitPurchaseOptionMember" xlink:label="loc_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:to="lab_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_734809AB39033E8D75179CDC03CA578A_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_734809AB39033E8D75179CDC03CA578A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_734809AB39033E8D75179CDC03CA578A_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_734809AB39033E8D75179CDC03CA578A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_734809AB39033E8D75179CDC03CA578A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_734809AB39033E8D75179CDC03CA578A" xlink:to="lab_us-gaap_NetIncomeLoss_734809AB39033E8D75179CDC03CA578A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss provided by (used in) to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_91CBE65DEF126294BAA69CDC03CA8E9D_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_91CBE65DEF126294BAA69CDC03CA8E9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_91CBE65DEF126294BAA69CDC03CA8E9D_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_91CBE65DEF126294BAA69CDC03CA8E9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_91CBE65DEF126294BAA69CDC03CA8E9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_91CBE65DEF126294BAA69CDC03CA8E9D" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_91CBE65DEF126294BAA69CDC03CA8E9D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_6578F73062319E20B3119CDC03CA341B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_6578F73062319E20B3119CDC03CA341B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_6578F73062319E20B3119CDC03CA341B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_6578F73062319E20B3119CDC03CA341B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_6578F73062319E20B3119CDC03CA341B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_6578F73062319E20B3119CDC03CA341B" xlink:to="lab_us-gaap_ShareBasedCompensation_6578F73062319E20B3119CDC03CA341B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_F04F5527BD2460A7FAF89CDC03CAF9EF_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_F04F5527BD2460A7FAF89CDC03CAF9EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_F04F5527BD2460A7FAF89CDC03CAF9EF_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_F04F5527BD2460A7FAF89CDC03CAF9EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_F04F5527BD2460A7FAF89CDC03CAF9EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_F04F5527BD2460A7FAF89CDC03CAF9EF" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_F04F5527BD2460A7FAF89CDC03CAF9EF" xlink:type="arc" />
    <link:label id="lab_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57_terseLabel_en-US" xlink:label="lab_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of inventory fair value associated with acquisition of TRx and Avadel</link:label>
    <link:label id="lab_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57_label_en-US" xlink:label="lab_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization Of Inventory Fair Value Adjustment</link:label>
    <link:label id="lab_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57_documentation_en-US" xlink:label="lab_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization Of Inventory Fair Value Adjustment</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AmortizationOfInventoryFairValueAdjustment" xlink:label="loc_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57" xlink:to="lab_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaidInKindInterest_C4A1B3D57A914C55A4949CDC03CB5B5E_terseLabel_en-US" xlink:label="lab_us-gaap_PaidInKindInterest_C4A1B3D57A914C55A4949CDC03CB5B5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_PaidInKindInterest_C4A1B3D57A914C55A4949CDC03CB5B5E_label_en-US" xlink:label="lab_us-gaap_PaidInKindInterest_C4A1B3D57A914C55A4949CDC03CB5B5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paid-in-Kind Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="loc_us-gaap_PaidInKindInterest_C4A1B3D57A914C55A4949CDC03CB5B5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest_C4A1B3D57A914C55A4949CDC03CB5B5E" xlink:to="lab_us-gaap_PaidInKindInterest_C4A1B3D57A914C55A4949CDC03CB5B5E" xlink:type="arc" />
    <link:label id="lab_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482_terseLabel_en-US" xlink:label="lab_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liability and unit purchase option liability</link:label>
    <link:label id="lab_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482_label_en-US" xlink:label="lab_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants And Investor Rights Obligation</link:label>
    <link:label id="lab_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482_documentation_en-US" xlink:label="lab_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of expense (income) related to adjustment to fair value of warrant liability and investor rights obligation.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation" xlink:label="loc_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482" xlink:to="lab_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_BFD84435C47F07FDE9DE9CDC03CBB9E5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_BFD84435C47F07FDE9DE9CDC03CBB9E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration and long-term royalty obligation</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_BFD84435C47F07FDE9DE9CDC03CBB9E5_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_BFD84435C47F07FDE9DE9CDC03CBB9E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_BFD84435C47F07FDE9DE9CDC03CBB9E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_BFD84435C47F07FDE9DE9CDC03CBB9E5" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_BFD84435C47F07FDE9DE9CDC03CBB9E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_095FB0FEAA0D1D5343989CDC03CBF67B_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_095FB0FEAA0D1D5343989CDC03CBF67B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_095FB0FEAA0D1D5343989CDC03CBF67B_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_095FB0FEAA0D1D5343989CDC03CBF67B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_095FB0FEAA0D1D5343989CDC03CBF67B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_095FB0FEAA0D1D5343989CDC03CBF67B" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_095FB0FEAA0D1D5343989CDC03CBF67B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_EACADEF7D2337B8683079CDC03CCABF5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_EACADEF7D2337B8683079CDC03CCABF5" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_EACADEF7D2337B8683079CDC03CCABF5_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_EACADEF7D2337B8683079CDC03CCABF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_EACADEF7D2337B8683079CDC03CCABF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_EACADEF7D2337B8683079CDC03CCABF5" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_EACADEF7D2337B8683079CDC03CCABF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_7D7DC62F23636566E3239CDC03CCA349_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables_7D7DC62F23636566E3239CDC03CCA349" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_7D7DC62F23636566E3239CDC03CCA349_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables_7D7DC62F23636566E3239CDC03CCA349" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_7D7DC62F23636566E3239CDC03CCA349" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables_7D7DC62F23636566E3239CDC03CCA349" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables_7D7DC62F23636566E3239CDC03CCA349" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_6B421F45D9D21FABE0189CDC03CCD71E_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_6B421F45D9D21FABE0189CDC03CCD71E" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_6B421F45D9D21FABE0189CDC03CCD71E_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_6B421F45D9D21FABE0189CDC03CCD71E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6B421F45D9D21FABE0189CDC03CCD71E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_6B421F45D9D21FABE0189CDC03CCD71E" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_6B421F45D9D21FABE0189CDC03CCD71E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0AC24F9503B7ABD9B8E69CDC03CC2FC6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0AC24F9503B7ABD9B8E69CDC03CC2FC6" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0AC24F9503B7ABD9B8E69CDC03CC2FC6_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0AC24F9503B7ABD9B8E69CDC03CC2FC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0AC24F9503B7ABD9B8E69CDC03CC2FC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0AC24F9503B7ABD9B8E69CDC03CC2FC6" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0AC24F9503B7ABD9B8E69CDC03CC2FC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets_AD24CFC82BB217FE94C49CDC03CCAB0C_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets_AD24CFC82BB217FE94C49CDC03CCAB0C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Escrowed cash receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets_AD24CFC82BB217FE94C49CDC03CCAB0C_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets_AD24CFC82BB217FE94C49CDC03CCAB0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deposit Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_AD24CFC82BB217FE94C49CDC03CCAB0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_AD24CFC82BB217FE94C49CDC03CCAB0C" xlink:to="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets_AD24CFC82BB217FE94C49CDC03CCAB0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_CFBC1E0F1B767BF949C89CDC03CD699A_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_CFBC1E0F1B767BF949C89CDC03CD699A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_CFBC1E0F1B767BF949C89CDC03CD699A_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_CFBC1E0F1B767BF949C89CDC03CD699A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_CFBC1E0F1B767BF949C89CDC03CD699A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_CFBC1E0F1B767BF949C89CDC03CD699A" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_CFBC1E0F1B767BF949C89CDC03CD699A" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_D27397B281A29DCFAD329CDC03CDCB0C_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_D27397B281A29DCFAD329CDC03CDCB0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_D27397B281A29DCFAD329CDC03CDCB0C_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_D27397B281A29DCFAD329CDC03CDCB0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_D27397B281A29DCFAD329CDC03CDCB0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_D27397B281A29DCFAD329CDC03CDCB0C" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_D27397B281A29DCFAD329CDC03CDCB0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_CAD0F19AB4523911EB7D9CDC03CD551F_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_CAD0F19AB4523911EB7D9CDC03CD551F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_CAD0F19AB4523911EB7D9CDC03CD551F_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_CAD0F19AB4523911EB7D9CDC03CD551F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_CAD0F19AB4523911EB7D9CDC03CD551F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_CAD0F19AB4523911EB7D9CDC03CD551F" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_CAD0F19AB4523911EB7D9CDC03CD551F" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_996655A706C856C5CC359CDC03CD1E86_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_996655A706C856C5CC359CDC03CD1E86" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_996655A706C856C5CC359CDC03CD1E86_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_996655A706C856C5CC359CDC03CD1E86" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_996655A706C856C5CC359CDC03CD1E86" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_996655A706C856C5CC359CDC03CD1E86" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_996655A706C856C5CC359CDC03CD1E86" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_F9C46C2051F0BC0DFB409CDC03CDA281_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_F9C46C2051F0BC0DFB409CDC03CDA281" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_F9C46C2051F0BC0DFB409CDC03CDA281_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_F9C46C2051F0BC0DFB409CDC03CDA281" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_F9C46C2051F0BC0DFB409CDC03CDA281" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_F9C46C2051F0BC0DFB409CDC03CDA281" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_F9C46C2051F0BC0DFB409CDC03CDA281" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7C0511CA917653C6342A9CDC03CE90BC_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7C0511CA917653C6342A9CDC03CE90BC" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7C0511CA917653C6342A9CDC03CE90BC_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7C0511CA917653C6342A9CDC03CE90BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7C0511CA917653C6342A9CDC03CE90BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7C0511CA917653C6342A9CDC03CE90BC" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7C0511CA917653C6342A9CDC03CE90BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2D0AA70884A86F68F6E9CDC03CE5CCD_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2D0AA70884A86F68F6E9CDC03CE5CCD" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2D0AA70884A86F68F6E9CDC03CE5CCD_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2D0AA70884A86F68F6E9CDC03CE5CCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2D0AA70884A86F68F6E9CDC03CE5CCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2D0AA70884A86F68F6E9CDC03CE5CCD" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2D0AA70884A86F68F6E9CDC03CE5CCD" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_7CA671FB194E48913EAD9CDC03CEE00B_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans_7CA671FB194E48913EAD9CDC03CEE00B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options and warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_7CA671FB194E48913EAD9CDC03CEE00B_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans_7CA671FB194E48913EAD9CDC03CEE00B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="loc_us-gaap_ProceedsFromStockPlans_7CA671FB194E48913EAD9CDC03CEE00B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans_7CA671FB194E48913EAD9CDC03CEE00B" xlink:to="lab_us-gaap_ProceedsFromStockPlans_7CA671FB194E48913EAD9CDC03CEE00B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_FD06F16D27974A3006A59CDC03CE660C_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_FD06F16D27974A3006A59CDC03CE660C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from underwritten public offering, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_FD06F16D27974A3006A59CDC03CE660C_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_FD06F16D27974A3006A59CDC03CE660C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_FD06F16D27974A3006A59CDC03CE660C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_FD06F16D27974A3006A59CDC03CE660C" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_FD06F16D27974A3006A59CDC03CE660C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_78EB5992B930F1145F3A9CDC03CF6510_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_78EB5992B930F1145F3A9CDC03CF6510" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_78EB5992B930F1145F3A9CDC03CF6510_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_78EB5992B930F1145F3A9CDC03CF6510" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_78EB5992B930F1145F3A9CDC03CF6510" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_78EB5992B930F1145F3A9CDC03CF6510" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_78EB5992B930F1145F3A9CDC03CF6510" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_DEDAA9C0459AD2FFB3CC9CDC03CFE6B8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_DEDAA9C0459AD2FFB3CC9CDC03CFE6B8" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_DEDAA9C0459AD2FFB3CC9CDC03CFE6B8_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_DEDAA9C0459AD2FFB3CC9CDC03CFE6B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_DEDAA9C0459AD2FFB3CC9CDC03CFE6B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_DEDAA9C0459AD2FFB3CC9CDC03CFE6B8" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_DEDAA9C0459AD2FFB3CC9CDC03CFE6B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_34A98E756C89D436CEBC9CDC03CF805F_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_34A98E756C89D436CEBC9CDC03CF805F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_34A98E756C89D436CEBC9CDC03CF805F_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_34A98E756C89D436CEBC9CDC03CF805F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34A98E756C89D436CEBC9CDC03CF805F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34A98E756C89D436CEBC9CDC03CF805F" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_34A98E756C89D436CEBC9CDC03CF805F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6651649D217803320EA19CDC03CF9B90_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6651649D217803320EA19CDC03CF9B90" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6651649D217803320EA19CDC03CF9B90_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6651649D217803320EA19CDC03CF9B90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6651649D217803320EA19CDC03CF9B90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6651649D217803320EA19CDC03CF9B90" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6651649D217803320EA19CDC03CF9B90" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44D2E8739160C35F9E629CDC03CF87A6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44D2E8739160C35F9E629CDC03CF87A6" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44D2E8739160C35F9E629CDC03CF87A6_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44D2E8739160C35F9E629CDC03CF87A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44D2E8739160C35F9E629CDC03CF87A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44D2E8739160C35F9E629CDC03CF87A6" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44D2E8739160C35F9E629CDC03CF87A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4DC6AA43E3958B09C1E69CDC03CFB81D_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4DC6AA43E3958B09C1E69CDC03CFB81D" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4DC6AA43E3958B09C1E69CDC03CFB81D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4DC6AA43E3958B09C1E69CDC03CFB81D" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4DC6AA43E3958B09C1E69CDC03CFB81D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestPaidNet_FE6BF606E15A794EDFB49CDC03D092BE_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet_FE6BF606E15A794EDFB49CDC03D092BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_FE6BF606E15A794EDFB49CDC03D092BE_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet_FE6BF606E15A794EDFB49CDC03D092BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_FE6BF606E15A794EDFB49CDC03D092BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet_FE6BF606E15A794EDFB49CDC03D092BE" xlink:to="lab_us-gaap_InterestPaidNet_FE6BF606E15A794EDFB49CDC03D092BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxesPaid_AF43F9E68B0ACF0D03669CDC03D0A436_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid_AF43F9E68B0ACF0D03669CDC03D0A436" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_AF43F9E68B0ACF0D03669CDC03D0A436_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid_AF43F9E68B0ACF0D03669CDC03D0A436" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_AF43F9E68B0ACF0D03669CDC03D0A436" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid_AF43F9E68B0ACF0D03669CDC03D0A436" xlink:to="lab_us-gaap_IncomeTaxesPaid_AF43F9E68B0ACF0D03669CDC03D0A436" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosures of non-cash activities</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_B924E08A8C99F11A94A39CDC03D0AF52_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_B924E08A8C99F11A94A39CDC03D0AF52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leased asset obtained in exchange for new operating lease liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_B924E08A8C99F11A94A39CDC03D0AF52_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_B924E08A8C99F11A94A39CDC03D0AF52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_B924E08A8C99F11A94A39CDC03D0AF52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_B924E08A8C99F11A94A39CDC03D0AF52" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_B924E08A8C99F11A94A39CDC03D0AF52" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_62EB738FA2AA0D3B886F9CDC03D1CAC2_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_62EB738FA2AA0D3B886F9CDC03D1CAC2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Debt assumed in Avadel Pediatric Products acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_62EB738FA2AA0D3B886F9CDC03D1CAC2_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_62EB738FA2AA0D3B886F9CDC03D1CAC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_62EB738FA2AA0D3B886F9CDC03D1CAC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_62EB738FA2AA0D3B886F9CDC03D1CAC2" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_62EB738FA2AA0D3B886F9CDC03D1CAC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D9D55CF6B707AFBE74039CDC03D140CC_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D9D55CF6B707AFBE74039CDC03D140CC" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D9D55CF6B707AFBE74039CDC03D140CC_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D9D55CF6B707AFBE74039CDC03D140CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D9D55CF6B707AFBE74039CDC03D140CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D9D55CF6B707AFBE74039CDC03D140CC" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D9D55CF6B707AFBE74039CDC03D140CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_D43613A10876F511322D9CDC03D1A6B6_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_D43613A10876F511322D9CDC03D1A6B6" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_D43613A10876F511322D9CDC03D1A6B6_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_D43613A10876F511322D9CDC03D1A6B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_D43613A10876F511322D9CDC03D1A6B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_D43613A10876F511322D9CDC03D1A6B6" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_D43613A10876F511322D9CDC03D1A6B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8DB31EF28C50B58D848E9CDC03D115FB_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8DB31EF28C50B58D848E9CDC03D115FB" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, non-current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8DB31EF28C50B58D848E9CDC03D115FB_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8DB31EF28C50B58D848E9CDC03D115FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8DB31EF28C50B58D848E9CDC03D115FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8DB31EF28C50B58D848E9CDC03D115FB" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8DB31EF28C50B58D848E9CDC03D115FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum Purchase Obligations</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Q2 2019 - Q4 2019</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Future Minimum Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618" xlink:to="lab_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Due in Second Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Due in Third Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Due in Fourth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF" xlink:to="lab_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD_totalLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD" xlink:to="lab_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum Purchase Obligations</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="lab_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Q2 2019 - Q4 2019</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments, Future Minimum Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428" xlink:to="lab_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Due in Second Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C" xlink:to="lab_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Due in Third Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604" xlink:to="lab_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Due in Fourth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F" xlink:to="lab_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004_totalLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004_label_en-US" xlink:label="lab_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004" xlink:to="lab_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58_label_en-US" xlink:label="lab_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="lab_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1_totalLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Q2 2019 - Q4 2019</link:label>
    <link:label id="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1_label_en-US" xlink:label="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Future Minimum Payments Due, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1" xlink:to="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21_totalLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Due in Second Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21" xlink:to="lab_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1_totalLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Due in Third Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1" xlink:to="lab_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF_totalLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Due in Fourth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF" xlink:to="lab_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90_totalLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90_label_en-US" xlink:label="lab_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90" xlink:to="lab_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_AC297AEFB9C469C613EC93A92967AAAB_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract_AC297AEFB9C469C613EC93A92967AAAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_AC297AEFB9C469C613EC93A92967AAAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_AC297AEFB9C469C613EC93A92967AAAB" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract_AC297AEFB9C469C613EC93A92967AAAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8E7E88DB881C5F119F4593AA6A437091_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8E7E88DB881C5F119F4593AA6A437091" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8E7E88DB881C5F119F4593AA6A437091_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8E7E88DB881C5F119F4593AA6A437091" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8E7E88DB881C5F119F4593AA6A437091" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8E7E88DB881C5F119F4593AA6A437091" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8E7E88DB881C5F119F4593AA6A437091" xlink:type="arc" />
    <link:label id="lab_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC_terseLabel_en-US" xlink:label="lab_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone [Axis]</link:label>
    <link:label id="lab_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC_label_en-US" xlink:label="lab_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone [Axis]</link:label>
    <link:label id="lab_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC_documentation_en-US" xlink:label="lab_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone [Axis]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneAxis" xlink:label="loc_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:to="lab_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:type="arc" />
    <link:label id="lab_cerc_MilestoneDomain_976296693067C26E94D29459811B030E_terseLabel_en-US" xlink:label="lab_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone [Domain]</link:label>
    <link:label id="lab_cerc_MilestoneDomain_976296693067C26E94D29459811B030E_label_en-US" xlink:label="lab_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone [Domain]</link:label>
    <link:label id="lab_cerc_MilestoneDomain_976296693067C26E94D29459811B030E_documentation_en-US" xlink:label="lab_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Milestone [Axis]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneDomain" xlink:label="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:to="lab_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:type="arc" />
    <link:label id="lab_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2_terseLabel_en-US" xlink:label="lab_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone One</link:label>
    <link:label id="lab_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2_label_en-US" xlink:label="lab_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone One [Member]</link:label>
    <link:label id="lab_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2_documentation_en-US" xlink:label="lab_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone One [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneOneMember" xlink:label="loc_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:to="lab_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:type="arc" />
    <link:label id="lab_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9_terseLabel_en-US" xlink:label="lab_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone Two</link:label>
    <link:label id="lab_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9_label_en-US" xlink:label="lab_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone Two [Member]</link:label>
    <link:label id="lab_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9_documentation_en-US" xlink:label="lab_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone Two [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneTwoMember" xlink:label="loc_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:to="lab_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:type="arc" />
    <link:label id="lab_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B_terseLabel_en-US" xlink:label="lab_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone Three</link:label>
    <link:label id="lab_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B_label_en-US" xlink:label="lab_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone Three [Member]</link:label>
    <link:label id="lab_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B_documentation_en-US" xlink:label="lab_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone Three [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneThreeMember" xlink:label="loc_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:to="lab_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8_label_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:to="lab_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E_label_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:to="lab_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED_label_en-US" xlink:label="lab_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Forecast [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED" xlink:to="lab_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED" xlink:type="arc" />
    <link:label id="lab_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75_terseLabel_en-US" xlink:label="lab_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75_label_en-US" xlink:label="lab_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75_documentation_en-US" xlink:label="lab_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionAxis" xlink:label="loc_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:to="lab_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:type="arc" />
    <link:label id="lab_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521_terseLabel_en-US" xlink:label="lab_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521_label_en-US" xlink:label="lab_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521_documentation_en-US" xlink:label="lab_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Asset Acquisition [Axis]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionDomain" xlink:label="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:to="lab_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:type="arc" />
    <link:label id="lab_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782_terseLabel_en-US" xlink:label="lab_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ichorion</link:label>
    <link:label id="lab_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782_label_en-US" xlink:label="lab_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ichorion [Member]</link:label>
    <link:label id="lab_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782_documentation_en-US" xlink:label="lab_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ichorion [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_IchorionMember" xlink:label="loc_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:to="lab_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Nonrecurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1" xlink:type="arc" />
    <link:label id="lab_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7_terseLabel_en-US" xlink:label="lab_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assembled Workforce</link:label>
    <link:label id="lab_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7_label_en-US" xlink:label="lab_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assembled Workforce [Member]</link:label>
    <link:label id="lab_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7_documentation_en-US" xlink:label="lab_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assembled Workforce [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssembledWorkforceMember" xlink:label="loc_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:to="lab_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Consideration issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6" xlink:type="arc" />
    <link:label id="lab_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF_terseLabel_en-US" xlink:label="lab_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF_label_en-US" xlink:label="lab_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Contingent Consideration, Liability</link:label>
    <link:label id="lab_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF_documentation_en-US" xlink:label="lab_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionContingentConsiderationLiability" xlink:label="loc_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:to="lab_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of shares issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F" xlink:type="arc" />
    <link:label id="lab_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955_terseLabel_en-US" xlink:label="lab_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955_label_en-US" xlink:label="lab_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Research And Development In Process</link:label>
    <link:label id="lab_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955_documentation_en-US" xlink:label="lab_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Research And Development In Process</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionResearchAndDevelopmentInProcess" xlink:label="loc_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:to="lab_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:type="arc" />
    <link:label id="lab_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53_terseLabel_en-US" xlink:label="lab_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash acquired</link:label>
    <link:label id="lab_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53_label_en-US" xlink:label="lab_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Cash And Equivalents</link:label>
    <link:label id="lab_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53_documentation_en-US" xlink:label="lab_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Cash And Equivalents</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:to="lab_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:type="arc" />
    <link:label id="lab_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21_terseLabel_en-US" xlink:label="lab_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of preclinical therapies</link:label>
    <link:label id="lab_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21_label_en-US" xlink:label="lab_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Preclinical Therapies</link:label>
    <link:label id="lab_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21_documentation_en-US" xlink:label="lab_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Preclinical Therapies</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfPreclinicalTherapies" xlink:label="loc_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:to="lab_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:type="arc" />
    <link:label id="lab_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC_terseLabel_en-US" xlink:label="lab_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC_label_en-US" xlink:label="lab_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisitions, Transaction Costs</link:label>
    <link:label id="lab_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC_documentation_en-US" xlink:label="lab_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisitions, Transaction Costs</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionsTransactionCosts" xlink:label="loc_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:to="lab_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Useful life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79" xlink:type="arc" />
    <link:label id="lab_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF_terseLabel_en-US" xlink:label="lab_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of contingent consideration milestones</link:label>
    <link:label id="lab_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF_label_en-US" xlink:label="lab_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Number Of Contingent Consideration Milestones</link:label>
    <link:label id="lab_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF_documentation_en-US" xlink:label="lab_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Number Of Contingent Consideration Milestones</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones" xlink:label="loc_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:to="lab_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:type="arc" />
    <link:label id="lab_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC_terseLabel_en-US" xlink:label="lab_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment for asset acquisition contingent consideration liability</link:label>
    <link:label id="lab_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC_label_en-US" xlink:label="lab_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment For Asset Acquisition Contingent Consideration Liability, Operating Activities</link:label>
    <link:label id="lab_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC_documentation_en-US" xlink:label="lab_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment For Asset Acquisition Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities" xlink:label="loc_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:to="lab_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash payment to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B655D23B8FC24C10898794598123D549_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B655D23B8FC24C10898794598123D549" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of debt assumed</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B655D23B8FC24C10898794598123D549" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B655D23B8FC24C10898794598123D549" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B655D23B8FC24C10898794598123D549" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB_label_en-US" xlink:label="lab_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB" xlink:to="lab_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72_terseLabel_en-US" xlink:label="lab_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill tax deductible period</link:label>
    <link:label id="lab_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72_label_en-US" xlink:label="lab_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Goodwill, Tax Deductible Period</link:label>
    <link:label id="lab_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72_documentation_en-US" xlink:label="lab_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Goodwill, Tax Deductible Period</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod" xlink:label="loc_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:to="lab_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unregistered shares of common stock issued or issuable as part of acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issued for purchase of business (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued upon closing (in shares)</link:label>
    <link:label id="lab_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B_label_en-US" xlink:label="lab_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Number of Shares Issued</link:label>
    <link:label id="lab_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Number of Shares Issued</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued" xlink:label="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:to="lab_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F_terseLabel_en-US" xlink:label="lab_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent shares issuable as part of acquisition (in shares)</link:label>
    <link:label id="lab_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F_label_en-US" xlink:label="lab_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued Or Issuable, Contingent Consideration, Number Of Shares</link:label>
    <link:label id="lab_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F_documentation_en-US" xlink:label="lab_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued Or Issuable, Contingent Consideration, Number Of Shares</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares" xlink:label="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:to="lab_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of sales and marketing agreement</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-lived Intangible Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8" xlink:type="arc" />
    <link:label id="lab_cerc_TemporaryEquityAndEquityDisclosureAbstract_02CB13CE86060AA028008DD52750862E_label_en-US" xlink:label="lab_cerc_TemporaryEquityAndEquityDisclosureAbstract_02CB13CE86060AA028008DD52750862E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CAPITAL STRUCTURE</link:label>
    <link:label id="lab_cerc_TemporaryEquityAndEquityDisclosureAbstract_02CB13CE86060AA028008DD52750862E_documentation_en-US" xlink:label="lab_cerc_TemporaryEquityAndEquityDisclosureAbstract_02CB13CE86060AA028008DD52750862E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">No definitions available.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TemporaryEquityAndEquityDisclosureAbstract" xlink:label="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_02CB13CE86060AA028008DD52750862E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_02CB13CE86060AA028008DD52750862E" xlink:to="lab_cerc_TemporaryEquityAndEquityDisclosureAbstract_02CB13CE86060AA028008DD52750862E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_11F2304B556C751D4CC18DD527509E84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_11F2304B556C751D4CC18DD527509E84" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of outstanding common stock warrants</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_11F2304B556C751D4CC18DD527509E84_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_11F2304B556C751D4CC18DD527509E84" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_11F2304B556C751D4CC18DD527509E84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_11F2304B556C751D4CC18DD527509E84" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_11F2304B556C751D4CC18DD527509E84" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0D35C95DA5B390B23012903F2BF1F1B4_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_0D35C95DA5B390B23012903F2BF1F1B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0D35C95DA5B390B23012903F2BF1F1B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_0D35C95DA5B390B23012903F2BF1F1B4" xlink:to="lab_us-gaap_IncomeStatementAbstract_0D35C95DA5B390B23012903F2BF1F1B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3_label_en-US" xlink:label="lab_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:to="lab_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:type="arc" />
    <link:label id="lab_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D_terseLabel_en-US" xlink:label="lab_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product revenue, net</link:label>
    <link:label id="lab_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D_label_en-US" xlink:label="lab_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Revenue, Product [Member]</link:label>
    <link:label id="lab_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D_documentation_en-US" xlink:label="lab_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales Revenue, Product [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SalesRevenueProductMember" xlink:label="loc_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:to="lab_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:type="arc" />
    <link:label id="lab_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD_verboseLabel_en-US" xlink:label="lab_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sales force revenue</link:label>
    <link:label id="lab_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD_label_en-US" xlink:label="lab_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Force Revenue [Member]</link:label>
    <link:label id="lab_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD_documentation_en-US" xlink:label="lab_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales Force Revenue [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SalesForceRevenueMember" xlink:label="loc_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:to="lab_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="lab_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="lab_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B" xlink:to="lab_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571" xlink:to="lab_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B" xlink:to="lab_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (expense) income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:type="arc" />
    <link:label id="lab_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977_negatedLabel_en-US" xlink:label="lab_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liability and unit purchase option liability</link:label>
    <link:label id="lab_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977_label_en-US" xlink:label="lab_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants And Investor Rights Obligation And Contingent Consideration</link:label>
    <link:label id="lab_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977_documentation_en-US" xlink:label="lab_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants And Investor Rights Obligation And Contingent Consideration</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration" xlink:label="loc_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:to="lab_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30_label_en-US" xlink:label="lab_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30" xlink:to="lab_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647" xlink:type="arc" />
    <link:label id="lab_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A_totalLabel_en-US" xlink:label="lab_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss before taxes</link:label>
    <link:label id="lab_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A_label_en-US" xlink:label="lab_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Before Taxes</link:label>
    <link:label id="lab_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A_documentation_en-US" xlink:label="lab_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Before Taxes</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NetIncomeLossBeforeTaxes" xlink:label="loc_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:to="lab_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_1F57291F56C0F4C2C9E9903F2C06924E_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_1F57291F56C0F4C2C9E9903F2C06924E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1F57291F56C0F4C2C9E9903F2C06924E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_1F57291F56C0F4C2C9E9903F2C06924E" xlink:to="lab_us-gaap_NetIncomeLoss_1F57291F56C0F4C2C9E9903F2C06924E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic and diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2F1AFF958EDB2742A4BA8DD5275FA425_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2F1AFF958EDB2742A4BA8DD5275FA425" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2F1AFF958EDB2742A4BA8DD5275FA425_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2F1AFF958EDB2742A4BA8DD5275FA425" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2F1AFF958EDB2742A4BA8DD5275FA425" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2F1AFF958EDB2742A4BA8DD5275FA425" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2F1AFF958EDB2742A4BA8DD5275FA425" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00799396814B8DA080138DD5275F5099_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00799396814B8DA080138DD5275F5099" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00799396814B8DA080138DD5275F5099_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00799396814B8DA080138DD5275F5099" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00799396814B8DA080138DD5275F5099" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00799396814B8DA080138DD5275F5099" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00799396814B8DA080138DD5275F5099" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2A4C2EEED9C69F8F4B8F8DD5275F19C3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2A4C2EEED9C69F8F4B8F8DD5275F19C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of fair value assumptions for options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2A4C2EEED9C69F8F4B8F8DD5275F19C3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2A4C2EEED9C69F8F4B8F8DD5275F19C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2A4C2EEED9C69F8F4B8F8DD5275F19C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2A4C2EEED9C69F8F4B8F8DD5275F19C3" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2A4C2EEED9C69F8F4B8F8DD5275F19C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_E3AA0E3B7E5272437BB68DD5275F9C1E_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_E3AA0E3B7E5272437BB68DD5275F9C1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_E3AA0E3B7E5272437BB68DD5275F9C1E_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_E3AA0E3B7E5272437BB68DD5275F9C1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_E3AA0E3B7E5272437BB68DD5275F9C1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_E3AA0E3B7E5272437BB68DD5275F9C1E" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_E3AA0E3B7E5272437BB68DD5275F9C1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_9C0DCF9FAFA69BEBC1408DD527BDEF49_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_9C0DCF9FAFA69BEBC1408DD527BDEF49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9C0DCF9FAFA69BEBC1408DD527BDEF49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9C0DCF9FAFA69BEBC1408DD527BDEF49" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_9C0DCF9FAFA69BEBC1408DD527BDEF49" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_D06BEFB2EF77DBA35B798DD527BDFBEC_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_D06BEFB2EF77DBA35B798DD527BDFBEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_D06BEFB2EF77DBA35B798DD527BDFBEC_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_D06BEFB2EF77DBA35B798DD527BDFBEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_D06BEFB2EF77DBA35B798DD527BDFBEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_D06BEFB2EF77DBA35B798DD527BDFBEC" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_D06BEFB2EF77DBA35B798DD527BDFBEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic and diluted loss per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169_netLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_D6B6C2B268ACFD847EDF94C84E76A922_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted_D6B6C2B268ACFD847EDF94C84E76A922" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic and diluted loss per share (in dollars per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_D6B6C2B268ACFD847EDF94C84E76A922" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted_D6B6C2B268ACFD847EDF94C84E76A922" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted_D6B6C2B268ACFD847EDF94C84E76A922" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities and Other Liabilities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:type="arc" />
    <link:label id="lab_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E_terseLabel_en-US" xlink:label="lab_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales returns and allowances</link:label>
    <link:label id="lab_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E_label_en-US" xlink:label="lab_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Sales Returns And Allowances</link:label>
    <link:label id="lab_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E_documentation_en-US" xlink:label="lab_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Sales Returns And Allowances</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedSalesReturnsAndAllowances" xlink:label="loc_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E" xlink:to="lab_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E" xlink:type="arc" />
    <link:label id="lab_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210_terseLabel_en-US" xlink:label="lab_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medicaid rebates</link:label>
    <link:label id="lab_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210_label_en-US" xlink:label="lab_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Medicaid Rebates</link:label>
    <link:label id="lab_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210_documentation_en-US" xlink:label="lab_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Medicaid Rebates</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedMedicaidRebates" xlink:label="loc_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210" xlink:to="lab_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210" xlink:type="arc" />
    <link:label id="lab_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A_terseLabel_en-US" xlink:label="lab_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum sales commitments, royalties payable, and purchase obligations</link:label>
    <link:label id="lab_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A_label_en-US" xlink:label="lab_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum Sales Commitments, Royalties Payable And Purchase Obligations, Current</link:label>
    <link:label id="lab_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A_documentation_en-US" xlink:label="lab_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum Sales Commitments, Royalties Payable And Purchase Obligations, Current</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent" xlink:label="loc_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A" xlink:to="lab_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A2CB3555F3DD7EE9CAC393BC7ABBC213_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A2CB3555F3DD7EE9CAC393BC7ABBC213" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A2CB3555F3DD7EE9CAC393BC7ABBC213_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A2CB3555F3DD7EE9CAC393BC7ABBC213" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_A2CB3555F3DD7EE9CAC393BC7ABBC213" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_A2CB3555F3DD7EE9CAC393BC7ABBC213" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A2CB3555F3DD7EE9CAC393BC7ABBC213" xlink:type="arc" />
    <link:label id="lab_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3_terseLabel_en-US" xlink:label="lab_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3_label_en-US" xlink:label="lab_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Research And Development Expenses</link:label>
    <link:label id="lab_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3_documentation_en-US" xlink:label="lab_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable for research and development.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedResearchAndDevelopmentExpenses" xlink:label="loc_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3" xlink:to="lab_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_6AAC392350DB36A30DF1941EB1671FE5_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent_6AAC392350DB36A30DF1941EB1671FE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_6AAC392350DB36A30DF1941EB1671FE5_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent_6AAC392350DB36A30DF1941EB1671FE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_6AAC392350DB36A30DF1941EB1671FE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent_6AAC392350DB36A30DF1941EB1671FE5" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent_6AAC392350DB36A30DF1941EB1671FE5" xlink:type="arc" />
    <link:label id="lab_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E_terseLabel_en-US" xlink:label="lab_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E_label_en-US" xlink:label="lab_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued General And Administrative Expenses</link:label>
    <link:label id="lab_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E_documentation_en-US" xlink:label="lab_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable for general and administrative expenses..</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedGeneralAndAdministrativeExpenses" xlink:label="loc_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E" xlink:to="lab_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_605773B8BF26F8E5D08793BC7ABB8136_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_605773B8BF26F8E5D08793BC7ABB8136" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_605773B8BF26F8E5D08793BC7ABB8136_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_605773B8BF26F8E5D08793BC7ABB8136" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_605773B8BF26F8E5D08793BC7ABB8136" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_605773B8BF26F8E5D08793BC7ABB8136" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_605773B8BF26F8E5D08793BC7ABB8136" xlink:type="arc" />
    <link:label id="lab_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D_totalLabel_en-US" xlink:label="lab_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses and other current liabilities</link:label>
    <link:label id="lab_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D_label_en-US" xlink:label="lab_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities And Other Current Liabilities</link:label>
    <link:label id="lab_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D_documentation_en-US" xlink:label="lab_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet..</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedLiabilitiesAndOtherCurrentLiabilities" xlink:label="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D" xlink:to="lab_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D" xlink:type="arc" />
    <link:label id="lab_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1_terseLabel_en-US" xlink:label="lab_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1_label_en-US" xlink:label="lab_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1_documentation_en-US" xlink:label="lab_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of information about significant accounting policies of the reporting entity.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfSignificantAccountingPoliciesTable" xlink:label="loc_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:to="lab_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for Change in Accounting Principle [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for Change in Accounting Principle [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:to="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for Change in Accounting Principle [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for Change in Accounting Principle [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:to="lab_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27" xlink:type="arc" />
    <link:label id="lab_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51_terseLabel_en-US" xlink:label="lab_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51_label_en-US" xlink:label="lab_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Significant Accounting [Line Items]</link:label>
    <link:label id="lab_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51_documentation_en-US" xlink:label="lab_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfSignificantAccountingLineItems" xlink:label="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="lab_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:type="arc" />
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification adjustment</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Period Reclassification Adjustment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2" xlink:type="arc" />
    <link:label id="lab_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F_terseLabel_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating leases</link:label>
    <link:label id="lab_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F_label_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Contracts</link:label>
    <link:label id="lab_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F_documentation_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Contracts</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseNumberOfContracts" xlink:label="loc_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:to="lab_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_644A2F836FB46EE54A3598DEC4F786A7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_644A2F836FB46EE54A3598DEC4F786A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_644A2F836FB46EE54A3598DEC4F786A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_644A2F836FB46EE54A3598DEC4F786A7" xlink:to="lab_us-gaap_OperatingLeaseLiability_644A2F836FB46EE54A3598DEC4F786A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:type="arc" />
    <link:label id="lab_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6_label_en-US" xlink:label="lab_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:to="lab_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337_label_en-US" xlink:label="lab_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:to="lab_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Award, Tranche One [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Award, Tranche Two [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche Three</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Award, Tranche Three [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823" xlink:to="lab_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823" xlink:type="arc" />
    <link:label id="lab_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773_terseLabel_en-US" xlink:label="lab_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773_label_en-US" xlink:label="lab_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:to="lab_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:type="arc" />
    <link:label id="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2_terseLabel_en-US" xlink:label="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:label id="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2_label_en-US" xlink:label="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:to="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:type="arc" />
    <link:label id="lab_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F_terseLabel_en-US" xlink:label="lab_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee</link:label>
    <link:label id="lab_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F_label_en-US" xlink:label="lab_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee [Member]</link:label>
    <link:label id="lab_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F_documentation_en-US" xlink:label="lab_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeMember" xlink:label="loc_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:to="lab_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7_terseLabel_en-US" xlink:label="lab_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Director</link:label>
    <link:label id="lab_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7_label_en-US" xlink:label="lab_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7" xlink:to="lab_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22_terseLabel_en-US" xlink:label="lab_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Board of Directors Chairman</link:label>
    <link:label id="lab_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22_label_en-US" xlink:label="lab_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="loc_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22" xlink:to="lab_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22" xlink:type="arc" />
    <link:label id="lab_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13_terseLabel_en-US" xlink:label="lab_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan (ESPP)</link:label>
    <link:label id="lab_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13_label_en-US" xlink:label="lab_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:label id="lab_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13_documentation_en-US" xlink:label="lab_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeStockPurchasePlanESPPMember" xlink:label="loc_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:to="lab_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:to="lab_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:to="lab_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:type="arc" />
    <link:label id="lab_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC_terseLabel_en-US" xlink:label="lab_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2016 Plan</link:label>
    <link:label id="lab_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC_label_en-US" xlink:label="lab_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2016 Plan [Member]</link:label>
    <link:label id="lab_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC_documentation_en-US" xlink:label="lab_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2016 Plan [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_The2016PlanMember" xlink:label="loc_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:to="lab_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:type="arc" />
    <link:label id="lab_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8_terseLabel_en-US" xlink:label="lab_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2015 Plan</link:label>
    <link:label id="lab_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8_label_en-US" xlink:label="lab_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2015 Plan [Member]</link:label>
    <link:label id="lab_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8_documentation_en-US" xlink:label="lab_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2015 Plan [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_The2015PlanMember" xlink:label="loc_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:to="lab_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:type="arc" />
    <link:label id="lab_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591_terseLabel_en-US" xlink:label="lab_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591_label_en-US" xlink:label="lab_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591" xlink:to="lab_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:to="lab_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:type="arc" />
    <link:label id="lab_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6_terseLabel_en-US" xlink:label="lab_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service Based Options</link:label>
    <link:label id="lab_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6_label_en-US" xlink:label="lab_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Based Options [Member]</link:label>
    <link:label id="lab_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6_documentation_en-US" xlink:label="lab_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Service Based Options [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ServiceBasedOptionsMember" xlink:label="loc_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:to="lab_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:type="arc" />
    <link:label id="lab_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23_terseLabel_en-US" xlink:label="lab_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options With Market Based Vesting Conditions</link:label>
    <link:label id="lab_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23_label_en-US" xlink:label="lab_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Options With Market Based Vesting Conditions [Member]</link:label>
    <link:label id="lab_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23_documentation_en-US" xlink:label="lab_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Options With Market Based Vesting Conditions [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockOptionsWithMarketBasedVestingConditionsMember" xlink:label="loc_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:to="lab_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5" xlink:to="lab_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5" xlink:type="arc" />
    <link:label id="lab_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148_terseLabel_en-US" xlink:label="lab_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148_label_en-US" xlink:label="lab_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Consultants And Directors Stock Options [Member]</link:label>
    <link:label id="lab_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148_documentation_en-US" xlink:label="lab_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">An arrangement whereby an employee, consultant, or member of the Board of Directors is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeConsultantsAndDirectorsStockOptionsMember" xlink:label="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:to="lab_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154" xlink:type="arc" />
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14" xlink:type="arc" />
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4_terseLabel_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in number of shares reserved for issuance (in shares)</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4_label_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Increase</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4_documentation_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the increase in the number of shares reserved for issuance under the incentive plan.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:to="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock remaining for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755" xlink:type="arc" />
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477_terseLabel_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual share reserve increase (as a percent)</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477_label_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Share Reserve Increase As Percent</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477_documentation_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The percent, applied to total number of outstanding shares of common stock on the last trading day in December of the prior year, by which the share reserve automatically increases on the first day of January of each calendar year beginning in 2016.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:to="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option Activity, Number of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Options exercises in period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeitures (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20668465E23518AE324994C84D16387A_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20668465E23518AE324994C84D16387A" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20668465E23518AE324994C84D16387A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20668465E23518AE324994C84D16387A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20668465E23518AE324994C84D16387A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option Activity, Weighted-average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeitures (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_B7BB9E2495CCC3DA007D94C84D1CBDD5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_B7BB9E2495CCC3DA007D94C84D1CBDD5" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">End of period (in dollars per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_B7BB9E2495CCC3DA007D94C84D1CBDD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_B7BB9E2495CCC3DA007D94C84D1CBDD5" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_B7BB9E2495CCC3DA007D94C84D1CBDD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029" xlink:type="arc" />
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781_terseLabel_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Awards Vesting, Percent</link:label>
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781_label_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Awards Vesting, Percent</link:label>
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781_documentation_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Awards Vesting, Percent</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:to="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option Activity, Fair value of options granted</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:type="arc" />
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B_terseLabel_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant date fair value of options granted</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B_label_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B_documentation_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the information pertaining to share based compensation arrangement by share based payment award options grants in period fair value.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:to="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:type="arc" />
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383_terseLabel_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant date fair value of options forfeited</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383_label_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Options, Forfeitures In Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383_documentation_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Options, Forfeitures In Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:to="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option Activity, Weighted-average remaining contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of options exercisable</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of options vested in period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Per share weighted average fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36" xlink:type="arc" />
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC_terseLabel_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market-based vesting condition share price floor (in dollars per share)</link:label>
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC_label_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Options, Market-based Vesting Condition, Share Price Floor</link:label>
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC_documentation_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Options, Market-based Vesting Condition, Share Price Floor</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:to="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:type="arc" />
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C_terseLabel_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market-based vesting condition number of consecutive days</link:label>
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C_label_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Options Market-based Vesting Condition, Measurement Period</link:label>
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C_documentation_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Options Market-based Vesting Condition, Measurement Period</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:to="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value assumptions</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance of Non-vested RSAs (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">RSAs vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0F366F8FDF08FD49D7E494C84D217B76_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0F366F8FDF08FD49D7E494C84D217B76" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance of Non-vested RSAs (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0F366F8FDF08FD49D7E494C84D217B76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0F366F8FDF08FD49D7E494C84D217B76" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0F366F8FDF08FD49D7E494C84D217B76" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonvested RSAs weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSAs vested in period weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of fair market value on the lower of first day or last day of the offering period at which employees may purchase stock under the ESPP</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum portion of earning an employee may contribute to the ESPP Plan</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445" xlink:type="arc" />
    <link:label id="lab_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF_terseLabel_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum annual amount of fair market value of the Company's common stock that a participant may accrue the rights to purchase</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF_label_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Fair Value Amount of Outstanding Stock Maximum</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF_documentation_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Fair Value Amount of Outstanding Stock Maximum</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum" xlink:label="loc_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:to="lab_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446" xlink:type="arc" />
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18_terseLabel_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Automatic increase to shares authorized as percentage of outstanding stock at end of preceding year</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18_label_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Automatic Increase To Shares Authorized As Percentage Of Outstanding Stock At End Of Preceding Year</link:label>
    <link:label id="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18_documentation_en-US" xlink:label="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Automatic Increase To Shares Authorized As Percentage Of Outstanding Stock At End Of Preceding Year</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:to="lab_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in shares available (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grants in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB" xlink:type="arc" />
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2_terseLabel_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of vesting installments</link:label>
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2_label_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Number Of Vesting Installments</link:label>
    <link:label id="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2_documentation_en-US" xlink:label="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Number Of Vesting Installments</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:to="lab_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:type="arc" />
    <link:label id="lab_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A_terseLabel_en-US" xlink:label="lab_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of awards</link:label>
    <link:label id="lab_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A_label_en-US" xlink:label="lab_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensatin Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Number Of Awards</link:label>
    <link:label id="lab_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A_documentation_en-US" xlink:label="lab_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensatin Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Number Of Awards</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards" xlink:label="loc_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:to="lab_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_FD392E41295EA99D8D919A25F38ADACE_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_FD392E41295EA99D8D919A25F38ADACE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual base rent</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_FD392E41295EA99D8D919A25F38ADACE_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_FD392E41295EA99D8D919A25F38ADACE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_FD392E41295EA99D8D919A25F38ADACE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_FD392E41295EA99D8D919A25F38ADACE" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_FD392E41295EA99D8D919A25F38ADACE" xlink:type="arc" />
    <link:label id="lab_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E_terseLabel_en-US" xlink:label="lab_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual increase in rent expense</link:label>
    <link:label id="lab_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E_label_en-US" xlink:label="lab_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense, Annual Increase, Percent</link:label>
    <link:label id="lab_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E_documentation_en-US" xlink:label="lab_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense, Annual Increase, Percent</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_OperatingLeasesRentExpenseAnnualIncreasePercent" xlink:label="loc_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E" xlink:to="lab_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_31B3452CF51C503B29169A25F38BB362_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_31B3452CF51C503B29169A25F38BB362" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_31B3452CF51C503B29169A25F38BB362_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_31B3452CF51C503B29169A25F38BB362" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_31B3452CF51C503B29169A25F38BB362" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_31B3452CF51C503B29169A25F38BB362" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_31B3452CF51C503B29169A25F38BB362" xlink:type="arc" />
    <link:label id="lab_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079_terseLabel_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of renewal options</link:label>
    <link:label id="lab_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079_label_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079_documentation_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:label="loc_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079" xlink:to="lab_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_A777E4167C895675F3FC9A25F38BA812_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_A777E4167C895675F3FC9A25F38BA812" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_A777E4167C895675F3FC9A25F38BA812_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_A777E4167C895675F3FC9A25F38BA812" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_A777E4167C895675F3FC9A25F38BA812" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_A777E4167C895675F3FC9A25F38BA812" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_A777E4167C895675F3FC9A25F38BA812" xlink:type="arc" />
    <link:label id="lab_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D_terseLabel_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining lease team</link:label>
    <link:label id="lab_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D_label_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Team</link:label>
    <link:label id="lab_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D_documentation_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Team</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseRemainingLeaseTeam" xlink:label="loc_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D" xlink:to="lab_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_1BF144211828051DEB219A25F38C70C8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate_1BF144211828051DEB219A25F38C70C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_1BF144211828051DEB219A25F38C70C8_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate_1BF144211828051DEB219A25F38C70C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_1BF144211828051DEB219A25F38C70C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDiscountRate_1BF144211828051DEB219A25F38C70C8" xlink:to="lab_us-gaap_LesseeOperatingLeaseDiscountRate_1BF144211828051DEB219A25F38C70C8" xlink:type="arc" />
    <link:label id="lab_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534_terseLabel_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rent abatement period</link:label>
    <link:label id="lab_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534_label_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Rent Abatement</link:label>
    <link:label id="lab_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534_documentation_en-US" xlink:label="lab_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Rent Abatement</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseRentAbatement" xlink:label="loc_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534" xlink:to="lab_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasePayments_DDAD19E1C62685F30D4B9A25F38C4B51_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_DDAD19E1C62685F30D4B9A25F38C4B51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_DDAD19E1C62685F30D4B9A25F38C4B51_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_DDAD19E1C62685F30D4B9A25F38C4B51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_DDAD19E1C62685F30D4B9A25F38C4B51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments_DDAD19E1C62685F30D4B9A25F38C4B51" xlink:to="lab_us-gaap_OperatingLeasePayments_DDAD19E1C62685F30D4B9A25F38C4B51" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_3B66C78D6B1A2CA018C298A29CF6DEB7_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_3B66C78D6B1A2CA018C298A29CF6DEB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3B66C78D6B1A2CA018C298A29CF6DEB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3B66C78D6B1A2CA018C298A29CF6DEB7" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_3B66C78D6B1A2CA018C298A29CF6DEB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD" xlink:type="arc" />
    <link:label id="lab_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D_terseLabel_en-US" xlink:label="lab_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingently issuable stock</link:label>
    <link:label id="lab_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D_label_en-US" xlink:label="lab_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingently Issuable Common Stock [Member]</link:label>
    <link:label id="lab_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D_documentation_en-US" xlink:label="lab_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingently Issuable Common Stock [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ContingentlyIssuableCommonStockMember" xlink:label="loc_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:to="lab_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537" xlink:to="lab_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at the beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B" xlink:to="lab_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at the beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768" xlink:to="lab_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498" xlink:type="arc" />
    <link:label id="lab_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030_terseLabel_en-US" xlink:label="lab_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options and warrants (in shares)</link:label>
    <link:label id="lab_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030_label_en-US" xlink:label="lab_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Stock Options And Warrants Exercised</link:label>
    <link:label id="lab_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030_documentation_en-US" xlink:label="lab_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Stock Options And Warrants Exercised</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:label="loc_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:to="lab_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:type="arc" />
    <link:label id="lab_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44_terseLabel_en-US" xlink:label="lab_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options and warrants</link:label>
    <link:label id="lab_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44_label_en-US" xlink:label="lab_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options And Warrants Exercised</link:label>
    <link:label id="lab_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44_documentation_en-US" xlink:label="lab_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options And Warrants Exercised</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:label="loc_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:to="lab_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units vested during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units vested during period</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesOutstanding_00EF5B136FA62065CAB998A29CFA26DF_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding_00EF5B136FA62065CAB998A29CFA26DF" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at the end (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_00EF5B136FA62065CAB998A29CFA26DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_00EF5B136FA62065CAB998A29CFA26DF" xlink:to="lab_us-gaap_SharesOutstanding_00EF5B136FA62065CAB998A29CFA26DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_61748E05FC48E9F676D098A29CFA8F89_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_61748E05FC48E9F676D098A29CFA8F89" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at the end</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_61748E05FC48E9F676D098A29CFA8F89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_61748E05FC48E9F676D098A29CFA8F89" xlink:to="lab_us-gaap_StockholdersEquity_61748E05FC48E9F676D098A29CFA8F89" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:type="arc" />
    <link:label id="lab_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9_terseLabel_en-US" xlink:label="lab_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:label id="lab_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9_label_en-US" xlink:label="lab_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
    <link:label id="lab_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9_documentation_en-US" xlink:label="lab_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants to purchase common stock of the entity.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsMember" xlink:label="loc_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:to="lab_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:to="lab_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="lab_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Price Volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Share Price</link:label>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742_label_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Risk Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Exercise Price</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC" xlink:to="lab_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Counterparty Credit Risk</link:label>
    <link:label id="lab_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70_label_en-US" xlink:label="lab_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Counterparty Credit Risk [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputCounterpartyCreditRiskMember" xlink:label="loc_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70" xlink:to="lab_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70" xlink:type="arc" />
    <link:label id="lab_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37_terseLabel_en-US" xlink:label="lab_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Milestone Success</link:label>
    <link:label id="lab_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37_label_en-US" xlink:label="lab_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Milestone Success [Member]</link:label>
    <link:label id="lab_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37_documentation_en-US" xlink:label="lab_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Milestone Success [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MeasurementInputProbabilityOfMilestoneSuccessMember" xlink:label="loc_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:to="lab_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:type="arc" />
    <link:label id="lab_cerc_EquityUnitPurchaseOptionMember_58EA8E600686CD42EB2993BC7AD91D6E_verboseLabel_en-US" xlink:label="lab_cerc_EquityUnitPurchaseOptionMember_58EA8E600686CD42EB2993BC7AD91D6E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity Unit Purchase Option</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EquityUnitPurchaseOptionMember" xlink:label="loc_cerc_EquityUnitPurchaseOptionMember_58EA8E600686CD42EB2993BC7AD91D6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_EquityUnitPurchaseOptionMember_58EA8E600686CD42EB2993BC7AD91D6E" xlink:to="lab_cerc_EquityUnitPurchaseOptionMember_58EA8E600686CD42EB2993BC7AD91D6E" xlink:type="arc" />
    <link:label id="lab_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B_terseLabel_en-US" xlink:label="lab_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Payable</link:label>
    <link:label id="lab_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B_label_en-US" xlink:label="lab_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Payable [Member]</link:label>
    <link:label id="lab_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B_documentation_en-US" xlink:label="lab_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Payable [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RoyaltyPayableMember" xlink:label="loc_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:to="lab_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3 Valuation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B" xlink:to="lab_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available under warrant (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and rights outstanding, measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77" xlink:type="arc" />
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product royalty net</link:label>
    <link:label id="lab_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815_label_en-US" xlink:label="lab_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Product Royalty, Net</link:label>
    <link:label id="lab_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Product Royalty, Net</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementProductRoyaltyNet" xlink:label="loc_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:to="lab_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty obligation (up to)</link:label>
    <link:label id="lab_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93_label_en-US" xlink:label="lab_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Royalty Obligation</link:label>
    <link:label id="lab_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Royalty Obligation</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementRoyaltyObligation" xlink:label="loc_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:to="lab_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D_terseLabel_en-US" xlink:label="lab_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of royalty obligation</link:label>
    <link:label id="lab_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D_label_en-US" xlink:label="lab_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Royalty Obligation, Fair Value Disclosure</link:label>
    <link:label id="lab_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D_documentation_en-US" xlink:label="lab_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Royalty Obligation, Fair Value Disclosure</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure" xlink:label="loc_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:to="lab_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:type="arc" />
    <link:label id="lab_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817_terseLabel_en-US" xlink:label="lab_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty obligation measurement input</link:label>
    <link:label id="lab_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817_label_en-US" xlink:label="lab_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Obligation, Measurement Input</link:label>
    <link:label id="lab_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817_documentation_en-US" xlink:label="lab_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Obligation, Measurement Input</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RoyaltyObligationMeasurementInput" xlink:label="loc_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:to="lab_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of contingent consideration and royalty</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination gross profit</link:label>
    <link:label id="lab_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A_label_en-US" xlink:label="lab_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Gross Profit</link:label>
    <link:label id="lab_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Gross Profit</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationGrossProfit" xlink:label="loc_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:to="lab_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liability measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected time to milestone</link:label>
    <link:label id="lab_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D_label_en-US" xlink:label="lab_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Expected Time To Milestone</link:label>
    <link:label id="lab_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Expected Time To Milestone</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone" xlink:label="loc_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:to="lab_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:type="arc" />
    <link:label id="lab_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665_terseLabel_en-US" xlink:label="lab_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of changes in valuation techniques</link:label>
    <link:label id="lab_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665_label_en-US" xlink:label="lab_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurements Changes In Valuation Techniques Number</link:label>
    <link:label id="lab_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665_documentation_en-US" xlink:label="lab_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of changes in valuation techniques during the period.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueMeasurementsChangesInValuationTechniquesNumber" xlink:label="loc_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:to="lab_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of transfers of assets from level 2 to level 1</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Level 2 to Level 1 Transfers, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C" xlink:to="lab_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of transfers of assets from level 1 to level 2</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Level 1 to Level 2 Transfers, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0" xlink:to="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_C582DAD197B419F8246B9030691D38A8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_C582DAD197B419F8246B9030691D38A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_C582DAD197B419F8246B9030691D38A8_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_C582DAD197B419F8246B9030691D38A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_C582DAD197B419F8246B9030691D38A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_C582DAD197B419F8246B9030691D38A8" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_C582DAD197B419F8246B9030691D38A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_11EE309A71F32450071E9030691D189E_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_11EE309A71F32450071E9030691D189E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_11EE309A71F32450071E9030691D189E_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_11EE309A71F32450071E9030691D189E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_11EE309A71F32450071E9030691D189E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_11EE309A71F32450071E9030691D189E" xlink:to="lab_us-gaap_CommonStockSharesIssued_11EE309A71F32450071E9030691D189E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_C4134D5463EE319934FF9030691D0CC3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_C4134D5463EE319934FF9030691D0CC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_C4134D5463EE319934FF9030691D0CC3_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_C4134D5463EE319934FF9030691D0CC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_C4134D5463EE319934FF9030691D0CC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_C4134D5463EE319934FF9030691D0CC3" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_C4134D5463EE319934FF9030691D0CC3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_38D542C4D1BC6A3F3F5C9030691C1051_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_38D542C4D1BC6A3F3F5C9030691C1051" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_38D542C4D1BC6A3F3F5C9030691C1051_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_38D542C4D1BC6A3F3F5C9030691C1051" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_38D542C4D1BC6A3F3F5C9030691C1051" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare_38D542C4D1BC6A3F3F5C9030691C1051" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare_38D542C4D1BC6A3F3F5C9030691C1051" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_749518D55C25D75EE3409030691C6926_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_749518D55C25D75EE3409030691C6926" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_749518D55C25D75EE3409030691C6926_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_749518D55C25D75EE3409030691C6926" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_749518D55C25D75EE3409030691C6926" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_749518D55C25D75EE3409030691C6926" xlink:to="lab_us-gaap_PreferredStockSharesIssued_749518D55C25D75EE3409030691C6926" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_89196D3380CE00F5A0BA9030691C09CB_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding_89196D3380CE00F5A0BA9030691C09CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_89196D3380CE00F5A0BA9030691C09CB_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding_89196D3380CE00F5A0BA9030691C09CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_89196D3380CE00F5A0BA9030691C09CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding_89196D3380CE00F5A0BA9030691C09CB" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding_89196D3380CE00F5A0BA9030691C09CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_A1114EDD36A0505862CE8DD5284166EF_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_A1114EDD36A0505862CE8DD5284166EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_A1114EDD36A0505862CE8DD5284166EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_A1114EDD36A0505862CE8DD5284166EF" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_A1114EDD36A0505862CE8DD5284166EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_NatureOfOperations_2BBEF09745609F1369EF8DD528417FE5_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations_2BBEF09745609F1369EF8DD528417FE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_2BBEF09745609F1369EF8DD528417FE5_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations_2BBEF09745609F1369EF8DD528417FE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_2BBEF09745609F1369EF8DD528417FE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_2BBEF09745609F1369EF8DD528417FE5" xlink:to="lab_us-gaap_NatureOfOperations_2BBEF09745609F1369EF8DD528417FE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:type="arc" />
    <link:label id="lab_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F_terseLabel_en-US" xlink:label="lab_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incentive Warrants</link:label>
    <link:label id="lab_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F_label_en-US" xlink:label="lab_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incentive Warrants [Member]</link:label>
    <link:label id="lab_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F_documentation_en-US" xlink:label="lab_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Incentive Warrants [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_IncentiveWarrantsMember" xlink:label="loc_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:to="lab_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:type="arc" />
    <link:label id="lab_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2_terseLabel_en-US" xlink:label="lab_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bought Deal</link:label>
    <link:label id="lab_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2_label_en-US" xlink:label="lab_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bought Deal [Member]</link:label>
    <link:label id="lab_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2_documentation_en-US" xlink:label="lab_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bought Deal [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BoughtDealMember" xlink:label="loc_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:to="lab_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39" xlink:to="lab_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39" xlink:type="arc" />
    <link:label id="lab_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3_terseLabel_en-US" xlink:label="lab_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Armistice</link:label>
    <link:label id="lab_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3_label_en-US" xlink:label="lab_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Armistice [Member]</link:label>
    <link:label id="lab_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3_documentation_en-US" xlink:label="lab_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Armistice [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ArmisticeMember" xlink:label="loc_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:to="lab_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="lab_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:type="arc" />
    <link:label id="lab_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C_terseLabel_en-US" xlink:label="lab_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of classes of stock authorized to issue</link:label>
    <link:label id="lab_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C_label_en-US" xlink:label="lab_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Class Of Stock Authorized</link:label>
    <link:label id="lab_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C_documentation_en-US" xlink:label="lab_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of classes of stock permitted to be issued by an entity's charter and bylaws.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfClassOfStockAuthorized" xlink:label="loc_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:to="lab_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:type="arc" />
    <link:label id="lab_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D_terseLabel_en-US" xlink:label="lab_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares of capital stock authorized to issue (in shares)</link:label>
    <link:label id="lab_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D_label_en-US" xlink:label="lab_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Stock Shares Authorized</link:label>
    <link:label id="lab_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D_documentation_en-US" xlink:label="lab_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The maximum number of capital stock, including common stock and preferred stock, solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CapitalStockSharesAuthorized" xlink:label="loc_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:to="lab_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from warrant exercises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46" xlink:type="arc" />
    <link:label id="lab_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262_terseLabel_en-US" xlink:label="lab_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution adjustment</link:label>
    <link:label id="lab_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262_label_en-US" xlink:label="lab_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Distribution Adjustment</link:label>
    <link:label id="lab_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262_documentation_en-US" xlink:label="lab_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Distribution Adjustment</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ClassOfWarrantOrRightDistributionAdjustment" xlink:label="loc_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:to="lab_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:type="arc" />
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB" xlink:to="lab_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_1050A64C836506E44132943A18D1F16D_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_1050A64C836506E44132943A18D1F16D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1050A64C836506E44132943A18D1F16D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1050A64C836506E44132943A18D1F16D" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_1050A64C836506E44132943A18D1F16D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from sale of stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7B5D8026752B6BDAA9BA943A18D237C4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7B5D8026752B6BDAA9BA943A18D237C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of stock (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7B5D8026752B6BDAA9BA943A18D237C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7B5D8026752B6BDAA9BA943A18D237C4" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7B5D8026752B6BDAA9BA943A18D237C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance or sale of equity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unregistered shares of common stock issued or issuable as part of acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967" xlink:type="arc" />
    <link:label id="lab_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA_terseLabel_en-US" xlink:label="lab_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of votes per share</link:label>
    <link:label id="lab_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA_label_en-US" xlink:label="lab_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Votes Per Share</link:label>
    <link:label id="lab_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA_documentation_en-US" xlink:label="lab_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of votes available to holders of the Preferred Stock for each share of Common Stock into which such share of Preferred Stock could be converted.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberofVotesPerShare" xlink:label="loc_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:to="lab_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9" xlink:type="arc" />
    <link:label id="lab_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6_terseLabel_en-US" xlink:label="lab_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of preemptive, conversion or subscription rights</link:label>
    <link:label id="lab_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6_label_en-US" xlink:label="lab_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Preemptive Conversion Or Subscription Rights</link:label>
    <link:label id="lab_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6_documentation_en-US" xlink:label="lab_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of preemptive, conversion or subscription rights held by common stock holders.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfPreemptiveConversionOrSubscriptionRights" xlink:label="loc_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:to="lab_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:type="arc" />
    <link:label id="lab_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78_terseLabel_en-US" xlink:label="lab_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of redemption or sinking fund provisions</link:label>
    <link:label id="lab_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78_label_en-US" xlink:label="lab_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Redemption Or Sinking Fund Provisions</link:label>
    <link:label id="lab_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78_documentation_en-US" xlink:label="lab_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of redemption or sinking fund provisions applicable to the entity's common stock.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfRedemptionOrSinkingFundProvisions" xlink:label="loc_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:to="lab_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_CDFF4DD58408AF22F7668DD528341BD4_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_CDFF4DD58408AF22F7668DD528341BD4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_CDFF4DD58408AF22F7668DD528341BD4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_CDFF4DD58408AF22F7668DD528341BD4" xlink:to="lab_us-gaap_DebtDisclosureAbstract_CDFF4DD58408AF22F7668DD528341BD4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_93AEEE985DF2C6CE1E0F8DD52835F2DF_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_93AEEE985DF2C6CE1E0F8DD52835F2DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deerfield Obligation</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_93AEEE985DF2C6CE1E0F8DD52835F2DF_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_93AEEE985DF2C6CE1E0F8DD52835F2DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_93AEEE985DF2C6CE1E0F8DD52835F2DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_93AEEE985DF2C6CE1E0F8DD52835F2DF" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_93AEEE985DF2C6CE1E0F8DD52835F2DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_347BE6D47613A51669C3903067D3416E_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_347BE6D47613A51669C3903067D3416E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_347BE6D47613A51669C3903067D3416E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_347BE6D47613A51669C3903067D3416E" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_347BE6D47613A51669C3903067D3416E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3BB71058A0EB6A6968628DD527CD2C6D_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3BB71058A0EB6A6968628DD527CD2C6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3BB71058A0EB6A6968628DD527CD2C6D_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3BB71058A0EB6A6968628DD527CD2C6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3BB71058A0EB6A6968628DD527CD2C6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3BB71058A0EB6A6968628DD527CD2C6D" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3BB71058A0EB6A6968628DD527CD2C6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6_label_en-US" xlink:label="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Receivables</link:label>
    <link:label id="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Receivables</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:label="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:to="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Identifiable Intangible Assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of liabilities assumed:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65_negatedTerseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65_label_en-US" xlink:label="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses And Other Current Liabilities</link:label>
    <link:label id="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses And Other Current Liabilities</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:to="lab_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B32C0811B2A1F249E64E90306892F7A4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B32C0811B2A1F249E64E90306892F7A4" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fair value of debt assumed</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B32C0811B2A1F249E64E90306892F7A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B32C0811B2A1F249E64E90306892F7A4" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B32C0811B2A1F249E64E90306892F7A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total identifiable net assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Period Adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Assets</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Assets</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Accounting Incomplete, Adjustment, Other Receivables</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Accounting Incomplete, Adjustment, Other Receivables</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables" xlink:label="loc_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:to="lab_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1_totalLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3_negatedTerseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F_negatedTerseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fair value of debt assumed</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-term Debt</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-term Debt</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6_negatedTerseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Contingent Liability</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Contingent Liability</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117_totalLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089_totalLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total identifiable net assets</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089_label_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets (Liabilities)</link:label>
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets (Liabilities)</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_76D0C536177A4455836098E172FB1A52_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_76D0C536177A4455836098E172FB1A52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_76D0C536177A4455836098E172FB1A52_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_76D0C536177A4455836098E172FB1A52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_76D0C536177A4455836098E172FB1A52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_76D0C536177A4455836098E172FB1A52" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_76D0C536177A4455836098E172FB1A52" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_FDAB5186392CDF5B09C6952C8677F646_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_FDAB5186392CDF5B09C6952C8677F646" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_FDAB5186392CDF5B09C6952C8677F646_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_FDAB5186392CDF5B09C6952C8677F646" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_FDAB5186392CDF5B09C6952C8677F646" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_FDAB5186392CDF5B09C6952C8677F646" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_FDAB5186392CDF5B09C6952C8677F646" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_CBD244FC4384B6EF5E518DD527CD4FB2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_CBD244FC4384B6EF5E518DD527CD4FB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_CBD244FC4384B6EF5E518DD527CD4FB2_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_CBD244FC4384B6EF5E518DD527CD4FB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_CBD244FC4384B6EF5E518DD527CD4FB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock_CBD244FC4384B6EF5E518DD527CD4FB2" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock_CBD244FC4384B6EF5E518DD527CD4FB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DC1549D345ABD4B995DB93BC7AE35E80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DC1549D345ABD4B995DB93BC7AE35E80" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of assets and liabilities that are measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DC1549D345ABD4B995DB93BC7AE35E80_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DC1549D345ABD4B995DB93BC7AE35E80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DC1549D345ABD4B995DB93BC7AE35E80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DC1549D345ABD4B995DB93BC7AE35E80" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DC1549D345ABD4B995DB93BC7AE35E80" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_821C3AC5A8F51503E2CB93BC7AE3A3B2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_821C3AC5A8F51503E2CB93BC7AE3A3B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of changes in the fair value of the Level 3 valuation for the Warrant Liability and the Investor Rights Obligation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_821C3AC5A8F51503E2CB93BC7AE3A3B2_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_821C3AC5A8F51503E2CB93BC7AE3A3B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_821C3AC5A8F51503E2CB93BC7AE3A3B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_821C3AC5A8F51503E2CB93BC7AE3A3B2" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_821C3AC5A8F51503E2CB93BC7AE3A3B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:type="arc" />
    <link:label id="lab_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15_terseLabel_en-US" xlink:label="lab_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants on common stock</link:label>
    <link:label id="lab_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15_label_en-US" xlink:label="lab_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Common Stock [Member]</link:label>
    <link:label id="lab_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15_documentation_en-US" xlink:label="lab_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the information pertaining to warrant common stock.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantCommonStockMember" xlink:label="loc_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:to="lab_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:type="arc" />
    <link:label id="lab_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4_terseLabel_en-US" xlink:label="lab_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock warrants, expiration date of October 2020</link:label>
    <link:label id="lab_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4_label_en-US" xlink:label="lab_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Warrants Expiration October2020 [Member]</link:label>
    <link:label id="lab_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4_documentation_en-US" xlink:label="lab_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants, with expiration date of October 2020, to purchase common stock of the entity.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsExpirationOctober2020Member" xlink:label="loc_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:to="lab_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:type="arc" />
    <link:label id="lab_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA_terseLabel_en-US" xlink:label="lab_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock warrants, expiration date of May 2022</link:label>
    <link:label id="lab_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA_label_en-US" xlink:label="lab_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Warrants Expiration May2022 [Member]</link:label>
    <link:label id="lab_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA_documentation_en-US" xlink:label="lab_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants, with expiration date of May 2022, to purchase common stock of the entity.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsExpirationMay2022Member" xlink:label="loc_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:to="lab_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:type="arc" />
    <link:label id="lab_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B_terseLabel_en-US" xlink:label="lab_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock warrants, expiration date June 2024</link:label>
    <link:label id="lab_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B_label_en-US" xlink:label="lab_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Warrants, Expiration Date June 2024 [Member]</link:label>
    <link:label id="lab_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B_documentation_en-US" xlink:label="lab_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock Warrants, Expiration Date June 2024 [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsExpirationDateJune2024Member" xlink:label="loc_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:to="lab_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:type="arc" />
    <link:label id="lab_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06_terseLabel_en-US" xlink:label="lab_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Structure</link:label>
    <link:label id="lab_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06_label_en-US" xlink:label="lab_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders Equity And Temporary Equity Note Disclosure [Text Block]</link:label>
    <link:label id="lab_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06_documentation_en-US" xlink:label="lab_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Also include temporary equity.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock" xlink:label="loc_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06" xlink:to="lab_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_F7FED8506B883BD4310F9030687AC39D_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_F7FED8506B883BD4310F9030687AC39D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_F7FED8506B883BD4310F9030687AC39D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_F7FED8506B883BD4310F9030687AC39D" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_F7FED8506B883BD4310F9030687AC39D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_F085FB78FAF711B145EA9030687A491A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_F085FB78FAF711B145EA9030687A491A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock (including contingently issuable shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_F085FB78FAF711B145EA9030687A491A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_F085FB78FAF711B145EA9030687A491A" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_F085FB78FAF711B145EA9030687A491A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3EEB4CD9C493290CFF5D9030687AB316_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3EEB4CD9C493290CFF5D9030687AB316" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3EEB4CD9C493290CFF5D9030687AB316" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3EEB4CD9C493290CFF5D9030687AB316" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3EEB4CD9C493290CFF5D9030687AB316" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_312A4B5BC575EF4381FA9030687A212D_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_312A4B5BC575EF4381FA9030687A212D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total consideration transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_312A4B5BC575EF4381FA9030687A212D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_312A4B5BC575EF4381FA9030687A212D" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_312A4B5BC575EF4381FA9030687A212D" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_3B2526A1BE0ED2E1668E9030687BBEB7_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_3B2526A1BE0ED2E1668E9030687BBEB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent payments</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_3B2526A1BE0ED2E1668E9030687BBEB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_3B2526A1BE0ED2E1668E9030687BBEB7" xlink:to="lab_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_3B2526A1BE0ED2E1668E9030687BBEB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="lab_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:type="arc" />
    <link:label id="lab_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617_terseLabel_en-US" xlink:label="lab_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underwritten Public Offering</link:label>
    <link:label id="lab_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617_label_en-US" xlink:label="lab_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwritten Public Offering [Member]</link:label>
    <link:label id="lab_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617_documentation_en-US" xlink:label="lab_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underwritten Public Offering [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UnderwrittenPublicOfferingMember" xlink:label="loc_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:to="lab_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:type="arc" />
    <link:label id="lab_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09_terseLabel_en-US" xlink:label="lab_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Neurological Clinical and Preclinical Stage Compounds</link:label>
    <link:label id="lab_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09_label_en-US" xlink:label="lab_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neurological Clinical And Preclinical Stage Compounds [Member]</link:label>
    <link:label id="lab_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09_documentation_en-US" xlink:label="lab_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Neurological Clinical And Preclinical Stage Compounds [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember" xlink:label="loc_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:to="lab_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:type="arc" />
    <link:label id="lab_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4_terseLabel_en-US" xlink:label="lab_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Three Preclinical Therapies</link:label>
    <link:label id="lab_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4_label_en-US" xlink:label="lab_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Preclinical Therapies [Member]</link:label>
    <link:label id="lab_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4_documentation_en-US" xlink:label="lab_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Three Preclinical Therapies [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ThreePreclinicalTherapiesMember" xlink:label="loc_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:to="lab_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:type="arc" />
    <link:label id="lab_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3_terseLabel_en-US" xlink:label="lab_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preclinical Pediatric Orphan Rare Disease Compound</link:label>
    <link:label id="lab_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3_label_en-US" xlink:label="lab_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preclinical Pediatric Orphan Rare Disease Compound [Member]</link:label>
    <link:label id="lab_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3_documentation_en-US" xlink:label="lab_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Preclinical Pediatric Orphan Rare Disease Compound [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember" xlink:label="loc_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:to="lab_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="lab_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:type="arc" />
    <link:label id="lab_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C_terseLabel_en-US" xlink:label="lab_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of products in development</link:label>
    <link:label id="lab_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C_label_en-US" xlink:label="lab_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Products In Development</link:label>
    <link:label id="lab_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C_documentation_en-US" xlink:label="lab_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Products In Development</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfProductsInDevelopment" xlink:label="loc_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:to="lab_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:type="arc" />
    <link:label id="lab_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6_terseLabel_en-US" xlink:label="lab_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of marketed medical devices</link:label>
    <link:label id="lab_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6_label_en-US" xlink:label="lab_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Marketed Medical Devices</link:label>
    <link:label id="lab_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6_documentation_en-US" xlink:label="lab_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Marketed Medical Devices</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfMarketedMedicalDevices" xlink:label="loc_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:to="lab_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_00FB1A64D93159B516CE938D56A4B13E_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_00FB1A64D93159B516CE938D56A4B13E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_00FB1A64D93159B516CE938D56A4B13E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_00FB1A64D93159B516CE938D56A4B13E" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_00FB1A64D93159B516CE938D56A4B13E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_23B4F31C7CCAA430EB7F938D56A404CE_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_23B4F31C7CCAA430EB7F938D56A404CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23B4F31C7CCAA430EB7F938D56A404CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23B4F31C7CCAA430EB7F938D56A404CE" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_23B4F31C7CCAA430EB7F938D56A404CE" xlink:type="arc" />
    <link:label id="lab_cerc_RoyaltyPayableMember_F5B64E21EFF547E1D12A945980B8E521_verboseLabel_en-US" xlink:label="lab_cerc_RoyaltyPayableMember_F5B64E21EFF547E1D12A945980B8E521" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Royalty Obligation</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RoyaltyPayableMember" xlink:label="loc_cerc_RoyaltyPayableMember_F5B64E21EFF547E1D12A945980B8E521" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_RoyaltyPayableMember_F5B64E21EFF547E1D12A945980B8E521" xlink:to="lab_cerc_RoyaltyPayableMember_F5B64E21EFF547E1D12A945980B8E521" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_174464A307099A3683F0945980BA55C7_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_174464A307099A3683F0945980BA55C7" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_174464A307099A3683F0945980BA55C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_174464A307099A3683F0945980BA55C7" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_174464A307099A3683F0945980BA55C7" xlink:type="arc" />
    <link:label id="lab_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2_terseLabel_en-US" xlink:label="lab_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2_label_en-US" xlink:label="lab_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Awards [Member]</link:label>
    <link:label id="lab_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2_documentation_en-US" xlink:label="lab_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Stock Awards [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RestrictedStockAwardsMember" xlink:label="loc_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:to="lab_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:type="arc" />
    <link:label id="lab_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32_terseLabel_en-US" xlink:label="lab_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underwriters' unit purchase option</link:label>
    <link:label id="lab_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32_label_en-US" xlink:label="lab_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwriters Unit Purchase Option [Member]</link:label>
    <link:label id="lab_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32_documentation_en-US" xlink:label="lab_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to the underwriter's unit purchase option that was offered as part of the IPO.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UnderwritersUnitPurchaseOptionMember" xlink:label="loc_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:to="lab_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6ABAD3FB8DF9BEA2653F98A29B1D939B_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_6ABAD3FB8DF9BEA2653F98A29B1D939B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6ABAD3FB8DF9BEA2653F98A29B1D939B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_6ABAD3FB8DF9BEA2653F98A29B1D939B" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_6ABAD3FB8DF9BEA2653F98A29B1D939B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_96942A7C09770706B28C98A29B1D5B60_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_96942A7C09770706B28C98A29B1D5B60" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_96942A7C09770706B28C98A29B1D5B60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_96942A7C09770706B28C98A29B1D5B60" xlink:to="lab_us-gaap_OperatingLeaseLiability_96942A7C09770706B28C98A29B1D5B60" xlink:type="arc" />
    <link:label id="lab_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB_terseLabel_en-US" xlink:label="lab_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of accrued expenses and other current liabilities</link:label>
    <link:label id="lab_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB_label_en-US" xlink:label="lab_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Accrued Liabilities And Other Current Liabilities [Table Text Block]</link:label>
    <link:label id="lab_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB_documentation_en-US" xlink:label="lab_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of the components of accrued expenses and other current liabilities.</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock" xlink:label="loc_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB" xlink:to="lab_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseCost_99BF528834533C7D15A8952367E03AA6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_99BF528834533C7D15A8952367E03AA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_99BF528834533C7D15A8952367E03AA6_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_99BF528834533C7D15A8952367E03AA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_99BF528834533C7D15A8952367E03AA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost_99BF528834533C7D15A8952367E03AA6" xlink:to="lab_us-gaap_OperatingLeaseCost_99BF528834533C7D15A8952367E03AA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_FB708ABBA930BB63CF619524690B813F_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet_FB708ABBA930BB63CF619524690B813F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_FB708ABBA930BB63CF619524690B813F_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet_FB708ABBA930BB63CF619524690B813F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_FB708ABBA930BB63CF619524690B813F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet_FB708ABBA930BB63CF619524690B813F" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet_FB708ABBA930BB63CF619524690B813F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A3294D27B960980A78DD52841869C_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A3294D27B960980A78DD52841869C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A3294D27B960980A78DD52841869C_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A3294D27B960980A78DD52841869C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A3294D27B960980A78DD52841869C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A3294D27B960980A78DD52841869C" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A3294D27B960980A78DD52841869C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8F4B8DF53EE87E234FAD98E1727A47A2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8F4B8DF53EE87E234FAD98E1727A47A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8F4B8DF53EE87E234FAD98E1727A47A2_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8F4B8DF53EE87E234FAD98E1727A47A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8F4B8DF53EE87E234FAD98E1727A47A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8F4B8DF53EE87E234FAD98E1727A47A2" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8F4B8DF53EE87E234FAD98E1727A47A2" xlink:type="arc" />
    <link:label id="lab_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0_terseLabel_en-US" xlink:label="lab_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0_label_en-US" xlink:label="lab_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations And Asset Acquisitions [Text Block]</link:label>
    <link:label id="lab_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0_documentation_en-US" xlink:label="lab_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combinations And Asset Acquisitions [Text Block]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock" xlink:label="loc_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0" xlink:to="lab_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_2CE5A7068D5C38A951BC950E4EDBD76E_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_2CE5A7068D5C38A951BC950E4EDBD76E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_2CE5A7068D5C38A951BC950E4EDBD76E_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_2CE5A7068D5C38A951BC950E4EDBD76E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_2CE5A7068D5C38A951BC950E4EDBD76E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock_2CE5A7068D5C38A951BC950E4EDBD76E" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock_2CE5A7068D5C38A951BC950E4EDBD76E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Revenue, Net [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C" xlink:to="lab_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C" xlink:type="arc" />
    <link:label id="lab_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE_terseLabel_en-US" xlink:label="lab_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prescribed dietary supplements</link:label>
    <link:label id="lab_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE_label_en-US" xlink:label="lab_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prescribed Dietary Supplements [Member]</link:label>
    <link:label id="lab_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE_documentation_en-US" xlink:label="lab_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prescribed Dietary Supplements [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PrescribedDietarySupplementsMember" xlink:label="loc_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:to="lab_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:type="arc" />
    <link:label id="lab_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94_terseLabel_en-US" xlink:label="lab_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prescription drugs</link:label>
    <link:label id="lab_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94_label_en-US" xlink:label="lab_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prescription Drugs [Member]</link:label>
    <link:label id="lab_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94_documentation_en-US" xlink:label="lab_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prescription Drugs [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PrescriptionDrugsMember" xlink:label="loc_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:to="lab_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:type="arc" />
    <link:label id="lab_cerc_SalesForceRevenueMember_3C10058939522B19AF0193AB9A4FD2EC_terseLabel_en-US" xlink:label="lab_cerc_SalesForceRevenueMember_3C10058939522B19AF0193AB9A4FD2EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales force revenue</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SalesForceRevenueMember" xlink:label="loc_cerc_SalesForceRevenueMember_3C10058939522B19AF0193AB9A4FD2EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_SalesForceRevenueMember_3C10058939522B19AF0193AB9A4FD2EC" xlink:to="lab_cerc_SalesForceRevenueMember_3C10058939522B19AF0193AB9A4FD2EC" xlink:type="arc" />
    <link:label id="lab_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68_label_en-US" xlink:label="lab_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:to="lab_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:type="arc" />
    <link:label id="lab_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:to="lab_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:type="arc" />
    <link:label id="lab_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539_terseLabel_en-US" xlink:label="lab_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Customer Number One</link:label>
    <link:label id="lab_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539_label_en-US" xlink:label="lab_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Customer Number One [Member]</link:label>
    <link:label id="lab_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539_documentation_en-US" xlink:label="lab_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Major Customer Number One [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MajorCustomerNumberOneMember" xlink:label="loc_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:to="lab_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:type="arc" />
    <link:label id="lab_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC_terseLabel_en-US" xlink:label="lab_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Customer Number Two</link:label>
    <link:label id="lab_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC_label_en-US" xlink:label="lab_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Customer Number Two [Member]</link:label>
    <link:label id="lab_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC_documentation_en-US" xlink:label="lab_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Major Customer Number Two [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MajorCustomerNumberTwoMember" xlink:label="loc_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:to="lab_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:type="arc" />
    <link:label id="lab_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC_terseLabel_en-US" xlink:label="lab_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Customer Number Three</link:label>
    <link:label id="lab_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC_label_en-US" xlink:label="lab_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Customer Number Three [Member]</link:label>
    <link:label id="lab_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC_documentation_en-US" xlink:label="lab_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Major Customer Number Three [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MajorCustomerNumberThreeMember" xlink:label="loc_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:to="lab_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F8C4B57E4BAF9BD5B25593AB1BF2026A_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F8C4B57E4BAF9BD5B25593AB1BF2026A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F8C4B57E4BAF9BD5B25593AB1BF2026A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F8C4B57E4BAF9BD5B25593AB1BF2026A" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F8C4B57E4BAF9BD5B25593AB1BF2026A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:to="lab_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:to="lab_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNet_36D5E9A6F3613559BFF790306929370E_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet_36D5E9A6F3613559BFF790306929370E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_36D5E9A6F3613559BFF790306929370E_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet_36D5E9A6F3613559BFF790306929370E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_36D5E9A6F3613559BFF790306929370E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet_36D5E9A6F3613559BFF790306929370E" xlink:to="lab_us-gaap_AccountsReceivableNet_36D5E9A6F3613559BFF790306929370E" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_56C3B6EF76E78564821B90306929F0AE_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_56C3B6EF76E78564821B90306929F0AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_56C3B6EF76E78564821B90306929F0AE_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_56C3B6EF76E78564821B90306929F0AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_56C3B6EF76E78564821B90306929F0AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_56C3B6EF76E78564821B90306929F0AE" xlink:to="lab_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_56C3B6EF76E78564821B90306929F0AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_5ADD3B8DB3138213BEDD903069298843_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_5ADD3B8DB3138213BEDD903069298843" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_5ADD3B8DB3138213BEDD903069298843_label_en-US" xlink:label="lab_us-gaap_InventoryNet_5ADD3B8DB3138213BEDD903069298843" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_5ADD3B8DB3138213BEDD903069298843" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_5ADD3B8DB3138213BEDD903069298843" xlink:to="lab_us-gaap_InventoryNet_5ADD3B8DB3138213BEDD903069298843" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_B67219B9B3DD0C20971790306929D66A_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_B67219B9B3DD0C20971790306929D66A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_B67219B9B3DD0C20971790306929D66A_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_B67219B9B3DD0C20971790306929D66A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_B67219B9B3DD0C20971790306929D66A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_B67219B9B3DD0C20971790306929D66A" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_B67219B9B3DD0C20971790306929D66A" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_DE7CF56AAE5FBD518EC29030692A9613_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_DE7CF56AAE5FBD518EC29030692A9613" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, current portion</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_DE7CF56AAE5FBD518EC29030692A9613" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_DE7CF56AAE5FBD518EC29030692A9613" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_DE7CF56AAE5FBD518EC29030692A9613" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_6CF012907B4FF09900FB9030692A74DF_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_6CF012907B4FF09900FB9030692A74DF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_6CF012907B4FF09900FB9030692A74DF_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_6CF012907B4FF09900FB9030692A74DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_6CF012907B4FF09900FB9030692A74DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_6CF012907B4FF09900FB9030692A74DF" xlink:to="lab_us-gaap_AssetsCurrent_6CF012907B4FF09900FB9030692A74DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3FFAC16FC976C879D2EC9030692ADD78_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_3FFAC16FC976C879D2EC9030692ADD78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3FFAC16FC976C879D2EC9030692ADD78_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_3FFAC16FC976C879D2EC9030692ADD78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3FFAC16FC976C879D2EC9030692ADD78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_3FFAC16FC976C879D2EC9030692ADD78" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_3FFAC16FC976C879D2EC9030692ADD78" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_A05C4D4AC335C46D164A9030692A4B0F_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_A05C4D4AC335C46D164A9030692A4B0F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangibles assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_A05C4D4AC335C46D164A9030692A4B0F_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_A05C4D4AC335C46D164A9030692A4B0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_A05C4D4AC335C46D164A9030692A4B0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_A05C4D4AC335C46D164A9030692A4B0F" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_A05C4D4AC335C46D164A9030692A4B0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_5003C9323AC48A69635D9030692A77A9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_5003C9323AC48A69635D9030692A77A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, net of current portion</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_5003C9323AC48A69635D9030692A77A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_5003C9323AC48A69635D9030692A77A9" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_5003C9323AC48A69635D9030692A77A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_E15F2D48C46E81772D619030692BB90D_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_E15F2D48C46E81772D619030692BB90D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_E15F2D48C46E81772D619030692BB90D_label_en-US" xlink:label="lab_us-gaap_Assets_E15F2D48C46E81772D619030692BB90D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_E15F2D48C46E81772D619030692BB90D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_E15F2D48C46E81772D619030692BB90D" xlink:to="lab_us-gaap_Assets_E15F2D48C46E81772D619030692BB90D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_2F3C781E0B73070117329030692B7F72_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_2F3C781E0B73070117329030692B7F72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_2F3C781E0B73070117329030692B7F72_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_2F3C781E0B73070117329030692B7F72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_2F3C781E0B73070117329030692B7F72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_2F3C781E0B73070117329030692B7F72" xlink:to="lab_us-gaap_AccountsPayableCurrent_2F3C781E0B73070117329030692B7F72" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_FDAC7DF4E1CDC7B7EE129030692CE732_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_FDAC7DF4E1CDC7B7EE129030692CE732" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_FDAC7DF4E1CDC7B7EE129030692CE732_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_FDAC7DF4E1CDC7B7EE129030692CE732" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities and Other Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_FDAC7DF4E1CDC7B7EE129030692CE732" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_FDAC7DF4E1CDC7B7EE129030692CE732" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_FDAC7DF4E1CDC7B7EE129030692CE732" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_9810E10084932D45BF5F9030692C4638_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent_9810E10084932D45BF5F9030692C4638" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_9810E10084932D45BF5F9030692C4638_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent_9810E10084932D45BF5F9030692C4638" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_9810E10084932D45BF5F9030692C4638" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent_9810E10084932D45BF5F9030692C4638" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent_9810E10084932D45BF5F9030692C4638" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtCurrent_53842DA91FF85138D0169030692CF62C_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_53842DA91FF85138D0169030692CF62C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_53842DA91FF85138D0169030692CF62C_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_53842DA91FF85138D0169030692CF62C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_53842DA91FF85138D0169030692CF62C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent_53842DA91FF85138D0169030692CF62C" xlink:to="lab_us-gaap_LongTermDebtCurrent_53842DA91FF85138D0169030692CF62C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_490EB4416D90F24E5F559030692C7D9A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_490EB4416D90F24E5F559030692C7D9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, current portion</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_490EB4416D90F24E5F559030692C7D9A_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_490EB4416D90F24E5F559030692C7D9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_490EB4416D90F24E5F559030692C7D9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_490EB4416D90F24E5F559030692C7D9A" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_490EB4416D90F24E5F559030692C7D9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_089FD6781AFBBC02754A9030692CA3BF_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_089FD6781AFBBC02754A9030692CA3BF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_089FD6781AFBBC02754A9030692CA3BF_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_089FD6781AFBBC02754A9030692CA3BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_089FD6781AFBBC02754A9030692CA3BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_089FD6781AFBBC02754A9030692CA3BF" xlink:to="lab_us-gaap_LiabilitiesCurrent_089FD6781AFBBC02754A9030692CA3BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_E482A8BDA2DB00AFEF0A9030692CD00B_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_E482A8BDA2DB00AFEF0A9030692CD00B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_E482A8BDA2DB00AFEF0A9030692CD00B_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_E482A8BDA2DB00AFEF0A9030692CD00B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_E482A8BDA2DB00AFEF0A9030692CD00B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_E482A8BDA2DB00AFEF0A9030692CD00B" xlink:to="lab_us-gaap_LongTermDebtNoncurrent_E482A8BDA2DB00AFEF0A9030692CD00B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0DFFEBF26E02736CDCC89030692C654C_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0DFFEBF26E02736CDCC89030692C654C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, net of current portion</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0DFFEBF26E02736CDCC89030692C654C_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0DFFEBF26E02736CDCC89030692C654C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0DFFEBF26E02736CDCC89030692C654C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0DFFEBF26E02736CDCC89030692C654C" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0DFFEBF26E02736CDCC89030692C654C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_2FCD883A781BE5C7E92F9030692D77A4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_2FCD883A781BE5C7E92F9030692D77A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_2FCD883A781BE5C7E92F9030692D77A4_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_2FCD883A781BE5C7E92F9030692D77A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2FCD883A781BE5C7E92F9030692D77A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2FCD883A781BE5C7E92F9030692D77A4" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_2FCD883A781BE5C7E92F9030692D77A4" xlink:type="arc" />
    <link:label id="lab_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5_terseLabel_en-US" xlink:label="lab_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License obligations</link:label>
    <link:label id="lab_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5_label_en-US" xlink:label="lab_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Obligation, Noncurrent</link:label>
    <link:label id="lab_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5_documentation_en-US" xlink:label="lab_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Obligation, Noncurrent</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseObligationNoncurrent" xlink:label="loc_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5" xlink:to="lab_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_EE5E46715CB3E0803DBE9030692D3935_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_EE5E46715CB3E0803DBE9030692D3935" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_EE5E46715CB3E0803DBE9030692D3935_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_EE5E46715CB3E0803DBE9030692D3935" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_EE5E46715CB3E0803DBE9030692D3935" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_EE5E46715CB3E0803DBE9030692D3935" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_EE5E46715CB3E0803DBE9030692D3935" xlink:type="arc" />
    <link:label id="lab_us-gaap_Liabilities_57AE9ECB3ED871E839FD9030692D50F8_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities_57AE9ECB3ED871E839FD9030692D50F8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_57AE9ECB3ED871E839FD9030692D50F8_label_en-US" xlink:label="lab_us-gaap_Liabilities_57AE9ECB3ED871E839FD9030692D50F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_57AE9ECB3ED871E839FD9030692D50F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_57AE9ECB3ED871E839FD9030692D50F8" xlink:to="lab_us-gaap_Liabilities_57AE9ECB3ED871E839FD9030692D50F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:to="lab_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_261500EB6CA8E55923569030692E3423_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_261500EB6CA8E55923569030692E3423" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock&#8212;$0.001 par value; 200,000,000 shares authorized at March 31, 2019 and December 31, 2018; 42,753,659 and 40,804,189 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_261500EB6CA8E55923569030692E3423_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_261500EB6CA8E55923569030692E3423" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_261500EB6CA8E55923569030692E3423" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_261500EB6CA8E55923569030692E3423" xlink:to="lab_us-gaap_CommonStockValue_261500EB6CA8E55923569030692E3423" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_5091683945F3D1FF2E3E9030692D6016_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_5091683945F3D1FF2E3E9030692D6016" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock&#8212;$0.001 par value; 5,000,000 shares authorized at March 31, 2019 and December 31, 2018; 2,857,143 shares issued and outstanding at March 31, 2019 and December 31, 2018</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_5091683945F3D1FF2E3E9030692D6016_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_5091683945F3D1FF2E3E9030692D6016" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_5091683945F3D1FF2E3E9030692D6016" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_5091683945F3D1FF2E3E9030692D6016" xlink:to="lab_us-gaap_PreferredStockValue_5091683945F3D1FF2E3E9030692D6016" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_2E566F9C2C27D3ACEBB49030692EAD1A_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital_2E566F9C2C27D3ACEBB49030692EAD1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_2E566F9C2C27D3ACEBB49030692EAD1A_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital_2E566F9C2C27D3ACEBB49030692EAD1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2E566F9C2C27D3ACEBB49030692EAD1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_2E566F9C2C27D3ACEBB49030692EAD1A" xlink:to="lab_us-gaap_AdditionalPaidInCapital_2E566F9C2C27D3ACEBB49030692EAD1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_8F29F45832AFCE11BBA09030692E933E_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_8F29F45832AFCE11BBA09030692E933E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_8F29F45832AFCE11BBA09030692E933E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_8F29F45832AFCE11BBA09030692E933E" xlink:to="lab_us-gaap_StockholdersEquity_8F29F45832AFCE11BBA09030692E933E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_5305113B0B0628AF616E9030692F6C42_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_5305113B0B0628AF616E9030692F6C42" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_5305113B0B0628AF616E9030692F6C42_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_5305113B0B0628AF616E9030692F6C42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5305113B0B0628AF616E9030692F6C42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5305113B0B0628AF616E9030692F6C42" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_5305113B0B0628AF616E9030692F6C42" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_90600D49104FEA4C28908DD52964D53E_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_90600D49104FEA4C28908DD52964D53E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_90600D49104FEA4C28908DD52964D53E_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_90600D49104FEA4C28908DD52964D53E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_90600D49104FEA4C28908DD52964D53E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_90600D49104FEA4C28908DD52964D53E" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_90600D49104FEA4C28908DD52964D53E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_6F64B0574BE9DA47B54798E1726BC788_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_6F64B0574BE9DA47B54798E1726BC788" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_6F64B0574BE9DA47B54798E1726BC788_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_6F64B0574BE9DA47B54798E1726BC788" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_6F64B0574BE9DA47B54798E1726BC788" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_6F64B0574BE9DA47B54798E1726BC788" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_6F64B0574BE9DA47B54798E1726BC788" xlink:type="arc" />
    <link:label id="lab_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D_label_en-US" xlink:label="lab_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document and Entity Information</link:label>
    <link:label id="lab_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D_documentation_en-US" xlink:label="lab_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_DocumentAndEntityInformationAbstract" xlink:label="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="lab_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_06928316E0CC9131D1BD90302CE0F7DB_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_06928316E0CC9131D1BD90302CE0F7DB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_06928316E0CC9131D1BD90302CE0F7DB_label_en-US" xlink:label="lab_dei_EntityRegistrantName_06928316E0CC9131D1BD90302CE0F7DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_06928316E0CC9131D1BD90302CE0F7DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_06928316E0CC9131D1BD90302CE0F7DB" xlink:to="lab_dei_EntityRegistrantName_06928316E0CC9131D1BD90302CE0F7DB" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_F8D7D10F49F8A3712EE990302CE14F06_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_F8D7D10F49F8A3712EE990302CE14F06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_F8D7D10F49F8A3712EE990302CE14F06_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_F8D7D10F49F8A3712EE990302CE14F06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_F8D7D10F49F8A3712EE990302CE14F06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_F8D7D10F49F8A3712EE990302CE14F06" xlink:to="lab_dei_EntityCentralIndexKey_F8D7D10F49F8A3712EE990302CE14F06" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3182DC4B2E799EE6CD3E90302CE1F951_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_3182DC4B2E799EE6CD3E90302CE1F951" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3182DC4B2E799EE6CD3E90302CE1F951_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_3182DC4B2E799EE6CD3E90302CE1F951" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_3182DC4B2E799EE6CD3E90302CE1F951" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_3182DC4B2E799EE6CD3E90302CE1F951" xlink:to="lab_dei_CurrentFiscalYearEndDate_3182DC4B2E799EE6CD3E90302CE1F951" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_81F1055007CAFA8EA45690302CE1A14F_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_81F1055007CAFA8EA45690302CE1A14F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_81F1055007CAFA8EA45690302CE1A14F_label_en-US" xlink:label="lab_dei_EntityFilerCategory_81F1055007CAFA8EA45690302CE1A14F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_81F1055007CAFA8EA45690302CE1A14F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_81F1055007CAFA8EA45690302CE1A14F" xlink:to="lab_dei_EntityFilerCategory_81F1055007CAFA8EA45690302CE1A14F" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_53D2191C1A3A8C54C5C690302D7A3EE8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_53D2191C1A3A8C54C5C690302D7A3EE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_53D2191C1A3A8C54C5C690302D7A3EE8_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_53D2191C1A3A8C54C5C690302D7A3EE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_53D2191C1A3A8C54C5C690302D7A3EE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_53D2191C1A3A8C54C5C690302D7A3EE8" xlink:to="lab_dei_EntityEmergingGrowthCompany_53D2191C1A3A8C54C5C690302D7A3EE8" xlink:type="arc" />
    <link:label id="lab_dei_EntitySmallBusiness_EB24641BFB63E231470190302D81826F_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness_EB24641BFB63E231470190302D81826F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_EB24641BFB63E231470190302D81826F_label_en-US" xlink:label="lab_dei_EntitySmallBusiness_EB24641BFB63E231470190302D81826F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_EB24641BFB63E231470190302D81826F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_EB24641BFB63E231470190302D81826F" xlink:to="lab_dei_EntitySmallBusiness_EB24641BFB63E231470190302D81826F" xlink:type="arc" />
    <link:label id="lab_dei_EntityExTransitionPeriod_CF3D99AE47FEDE29B14790302D84F40E_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod_CF3D99AE47FEDE29B14790302D84F40E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_CF3D99AE47FEDE29B14790302D84F40E_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod_CF3D99AE47FEDE29B14790302D84F40E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_CF3D99AE47FEDE29B14790302D84F40E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_CF3D99AE47FEDE29B14790302D84F40E" xlink:to="lab_dei_EntityExTransitionPeriod_CF3D99AE47FEDE29B14790302D84F40E" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_90FF1A66207600FA29F890302CE1741E_terseLabel_en-US" xlink:label="lab_dei_DocumentType_90FF1A66207600FA29F890302CE1741E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_90FF1A66207600FA29F890302CE1741E_label_en-US" xlink:label="lab_dei_DocumentType_90FF1A66207600FA29F890302CE1741E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_90FF1A66207600FA29F890302CE1741E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_90FF1A66207600FA29F890302CE1741E" xlink:to="lab_dei_DocumentType_90FF1A66207600FA29F890302CE1741E" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_B42E889EFC3A3310103690302CE139E5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_B42E889EFC3A3310103690302CE139E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_B42E889EFC3A3310103690302CE139E5_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_B42E889EFC3A3310103690302CE139E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_B42E889EFC3A3310103690302CE139E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_B42E889EFC3A3310103690302CE139E5" xlink:to="lab_dei_DocumentPeriodEndDate_B42E889EFC3A3310103690302CE139E5" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_57A867A7DC3CFA3B0DF990302CE14256_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_57A867A7DC3CFA3B0DF990302CE14256" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_57A867A7DC3CFA3B0DF990302CE14256_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_57A867A7DC3CFA3B0DF990302CE14256" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_57A867A7DC3CFA3B0DF990302CE14256" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_57A867A7DC3CFA3B0DF990302CE14256" xlink:to="lab_dei_DocumentFiscalYearFocus_57A867A7DC3CFA3B0DF990302CE14256" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_B63029151C37D9A5DCBB90302CE24479_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_B63029151C37D9A5DCBB90302CE24479" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_B63029151C37D9A5DCBB90302CE24479_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_B63029151C37D9A5DCBB90302CE24479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_B63029151C37D9A5DCBB90302CE24479" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_B63029151C37D9A5DCBB90302CE24479" xlink:to="lab_dei_DocumentFiscalPeriodFocus_B63029151C37D9A5DCBB90302CE24479" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_A45EFC952DF7F8DE261690302CE274F2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_A45EFC952DF7F8DE261690302CE274F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_A45EFC952DF7F8DE261690302CE274F2_label_en-US" xlink:label="lab_dei_AmendmentFlag_A45EFC952DF7F8DE261690302CE274F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_A45EFC952DF7F8DE261690302CE274F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_A45EFC952DF7F8DE261690302CE274F2" xlink:to="lab_dei_AmendmentFlag_A45EFC952DF7F8DE261690302CE274F2" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_3DF2F546F8BE84A2280490302CE2D5A7_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_3DF2F546F8BE84A2280490302CE2D5A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_3DF2F546F8BE84A2280490302CE2D5A7_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_3DF2F546F8BE84A2280490302CE2D5A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3DF2F546F8BE84A2280490302CE2D5A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_3DF2F546F8BE84A2280490302CE2D5A7" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_3DF2F546F8BE84A2280490302CE2D5A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:to="lab_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:to="lab_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:type="arc" />
    <link:label id="lab_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94_terseLabel_en-US" xlink:label="lab_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deerfield Obligation</link:label>
    <link:label id="lab_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94_label_en-US" xlink:label="lab_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deerfield Obligation [Member]</link:label>
    <link:label id="lab_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94_documentation_en-US" xlink:label="lab_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deerfield Obligation [Member]</link:label>
    <link:loc xlink:href="cerc-20190331.xsd#cerc_DeerfieldObligationMember" xlink:label="loc_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:to="lab_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="lab_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balloon payment to be paid</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deerfield Obligation</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>cerc-20190331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="cerc-20190331.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="cerc-20190331.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="cerc-20190331.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/Acquisitions" xlink:href="cerc-20190331.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsNarrativeDetails" xlink:href="cerc-20190331.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsProFormaInformationDetails" xlink:href="cerc-20190331.xsd#AcquisitionsProFormaInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" xlink:href="cerc-20190331.xsd#AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfConsiderationTransferredDetails" xlink:href="cerc-20190331.xsd#AcquisitionsScheduleOfConsiderationTransferredDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" xlink:href="cerc-20190331.xsd#AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/AcquisitionsTables" xlink:href="cerc-20190331.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:href="cerc-20190331.xsd#BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/Business" xlink:href="cerc-20190331.xsd#Business" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/BusinessDetails" xlink:href="cerc-20190331.xsd#BusinessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructure" xlink:href="cerc-20190331.xsd#CapitalStructure" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructureCommonStockDetails" xlink:href="cerc-20190331.xsd#CapitalStructureCommonStockDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructureTables" xlink:href="cerc-20190331.xsd#CapitalStructureTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CapitalStructureWarrantsDetails" xlink:href="cerc-20190331.xsd#CapitalStructureWarrantsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingencies" xlink:href="cerc-20190331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesDetails" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetails" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesMinimumFutureObligationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CommitmentsAndContingenciesTables" xlink:href="cerc-20190331.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cerc-20190331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cerc-20190331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="cerc-20190331.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="cerc-20190331.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="cerc-20190331.xsd#ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/DeerfieldObligation" xlink:href="cerc-20190331.xsd#DeerfieldObligation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/DeerfieldObligationNarrativeDetails" xlink:href="cerc-20190331.xsd#DeerfieldObligationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/DocumentAndEntityInformation" xlink:href="cerc-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurements" xlink:href="cerc-20190331.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsDetails" xlink:href="cerc-20190331.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="cerc-20190331.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsRollforwardDetails" xlink:href="cerc-20190331.xsd#FairValueMeasurementsRollforwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/FairValueMeasurementsTables" xlink:href="cerc-20190331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/IncomeTaxes" xlink:href="cerc-20190331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/IncomeTaxesDetails" xlink:href="cerc-20190331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/Leases" xlink:href="cerc-20190331.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesAssetsAndLiabilitiesDetails" xlink:href="cerc-20190331.xsd#LeasesAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesLeaseCostDetails" xlink:href="cerc-20190331.xsd#LeasesLeaseCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesLeaseMaturityDetails" xlink:href="cerc-20190331.xsd#LeasesLeaseMaturityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesNarrativeDetails" xlink:href="cerc-20190331.xsd#LeasesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/LeasesTables" xlink:href="cerc-20190331.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShare" xlink:href="cerc-20190331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareAntiDilutiveSecuritiesDetails" xlink:href="cerc-20190331.xsd#NetLossPerShareAntiDilutiveSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareNarrativeDetails" xlink:href="cerc-20190331.xsd#NetLossPerShareNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareOfCommonStockBasicAndDilutedTables" xlink:href="cerc-20190331.xsd#NetLossPerShareOfCommonStockBasicAndDilutedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/NetLossPerShareScheduleOfEarningsPerShareDetails" xlink:href="cerc-20190331.xsd#NetLossPerShareScheduleOfEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomers" xlink:href="cerc-20190331.xsd#RevenueFromContractsWithCustomers" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomersDetails" xlink:href="cerc-20190331.xsd#RevenueFromContractsWithCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/RevenueFromContractsWithCustomersTables" xlink:href="cerc-20190331.xsd#RevenueFromContractsWithCustomersTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/SignificantAccountingPoliciesDetails" xlink:href="cerc-20190331.xsd#SignificantAccountingPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/SignificantAccountingPoliciesPolicies" xlink:href="cerc-20190331.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/StockBasedCompensation" xlink:href="cerc-20190331.xsd#StockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/StockBasedCompensationDetails" xlink:href="cerc-20190331.xsd#StockBasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cerecor.com/role/StockBasedCompensationTables" xlink:href="cerc-20190331.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_B1BDF083A571BF1407428DD52964344A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_90600D49104FEA4C28908DD52964D53E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_B1BDF083A571BF1407428DD52964344A" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_90600D49104FEA4C28908DD52964D53E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedSalesReturnsAndAllowances" xlink:label="loc_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="loc_cerc_AccruedSalesReturnsAndAllowances_29D89C7C45C8F0C0230C93BC7ABB622E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedMedicaidRebates" xlink:label="loc_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="loc_cerc_AccruedMedicaidRebates_314F7D92A7679114ACFE941DA936C210" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent" xlink:label="loc_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="loc_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent_6A28D01778B1C6D878A393BC7ABB7C0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_A2CB3555F3DD7EE9CAC393BC7ABBC213" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_A2CB3555F3DD7EE9CAC393BC7ABBC213" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedResearchAndDevelopmentExpenses" xlink:label="loc_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="loc_cerc_AccruedResearchAndDevelopmentExpenses_07369E49D0B5F1A41F3B93BC7ABB78A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_6AAC392350DB36A30DF1941EB1671FE5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_6AAC392350DB36A30DF1941EB1671FE5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedGeneralAndAdministrativeExpenses" xlink:label="loc_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="loc_cerc_AccruedGeneralAndAdministrativeExpenses_C37DC9C9C8EE329A721D93BC7ABBF94E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_605773B8BF26F8E5D08793BC7ABB8136" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_605773B8BF26F8E5D08793BC7ABB8136" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AccruedLiabilitiesAndOtherCurrentLiabilities" xlink:label="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_26DAC072F655C6037C9F93BC7ABA7C67" xlink:to="loc_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities_9E6A6D36390DE33F5EC293BC7ABCB75D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_8E261CCFDD111175003C8DD528606996" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock" xlink:label="loc_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_8E261CCFDD111175003C8DD528606996" xlink:to="loc_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock_03445ACFC6E0DB8497F28DD52860F7EB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract" xlink:label="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_C53F366913D900B133A98E7976CDABFF" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock" xlink:label="loc_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_C53F366913D900B133A98E7976CDABFF" xlink:to="loc_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock_A40F9C74059F9A1D64C88E7976CDF5D0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract" xlink:label="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_83CD7800365D16D69BC59459811B68B7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_83CD7800365D16D69BC59459811B68B7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneAxis" xlink:label="loc_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneDomain" xlink:label="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_MilestoneAxis_5ECB962738D61BEB312A9459811BBBEC" xlink:to="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneOneMember" xlink:label="loc_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:to="loc_cerc_MilestoneOneMember_CD644DEED07B8535ADE79459811C46D2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneTwoMember" xlink:label="loc_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:to="loc_cerc_MilestoneTwoMember_ED9B007C39CBA57B38FA9459811C27B9" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneThreeMember" xlink:label="loc_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_MilestoneDomain_976296693067C26E94D29459811B030E" xlink:to="loc_cerc_MilestoneThreeMember_CE5A51AB2DACB5FCDF2D9459811CAF6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_342C885938CE509F19EE9459811CB9C8" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_FC3F1927D14E3AB506259459811CFF9E" xlink:to="loc_us-gaap_ScenarioForecastMember_D9A1AF01C33F096F361B9459811DEDED" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionAxis" xlink:label="loc_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionDomain" xlink:label="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_AssetAcquisitionAxis_45935AC0823E838B77849459811DFF75" xlink:to="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_IchorionMember" xlink:label="loc_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_AssetAcquisitionDomain_B62BBD770F54F54246AB9459811D0521" xlink:to="loc_cerc_IchorionMember_E6399F7B4290F19553C09459811D7782" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_CDBC0A9E34660D7DCF409459811E6EC6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_CDBC0A9E34660D7DCF409459811E6EC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_59DE8011A44AE47258D29459811E277F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_CDBC0A9E34660D7DCF409459811E6EC6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_59DE8011A44AE47258D29459811E277F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_59DE8011A44AE47258D29459811E277F" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_98A6F96FF52BE451B4C99459811EF5C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B3113B9D4B324C325C649459811E2C66" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B3113B9D4B324C325C649459811E2C66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07EE80919C21DEBAB3839459811EB2D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B3113B9D4B324C325C649459811E2C66" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07EE80919C21DEBAB3839459811EB2D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_A0AA1291D3AB32F83A499459811F8128" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07EE80919C21DEBAB3839459811EB2D4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_A0AA1291D3AB32F83A499459811F8128" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_F90570639BF3F0D8CD279459811F6E91" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_dei_LegalEntityAxis_F90570639BF3F0D8CD279459811F6E91" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_D1FFD1F2E559259EF26E9459811F5868" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_F90570639BF3F0D8CD279459811F6E91" xlink:to="loc_dei_EntityDomain_D1FFD1F2E559259EF26E9459811F5868" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_5936FE2380378E846C329459811FE5DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_D1FFD1F2E559259EF26E9459811F5868" xlink:to="loc_cerc_TRxMember_5936FE2380378E846C329459811FE5DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A2A2AFC63805BB3EC530945981207AD6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A2A2AFC63805BB3EC530945981207AD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A2A2AFC63805BB3EC530945981207AD6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssembledWorkforceMember" xlink:label="loc_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF" xlink:to="loc_cerc_AssembledWorkforceMember_A444588FDFDB319D9570945E489729B7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PAISalesAndMarketingAgreementMember" xlink:label="loc_cerc_PAISalesAndMarketingAgreementMember_E1F812401C2B2FA72007945981205457" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_AF154EC37A53F9216596945981207EDF" xlink:to="loc_cerc_PAISalesAndMarketingAgreementMember_E1F812401C2B2FA72007945981205457" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_D942C80DB99A15F837C09459812036B2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_D942C80DB99A15F837C09459812036B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D942C80DB99A15F837C09459812036B2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AvadelMember" xlink:label="loc_cerc_AvadelMember_6BD94B63D471A35A9064945981217667" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E" xlink:to="loc_cerc_AvadelMember_6BD94B63D471A35A9064945981217667" xlink:type="arc" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3AFF7929C704B8173E5294598120BA2E" xlink:to="loc_cerc_TRxMember_5936FE2380378E846C329459811FE5DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1BE6288DE9BE9AE556369459811B3E44" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C3A20D7808A5F2669BD194598121F801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_EE41FD03044CA8A3E4C094598122DAB6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionContingentConsiderationLiability" xlink:label="loc_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionContingentConsiderationLiability_F96D8931118E9791A6209459812219AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_494D47514BECC77607AC94598122A53F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionResearchAndDevelopmentInProcess" xlink:label="loc_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionResearchAndDevelopmentInProcess_192CD63962AD8CCEC7DF94598122F955" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_D42D8E72E5154CF58E53945981220A53" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfPreclinicalTherapies" xlink:label="loc_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_NumberOfPreclinicalTherapies_DD63510B7F9688E9DB9D945981229D21" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionsTransactionCosts" xlink:label="loc_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionsTransactionCosts_8287A09334E4B042528A9459812314EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EAD1CE089C9B97253A61945981237F79" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones" xlink:label="loc_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones_7991DF817DC98A7796C59459812337CF" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities" xlink:label="loc_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities_9747A785FFF027A56D849459812305DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_14E20518D9912D084F8B945981230A42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B655D23B8FC24C10898794598123D549" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B655D23B8FC24C10898794598123D549" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_DE31DA7DDC35BF5B1A509459812449E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_Goodwill_4AB96CE91D17ED3111269459812412AB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod" xlink:label="loc_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod_593DE02B8F8002952AF7945981247D72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2AA66666E7E1B5952B18945981246DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_30551C77F632CD01152E9459812405EF" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued" xlink:label="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_97FC5832CDED1988DF5094598125092B" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares" xlink:label="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_AE76214FA67BA58229E794598125762F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6DDD98660EDA62FBBD1494598125FDFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_361E709481E5D496049C945981251A3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_64BEE9C3E1EE12128C8194598121915C" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1E2690D7798D9C8C277E94598125CEC8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/AcquisitionsProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract" xlink:label="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_7AD2DC5DDCFF417A7DCD98A29C644CE1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BA61696FB4D5B704341B98A29C6546F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_7AD2DC5DDCFF417A7DCD98A29C644CE1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BA61696FB4D5B704341B98A29C6546F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_E83B9C61F2420E81110E98A29C65D8CE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BA61696FB4D5B704341B98A29C6546F3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_E83B9C61F2420E81110E98A29C65D8CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_E83B9C61F2420E81110E98A29C65D8CE" xlink:to="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC" xlink:to="loc_us-gaap_CommonStockMember_BCBA99C2FA1A2210EFD098A29C6639F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_08337DA35D76E005C5FB98A29C66A137" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4CD1BB4E253EF0E0F59E98A29C65DDFC" xlink:to="loc_us-gaap_PreferredStockMember_08337DA35D76E005C5FB98A29C66A137" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_CA58A6ABBBFB2EEE536F98A29C66DA33" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BA61696FB4D5B704341B98A29C6546F3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_CA58A6ABBBFB2EEE536F98A29C66DA33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2C00268DBB384E0B1F4A98A29C669489" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_CA58A6ABBBFB2EEE536F98A29C66DA33" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2C00268DBB384E0B1F4A98A29C669489" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_EE8CFA7AE73B321EAA8598A29C668158" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2C00268DBB384E0B1F4A98A29C669489" xlink:to="loc_cerc_TRxMember_EE8CFA7AE73B321EAA8598A29C668158" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BA61696FB4D5B704341B98A29C6546F3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_FF978743A272907E551B98A29C67D4AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75FDE330BC443BDBB62698A29C67D8AC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted" xlink:label="loc_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FEF3B5D5064B6301964E98A29C673A82" xlink:to="loc_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted_49C10BDB2A6B71F1C3AF98A29C678869" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/AcquisitionsScheduleOfAllocationOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract" xlink:label="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_CC0EA3C3CEDF4D2A42EC9030688C1DAE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_CC0EA3C3CEDF4D2A42EC9030688C1DAE" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_073A0F47EC8AF36F08719030688C384D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:to="loc_srt_RestatementAxis_073A0F47EC8AF36F08719030688C384D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_402F289736B160DA1D449030688DC264" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_073A0F47EC8AF36F08719030688C384D" xlink:to="loc_srt_RestatementDomain_402F289736B160DA1D449030688DC264" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_B134973455FAB516DAF79030688DFD33" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_402F289736B160DA1D449030688DC264" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_B134973455FAB516DAF79030688DFD33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_79AE043A5C322EBAC8589030688DC601" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:to="loc_srt_ProductOrServiceAxis_79AE043A5C322EBAC8589030688DC601" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_79AE043A5C322EBAC8589030688DC601" xlink:to="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MetafolinMember" xlink:label="loc_cerc_MetafolinMember_AFE6E9449BBA1D8664009030688EF4F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:to="loc_cerc_MetafolinMember_AFE6E9449BBA1D8664009030688EF4F7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MillipredMember" xlink:label="loc_cerc_MillipredMember_AB0060EC7F63A0E7D2189030688E88DE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:to="loc_cerc_MillipredMember_AB0060EC7F63A0E7D2189030688E88DE" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaMember" xlink:label="loc_cerc_UlesfiaMember_87A7B1B6F66AB5E252F09030688EAAC7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9A0301BC8F1DE83051289030688D0B4D" xlink:to="loc_cerc_UlesfiaMember_87A7B1B6F66AB5E252F09030688EAAC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FBD20FB1F64C46A96A4A9030688EEB50" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FBD20FB1F64C46A96A4A9030688EEB50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_FBD20FB1F64C46A96A4A9030688EEB50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AcquiredProductMarketingMember" xlink:label="loc_cerc_AcquiredProductMarketingMember_241CC1EFA3F85FA71B249030688FE68D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4" xlink:to="loc_cerc_AcquiredProductMarketingMember_241CC1EFA3F85FA71B249030688FE68D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PAISalesAndMarketingAgreementMember" xlink:label="loc_cerc_PAISalesAndMarketingAgreementMember_A987B876764000A21D7A9030688F8631" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C33B088616852F49CBD79030688EEEC4" xlink:to="loc_cerc_PAISalesAndMarketingAgreementMember_A987B876764000A21D7A9030688F8631" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_C068876274B241FF251A9030688FD049" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_C068876274B241FF251A9030688FD049" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C068876274B241FF251A9030688FD049" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AvadelMember" xlink:label="loc_cerc_AvadelMember_06E4086A29461AC1DBBA90306890648D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72" xlink:to="loc_cerc_AvadelMember_06E4086A29461AC1DBBA90306890648D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_2D0BF963FD87C8E6D8EC90306890E9C8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6C5E7A4B1D67B20352219030688FFF72" xlink:to="loc_cerc_TRxMember_2D0BF963FD87C8E6D8EC90306890E9C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_F555D5DB79CBAA1942BC9030688C12D6" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_68A53DB1FAEA6598AC0690306890C404" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_D98869EF5389F2B7BE8890306890D065" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_F4BBAC68D4EC273B3387903068912F9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5BD6F163E72375E5461C9030689167C3" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:label="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_EE03ED766AA32FBC61BB9030689180D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7590632D72724B7D5A739030689199AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_EF185CBC4080526E2A599030689168EA" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7590632D72724B7D5A739030689199AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_EA3DBA616C6B458CAC0690306892A81B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_42AD5BD345E4000E2C73903068921C7D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities_9A4E4242B4B613A80103903068925C65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0843EE1E31BBD0E0D4C890306892FF83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B32C0811B2A1F249E64E90306892F7A4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_B32C0811B2A1F249E64E90306892F7A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_43D79708F32DC0DCFE9D90306893EAB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_F4E2BC8C4FB3607FF864903068921C0E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7C80E9B45DD7372ACAFC90306893AF06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_324C3B13C8C0EC18BE3B90306893CAD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1A760D6DDE9EC14655A490306893F337" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_E1BAC71F3C68B32E836F903068939B97" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_Goodwill_E1BAC71F3C68B32E836F903068939B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_819F8710783B40C5BD38903068906EA2" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_FC59596C5593B424CC6890306894A4F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_8FB4924B7606F4E14DB89030689403A2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets_2966CEBF72FA6C64650090306894C874" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables" xlink:label="loc_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables_EEF9A8040CA8290F234390306894681D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_9AB1FC0A4121FC6D3A11903068946BD1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_9AB1FC0A4121FC6D3A11903068946BD1" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_DA2481126E4F8C2BAD5F90306894DBA1" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_BA6163BDBE7742F0A68890306895B8D7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_08A89EEBF21EDDE0BD7090306895F4C3" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_05D7ECDC640CA493BC409030689568FD" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt_D9C1CBBB1DBB6EC8E7BD90306895119F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_6781CC75B6400B506BB490306895ECC6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_FEA50318E6B14011C7B090306895C117" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities_DEAD82FA59968D34765790306896D089" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_59662C6FD2258130A16590306896E34D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_20D1A0A2FEEE540098FA903068936582" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_177854F50A074E5A9C0790306896C299" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/AcquisitionsScheduleOfConsiderationTransferredDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract" xlink:label="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_A7BF53A227EFC8790CDD90306878E75D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_82BFCDD9A7FDBB281D3D90306878BFAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_A7BF53A227EFC8790CDD90306878E75D" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_82BFCDD9A7FDBB281D3D90306878BFAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_12B4E0407CA35B1535E190306878AF3E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_82BFCDD9A7FDBB281D3D90306878BFAE" xlink:to="loc_srt_RestatementAxis_12B4E0407CA35B1535E190306878AF3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1563CA83A0427040320790306879E02D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_12B4E0407CA35B1535E190306878AF3E" xlink:to="loc_srt_RestatementDomain_1563CA83A0427040320790306879E02D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_DFE58D6B934244A71EFA9030687926E5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_1563CA83A0427040320790306879E02D" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_DFE58D6B934244A71EFA9030687926E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_294229ECB1F5983B47BE90306879F713" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_82BFCDD9A7FDBB281D3D90306878BFAE" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_294229ECB1F5983B47BE90306879F713" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_574BCE616ABE6DD6B6A090306879A95C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_294229ECB1F5983B47BE90306879F713" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_574BCE616ABE6DD6B6A090306879A95C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_3FFD9CDBC0DC3760159B903068794202" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_574BCE616ABE6DD6B6A090306879A95C" xlink:to="loc_cerc_TRxMember_3FFD9CDBC0DC3760159B903068794202" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_82BFCDD9A7FDBB281D3D90306878BFAE" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_F7FED8506B883BD4310F9030687AC39D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_F7FED8506B883BD4310F9030687AC39D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_F085FB78FAF711B145EA9030687A491A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_F085FB78FAF711B145EA9030687A491A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3EEB4CD9C493290CFF5D9030687AB316" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3EEB4CD9C493290CFF5D9030687AB316" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_312A4B5BC575EF4381FA9030687A212D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_312A4B5BC575EF4381FA9030687A212D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability" xlink:label="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_3B2526A1BE0ED2E1668E9030687BBEB7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability_3B2526A1BE0ED2E1668E9030687BBEB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_3DD976E879F7336CA28B9030687B7A06" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_DCA8486721CFB427D6F69030687A3AE7" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_3DD976E879F7336CA28B9030687B7A06" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract" xlink:label="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_DC21EBE6939D53147CF693BC7AF84438" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_DC21EBE6939D53147CF693BC7AF84438" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="loc_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_D31DAF475F6675BAE86893BC7AF8F928" xlink:to="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_6087AA071A6675A0340D93BC7AF809B1" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_2051E7136DDE611E58CB93BC7AF9C91E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="loc_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9CC59730462A58D7512393BC7AF9AE77" xlink:to="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_KarbinalMember" xlink:label="loc_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_KarbinalMember_32F52E99E5D4B62C261B93BC7AF9B9FC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AcipHexMember" xlink:label="loc_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_AcipHexMember_F10A70AB177FAC0CEAAE93BC7AFAD364" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CefaclorMember" xlink:label="loc_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_CefaclorMember_B926657A8446E5C3E92093BC7AFAE091" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FlexichamberMember" xlink:label="loc_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_FlexichamberMember_D68DFFB710208D6CCBBA93BC7AFA581B" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LiquiTimeProcessMember" xlink:label="loc_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_LiquiTimeProcessMember_95A735A5CC902754237593BC7AFAC726" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MetafolinMember" xlink:label="loc_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_MetafolinMember_3FF2C4E7BC39200CE16093BC7AFACA6A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MillipredMember" xlink:label="loc_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_MillipredMember_D789376B1FB8C67FA92D93BC7AFA3FCB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaMember" xlink:label="loc_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ACC92E2FD879115829BD93BC7AF9C295" xlink:to="loc_cerc_UlesfiaMember_71B81F54AA9838E037C693BC7AFAB65A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DDA6F2ECF20DFE72091C93BC7AFBAD83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AcquiredProductMarketingMember" xlink:label="loc_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:to="loc_cerc_AcquiredProductMarketingMember_DD63F28FAB509FC94B7C93BC7AFB855E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_18A991B1E1099D75D91993BC7AFB2A2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_2CCE7AFCD208125FF86093BC7AFB88F0" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PAISalesAndMarketingAgreementMember" xlink:label="loc_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9C764BE505661C1BFA7493BC7AFB2D0A" xlink:to="loc_cerc_PAISalesAndMarketingAgreementMember_106D59D6017148582A8193BC7AFCE080" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D6F641711706B53C03E493BC7AFC08CB" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AvadelMember" xlink:label="loc_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:to="loc_cerc_AvadelMember_BFB04C6F53573371161B93BC7AFC5790" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_449B2506D31DF11B461493BC7AFCFEF8" xlink:to="loc_cerc_TRxMember_74868885C377E39C323C93BC7AFD1D4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06AE2E198493404FE23193BC7AF8050D" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1E1A95679F21349855A293BC7AFD0A2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_4B16BD73355655458C6193BC7AFDCD9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B1311C978FC6AD3928AB93BC7AFDE908" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_663B64B7846FCD37C65793BC7AFDB63C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract" xlink:label="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_5228EDD6B4A96DCCBC6D93BC7B331B82" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_CE4A086B78149E65B1E093BC7B333B64" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_5228EDD6B4A96DCCBC6D93BC7B331B82" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_CE4A086B78149E65B1E093BC7B333B64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_9D66899C31C0CF2C8D8E93BC7B346FA0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_5228EDD6B4A96DCCBC6D93BC7B331B82" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_9D66899C31C0CF2C8D8E93BC7B346FA0" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock" xlink:label="loc_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_5228EDD6B4A96DCCBC6D93BC7B331B82" xlink:to="loc_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock_0B51B890E50C7CCE6BA293BC7B34DDB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_29429767FD538B56312993BC7B34B856" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract_5228EDD6B4A96DCCBC6D93BC7B331B82" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_29429767FD538B56312993BC7B34B856" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_B1BCA9AA33A8F554CEC498E172FAAB17" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_76D0C536177A4455836098E172FB1A52" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_B1BCA9AA33A8F554CEC498E172FAAB17" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_76D0C536177A4455836098E172FB1A52" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/Business" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_A1114EDD36A0505862CE8DD5284166EF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_2BBEF09745609F1369EF8DD528417FE5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_A1114EDD36A0505862CE8DD5284166EF" xlink:to="loc_us-gaap_NatureOfOperations_2BBEF09745609F1369EF8DD528417FE5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/BusinessDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_932A901A90733A05A871938D56974A5D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_932A901A90733A05A871938D56974A5D" xlink:to="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_44C5F40655B0FF5E466D9395AAC143F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="loc_srt_CounterpartyNameAxis_44C5F40655B0FF5E466D9395AAC143F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_F184027F69FBCA3F6B659395AAC2F44A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_44C5F40655B0FF5E466D9395AAC143F1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_F184027F69FBCA3F6B659395AAC2F44A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ArmisticeMember" xlink:label="loc_cerc_ArmisticeMember_B413260CBFA8E7B7230B9396382A3016" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_F184027F69FBCA3F6B659395AAC2F44A" xlink:to="loc_cerc_ArmisticeMember_B413260CBFA8E7B7230B9396382A3016" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1A262348EBD3FF933B019391E5E80411" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1A262348EBD3FF933B019391E5E80411" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_DC2BED3759578F4EADC49391E702F3FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1A262348EBD3FF933B019391E5E80411" xlink:to="loc_us-gaap_ClassOfStockDomain_DC2BED3759578F4EADC49391E702F3FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_8A7D593CAA6CC7F328D793928E863DDE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_DC2BED3759578F4EADC49391E702F3FD" xlink:to="loc_us-gaap_CommonStockMember_8A7D593CAA6CC7F328D793928E863DDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_821D9455DE92D9CAD111938EEBFF1AEB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_821D9455DE92D9CAD111938EEBFF1AEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_574F997BBD7FC64AC146938EED568A9D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_821D9455DE92D9CAD111938EEBFF1AEB" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_574F997BBD7FC64AC146938EED568A9D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UnderwrittenPublicOfferingMember" xlink:label="loc_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_574F997BBD7FC64AC146938EED568A9D" xlink:to="loc_cerc_UnderwrittenPublicOfferingMember_12C79625C3B4A3B513429391AE405617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_0FDA8B7963B9F8EABFE4938D569B1779" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="loc_srt_ProductOrServiceAxis_0FDA8B7963B9F8EABFE4938D569B1779" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0FDA8B7963B9F8EABFE4938D569B1779" xlink:to="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember" xlink:label="loc_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:to="loc_cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember_C4A36AE721123A7F8691938D56A1DB09" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ThreePreclinicalTherapiesMember" xlink:label="loc_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:to="loc_cerc_ThreePreclinicalTherapiesMember_1F9684CE1E56BBB4742C938D56A1A5E4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember" xlink:label="loc_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_B266C545E6B046B9E5F1938D56A1868D" xlink:to="loc_cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember_3A80B2B3A2A02143DDF7938D56A2A0D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_BBD05318E9AECEAF5F2F938D569AC115" xlink:to="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfProductsInDevelopment" xlink:label="loc_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_cerc_NumberOfProductsInDevelopment_8212A50B31140BF9306F938D56A3597C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfMarketedMedicalDevices" xlink:label="loc_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_cerc_NumberOfMarketedMedicalDevices_94273918362AD2EF5D18938D56A31BE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_608BECF7A79498605D98938D56A4E0BF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_NetIncomeLoss_608BECF7A79498605D98938D56A4E0BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_00FB1A64D93159B516CE938D56A4B13E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_00FB1A64D93159B516CE938D56A4B13E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E0D230745A84F29E2DE0938D56A4B5F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23B4F31C7CCAA430EB7F938D56A404CE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23B4F31C7CCAA430EB7F938D56A404CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_D99131D39339231BC89B938E29A851E5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_D99131D39339231BC89B938E29A851E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_19B9499565A8B4393E9693949D2C45E9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_19B9499565A8B4393E9693949D2C45E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1F4BBCAECF94BA7A605D93973549B42D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_25289CE34DB3DDADBCA7938D56A26B7B" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1F4BBCAECF94BA7A605D93973549B42D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CapitalStructure" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TemporaryEquityAndEquityDisclosureAbstract" xlink:label="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_F07D16DC02D4B14F139C8DD52983BF4F" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock" xlink:label="loc_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_F07D16DC02D4B14F139C8DD52983BF4F" xlink:to="loc_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock_E005577F32BC9315D11B8DD529839C06" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CapitalStructureCommonStockDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TemporaryEquityAndEquityDisclosureAbstract" xlink:label="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_98AF3900D299C24D9AF4943A18C698FC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_98AF3900D299C24D9AF4943A18C698FC" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_7C9D724EAF71BE03414F943A18C7650B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_7C9D724EAF71BE03414F943A18C7650B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_F1209FEFB3B349401ADE943A18C86AFB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_7C9D724EAF71BE03414F943A18C7650B" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_F1209FEFB3B349401ADE943A18C86AFB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_IncentiveWarrantsMember" xlink:label="loc_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_F1209FEFB3B349401ADE943A18C86AFB" xlink:to="loc_cerc_IncentiveWarrantsMember_0ABEA57D3BE1291A40AA943A18C8FF4F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionAxis" xlink:label="loc_cerc_AssetAcquisitionAxis_C87B9AA568D5BA9C5DB9943A18C8C199" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_cerc_AssetAcquisitionAxis_C87B9AA568D5BA9C5DB9943A18C8C199" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetAcquisitionDomain" xlink:label="loc_cerc_AssetAcquisitionDomain_6398F032556F352A3568943A18C8DB92" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_AssetAcquisitionAxis_C87B9AA568D5BA9C5DB9943A18C8C199" xlink:to="loc_cerc_AssetAcquisitionDomain_6398F032556F352A3568943A18C8DB92" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_IchorionMember" xlink:label="loc_cerc_IchorionMember_9E0B7A31F2ACC9B7A2B5943A18C8E958" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_AssetAcquisitionDomain_6398F032556F352A3568943A18C8DB92" xlink:to="loc_cerc_IchorionMember_9E0B7A31F2ACC9B7A2B5943A18C8E958" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_67527210B93ADCE4CC30943A18C95A9C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_67527210B93ADCE4CC30943A18C95A9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85A7346B98469B3B9230943A18C9E81C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_67527210B93ADCE4CC30943A18C95A9C" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85A7346B98469B3B9230943A18C9E81C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_64E0AEC67B0E4CFF9D11943A18C97147" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85A7346B98469B3B9230943A18C9E81C" xlink:to="loc_cerc_TRxMember_64E0AEC67B0E4CFF9D11943A18C97147" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_C7D0B66643787B5FFB70943A18C9F05E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_C7D0B66643787B5FFB70943A18C9F05E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_C7D0B66643787B5FFB70943A18C9F05E" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_A419F90876B442246DC2943A18CAAFE5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC" xlink:to="loc_us-gaap_PrivatePlacementMember_A419F90876B442246DC2943A18CAAFE5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BoughtDealMember" xlink:label="loc_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_026D535A58A467A3168B943A18CAD6EC" xlink:to="loc_cerc_BoughtDealMember_EFA76DC399B71B598471943A18CAAAC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_FAA4D3DC6E020D486E40943A18CBBF94" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_StatementClassOfStockAxis_FAA4D3DC6E020D486E40943A18CBBF94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_FAA4D3DC6E020D486E40943A18CBBF94" xlink:to="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF" xlink:to="loc_us-gaap_CommonClassAMember_EFB3FE7C9ED4062DB362943A18CC7E39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_6DC8CF1C9C603465E5A0943A18CC0769" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6BD835747F83D2A51530943A18CBC5AF" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_6DC8CF1C9C603465E5A0943A18CC0769" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_E207E809817E5CAFC264943A18CC7E09" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_srt_CounterpartyNameAxis_E207E809817E5CAFC264943A18CC7E09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_88E573070421AF38632F943A18CD8038" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_E207E809817E5CAFC264943A18CC7E09" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_88E573070421AF38632F943A18CD8038" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ArmisticeMember" xlink:label="loc_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_88E573070421AF38632F943A18CD8038" xlink:to="loc_cerc_ArmisticeMember_5CDA7DE8614D9D91CA99943A18CD65F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_24E0615264588E9F5F42943A18CD028F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_24E0615264588E9F5F42943A18CD028F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_24E0615264588E9F5F42943A18CD028F" xlink:to="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_4FDDB6BBA72A77D20CBC943A18CE811F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E" xlink:to="loc_us-gaap_CommonStockMember_4FDDB6BBA72A77D20CBC943A18CE811F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_EE238AC287BCA45AFC71943A18CEACC9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_A560400E378A38241412943A18CECB5E" xlink:to="loc_us-gaap_PreferredStockMember_EE238AC287BCA45AFC71943A18CEACC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_B696158B1D3B512BE38B943A18C67506" xlink:to="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfClassOfStockAuthorized" xlink:label="loc_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_NumberOfClassOfStockAuthorized_C0C884FB68B76BB55420943A18CED80C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CapitalStockSharesAuthorized" xlink:label="loc_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_CapitalStockSharesAuthorized_0807B6D2A64DE60EFE1D943A18CFF80D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_220670A8B0D230BEB1D1943A18CF00BA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_220670A8B0D230BEB1D1943A18CF00BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_89B199669F6F0BAF87E2943A18CF6C4A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_89B199669F6F0BAF87E2943A18CF6C4A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_12F3ED2E2D4A42BCD411943A18CF3679" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_12F3ED2E2D4A42BCD411943A18CF3679" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockholdersEquityNotePreferredStockConversionRatio" xlink:label="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_1AEA700707FD1A513FB4943A18CF6AD3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_1AEA700707FD1A513FB4943A18CF6AD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_39987C8974205D238B57943A18D3FE4F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_39987C8974205D238B57943A18D3FE4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_BC3A600055035DA0FF3E943A18D304B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_C7245AEF2B737BFDFA41943A18D0D062" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_C7245AEF2B737BFDFA41943A18D0D062" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_467D2F286549423E00DC943A18CFEF46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_B94AE574D37062B05FB1943A18D363CB" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_B94AE574D37062B05FB1943A18D363CB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ClassOfWarrantOrRightDistributionAdjustment" xlink:label="loc_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_ClassOfWarrantOrRightDistributionAdjustment_26E5B61C37BD134009AA943A18D32262" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_C0E6939E3E22D8F4EE86943A18D089CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1050A64C836506E44132943A18D1F16D" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1050A64C836506E44132943A18D1F16D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2E9815F2FCB062EAB21F943A18D25CFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7B5D8026752B6BDAA9BA943A18D237C4" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7B5D8026752B6BDAA9BA943A18D237C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_97E0B3956724B0E73FA4943A18D208E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_B3CA95D249980B24CD37943A18D23289" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_B3CA95D249980B24CD37943A18D23289" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_B331ED8F837394E89F55943A18D3F967" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued" xlink:label="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_59A27697CBE08EE77290943A18D3C49D" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued_59A27697CBE08EE77290943A18D3C49D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares" xlink:label="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_F47BE69A78EDDD45DA26943A18D4F959" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares_F47BE69A78EDDD45DA26943A18D4F959" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberofVotesPerShare" xlink:label="loc_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_NumberofVotesPerShare_E7F5D5660EA47FA8AB4A943A18D461EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_65065C03ADF093B4748A943A18D48BD9" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfPreemptiveConversionOrSubscriptionRights" xlink:label="loc_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_NumberOfPreemptiveConversionOrSubscriptionRights_F037277312385F8B8745943A18D4C3C6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NumberOfRedemptionOrSinkingFundProvisions" xlink:label="loc_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_785A42BAE150FA345A9A943A18CEE027" xlink:to="loc_cerc_NumberOfRedemptionOrSinkingFundProvisions_7473FDE94E26ABC09FAF943A18D4CD78" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CapitalStructureTables" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TemporaryEquityAndEquityDisclosureAbstract" xlink:label="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_02CB13CE86060AA028008DD52750862E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_11F2304B556C751D4CC18DD527509E84" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_02CB13CE86060AA028008DD52750862E" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_11F2304B556C751D4CC18DD527509E84" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CapitalStructureWarrantsDetails" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TemporaryEquityAndEquityDisclosureAbstract" xlink:label="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_E9705F5BA57C0249531F943A18B9282F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_TemporaryEquityAndEquityDisclosureAbstract_E9705F5BA57C0249531F943A18B9282F" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CDD9D40891A3D214715B943A18B9BB0D" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantCommonStockMember" xlink:label="loc_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_005E72F7D2592C8968B1943A18B9C9B2" xlink:to="loc_cerc_WarrantCommonStockMember_70E304E9835D6CF3A4BB943A18BA4E15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0D34FAD49AFFDAF4B9FC943A18BA910F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0D34FAD49AFFDAF4B9FC943A18BA910F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0D34FAD49AFFDAF4B9FC943A18BA910F" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsExpirationOctober2020Member" xlink:label="loc_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:to="loc_cerc_CommonStockWarrantsExpirationOctober2020Member_5608C1E2B42687A40D9E943A18BB1EA4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsExpirationMay2022Member" xlink:label="loc_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:to="loc_cerc_CommonStockWarrantsExpirationMay2022Member_0E3C7994F2D60BBCACD1943A18BB14DA" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsExpirationDateJune2024Member" xlink:label="loc_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_542AF89E8BD4A22C4297943A18BA5E11" xlink:to="loc_cerc_CommonStockWarrantsExpirationDateJune2024Member_41B2493F692B3672B328944A0C6E1D6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_50F6BC3F66896724729A943A18BB6C93" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_50F6BC3F66896724729A943A18BB6C93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_F68D0EAFD79475567EFD943A18BCD5CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_50F6BC3F66896724729A943A18BB6C93" xlink:to="loc_us-gaap_ClassOfStockDomain_F68D0EAFD79475567EFD943A18BCD5CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_3C761958C634E4707CF8943A18BC38D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_F68D0EAFD79475567EFD943A18BCD5CC" xlink:to="loc_us-gaap_CommonClassAMember_3C761958C634E4707CF8943A18BC38D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_90130E4CA2451E1C9FF5943A18B935F2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5626324DD30A8ED38607943A18BCC20C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5626324DD30A8ED38607943A18BCC20C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_88C06D3F9B38CFA87B57943A18BDD4BA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_83F06E672EB60B6E0D10943A18BC0F23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_88C06D3F9B38CFA87B57943A18BDD4BA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_F8CE9F92E9741E62A5D28DD527CD6B82" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3BB71058A0EB6A6968628DD527CD2C6D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_F8CE9F92E9741E62A5D28DD527CD6B82" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3BB71058A0EB6A6968628DD527CD2C6D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C62E32B42AA1F8BA7FE298E52540E8B3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C62E32B42AA1F8BA7FE298E52540E8B3" xlink:to="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_5D0D735576B0ADDC6A4C98E52540687C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_srt_ProductOrServiceAxis_5D0D735576B0ADDC6A4C98E52540687C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_F1CAAF5780C5AC34017298E52540380D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5D0D735576B0ADDC6A4C98E52540687C" xlink:to="loc_srt_ProductsAndServicesDomain_F1CAAF5780C5AC34017298E52540380D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicenseMember" xlink:label="loc_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_F1CAAF5780C5AC34017298E52540380D" xlink:to="loc_us-gaap_LicenseMember_D9F6A8E6CA96A31C74DE98E525419F42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_01DCA2BF171394A4B31E98E52541A32C" xlink:to="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_07B8DAE668ED779AC61E98E525416F8D" xlink:to="loc_srt_MinimumMember_64C9FD52994CB2FAA5CB98E525415C13" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_AC4340C479FB31FCEC0C98E52542AD20" xlink:to="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ZyleraMember" xlink:label="loc_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:to="loc_cerc_ZyleraMember_3B764CB9FB1BEF8C01AB98E525427111" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LachlanPharmaceuticalsMember" xlink:label="loc_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2B31F04C9985BA58EAAF98E5254294F4" xlink:to="loc_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_FF8A049F73D5B61F904098E5254364F9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:to="loc_cerc_LachlanPharmaceuticalsMember_955CF03641619EA9150698E52542079B" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRISPharmaMember" xlink:label="loc_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6E81ADFCF1D779D034A398E525439CFD" xlink:to="loc_cerc_TRISPharmaMember_A21FA7F9259531017FD098E52543BDD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4B672B04E4C65ABC20F398E52543A91E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaSupplyAgreementMember" xlink:label="loc_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:to="loc_cerc_UlesfiaSupplyAgreementMember_8E3B891CCF6004FA4B0C98E525449AE1" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_KarbinalAgreementMember" xlink:label="loc_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E0BF849CB08DDD9FD29B98E52543EB5F" xlink:to="loc_cerc_KarbinalAgreementMember_6C6EF2133C8D85AAF09798E52544741D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_89CA32378B958ABA67C298E52540E121" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8FBA923318AAB941D40E98E52545CCF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired_D85121AF754AF5EF594C98E525451B6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_5BB8EBBC719949E7D49098E52545B722" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementPricePerUnit" xlink:label="loc_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementPricePerUnit_3EF854F608BBD79A2B3E98E52545D6EC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit" xlink:label="loc_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit_4748CD73DB01B94E2B4498E5254535D8" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent" xlink:label="loc_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent_D3315E0B4C80C9AAEBF898E525465623" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementMinimumRoyalty" xlink:label="loc_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementMinimumRoyalty_C23CB332D21033B70C0698E525468F51" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseObligationCurrent" xlink:label="loc_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseObligationCurrent_AB78117258E976E88D1198E52546D34F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent" xlink:label="loc_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent_A72B6725CBB02EB3138098E52546855A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments" xlink:label="loc_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments_58D98ECDE4D339D27D7498E52546B0D4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent" xlink:label="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_C727766D4E584D97A68298E525461DE5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnityReceivable" xlink:label="loc_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementIndemnityReceivable_417140874BAC56EB208298E525466F81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_36EEFDF7D85ED611B51198E525474AAA" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementMakeWholePaymentPerUnit" xlink:label="loc_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementMakeWholePaymentPerUnit_774E2F727030F9C37ADC98E52547B608" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementMakeWholePayment" xlink:label="loc_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementMakeWholePayment_897388DE836BE6235A0098E52547FD43" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementAccruedMakeWholePayment" xlink:label="loc_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_LicenseAgreementAccruedMakeWholePayment_5809983AB2357CEDF2A598E525479A9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EEE3CB0FB68C39B09437992E132815F8" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PotentialFutureRegulatoryMilestone" xlink:label="loc_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_09A70B586ADE0D78FFAB98E52544EDDB" xlink:to="loc_cerc_PotentialFutureRegulatoryMilestone_DB4F33FEA2DC96B7DFB398E525454BCD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9D66DD160F4DE8A54E42952FCD60C302" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9D66DD160F4DE8A54E42952FCD60C302" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22B9DAC2C52F1F7BBB6D953C84144CBA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22B9DAC2C52F1F7BBB6D953C84144CBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_60072EA41CD7BF314E8D953C8415EE57" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22B9DAC2C52F1F7BBB6D953C84144CBA" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_60072EA41CD7BF314E8D953C8415EE57" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UlesfiaSupplyAgreementMember" xlink:label="loc_cerc_UlesfiaSupplyAgreementMember_7C1DB368D54C2C9A321B953C84FB06F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_60072EA41CD7BF314E8D953C8415EE57" xlink:to="loc_cerc_UlesfiaSupplyAgreementMember_7C1DB368D54C2C9A321B953C84FB06F8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_BC7989E2BDE85D2BFE10953C83ABE7CA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:to="loc_dei_LegalEntityAxis_BC7989E2BDE85D2BFE10953C83ABE7CA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_D82910056F05A931F474953C83AD4F64" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_BC7989E2BDE85D2BFE10953C83ABE7CA" xlink:to="loc_dei_EntityDomain_D82910056F05A931F474953C83AD4F64" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ZyleraMember" xlink:label="loc_cerc_ZyleraMember_272C4D00B584F56323C3953C84823FCA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_D82910056F05A931F474953C83AD4F64" xlink:to="loc_cerc_ZyleraMember_272C4D00B584F56323C3953C84823FCA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_B42DD77E50F20A4B1CE5953C8347D72A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:to="loc_srt_CounterpartyNameAxis_B42DD77E50F20A4B1CE5953C8347D72A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_B2F36A2E5E8A5E512C73953C83487AC5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_B42DD77E50F20A4B1CE5953C8347D72A" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_B2F36A2E5E8A5E512C73953C83487AC5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LachlanPharmaceuticalsMember" xlink:label="loc_cerc_LachlanPharmaceuticalsMember_DCED22FD863FB45DCC8A953C84BD32CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_B2F36A2E5E8A5E512C73953C83487AC5" xlink:to="loc_cerc_LachlanPharmaceuticalsMember_DCED22FD863FB45DCC8A953C84BD32CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_BE5A62482FE2D6C061D9952FD1FF30EB" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_462DCD3F43610B879E4A9531D5E3E618" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_D6B516CEF8D178002F399530404FF0FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_30C9F22D4FA56F2A75EB95304164151B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_6BD370C0E038390B5A509530429099EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_A52D8D4A41F786E5C0C4953E4052AE37" xlink:to="loc_us-gaap_PurchaseObligation_970D597A7478FCF1F092953043ADD2CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_28AF1887582ABCC2BCB095327F7B9428" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitmentDueInSecondYear_2D05E53FFD496FD77FC595304465E81C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitmentDueInThirdYear_0C31B9C0E6338D9D02269530457FA604" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitmentDueInFourthYear_2C5E0A97AEAE6E6ABCFD9530469A0D5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentFiscalYearMaturityAbstract_5AED96B483AB972F342F953F8348C67D" xlink:to="loc_us-gaap_OtherCommitment_132CBBDA232011A9A42A953047CA7004" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_B4CE49520F2EC13AEAA3953310E06BB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_5DEFA16D22435EC0FA3195304887BC21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_AFFE22AC117ADE1E2A0D9530498821E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_1DA63B87438241AF5DFA95304AB95CCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityAbstract_D2C1C42F9AA27AB5D8169540A0FFEA58" xlink:to="loc_us-gaap_ContractualObligation_37C8AEAC525D833391AD95304BCF7F90" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent" xlink:label="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_01EC2CA3586136595CFF953C830C999C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_D9856AE85B6E1A5FD8AE952FD201C3DD" xlink:to="loc_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent_01EC2CA3586136595CFF953C830C999C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CommitmentsAndContingenciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_658370C18FAA7F7FEF80952C86733CA7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_FDAB5186392CDF5B09C6952C8677F646" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_658370C18FAA7F7FEF80952C86733CA7" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_FDAB5186392CDF5B09C6952C8677F646" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_E8ED1915FE5F22FB2CD4903069282704" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_E8ED1915FE5F22FB2CD4903069282704" xlink:to="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:to="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AFB92F6B97070DC8C479903069288A19" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AFB92F6B97070DC8C479903069288A19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_36D5E9A6F3613559BFF790306929370E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:to="loc_us-gaap_AccountsReceivableNet_36D5E9A6F3613559BFF790306929370E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_56C3B6EF76E78564821B90306929F0AE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:to="loc_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_56C3B6EF76E78564821B90306929F0AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_5ADD3B8DB3138213BEDD903069298843" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:to="loc_us-gaap_InventoryNet_5ADD3B8DB3138213BEDD903069298843" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_B67219B9B3DD0C20971790306929D66A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_B67219B9B3DD0C20971790306929D66A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_DE7CF56AAE5FBD518EC29030692A9613" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A0023E7BB4F7BACCC9219030692803F6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_DE7CF56AAE5FBD518EC29030692A9613" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_6CF012907B4FF09900FB9030692A74DF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:to="loc_us-gaap_AssetsCurrent_6CF012907B4FF09900FB9030692A74DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3FFAC16FC976C879D2EC9030692ADD78" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3FFAC16FC976C879D2EC9030692ADD78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_A05C4D4AC335C46D164A9030692A4B0F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_A05C4D4AC335C46D164A9030692A4B0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_FAD87C55F4793A2F40949030692A6DA6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:to="loc_us-gaap_Goodwill_FAD87C55F4793A2F40949030692A6DA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_5003C9323AC48A69635D9030692A77A9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_5003C9323AC48A69635D9030692A77A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_E15F2D48C46E81772D619030692BB90D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_AE1D39B2272345E730A590306928260D" xlink:to="loc_us-gaap_Assets_E15F2D48C46E81772D619030692BB90D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_E8ED1915FE5F22FB2CD4903069282704" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_2F3C781E0B73070117329030692B7F72" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:to="loc_us-gaap_AccountsPayableCurrent_2F3C781E0B73070117329030692B7F72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_FDAC7DF4E1CDC7B7EE129030692CE732" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_FDAC7DF4E1CDC7B7EE129030692CE732" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_9810E10084932D45BF5F9030692C4638" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_9810E10084932D45BF5F9030692C4638" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_53842DA91FF85138D0169030692CF62C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:to="loc_us-gaap_LongTermDebtCurrent_53842DA91FF85138D0169030692CF62C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_490EB4416D90F24E5F559030692C7D9A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_490EB4416D90F24E5F559030692C7D9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_089FD6781AFBBC02754A9030692CA3BF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2C94BF8B1EDBB475D62B9030692B06A7" xlink:to="loc_us-gaap_LiabilitiesCurrent_089FD6781AFBBC02754A9030692CA3BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_E482A8BDA2DB00AFEF0A9030692CD00B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_E482A8BDA2DB00AFEF0A9030692CD00B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0DFFEBF26E02736CDCC89030692C654C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0DFFEBF26E02736CDCC89030692C654C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2FCD883A781BE5C7E92F9030692D77A4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2FCD883A781BE5C7E92F9030692D77A4" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseObligationNoncurrent" xlink:label="loc_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="loc_cerc_LicenseObligationNoncurrent_9F25F89F2650B0445A6D9030692D68A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_EE5E46715CB3E0803DBE9030692D3935" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_EE5E46715CB3E0803DBE9030692D3935" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_57AE9ECB3ED871E839FD9030692D50F8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="loc_us-gaap_Liabilities_57AE9ECB3ED871E839FD9030692D50F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="loc_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_261500EB6CA8E55923569030692E3423" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:to="loc_us-gaap_CommonStockValue_261500EB6CA8E55923569030692E3423" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_5091683945F3D1FF2E3E9030692D6016" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:to="loc_us-gaap_PreferredStockValue_5091683945F3D1FF2E3E9030692D6016" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2E566F9C2C27D3ACEBB49030692EAD1A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2E566F9C2C27D3ACEBB49030692EAD1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8ABBE1AC389D7CBD638B9030692EE948" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8ABBE1AC389D7CBD638B9030692EE948" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_8F29F45832AFCE11BBA09030692E933E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAFE95852EA3402DF15F9030692D9C62" xlink:to="loc_us-gaap_StockholdersEquity_8F29F45832AFCE11BBA09030692E933E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5305113B0B0628AF616E9030692F6C42" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_BD97C240E6F4AC8BB4919030692B397C" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5305113B0B0628AF616E9030692F6C42" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_67248EC80B18DB5EEADB9030691DF742" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_67248EC80B18DB5EEADB9030691DF742" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_C582DAD197B419F8246B9030691D38A8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_C582DAD197B419F8246B9030691D38A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_11EE309A71F32450071E9030691D189E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:to="loc_us-gaap_CommonStockSharesIssued_11EE309A71F32450071E9030691D189E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_C4134D5463EE319934FF9030691D0CC3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_C4134D5463EE319934FF9030691D0CC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_38D542C4D1BC6A3F3F5C9030691C1051" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_38D542C4D1BC6A3F3F5C9030691C1051" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9F5308368F2452B70CCB9030691CB61F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9F5308368F2452B70CCB9030691CB61F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_749518D55C25D75EE3409030691C6926" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:to="loc_us-gaap_PreferredStockSharesIssued_749518D55C25D75EE3409030691C6926" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_89196D3380CE00F5A0BA9030691C09CB" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2EA136023BF5227F45759030691CB1FF" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_89196D3380CE00F5A0BA9030691C09CB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_734809AB39033E8D75179CDC03CA578A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:to="loc_us-gaap_NetIncomeLoss_734809AB39033E8D75179CDC03CA578A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_91CBE65DEF126294BAA69CDC03CA8E9D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_91CBE65DEF126294BAA69CDC03CA8E9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_6578F73062319E20B3119CDC03CA341B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="loc_us-gaap_ShareBasedCompensation_6578F73062319E20B3119CDC03CA341B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_F04F5527BD2460A7FAF89CDC03CAF9EF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_F04F5527BD2460A7FAF89CDC03CAF9EF" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AmortizationOfInventoryFairValueAdjustment" xlink:label="loc_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="loc_cerc_AmortizationOfInventoryFairValueAdjustment_E9412761B5F0E7C18F949CDC03CBCF57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="loc_us-gaap_PaidInKindInterest_C4A1B3D57A914C55A4949CDC03CB5B5E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="loc_us-gaap_PaidInKindInterest_C4A1B3D57A914C55A4949CDC03CB5B5E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation" xlink:label="loc_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="loc_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation_26700ACBAAEDE7C097AD9CDC03CB9482" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_BFD84435C47F07FDE9DE9CDC03CBB9E5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_BFD84435C47F07FDE9DE9CDC03CBB9E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_095FB0FEAA0D1D5343989CDC03CBF67B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_095FB0FEAA0D1D5343989CDC03CBF67B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2CF0970CDAF8440D65E59CDC03CA6FD0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_EACADEF7D2337B8683079CDC03CCABF5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_EACADEF7D2337B8683079CDC03CCABF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_7D7DC62F23636566E3239CDC03CCA349" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_7D7DC62F23636566E3239CDC03CCA349" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6B421F45D9D21FABE0189CDC03CCD71E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6B421F45D9D21FABE0189CDC03CCD71E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0AC24F9503B7ABD9B8E69CDC03CC2FC6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0AC24F9503B7ABD9B8E69CDC03CC2FC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_AD24CFC82BB217FE94C49CDC03CCAB0C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:to="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_AD24CFC82BB217FE94C49CDC03CCAB0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_CFBC1E0F1B767BF949C89CDC03CD699A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_CFBC1E0F1B767BF949C89CDC03CD699A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_D27397B281A29DCFAD329CDC03CDCB0C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_D27397B281A29DCFAD329CDC03CDCB0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_CAD0F19AB4523911EB7D9CDC03CD551F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62AFE4F52DE465A734109CDC03CBA8E4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_CAD0F19AB4523911EB7D9CDC03CD551F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_996655A706C856C5CC359CDC03CD1E86" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2A34B1AFF4834A2E64A79CDC03C9CEE3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_996655A706C856C5CC359CDC03CD1E86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_F9C46C2051F0BC0DFB409CDC03CDA281" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_F9C46C2051F0BC0DFB409CDC03CDA281" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7C0511CA917653C6342A9CDC03CE90BC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7C0511CA917653C6342A9CDC03CE90BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2D0AA70884A86F68F6E9CDC03CE5CCD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_C25990BA06EB7B4167209CDC03CDCB85" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2D0AA70884A86F68F6E9CDC03CE5CCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="loc_us-gaap_ProceedsFromStockPlans_7CA671FB194E48913EAD9CDC03CEE00B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:to="loc_us-gaap_ProceedsFromStockPlans_7CA671FB194E48913EAD9CDC03CEE00B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_FD06F16D27974A3006A59CDC03CE660C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_FD06F16D27974A3006A59CDC03CE660C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_78EB5992B930F1145F3A9CDC03CF6510" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_78EB5992B930F1145F3A9CDC03CF6510" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_DEDAA9C0459AD2FFB3CC9CDC03CFE6B8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_DEDAA9C0459AD2FFB3CC9CDC03CFE6B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34A98E756C89D436CEBC9CDC03CF805F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_D29122E50CE611CC746C9CDC03CE2FC2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34A98E756C89D436CEBC9CDC03CF805F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6651649D217803320EA19CDC03CF9B90" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6651649D217803320EA19CDC03CF9B90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44D2E8739160C35F9E629CDC03CF87A6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44D2E8739160C35F9E629CDC03CF87A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4DC6AA43E3958B09C1E69CDC03CFB81D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4DC6AA43E3958B09C1E69CDC03CFB81D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_FE6BF606E15A794EDFB49CDC03D092BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2" xlink:to="loc_us-gaap_InterestPaidNet_FE6BF606E15A794EDFB49CDC03D092BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_AF43F9E68B0ACF0D03669CDC03D0A436" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4433E209911C85CC41DE9CDC03CFD8E2" xlink:to="loc_us-gaap_IncomeTaxesPaid_AF43F9E68B0ACF0D03669CDC03D0A436" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_B924E08A8C99F11A94A39CDC03D0AF52" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_B924E08A8C99F11A94A39CDC03D0AF52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_62EB738FA2AA0D3B886F9CDC03D1CAC2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_EFFB50902C9C836121CC9CDC03D06618" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_62EB738FA2AA0D3B886F9CDC03D1CAC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D9D55CF6B707AFBE74039CDC03D140CC" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D9D55CF6B707AFBE74039CDC03D140CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_D43613A10876F511322D9CDC03D1A6B6" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_D43613A10876F511322D9CDC03D1A6B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8DB31EF28C50B58D848E9CDC03D115FB" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_321072ED57FC8F9CDC659CDC03C90E29" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8DB31EF28C50B58D848E9CDC03D115FB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0D35C95DA5B390B23012903F2BF1F1B4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0D35C95DA5B390B23012903F2BF1F1B4" xlink:to="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_E02048AFA7564DBD25A1903F2C02E7C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:to="loc_srt_ProductOrServiceAxis_E02048AFA7564DBD25A1903F2C02E7C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_E02048AFA7564DBD25A1903F2C02E7C4" xlink:to="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SalesRevenueProductMember" xlink:label="loc_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276" xlink:to="loc_cerc_SalesRevenueProductMember_8478F3AF8E3D66A25417903F2C03B59D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SalesForceRevenueMember" xlink:label="loc_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_F5853A3B76498D512CBE903F2C033276" xlink:to="loc_cerc_SalesForceRevenueMember_271A369F01EF9F1165D6903F2C03D5DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_41897C8363407D3B5DB6903F2C0363FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_41897C8363407D3B5DB6903F2C0363FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_41897C8363407D3B5DB6903F2C0363FE" xlink:to="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_A350D176C5AD4B6509D39040DE383CBE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2" xlink:to="loc_us-gaap_CommonStockMember_A350D176C5AD4B6509D39040DE383CBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_D36700AAD2E24AE43AC290410F203E73" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_C4532CC6CF33167FF93F903F2C03E1D2" xlink:to="loc_us-gaap_PreferredStockMember_D36700AAD2E24AE43AC290410F203E73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_AE7555F86132376898C7903F2C021EC3" xlink:to="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0F9641CEEF5C11F36E3C903F2C04B266" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0F9641CEEF5C11F36E3C903F2C04B266" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_BD895CD0E645821BD276903F2C056694" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_BD895CD0E645821BD276903F2C056694" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6F1E1602054153B72E8E903F2C04D6B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6E2EC2A87A93197F645C903F2C04E3E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_SellingAndMarketingExpense_D508EF2FADD1E09B7F24903F2C05086B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_DEE17BE54CA0F72F3C69903F2C05766B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_26A20622947FC34E2A14903F2C05A233" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_66614D9EACC896524699903F2C043FDC" xlink:to="loc_us-gaap_OperatingExpenses_FDDC2F12C725DB78E3C9903F2C057571" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_OperatingIncomeLoss_40FBCB8F1DDF873F6247903F2C05386B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration" xlink:label="loc_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:to="loc_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration_944BFDEF1056A0568851903F2C05D977" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:to="loc_us-gaap_OtherIncome_3E0052E3DD3DAD8FF3EC903F2C060E30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_CCF409E70207E57C0E1D903F2C05D7C7" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_33AF50CF6FF4A2C61A54903F2C06D8FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5E46B5F2395DFD649619903F2C060647" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_NetIncomeLossBeforeTaxes" xlink:label="loc_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_cerc_NetIncomeLossBeforeTaxes_8E64AB27D00192B4DD22903F2C06765A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_08F3D7B5E326DC495E7B903F2C0643A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1F57291F56C0F4C2C9E9903F2C06924E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_NetIncomeLoss_1F57291F56C0F4C2C9E9903F2C06924E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_69F746E250783B4A4353903F2C04C0C0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_EEB79D5DF2215DE33502903F2C07E7FB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3B66C78D6B1A2CA018C298A29CF6DEB7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_4531D2E65A50B2D90A6C98A29CF6DADE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3B66C78D6B1A2CA018C298A29CF6DEB7" xlink:to="loc_us-gaap_StatementTable_4531D2E65A50B2D90A6C98A29CF6DADE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4CCB05080D3EBD8A7D6B98A29CF6AE6F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4531D2E65A50B2D90A6C98A29CF6DADE" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4CCB05080D3EBD8A7D6B98A29CF6AE6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4CCB05080D3EBD8A7D6B98A29CF6AE6F" xlink:to="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_69B5534FFE1E3817E83898A29CF795C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_us-gaap_CommonStockMember_69B5534FFE1E3817E83898A29CF795C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_4011B4FCFF6FEA38050D98A29CF75DEF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_us-gaap_PreferredStockMember_4011B4FCFF6FEA38050D98A29CF75DEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_05A58A9721859C9B2FCD98A29CF72FAD" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ContingentlyIssuableCommonStockMember" xlink:label="loc_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_cerc_ContingentlyIssuableCommonStockMember_59A40E7714D746CB1AAC98A29CF7AF6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_30D84A5DA5A0DAA9BF3E98A29CF6F84E" xlink:to="loc_us-gaap_RetainedEarningsMember_CD10DD1727AF49A521E098A29CF89537" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_BAD670DCA65BC5F5921498A29CF820A0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4531D2E65A50B2D90A6C98A29CF6DADE" xlink:to="loc_us-gaap_StatementLineItems_BAD670DCA65BC5F5921498A29CF820A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_BAD670DCA65BC5F5921498A29CF820A0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_SharesOutstanding_3F9E297CB752870C00D098A29CF8616B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockholdersEquity_0525B8A4CBC35D8D924498A29CF82768" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_B1CEF45EF71E4FD8D51F98A29CF81F20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4591743AC1D832C9D23998A29CF9D498" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:label="loc_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_472EFDA96DA3A9394C2798A29CF93030" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:label="loc_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_B0FAD5799CF7471AA52298A29CF98C44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8609F6DCFD8472F29FB498A29CF9D6BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_33EC6325DC6B0106815898A29CF91A91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_02D0F25DA70139DF632698A29CFA33EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_D975E771AE7AADEFD56D98A29CFA8421" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_NetIncomeLoss_D975E771AE7AADEFD56D98A29CFA8421" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_00EF5B136FA62065CAB998A29CFA26DF" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_SharesOutstanding_00EF5B136FA62065CAB998A29CFA26DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_61748E05FC48E9F676D098A29CFA8F89" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_FC88182018FE6A03035998A29CF8B0FD" xlink:to="loc_us-gaap_StockholdersEquity_61748E05FC48E9F676D098A29CFA8F89" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/DeerfieldObligation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_CDFF4DD58408AF22F7668DD528341BD4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_93AEEE985DF2C6CE1E0F8DD52835F2DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_CDFF4DD58408AF22F7668DD528341BD4" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_93AEEE985DF2C6CE1E0F8DD52835F2DF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/DeerfieldObligationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_EF7521B4850E0994E8AB901F19BFFD34" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_EF7521B4850E0994E8AB901F19BFFD34" xlink:to="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_79887956E5A29DBE086A901F19C0015D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:to="loc_us-gaap_StatementScenarioAxis_79887956E5A29DBE086A901F19C0015D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_ACE81B3FE8C9621C1998901F19C08CBA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_79887956E5A29DBE086A901F19C0015D" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_ACE81B3FE8C9621C1998901F19C08CBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_20EE7E231717C56B4DFE901F19C000A6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_ACE81B3FE8C9621C1998901F19C08CBA" xlink:to="loc_us-gaap_ScenarioForecastMember_20EE7E231717C56B4DFE901F19C000A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:to="loc_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_B89488790A00C1D45C58901F19C0912B" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_DeerfieldObligationMember" xlink:label="loc_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D0F1B327A09149E3B3DC901F19C00D6E" xlink:to="loc_cerc_DeerfieldObligationMember_81048013D1E426CEE864901F19C14F94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_44C96E118260CD169DD2901F19BF203F" xlink:to="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_C14749CEB319967C1B73901F19C1B8EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_34385F900C68FB9734E3901F19C14D04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_40A1690949CC2D721BB1901F19C211B1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_40A1690949CC2D721BB1901F19C211B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_B38E3E055AF7932C162C901F19C2EE8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_02AC9EA405B6D44B41FD901F19C22DB6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_779A80D9631F9E84275A901F19C184BF" xlink:to="loc_us-gaap_LongTermDebtCurrent_02AC9EA405B6D44B41FD901F19C22DB6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="cerc-20190331.xsd#cerc_DocumentAndEntityInformationAbstract" xlink:label="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_06928316E0CC9131D1BD90302CE0F7DB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_EntityRegistrantName_06928316E0CC9131D1BD90302CE0F7DB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_F8D7D10F49F8A3712EE990302CE14F06" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_EntityCentralIndexKey_F8D7D10F49F8A3712EE990302CE14F06" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_3182DC4B2E799EE6CD3E90302CE1F951" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_CurrentFiscalYearEndDate_3182DC4B2E799EE6CD3E90302CE1F951" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_81F1055007CAFA8EA45690302CE1A14F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_EntityFilerCategory_81F1055007CAFA8EA45690302CE1A14F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_53D2191C1A3A8C54C5C690302D7A3EE8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_EntityEmergingGrowthCompany_53D2191C1A3A8C54C5C690302D7A3EE8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_EB24641BFB63E231470190302D81826F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_EntitySmallBusiness_EB24641BFB63E231470190302D81826F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_CF3D99AE47FEDE29B14790302D84F40E" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_EntityExTransitionPeriod_CF3D99AE47FEDE29B14790302D84F40E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_90FF1A66207600FA29F890302CE1741E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_DocumentType_90FF1A66207600FA29F890302CE1741E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_B42E889EFC3A3310103690302CE139E5" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_DocumentPeriodEndDate_B42E889EFC3A3310103690302CE139E5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_57A867A7DC3CFA3B0DF990302CE14256" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_DocumentFiscalYearFocus_57A867A7DC3CFA3B0DF990302CE14256" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_B63029151C37D9A5DCBB90302CE24479" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_DocumentFiscalPeriodFocus_B63029151C37D9A5DCBB90302CE24479" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_A45EFC952DF7F8DE261690302CE274F2" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_AmendmentFlag_A45EFC952DF7F8DE261690302CE274F2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3DF2F546F8BE84A2280490302CE2D5A7" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_DocumentAndEntityInformationAbstract_DC9434297DF9F7949D8490302CE0478D" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_3DF2F546F8BE84A2280490302CE2D5A7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_BD746901B2A589B4B0A98DD527CD1000" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_CBD244FC4384B6EF5E518DD527CD4FB2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_BD746901B2A589B4B0A98DD527CD1000" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_CBD244FC4384B6EF5E518DD527CD4FB2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4A5EFC24DEB17D0475848E796B5AF2E2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4A5EFC24DEB17D0475848E796B5AF2E2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4EF13F473772664CAB518E796B5B8A72" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ADA94ADA127304A5A448E796B5B9319" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_E86B4BA00F2CF5B851398E796B5B45D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BEC9F8E3CACCDACFA9E08E796B5C52AC" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_06061334C5FF11768D628E796B5C671E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FCB1691038D9A432275E8E796B5C8948" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_807B4F11723B5CE605D88E796B5CC560" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_3F7FCBBCEDBD244A75F08E796B5C44D5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ContingentConsiderationMember" xlink:label="loc_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:to="loc_cerc_ContingentConsiderationMember_A7D04B4EB8E4C0F035078E796B5DA63F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantLiabilityMember" xlink:label="loc_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:to="loc_cerc_WarrantLiabilityMember_3B79AFB76D255A3FB1C08E796B5DD621" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EquityUnitPurchaseOptionMember" xlink:label="loc_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9988FA5097488AF0CB2B8E796B5D654A" xlink:to="loc_cerc_EquityUnitPurchaseOptionMember_A8768F27C240FE4B169C8E796B5DC321" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7F36F9D0B0D0019025718E796B5B7A41" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_538AA95FE7AD524259D38E796B5EAB31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41A8D5E2C63D9F6925288E796B5E2964" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_E6724C7858A6F3C5C60F8E796B5E29AC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1E8A5AB00D3FDE51B81493BC7AD7165D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1E8A5AB00D3FDE51B81493BC7AD7165D" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3619F042520DA81DBAC3941B05245D53" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_CommonStockWarrantsMember" xlink:label="loc_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_BF9D687662DDA7A940DB941B052BE51F" xlink:to="loc_cerc_CommonStockWarrantsMember_58F1E3EADF92BBD77A0F941B0557F1A9" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneAxis" xlink:label="loc_cerc_MilestoneAxis_A59CFCB5E283330B274C940BF7469C9E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_cerc_MilestoneAxis_A59CFCB5E283330B274C940BF7469C9E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneDomain" xlink:label="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_MilestoneAxis_A59CFCB5E283330B274C940BF7469C9E" xlink:to="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneOneMember" xlink:label="loc_cerc_MilestoneOneMember_3C2FC422771035AF7C2A940BF872F038" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:to="loc_cerc_MilestoneOneMember_3C2FC422771035AF7C2A940BF872F038" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneTwoMember" xlink:label="loc_cerc_MilestoneTwoMember_5ECD4BC71983EF5ED3B7940BF88B4925" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:to="loc_cerc_MilestoneTwoMember_5ECD4BC71983EF5ED3B7940BF88B4925" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MilestoneThreeMember" xlink:label="loc_cerc_MilestoneThreeMember_26339E4CE1DC4DB74EAC940BF8A20F3C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_MilestoneDomain_382B69EDDF019853FD1B940BF7471355" xlink:to="loc_cerc_MilestoneThreeMember_26339E4CE1DC4DB74EAC940BF8A20F3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_A1ABC281E21636564E3A940BF71D6BBE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_A1ABC281E21636564E3A940BF71D6BBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A1ABC281E21636564E3A940BF71D6BBE" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AvadelMember" xlink:label="loc_cerc_AvadelMember_C487F23506A45A5578FB940BF80150DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D" xlink:to="loc_cerc_AvadelMember_C487F23506A45A5578FB940BF80150DF" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_TRxMember" xlink:label="loc_cerc_TRxMember_E6C39861F85EE6295404940BF85CE606" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9BE667FA9CC7EF275292940BF71EE94D" xlink:to="loc_cerc_TRxMember_E6C39861F85EE6295404940BF85CE606" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_C2C2114A3BCF6A4149D6940BF6EC6B00" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_C2C2114A3BCF6A4149D6940BF6EC6B00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_C2C2114A3BCF6A4149D6940BF6EC6B00" xlink:to="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_65A4DA7B768F93C3AC6F940BF791576B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5" xlink:to="loc_us-gaap_PreferredStockMember_65A4DA7B768F93C3AC6F940BF791576B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_755DCD9CE143CE9515E2940BF7A4AFF4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_B7FE1C3A0626D0478017940BF6ED83D5" xlink:to="loc_us-gaap_CommonStockMember_755DCD9CE143CE9515E2940BF7A4AFF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_50D9C57F621EC51498CC940BF6CB0FDA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_StatementClassOfStockAxis_50D9C57F621EC51498CC940BF6CB0FDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_4D82D62E3752AF166E36940BF6CC4230" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_50D9C57F621EC51498CC940BF6CB0FDA" xlink:to="loc_us-gaap_ClassOfStockDomain_4D82D62E3752AF166E36940BF6CC4230" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_125872BC06F71F4F9C1E940BF77D3A5A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4D82D62E3752AF166E36940BF6CC4230" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_125872BC06F71F4F9C1E940BF77D3A5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_A454A8CC5FB14FA0A4D793FA0CCED18E" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_107A86C62574FFF63A42940BF7B933D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_7ADD7B4C31450CBE11A093FA0D898742" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_B632D10FFC6EF4D730A1940BF819E065" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_22A0C79A5262F94EA420940BF7CCC4F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_D734540DFD78DBA01F6B940BF7E20ACC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputCounterpartyCreditRiskMember" xlink:label="loc_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_us-gaap_MeasurementInputCounterpartyCreditRiskMember_09D75868D81C9EA573A9940BF82FEF70" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MeasurementInputProbabilityOfMilestoneSuccessMember" xlink:label="loc_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_202E7E684E8674A973AD93FA0CD00B87" xlink:to="loc_cerc_MeasurementInputProbabilityOfMilestoneSuccessMember_2A30554438B886F410F6940BF8BD9C37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_9BABA54B06DAA71E5A4693BC7AD90B75" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_9BABA54B06DAA71E5A4693BC7AD90B75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_9BABA54B06DAA71E5A4693BC7AD90B75" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantLiabilityMember" xlink:label="loc_cerc_WarrantLiabilityMember_233BAA2C5184A18F83EC93BC7AD9063A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:to="loc_cerc_WarrantLiabilityMember_233BAA2C5184A18F83EC93BC7AD9063A" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EquityUnitPurchaseOptionMember" xlink:label="loc_cerc_EquityUnitPurchaseOptionMember_58EA8E600686CD42EB2993BC7AD91D6E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:to="loc_cerc_EquityUnitPurchaseOptionMember_58EA8E600686CD42EB2993BC7AD91D6E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RoyaltyPayableMember" xlink:label="loc_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87939388CE3BDCE113B293BC7AD9F195" xlink:to="loc_cerc_RoyaltyPayableMember_8CD09956E7F0BADDB91F940BF845491B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3004948436AC7FCDBFD893BC7AD95938" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3004948436AC7FCDBFD893BC7AD95938" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3004948436AC7FCDBFD893BC7AD95938" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0CB889E2312F872E806593BC7ADA322E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_E7C29485905D21BF435D93BC7ADA4921" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6105F279133B63AB6A2F93BC7AD990CD" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_E7C29485905D21BF435D93BC7ADA4921" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FB6A74178E7EEBEF794393BC7AD70BDE" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_LongTermDebtFairValue_060EDCC6BB1E3CA532B893BC7ADC303B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8542E4C4662855055E7593BC7ADDCDAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_EB28178D1563C385180F93BC7ADD3F77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_E70F0B33303FFCB1866093BC7ADD3BC5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementProductRoyaltyNet" xlink:label="loc_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_LicenseAgreementProductRoyaltyNet_5DED80AD6B553975C4AC940BF635F815" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementRoyaltyObligation" xlink:label="loc_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_LicenseAgreementRoyaltyObligation_8CDA860A22547777A0F1940BF6438C93" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure" xlink:label="loc_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure_F881EA16261A0E8C31EF940BF654517D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RoyaltyObligationMeasurementInput" xlink:label="loc_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_RoyaltyObligationMeasurementInput_DE4DD0757161D32A0746940BF6631817" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_9458D7E2765F1E535709940BF682F015" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0CC9A5073579FCF28B91940BF691AA76" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0CC9A5073579FCF28B91940BF691AA76" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationGrossProfit" xlink:label="loc_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_BusinessCombinationGrossProfit_DC4A46EFC562CF058741940BF6A1472A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_61DA577F3C39757F7498940BF6737A3E" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone" xlink:label="loc_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone_53F36217475FA0B5F91E940BF6B5814D" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_FairValueMeasurementsChangesInValuationTechniquesNumber" xlink:label="loc_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber_DD50A7019492E8D4A2CF93BC7ADEF665" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_A34E4CB502B331205A8B93BC7ADE2F7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5809E4A3696EFD79FA1493BC7ADC91C8" xlink:to="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_9006CAD4FE394BB4D42493BC7ADECEF0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsRollforwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9D701E30F0F08D2E7B11945980B6E598" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9D701E30F0F08D2E7B11945980B6E598" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_E1EED7DE84640E8F4BD1945980B656ED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_E1EED7DE84640E8F4BD1945980B656ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_E1EED7DE84640E8F4BD1945980B656ED" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantLiabilityMember" xlink:label="loc_cerc_WarrantLiabilityMember_044F31ED3BF97D68FE2D945980B77713" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:to="loc_cerc_WarrantLiabilityMember_044F31ED3BF97D68FE2D945980B77713" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EquityUnitPurchaseOptionMember" xlink:label="loc_cerc_EquityUnitPurchaseOptionMember_422430C4D3D3BA3FC323945980B7ABBD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:to="loc_cerc_EquityUnitPurchaseOptionMember_422430C4D3D3BA3FC323945980B7ABBD" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ContingentConsiderationMember" xlink:label="loc_cerc_ContingentConsiderationMember_C5BD62E64EE46C674779945980B797F5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:to="loc_cerc_ContingentConsiderationMember_C5BD62E64EE46C674779945980B797F5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RoyaltyPayableMember" xlink:label="loc_cerc_RoyaltyPayableMember_F5B64E21EFF547E1D12A945980B8E521" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_DE26DBBCF06D886804EF945980B7892C" xlink:to="loc_cerc_RoyaltyPayableMember_F5B64E21EFF547E1D12A945980B8E521" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25738FF376E03FA28AEC945980B88CF2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25738FF376E03FA28AEC945980B88CF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_A285B54CF38BA9947B8D945980B87FE4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25738FF376E03FA28AEC945980B88CF2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_A285B54CF38BA9947B8D945980B87FE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_2BE57425CAD50909F16F945980B88031" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_A285B54CF38BA9947B8D945980B87FE4" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_2BE57425CAD50909F16F945980B88031" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78D8C7933779A8944941945980B8994D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78D8C7933779A8944941945980B8994D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_F8E7B325B86D6462BDB1945980B8E568" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78D8C7933779A8944941945980B8994D" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_F8E7B325B86D6462BDB1945980B8E568" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8290E75AD4B20BC061AE945980B9290D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_F8E7B325B86D6462BDB1945980B8E568" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8290E75AD4B20BC061AE945980B9290D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2038F42D27F11F2A0849945980B93298" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3DA5820EE9F9C42AAF8E945980B6649A" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2038F42D27F11F2A0849945980B93298" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2038F42D27F11F2A0849945980B93298" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83CB324BF27FEFC7FEAC945980BA8EC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_17A4B289B1169F023EC0945980BAABED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_552A90A587FC0B7B1B6E945980BA4AB9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_552A90A587FC0B7B1B6E945980BA4AB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2333FEF03FEF6DCA9610945980BA8F61" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2333FEF03FEF6DCA9610945980BA8F61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_174464A307099A3683F0945980BA55C7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5B8D32252B5FEB45FA64945980B9EE02" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_174464A307099A3683F0945980BA55C7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_C0533BAA4869DEADBCD293BC7AE3F15C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DC1549D345ABD4B995DB93BC7AE35E80" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_C0533BAA4869DEADBCD293BC7AE3F15C" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DC1549D345ABD4B995DB93BC7AE35E80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_821C3AC5A8F51503E2CB93BC7AE3A3B2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_C0533BAA4869DEADBCD293BC7AE3F15C" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_821C3AC5A8F51503E2CB93BC7AE3A3B2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9C0DCF9FAFA69BEBC1408DD527BDEF49" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_D06BEFB2EF77DBA35B798DD527BDFBEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9C0DCF9FAFA69BEBC1408DD527BDEF49" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_D06BEFB2EF77DBA35B798DD527BDFBEC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4A5AF9608F45B0981A22903067D3575C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_347BE6D47613A51669C3903067D3416E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4A5AF9608F45B0981A22903067D3575C" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_347BE6D47613A51669C3903067D3416E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/Leases" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_E7613447447276E82664950E4EAF02EF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_2CE5A7068D5C38A951BC950E4EDBD76E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_E7613447447276E82664950E4EAF02EF" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_2CE5A7068D5C38A951BC950E4EDBD76E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/LeasesAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_31117BC7D700A008603E98A29B1DAA57" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6ABAD3FB8DF9BEA2653F98A29B1D939B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31117BC7D700A008603E98A29B1DAA57" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6ABAD3FB8DF9BEA2653F98A29B1D939B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_96942A7C09770706B28C98A29B1D5B60" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31117BC7D700A008603E98A29B1DAA57" xlink:to="loc_us-gaap_OperatingLeaseLiability_96942A7C09770706B28C98A29B1D5B60" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_C8D09BF71FE5FFB3A6BE9523044C4320" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_99BF528834533C7D15A8952367E03AA6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C8D09BF71FE5FFB3A6BE9523044C4320" xlink:to="loc_us-gaap_OperatingLeaseCost_99BF528834533C7D15A8952367E03AA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_FB708ABBA930BB63CF619524690B813F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C8D09BF71FE5FFB3A6BE9523044C4320" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_FB708ABBA930BB63CF619524690B813F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/LeasesLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9D1780696C526CB4857F9526C0DC70CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9D1780696C526CB4857F9526C0DC70CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6D6E658443A315C88B0F9526D9C598E8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6D6E658443A315C88B0F9526D9C598E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D09AF55AE300D483332B9526F4CB2324" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D09AF55AE300D483332B9526F4CB2324" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_293D8971F5400655CF6995270C091F6A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_293D8971F5400655CF6995270C091F6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15E7521FA5894C1894B295271F6FAAB2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15E7521FA5894C1894B295271F6FAAB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_F7E3FBB33A688E6317E7952732FB2545" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_F7E3FBB33A688E6317E7952732FB2545" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B54EA29E60CC3ED62308952747F44526" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B54EA29E60CC3ED62308952747F44526" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D87179C80E427CBE200995276AA28089" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D87179C80E427CBE200995276AA28089" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_9A87B7A3496848C199269527A2190551" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8D8AF4E6B7FCCB41F198952696492DC2" xlink:to="loc_us-gaap_OperatingLeaseLiability_9A87B7A3496848C199269527A2190551" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseNumberOfContracts" xlink:label="loc_cerc_LesseeOperatingLeaseNumberOfContracts_3EF6831CCD2FF754AEC09A25F38A0426" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_cerc_LesseeOperatingLeaseNumberOfContracts_3EF6831CCD2FF754AEC09A25F38A0426" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_FD392E41295EA99D8D919A25F38ADACE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_FD392E41295EA99D8D919A25F38ADACE" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_OperatingLeasesRentExpenseAnnualIncreasePercent" xlink:label="loc_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent_759F538F779EB33B2E019A25F38BFD1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_31B3452CF51C503B29169A25F38BB362" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_31B3452CF51C503B29169A25F38BB362" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:label="loc_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_cerc_LesseeOperatingLeaseNumberOfRenewalOptions_5BC278CCA7A6702218BA9A25F38BE079" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_A777E4167C895675F3FC9A25F38BA812" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_A777E4167C895675F3FC9A25F38BA812" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseRemainingLeaseTeam" xlink:label="loc_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_cerc_LesseeOperatingLeaseRemainingLeaseTeam_626C3627194587F8FD6A9A25F38BEA6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_1BF144211828051DEB219A25F38C70C8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_1BF144211828051DEB219A25F38C70C8" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseRentAbatement" xlink:label="loc_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_cerc_LesseeOperatingLeaseRentAbatement_F5BF91D2D4E780A246C49A25F38C8534" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_DDAD19E1C62685F30D4B9A25F38C4B51" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0BEEC74AB22A2574D7469A25F38A468D" xlink:to="loc_us-gaap_OperatingLeasePayments_DDAD19E1C62685F30D4B9A25F38C4B51" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_A02521393C89E2AD3756950E4EB765D8" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:label="loc_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A02521393C89E2AD3756950E4EB765D8" xlink:to="loc_cerc_AssetsAndLiabilitiesLesseeTableTextBlock_93E6B56EAE5B2F522BF5951EBDD05C0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_38DCF2BBFECAE8C433D2952287216F52" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A02521393C89E2AD3756950E4EB765D8" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_38DCF2BBFECAE8C433D2952287216F52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0E80E6A713DA2BFBBCC09525C1C36BA7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A02521393C89E2AD3756950E4EB765D8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0E80E6A713DA2BFBBCC09525C1C36BA7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_E0970178178CF0232CB598E1726BC2C1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_6F64B0574BE9DA47B54798E1726BC788" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_E0970178178CF0232CB598E1726BC2C1" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_6F64B0574BE9DA47B54798E1726BC788" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/NetLossPerShareAntiDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_112BB8B884922CCC15B194C84E6FD1D5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1B366B4C212232B1AEB294C84E6F5DC6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_112BB8B884922CCC15B194C84E6FD1D5" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1B366B4C212232B1AEB294C84E6F5DC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_D37D4F103DDB12E0A3AF94C84E6F2042" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1B366B4C212232B1AEB294C84E6F5DC6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_D37D4F103DDB12E0A3AF94C84E6F2042" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_D37D4F103DDB12E0A3AF94C84E6F2042" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeConsultantsAndDirectorsStockOptionsMember" xlink:label="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_B9AE5686E43456EB96CD94C84E70D233" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:to="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_B9AE5686E43456EB96CD94C84E70D233" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_WarrantCommonStockMember" xlink:label="loc_cerc_WarrantCommonStockMember_196E1F42F7EA9090AB4594C84E700002" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:to="loc_cerc_WarrantCommonStockMember_196E1F42F7EA9090AB4594C84E700002" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_RestrictedStockAwardsMember" xlink:label="loc_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:to="loc_cerc_RestrictedStockAwardsMember_00BED27628D7EF851A3394C84E7049A2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_UnderwritersUnitPurchaseOptionMember" xlink:label="loc_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_90DC272648940F5B78CD94C84E6F4D12" xlink:to="loc_cerc_UnderwritersUnitPurchaseOptionMember_B2934CC911388D3DBF3894C84E70CD32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22C5FCE90C6EEFB79AF094C84E70B201" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1B366B4C212232B1AEB294C84E6F5DC6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22C5FCE90C6EEFB79AF094C84E70B201" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22C5FCE90C6EEFB79AF094C84E70B201" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_EE2577B272F7CEB922CB94C84E718C5F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/NetLossPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8EE5BF4F90BFB853E9C49459813C5738" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8EE5BF4F90BFB853E9C49459813C5738" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:to="loc_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_B7AD6BE9434DCC088A429459813C5C48" xlink:to="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9BC402F6D0E0AEA5FE959459813D0E2B" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_3977227712D91583BB589459813DA2BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_FDACBF08B9CC0DEC336D9459813D5DCF" xlink:to="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F8BD2F362D9C02F09C1B9459813D567E" xlink:to="loc_us-gaap_PreferredStockMember_4B567E5711899A46C41C9459813E3A7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_784C82BEF5CC10D18D399459813ED4EE" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_E67D5F944EB487B838849459813E92BC" xlink:to="loc_us-gaap_PrivatePlacementMember_7A1E4B8AC7A7E1FBECB49459813E533F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6F80F168C3A76FC521319459813C508C" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4043B31C8B01A691726C9459813F59C5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockholdersEquityNotePreferredStockConversionRatio" xlink:label="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3104308FB681779158869459813FCC59" xlink:to="loc_cerc_StockholdersEquityNotePreferredStockConversionRatio_4CC4A80470DFB6BEF3189459813F7589" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/NetLossPerShareOfCommonStockBasicAndDilutedTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_35697E54D365FBDAF7C99392C4149ADA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7FDFA6C23AEFC8B988F49392C4145FCE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35697E54D365FBDAF7C99392C4149ADA" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7FDFA6C23AEFC8B988F49392C4145FCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_588EFD44D86F23E8998F9392C414A1C8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35697E54D365FBDAF7C99392C4149ADA" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_588EFD44D86F23E8998F9392C414A1C8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/NetLossPerShareScheduleOfEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_60AFC9BA1567A4C0728494C84E749568" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_60AFC9BA1567A4C0728494C84E749568" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_15B9C56483FD4BC5568594C84E749830" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:to="loc_us-gaap_StatementClassOfStockAxis_15B9C56483FD4BC5568594C84E749830" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_15B9C56483FD4BC5568594C84E749830" xlink:to="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_19B4CBAE0838944FFAEA94C84E7530F6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447" xlink:to="loc_us-gaap_CommonStockMember_19B4CBAE0838944FFAEA94C84E7530F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_8C1EDB12FC68CC3A577894C84E75DB90" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_67EDE58984A9B74319C894C84E757447" xlink:to="loc_us-gaap_PreferredStockMember_8C1EDB12FC68CC3A577894C84E75DB90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_06081B14EC4F2F6347BD94C84E74EB36" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_BB5C6BB01C559FCDB6F294C84E752169" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_01AA18570A982163D2DC94C84E7643D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_D6B6C2B268ACFD847EDF94C84E76A922" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_CC3375268B0D2E6D6B9D94C84E75FCA4" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_D6B6C2B268ACFD847EDF94C84E76A922" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/RevenueFromContractsWithCustomers" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_C10E53A838BBC2C3BDF298E1727A6CFE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8F4B8DF53EE87E234FAD98E1727A47A2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_C10E53A838BBC2C3BDF298E1727A6CFE" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8F4B8DF53EE87E234FAD98E1727A47A2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/RevenueFromContractsWithCustomersDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_88F03EB807DE174745DD93A9296DC6A5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_88F03EB807DE174745DD93A9296DC6A5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_61DFF4549FB3BC25A72093B0CECAD67F" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_0DA105A3C9FD793468A493B0CECBD1F3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_BE14AB8841BD86A8BA2093B0CFBF5632" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_DFFF3025A1B4A9C4226893AD6751871A" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F3FD6082222F25B19F3393AD676232FC" xlink:to="loc_us-gaap_SalesRevenueNetMember_11A82251DB09457B9EF393B0D164F12C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_AF40D29485EABA1FF0FB93AADE3B0DE5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="loc_srt_ProductOrServiceAxis_AF40D29485EABA1FF0FB93AADE3B0DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_AF40D29485EABA1FF0FB93AADE3B0DE5" xlink:to="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PrescribedDietarySupplementsMember" xlink:label="loc_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:to="loc_cerc_PrescribedDietarySupplementsMember_7289B1477CF45396C3EF93AB67784CAE" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_PrescriptionDrugsMember" xlink:label="loc_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:to="loc_cerc_PrescriptionDrugsMember_4695BB6715C5A5FFCDE193AB79E13E94" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SalesForceRevenueMember" xlink:label="loc_cerc_SalesForceRevenueMember_3C10058939522B19AF0193AB9A4FD2EC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_32197DCEA573E1FF0A7D93AADE3C3E26" xlink:to="loc_cerc_SalesForceRevenueMember_3C10058939522B19AF0193AB9A4FD2EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="loc_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_1A9D78D8B7E9EF671ED193AADE472E68" xlink:to="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MajorCustomerNumberOneMember" xlink:label="loc_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:to="loc_cerc_MajorCustomerNumberOneMember_E371E378BAAEF390387993B0CE0F9539" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MajorCustomerNumberTwoMember" xlink:label="loc_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:to="loc_cerc_MajorCustomerNumberTwoMember_2F21DEF648AAF0DEADAA93B105E31ADC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_MajorCustomerNumberThreeMember" xlink:label="loc_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_F1C0471D48368288CB0D93AADE484DCA" xlink:to="loc_cerc_MajorCustomerNumberThreeMember_54BDF0EE34A0EF800B8393B1488B98AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_82A7BDD60DEE5C4538E593AADE3BA81A" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F8C4B57E4BAF9BD5B25593AB1BF2026A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F8C4B57E4BAF9BD5B25593AB1BF2026A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_34B58E5461C595F4611893AADE489807" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_B79CBB333C9681C25CC793AD2782A110" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/RevenueFromContractsWithCustomersTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_AC297AEFB9C469C613EC93A92967AAAB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8E7E88DB881C5F119F4593AA6A437091" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_AC297AEFB9C469C613EC93A92967AAAB" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8E7E88DB881C5F119F4593AA6A437091" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_53C82C49C40DFCCC6E7098DEC4F063DF" xlink:type="locator" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfSignificantAccountingPoliciesTable" xlink:label="loc_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_53C82C49C40DFCCC6E7098DEC4F063DF" xlink:to="loc_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_66B82504129D0D816E5198DEC4F5CDFE" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember_9E5B3B647778E62AEA2198DEC4F6D713" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_4B2DC594B7175132C36098DEC4F6DD27" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ScheduleOfSignificantAccountingLineItems" xlink:label="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_ScheduleOfSignificantAccountingPoliciesTable_71D7A8A435FCFB36407E98DEC4F578C1" xlink:to="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustment_E4B69BD2496154E9735B98DEC4F63CA2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_LesseeOperatingLeaseNumberOfContracts" xlink:label="loc_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="loc_cerc_LesseeOperatingLeaseNumberOfContracts_64F50D7FB716F500346098DEC4F7CD4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_644A2F836FB46EE54A3598DEC4F786A7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="loc_us-gaap_OperatingLeaseLiability_644A2F836FB46EE54A3598DEC4F786A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cerc_ScheduleOfSignificantAccountingLineItems_3EACFE65C42356259F4898DEC4F62A51" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_D4D751FEE08990F0507198DEC4F7BEC0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_C2E8C436F6817976424698A29CEFF78D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5BE16A491CBAA476E5C498A29CEF07C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C2E8C436F6817976424698A29CEFF78D" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5BE16A491CBAA476E5C498A29CEF07C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60368AA67DCEC69DFE2398A29CEFB715" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C2E8C436F6817976424698A29CEFF78D" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60368AA67DCEC69DFE2398A29CEFB715" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_FB7AB0BCF6B32312E30098A29CF0E8C5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C2E8C436F6817976424698A29CEFF78D" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_FB7AB0BCF6B32312E30098A29CF0E8C5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_6F56092EC8FA0CECD0FA8DD5284121AB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A3294D27B960980A78DD52841869C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_6F56092EC8FA0CECD0FA8DD5284121AB" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_E46A3294D27B960980A78DD52841869C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_20029A2D4A1A7F89823694C84D0E1F7E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_20029A2D4A1A7F89823694C84D0E1F7E" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_FF3F36E5FCB435A0196D94EDEC74C3D6" xlink:to="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34F08B6F3A188BD4971694EE1C6C7491" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_F8CC8AAC70347F685BA194EF553E2592" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_7B187E7DC5C5C8076FDC94EE61329337" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_656BD967DEB5B3E723B494FA10A2C0A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_95DE1ADB5A85F4F6D97694EA91E1E58C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0E1BB18D07CA0FC9DC5994EA91E5C53A" xlink:to="loc_us-gaap_SubsequentEventMember_1A2109648593AD386EC894EAB8909823" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_D55A2B340ADBAF01391594C84D0EE773" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeMember" xlink:label="loc_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:to="loc_cerc_EmployeeMember_C2AA84DAD3A300075B2894C84D0F406F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:to="loc_us-gaap_DirectorMember_C7BF10DC81BB136A79F594C84D0F7EB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="loc_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_720AF809EAF677D6C9A894C84D0E63C2" xlink:to="loc_us-gaap_BoardOfDirectorsChairmanMember_CA7FF52E2E7A40F48DCE94F192389F22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9A639D12F5A57EFFA24694C84D0F195B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9A639D12F5A57EFFA24694C84D0F195B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0DC61D8DE0A7C3C2415994C84D0F5807" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9A639D12F5A57EFFA24694C84D0F195B" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0DC61D8DE0A7C3C2415994C84D0F5807" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeStockPurchasePlanESPPMember" xlink:label="loc_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0DC61D8DE0A7C3C2415994C84D0F5807" xlink:to="loc_cerc_EmployeeStockPurchasePlanESPPMember_EF7BE5210F898C79C6E594C84D0F5D13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_477945821CBC6891898F94C84D107B0A" xlink:to="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_The2016PlanMember" xlink:label="loc_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:to="loc_cerc_The2016PlanMember_DBAA4BB738107348895E94C84D10CCAC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_The2015PlanMember" xlink:label="loc_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_627A8ECD6E30E897A00194C84D1032F7" xlink:to="loc_cerc_The2015PlanMember_A832541797FABA9D412194C84D1079F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C04072106B1A5F94CD1D94C84D116CF1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_srt_RangeAxis_C04072106B1A5F94CD1D94C84D116CF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_C04072106B1A5F94CD1D94C84D116CF1" xlink:to="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_9DB815BD17B152D47EED94C84D11CADA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD" xlink:to="loc_srt_MinimumMember_9DB815BD17B152D47EED94C84D11CADA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_941086BE1491115B810994C84D11DFCD" xlink:to="loc_srt_MaximumMember_9A542BBDCB8320F78F9494C84D11F591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_95F927CF7B4C71144FFD94C84D12E988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ServiceBasedOptionsMember" xlink:label="loc_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:to="loc_cerc_ServiceBasedOptionsMember_BF4D283A7B7A5AF9FA7494C84D12B3D6" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_StockOptionsWithMarketBasedVestingConditionsMember" xlink:label="loc_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:to="loc_cerc_StockOptionsWithMarketBasedVestingConditionsMember_2FD55616494381C5AB5094C84D128D23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:to="loc_us-gaap_RestrictedStockMember_5DB3299867A0D01648ED94C84D1275A5" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_EmployeeConsultantsAndDirectorsStockOptionsMember" xlink:label="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1DD46CA7AC064E0EA28894C84D12D318" xlink:to="loc_cerc_EmployeeConsultantsAndDirectorsStockOptionsMember_37DD85CFEFDAE5F18E9D94C84D130148" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2B3BE04979C1B295E26794C84D135E68" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_E67477DBF3585A2268FD94C84D133154" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_923CD49DEE24022D104A94C84D1330FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7E41ADFCECD40ADBD22394C84D13267C" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_4ACE74317EA3E53D92A794C84D14CB14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E3F7518D2EB7FFF13D4194C84D0E2A9E" xlink:to="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease_E6E821BFF8D584C9953794C84D14F8F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D3B4A14C1FB7BC10C3F494C84D143755" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent_1D430CF0D75F6DD607CA94C84D14A477" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_761BB334A99961771DA494C84D15CB21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D83ECDF490D01FE9E31394C84D156387" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_07C040DC7CE9C7C6EA0E94C84D15A878" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_A75E2B8BD492132B108094C84D154887" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C56BD1DA448174501CE294C84D159A1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B67617F829B7C471F8D94C84D165CD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ECE96E675A9467A713894C84D167FAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4114CB3F805B571D3C6094C84D169E3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20668465E23518AE324994C84D16387A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20668465E23518AE324994C84D16387A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D6AE8D775B4646EB6B8D94C84D15F378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_E06829E8E2CA1415E54A94C84D162D5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6B242831C0CFD2192FDC94C84D1736F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_AEE3B310C558AEC5641B94C84D17A71E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9287083876571654342E94C84D1CC446" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_FABA4AF5377A440D32AB94C84D1CA8B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_B7BB9E2495CCC3DA007D94C84D1CBDD5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_B7BB9E2495CCC3DA007D94C84D1CBDD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_B838B4220BE943DC255594C84D16723A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9E568A12736928E4106E94C84D1DE029" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent_78A8344EFAD436330E5694EDA720F781" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_2394C14FEB1707D685FC94C84D1D3F3B" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_BB7DBE78A61D9C1BD72894C84D1DBCBB" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_59D2FCEA307D9DAEF23994C84D239383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5FB0D0275F48E20F60F394C84D1E1D59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_BBC4707944C5BF0EBC0994C84D1D0E75" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2CA40384CA95AA7CD1F994C84D1EE10C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_69F471C0416EAFE8FDC894C84D1EFA3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0A94DE15FB7F3F92EFFA94CE02AEA5F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_DDF99FBC1FDA772E7DB794CE0356A91A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1FF75248B0B1187A1F8C94C84D1E9866" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_A13316A7AB1401234F3B94C84D1E80A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C3E6C79C77A83E9F2F8B94C84D1E9FB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_71C234188F23A806528294C84D1F5F18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_601110E1D2C46031408F94C84D1E260D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C0266FD49AB5D072C3B794C84D1F1A36" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor_6B2CE72B9D1FA50257B694D62F6131EC" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod_97AEBB2329519F1673C394D7EA93C46C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7DA669A069C7603E60B094C84D1F987A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20BEA9B675AABFC5DC7E94C84D1F4F9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_B2BA9E0BDE404B25083F94C84D204330" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5A67AC3A4EB3C7EBAA5194C84D1FE885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_E7FB2B016088FF40A07C94C84D20A119" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A979051D1E330788FA3494C84D20EF2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4BA1A628D6802B1314D894C84D219E21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0F366F8FDF08FD49D7E494C84D217B76" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_04FD57489715B4780A3F94C84D205F03" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0F366F8FDF08FD49D7E494C84D217B76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_383FBDAC29B8B1B41FB894C84D21B8AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9376518624C7D22F051C94C84D216D54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5C0D60A553BB5A3C3D0494C84D22537D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4B0592BB980C59DA834B94C84D22C4C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2AB70141B4B1897DA43394C84D227445" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum" xlink:label="loc_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum_2A26B1ED267225BC236594C84D2295FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_E1C782CA030A58F30D4594C84D234446" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear" xlink:label="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear_E8198E11208BE55CCD6794C84D23EC18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_8195C1932C29F71E556C94C84D23B0E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB" xlink:type="locator" />
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1C69B27BE1B5290AED9894FBB574D3FB" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments" xlink:label="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:type="locator" />
    <link:presentationArc order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments_86D89EC32729626974BF94FF15A2A1C2" xlink:type="arc" />
    <link:loc xlink:href="cerc-20190331.xsd#cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards" xlink:label="loc_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:type="locator" />
    <link:presentationArc order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7FA397C04DEF4628B2BD94C84D147A49" xlink:to="loc_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards_97AA338313B815D013729500A1DF5C9A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerecor.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2F1AFF958EDB2742A4BA8DD5275FA425" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2F1AFF958EDB2742A4BA8DD5275FA425" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00799396814B8DA080138DD5275F5099" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00799396814B8DA080138DD5275F5099" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2A4C2EEED9C69F8F4B8F8DD5275F19C3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2A4C2EEED9C69F8F4B8F8DD5275F19C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_E3AA0E3B7E5272437BB68DD5275F9C1E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_B5E52A24491DD821D8708DD5275F8033" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_E3AA0E3B7E5272437BB68DD5275F9C1E" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>pipelinechart10q1a01.jpg
<TEXT>
begin 644 pipelinechart10q1a01.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ,2!70# 2(  A$! Q$!_\0
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MA_%OQQ;6WCCQ':P6^N7T,<=OJUPB(JW#@*H#\  # ]JXW_AH#XA?]%"\5?\
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MQ<+Y_A_D'UZL>D_\- ?$+_HH7BK_ ,'-S_\ %T?\- ?$+_HH7BK_ ,'-S_\
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MTNK_ '6-/K>(Y.>VG>SL=E_PT!\0O^BA>*O_  <W/_Q='_#0'Q"_Z*%XJ_\
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M_P 77FU%']BX7S_#_(/KU8])_P"&@/B%_P!%"\5?^#FY_P#BZ/\ AH#XA?\
M10O%7_@YN?\ XNO-J*/[%POG^'^0?7JQZ3_PT!\0O^BA>*O_  <W/_Q='_#0
M'Q"_Z*%XJ_\ !S<__%UYM11_8N%\_P /\@^O5CTG_AH#XA?]%"\5?^#FY_\
MBZ/^&@/B%_T4+Q5_X.;G_P"+KS:BC^Q<+Y_A_D'UZL>D_P##0'Q"_P"BA>*O
M_!S<_P#Q='_#0'Q"_P"BA>*O_!S<_P#Q=>;44?V+A?/\/\@^O5CTG_AH#XA?
M]%"\5?\ @YN?_BZ/^&@/B%_T4+Q5_P"#FY_^+KS:BC^Q<+Y_A_D'UZL>D_\
M#0'Q"_Z*%XJ_\'-S_P#%T?\ #0'Q"_Z*%XJ_\'-S_P#%UYM11_8N%\_P_P @
M^O5CTG_AH#XA?]%"\5?^#FY_^+H_X: ^(7_10O%7_@YN?_BZ\VHH_L7"^?X?
MY!]>K'I/_#0'Q"_Z*%XJ_P#!S<__ !='_#0'Q"_Z*%XJ_P#!S<__ !=>;44?
MV+A?/\/\@^O5CZ%U;5/C7HOPCT?XE77CGQ&OA75KIK.UF7Q!.9&D#2J04WY
MS!)S[#UK@_\ AH#XA?\ 10O%7_@YN?\ XNO?_B/_ ,HS?A?_ -C%+_Z.U&OC
M>N+"Y70K*;E?237W/T.BMBZE-QMU2?WGI/\ PT!\0O\ HH7BK_P<W/\ \71_
MPT!\0O\ HH7BK_P<W/\ \77FU%=O]BX7S_#_ ".?Z]6/2?\ AH#XA?\ 10O%
M7_@YN?\ XNC_ (: ^(7_ $4+Q5_X.;G_ .+KS:BC^Q<+Y_A_D'UZL>D_\- ?
M$+_HH7BK_P '-S_\71_PT!\0O^BA>*O_  <W/_Q=>;44?V+A?/\ #_(/KU8]
M)_X: ^(7_10O%7_@YN?_ (NC_AH#XA?]%"\5?^#FY_\ BZ\VHH_L7"^?X?Y!
M]>K'I/\ PT!\0O\ HH7BK_P<W/\ \71_PT!\0O\ HH7BK_P<W/\ \77FU%']
MBX7S_#_(/KU8])_X: ^(7_10O%7_ (.;G_XNC_AH#XA?]%"\5?\ @YN?_BZ\
MVHH_L7"^?X?Y!]>K'I/_  T!\0O^BA>*O_!S<_\ Q='_  T!\0O^BA>*O_!S
M<_\ Q=>;44?V+A?/\/\ (/KU8])_X: ^(7_10O%7_@YN?_BZ/^&@/B%_T4+Q
M5_X.;G_XNO-J*/[%POG^'^0?7JQZ3_PT!\0O^BA>*O\ P<W/_P 71_PT!\0O
M^BA>*O\ P<W/_P 77FU%']BX7S_#_(/KU8])_P"&@/B%_P!%"\5?^#FY_P#B
MZ/\ AH#XA?\ 10O%7_@YN?\ XNO-J*/[%POG^'^0?7JQZ3_PT!\0O^BA>*O_
M  <W/_Q='_#0'Q"_Z*%XJ_\ !S<__%UYM11_8N%\_P /\@^O5CTG_AH#XA?]
M%"\5?^#FY_\ BZ/^&@/B%_T4+Q5_X.;G_P"+KS:BC^Q<+Y_A_D'UZL>D_P##
M0'Q"_P"BA>*O_!S<_P#Q='_#0'Q"_P"BA>*O_!S<_P#Q=>;44?V+A?/\/\@^
MO5CTG_AH#XA?]%"\5?\ @YN?_BZ/^&@/B%_T4+Q5_P"#FY_^+KS:BC^Q<+Y_
MA_D'UZL>D_\ #0'Q"_Z*%XJ_\'-S_P#%T?\ #0'Q"_Z*%XJ_\'-S_P#%UYM1
M1_8N%\_P_P @^O5CTG_AH#XA?]%"\5?^#FY_^+H_X: ^(7_10O%7_@YN?_BZ
M\VHH_L7"^?X?Y!]>K'I/_#0'Q"_Z*%XJ_P#!S<__ !='_#0'Q"_Z*%XJ_P#!
MS<__ !=>;44?V+A?/\/\@^O5CTG_ (: ^(7_ $4+Q5_X.;G_ .+H_P"&@/B%
M_P!%"\5?^#FY_P#BZ\VHH_L7"^?X?Y!]>K'I/_#0'Q"_Z*%XJ_\ !S<__%T?
M\- ?$+_HH7BK_P '-S_\77FU%']BX7S_  _R#Z]6/2?^&@/B%_T4+Q5_X.;G
M_P"+H_X: ^(7_10O%7_@YN?_ (NO-J*/[%POG^'^0?7JQZ3_ ,- ?$+_ **%
MXJ_\'-S_ /%T?\- ?$+_ **%XJ_\'-S_ /%UYM11_8N%\_P_R#Z]6/2?^&@/
MB%_T4+Q5_P"#FY_^+H_X: ^(7_10O%7_ (.;G_XNO-J*/[%POG^'^0?7JQZ3
M_P - ?$+_HH7BK_P<W/_ ,71_P - ?$+_HH7BK_P<W/_ ,77FU%']BX7S_#_
M "#Z]6/2?^&@/B%_T4+Q5_X.;G_XNC_AH#XA?]%"\5?^#FY_^+KS:BC^Q<+Y
M_A_D'UZL>D_\- ?$+_HH7BK_ ,'-S_\ %T?\- ?$+_HH7BK_ ,'-S_\ %UYM
M11_8N%\_P_R#Z]6/2?\ AH#XA?\ 10O%7_@YN?\ XNC_ (: ^(7_ $4+Q5_X
M.;G_ .+KS:BC^Q<+Y_A_D'UZL>D_\- ?$+_HH7BK_P '-S_\71_PT!\0O^BA
M>*O_  <W/_Q=>;44?V+A?/\ #_(/KU8])_X: ^(7_10O%7_@YN?_ (NC_AH#
MXA?]%"\5?^#FY_\ BZ\VHH_L7"^?X?Y!]>K'I/\ PT!\0O\ HH7BK_P<W/\
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MR/R9_:!_Y+)\0O\ L8M0_P#2F2O-J])_:!_Y+)\0O^QBU#_TIDKS:OT;)?\
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M]#7SI^S_ /M&?#J3]F/4OA+XR\0ZEX#NR9EBUK3[:6;S5DE\W(\I68'.592
M"O1N3CK?#'QR^!GPR_9S\<^ =!\>:EK>IZA97@2[U'3;I3?7,ML$'ECRR(TR
M%4!R,$$G(Y/1C*%3VLW3IM.+7*TI/16UO>R]+7_,G!U(6A[2>C;YKM+?O?5W
M_K0[?]F'Q5I?@?\ 8';Q#K.E1:W8:6;V[.GS*"D\B73-&IR"!\X3G!QC/:NL
M_9[^,&A_MF?#O7AXU\%:88]%O8\V;K]HA9<;XV7<,AAM((Z$>Q(KYB\&?M >
M M)_81UCX=W6O>5XQN([E8]-^QW!W%[G>O[P1^6,KSRU2?L(?M!> ?@SX/\
M'%CXQU[^Q[K4IH7M8_L=Q/Y@6-P3F*-@.2.N*G$X.<HXJLH/G33COW5VN_\
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M1M__ $:M?1__  4I_P"3CD_[ MK_ .A2U\X> _\ D>/#O_81M_\ T:M?1_\
MP4I_Y..3_L"VO_H4M>94_P!]I?X9?H=L/]VGZK]3Y4HHHKTSB"BBB@#H!\0_
M%0\*_P#",#Q-K \-?] ;[?+]C^_O_P!3NV??^;IUYZUS]%%)12NTMQMMZ,Z
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M!_P4(_:*US4_%7B#X32:=IZZ)8W%I=)>JLGVEF\E9,$[MN,R'^'H!7A_P_\
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M!AI4Z:IQJ-77/;R;>C?D>O\ P]\7>&_^"@WPG\5Z?XG\+6>D>)]&4)!J%O\
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M[$K@D5]7?"GQ+^RMXF^%VAZ'X^TF_P##WB338#'<:ND,Y>ZD9BS.'M]V\9.
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M3-D*$C5<[O2HKPES2GB8N7N+EUMRNVM]5;76Y4912E"A)1]]W[-7T2^6EO\
MAWS7BWX,Z-\9O^"@VIVWB&!;S1M(T.VU&6S?[EPRA$1&]5R^XCOMP>#7M_\
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MOTWW"BBBNPY HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX#_Y'CP[_P!A&W_]&K7T?_P4I_Y..3_L"VO_ *%+7SAX#_Y'CP[_ -A&W_\
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M "=9X._ZYWW_ *1S5Q8[_=:O^%_D=&'_ (T/5?F>=?M$?\E_^)?_ &,NI?\
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M\*_(****]0XPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KV+X&_M2^*_@!H.OZ3X>T_1[RVUI
ME:X;4X99'7"LHV%)4 X8]0:\=HK.K2A6@Z=17B]T5&3IS4XZ-;?D%%%%:$A1
M110 4444 %%%% !1110 4444 %%%% !1110!Z)\%_CYXP^ >N7.I>$KV& W:
MJEW:W4"RPW"J25# _,,$GE2#SUKVW6O^"E_Q;U;2Y[2WM/#>D32+M%[96,IF
MC]U\R9TS]5-?)U%<E;!X>O+GJP39O3KU:2M"5BUJNJWFN:G=ZCJ%S+>W]U*T
MT]Q,Q9Y'8Y9F)ZDDU5HHKJ2459&+;D[O<****8@HHHH **** "BBB@ HHHH
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M/^%3^"/^A-\/_P#@K@_^(H_UBA_S[?WA_94OY_P/PJHK]U?^%3^"/^A-\/\
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M'V;T7<F65RE)OG_ _"JBOW5_X5/X(_Z$WP__ ."N#_XBC_A4_@C_ *$WP_\
M^"N#_P"(K3_6*'_/M_>3_94OY_P/PJHK]U?^%3^"/^A-\/\ _@K@_P#B*/\
MA4_@C_H3?#__ (*X/_B*/]8H?\^W]X?V5+^?\#\*J*_=7_A4_@C_ *$WP_\
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MA_94OY_P/PJHK]U?^%3^"/\ H3?#_P#X*X/_ (BC_A4_@C_H3?#_ /X*X/\
MXBC_ %BA_P ^W]X?V5+^?\#\*J*_=7_A4_@C_H3?#_\ X*X/_B*/^%3^"/\
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M?\*G\$?]";X?_P#!7!_\11_K%#_GV_O#^RI?S_@?A517[J_\*G\$?]";X?\
M_!7!_P#$4?\ "I_!'_0F^'__  5P?_$4?ZQ0_P"?;^\/[*E_/^!^%5%?NK_P
MJ?P1_P!";X?_ /!7!_\ $4?\*G\$?]";X?\ _!7!_P#$4?ZQ0_Y]O[P_LJ7\
M_P"!^%5%?NK_ ,*G\$?]";X?_P#!7!_\11_PJ?P1_P!";X?_ /!7!_\ $4?Z
MQ0_Y]O[P_LJ7\_X'X545^ZO_  J?P1_T)OA__P %<'_Q%'_"I_!'_0F^'_\
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MG\$?]";X?_\ !7!_\11_K%#_ )]O[P_LJ7\_X'X545^ZO_"I_!'_ $)OA_\
M\%<'_P 11_PJ?P1_T)OA_P#\%<'_ ,11_K%#_GV_O#^RI?S_ ('X545^ZO\
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M#^RI?S_@?A517[J_\*G\$?\ 0F^'_P#P5P?_ !%'_"I_!'_0F^'_ /P5P?\
MQ%'^L4/^?;^\/[*E_/\ @?A517[J_P#"I_!'_0F^'_\ P5P?_$4?\*G\$?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M #Z8_P"V,!_S^1] T5X /VU/!!_YA7B#_P !X/\ X]2C]M+P0?\ F%Z__P"
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M\_4>V45XI_PUEX1_Z!VM?]^(?_CM.'[6'A$_\P[6O^_$/_QVE_9N+_Y]L?\
M:F#_ .?J/::*\8_X:L\)'_F':U_WXA_^.T[_ (:I\)G_ )A^L_\ ?B'_ ..T
M?V;B_P#GVQ_VG@_^?B/9:*\;_P"&IO"G_0/UG_OS%_\ ':</VI/"I_YA^L?]
M^8O_ ([2_L[%_P#/MA_:6#_Y^(]BHKQ\?M0>%3_S#]8_[\Q?_':=_P -/>%O
M^?#6/^_,7_QVC^S\5_S[8_[2PG_/Q'KU%>1?\--^%S_RX:O_ -^8O_CE.'[3
M'A<_\N&K_P#?F+_XY2_L_%?\^V/^T<)_S\1ZW17DP_:4\,'_ )<=6_[\Q?\
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M3H>H)K<7V'?I:VDGVA-NHQNW[O&X84%NG &>E?3]%/F=[^:?EIV0N7^O7S/
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M;HR,T /T/H>QI1]Z47:ZO+YVA>WY:C=E&2O9VC\KR2O^>A[S[UXC\/?CY?\
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M[X3:#*OV5M8BANYX5X"R3F-!^67_ #K2=-5Y1C"W+*5M%9]_R"/N/FGT3?\
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M!LR !]TXQFN%_P"&((;FZAM;SQ[JUSX<ADW1:6T/S(OH'+E0<=Q'^%?32<8
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MC[WA'^/5]%^9V%%%%?FQ^H!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<AX/\  '_")^+/&>M?;_M7_"17L-YY'D[/L^R!
M(MN[<=V=F<X'7&.]=?136FJ]/R?Z(/(****0!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK-;_ )^+[F?GPM2KTK] _P#A6/@[_H4]#_\ !;#_ /$TO_"LO!__ $*>A_\
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M &%V_P#1+UI3^)&=3X6>]_LN_P#)O'P]_P"P/;_^@T4?LN_\F\?#W_L#V_\
MZ#142W94=D?F!X\_Y.+\>?\ 8>U+_P!*)*T*S_'G_)Q?CS_L/:E_Z425H5^L
M\.?[D_\ $_R1^/\ $W^_+_"OS85):HDES$DC;$9P&;.,#/)J.E52S!0,DG
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M #^+_P!\-_A1_P )9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\ ?#?X4?\
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M_P )9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\ ?#?X4?\ "6:3_P _B_\
M?#?X4 :]%9'_  EFD_\ /XO_ 'PW^%'_  EFD_\ /XO_ 'PW^% &O161_P )
M9I/_ #^+_P!\-_A1_P )9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\ ?#?X
M4?\ "6:3_P _B_\ ?#?X4 :]%9'_  EFD_\ /XO_ 'PW^%'_  EFD_\ /XO_
M 'PW^% &O161_P )9I/_ #^+_P!\-_A1_P )9I/_ #^+_P!\-_A0!KT5D?\
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M_P )9I/_ #^+_P!\-_A1_P )9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\
M?#?X4?\ "6:3_P _B_\ ?#?X4 :]%9'_  EFD_\ /XO_ 'PW^%'_  EFD_\
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M!KT5D?\ "6:3_P _B_\ ?#?X4?\ "6:3_P _B_\ ?#?X4 :]%9'_  EFD_\
M/XO_ 'PW^%'_  EFD_\ /XO_ 'PW^% &O161_P )9I/_ #^+_P!\-_A1_P )
M9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\ ?#?X4?\ "6:3_P _B_\ ?#?X
M4 :]%9'_  EFD_\ /XO_ 'PW^%'_  EFD_\ /XO_ 'PW^% &O161_P )9I/_
M #^+_P!\-_A1_P )9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\ ?#?X4?\
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M_P )9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\ ?#?X4?\ "6:3_P _B_\
M?#?X4 :]%9'_  EFD_\ /XO_ 'PW^%'_  EFD_\ /XO_ 'PW^% &O161_P )
M9I/_ #^+_P!\-_A1_P )9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\ ?#?X
M4?\ "6:3_P _B_\ ?#?X4 :]%9'_  EFD_\ /XO_ 'PW^%'_  EFD_\ /XO_
M 'PW^% &O161_P )9I/_ #^+_P!\-_A1_P )9I/_ #^+_P!\-_A0!KT5D?\
M"6:3_P _B_\ ?#?X4?\ "6:3_P _B_\ ?#?X4 :]%9'_  EFD_\ /XO_ 'PW
M^%'_  EFD_\ /XO_ 'PW^% &O161_P )9I/_ #^+_P!\-_A1_P )9I/_ #^+
M_P!\-_A0!KT5D?\ "6:3_P _B_\ ?#?X4?\ "6:3_P _B_\ ?#?X4 :]%9'_
M  EFD_\ /XO_ 'PW^%'_  EFD_\ /XO_ 'PW^% &O161_P )9I/_ #^+_P!\
M-_A1_P )9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\ ?#?X4?\ "6:3_P _
MB_\ ?#?X4 :]%9'_  EFD_\ /XO_ 'PW^%'_  EFD_\ /XO_ 'PW^% &O161
M_P )9I/_ #^+_P!\-_A1_P )9I/_ #^+_P!\-_A0!KT5D?\ "6:3_P _B_\
M?#?X4?\ "6:3_P _B_\ ?#?X4 :]%9'_  EFD_\ /XO_ 'PW^%'_  EFD_\
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M 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\
MGFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R
M(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B
M@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?
M(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:
M_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_
M .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*
M/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_
M 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\
MGFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R
M(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B
M@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?
M(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:
M_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_
M .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*
M/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_
M 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\
MGFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R
M(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B
M@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?
M(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:
M_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_
M .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*
M/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_
M 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\
MGFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R
M(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B
M@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?
M(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:
M_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_
M .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*
M/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_
M 'R*/(C_ .>:_P#?(J2B@"/R(_\ GFO_ 'R*/(C_ .>:_P#?(J2B@"/R(_\
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M]%?:_P!CX#_GRCX7^VLQ_P"?S/I#_AO'Q_\ ] CPW_X#7'_Q^C_AO'Q__P!
MCPW_ . UQ_\ 'Z^;Z*/['P'_ #Y0?VUF/_/YGTA_PWCX_P#^@1X;_P# :X_^
M/T#]O#Q__P! CPW_ . UQ_\ 'Z^;Z%ZT?V/@/^?*#^VLQ_Y_,^DQ^W=X^/\
MS"/#?_@-<?\ Q^GC]NKQZ?\ F$>'/_ :X_\ C]?-R]JE7M2_L? ?\^44LZS#
M_G\SZ07]N?QXW_,)\._^ UQ_\?IX_;D\=G_F$^'?_ :?_P"/5\Y)4J]JAY1@
M/^?2+_MG,/\ G\SZ+7]N'QV?^83X=_\  :?_ ./5(O[;OCD_\PKP]_X#3_\
MQZOG5:F2H>4X'_GTBUG&8?\ /YGT.O[;/CD_\PKP_P#^ \__ ,>IX_;6\<'_
M )A7A_\ \!Y__CU?/:U(O:H_LG _\^D7_;&/_P"?S/H,?MJ>-_\ H%^'_P#P
M'G_^/5(O[:'C9O\ F%Z!_P" \_\ \>KY]7I4R5']E8'_ )](M9OC_P#GZSZ
M'[9GC4_\PO0?_ >?_P"/4Y?VRO&A_P"87H/_ (#S_P#QZO U[5(M0\KP7_/I
M%+-L=_S]9[XO[8WC-O\ F&:#_P" \W_QZI%_;"\9'_F&:%_X#S?_ !ZO!4J9
M:C^R\%_SZ1JLVQW_ #]9[L/VO_&1_P"89H?_ 'XF_P#CM2+^UYXQ;_F&Z'_W
MXF_^.UX2O:IDJ?[,P?\ SZ12S7&_\_6>Z+^UQXP/_,-T/_OQ-_\ ':>/VM/%
MY_YAVB?]^)O_ ([7AR5*O:LWEN#_ .?:+_M3&_\ /UGMX_:R\7'_ )AVB_\
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M;^1_QKKJ\:I3E3ERL]NG4C4CS1"BBBLC4**** "BBB@ HHHH **** "BBB@
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M*7NSC*6FM_QO^!\Z_"_;\%+7X?\ B4,(/!OC'1].L]7W'$=EJ0MT6"Y/95E
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M*_:,^*:>(6FOM!M8]*)T?SF2WN)C;G#S!2/,"@$!6ROS$XSBM;PKX3L?@_\
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M>-;"&XMIERDB&.8%2/0BB<>6I[/S2^]V'&5X.?DW]RN>Y45Y+=?LI_"N:/\
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M)LGBEDT_R8V1HY0H0$*RD;G?D YQUKNK']F'X5R>)9_#C^-[Z?7M[^78PW,
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M9R^P?)NW?>XZ?I7;?'#X"P?#73[#7-$U)]5\/WC+&KRE6=&9=RG<H"LK '!
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M;P/X=\/Z/K>I:RUIINKAC8RO97&Z8+C)""/<!R.2!G(Q7@GQ@DE^-O[2&A>
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M29^$/^PNW_HEZTI_$C.I\+/>_P!EW_DWCX>_]@>W_P#0:*/V7?\ DWCX>_\
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M?9+[FW^IPG@?XT>&OB5KMS8>%Y;K6K2VA\V;6+>W;[ K9 $0F; >0@YP@8
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M'_/Y%+)<P_Y\L^>4J5>U?0J_L,>/%_YBWAW_ ,";C_XQ3Q^PWX['_,6\._\
M@3/_ /&*AYO@/^?J+_L;,/\ GRSY\6IDKZ 7]A[QV/\ F+>'?_ F?_XS4B_L
M1>.1_P Q7P]_X$S_ /QFH>;8'_GZBUD^8?\ /EG@*U(O:O?5_8F\<C_F*^'_
M /P(G_\ C-/'[%/C@?\ ,5\/_P#@1/\ _&:C^UL#_P _47_8^/\ ^?+/!%Z5
M,E>\#]BOQO\ ]!3P_P#^!$__ ,9J1?V+_&R_\Q30/_ B?_XS4?VK@?\ GZBU
ME&/_ .?3/"5[5(M>[#]C/QJ/^8IH/_@1/_\ &:<O[&OC0?\ ,4T'_P ")_\
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M5']HX3_GXB_[-QG_ #[9Y(O:I5[5ZR/V8O%(_P"7_1_^_P!+_P#&J>/V9?%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7QG_P %.O\ DF?A#_L+M_Z)>OLROC/_ (*=?\DS\(?]A=O_ $2]:4_B1G4^
M%GO?[+O_ ";Q\/?^P/;_ /H-%'[+O_)O'P]_[ ]O_P"@T5$MV5'9'Y@>//\
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MIJVZ* ,3S?$'_/&P_P"^FH\WQ!_SQL/^^FK;HH Q/-\0?\\;#_OIJ/-\0?\
M/&P_[Z:MNB@#$\WQ!_SQL/\ OIJ/-\0?\\;#_OIJVZ* ,3S?$'_/&P_[Z:CS
M?$'_ #QL/^^FK;HH Q/-\0?\\;#_ +Z:CS?$'_/&P_[Z:MNB@#$\WQ!_SQL/
M^^FH\WQ!_P \;#_OIJVZ* ,3S?$'_/&P_P"^FH\WQ!_SQL/^^FK;HH Q/-\0
M?\\;#_OIJ/-\0?\ /&P_[Z:MNB@#$\WQ!_SQL/\ OIJ/-\0?\\;#_OIJVZ*
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MQ!_SQL/^^FK;HH Q/-\0?\\;#_OIJ/-\0?\ /&P_[Z:MNB@#$\WQ!_SQL/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<?_P +D\ ?]#QX;_\ !O;_
M /Q==A7X_P!?2Y-E4,T]ISR<>6VWG?\ R/E\[S>>5>SY(*7-??RM_F?JA_PN
M3P!_T/'AO_P;V_\ \71_PN3P!_T/'AO_ ,&]O_\ %U^5]%?2_P"JE'_GZ_N1
M\Q_K=7_Y]+[V?JA_PN3P!_T/'AO_ ,&]O_\ %T?\+D\ ?]#QX;_\&]O_ /%U
M^5]%'^JE'_GZ_N0?ZW5_^?2^]GZH?\+D\ _]#QX;_P#!M;__ !=+_P +B\!?
M]#OX<_\ !M;_ /Q=?E@M31TO]5:/_/U_<@_UNK_\^E][/U*_X7!X#_Z';P[_
M .#:W_\ BZ/^%O>!/^AU\._^#6#_ .+K\O(ZG6H?"U'_ )^O[D5_K97_ .?2
M^]GZ>_\ "W/ O_0Z>'O_  :P?_%TO_"VO W_ $.?A[_P:0?_ !=?F.E3K4_Z
MKT?^?C^Y&G^M5;_GTOO9^F7_  MGP/\ ]#EX?_\ !I!_\72_\+8\$?\ 0X^'
M_P#P:0?_ !=?FDM3+VJ?]6:/_/Q_<BO]:JW_ #Z7WL_2C_A:W@G_ *'#0/\
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MM)_\#HO_ (JOC!?NU,E1_8E/^=E?V[4_D1]E?\)UX;_Z&'2O_ V+_P"*I?\
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MXR3UXKUA?$&E:L&M+/6K0W,RLL?V:XC>0'!Y4<Y(Z]#TJO\ EW!^O_I4B?\
MEY._E_Z3$UJ^=?"?@V7XG?%;XK#5?%?BZU@TK6(;:SM=+\0W=I#%&;6)R!'&
MX4?,2>G>O4_"OP_USP]K"7E]\0?$'B*W564V.H0V2Q,2.&)BMT;(_P!ZO(O
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M[]MX7^%.K>"?$UM>:9X[UZ_T-@XO-'\0SG40^5^1HIW/F1$'D@LP([#K7"_
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M*%5'?RXQ'_Z%(*S?'7Q,\->(/$'@WP7H=W;Q>'--OH)+J]F<)!LBX5 [$9
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M?Q8CTKQ'X>TC7!KK//;ZMHTMU=O9^6@M75UN8_W6S@ +@$-SS7J_A?\ 9[\
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MIB$!"*&F=R  3@ @<UUE)VOH"OU"BBBD,**** "BBB@ HHHH **** "BBB@
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M=!CCU>1=IU*\GEO+H+C!433.[@>P.*F2C.,8R[)/Y))_>7S2C-SCW;7S;?\
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M2O=V7?\ 78^]Q4*&$E7C];;BXVY;MMOELE?:WZ:,^<****^[/SX*_5#X-_\
M)(? _P#V K'_ -)TK\KZ_5#X-_\ )(? _P#V K'_ -)TKX7BO^#2]7^1][PC
M_'J^B_,["BBBOS8_4 HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_CI?^8MX>_\  F?_ .,U*O[$OCD?\Q7P]_X$3_\ QFOMJBE_K%CNZ^XK_5O
M=G]Y\4C]BCQQ_P!!7P__ .!$_P#\9IX_8L\;C_F*>'__  (G_P#C-?:=%+_6
M#'=U]P_]7,!V?WGQBO[&/C9?^8IH'_@1/_\ &:D7]C7QJ/\ F*:#_P"!$_\
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M44O[6Q7=?</^QL)V?WGSFO[.?B4?\OVE?]_9?_C=2+^SOXC7_E]TO_O[)_\
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M=D?F!X\_Y.+\>?\ 8>U+_P!*)*T*S_'G_)Q?CS_L/:E_Z425H5^L\.?[D_\
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MN)&"*\>_:E^(G@7X@^)[6?P?IH2YB+_;=66'R5O"=NW"\$D?-\S $^XQ7P^
MP\5C?8\SJ*+OS)NRMK:73[G^MOO\=BI/ _6.2-)M6Y915WYQZ_>OF>(4445^
M@GYN%?JA\&_^20^!_P#L!6/_ *3I7Y7U^J'P;_Y)#X'_ .P%8_\ I.E?"\5_
MP:7J_P C[WA'^/5]%^9V%%%%?FQ^H!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC^RL;_SZ8?7</_.CZYHKY&_X>;?"[_H ^+O_  #M?_DFC_AYM\+O^@#XN_\
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MR<7X\_[#VI?^E$E:%9_CS_DXOQY_V'M2_P#2B2M"OUGAS_<G_B?Y(_'^)O\
M?E_A7YL*]P_9E^,GA#X.W6L7OB'1[R_U"X\M;.YLK:*1X5 ;>-SNI7=E>G7'
M->'T5]!B,/#%4I4:FS['SF&Q$\+6C7I[QVN?;7B']L3X2^+8(H-<\(ZMK$$3
M;TCOM.M9E5L8R TQ ..]>:?%;XS_  >\5> =4TOPQX#;1]<G$8M[TZ3:0^7B
M12WSI(6&5!' [U\X45Y%'),+0E&5-R5G?XG8]NMGV+KIJHHNZM\*N%%%%?0'
MS@5^J'P;_P"20^!_^P%8_P#I.E?E?7ZH?!O_ ))#X'_[ 5C_ .DZ5\+Q7_!I
M>K_(^]X1_CU?1?F=A1117YL?J 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 <]??$#P_IOC73_"5UJ4<'B'4+9[NTLG1@9HT.&*MC
M;D<_+G. 3C K3UW6[+PUHFH:OJ4WV;3["WDNKF;8S;(T4LS84$G !. ":^<_
MC=\-X_BA^T=I&F)>R:5JMMX0N+[2]3A)#V5W'>Q>7*,=<9(([AB*UKKXHW7C
M3X#_ !,T'Q+;KI?CW0-"O;?6-/'"N?L[[;F+^]%(/F!'3./3*D[4?:+>S?W-
MK]-?ZLXZUN1[72^])_KI_5_>=(U:UU[2;+4[&7S[*\@2Y@EVE=\;J&5L$ C(
M(X(S5NO!?$GC+6/!'[/?PQO=%O/L5S<2Z!92OY22;H93$DBX<$#*DC(Y'8BO
M1_C/X@U#PG\)?&&M:5<?9=3T_2KBYMI]BOY<BQDJVU@0<$=""*TK)4^:71-K
M[K/]3.BW5Y%UDD_ONOT.SHKQ?Q+\3/$LFE?#KPUX=>U/C'Q99+<R:E?1;X;*
M".%'GN#&I7<V7 5.!EN>!6WH/@_XE^&_$&FSW'CZ#Q=H[MLU&TU72X;22-<'
M]Y;O;J.0V/DD!!!/S TW!IM/O;[O^#I_3!34HJ2ZJ_\ 7]?FCJ]!\<V'B+Q3
MXFT"VAN$O/#\L$5T\JJ(W,T0E780Q) 5@#D#GUZUT5>*^#=;MO#7Q0^/&KWK
M%;.PDL+J9E&2$33E9L?@#7G>C_&Z?QMI,6OW?Q[\+>![N\03V_AR".QN8K13
MRL=P\K>8[XQNV-'@Y Z5G'WDO2+?S7_#E/1:GU=17SY8?M,7FL?"2UU/2[73
M-5\8W>N?\(O;1VDY?3YK[=Q.K@[C 4_>]<X^7.>:U/$6@_%SP/X>NO$EO\0+
M?Q7>:?"]W<Z!>:-!;VERBC<\<,D>)8VP#M+,_.,BJ:Y;N3LEU^2?KLT_F"?-
M91U?;YV]-TU\CV^J^H7G]GV-S=&&:X$,;2>3;IOD? )VJO=CC '<U\^^-?CC
M=^(-9\!6VF^+;7X<>&?$FC'6!XAO[>&1I9"4VV:--^Z1]K%B6!)P !7H_A&S
M\3:+H&MWFH^.H/&MDUN9M/O%T^""6)@K;MSPGRY!]W&$'?.:F:<(2E+2U_PT
M'3:J3C&.M[?B=7X/\2#QAX9T[65TW4=(6\B\T6.K6_D74/)^61,G:>.F>]3^
M)-<@\+^'M3UFZ222UT^UENY4A +E$0L0H) S@<9(KQ&U^-'B:'X$_#.\M!;Z
MOX\\9):V=M+>((X!,\9>2>18P/E159BJXSP*K_%;PG\4_"OPM\3ZB?'L?C-%
MTJY%]I-]I%O:(\1B8.T$D(#(R@D@.7!QCC.:=>+I\]M+77S7]+^KBHM3Y+ZW
ML_D_Z9[EX5\16WC#PQI.NV:2Q6FIVD5Y"DX D5)$#*& ) .",X)^M:M?.=W\
M73\,?@/\)K*VU#2]'U/7M.L[2'4]:D"VEE&MJKRSOEEW%0 %3(W,RC-8&I?'
MQ/AO';ZVOQO\/?$>QCEC34-$ECLH+@Q,X5I+5H"#N3.[8X?(!&0<&MIT_P![
M*$=D[?U_GM]S,:=1NG&4MVD_Z_K]#ZKHIJ,)%5E.589!IU8&V^J"BBB@8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^"-?O=7X(U
M]QPS_P OO^W?U/G,X_Y=_/\ 0***^I?A_P# 'X4Q_LUZ;\4?'NH^+8?M%])9
M20Z#);%01*Z(0LD9/1>?FKZ_$8B&&BI3ZM+3N]CPJ5*5:7+'S?W:GRU17TO\
M2?V3;&^T/P+XD^$6HWWBC1?%T[V5I9:LT,-U'<*DCE6<[$Z12@YQ@IU;<*\W
M\3?LS?$[P?JFB:9JOA&[AU#6IY;;3[6*6*>2=X\>9A8W8A0"#N.%QR#CFLZ>
M,H5-.:SU5GH[K?1]BY8>I'5*ZM>ZU5CS"BO4OB'^S#\3_A5H/]M>)_"5QI^E
M!@CW4<\-PD9/ W^4[; 3@9; R0.IK0TK]D'XPZUX937[3P-?/ITD1F3?-#'.
MR=<B!G$ASV 7)XQG-7];P_+S^TC;:]U:Y/L*O-R\COZ,\=HKZ=\,_LZ>&H?A
M3\)/&=[8:UKFJ^(_$_\ 9.HZ"EU% DL:RW"^7&65"CGR5!+2 <MRO!&'XV_9
MG\4>-?BMXVL/AQ\/[W3M*T.>"*72+K4[>2>T,D2LH+&=M^XAF^5WP#@FLOKM
M'GE!NW+>[=DO=:3Z]VO(KZO-*_>VG76_^3/!['_75V^B_P -=+>?LX^.OA;X
MN\*IXY\'W<.FZIJ4%JL<%W XN<N,PB5)"J.RYQN([GH"1Z7X^^"][J_QOU+P
MMX!\!:GHPMH(7;2+F[CN&@W1AB[RB5T16R,9D/U!.T*6+HMI1DFFF[IJVEK]
M?/\ S&L/4]YM6M;H^NQQFB_PUWNB]5I9O@/X^\+ZUI>DZEX:N8;[46*6J1O'
M*LC $D;T8J" "2"> ,]*[35/@SXR\"Z<NH:WH<EG9[@IF6:.55)Z;MC-MYXR
M>]8/$T)6M-:[:K7T-%1J*]XO3R+&C_=KVSX0_%YO#KQ:-K,I;2V.V&X;DVY]
M#_L?R^E<?\1/ >G^ =4TRUT^:YFCNK);ES<LK$,2PP-JCCBN7KAG"CCZ.JT9
MTQE4PM33?_/4^X4D61%=&#HPR&4Y!'K3J^=/A#\7F\.O%HVLREM+8[8;AN3;
MGT/^Q_+Z5]$I(LB*Z,'1AD,IR"/6O@L7A*F#J<D]NC[GTU"O&O'FB.HHHKA.
MD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+<5S_P +?A;K&F>*O&7B&+PA9_#O2-4TI;&#PO9W44GG7"EC]JD6']S&Q!"
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M4G)]7?\ K^OU)C!1BHKHK!11169H%%%% !1110 4444 %%%% !1110 4444
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M/XO^+[KXD^)O"?A;P-8ZX-!2U>XO+S7C9;O/C+J GV=^F"/O=J]=KQKX:_\
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MG'_+OY_H%?:O@7XL_#WPK^Q#H^F>)M/TKQM>1ZM*S^%6UD6ET,SR%92J9D
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MEET2 W-W:3BSB(+0#YGC96'*9*E>1@YJTDY6?9_G&WZ]KZ=]9UY6UW7Y._\
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MBUFP\/\ @ >%;R_>&X/AS3($DD5OM,7++",%S&BL<9QC&3C-:24=H[75OO\
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M6O1!1117S![(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7QG_P4Z_Y)GX0
M_P"PNW_HEZ^S*^,_^"G7_),_"'_87;_T2]:4_B1G4^%GO?[+O_)O'P]_[ ]O
M_P"@T4?LN_\ )O'P]_[ ]O\ ^@T5$MV5'9'Y@>//^3B_'G_8>U+_ -*)*T*S
M_'G_ "<7X\_[#VI?^E$E:%?K/#G^Y/\ Q/\ )'X_Q-_OR_PK\V%%%%?4GR@4
M444 %%%% !7ZH?!O_DD/@?\ [ 5C_P"DZ5^5]?JA\&_^20^!_P#L!6/_ *3I
M7PO%?\&EZO\ (^]X1_CU?1?F=A1117YL?J 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7.>&_ MAX7\0>)M8M9KF2Y\074
M=W=),RE$=(EB 0!00-J \D\Y^E='11MM_7]6 **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ K\$:_>ZN!_X9_P#A=_T3;PC_ ."*U_\ C=?093F4,OY^:+?-
M;\+_ .9YF-PDL5R\KM:_Z'XGT5^V'_#/_P +O^B;>$?_  16O_QNC_AG_P"%
MW_1-O"/_ ((K7_XW7O\ ^LM+_GV_O1Y?]D3_ )T?B?17[8?\,_\ PN_Z)MX1
M_P#!%:__ !NC_AG_ .%W_1-O"/\ X(K7_P"-T?ZRTO\ GV_O0?V1/^='XGT5
M^V'_  S_ /"[_HFWA'_P16O_ ,;H_P"&?_A=_P!$V\(_^"*U_P#C='^LM+_G
MV_O0?V1/^='XGT5^V'_#/_PN_P"B;>$?_!%:_P#QNC_AG_X7?]$V\(_^"*U_
M^-T?ZRTO^?;^]!_9$_YT?BQ8_P"NKM]%_AK]<5^ /PP4Y7X<>$0?;0K7_P"-
MU/'\#_AS']SP!X73_=T:V'_LE2^)*3_Y=O[T-93/^='YB:+_  UWNB]5K]!H
M_@_X#C^YX)\.I_NZ3;C_ -DJ>/X7^#8_N>$M"3_=TV$?^RUB^(*3_P"7;-%E
M<U]I'QAH:-(51%+NQP%49)/I7T[\(?A"OAU(M9UF(/JC#=#;MR+<>I_V_P"7
MUKO[+P3X=TVXCGM-!TRUGC.Y)8;.-&4^H(7(K:KR<;FTL1#V=)<J>YVX? JC
M+FF[L****^>/5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/_@[/_QBC_AZQ=_]$TA_\'9_^,5\1_8V._D_%?YGWG]H8;^;\&?H317Y[?\
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M%']C8[^3\5_F']H8;^;\&?H317Y[?\/6+O\ Z)I#_P"#L_\ QBC_ (>L7?\
MT32'_P '9_\ C%']C8[^3\5_F']H8;^;\&?H317Y[?\ #UB[_P"B:0_^#L__
M !BC_AZQ=_\ 1-(?_!V?_C%']C8[^3\5_F']H8;^;\&?H317Y[?\/6+O_HFD
M/_@[/_QBC_AZQ=_]$TA_\'9_^,4?V-COY/Q7^8?VAAOYOP9^A-%?GM_P]8N_
M^B:0_P#@[/\ \8H_X>L7?_1-(?\ P=G_ .,4?V-COY/Q7^8?VAAOYOP9^A-%
M?GM_P]8N_P#HFD/_ (.S_P#&*/\ AZQ=_P#1-(?_  =G_P",4?V-COY/Q7^8
M?VAAOYOP9^A-%?GM_P /6+O_ *)I#_X.S_\ &*/^'K%W_P!$TA_\'9_^,4?V
M-COY/Q7^8?VAAOYOP9^A-%?GM_P]8N_^B:0_^#L__&*/^'K%W_T32'_P=G_X
MQ1_8V._D_%?YA_:&&_F_!GZ$T5^>W_#UB[_Z)I#_ .#L_P#QBC_AZQ=_]$TA
M_P#!V?\ XQ1_8V._D_%?YA_:&&_F_!GZ$T5^>W_#UB[_ .B:0_\ @[/_ ,8H
M_P"'K%W_ -$TA_\ !V?_ (Q1_8V._D_%?YA_:&&_F_!GZ$T5^>W_  ]8N_\
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MD_%?YA_:&&_F_!GZ$T5^>W_#UB[_ .B:0_\ @[/_ ,8H_P"'K%W_ -$TA_\
M!V?_ (Q1_8V._D_%?YA_:&&_F_!GZ$T5^>W_  ]8N_\ HFD/_@[/_P 8H_X>
ML7?_ $32'_P=G_XQ1_8V._D_%?YA_:&&_F_!GZ$T5^>W_#UB[_Z)I#_X.S_\
M8H_X>L7?_1-(?_!V?_C%']C8[^3\5_F']H8;^;\&?H317Y[?\/6+O_HFD/\
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M32'_ ,'9_P#C%']C8[^3\5_F']H8;^;\&?H317Y[?\/6+O\ Z)I#_P"#L_\
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M#_\ $T?\*U\(_P#0JZ+_ ."Z'_XFMZ\O+?3[66YNIX[:VB4O)-,X1$4=22>
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M (+H?_B:Z2BG[2?=ARQ['-_\*U\(_P#0JZ+_ ."Z'_XFC_A6OA'_ *%71?\
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MBN[>"=7DMW(W!9%!RA(.0#CBCVD^[#ECV,G_ (5KX1_Z%71?_!=#_P#$T?\
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M ,%T/_Q-'_"M?"/_ $*NB_\ @NA_^)KI**/:3[L.6/8YO_A6OA'_ *%71?\
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M $*NB_\ @NA_^)KI**/:3[L.6/8YO_A6OA'_ *%71?\ P70__$T?\*U\(_\
M0JZ+_P""Z'_XFNDHH]I/NPY8]CF_^%:^$?\ H5=%_P#!=#_\31_PK7PC_P!"
MKHO_ (+H?_B:Z2BCVD^[#ECV.;_X5KX1_P"A5T7_ ,%T/_Q-'_"M?"/_ $*N
MB_\ @NA_^)KI**/:3[L.6/8YO_A6OA'_ *%71?\ P70__$T?\*U\(_\ 0JZ+
M_P""Z'_XFNDHH]I/NPY8]CF_^%:^$?\ H5=%_P#!=#_\31_PK7PC_P!"KHO_
M (+H?_B:Z2BCVD^[#ECV.;_X5KX1_P"A5T7_ ,%T/_Q-'_"M?"/_ $*NB_\
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M *%71?\ P70__$T?\*U\(_\ 0JZ+_P""Z'_XFNDHH]I/NPY8]CF_^%:^$?\
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M,=W"BC)F3&& 'S*3W%>A_'CXF>)_ ^@Z3I'A3P]K-_J^J+Y;ZO8Z1/?P:5$
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M>AZ;\2O&'@_Q9HND^.T\/:AIVN7/V*RUCPZ98A#<E2R1302LY ?:0KJYY !
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MF,9WOU %9X\6_&-M._MP:?X)$&WSQX9:YG^V^7C/E_:\^6)>W^JVY[]Z;/\
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M9XD_Y\=*_P"_4O\ \<KRA>U2+6JSO,?^?S(>5X+_ )](]67]HKQ(?^7+2_\
MOU)_\<J1?VAO$9_Y<M+_ ._4G_QRO*5[5,M:K.LQ_P"?S,WE>#_Y](]37]H+
MQ$?^7+2_^_4G_P <IX_: \0_\^>F?]^I/_CE>7+VJ1>E:K.<P_Y_,S>6X/\
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MD'Q<U@_\NUC_ -^W_P#BZX)*F7M6JS+%_P#/QF;P.&_D1W0^+6K_ //M9?\
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M^%Y>&/[1^S_8/(M_/^U;?*V>=)G=NXQCUJG\>/\ A!O['T\^&_[+_M;[0/\
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M7SSX+\*1_M,R:GXM\9S75YX0^WSVFA>&H[EXK0PPR&,W,ZH1YLCLK$!LJHZ
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M='Q>^(-O9QZO>?"&^CT%B&9;;5HI]4CB/1S9A,$X/*+(6'I7L$<@EC5P& 8
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M\#2]IJ79W_/3\3Q']F7XJ>&-8^'OA#P=;ZECQ3I>CPVU]I,D,B3VLD*+'()
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M ";Q\/?^P/;_ /H-%1+=E1V1^<MO_P G8^-_^PUJO_H^2O:*\7M_^3L?&_\
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M%;_"OS/B.*?X-+U?Y'0T445^OGYR%%%% !1110 4444 %%%% !1110 4444
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M0C#Y6(4G .#@]\&G;1Z?\,TFOZ_4F]VOG^#L;-%%%9FH4444 %%%% !1110
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MY7C_ 'KM*L:EC&65=Y8J0=HS4OP)A;QGJ7B3XGW2,#XBF%MI*R @Q:7 2L)
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MTO)>MFE?YEG_ (:4TFXADU#3O"/C#6/#:-SXAL-)WV;(#S(@+B62,<_,D;#
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MON9]W]8H_P Z^]'/T5T'_"O/%7_0LZQ_X 2__$T?\*\\5?\ 0LZQ_P" $O\
M\31]4Q'_ #[E]S#ZQ1_G7WHPEJ5>U;:_#WQ5_P!"SK'_ ( 2_P#Q-2#X?>*>
M/^*:UC_P E_^)K187$?\^Y?<R'B*/\Z^]&(M2K6TOP_\4?\ 0MZO_P" $O\
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M^#?$''_$BU+_ ,!)/\*V6'K?R/[F9^VI?S+[S+7M4J]*TU\':_Q_Q(]2_P#
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M-[7F=F^6_I;I;_ASX%XJ?M'6]HN;GY?9V6U[>M^MSYNHHHK\L/O@K[B^'?\
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MA=O_ $2]?9E?&?\ P4Z_Y)GX0_["[?\ HEZTI_$C.I\+/>_V7?\ DWCX>_\
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M_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P"
MZT?V?K?_ $%H_P#P'6MNB@#$_L_6_P#H+1_^ ZT?V?K?_06C_P# =:VZ* ,3
M^S];_P"@M'_X#K1_9^M_]!:/_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:
M/_P'6MNB@#$_L_6_^@M'_P" ZT?V?K?_ $%H_P#P'6MNB@#$_L_6_P#H+1_^
M ZT?V?K?_06C_P# =:VZ* ,3^S];_P"@M'_X#K1_9^M_]!:/_P !UK;HH Q/
M[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P" ZT?V?K?_ $%H
M_P#P'6MNB@#$_L_6_P#H+1_^ ZT?V?K?_06C_P# =:VZ* ,3^S];_P"@M'_X
M#K1_9^M_]!:/_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_
ML_6_^@M'_P" ZT?V?K?_ $%H_P#P'6MNB@#$_L_6_P#H+1_^ ZT?V?K?_06C
M_P# =:VZ* ,3^S];_P"@M'_X#K1_9^M_]!:/_P !UK;HH Q/[/UO_H+1_P#@
M.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P" ZT?V?K?_ $%H_P#P'6MNB@#$
M_L_6_P#H+1_^ ZT?V?K?_06C_P# =:VZ* ,3^S];_P"@M'_X#K1_9^M_]!:/
M_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P"
MZT?V?K?_ $%H_P#P'6MNB@#$_L_6_P#H+1_^ ZT?V?K?_06C_P# =:VZ* ,3
M^S];_P"@M'_X#K1_9^M_]!:/_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:
M/_P'6MNB@#$_L_6_^@M'_P" ZT?V?K?_ $%H_P#P'6MNB@#$_L_6_P#H+1_^
M ZT?V?K?_06C_P# =:VZ* ,3^S];_P"@M'_X#K1_9^M_]!:/_P !UK;HH Q/
M[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P" ZT?V?K?_ $%H
M_P#P'6MNB@#$_L_6_P#H+1_^ ZT?V?K?_06C_P# =:VZ* ,3^S];_P"@M'_X
M#K1_9^M_]!:/_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_
ML_6_^@M'_P" ZT?V?K?_ $%H_P#P'6MNB@#$_L_6_P#H+1_^ ZT?V?K?_06C
M_P# =:VZ* ,3^S];_P"@M'_X#K1_9^M_]!:/_P !UK;HH Q/[/UO_H+1_P#@
M.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P" ZT?V?K?_ $%H_P#P'6MNB@#$
M_L_6_P#H+1_^ ZT?V?K?_06C_P# =:VZ* ,3^S];_P"@M'_X#K1_9^M_]!:/
M_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P"
MZT?V?K?_ $%H_P#P'6MNB@#$_L_6_P#H+1_^ ZT?V?K?_06C_P# =:VZ* ,3
M^S];_P"@M'_X#K1_9^M_]!:/_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:
M/_P'6MNB@#$_L_6_^@M'_P" ZT?V?K?_ $%H_P#P'6MNB@#$_L_6_P#H+1_^
M ZT?V?K?_06C_P# =:VZ* ,3^S];_P"@M'_X#K1_9^M_]!:/_P !UK;HH Q/
M[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P" ZT?V?K?_ $%H
M_P#P'6MNB@#$_L_6_P#H+1_^ ZT?V?K?_06C_P# =:VZ* ,3^S];_P"@M'_X
M#K1_9^M_]!:/_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_
ML_6_^@M'_P" ZT?V?K?_ $%H_P#P'6MNB@#$_L_6_P#H+1_^ ZT?V?K?_06C
M_P# =:VZ* ,3^S];_P"@M'_X#K1_9^M_]!:/_P !UK;HH Q/[/UO_H+1_P#@
M.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P" ZT?V?K?_ $%H_P#P'6MNB@#$
M_L_6_P#H+1_^ ZT?V?K?_06C_P# =:VZ* ,3^S];_P"@M'_X#K1_9^M_]!:/
M_P !UK;HH Q/[/UO_H+1_P#@.M']GZW_ -!:/_P'6MNB@#$_L_6_^@M'_P"
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M1_\ P/B_^*KH:_/ROD.(,\J9-[+V<%+GOOY6_P SZ/)\KAF7M.>37+;;SO\
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M-+_PDFD_]!2R_P# A/\ &OGZ.K$?05M'/JK^PC)Y3!?;9[U_PD6E?]!.S_\
M A/\:7^W],_Z"-I_W_7_ !KPV/M5E.E;QSJH_L(R>5P7VF>U?V[IO_00M?\
MO^O^-+_;6G?\_P#:_P#?Y?\ &O'(^U6H^U;1S>;^PC)Y=%?:/6O[8L/^?ZV_
M[^K_ (U-!>6]T2(9XYB.OEN&Q^5>3I5_3[N6QN%FA;:ZG\_8UT0S.3:YHZ&,
ML"DM)'I]%4-(U:+5K?<ORRK]^/T_^M5^O=C)32E%Z'E2BXNS"BBBJ)"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KXS_ ."G7_),_"'_ &%V_P#1+U]F5\9_\%.O^29^$/\ L+M_Z)>M
M*?Q(SJ?"SWO]EW_DWCX>_P#8'M__ $&BC]EW_DWCX>_]@>W_ /0:*B6[*CLC
M\Y;?_D['QO\ ]AK5?_1\E>T5XO;_ /)V/C?_ +#6J_\ H^2O:*_%N-_^1G'_
M  +\V?IW"O\ N$O\3_)!7K?[,?\ R42?_L'R?^AQUY)6SX4\7:IX*U-K_2)U
MM[IHS$6:-7&TD$C# ]P*^4RK%0P6-I8BI?EB[NVY]'CZ$L5AIT8;R1W?BCX'
M^-]2\3:M=P:+YL%Q=S2QO]K@&Y6<D'!?/0]Z[_X2>!->\$^$_&,>N67V,7-M
MF)3-'(&Q')N^ZQQU'6O,_P#AH3QQ_P!!2+_P$B_^)J*Z^/7C2]M9K>74XVBF
M1HW'V6(94C!_AKZ.CC,DP<IU:'M7-QDM>6VJMTU/"K87-<125"I[/ETVYKZ-
M/]#SVBBBOASZL*^XOAW_ ,D_\,_]@RU_]%+7P[7W%\._^2?^&?\ L&6O_HI:
M_2>"/]XK?X5^9\1Q3_!I>K_(Z&BO/OB=\6[?P#);:?:VC:KK=T,Q6B' 4$X!
M; )Y/0#DX[5RDWQ1^)'A^*&_USP;;G3'8 BUW"49.!G#OM/U4<U^B5LXPM&I
M*D[OE^)J+:CZM+0^.I9;B*T%45ES;7:3?HF>V45Y'\5/BUKO@^\T"#2M.MO,
MU*'>8-01C(CD@!?E< 'GFFP^)?C&TT8D\*:.L98;B)5R!GG_ )>*4LWHJO*A
M&$Y.+L[1;2?JAQRRJZ<:LI1BI;7DD>O45Y%\4/BIXD\*^.-.\/Z%8:?>27EO
M&Z+=*VXR,[KC(D4 ?*.OYUG7OQB\;^"+JUD\9>%[:WTV=]GG63<@_42."<9.
MTXSBLY9YA*=2<)\R47RN7*^5/SELBH95B*D(SC:\E=*ZNUY(]NHKBO'OQ4TO
MP/X=M=28&]DO5#6=O&VTR@@'<3V4 CG'<5PW_"SOB='I_P#;$G@VU_L@#S"H
M#";9USC?NZ=]E;XC-L-AJCI2NW'67+%RY5WE9:&5'+J]>"J*R3T5VE=]E?<]
MNHK(\*:[)XF\/V6IR6,VFM<)O^SW&-R^_P!#U'3CM6O7KQDI)26S/.E%PDXR
MW045Y=K'Q2U74OB/#X5\*VUG="'_ (_[RZ1W2+!^;&UE^[TYZL<=N>S\;>,+
M/P+X<N=6O072+"I$O#2N?NJ/K^@!->?#,,/4IU*RE[D&TWTTWMWMMZ['7/!U
MH2A!KWI[+KKM?M<WJ*\'_P"%V>.+/38?$-[X4ME\,RN,2(S"3:3@'.X_]]%
M#7I.J?$_1M+\"Q>*6=Y+*9 88U&'D<YPGL<@Y],&L*.;X2M"<^9QY%=\R<7;
MH[/H^AO5RW$T7%6OS.RLT]>VG4Z^BO$[/XF_$W7+4:IIG@VT;27^:-9"WFLO
MJ,R*6^H6O9;*2>2S@>YC6&X9%,D:MN"MCD ]\&NG"8VGC4W3C))6^*+C>_57
MW,,3A)X6RFTV^S3MZV)Z***] X@HHHH **** /"_$4.H?'#XO:YX.DU.\TOP
M-X7AM_[4@TZ=H)M4NYT+K"TJ$,L21X+*I!);D^FO+^RQ\/K/RI_#NG7'@W5X
M2##JV@74EO<K@Y^8Y*R ]") P.:R/$4U_P# _P"+^N>,)-,O-4\#^*8+?^U)
M]-MVGETN[@0HLSQ("S1/'@%E!(*\CUV9/VI/A_?+%#X=U&X\8ZK,0(M*T"TD
MN+AB3CYA@+&!W,A4#!JH7M'DWZ][_P!;>5B96N^;;\+?UOYGGG[1>C^*-1^/
M7P\F\'7XMO$NFZ+J5]:)-CRKPH\&ZWDZ?+(I9<\8)!XQ7I%C\3M/^+'P+\2:
MQ9QO9W2:9>6VH:;/Q-8W20L)(9!U!4^W((/>LWQ<2W[5GPY)!4GP_JO!ZCY[
M>N>_:$\#ZSX&?7_B)X*LC>?VAILMEXFT2'(^VP&-E6Z0#_EM%G_@29'UBI_N
MZB^JE\GS2_!_AOW-8_Q^9=.7YKEC^/;OMVMG:OJ&MZ;^QCX#ET>74+: Z;HZ
MZK<Z2K&[@T\K']I>+;\P8)GE>0,FM?P=\'_@)X^L8[CP8VGRWR+YJ:GH6KRI
MJ4+'G>\BR>:&_P"NGXBN@^&?C:W\ _LV_#G5;O3M4U"S&C:?'.=*M&NI+=#
MN96C7YBBXY*@D9Z5YI\7_%WP-^)7A[4)= CL];^(,T3-I+^';*1-8%X ?*;<
MB"1,-@GS"  #FNJLW&K4LK^\]M_3S\MM;_+CHI.E3N[>ZM]O7_/?2WS^K(XQ
M%&B L0H !8DDX]2>IKPO]ICQOXX\)WG@J/PSID+V-UKUC"]U_:IMGN)&=P;1
MD\IL1L ,R9./[IQ76Q_"A?&7ASPY-XOO]:3Q!;:;!!>-I>N75G&TP0&0E8)$
M5CN+?-C]*Y;]HK2D\*_#_P %7<*7MQH_AGQ'IM]>3.\MW-%:Q.0\KL2SOM#
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M:[OQI\5D\+6>@V]CH]SK_B77E+:=HEG(J-)M0-([R/A8XT!&7/J  2<5XO\
MM*_M!^$?&_P-\6Z3X.NF\77ES8GS_L$+M#8P@@M+/(5"QX X4G<6( %:/QF\
M(I:^*/ /C76+?7)_"MGI$FEZI)H%U=0W-AO\N1+@BW82-'E"K@9QP<'%:6NO
M>5M?T??SLK[?<R&[6Y7?1_FOT;=O\T>AZ7\7M>TOQ'I>D^.O!A\*)JTPMM/U
M*SU--0M)+@@D0R,$1HW8 [<J58\!L\5Y_9_$CXJG]H/Q1I5OX4L;ZWM](M98
M])F\2&.&)6FE N WV8_.X4 ICC:/F-0>'+3X,>.O%FB:9H.L>*/&EXEU'>KY
M.MZG>6MD\7[Q);@O+Y:890 &YR1QUK6\1>--&^$W[36LZSXMO1HFCZUX;M;>
MQO[B-O)EFAFE,D6X C?AU(7J0>*I64HMK^;_ -)=OQNO^"+5QE9]O_2E?\-?
M^ >A^._BE<^&]<L?#>@>'Y_%7BV\MS=C38;A+>*WMPVTS3SL"$7=\HP&9B#@
M<56\+?%C5)O%EMX8\9>%9/".L7R22:=)%?)?6=Z$&71)@J$2*.=C(. 2":\I
M^*FBZ-IOQ@A\=^))/$"^!==T2WMQK&B7E[:BPFC9G3[0MNRN(W63AF&%8'.,
MYK7^'>G_  E\8?$#2W\+:AXD\6WNDEKZ+4I-6U&]T^SDV[ &DEE,?F,KL HR
M<!LXJ81[KO?RU?Z:Z_J@D^B?:WGHOUTT.MNOC5KGB#Q)JVE^ /!3>++?1YVM
M+_5;S4TT^T6X4?-#$Q21I67.&PH4'C-<=\.?&DWC/]K#56O=%O/#NK6/@V.U
MO=-O2K&*07I<%)%)61"KJ0RGG/8@BF_"_P"(FA_L^VNL^"?']U_PC<\.JWEY
M8:I>1.+;4[>:9I5=)0"ID&_:R$[A@=:3X;^.(?B!^UGK.K66GW5II)\'1QV5
MU=V[0->QB\YF5& 8(6+*I8#(7/0BE!>]%[Z/7SY'_P -;?[F%1^[->:^[G5O
M\[[?>CZ/KQGXL:IK?C;XEZ'\,=$U6YT"SN+"36-<U.P?9="T601I#"_\#2.3
MEQR O%=Q\-/B9IOQ3T6]U/2[6_LX;2_GTZ2+48!#)YL3;6.W)XSTSSZ@$$5P
M_P 6-+UKP3\2M#^)VB:5=:_9V]A)HVN:98)ONC:-()$FA3^-HWR2@Y(;BH5N
M:/-M_P !V^5[>7?2Y;ORRY=_^#K\[7^>VI8D_9/^&"V^+3P\VFZ@N6CUBSO9
MX[^-_P#GH+C?O+9Y^8D'N#5#XE7VOKJW@;X4Z#XAU"WOM6MY9M4\1NR&^CL;
M=5#LK!0!-(S*H<#CD]:T6_:M^&,EO_H?B%]2U _*FCV5C/)?N_\ SS%OLWAL
M\?, !W(K.^)5CKYU;P-\5M!\/W]S?:3;RPZIX<95%])8W"J755#$&:-E5@@/
M/(ZU:O=<_P -_P!';Y7M?RW)TL^7XK:?A?YVO;S+_P#PR?\ "[[+M;PXSWV=
MQU9KVX-_O_YZ?:-_F;L\]<>U,^#NO:UH7C+Q9\-O$.J3:]/H<4%]IFK71!N+
MBQFW!5F8?>DC9&4OU88-/_X:P^%WV7<WB-DOL[3I+65P+_?_ ,\_L^SS-V>.
MF/>F?!W0=:USQEXL^)/B'2YM!GUR*"QTS2;H 7%O8P[BK3*/NR2,[,4ZJ,"E
M+FY9<VUG_P "WG?\+A[ME;>Z_P"#?RM?YV/+?V,_&&J>&--T_P +:],9=*\0
M->:AX=N6& KQW$BW-H3ZC:)5]F?TKN/VKO%FI77A6]\"^&YS!K&HZ7=:AJ-T
MG6RTV%&,C'T:5@(E_P!YCVKG_A'\/Y/B%^RGH%O8SBQ\0:?>7>H:/?XYMKR.
M\F,;?[IY5AW5C716G@O6M)^#OQ(\4>,888_&WB+2KN:^AA<2)90I ZPVL; D
M%47))!P6=CS4XCX)-_93^?;_ (/DM=9&E&_M%;J_NUU_X'F^R-7P+\)?!WQ*
M^#OPYE\4^'+#79+30;18&O(MYC#0QE@/3.!^5>9_ ']G_P"''B34OB@FI^#=
M)ODT[Q?=V5HLT /DP+'$5C7T4%CQ[U[S\#?^2+^!/^P%9?\ HA*X?]F;_D+?
M&'_L>;[_ -%0UTU-,152[2_]+B<E/6A2;_N_^DR/9]/T^WTG3[:QLX5M[2VB
M6&&&,85$4 *H]@ !5BBBN??5G3MH@HHKQM?C)XUUSQMXNT+POX!T_5[;P[>)
M937EYXA-HTC-"DH(C^S/@8?'WCTI+5V7K^7^:&]%=^GY_P"1[)17F/A/XPW]
MQXRMO"7C+PM-X.U^^BDGT[%XE[9WZQ@&013*%.]0<E&13CGFO3J;5M17Z!11
M12&%%<-\%?'-_P#$?X=V.O:E#;P7D\]U$R6JLL8$=Q)$N S,<[4&>>N>G2MO
MQPWB9?#5T?""Z4_B#*?9QK1D%KC<-^_R_F^[NQCOB@%J;U%-CW^6OF;=^!NV
M],]\4Z@04444#"BBB@ HHKS_ .(?C3Q#X;\<?#[2=&LK"[L=<U":VU%KDOYT
M420M+OB (' 1LEL_PC'.0UJTNX;)L] HHHI %%>8?$?XK:]X6\?>'O"/ASPK
M;>(]2U>SN;T-=ZM]A2)860$9\F3)/F#TZ5G:E\7/'WA&$ZAXF^%DB:)$"US=
M^'=:34IK=1U<P-%$S*.IV;B #Q3Z<W3_ (-OS0/1\O7_ (%_R9[!17):EXDU
M'Q9\._[:^'5UH^I7U[ DVFW&IM)]CD!89+^7\X^7=QP0PP<<UU-OYOV>/S]G
MG;1O\O.W=CG&>V:+-73Z"332:ZDE%%%(84444 %%%% !1110 5^?E?H'7Y^5
M^5\<_P#,-_V__P"VGW_"O_+_ /[=_P#;@I5ZTE>C^+?@_P#\(KX!TSQ-_:WV
MK[8(3]E^S;-GF)N^]O.<=.G-?F]'"5Z]*I6IQO&%N9Z:7V_I'VU3$4J,X0F[
M.6B\S@(^U68^U>D:M\![VQ\"6OB.RU#^T"]M'=2V8M]C(C*&)!W'=MSZ#@$^
MU8?PQ\!_\+#UR;3OMW]G^7 T_F>3YF<,HQC</[WKVKTWE.-IXF.#G3M4ELKK
M7YWMT[G%]?PTZ4J\9^['??3Y;G-Q]!5E:[/PW\+_ .WO'NI^&O[3\C[")#]J
M^S[M^QE7[NX8SGU/2NO_ .%!Z:MXUI_PFEK]K4X,!MUW@^FWS<UVX;)\;B(*
MI2A=7:WBM5ZLXZV986E+DG+6U]GM\D>2Q]JM1UT_C;X7ZKX%*S3E+NP9MJW4
M(. ?1A_"?S'O7,1UE4HU,/4=*K&TET-85J=>'M*;NF6(ZM1UUOP\^&?_  G-
MC=W)U+["+>0)M\CS,\9SG<,5OK\)='7_ )G2Q/\ P!/_ ([7M4<JQ=2G&K&&
MCVUBOS9YE7,,/3FZ<I:K?1_Y'G4=68Z74+1+#4KNVCF6YCAE:-9EZ. <!AR>
MOUI(ZY(JSLS=NZ319CJS'WJM'5F/O77 YY%F.K$?05T'@'PO:^)[JZCNI)HU
MB0,ODL >3CG(-8UU MK>7$*DE8Y60%NN <5Z?L9TZ<*KVE>WR.'VL95)4UNO
MU'1]JLITJ]X1T>'7-8CM)VD2-E9B8R >![@ULPZ=HVD^)KRTU%I&LXAA"Q).
M[ /.T9[FN^CAIRC&;:2;M=LY:E:,9.%FVE?0P(^U6H^U&H?9?[0F^Q;OLN[]
MWNZXHC[4TK.Q+=U<L)5F.JR59CKIB82+UE=2V<RRQ-M=?U]J[G2]4CU.'<OR
MR+]]/3_ZU<"E7;.YDM)UEB;:R_YQ7KX6NZ+MT/.KT547F=_15/3=2CU"'<OR
MR#[R>G_UJN5]%&2DKH\5IQ=F%%%%4(**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^,_\ @IU_R3/PA_V%V_\
M1+U]F5\9_P#!3K_DF?A#_L+M_P"B7K2G\2,ZGPL][_9=_P"3>/A[_P!@>W_]
M!HH_9=_Y-X^'O_8'M_\ T&BHENRH[(_.6W_Y.Q\;_P#8:U7_ -'R5[17B]O_
M ,G8^-_^PUJO_H^2O:*_%N-_^1G'_ OS9^G<*_[A+_$_R04445^?GV)[!8?
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M !EF/ & ,"G%^YROI;^G_GW]="2]_F7G_2_R[>AP?C#_ ).M^'7_ &+^K?\
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MM_Z_K_,6OS\K] Z_/ROR?CG_ )AO^W__ &T_0^%?^7__ &[_ .W!7T=\7/\
MD@?AK_<L_P#T2:^<:]K^(GQ$\/:]\(]#T2QU#S]3MEMA+!Y,B[=D15OF*A3@
M^AKY3*ZU*GEV-A.23DH63>KU>W<^AS"G.>)PTHQ;2D[^6G4]9M_&=IX)^'_@
MZYOU_P!#NHK6UDD_YY!H"0Q'<949]B:@\,_#:+PO\2+G6M,"?V/?V;_NXR,1
M2%T.!_LD D8Z<CTKROXC>/M!\0?"GPWH]A?^?J5I]G\Z'R9%V;865OF*@'!(
M'!K4^#/QIMM#TUM'\1W31VL"YM;HHTA4?\\R%!./3TZ>E?HCS?!5LS5*M.-H
M6<)IJR?+:2;VL_S^1\C++\33PDZM&+O)M2C9ZJ^C2\OR^9I_#O\ Y+UXG_W;
MC_T8E>?_ !8_Y*-KG_7<?^@K71>"_'.B:7\7-=UJZO?*TRZ$PBG\ISNW.I'R
MA=PX!ZBM[5YOA3KNNW.JWNL74T]P^]XQ',J$X [1@]O6OFO9T\;E].C&M"+4
MY/WI):,]*,IX7&.K*G)IPBM(MZZ&MX5N)=<^!.HC4F:<0P3K$\O)(0;DY/H1
M@?2N3T/X'ZOK6DV>H17UDD5U$LRJY?< PR ?EZT_QY\5-/OM"7PYX:M3:Z4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX +$#)]:9^T5J5G?:+X-\3P31ZUX:\-^)[:^UI;%A<"*%%93(P7.?*9T<CJ
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M?\"=F/XUUE.24;16MDE]RL3'6\N[;^]W"BBBI*"BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M HHHH **** "BBB@ HHHH **** "OC/_ (*=?\DS\(?]A=O_ $2]?9E?&?\
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M_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_?
MH E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO
M_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X
M%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-
M_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7
M_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6
M_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\
MC1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?
M_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7
M^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,
M'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\
M(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ
M@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\
MA']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__
M ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_
M #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#O
MZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_
MY_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\
M"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_
M ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O
M@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?T
MW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&
MHO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S
M^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']
MK6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M
M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_
MM:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!
M_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"
M/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?
M&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO
M^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W
M]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:
MUC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO
M^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'
M_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_?
MH E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO
M_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X
M%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-
M_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7
M_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6
M_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\
MC1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?
M_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7
M^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,
M'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\
M(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ
M@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\
MA']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__
M ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_
M #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#O
MZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_
MY_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\
M"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_
M ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O
M@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?T
MW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&
MHO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S
M^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']
MK6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M
M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_
MM:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!
M_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"
M/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?
M&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO
M^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W
M]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:
MUC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO
M^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'
M_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_?
MH E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO
M_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7_&HO^$?TW_GQ@_[X
M%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6_P#W]7_&HO\ A']-
M_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\ C1_:UC_S^6__ ']7
M_&HO^$?TW_GQ@_[X%'_"/Z;_ ,^,'_? H E_M:Q_Y_+?_OZO^-']K6/_ #^6
M_P#W]7_&HO\ A']-_P"?&#_O@4?\(_IO_/C!_P!\"@"7^UK'_G\M_P#OZO\
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M3/!'PWOO&.F?&;Q,-0M+5KNUU.\\0"[M+N7:2B&W.8G5S@!44'GBC[/,]O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\9_\%.O^29^$/\
ML+M_Z)>OLROC/_@IU_R3/PA_V%V_]$O6E/XD9U/A9[W^R[_R;Q\/?^P/;_\
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MOKO3899P1T(=E+<?6DFDN5;:?J_U?H4TY/F>_P#P$OT7KKIV\%\=>#]!T?\
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MZ+"XKF7)/<\;$4.7WX[&S1117J' %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7QG_P4Z_Y)GX0_["[?^B7K[,KXS_X*=?\
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MKIJ]K_:T].WWOY<K3)GY=-?7NONV_O%[X\?'#6_A'\7? L48:X\(7-G=3ZY
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M5\Y_LVZ7X^OO@[H)\.>+?"MI;JC)=VMSX>GDN8KL,?/6=A=KNEW[MQ*C.<X
M(K*\>>![KP/\$]0AO_$&GZ[X8OO&5O>:TNAVIM[6TLFG07<(3S9-J"127&[C
M<X(JW"SY+ZZ*_35I?=K>]]EYB4FUSI::^NB;^_2UK?D>Q6/[3GPRU+4+>UA\
M4(!<3>1#>36=Q%9RR9P%6Y>,0L2>F'Y[5U/CKXF^&/AK:VT_B/5H]/\ M3^7
M;PA'FGG;N(XHU9WQWVJ<5;UH>&CX1D_M8:6?#'D+O^V>7]B\GC;G=\FW[N.W
M2O"=2M_$US^U5K\6E:WH>BWKZ#9_V.=9TN2\\ZU!?SQ;E9X@I$F"X&21LZ 5
M%DVHKS_*_P#7EKT'>R<G_6J7Z_U<]G\"_%7PK\2OM:^'M72]N+,A;FTEBDM[
MF#/0O#*JR*#V)7![5D:U^T!X!\/SW-O>Z^!>6][)I[V<%I/-<&>-5:15B2,N
MX4.N64%>>M<UI_P\\53?&#PWXA\0^,O#<^HZ=:W*&QTO2'M+F\M7 4JQ:YD)
MC20QM]W /IFL7]G/_A'_ /A;'QK\OR?^$H_X2-_/W8\W[)L3R]O?9O\ ,SCO
MC/:FDF[+LW]S2_7Y?(3DXK7NE]Z;_3^NGJ/ACXO^$/&GA_4]:T364U*RTQ6:
M]2&&3[1;[020\!7S0V%.%*Y.. :X+X3_ +4&A_$/7-7TJX2[MKJ/6IM/TX1Z
M/?!)H5"['E=HML3G)RKE2,#(&:-4^S?\-<:!_8GE_;?^$=NO^$@\C'^J\R/[
M+YN/XM^_;GG&>U6/V<6'V[XKIGYU\;7Y*]QE(B,CW%$+-WZ.+?W24?Z_7<)M
MK3KS)??%O^OTV.S\<?&+P?\ #F^M;'7M86WU&Z7?#86UO+=W+J/XQ#"COMX/
MS8QQUJ]X%^)'AKXE:=+>^&M7@U2&%_*G5 R2P/\ W9(W =#[, :\U^ OV;_A
M9/Q=_M/;_P )A_;[>9YW^N_L[RT^R;<\^5C=C'&[-$OV?_AKZT_L39Y__",2
M_P#"0^1]W_7)]D\W''F?ZS&>=OM2BN;E3^TK_P#DO-_P/4J3:YFNCM^/+_P?
M0[&Q^/'@75-8LM*L]=6[U*[N9+2*TAM9WD$D<K0N74)F-!(K+YCX0X.":[ZO
M$OV3]#LM-\%>);Z"!$NM1\4:M+<R@?,Y6[D1<GT"J,?4^M>VT-62]$_O5Q_:
MDNB;7W-H****D84444 %%%% !1110 5YS\/_ (:77ACQM\0]8U'[#<V_B'5(
MKVT6/+O'&MO'&0^Y0 =R$\$C&.>U>C5YYXI^/_@/P?KD^BZAKC2ZK;C=/9Z=
M97%]) ,9_>""-]G'.&Q33LW;JK?BG^@/5:]'?\U^IZ#'&D*!$540=%48 KQ3
M0?A_\3/AK<:WIGA&;PGJ'A[4-1N-2@N-::YBN[5YW+R*R1J5F 8G'S(<<$UZ
M5X'^(GAKXE:6^H>&=8MM7M8W\J4PDAXGQG;(A 9&QV8 UT=%G%Z_UU%=26G]
M?UJ>-^"?@[XA\/\ PM^(/AW5-6L]4UCQ%>:E<Q7P#(C&XB"J9%"_)\P.57<
M,8+5Z1X%T.?PSX)\/:/=/')<Z?IUO:2O"249XXE1BI(!QD'&0*C\7>,%\(C2
M=VD:MJ_]H7T=B/[)M#/]GWY_>S<C9$N.6YQD<5T%'3[E_P" K3\&*RNOF_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OC/\ X*=?\DS\(?\
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MBTK7O?O>U];'RQ1117Y$?HP5]Q?#O_DG_AG_ +!EK_Z*6OAVON+X=_\ )/\
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M]=+_ +-%A;#3MNS[((5\G;Z;,8Q[8I^FZ59:-:BVT^SM[&W!+"&VB6-,GJ<
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M4 %%%% !1110 4444 %%%% !1110 4444 %?GY7Z!U^?E?E?'/\ S#?]O_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^,_^"G7_),_"'_87;_T2]?9E?&?
M_!3K_DF?A#_L+M_Z)>M*?Q(SJ?"SWO\ 9=_Y-X^'O_8'M_\ T&BC]EW_ )-X
M^'O_ &![?_T&BHENRH[(_.6W_P"3L?&__8:U7_T?)7M%>+V__)V/C?\ [#6J
M_P#H^2O:*_%N-_\ D9Q_P+\V?IW"O^X2_P 3_)!6]X*\&ZAX\UZ/2].""5E,
MCR2-A8T! +'UZC@>M8-:_ACQ9JO@W46O]'NOL=TT9B,GEH_RD@D88$=0*^)P
MKH1KP>)3<+ZVWL?5U_:NG)4;<W2^Q]4Z#X"B^%/AJ0^'M';7M<D7:\S21Q-(
MWNS,-J _PC)Z=>M>*>-?AW\3/%%Y<ZQK>FF3RT9\"[@V0H.<(HDX 'XGW-9?
M_"_/'G_0=_\ ).#_ .-U%=?'3QO>6TMO-K>^&5#&Z_9(!E2,$<)Z5]KF.:Y1
MCJ*HQ56,8KW8KD4;]WJWZZGRN$R_,L-4=5NG*4MY/F;MV6R1P=%%%? 'V 5]
MQ?#O_DG_ (9_[!EK_P"BEKX=K[B^'?\ R3_PS_V#+7_T4M?I/!'^\5O\*_,^
M(XI_@TO5_D=#1117Z^?G(4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 >&^)M4CUSXNZY9^%?ACHOB?Q#I=O;Q:IK^MW26J0>8A>*%
M&\F5W^0Y.  ,C.:SOV?;/4-#^,WQ2TN[T;2_#:M!I=\VDZ)=&>TCFD6=7D7,
M4>UG$:%@%[ Y.:[WQ5\$;#Q#XLG\2:=XA\0^$=8NH4@O9] NTB6\5 0GFI)&
MZ%E!(# !@.,U/\.O@MH?PRU[6]8TRZU.[O\ 68K>.]FU*Z^T/,T7F8E+D;B[
M>8<Y)& H 4#%7!I1UWM_7R_KS(FF]O+]/^#_ %H><?LK?#/P[+X%U'7KW2;3
M4M4U'6-31KB]A69HXEO)D$2%@=J9#-M'!+L3UK9^"7AVP\/^.OBYX2M+6%/#
M=IJMK<VNF>6/(@,]K'+(J)T52_.T< ]*]*\ ^!;#X<^&UT739KF>U6YN+H/=
M,K/NFF>9QE548#2$#CH!UZTN@^!K#P[XI\3:_;2W#WGB"6"6Z25E,:&&(1+L
M 4$ JH)R3SZ=*5]?*UOQC_DQVWOW;_/]&>8?LAZ/81_!S3KQ;&V6[&HZFHN!
M"HDQ]NG&-V,]./I6/H-W)XVN/$-[X(^#WA>[T2XU"Y@GUC7KU+9]3E21DF;R
MUMI6*[PX!<\@'@5W_AGX%Z=X.\3RZIHWB/Q'8:=)>27[>'H[U/[.\Z3)<[#'
MOVDDMMW[<G.*I3_L[Z9%J6I3Z/XK\6>&=.U*X:ZNM'T?4EBM'D<YD90T;/$7
M))/ENO)[4:-IOM_E_P '_+L;72[W^6OXZK\3Q&QUK6/"_P"R7XWM+:8:*++Q
M-=:06T^X,J:99O>HDHAD*J2B+(X5L# YP*^A8?@;\/(?!2^'8_"VDC1%A &+
M=-W XE\S&[?W\S.[/.:BT/X3Z%\-?ASXA\/Z-HUQK^EWLEU=MHMQ+&?.,W+0
M*S[5"GH-Y)]6->%)I.DVFFG1HM'^.,VEK^[3P=)#(+(KT$!N@.(>V/M&W'KT
MIWYDX]=/R2]=[M;[L/A:ETN_Q=_RTZ;:=3%\*ZI/HW[&\%O8:O<1Z??^*9-,
MO=924^:ME-J+1RS;^Q9#RW^V37T9XB^!_P .Y?A[=:#-X:TFPT6"U;9+%;(C
MVVU<^<L@&Y77&[?G.1DFJ/P9^#\/AGX(V_@[Q+IEG(E\+F:_TQ,/!'Y\KR&!
M<<$('"Y']W([53/[,ND3V::5>^+_ !EJ/AA/E_X1VZU?=:-&.D3,$$S1C@;6
MD(P,4ZGO*4+Z]_DE^#3:]7MU4=U.VFNGJV_Q6COV1Y1JOVWXK? 'X")XDN+B
M:;5/$=E%=S[RDMQ"([E<EAS^\C49/?>:] _:8^'7AK0_@3K>I:3H6G:1J/AV
M!+_2KJQM4ADM)8G5E,;* 5Z8('4&O4?$7PZTGQ)'X8B<2V,'AW4(=1LH;+9&
M@>*-T1""I^3:YX&#P.:L?$#P38_$?P9J_AG4I;B"PU. V\TEJRK*JGNI96 /
M'<&ARNY26EY-_@K?D.,4G%2V44OQ=_P9YY\89#)X\^"CMRS>(9"?_ "XK$U+
MX>^)?!?Q-\7^)X/ ^D_$BR\0312I)+=Q0:C9(L2H8%$Z>6T>5R )%ZG(->L>
M(_ &G^)]5\+:A=374<WAV\-[:+"RA7<PO%B3*G(VR$\8.0.>U<UK?P/BU#7+
M_4],\;>,?#+WSF6YM=+U16MW<]66.>.41D_[&VE>VWG^-O\ +^KB2?+%2W27
MWIR_S_JQY%\6-6\(>*OV6/&[^'O#">&GTJ]^RW>DW%C%;RV5W]IA,H*IE<L&
M4[E)!!%?36DZ59:7;!;*SM[,.%+"WB5-QQWP.:X_3_@AX5L?A[JW@U[>YOM+
MU<R2:C->7+RW-Y+)C?-)*3DOD*<C&-HP!BKGP]^'#?#^.=&\5>(_$JR1I$@U
MZ[280JF<! D:<\\L<DX&3Q1IJOZV5_Q6GD*ST?K^>G_!\SLJ***@T"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\_*_0.N>
M_P"%>>%?^A9T?_P B_\ B:^0X@R.IG/LO9S4>2^_G;_(^CR?-(9;[3GBWS6V
M\K_YGP[17W%_PKSPK_T+.C_^ $7_ ,31_P *\\*_]"SH_P#X 1?_ !-?(?ZD
M8C_G]'[F?2?ZTT?^?3^]'P^E3K7VU_PKWPK_ -"SH_\ X 1?_$TO_"OO"W_0
MM:1_X 1?_$U2X*Q"_P"7T?N9+XHH_P#/M_>CXK7M5A*^S/\ A /"_P#T+>D?
M^ ,7_P 32_\ "!>&?^A<TG_P!B_^)K5<&XA?\OE]S,WQ-1?_ "[?WH^.4[5,
ME?8/_"">&O\ H7=*_P# *+_XFE_X07PW_P!"]I7_ (!1?_$UJN$*Z_Y>K[F9
MOB2D_P#EV_O1\BQ]JGCKZT_X0?PY_P!"_I?_ (!1_P#Q-+_PA/AW_H Z9_X!
MQ_\ Q-;+A.NO^7J^YF;XAI/_ )=L^4$JPE?5'_"%^'O^@%IG_@''_P#$TO\
MPAN@?] /3?\ P$C_ ,*U7"M9?\O5]S(>?TG_ ,NV?+J_=J=*^G/^$/T'_H":
M=_X"1_X4?\(CH7_0%T[_ ,!(_P#"M5PS67_+Q?<S-Y[3?V&?-:5.GWJ^CO\
MA$]#_P"@-I__ ("Q_P"%+_PBNB?] >P_\!4_PK5<-U5_R\7W,S_MJG_(SYV2
MK$?:OH+_ (1;1?\ H$6'_@,G^%+_ ,(QH_\ T";'_P !D_PK5</U5_R\1F\X
MI_R,\#3M4Z]J]V_X1K2/^@59?^ Z?X4O_".:3_T"[+_P'3_"M5D-1?;1F\V@
M_LL\/C[582O:?^$=TK_H&6?_ (#I_A2_V!I?_0-M/^_"_P"%:K):B^VC-YI!
M_99XW'4Z=:]=_L'3/^@=:?\ ?A?\*7^P]._Z!]K_ -^5_P *V63U%]M&;S*#
M^R>4IVJ9>U>H_P!BZ?\ \^%M_P!^5_PI?['L/^?&V_[\K_A6JRJ:^TB'F$7]
MD\UC[5<L[62\F2*)=SL?\FN__LFQ_P"?*W_[]+_A4L-G!;$F&".(G@E$ _E6
MT,MDFN:6AE+&IK1%;2=)CTN' ^:5OOOZ^P]JOT45[<8J"Y8['ERDY.["BBBJ
M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCV4@]K$_1VBOSB_X;N^._P#T)NF?^"6[_P#CM'_#=WQW_P"A-TS_ ,$MW_\
M':/92#VL3]':*_.+_AN[X[_]";IG_@EN_P#X[1_PW=\=_P#H3=,_\$MW_P#'
M:/92#VL3]':*_.+_ (;N^.__ $)NF?\ @EN__CM'_#=WQW_Z$W3/_!+=_P#Q
MVCV4@]K$_1VBOSB_X;N^._\ T)NF?^"6[_\ CM'_  W=\=_^A-TS_P $MW_\
M=H]E(/:Q/T=HK\XO^&[OCO\ ]";IG_@EN_\ X[1_PW=\=_\ H3=,_P#!+=__
M !VCV4@]K$_1VBOSB_X;N^.__0FZ9_X);O\ ^.T?\-W?'?\ Z$W3/_!+=_\
MQVCV4@]K$_1VBOSB_P"&[OCO_P!";IG_ ();O_X[1_PW=\=_^A-TS_P2W?\
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MW?\ \=H]E(/:Q/T=HK\XO^&[OCO_ -";IG_@EN__ ([1_P -W?'?_H3=,_\
M!+=__':/92#VL3]':*_.+_AN[X[_ /0FZ9_X);O_ ..T?\-W?'?_ *$W3/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
..HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>rdmilestonechart10q1a01.jpg
<TEXT>
begin 644 rdmilestonechart10q1a01.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *U!7@# 2(  A$! Q$!_\0
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MS?<M;*%I7([G ' '<G@=Z]ANOV&?CC:6+W;^ YVB1=Y6*_M)),8SQ&LI8GV
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MG)VAR.>F:]O_ &;?''@#QAX,O8/AEI1T[PCI-X;*&1;8V\=Q)L5W=%;YS]\
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M[/\ ]%UZ=3!X=9I"FH+E<;VZ7U6QS4JU5X*I-R=[_P"1]H_&ZZM/CE^P_?\
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MK_P3?^)?B;7X_%'@K5K^.ZT7PO!##I\,<,:^7NEEWG>HRV2.Y->>?M"?L?\
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M2ZB^*&L^$M>TEHB8;C1Q*EVDN1@$>3&A3&[WSCK7Q!^U+XIU3]FW]K[6M=\
MS0Z-?:I813S?Z-'(@,P'FX5@1EFC#$XSECZU[Q^R7^R?+^SM\4)M5\7>+](O
M?$VI6LUIIVE:?*[-+'E9))FWJK$@)T"X&>6)(%?.'_!2!MO[2LA]-)M#_P"A
MUG@5269PBFI0DM;1LFM;JW78VK.7U2;DFFFK7=WTU\OZ[GV_^V9\5O$OP?\
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MKI_AC]NWPS)I\*P#5+W2M0G1% 7SFN C, /[WEACZDDUD?\ !-/_ ).,G_[
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MVVO!OB5VE@TY=<M;73+5C@P6JRX4''\39+-[L1T KV/_ (*K_P"K^&_UO_\
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M+*0ZS1R1HH/NO!ST&,G\=_BIX5@\#_$SQ7X>MG,EMI>J7-G"S')*)*RKD^N
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MBB@ KL?@]XNT;P'\3O#GB'Q!I$FNZ5IMVES+8Q2!&<KRI!((.UMK;3@-MP2
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MR5KQM_V'+[_TH>N1KKI?PX^B,)_$PHHHK0@**** "BBB@ HHHH *^R?^"?\
M^T#X!^"6F^,XO&NO?V+)J$UJUL/L=Q/Y@19 W^JC;&-PZXZU\;45AB*,<31E
M1GM+MZI_H73FZ=2-1;K_ "M^IW'QR\2:=XP^,GC77-(N/M>E:CJ]S=6MQL9/
M,C>1F5MK ,,@C@@&N'HHJZ=-4H1IQV2M]Q5:HZU2566\FW]X4445H9!1110
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M_P#&Z/\ AGKX5_\ 1-/!_P#X(;7_ .-U\-_K#2_Y]L^^_LJ?\R/P_HK]P/\
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MK#2_Y]L/[*G_ #(_#^BOW _X9Z^%?_1-/!__ ((;7_XW1_PSU\*_^B:>#_\
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MSU\*_P#HFG@__P $-K_\;H_UAI?\^V']E3_F1^']%?N!_P ,]?"O_HFG@_\
M\$-K_P#&Z/\ AGKX5_\ 1-/!_P#X(;7_ .-T?ZPTO^?;#^RI_P R/P_HK]P/
M^&>OA7_T33P?_P""&U_^-T?\,]?"O_HFG@__ ,$-K_\ &Z/]8:7_ #[8?V5/
M^9'X?T5^X'_#/7PK_P"B:>#_ /P0VO\ \;H_X9Z^%?\ T33P?_X(;7_XW1_K
M#2_Y]L/[*G_,C\/Z*_<#_AGKX5_]$T\'_P#@AM?_ (W1_P ,]?"O_HFG@_\
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M_/MA_94_YD?A_17[@?\ #/7PK_Z)IX/_ /!#:_\ QNC_ (9Z^%?_ $33P?\
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M#^BOW _X9Z^%?_1-/!__ ((;7_XW1_PSU\*_^B:>#_\ P0VO_P ;H_UAI?\
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M;H_UAI?\^V']E3_F1^']%?N!_P ,]?"O_HFG@_\ \$-K_P#&Z/\ AGKX5_\
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MKX5_]$T\'_\ @AM?_C=5_K#2_P"?;)_LJ?\ ,C\/Z*_<#_AGKX5_]$T\'_\
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M_P#1-/!__@AM?_C='^L-+_GVP_LJ?\R/P_HK]P/^&>OA7_T33P?_ ."&U_\
MC='_  SU\*_^B:>#_P#P0VO_ ,;H_P!8:7_/MA_94_YD?A_17[@?\,]?"O\
MZ)IX/_\ !#:__&Z/^&>OA7_T33P?_P""&U_^-T?ZPTO^?;#^RI_S(_#^BOW
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M/^&>OA7_ -$T\'_^"&U_^-T?ZPTO^?;#^RI_S(_#^BOW _X9Z^%?_1-/!_\
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M%OFA6664 X,@#?)''[OGMR,XJAJGQ._:*^$ZPZIXJTZ+5M*:18V5X+9T!)P
M6ML,A/0$\9(Z]*^@CDN(:CSRC&4MHN5I/Y'ST\\P\924(2G&.\HQO%?/_(^R
M:*^??VC/BYXL\'_"#P[XBTA9O"FL7US&MQ:W$4,[PAHW8H=RL.H'. ?4 Y%>
M8^%?$/[3OC3P_9:WI%^EUIMXA>&8QZ:A8 D9VLH(Y!ZBLZ.4U*U+VTJD(*[7
MO.VJ^37XFF(S>E1JJC&G.<G%2]U7T?DVG^!]H45XM\!8_C$FK:K_ ,+,D62Q
M\A?L>T6G^LW?-_J!GIZ\5\]:/\;OCAX[\>:IX>\+ZZMU<PRSLD#6EE'B-'Q]
MYXQTR.^:=+**E:I.$*L&H*[=]/OM]XJN<4Z-*%2=*:<W91LN:_I?[C[NHKXN
MUGXT_'GX*7=E>^.;.#4=+N'V!9HK?8W<J)+?&UL XW9^AKZ6C^,GAW_A5,7C
M^:=H=&>V$^UL>9OSM,0'=]X*_4>E88G+*V'C&::G&3LG%W5^WJ;X7-*.)G*D
MTX2BKM25G;OZ'=T5\:6OQ\^-7QLU2[/P[TB/3-+MFQO6*%\#L'EG^0MCLH'T
M[UM>$_C)\;/!?CS2/#?C;PRVN_VE(%C\F*))2O\ $R2Q'RCM')#= .2O6NJ6
M28B*:E."G:_+S+F[^GXG(L\P\G>,)N%[<W*^7MZ_@?6-%%<C\5_B);?"SP'J
M?B.YA-S]E4"* ''F2,0J+GL,GD^F:\*$)5)*$%=O1?,^@E*,(N<G9+5^B.NH
MKXK\/?%#]HGXL6=QK_A6.&'2%D9%CMX+14)')5?/R[8Z9!KTG]F?]I#5OB5K
M=_X5\56<<.NVD32QW$,9C$@1@KI(G\+@GM@'G@8Y]NODV(HTY3YHR<?B2=VO
M5'@T<[P]:I"'+**GI%N-HOT9]%T5\P?&[]I;Q'#X^7P#\.+-+K6Q(()KLQB5
MO.QDQQJWRC:/O,V0,'IC-<I_PT!\7_@GXDL(?B=IZZAI=X<Y$<"N%!&XQO!A
M2PS]UNOMG-%')L36IQFG%.2NHMVDUY(JMG6&H5)0:DU%VE)*\8OLV?95%> _
M'+7/BO>#2]<^%][&?##:9]LGG M"&ZN& F!;[F#Q_.N=_93^,WCCXE6OC5M9
MOEU^[T^W@>PMVAAMP9&$ORED5>"549/2L%EE66%EBE.-H[J_O+6VJMI]YK+-
M*4<5#"N$O?VE;W7I?1WUM?L?4%%?"_B3]J[Q18_$;0[O5M/N-/N]#2XMM3T2
MROV6TO)BK!&*@D<,PZ[L;>#Z?7WPPUSQ!XC\$Z=J/B?3(=)UBX4O);6\@=-I
M)*,.3C*[>,G^E&,RNO@J4:M2UI>:\]N^EG?S0\)FE#&5IT:=[Q\GY;]G>ZL^
MS.JHHHKR#V HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BO'_VLO'FO?#7X%Z[X@\-7_P#9NL6TENL-SY,<NT-,BM\LBLIR
M"1R*R(OA/\:)K>.1?C[(&90P#>#[ CUP<$4XKF3?9V_!/]12?*TNY[O17B'P
MS^*'C#1_B=+\,_B1'I]SK4ED=0TG7M+1HX=1A4X</&?N2KU(''!]B9?B?\9O
M$/\ PGD?PY^&NE6FK^,/(6ZO[[4F86&DP-]UI=OS,YR,(/4'GI3Y=4EK?;]?
MNL[W%?>^EM_Z\[H]JHKPC_A6/QV@C^UQ_&JPN;P?.-.G\*VZ6A/]PR*WF!?]
MKK[5Z5\,=4\8:IX9#>.-&L=&UZ&9X773;GSK>X53@3)GE%;G"L21CGTHY?,+
M^1UM%?-'PK_:*U:^_:3\=?#WQ-/YFG'4)8?#]RT*1JK1*&DMMR@;CL8.-V3P
M>>17TO2M[L9=&KCO[TH]G8**^:OB%^T1JT?[4'@GX>^&Y_+T=+OR->N!"CK+
M*\3.EN&8':550QVX/S8[5T'[06D_$O0=%\4^,?#7Q1?0=+TW3WNXM"&@6EP-
MT<>6'GR M\Q!/0XS2V@JCVU_#_A]"DKS]FM]/Q/=:*X[X-^(+_Q7\)?!NM:K
M/]JU/4-(M;JYGV*GF2/$K,VU0 ,DG@ "KWQ'U:[T'X>^)]3L)?(OK/3+FX@E
MVAMDB1,RM@@@X('!&**W[GFYOLW_  )I/VRBX];?B='17S#\)_#?QH^)GPW\
M/>*F^.,FG-JUHMT;4>%+"019_AW8&?K@5I>(/%/Q@_9_MO[;\47]C\4_!4!W
M:C>6>GKI^IV4?>41(3&Z+U(Z^ZC)K24.23C)V:(C+F2E%7N?1E%4-!UVP\3Z
M)8ZOI=REYIU]"EQ;W$9RKQL 5(_ UC:I\4O!>AZP-)U+Q?H.GZJ2%%C=:G#%
M/D]!L9@V?PJ+-/E>Y:::YEL=115'6-=TWP[I<VIZKJ%KIFFP*&EO+R=8H8P2
M "SL0 ,D#D]Z^0?#_C32/C=XJ\8:OX@^.]YX(BL]9FTW0M)T3Q';V$3V\>T)
M.R-GS]Y.<]#R >F"*<I<J_K9?J$FHQYGZ?K^A]F45YGH/AV6R^-VIWS_ !)G
MU3_B3PPGP9),A^SX*C[64#Y&X@\[!RY^8C '=Z]XCTGPKI[7^M:I9:18J0&N
MK^X2"($] 68@4.R2?];@KO2W]6N:-%8OAGQIX>\:6\EQX>U[3->@C.UY=,O(
M[A5/H2C$ UR-KHCK\>KW4_\ A8DDRMHZI_P@WG+MA&\?Z7Y>_(!(QNV#DXW$
M<46UL_ZTN%]+K^M3TBBL[7?$6E>%]/>_UG4[/2+%#AKJ^N$@B4^[,0*@\->,
MM \:6LESX?US3==MHVVO-IMW'<(I]"4) -(9L45GWWB#2]+U"PL;W4K.SOM0
M9DL[:>=$DN64981J3ER!R0,X%8W_  M7P5_;G]B_\)AH']L[_*_L[^TX/M&_
M^[Y>[=GVQ0M=@VW.IHHKGO$WQ$\*>"YHHO$/B?1M!EF&8TU/4(K9G'J [#/X
M4 =#16->>-/#VG^'TUVZUW3+;1'V[=2FO(TMFW'"XD+;3D\#GDUL!@P!!R#T
M-/40M%9__"0:7_;G]B_VE9_VSY'VK^S_ #T^T>3NV^9Y>=VS=QNQC/%:%(84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !17&?&?Q!J'A/X2^,-:TJX^RZGI^E7%S;3[%?RY%C)5MK @
MX(Z$$5X]\.O!OQH\>> ?#GB1OCI+9-JVGP7QMAX3L'$7F1A]N[C.,XS@4XKF
MOY6_&_\ D*7NV\[_ (6_S1]*45YW\-O _CWPOJEU/XL^);^-K.2'9%:-H=M8
M>5)N!\S?%RW (P>.<UY#X;N_BO\ %CXG?$ZQTGXJ/X3TKP[K'V&ULU\/V=Y\
MA7</G=0W&.Y/UIVN[)]+_BE^J%S65VNMOP;_ $/J*BO [[P;\??!L+ZEI7Q%
MTGXA21#<VBZSH4.GB8#JJ30-PY[;L+GK7??!GXO:?\8_"TFI6]I-I.J65PUE
MJFD71_?6-RGWHV]1Z-@9'8'(!RW3:>P<VJNMSOJ*\X_:"^)5Q\+?AAJ6J:<O
MG:_=,FGZ1;X#-+>3'9$ I^]@DMCN%-<_^S9\0O$OB*Q\1^%/'=S'<^.O"]^;
M:^FCB2);F&0;X)E5%5=I7(X ^Z#WHBN:[73_ ('Y75_5#D^6U^O]?C9V]#V>
MBBO'_P!K+QYKWPU^!>N^(/#5_P#V;K%M);K#<^3'+M#3(K?+(K*<@D<BIZI+
MJTOO=BTN9V/8**\)A^$OQHFMTD'Q^E4NH89\'V! R/K6=)\5/B!\"=>TRR^*
MC:=XB\(:C<+9P^,M+@-L]K,W"B[@R556/\2<#WZ5?+=\J>IBIWCSVT/H>BO.
M_CQI!UWX>S6Z_$!OAJ/M,#G7TG6+: X_=[BZ??) ^\,G'4<'M[B^MM$THW.H
M7T4-K;Q@RWEU(L:  <NS' '\JCI<OJDB[17,^'?B?X-\7WAM-!\6Z'K=V!DP
M:=J4-Q(!_NHQ-=!>7MOIUK+=7<\=K;1*7DFF<(B*.I)/ %#TW&M=B:BN;\-_
M$OPAXQO)+30/%6B:Y=1C<\&FZC#<.H]2J,2*T[_Q%I.E:EI^G7NIV=GJ&H,R
MV5I<7")+<E1EA&A.7(!!.T'&:=GL*Z-&BFNZQJS,P55&2S'  ]:HZ'X@TOQ1
MID6I:-J5GJ^G3%A'=V,Z31/M)5L.I(.""#SU!I#-"BN1N/B]X$L]6;2I_&OA
MV'5%?RS92:K LP;^Z4+[L^V*ZF:ZAM[9[B6:.*W12[2NP"*H&223P!CO1TOT
M#K8EHKE-$^+'@CQ-J0T_1_&7A_5;\G M;'5()I3_ , 5R?TK#^)^AOJGC#P%
M<+\0Y/!HM=19_P"R4F5!KG"_Z/@NN[ !XP_#'C."';5)]17T;['H]%1W%Q%:
MP233R)##&I9Y)&"JH'4DGH*YS0?BAX-\5:BVGZ)XMT+6+]02;6PU*&>48Z_*
MC$TM]A[;G3T53UC6=/\ #VFW&HZK?6VF:?;KOFN[R98HHUSC+.Q  R1U-8VO
M?$WP?X5:V&M^+-#T<W*"2 7^HPP>:IZ,N]AN!]10!TM%06-];:G9PW=G<17=
MK,H>.>!PZ.IZ%6'!'TJ>@ HHHH **\I^(W_"V?$'BV/0_!CZ5X4\/K;K-<>*
M;Z,7D[2$D>5#;9 R,9)?@@\$8P?//'/B#XN?LXZ=#XM\0>-++XD^$(KB*'5;
M:;1HM/NK6)W">;"83AB&(X;U_$5%<UM;7T_3^KBDVME?^OZV/IFBO&_VJ?B)
MK?P]^"=WXB\+Z@+#41=6:170ACE'ER3(K?*ZLO*D]N]>PPL6A1CR2H)HY79R
M\[?@G^HN972[J_XM?H/HKQSX\?$#7O!?C'X3V.C7_P!CM=<\1QV&H1^3&_GP
M%<E,LI*_5<'WJK\>=#^).FZ7XE\6^&?B@_AW3-,TR6\31!H-K<AFBB9S^^DR
MWS%?0XS4-I1YWMK^"3_4I>]+D6^GXMK]#VVBO!O^%\:EX1_9;\,>.=2A/B#Q
M-JEE9Q0086(7=[/@*"% "C)). . <4VW^'GQ]O+5-3N?BWI.G:FZB5M#M_#<
M,MBC=?*\YF\TKVW=?K6LH.,I1?1V^?YD1FI1BUU5SWNBO,O@?\6+WXB6>N:3
MX@L8-*\9>&[S[!J]E:N6A+8RDT1//ENO(SR,$>]>FU+7*-.X4445)04444 %
M%%% !1110!^<7[$/_)X/C'_KVU+_ -*HZ*/V(?\ D\'QC_U[:E_Z51T5K4^(
MQI?"?,G@G_D/7W^XW_H0KN*X?P3_ ,AZ^_W&_P#0A7<5^N9#_N,?5_F?CG$/
M^_R]%^0444JJ68*H)). !WKZ(^;$HKUWXD?LU>(OAG\.M)\5:E+'(;IPEW91
MH=UEN&8]S9P2>0>  <#)S3?A7^S?XA^+/@G6_$&F31P?8G\NTMYE(^VN!EU5
ML_+@%<'!!)QQ@FO/_M#"^R=?VBY4[7\]OZ\M=CT?[/Q?M8T/9OGDKI>6_P"G
MZ;GDE%.FB>WE>*5&CD1BK(PP5(X((]:;7>><[K1A16CI?AO5M<M;VYT[3+N_
MM[%!)=26T#2+ ISAG('RC@\GTK4\"_#?Q+\2]0EL?#6DS:I<0IYDNQE1(UZ#
M<[D*,]LGG!K.52$$W*226_EZFD:52;2C%MO;3?T.:HK=\9>!=>^'NL-I?B'3
M)M+O@H<1RX(93T964E6'49!(R"*PJJ$XU(J<'=/JA3ISIR<)JS71[A1115D'
M[ 4445_/A_1H4444 %>??M 7%S:_!7QE):,RS#3I!N3J%(PW_CI->@U7U"QM
M]4L;FRNXEGM;B-H98VZ.C#!!^H-:4Y^SG&;5[.Y$X\T7&]KGRW^P)9V \,>*
MKI IU,WD44AP-PA"93GT+%_RKZK90W!&1UYKXLO_ (,?$_\ 9S\:76N?#R)]
M>T6?Y3!&GG,T><B.:'(9B.S)S[C)%7=1^(G[1'Q2$.DV'A6X\* R*SW<=E+9
M'@@\R3MPOLO)Z<]*^NQ^#698AXNC6CR2MN[..EM4?&Y?C'E>'6#KT9<\;VY5
M=2U;NF=G^W?_ ,DMTC_L*I_Z*DKR_P"%_P :/C-X;\ Z-IOASP"FJZ);Q%;6
M\.DW<IE7>Q)WI(%/)(X':O3_ -JKPGXN\0_!;PU8R64OB/Q%#>1M>G1;.212
MPB<,X102%R1S@#)Z#.!YUX"^+OQK^'OA#3/#MA\,;NXL[",QQR7&B7ID8%BW
M)! ZGL*Z\!&,LM]DHQFU-Z2=EMNMCES&<HYDJKE.FG36L5=WOL]SZ1^!/C3Q
MEXX\+WUYXVT!?#VI17AAAMUM);??%L0A]LC,3\Q89!QQ7QA\'_B=I/PE^.&M
MZ[K,5U-9YN[?;9HKON:08X9E&.#WKZG^!/Q7^(_CWQ-?67C+P8WAO3X;,S17
M+:=<V^^7>@";I20>"QP.>*\3^ /PAU&X^.VKR^*_!5U)H;I=LCZSI3&V9C("
MA!D3:3C.*C!JGAYXM5TDG':+Z:Z)E8N53$TL(\/)RDI_%)=>[78K_M%?M+:3
M\:?#5AX6\+Z1J3O+>),[W42AV8 A4C1&8DDM_3%3_'#PEK'PY_99\ Z!?!HI
MOM[2WL0/".XED5&^F['U%;_[07P-UCP#XXT;QW\,=&F61)5\W3]'M2_D2J.&
M6*,?ZMUR& &.O]ZO==9\.VW[07P?6SUK3;W0;B_A#FWO+=XI[*Y7OM8 D!@<
M'^)3[T2Q>'PU##3PR_=<_-+6\D]ORV[E1P>)Q6)Q,,5+][R<L6E:+3_X._;7
M<J?LNV=A9_ KPK]@"[)8&EF90 6E+MOSZD$$?0"O5-HR#CD=#7Q+X:L/CE^S
M5-=:3I6@-XGT.20O&L-M)>0$G^-!&1)&3CD' ]N]=9X2US]H/XE^.M(U*>P7
MPAH]G)F:&[MGM[=T/W@T3MYDA(Z<X!Z%>M>?C,M=:M4Q,:T.23;NY=];6WOT
M.[!YE]7H4\+.A/VD4E91[:7OM;KN>F?$C]J?PA\+?%=QX>U>TU>6^@1)&:T@
MC>/#*&&"9 >A]*Y_XJ?%CP5\2OV<-7UR[BU"/2+N7[);1.B)<&Y5LI@!F& 1
MDY/0&O8-9^''A/Q'?/?:MX7T75+UP%:YO-/AFD8 8 +,I/ K@_C?\![/QY\+
M9/#GAJTL=$GM;@7MG;V\*P0-( 0RD( !N#'G'7%<&'J8%.C=2C).-Y7TWU:/
M3KT\=^]:<91<96C;6]M$V?+?P7_X7M;^!YCX!ANO^$<>1W5F2VP7Z,8O.^8\
MC^#(R#WS71_L976F:7\7-;M/$"7L/C.XCEB@%P,+D-NG5@?F$GRYYXP&[U-X
M)\<_';X-^'8O"=OX FU&UM&<02OID]QY>YBQ DA;:PW$G\>M=+^SO\#/&=U\
M4I?B1XXMSIEQOFN([>0*LTTTJLI8H/N* S<'!SCC'-?8XNM'V>)=5PC&2?*X
MOWI=K]_/^F?#X2A-3PL::J2G"2YHR3Y(][=K=/\ /0XW]EM4O/VH=>FO3NNU
M6_D0N.?,,H!_':7KU/\ ;PAMF^%VCR28^TIJJ"+UP8I-W\A7+_&#X)^-/AW\
M6/\ A8_PYLVU$23-<RV<*>9)%(P(D4QCET?)^[R-QZ8!KG-?\._&+]J+7M*L
M_$/A]O"NC63Y9Y[22UBCW8W/ME)>1\#  X^F2:X_W>*Q.'S"-6*A"*YKO5-7
MTL>BY5,'0Q6 E2E*<Y2Y;*Z:EUOY=>Q[G\%IIYOV4].:X+&0:/=J-W7:#*%_
M#:!7C?[".FPZQ#\0K"XW>1=6UK#)L8JVUO/!P1T.#7U/=^&8/#OPRN= TJ!V
M@M-*DM+>)1N=L1%5''5C^I-?/7[#O@OQ!X3N_&)US0M2T83I:"(ZA9R0>9@R
MYV[U&<9&<>HKS*>(A5PN/FG;F<6O_ KGH5L/4HU\MIM7<$TWZ1BC7O?V+]!B
M\8>&38002^%K6"9-52\NI/MEU(RL$<%5V\$J>"H&.GK[E\._ &F?#'PG:>']
M(:X>RMV=E:YDWR$LQ8Y. ._8#I72T5X6(Q^)Q4%3JS;2_P V_P!?N/H,/E^%
MPM1U:,$F_P#)+3[OO"BBBO//1"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH \ _;L.W]F7Q.3T\VT_\ 2F.I[?\ ;:^"L-G"
MK>-HRZHH*KIUXQSCH (>:L_MG>'M5\4_L\^(M-T73+S5]1EEM3':6$#SROBX
MC)PB@DX )Z=!7M-FI6S@5@00B@@_2KA_#=_YOTB34^*%NS_,^=? <VI_'3]H
M+3?B1!HFH:)X+\.Z7-8Z9=:I 8)M2FF.&D2,\B(*3@GKQ[@6?V4E6X\6?&N^
MO /[=D\87$%QN^\($4" ?[H!?%?0]>!^/_ASXQ^'GQ0N_B7\-;.#6_[4B2+Q
M#X5FF%O]NV#"3PR'Y5E XYZ\]2<41DD[;*S7WR4M?G?TOV$XMIO=W3^Y<OY:
M_(]\KB/AC\4(/B9-XMC@L)+'_A']<N-$D,D@?SFB"YD&!P#NZ>U<!_PU!J4T
M?V>#X,?$IM6/RB";1UCM]_O<&3:%S_%C\*U?V:? GB7P=H7BO4/%5C;Z5JOB
M;Q!=:Z=-M[@7'V19@F(F< *S J>5R.GTH47=M[6_&Z_2X.6R6]_PL_UL>-Z?
M\+YOB=<_'6/2Y?LGBG2?&(U/1+T'#0W<42LHSZ-RI^N>U>GO^TU:R?L]IXW@
MM=WB25AI*:)@^9_:Y/E_9MO7A_F]=G-7/@#X?U31O'GQCN-0TV\L;>_\2F>T
MEN8'C6XC\I1OC+ !USW&12P_LSZ5#\>I/B%]M<Z>V;Y="(/DKJ97RS=XSC=L
M]L[CG-"LXQA+9QC\FHJ_WK3R:7F#NG*:6J<OFN9V^YZ^C?6QY7>?#)_A=XF^
M -E?2B\\17_B.\U'6K[JUQ>2VY:0Y[@?='LHKWG]HK_D@_Q _P"P'=_^BFKF
M?CEX?U35OBM\%[NQTV\O;33]:N);R>W@>2.V0P$!I& P@)XR<5UWQXTV[UCX
M*^.+&PM9KV]N-'NHH;:WC,DDKF-@%50,DD]A45I<U&7J_P#TF)K17+6A\O\
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M+Y?J]WYA&]KRW>K_ *\MEY!1114%A1110 4444 %%%% !1110 4444 %%%%
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MCEBQQS@5[3X MIK/P'X;M[B)X)XM-MHY(I%*LC")05(/((/:MYR7/4<>MO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** .3^)5EXSO/#\?_  @NI:5IVMQ3K+C6;=Y;:>, YB8H=R D
M@[ER>/?-<+\/?A/XON_B-_PG_P 2]4TB_P!?M+1K#2M-T&.46-A&YS)(&E^=
MI'Z$D<#/7(Q[-13B^75?UI;\A27-H_ZUO^84444AA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ:?^3UMT4 8FSQ#_ ,]-/_)Z-GB'_GII_P"3UMT4 8FSQ#_STT_\GHV>(?\
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MC9XA_P">FG_D];=% &)L\0_\]-/_ ">C9XA_YZ:?^3UMT4 8FSQ#_P ]-/\
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MTT_\GHV>(?\ GII_Y/6W10!B;/$/_/33_P GHV>(?^>FG_D];=% &)L\0_\
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M/85]%N?-'Z%:3JGPX_:U\&:>FK)"VJVR[GLA/Y5W9R$ .4P<LAXYP5.!D9&
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M^)J^@R?%5L7AG.NUS)M:=+'SV=87#X3$1CAD^5Q3UZWOJO+];A1117N'@'[
M4445_/A_1H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG\?:Q\0M&U*\UKP?J'@R>UU":SBM=1;+SQIC;,ORK\K9/8C@X+#FO,?V,O\
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MC_U[:E_Z51T4?L0_\G@^,?\ KVU+_P!*HZ*UJ?$8TOA/F3P3_P AZ^_W&_\
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M^?77/_ 2/_XY7SI^R_\  2'XQ:_=WNL&1/#FF%?/2-BK7,AY$08=!@98CG!
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M_@OX5^$-K=IX?LI!>WS>9>ZG>3-/=W;?WI)6Y/4G P,DG'-=Q&@CC5%&%48
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP+H?BK6-!U75+'[5?Z'<-=:=-YLB>1(R[6;"L W'&&!%$79P?\O+_P"2VO\
MD5;2:[\WXW_S/"_B-K$?P-_:9MOB%KT4J^#/$6C)HESJJ(733KE) Z&4 9",
M !GU)]*[OQ?^TS\/]#T-IM*\2Z9XHU>Y'E:?H^B7<=W<W<S<)&J1DD9/!8X
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M $JCHH_8A_Y/!\8_]>VI?^E4=%:U/B,:7PGS)X)_Y#U]_N-_Z$*[BN'\$_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ,*/^$RTC_GZ_P#(;_X4 ;5%8O\ PF6D?\_7_D-_\*/^$RTC_GZ_\AO_ (4
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MY#?_  H_X3+2/^?K_P AO_A0!M45B_\ "9:1_P _7_D-_P#"C_A,M(_Y^O\
MR&_^% &U16+_ ,)EI'_/U_Y#?_"C_A,M(_Y^O_(;_P"% &U16+_PF6D?\_7_
M )#?_"C_ (3+2/\ GZ_\AO\ X4 ;5%8O_"9:1_S]?^0W_P */^$RTC_GZ_\
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MZ]M2_P#2J.BF_L/2+)^U]XN=3E7M=2*^_P#I,9HK6I\1C2^$^9O!/_(>OO\
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M5NK"BBBO2/*/U_HI:*_GP_HT2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
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MGP9^T-X9'C/]K"303<&T&I7%C:&X";_+WQ1KNVY&<9Z9%>@_\._8/^AYD_\
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M?V=]9JVY8KB*-U<*?[IX(],XYZU8_9#_ .3;/ /_ &#_ /VH]7K^\O\ W?\
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MCU\]_MJ?\B'X-_[&_3/_ $-J]0^)?BKQ=X6L[&3PEX&;QO/,[+/"NJP6'D*
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MM>4^ ?B#K/B#X\?%+PO>31OI&@1Z8UC&L05D,\#/)ENK9('7I24I2;C?I?\
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M\%WL?A:U>:[;2HM0\V/S0-FR1@%Y(.X>F*F'\2/S_P#2654_AR^7_I2/0?\
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MIYSX4^#=G\/_ (,7/@70YVF:2QN83>7K?-/<3*VZ60@'JS9X!P..<5Y=\-O
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M%]/N9W\*^*/&G@&UG<R26'AC7'M[9F/4['5P/PP!VK3F<IN3Z_UJ2UI;SO\
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MQ\(PS)/<Z-X0CN,ZD5((2:6;!5,@'"]?K@CZ!@ACMH8X8D6**-0B(HP%4#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2+GGQ_\ /1?^^A1Y\?\ ST7_ +Z%4_\ AEG4_P#H.VG_ 'Y;_&C_ (99U/\
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M?S!S3_E/T!_MS3O^@A:_]_E_QH_MS3O^@A:_]_E_QK\_O^'8/B7_ *'?2O\
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M/[<T[_H(6O\ W^7_ !K\_O\ AV#XE_Z'?2O_  $E_P :/^'8/B7_ *'?2O\
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MO^'8/B7_ *'?2O\ P$E_QH_X=@^)?^AWTK_P$E_QHY8?S!S3_E/T!_MS3O\
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ME_QK\_O^'8/B7_H=]*_\!)?\:/\ AV#XE_Z'?2O_  $E_P :.6'\P<T_Y3]
M?[<T[_H(6O\ W^7_ !H_MS3O^@A:_P#?Y?\ &OS^_P"'8/B7_H=]*_\  27_
M !H_X=@^)?\ H=]*_P# 27_&CEA_,'-/^4_0'^W-._Z"%K_W^7_&C^W-._Z"
M%K_W^7_&OS^_X=@^)?\ H=]*_P# 27_&C_AV#XE_Z'?2O_ 27_&CEA_,'-/^
M4_0'^W-._P"@A:_]_E_QH_MS3O\ H(6O_?Y?\:_/[_AV#XE_Z'?2O_ 27_&C
M_AV#XE_Z'?2O_ 27_&CEA_,'-/\ E/T!_MS3O^@A:_\ ?Y?\:/[<T[_H(6O_
M '^7_&OS^_X=@^)?^AWTK_P$E_QH_P"'8/B7_H=]*_\  27_ !HY8?S!S3_E
M/T!_MS3O^@A:_P#?Y?\ &C^W-._Z"%K_ -_E_P :_/[_ (=@^)?^AWTK_P !
M)?\ &C_AV#XE_P"AWTK_ ,!)?\:.6'\P<T_Y3] ?[<T[_H(6O_?Y?\:/[<T[
M_H(6O_?Y?\:_/[_AV#XE_P"AWTK_ ,!)?\:/^'8/B7_H=]*_\!)?\:.6'\P<
MT_Y3] ?[<T[_ *"%K_W^7_&C^W-._P"@A:_]_E_QK\_O^'8/B7_H=]*_\!)?
M\:/^'8/B7_H=]*_\!)?\:.6'\P<T_P"4_0'^W-._Z"%K_P!_E_QH_MS3O^@A
M:_\ ?Y?\:_/[_AV#XE_Z'?2O_ 27_&C_ (=@^)?^AWTK_P !)?\ &CEA_,'-
M/^4_0'^W-._Z"%K_ -_E_P :/[<T[_H(6O\ W^7_ !K\_O\ AV#XE_Z'?2O_
M  $E_P :/^'8/B7_ *'?2O\ P$E_QHY8?S!S3_E/T!_MS3O^@A:_]_E_QH_M
MS3O^@A:_]_E_QK\_O^'8/B7_ *'?2O\ P$E_QH_X=@^)?^AWTK_P$E_QHY8?
MS!S3_E/T!_MS3O\ H(6O_?Y?\:/[<T[_ *"%K_W^7_&OS^_X=@^)?^AWTK_P
M$E_QH_X=@^)?^AWTK_P$E_QHY8?S!S3_ )3] ?[<T[_H(6O_ '^7_&C^W-._
MZ"%K_P!_E_QK\_O^'8/B7_H=]*_\!)?\:/\ AV#XE_Z'?2O_  $E_P :.6'\
MP<T_Y3] ?[<T[_H(6O\ W^7_ !H_MS3O^@A:_P#?Y?\ &OS^_P"'8/B7_H=]
M*_\  27_ !H_X=@^)?\ H=]*_P# 27_&CEA_,'-/^4_0'^W-._Z"%K_W^7_&
MC^W-._Z"%K_W^7_&OS^_X=@^)?\ H=]*_P# 27_&C_AV#XE_Z'?2O_ 27_&C
MEA_,'-/^4_0'^W-._P"@A:_]_E_QH_MS3O\ H(6O_?Y?\:_/[_AV#XE_Z'?2
MO_ 27_&C_AV#XE_Z'?2O_ 27_&CEA_,'-/\ E/T!_MS3O^@A:_\ ?Y?\:/[<
MT[_H(6O_ '^7_&OS^_X=@^)?^AWTK_P$E_QH_P"'8/B7_H=]*_\  27_ !HY
M8?S!S3_E/T!_MS3O^@A:_P#?Y?\ &C^W-._Z"%K_ -_E_P :_/[_ (=@^)?^
MAWTK_P !)?\ &C_AV#XE_P"AWTK_ ,!)?\:.6'\P<T_Y3] ?[<T[_H(6O_?Y
M?\:/[<T[_H(6O_?Y?\:_/[_AV#XE_P"AWTK_ ,!)?\:/^'8/B7_H=]*_\!)?
M\:.6'\P<T_Y3] ?[<T[_ *"%K_W^7_&C^W-._P"@A:_]_E_QK\_O^'8/B7_H
M=]*_\!)?\:/^'8/B7_H=]*_\!)?\:.6'\P<T_P"4_0'^W-._Z"%K_P!_E_QH
M_MS3O^@A:_\ ?Y?\:_/[_AV#XE_Z'?2O_ 27_&C_ (=@^)?^AWTK_P !)?\
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M_P"O5O\ T8M?05?A'&7_ "-Y^D?R/UCAC_D6Q]7^84445\0?5A1110 4444
M%%%% !1110 4444 ?H'1117]4'X$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>9XF_P"$8GU'[=Y,8_TA8797V!=G! .-N/:LW*T92_EM^-_\F:)<THQ_FO\
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MG=QCTQR<M[<NM[_@KO\ #4.;>^EK?B[+\=#W.L0>-=$/C$^%!J,?_"0BS_M
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M\XRTY;?K_E^?D0Y^Y"<=;_Y?F?0]]X^UFU^+6G>$H_!^HW&B75@]Y+XG1O\
M18) 2!"PVXW' _B!^884C)';UXYK7C_7K3]JKP[X/BO]GAR[\.3W\UEY,9W3
MK*55]Y7>,#L&Q[5G^/?B9XR\8?%"Z^&_PTDL--N]-MX[G7?$FHP^>FGB3F..
M*+.'E(^;#<8_$C->]&-MW?\ !M?A;\NK+>CE?96_%+\[_P!(]SHKP_2=!^-_
M@/Q)I#W7BO3_ (H:!=7"P:A%<:9!I5U91GK-$8VVN%ZE3R>@'<>X4VM+IB3U
MLT%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM+&XIOE3LDMV_P#([7P_^T-X0UZ\2V::YTQW.U6OX@J$_P"\K,!^.!6WX_\
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M JW1#17 4=%\V,J^/;.*-$DEWO\ @EI]WYAK)W?:WXW?W_A8\>U.;Q5^S_\
M%7X>Z%:?$/5/&VC>)=0^P3Z'XC,=S?0H5)-RDZJ'*KWR,?TUKB1-/_;OMFN7
M6 7O@AHK;>0/-=;L,57U("DX]!7H?P[_ &>OAW\*-0DU#POX7MM.U"12IO))
M)+B<*>H625F90>X!&:T/B5\&O!GQ@M;6W\7:#!K"VC%[>1I)(I8B<9VR1LK
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M=:[_ %/>Z*\ T_P=\?O%&GQ:Y=_$C2?"%[.HF3PS:^'XKJWA!Y6.2=V\PG&
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M45YFWR+&-H9E!Y<=2.,UYLG[5GF0K*OP?^*C1, P=?#BL"#W&)N?PI?VWO\
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MUKYK4^DC95 <Y!&[((P<5Z_5#2=!TW0?M7]FZ?:V'VN=KFX^S0K'YLK?>D;
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M[^U)\:F\8:XFC#4&TL6VZWEE\S9;MO\ ]6C8QO7KCK7I?_#;GP3_ .AYA_\
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MM8D=0RH9G;S#P1D]CG&:Z_XF>)O&_@+]FWQ#K>I:AIT7C;3M.DF-[I,!-L)
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MLJR/<.!RJ*J'YC_0X]5^(_P;\%_%RUA@\6^'K761!_J9I-T<T6>H65"KJ#Z
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MB_C\JYM_,>/>N0<;D(8<@="*74O">C:UX;?P_J&FV]_HKPK;M972>9&T:@
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M=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\
M"':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &
MW16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^
M_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;
M_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AV
ME?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (
M=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=
M%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^
MM_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^
M_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5
M_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AV
ME?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5
MB?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW
M^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^
MM_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_
M #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5
M_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)
M_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?X
MT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW
M^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\
M/!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_
M #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_
M  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1
M_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?X
MT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \
M&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\
M/!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\
M"':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_
M  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0
M!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;
M_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \
M&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (
M=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\
M"':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &
MW16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^
M_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;
M_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AV
ME?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (
M=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=
M%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^
MM_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^
M_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5B?\ "':5
M_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW^-'_  AV
ME?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^M_C0!MT5
MB?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_ #P;_OZW
M^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5_P \&_[^
MM_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)_P (=I7_
M #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?XT?\ "':5
M_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW^- &W16)
M_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\ /!O^_K?X
MT?\ "':5_P \&_[^M_C0!MT5B?\ "':5_P \&_[^M_C1_P (=I7_ #P;_OZW
M^- &W16)_P (=I7_ #P;_OZW^-'_  AVE?\ /!O^_K?XT ;=%8G_  AVE?\
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MQ%>E4Q$HJ&UY:^K\O0]1_:0T?P]H'AO3K?3])LM.U":Z#A[6S6,M&J,&&]5
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MX!V<+2Y&]=OF9*?-'F2TW/HNBO/_ (U6*>)/A;J*0>//^%?03"&1?$T4ZQK
MN]2/G+I@/PN0XSN'/8]A921:3H-N]WJ*W$-O;+YNH7#JHD"J,RLW09ZD].:C
MHV^A?:W4T**Y70OBMX)\4:@+#1O&&@:O?'I:V.IP3R_]\JQ-=+=74-C;R7%Q
M-';P1J7>65@JJHZDD\ 4GIN-:[$M%<WX=^)7A'QA>26>@^*M%UN[C!+P:=J,
M-Q(H'4E48D5T4DB0QM)(RHBC<S,<  =230]-PWV'45RFE_%KP/K>K+I>G>,_
M#]_J;-L%E:ZI!),6] BN6S^%=43CD\"CS#R%HKD;?XP> [K5O[+@\;>'9M3W
M^7]BCU:!IMW]W8'SGVQ76YP,G@4=+AUL+17+Z?\ %/P7J^M?V/8^+]!O=6W%
M/L%OJ<$D^X=1Y8;=G\*ZB@/(**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\<UKQ_KUI^U5X
M=\'Q7^SPY=^')[^:R\F,[IUE*J^\KO&!V#8]J:UDH][_ ()O] >B<NUOQ:7Z
MGL=%?-O[6OQR\6_!7Q1\.9?#D;:A8WDM[)JFE1P([7<$*1,P#%2R%5,C94CI
MSD#%>Z>!?&VD?$;PGIOB/0KI;S2[^(2Q2#J/56'9E.01V(-$4Y0YUM>PF^62
MB^JN;U%>-I\0-?;]K1_!AO\ _BFAX3_M,6/DQ_\ 'Q]I";]^W?\ =.,;L>U8
M/QX\4>.I/C5\.?!/A#Q@W@^#7K6^EN;I=-M[T[H45U^65?J.".O>FHN7+;[5
M_P +W_)A)J/,W]FWXV_^21]!45X5)\*?C=;+YMM\=8[R9/F6WO/"5FD4G^RS
M(=P'N.:O?"WXT:]<>.+CX=_$;2;71/&L5N;NTN=/=FL=6MP<&2 M\RL.<H>>
M">,$!J-]$]2>:VK6A[/117SY\;?$OCR[^._@3P-X1\9MX.M=8TZ\NKBX73+>
M]):(;A\LJ^@QP1U[U"UDHKK^B;_0IOEBY/I;\6E^I]!T5X;_ ,*A^,__ $7Z
M;_PC[#_&MCXH>%=4F^$NFZ7JWQ8D\(ZI;W%O]I\6*L5D;IPWW"H=%7?D#:&Z
M@<$9!KE6FO5?C_7^0K[Z=SUJBO"OVOO$&K>%OA?H]QI&JWNF7;:_I\#W%G<-
M#(\;.0RDH1P>XZ&NM^-FAOK6G^&U7XB2?#ORM8@?SXYEB_M \XM,LZY+]E^;
M..5:B*YM?.WY:_B'-;3RO^>GX'I%%9^J^(-+T%K-=2U*STYKV=;6U%U.D1GF
M;[L:;B-SG!PHY.*QM0^*G@K2-:_L>^\8:#9:MN"?8+C4X(Y]QZ#RRV[/MBIW
MV*VW.IHI <C(Y%87B;Q]X8\$^5_PD7B/2=!\WF/^T[Z*VW_3>PS0!O45AKXZ
M\-M8Z=>+X@TIK/4IEMK*X%[%Y=U*WW8XFW8=C@X5<DXK<IZB"BBBD,**X[XE
M>%_%GBC3[.'PGXV;P1<Q2EYKA=*@O_/3& FV7A<'G(YKSO\ 9A\8>+O$%]\1
M]'\7>(CXGN?#NNMIMO?&RAM"R*@YV1*!R>><_6G%<U_)7_%+]12?+;ST_-_H
M>ZT5XW\/_B!K^N?M(?%+PM>W_G:%HMMILEA:>3&ODM+#ND.\*&;)Y^8G';%>
MR46]V,NZN/JUV_RO^H45XE^S_P#$?Q/XTTGXFSZG+_;EWHOB?4-/TVVVQ6_[
MF)4,4.Y5 ZDC<V3SR36?8>$?C[XXM5U74OB%I?PXEF&Z/0=+T*'4O(4]!+-,
MW+@==G&>AIVV]$_O5U_2$W:_DVON=F>^T5XI\&OB9XL;XA^(OAIX_-C>>(](
MM8]1M=7TZ,Q1:A:.=N]HS]QPQ ('')QTR<_Q1\1O''Q.^)NL>!?AI>V7AZRT
M!476_%5Y:B[,4[C*V]O"2%9P/O%N!@CC W'*[I+6^OR_K3UTW%S*SOI;^O\
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MO<<_B:\_T9\UG$:$94_9J*G;WE':_06BBBOJ3YX**** "BBB@ HHHH ****
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MA^TQX5'A/0_A!XKT[6[B:(Q:]XKTI-/BTQ1(I:592Q8L "-J=03UZ5Z!\4/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC'_KVU+_ -*HZ*UJ?$8TOA/%_P!GG_D==9_Z]6_]&+7T%7S[^SS_ ,CKK/\
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MN9W,D\SM)(YZLQ.2?S-0U/?64NFWUQ:3KLGMY&BD7T9201^8KJ_ _P )]?\
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MIJVZ* ,3SO$'_/"Q_P"^FH\[Q!_SPL?^^FK;HH Q/.\0?\\+'_OIJ/.\0?\
M/"Q_[Z:MNB@#$\[Q!_SPL?\ OIJ/.\0?\\+'_OIJVZ* ,3SO$'_/"Q_[Z:CS
MO$'_ #PL?^^FK;HH Q/.\0?\\+'_ +Z:CSO$'_/"Q_[Z:MNB@#$\[Q!_SPL?
M^^FH\[Q!_P \+'_OIJVZ* ,3SO$'_/"Q_P"^FH\[Q!_SPL?^^FK;HH Q/.\0
M?\\+'_OIJ/.\0?\ /"Q_[Z:MNB@#$\[Q!_SPL?\ OIJ/.\0?\\+'_OIJVZ*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN"YI),\'T']LC3O%6EQ:GHOPN^)>KZ;*6$=Y8Z'%+$^UBK;66?!P01]176>
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MRG&%MSWRBN.^#?B"_P#%?PE\&ZUJL_VK4]0TBUNKF?8J>9(\2LS;5  R2>
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MO"+7L-IJMO+HL.GW%I'(P02Q&(X;#$<-Z@=\AQCS.U]W9>?3^KV!NRO;I?\
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M\)=\&_[.\O\ X3+_ (2NV^Q^7CSOLO/VCW\O&S/:NI^*_P 3/%$WCW3/AO\
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M/"?VH/#NL6$W@OXE>'["75=0\%7[W-S86ZYEN+&50EP$ ZL%&<>FXUZC\/\
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M!KF?C/\ #'X8>*/"^I:CX[TK1XK586,FL3JD,\(QD%9QA@?0 \],'I78>,O
M/ASXB:7_ &=XFT2QURR!W+%>PK)L;&-RD\J?<$&O-=+_ &-?@UH^H17D'@>U
MEEB;<B7=W<W,0/\ URDD9#],5'*I*ST??^O\RKM.Z_K^O0\&O])\4^//V$?#
M^H7LFJ7\VC:DFI)+$Y6]FT^&=PKJQY#+&=RGT0&O4_"/P-\/>//#=MKV@_&[
MXFZCI5Q'YBW$/BUB%XR0WR?*P[J<$=Z^C(88[>%(8HUCB10BQHH"JH&  .PQ
M7D.O_LA?"#Q+K$NIWW@BS%W,VZ3[+//;1N<YR8XI%0\\]*V<[REV;O\ @E^B
M[:W^6?+HO+3RWO\ *U_/3T$_9_\ AYX.\,W?BC7?"OC/5O&]QJ4\=IJ.H:KJ
M:W["6W! 7S H.0'QR3P%QQ7,_L5W4-C\&]<N+B5(+>'Q#J<DDLC!511)DL2>
M@ [U[KX;\,Z3X/T>WTG0]-M=)TRW&(K6SB$<:^IP.Y/)/4GK7.6/P8\':;X&
MU;P=;:.8O#FJO-)>68NICYK2G,AWE]XR?1A[5,I.[:_ELOO7X:#4=K][_@U^
MJ/*_ UK-^TI\1HO'^IPR+\/?#T[1^&+"8$+?W"G:]^ZG@J#D1_3/&#GU?XT:
M'<^)OA#XTTJR0R7EYH]U##&HR7<Q-M4?4X'XUY^O[$?P710J^$)54< #6;_
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M]X9\-:;X/\/:?H>D6WV32M/@6WMK?>S[(U& NYB6/'<DFNFK/][4E'K)-?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _.+]B'_D\'QC_ ->VI?\
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M .2*/9R[![2/<^M:*^2O^'E_PO\ ^@)XL_\  .V_^2*/^'E_PO\ ^@)XL_\
M .V_^2*/9R[![2/<^M:*^2O^'E_PO_Z GBS_ , [;_Y(H_X>7_"__H">+/\
MP#MO_DBCV<NP>TCW/K6BODK_ (>7_"__ * GBS_P#MO_ )(H_P"'E_PO_P"@
M)XL_\ [;_P"2*/9R[![2/<^M:*^2O^'E_P +_P#H">+/_ .V_P#DBC_AY?\
M"_\ Z GBS_P#MO\ Y(H]G+L'M(]SZUHKY*_X>7_"_P#Z GBS_P  [;_Y(H_X
M>7_"_P#Z GBS_P  [;_Y(H]G+L'M(]SZUHKY*_X>7_"__H">+/\ P#MO_DBC
M_AY?\+_^@)XL_P# .V_^2*/9R[![2/<^M:*^2O\ AY?\+_\ H">+/_ .V_\
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M[![2/<^M:*^2O^'E_P +_P#H">+/_ .V_P#DBC_AY?\ "_\ Z GBS_P#MO\
MY(H]G+L'M(]SZUHKY*_X>7_"_P#Z GBS_P  [;_Y(H_X>7_"_P#Z GBS_P
M[;_Y(H]G+L'M(]SZUHKY*_X>7_"__H">+/\ P#MO_DBC_AY?\+_^@)XL_P#
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ML_\  .V_^2*/^'E_PO\ ^@)XL_\  .V_^2*/9R[![2/<^M:*^2O^'E_PO_Z
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M+/\ P#MO_DBC_AY?\+_^@)XL_P# .V_^2*/9R[![2/<^M:*^2O\ AY?\+_\
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M\ [;_P"2*/9R[![2/<^M:*^2O^'E_P +_P#H">+/_ .V_P#DBC_AY?\ "_\
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M)XL_\ [;_P"2*/\ AY?\+_\ H">+/_ .V_\ DBCV<NP>TCW/K6BODK_AY?\
M"_\ Z GBS_P#MO\ Y(H_X>7_  O_ .@)XL_\ [;_ .2*/9R[![2/<^M:*^2O
M^'E_PO\ ^@)XL_\  .V_^2*/^'E_PO\ ^@)XL_\  .V_^2*/9R[![2/<^M:*
M^2O^'E_PO_Z GBS_ , [;_Y(H_X>7_"__H">+/\ P#MO_DBCV<NP>TCW/K6B
MODK_ (>7_"__ * GBS_P#MO_ )(H_P"'E_PO_P"@)XL_\ [;_P"2*/9R[![2
M/<^M:*^2O^'E_P +_P#H">+/_ .V_P#DBC_AY?\ "_\ Z GBS_P#MO\ Y(H]
MG+L'M(]SZUHKY*_X>7_"_P#Z GBS_P  [;_Y(H_X>7_"_P#Z GBS_P  [;_Y
M(H]G+L'M(]SZUHKY*_X>7_"__H">+/\ P#MO_DBC_AY?\+_^@)XL_P# .V_^
M2*/9R[![2/<^M:*^2O\ AY?\+_\ H">+/_ .V_\ DBC_ (>7_"__ * GBS_P
M#MO_ )(H]G+L'M(]SZUHKY*_X>7_  O_ .@)XL_\ [;_ .2*/^'E_P +_P#H
M">+/_ .V_P#DBCV<NP>TCW/K6BODK_AY?\+_ /H">+/_  #MO_DBC_AY?\+_
M /H">+/_  #MO_DBCV<NP>TCW/K6BODK_AY?\+_^@)XL_P# .V_^2*/^'E_P
MO_Z GBS_ , [;_Y(H]G+L'M(]SZUHKY*_P"'E_PO_P"@)XL_\ [;_P"2*/\
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MQD"F7YB<"0 8 KNZ336X[W"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838370992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>May 03, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cerecor Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,753,659<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6836709552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 16,121,388<span></span>
</td>
<td class="nump">$ 10,646,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">2,718,396<span></span>
</td>
<td class="nump">3,157,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Other receivables</a></td>
<td class="nump">5,531,025<span></span>
</td>
<td class="nump">5,469,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">1,046,982<span></span>
</td>
<td class="nump">1,110,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,248,465<span></span>
</td>
<td class="nump">1,529,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash, current portion</a></td>
<td class="nump">77,846<span></span>
</td>
<td class="nump">18,730<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">26,744,102<span></span>
</td>
<td class="nump">21,931,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,477,067<span></span>
</td>
<td class="nump">586,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangibles assets, net</a></td>
<td class="nump">30,160,621<span></span>
</td>
<td class="nump">31,239,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,411,123<span></span>
</td>
<td class="nump">16,411,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash, net of current portion</a></td>
<td class="nump">77,118<span></span>
</td>
<td class="nump">81,725<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">74,870,031<span></span>
</td>
<td class="nump">70,250,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,249,470<span></span>
</td>
<td class="nump">1,446,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">21,815,097<span></span>
</td>
<td class="nump">19,731,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">1,814,650<span></span>
</td>
<td class="nump">2,032,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term debt, current portion</a></td>
<td class="nump">1,050,000<span></span>
</td>
<td class="nump">1,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration, current portion</a></td>
<td class="nump">2,205,647<span></span>
</td>
<td class="nump">1,956,807<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">28,134,864<span></span>
</td>
<td class="nump">26,216,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">14,303,540<span></span>
</td>
<td class="nump">14,327,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration, net of current portion</a></td>
<td class="nump">6,796,641<span></span>
</td>
<td class="nump">7,093,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability, net</a></td>
<td class="nump">75,179<span></span>
</td>
<td class="nump">69,238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseObligationNoncurrent', window );">License obligations</a></td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">1,189,277<span></span>
</td>
<td class="nump">385,517<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">51,749,501<span></span>
</td>
<td class="nump">49,342,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock&#8212;$0.001 par value; 200,000,000 shares authorized at March 31, 2019 and December 31, 2018; 42,753,659 and 40,804,189 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively</a></td>
<td class="nump">42,754<span></span>
</td>
<td class="nump">40,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock&#8212;$0.001 par value; 5,000,000 shares authorized at March 31, 2019 and December 31, 2018; 2,857,143 shares issued and outstanding at March 31, 2019 and December 31, 2018</a></td>
<td class="nump">2,857<span></span>
</td>
<td class="nump">2,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">128,747,037<span></span>
</td>
<td class="nump">119,082,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(105,672,118)<span></span>
</td>
<td class="num">(98,218,070)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">23,120,530<span></span>
</td>
<td class="nump">20,907,748<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 74,870,031<span></span>
</td>
<td class="nump">$ 70,250,721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Obligation, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 310<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68065756&amp;loc=d3e49354-109356<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, the amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 305<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84242212&amp;loc=d3e2352-115587<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6840602256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">42,753,659<span></span>
</td>
<td class="nump">40,804,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">42,753,659<span></span>
</td>
<td class="nump">40,804,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">2,857,143<span></span>
</td>
<td class="nump">2,857,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">2,857,143<span></span>
</td>
<td class="nump">2,857,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6836666240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 5,411,443<span></span>
</td>
<td class="nump">$ 4,482,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of product sales</a></td>
<td class="nump">1,947,892<span></span>
</td>
<td class="nump">863,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">3,401,189<span></span>
</td>
<td class="nump">1,649,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">2,716,983<span></span>
</td>
<td class="nump">2,918,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">3,108,902<span></span>
</td>
<td class="nump">1,524,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">1,078,847<span></span>
</td>
<td class="nump">1,017,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">180,402<span></span>
</td>
<td class="nump">262,769<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">12,434,215<span></span>
</td>
<td class="nump">8,237,311<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(7,022,772)<span></span>
</td>
<td class="num">(3,754,536)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration', window );">Change in fair value of warrant liability and unit purchase option liability</a></td>
<td class="num">(47,577)<span></span>
</td>
<td class="num">(23,251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other (expense) income, net</a></td>
<td class="num">(9,400)<span></span>
</td>
<td class="nump">18,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="num">(207,941)<span></span>
</td>
<td class="num">(100,402)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(264,918)<span></span>
</td>
<td class="num">(104,998)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NetIncomeLossBeforeTaxes', window );">Net loss before taxes</a></td>
<td class="num">(7,287,690)<span></span>
</td>
<td class="num">(3,859,534)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">166,358<span></span>
</td>
<td class="nump">23,313<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,454,048)<span></span>
</td>
<td class="num">$ (3,882,847)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_SalesRevenueProductMember', window );">Product revenue, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 5,411,443<span></span>
</td>
<td class="nump">$ 4,260,119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_SalesForceRevenueMember', window );">Sales force revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 222,656<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Adjustment of Warrants And Investor Rights Obligation And Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_FairValueAdjustmentofWarrantsAndInvestorRightsObligationAndContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_NetIncomeLossBeforeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) Before Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_NetIncomeLossBeforeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_SalesRevenueProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_SalesRevenueProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_SalesForceRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_SalesForceRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838985488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,454,048)<span></span>
</td>
<td class="num">$ (3,882,847)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss provided by (used in) to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,098,478<span></span>
</td>
<td class="nump">1,023,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">596,693<span></span>
</td>
<td class="nump">242,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes</a></td>
<td class="nump">5,941<span></span>
</td>
<td class="nump">15,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AmortizationOfInventoryFairValueAdjustment', window );">Amortization of inventory fair value associated with acquisition of TRx and Avadel</a></td>
<td class="nump">22,603<span></span>
</td>
<td class="nump">45,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">105,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation', window );">Change in fair value of warrant liability and unit purchase option liability</a></td>
<td class="nump">47,577<span></span>
</td>
<td class="nump">23,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration and long-term royalty obligation</a></td>
<td class="nump">180,402<span></span>
</td>
<td class="nump">262,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">21,412<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">439,159<span></span>
</td>
<td class="nump">104,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="num">(62,014)<span></span>
</td>
<td class="nump">371,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory, net</a></td>
<td class="nump">41,195<span></span>
</td>
<td class="num">(554,445)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">281,051<span></span>
</td>
<td class="num">(71,085)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Escrowed cash receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,065)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(196,671)<span></span>
</td>
<td class="nump">1,866,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(217,608)<span></span>
</td>
<td class="nump">7,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">2,074,278<span></span>
</td>
<td class="nump">160,627<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(3,121,552)<span></span>
</td>
<td class="num">(280,423)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(165,969)<span></span>
</td>
<td class="num">(19,224)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(165,969)<span></span>
</td>
<td class="num">(19,225)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from exercise of stock options and warrants</a></td>
<td class="nump">94,177<span></span>
</td>
<td class="nump">363,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from underwritten public offering, net</a></td>
<td class="nump">8,975,960<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration</a></td>
<td class="num">(228,678)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payment of long-term debt</a></td>
<td class="num">(24,342)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">8,817,117<span></span>
</td>
<td class="nump">363,390<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">5,529,596<span></span>
</td>
<td class="nump">63,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">10,746,756<span></span>
</td>
<td class="nump">2,605,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">16,276,352<span></span>
</td>
<td class="nump">2,669,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">262,500<span></span>
</td>
<td class="nump">44,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for taxes</a></td>
<td class="nump">378,025<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of non-cash activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased asset obtained in exchange for new operating lease liability</a></td>
<td class="nump">743,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Debt assumed in Avadel Pediatric Products acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(15,075,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">16,121,388<span></span>
</td>
<td class="nump">2,523,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash, current</a></td>
<td class="nump">77,846<span></span>
</td>
<td class="nump">13,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash, non-current</a></td>
<td class="nump">$ 77,118<span></span>
</td>
<td class="nump">$ 131,359<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AmortizationOfInventoryFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Inventory Fair Value Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AmortizationOfInventoryFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability and investor rights obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_FairValueAdjustmentOfWarrantsAndInvestorRightsObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 305<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84242212&amp;loc=d3e2352-115587<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838491424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Preferred Stock</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th"><div>Contingently issuable stock</div></th>
<th class="th"><div>Accumulated deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,266,989<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2017</a></td>
<td class="nump">$ 27,859,608<span></span>
</td>
<td class="nump">$ 31,268<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 83,338,136<span></span>
</td>
<td class="nump">$ 2,655,464<span></span>
</td>
<td class="num">$ (58,165,260)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised', window );">Exercise of stock options and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised', window );">Exercise of stock options and warrants</a></td>
<td class="nump">363,390<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="nump">242,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,882,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,882,847)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,410,335<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2018</a></td>
<td class="nump">24,582,975<span></span>
</td>
<td class="nump">$ 31,411<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">83,944,207<span></span>
</td>
<td class="nump">2,655,464<span></span>
</td>
<td class="num">(62,048,107)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,804,189<span></span>
</td>
<td class="nump">2,857,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2018</a></td>
<td class="nump">20,907,748<span></span>
</td>
<td class="nump">$ 40,804<span></span>
</td>
<td class="nump">$ 2,857<span></span>
</td>
<td class="nump">119,082,157<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(98,218,070)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,818,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="nump">8,975,960<span></span>
</td>
<td class="nump">$ 1,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,974,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised', window );">Exercise of stock options and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised', window );">Exercise of stock options and warrants</a></td>
<td class="nump">94,177<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="nump">596,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted Stock Units vested during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted Stock Units vested during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(7,454,048)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,454,048)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,753,659<span></span>
</td>
<td class="nump">2,857,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2019</a></td>
<td class="nump">$ 23,120,530<span></span>
</td>
<td class="nump">$ 42,754<span></span>
</td>
<td class="nump">$ 2,857<span></span>
</td>
<td class="nump">$ 128,747,037<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (105,672,118)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Stock Options And Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Stock Options And Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation for stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829556304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Business</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1. Business</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cerecor Inc. (the "Company" or &#8220;Cerecor&#8221;) is a fully integrated biopharmaceutical company with commercial operations and research and development capabilities.  The Company is building a pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases.  The Company's neurology pipeline is led by CERC-301, which recently received positive interim results from the Phase I safety study of Neurogenic Orthostatic Hypotension ("nOH").  The Company is also developing </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other neurological compounds, </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> of which is in preclinical testing and the other is in the clinical ready stage.  The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802, and CERC-803.  All </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> of these compounds are therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation ("CDGs") by means of substrate replacement therapy.  The U.S. Food and Drug Administration ("FDA") has granted Rare Pediatric Disease designation ("RPDD") and Orphan Drug Designation ("ODD") to all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> compounds.  Under the FDA&#8217;s Rare Pediatric Disease Priority Review Voucher ("PRV") program, upon the approval of a new drug application ("NDA") for the treatment of a rare pediatric disease, the sponsor of such application would be eligible for a PRV that can be used to obtain priority review for a subsequent new drug application or biologics license application.  The PRV may be sold or transferred an unlimited number of times.  The Company plans to leverage the 505(b)(2) NDA pathway for all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> compounds to accelerate development and approval.  The Company is also in the process of developing </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> other preclinical pediatric orphan rare disease compound. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also has a diverse portfolio of marketed products.  Our marketed products are led by our prescribed dietary supplements and prescribed drugs.  Our prescribed dietary supplements include Poly-Vi-Flor and Tri-Vi-Flor, which are prescription vitamin and fluoride supplements used in infants and children to treat or prevent deficiency of essential vitamins and fluoride.  The Company also markets a number of prescription drugs that treat a range of pediatric diseases, disorders and conditions.  Cerecor's prescription drugs include Millipred&#174;, Ulesfia&#174;, Karbinal&#8482; ER, AcipHex&#174; Sprinkle&#8482;, and Cefaclor for Oral Suspension. Finally, the Company has </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> marketed medical device, Flexichamber&#8482;. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cerecor was incorporated in 2011, commenced operations in the second quarter of 2011 and completed an initial public offering in October 2015. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 17, 2017, the Company acquired TRx Pharmaceuticals, LLC (&#8220;TRx&#8221;) and its wholly-owned subsidiaries (see "TRx Acquisition" in Note 5 below for a description of this transaction).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2018, Cerecor acquired all rights to Avadel Pharmaceuticals PLC&#8217;s (&#8220;Avadel&#8221;) marketed pediatric products (the &#8220;Acquired Products&#8221;) in exchange for Cerecor assuming certain financial obligations of Avadel (see "Avadel Pediatric Products Acquisition" in Note 5 below for a description of this transaction).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 25, 2018, the Company acquired Ichorion Therapeutics, Inc., a privately-held biopharmaceutical company focused on developing treatments and increasing awareness of inherited metabolic disorders known as CDGs (see "Ichorion Asset Acquisition" in Note 5 below for a description of this transaction).</font></div><div style="line-height:120%;text-align:justify;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidity</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In order to meet its cash flow needs, the Company applies a disciplined decision-making methodology as it evaluates the optimal allocation of the Company's resources between investing in the Company's current commercial product line, the Company's development portfolio and acquisitions or in-licensing of new assets.  For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, Cerecor generated </font><font style="font-family:inherit;font-size:10pt;">a net loss</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">$7.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">negative</font><font style="font-family:inherit;font-size:10pt;"> cash flow from operations of </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;">.  As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, Cerecor had an accumulated deficit of </font><font style="font-family:inherit;font-size:10pt;">$105.7 million</font><font style="font-family:inherit;font-size:10pt;"> and a balance of </font><font style="font-family:inherit;font-size:10pt;">$16.1 million</font><font style="font-family:inherit;font-size:10pt;"> in cash and cash equivalents.  During the first quarter of 2019, the Company closed an underwritten public offering of common stock for </font><font style="font-family:inherit;font-size:10pt;">1,818,182</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock of the Company, at a price to the public of </font><font style="font-family:inherit;font-size:10pt;">$5.50</font><font style="font-family:inherit;font-size:10pt;"> per share ("public price"). Armistice Capital Master Fund Ltd. ("Armistice"), our largest stockholder, participated in the offering by purchasing </font><font style="font-family:inherit;font-size:10pt;">363,637</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock of the Company from the underwriter at the public price.  Cerecor director Steven J. Boyd is Armistice's Chief Investment Officer.  The net proceeds of the offering were approximately </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;"> (see "Common Stock Offering" in Note 9 below for description of the transaction).  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company plans to use cash and the anticipated cash flows from the Company's existing product sales to offset costs related to its neurology programs, pediatric rare disease programs, business development, costs associated with its organizational infrastructure, and debt principal and interest payments.  Cerecor expects to continue to incur significant expenses and operating losses for the immediate future as it continues to invest in the Company's pipeline assets.  Our ability to achieve and maintain profitability in the future is dependent on, among other things, the development, regulatory approval, and commercialization of our new product candidates and achieving a level of revenues from our existing product sales adequate to support our cost structure, which includes significant investment in our pipeline assets. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company believes it will require additional financing to continue to execute its clinical development strategy and fund future operations. The Company plans to meet its capital requirements through operating cash flows from product sales and some combination of equity or debt financings, collaborations, out-licensing arrangements, strategic alliances, federal and private grants, marketing, distribution, or licensing arrangements, or the sale of current or future assets.  If the Company is not able to secure adequate additional funding, the Company may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs. If the Company raises additional funds through collaborations, strategic alliances, or licensing arrangements with third parties, the Company may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our plan to aggressively develop our pipeline will require substantial cash inflows in excess of what the Company expects our current commercial operations to generate.&#160; However, the Company expects that our existing cash and cash equivalents, together with anticipated revenue, will enable us to fund our operating expenses, capital expenditure requirements, and other non-operating cash payments, such as fixed quarterly payments on our outstanding debt balances, through at least May 2020.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6656897008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation and Significant Accounting Policies </font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;).   Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows. The condensed consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> has been derived from audited financial statements at that date. The interim results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosure normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (&#8220;SEC&#8221;). Certain prior period amounts have been reclassified to conform to the current year presentation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company believes that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> audited consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassification</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2018, the Company concluded that going forward it would include change in fair value of contingent consideration within its own stand-alone line in operating expenses in the Company's statements of operations.  The Company has reclassified </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> from other expenses to operating expenses in the March 31, 2018 statement of operations to conform with current period presentation.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant Accounting Policies </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended March 31, 2019, there have been no significant changes to the Company&#8217;s summary of significant accounting policies contained in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on March 18, 2019 and amended on April 23, 2019, except for the recently adopted accounting standards described below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following significant accounting policy was updated in 2019 to reflect changes upon our adoption of ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;"> (Topic 842) ("ASU 2016-02").</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines if an arrangement is a lease at inception.  If an arrangement contains a lease, the Company performs a lease classification test to determine if the lease is an operating lease or a finance lease.  The Company has identified </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> operating lease for its corporate headquarters. Right-of-use ("ROU") assets represent the right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.  Operating lease liabilities are recognized on the commencement date of the lease based on the present value of the future lease payments over the lease term and are included in other long-term liabilities on our condensed consolidated balance sheet.  Right-of-use assets are valued at the initial measurement of the lease liability, plus any indirect costs or rent prepayments, and reduced by any lease incentives and any deferred lease payments.  Operating right-of-use assets are recorded in property and equipment, net on the condensed consolidated balance sheet and are amortized over the lease term.  To determine the present value of lease payments on lease commencement, we use the implicit rate when readily determinable, however as most leases do not provide an implicit rate, we use our incremental borrowing rate based on information available at commencement date. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Furthermore, the Company has elected the practical expedient to account for the lease and non-lease components as a single lease component for the leased property asset class.  Lease expense is recognized on a straight-line basis over the life of the lease and is included within general and administrative expenses. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adoption of ASC 842</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;"> (Topic 842) ("ASU 2016-02"). This guidance revises existing practice related to accounting for leases under ASC No. 840,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">&#160;(&#8220;ASC 840&#8221;) for both lessees and lessors. The new guidance in ASU 2016-02 requires lessees to recognize a right-of-use asset and a lease liability for nearly all leases (other than leases that meet the definition of a short-term lease). The lease liability will be equal to the present value of lease payments and the right-of-use asset will be based on the lease liability, subject to adjustment such as for initial direct costs. For income statement purposes, the new standard retains a dual model similar to ASC 840, requiring leases to be classified as either operating leases or finance leases. For lessees, operating leases will result in straight-line expense (similar to current accounting by lessees for operating leases under ASC 840) while finance leases will result in a front-loaded expense pattern (similar to current accounting by lessees for capital leases under ASC 840). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted the standard using the simplified transition method on its effective date of January 1, 2019 and therefore did not adjust prior comparative periods as permitted by the codification improvements issued by FASB in July 2018.  Additionally, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allows the Company to carryforward the historical lease classification.  As a result of the standard, the Company recorded a lease liability of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> and a right-of-use asset of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, which is equal to the initial measurement of the lease liability reduced by the unamortized balance of lease incentive received and deferred rent.  There was no material impact to our condensed consolidated income statement (see Note 12 below for more information). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Adopted Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532&#160;Disclosure Update and&#160;Simplification, to eliminate or modify certain disclosure rules that are redundant, outdated, or duplicative of GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of stockholders' equity are expanded for interim financial statements. An analysis of the changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement.  The Company has provided this disclosure beginning in the first quarter of 2019.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829636624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customers</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue from Contracts with Customers </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#ff0000;"></font><font style="font-family:inherit;font-size:10pt;">The Company generates substantially all of its revenue from sales of prescription pharmaceutical products to its customers.  The following table presents net revenues disaggregated by type (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.07407407407408%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:68%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prescribed dietary supplements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prescription drugs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,029</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales force revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,411</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,483</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the pharmaceutical industry, the Company sells its prescription pharmaceutical products (which include prescribed dietary supplements and prescription drugs) in the United States primarily through wholesale distributors and a specialty contracted pharmacy.  Wholesale distributors account for substantially all of the Company&#8217;s net product revenues and trade receivables. In addition, the Company earns revenue from sales of its prescription pharmaceutical products directly to retail pharmacies. &#160;&#160;For the three months ended March 31, 2019, the Company&#8217;s three largest customers accounted for approximately </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">33%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of the Company's total net product revenues from sale of prescription pharmaceutical products.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829617872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Loss Per Share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The Company computes earnings per sh</font><font style="font-family:inherit;font-size:10pt;">are ("EPS") using the two-class method.  The two-class method of computing EPS is an earnings allocation formula that determines EPS for common stock and any participating securities according to dividends declared and participation rights in undistributed earnings.  The Company has two classes of stock outstanding, common stock and preferred stock.  The preferred stock was issued in the fourth quarter of 2018 upon Armistice exercising preferred stock warrants to acquire an aggregate of </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;"> shares of the Series B Convertible Preferred Stock ("convertible preferred stock").  The convertible preferred stock has the same rights and preferences as common stock other than being non-voting and convertible to shares of common stock on a 1-to-</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> ratio.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the two-class method, the convertible preferred stock is considered a separate class of stock for EPS purposes and therefore basic and diluted EPS is provided below for both common stock and preferred stock.  EPS for common stock and EPS for preferred stock is computed by dividing the sum of distributed earnings and undistributed earnings for each class of stock by the weighted average number of shares outstanding for each class of stock for the period.  In applying the two-class method, undistributed earnings are allocated to common stock and preferred stock based on the weighted average shares outstanding during the period, which assumes the convertible preferred stock has been converted to common stock.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Diluted net (loss) income per share includes the potential dilutive effect of common stock equivalents as if such securities were converted or exercised during the period, when the effect is dilutive.  Common stock equivalents include: (i) outstanding stock options and restricted stock units, which are included under the "treasury stock method" when dilutive, (ii) common stock to be issued upon the assumed conversion of the Company's unit purchase option shares, which are included under the "if-converted method" when dilutive; (iii) prior to issuance, the contingently issuable shares in the TRx acquisition, if contingencies would have been satisfied if the end of the contingency period were as of the balance sheet date under the "if-converted method" when dilutive; and (iv) common stock to be issued upon the exercise of outstanding warrants, which are included under the "treasury stock method" when dilutive.  Because the impact of these items is generally anti-dilutive during periods of net loss, there is no difference between basic and diluted loss per common share for periods with net losses.  </font><font style="font-family:inherit;font-size:10pt;">In periods of net loss, losses are allocated</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">to the participating security only if the security has not only the right to participate in earnings, but also a contractual obligation to share in the Company's losses.</font><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted net loss per share of common stock and preferred stock for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, which includes both classes of participating securities:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.25925925925925%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Preferred stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Preferred stock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net&#160;loss&#160;per&#160;share,&#160;basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator: </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allocation of undistributed net loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,537,787</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,916,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,882,847</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,284,168</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,857,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,316,246</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and diluted net loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.13</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.67</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following outstanding securities at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> have been excluded from the computation of diluted weighted shares outstanding, as they could have been anti-dilutive:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,345,305</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,909,384</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrants on common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,024,708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,986,659</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Underwriters' unit purchase option</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829630928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract', window );"><strong>Business Combinations and Asset Acquisitions [Abstract] [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock', window );">Acquisitions</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Acquisitions </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Ichorion Asset Acquisition </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September&#160;24, 2018, the Company entered into, and subsequently consummated the transactions contemplated by, an agreement and plan of merger (the "Merger Agreement") by and among the Company and&#160;Ichorion Therapeutics,&#160;Inc., a Delaware corporation (the &#8220;Ichorion Asset Acquisition&#8221;), with Ichorion surviving as a wholly owned subsidiary of the Company.&#160; The consideration for the Ichorion Asset Acquisition consisted of approximately&#160;</font><font style="font-family:inherit;font-size:10pt;">5.8 million</font><font style="font-family:inherit;font-size:10pt;">&#160;shares of the Company&#8217;s common stock, par value&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.001</font><font style="font-family:inherit;font-size:10pt;">&#160;per share, as adjusted for Estimated Working Capital as defined in the Merger Agreement.&#160; The shares of common stock issued as part of the acquisition may not be resold until January 2020.  Consideration for the Ichorion Asset Acquisition includes certain development milestones worth up to an additional&#160;</font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;">, payable either in shares of the Company's common stock or in cash, at the election of the Company.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the common stock shares transferred at closing was approximately&#160;</font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;">&#160;based on the Company's stock price close on September 24, 2018 and offset by an estimated discount for lack of marketability calculated using guideline public company volatility for comparable companies. The assets acquired consisted primarily of&#160;</font><font style="font-family:inherit;font-size:10pt;">$18.7 million</font><font style="font-family:inherit;font-size:10pt;">&#160;of IPR&amp;D,&#160;</font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;"> of cash and&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#160;assembled workforce. The Company recorded this transaction as an asset purchase as opposed to a business combination as management concluded that substantially all of the value received was related to one group of similar identifiable assets, which was the IPR&amp;D for the&#160;</font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#160;preclinical therapies for inherited metabolic disorders known as CDGs (CERC-801, CERC-802, and CERC-803). The Company has considered these assets similar due to similarities in the risks for development, compound type, stage of development, regulatory pathway, patient population and economics of commercialization.&#160; The fair value of the IPR&amp;D was immediately recognized as Acquired In-Process Research and Development expense as the IPR&amp;D asset has no other alternate use due to the stage of development.&#160; The&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.2</font><font style="font-family:inherit;font-size:10pt;"> million&#160;of transaction costs incurred were recorded to acquired IPR&amp;D expense. The assembled workforce asset recorded to intangible assets will be amortized over an estimated useful life of&#160;</font><font style="font-family:inherit;font-size:10pt;">two years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contingent consideration of up to an additional </font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;"> relates to </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> future development milestones.  The first milestone is the first product being approved for marketing by the FDA on or prior to December 31, 2021.  If this milestone is met, the Company is required to make a milestone payment of </font><font style="font-family:inherit;font-size:10pt;">$6 million</font><font style="font-family:inherit;font-size:10pt;">.  The second milestone is the second product being approved for marketing by the FDA on or prior to December 31, 2021.  If this milestone is met, the Company is required to make a milestone payment of </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;">.  The third milestone is a protide molecule being approved by the FDA on or prior to December 31, 2023.  If this milestone is met, the Company is required to make a milestone payment of </font><font style="font-family:inherit;font-size:10pt;">$4 million</font><font style="font-family:inherit;font-size:10pt;">.  All milestones are payable in either shares of the Company's common stock or cash, at the election of the Company. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contingent consideration related to the development milestones will be recognized if and when such milestones are probable and can be reasonably estimated.  As of March 31, 2019, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> contingent consideration related to the development milestone has been recognized.  The Company will continue to monitor the development milestones at each reporting period. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Avadel Pediatric Products Acquisition</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2018, the Company entered into an Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Avadel US Holdings, Inc., Avadel Pharmaceuticals (USA), Inc., Avadel Pediatrics, Inc., Avadel Therapeutics, LLC and Avadel Pharmaceuticals PLC (collectively, the &#8220;Sellers&#8221;) to purchase and acquire all rights to the Sellers&#8217; pediatric products. Total consideration transferred to the Sellers consisted of: (1) a cash payment of&#160;</font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> dollar, (2) the Company's assumption of existing seller debt due in January 2021 with a fair value of&#160;</font><font style="font-family:inherit;font-size:10pt;">$15.1 million</font><font style="font-family:inherit;font-size:10pt;">,&#160;and (3) contingent consideration relating to royalty obligations through February 2026 with a fair value at acquisition date of approximately&#160;</font><font style="font-family:inherit;font-size:10pt;">$7.9 million</font><font style="font-family:inherit;font-size:10pt;">. As a result of the Avadel pediatric products acquisition, the Company recorded goodwill of&#160;</font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;">, which is deductible over&#160;</font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> years for income tax purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The transaction was accounted for as a business combination under the acquisition method of accounting. Accordingly, the tangible and identifiable intangible assets acquired and liabilities assumed were recorded at fair value as of the date of acquisition, with the remaining purchase price recorded as goodwill. The goodwill recognized is attributable primarily to strategic opportunities related to an expanded commercial footprint and diversified pediatric product portfolio that is expected to provide revenue and cost synergies. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the second quarter of 2018, the Company identified and recorded measurement period adjustments to the preliminary purchase price allocation. These adjustments are reflected in the tables below. The measurement period adjustments were the result of additional analysis performed and information identified during the second quarter of 2018 based on facts and circumstances that existed as of the purchase date. There were no additional measurement adjustments recorded in 2018.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition and as adjusted for measurement period adjustments identified during the second quarter of 2018: &#160; &#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (as adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,549,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,831,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">718,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">570,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">570,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,453,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,838,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,291,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(362,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(362,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of debt assumed</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,272,303</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197,303</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,075,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,875,165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44,835</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,920,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net liabilities assumed</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,145,468</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367,468</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,778,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consideration exchanged</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(240,999</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,386,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(608,467</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,778,001</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price allocation related to the acquisition of Avadel's pediatric products was finalized in 2018.  The fair values of intangible assets, including marketing rights, licenses, and developed technology, were determined using variations of the income approach. Varying discount rates were also applied to the projected net cash flows. The Company believes the assumptions are representative of those a market participant would use in estimating fair value.  The fair value of intangible assets, both as of the date of acquisition and as adjusted by measurement period adjustments identified during the second quarter of 2018, includes the following: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (as adjusted)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Product Marketing Rights - Karbinal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,221,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,200,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Product Marketing Rights - AcipHex</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,520,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">283,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,803,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Product Marketing Rights - Cefaclor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,291,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,320,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,611,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Developed Technology - Flexichamber</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,131,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,677,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired IPR&amp;D - LiquiTime formulations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">290,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(290,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indefinite</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,453,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,838,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,291,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">TRx Acquisition&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 17, 2017, the Company entered into, and consummated the transactions contemplated by, an equity interest purchase agreement (the &#8220;TRx Purchase Agreement&#8221;) by and among the Company, TRx, Fremantle Corporation, and LRS International LLC, the selling members of TRx (collectively, the &#8220;TRx Sellers&#8221;), which provided for the purchase of all of the equity and ownership interests of TRx by the Company (the "TRx Acquisition").  The consideration for the TRx Acquisition consisted of </font><font style="font-family:inherit;font-size:10pt;">$18.9 million</font><font style="font-family:inherit;font-size:10pt;"> in cash, as adjusted for estimated working capital, estimated cash on hand, estimated indebtedness and estimated transaction expenses, as well as </font><font style="font-family:inherit;font-size:10pt;">7,534,884</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock having an aggregate value on the closing date of </font><font style="font-family:inherit;font-size:10pt;">$8.5 million</font><font style="font-family:inherit;font-size:10pt;"> (the "Equity Consideration") and certain potential contingent payments.  Upon closing, the Company issued </font><font style="font-family:inherit;font-size:10pt;">5,184,920</font><font style="font-family:inherit;font-size:10pt;"> shares of its common stock to the TRx Sellers.&#160; Pursuant to the TRx Purchase Agreement, the issuance of the remaining </font><font style="font-family:inherit;font-size:10pt;">2,349,968</font><font style="font-family:inherit;font-size:10pt;"> shares was subject to the Company's stockholder approval.  In May 2018, stockholder approval was obtained and the remaining shares were issued to the TRx Sellers.  The contingent shares were initially recorded to contingently issuable shares, which is recorded within stockholder's equity and were reclassed to common stock and additional paid in capital upon issuance, on the consolidating balance sheet date. As a result of the TRx Acquisition, the Company has currently recorded goodwill of </font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;"> was deductible for income taxes. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the third quarter of 2018, the Company identified and recorded measurement period adjustments to our preliminary purchase price allocation that was disclosed in prior periods. These adjustments are reflected in the tables below. The measurement period adjustments were the result of an arbitration ruling discussed in further detail in Note 13, the facts and circumstances of which existed as of the acquisition date.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary acquisition-date fair value of the consideration transferred at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2017 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17, 2017 (as adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,900,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,900,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock (including contingently issuable shares)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,514,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,514,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,576,633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,366,633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total consideration transferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,991,052</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,781,052</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The TRx Acquisition was accounted for as a business combination under the acquisition method of accounting. Accordingly, the tangible and identifiable intangible assets acquired and liabilities assumed were recorded at fair value as of the date of acquisition, with the remaining purchase price recorded as goodwill. The goodwill recognized is attributable primarily to strategic opportunities related to leveraging TRx&#8217;s research and development, intellectual property, and processes.  </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2017 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17, 2017 (as adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,068</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,068</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,872,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,872,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other receivables</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,764,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,764,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable Intangible Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Metafolin</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,465,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,987,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PAI sales and marketing agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,334,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,553,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Millipred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,714,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,056,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Ulesfia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">555,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(555,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets acquired</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,581,671</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,292,515</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,874,186</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of liabilities assumed:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192,706</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192,706</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,850,422</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,764,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,614,937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">839,773</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,840</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">918,613</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities assumed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,882,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,843,355</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,726,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,698,770</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449,160</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,147,930</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of consideration transferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,991,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,781,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,292,282</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,659,160</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,633,122</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price allocation related to the acquisition of TRx was finalized in 2018.  The fair values of intangible assets, including marketing rights, licenses and developed technology, were determined using variations of the income approach, specifically the multi-period excess earnings method. Varying discount rates were also applied to the projected net cash flows. The Company believes the assumptions are representative of those a market participant would use in estimating fair value. The final fair value of intangible assets both as disclosed in prior periods and as adjusted by measurement period adjustments identified during the third quarter of 2018 includes the following: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17,<br clear="none"/>2017 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17, 2017 (as adjusted)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Metafolin</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,465,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,987,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PAI sales and marketing agreement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,334,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,553,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Millipred</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,714,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,056,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Ulesfia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">555,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(555,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,068,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,528,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,596,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company received written notice to terminate the PAI sales and marketing agreement in the second quarter of 2018.  As a result, the Company reassessed the fair value of the PAI sales and marketing agreement on that date (a level III non-recurring fair value measurement) and concluded due to the absence of future cash flows beyond the date of termination that the fair value was </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;">.  An impairment charge was recognized in the second quarter of 2018 in the amount of </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;">, representing the remaining net book value of the PAI sales and marketing agreement intangible asset. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Pro Forma Impact of Business Combinations</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following supplemental unaudited pro forma information presents Cerecor&#8217;s financial results as if the acquisition of the Avadel pediatric products, which was completed on February 16, 2018, had occurred on January 1, 2018:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.48148148148148%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,187,775</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,928,446</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Basic and diluted net loss per share of common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Basic and diluted net loss per share of preferred stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The above unaudited pro forma information was determined based on the historical GAAP results of Cerecor and Avadel's pediatric products.  The unaudited pro forma consolidated results are provided for informational purposes only and are not necessarily indicative of what Cerecor&#8217;s consolidated results of operations would have been had the acquisition of Avadel's pediatric products been completed on the date indicated or what the consolidated results of operations will be in the future.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combinations And Asset Acquisitions [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationsAndAssetAcquisitionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combinations and Asset Acquisitions [Abstract] [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6649338992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC No. 820, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;"> (&#8220;ASC 820&#8221;), defines fair value as the price that would be received to sell an asset, or paid to transfer a liability, in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value standard also establishes a three&#8209;level hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level&#160;1&#8212;inputs to the valuation methodology are quoted prices (unadjusted) for an identical asset or liability in an active market.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level&#160;2&#8212;inputs to the valuation methodology include quoted prices for a similar asset or liability in an active market or model&#8209;derived valuations in which all significant inputs are observable for substantially the full term of the asset or liability.&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level&#160;3&#8212;inputs to the valuation methodology are unobservable and significant to the fair value measurement of the asset or liability.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents, for each of the fair value hierarchy levels required under ASC 820, the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis:</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;prices&#160;in</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant&#160;other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">active&#160;markets&#160;for</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">observable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">unobservable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">identical&#160;assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in money market funds*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,965,626</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,002,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrant liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unit purchase option liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,993</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;prices&#160;in</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant&#160;other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">active&#160;markets&#160;for</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">observable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">unobservable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">identical&#160;assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in money market funds*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,324,932</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,050,564</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrant liability**</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,950</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unit purchase option liability**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,216</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Investments in money market funds are reflected in cash and cash equivalents on the accompanying condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**Warrant liability and unit purchase option liability are reflected in accrued expenses and other current liabilities on the accompanying condensed consolidated balance sheets. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of  </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s financial instruments included cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses and other current liabilities, short term and long-term debt, warrant liability, the underwriters' unit purchase option liability, and contingent consideration.  The carrying amounts reported in the accompanying condensed consolidated financial statements for cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses, and other current liabilities approximate their respective fair values because of the short-term nature of these accounts. The estimated fair value of the Company&#8217;s long-term debt of </font><font style="font-family:inherit;font-size:10pt;">$14.9 million</font><font style="font-family:inherit;font-size:10pt;"> as of March 31, 2019 was based on current interest rates for similar types of borrowings and is in Level 2 of the fair value hierarchy.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Level&#160;3 Valuation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">The tables presented below are a summary of changes in the fair value of the Company&#8217;s Level&#160;3 valuations for the warrant liability, unit purchase option liability, and contingent consideration for the three months ended March 31, 2019 and 2018:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.62962962962963%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Warrant</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unit purchase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">option&#160;liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,950</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,216</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,050,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,060,730</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228,678</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228,678</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227,979</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,750</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,993</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,002,288</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,060,031</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.07407407407408%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Warrant liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unit purchase option liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Royalty Obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,991</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,576,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,611,809</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance of contingent consideration and royalty</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,875,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">240,744</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,115,909</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,846</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286,020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,590</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,837</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,651,081</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">304,230</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,013,738</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2014, the Company issued warrants to purchase </font><font style="font-family:inherit;font-size:10pt;">625,208</font><font style="font-family:inherit;font-size:10pt;"> shares of convertible preferred stock. Upon the closing of our initial public offering ("IPO") in October 2015 these warrants became warrants to purchase </font><font style="font-family:inherit;font-size:10pt;">22,328</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock, in accordance with their terms.   The warrants expire in October 2020. The warrants represent a freestanding financial instrument that is indexed to an obligation, which the Company refers to as the warrant liability.  The warrant liability is marked-to-market each reporting period with the change in fair value recorded to other income, net in the accompanying statements of operations until the warrants are exercised, expire or other facts and circumstances lead the warrant liability to be reclassified to stockholders&#8217; equity. The fair value of the warrant liability is estimated using a Black-Scholes option-pricing model. The significant assumptions used in preparing the option pricing model for valuing the warrant liability as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, include (i)&#160;volatility of </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">, (ii)&#160;risk free interest rate of </font><font style="font-family:inherit;font-size:10pt;">2.33%</font><font style="font-family:inherit;font-size:10pt;">, (iii)&#160;strike price </font><font style="font-family:inherit;font-size:10pt;">$8.40</font><font style="font-family:inherit;font-size:10pt;">, (iv)&#160;fair value of common stock </font><font style="font-family:inherit;font-size:10pt;">$5.84</font><font style="font-family:inherit;font-size:10pt;">, and (v)&#160;expected life of </font><font style="font-family:inherit;font-size:10pt;">1.60 years</font><font style="font-family:inherit;font-size:10pt;">&#160;years.</font></div><div style="line-height:120%;text-align:justify;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The underwriters&#8217; unit purchase option (the &#8220;UPO&#8221;) was issued to the underwriters of the Company's IPO in 2015 and provides the underwriters the option to purchase up to a total of </font><font style="font-family:inherit;font-size:10pt;">40,000</font><font style="font-family:inherit;font-size:10pt;"> units. The units underlying the UPO will be, immediately upon exercise, separated into shares of common stock, underwriters&#8217; Class A warrants, and underwriters&#8217; Class B warrants (such warrants together referred to as the Underwriters&#8217; Warrants).  The Underwriters&#8217; Warrants were warrants to purchase shares of common stock.  The Class B warrants expired in April 2017 and the Class A warrants expired in October 2018, while the UPO expires in October 2020. The Company classifies the UPO as a liability, as it is a freestanding marked-to-market derivative instrument that is precluded from being classified in stockholders&#8217; equity.  The UPO liability is marked-to-market each reporting period with the change in fair value recorded to other income, net in the accompanying statements of operations until the UPO is exercised, expires or other facts and circumstances lead the UPO to be reclassified to stockholders&#8217; equity. The fair value of the UPO liability is estimated using a Black-Scholes option-pricing model. The significant assumptions used in preparing the simulation model for valuing the UPO as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, include (i)&#160;volatility of </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">, (ii)&#160;risk free interest rate of </font><font style="font-family:inherit;font-size:10pt;">2.33%</font><font style="font-family:inherit;font-size:10pt;">, (iii)&#160;unit strike price </font><font style="font-family:inherit;font-size:10pt;">$7.47</font><font style="font-family:inherit;font-size:10pt;">, (iv) fair value of underlying equity </font><font style="font-family:inherit;font-size:10pt;">$5.84</font><font style="font-family:inherit;font-size:10pt;">, and (v)&#160;expected life of </font><font style="font-family:inherit;font-size:10pt;">1.6 years</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's business acquisitions of Avadel's pediatric products and TRx (see Note 5) involve the potential for future payment of consideration that is contingent upon the achievement of operation and commercial milestones and royalty payments on future product sales.  The fair value of contingent consideration was determined at the acquisition date utilizing unobservable inputs such as the estimated amount and timing of projected cash flows, the probability of success (achievement of the contingent event), and the risk-adjusted discount rate used to present value the probability-weighted cash flows.  Subsequent to the acquisition date, at each reporting period, the contingent consideration liabilities are remeasured at the current fair value with changes recorded in the condensed consolidated statement of operations.    </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the acquisition of Avadel's pediatric products, the Company will pay a </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> annual royalty on net sales of the acquired Avadel pediatric products through February 2026, up to an aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;">.  The fair value of the future royalty is the expected future value of the contingent payments discounted to a present value.  The estimated fair value of the royalty payments as of March 31, 2019 was </font><font style="font-family:inherit;font-size:10pt;">$7.7 million</font><font style="font-family:inherit;font-size:10pt;">.  The significant assumptions used in estimating the fair value of the royalty payment as of March 31, 2019 include (i) the expected net sales of the acquired Avadel pediatric products for that are subject to the </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> royalty based on the Company's net sales forecast and (ii) the risk-adjusted discount rate of  </font><font style="font-family:inherit;font-size:10pt;">8.4%</font><font style="font-family:inherit;font-size:10pt;">, which is comprised of the risk-free interest rate of </font><font style="font-family:inherit;font-size:10pt;">2.3%</font><font style="font-family:inherit;font-size:10pt;"> and a counterparty risk of </font><font style="font-family:inherit;font-size:10pt;">6.1%</font><font style="font-family:inherit;font-size:10pt;"> utilized to discount the expected royalty payments.  The liability is reduced by periodic payments. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, as part of the initial purchase price allocation for the acquisition of Avadel's pediatric products performed during the first quarter of 2018, contingent consideration of </font><font style="font-family:inherit;font-size:10pt;">$240,744</font><font style="font-family:inherit;font-size:10pt;"> was assigned to future royalty obligations for the use of the Sellers' LiquiTime process technology.  In the second quarter of 2018, we identified measurement period adjustments which included the adjustment of the fair value of the LiquiTime intangible asset down to </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consideration for the TRx acquisition includes certain potential contingent payments.  First, pursuant to the TRx Purchase Agreement, the Company would have been required to pay </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> to the Sellers if the gross profit related to TRx products equaled or exceeded </font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;"> in 2018.  The Company did not achieve this contingent event in 2018 and therefore </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> value was assigned to the contingent payout as of December 31, 2018.  Additionally, the Company is required to pay </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> upon the transfer of the Ulesfia NDA to the Company ("NDA Transfer Milestone").  Finally, the Company will pay </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> upon FDA approval of a new dosage of Ulesfia ("FDA Approval Milestone").  The main inputs utilized to determine the fair value of each milestone is the probability of the milestone's success, the expected time to successfully reach the milestone, and the risk-adjusted discount rate.  The estimated fair value of the NDA Transfer Milestone as of March 31, 2019 was </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> and the significant assumptions used in estimating the fair value include (i) probability of milestone success of </font><font style="font-family:inherit;font-size:10pt;">45.0%</font><font style="font-family:inherit;font-size:10pt;">, (ii) expected time to milestone of </font><font style="font-family:inherit;font-size:10pt;">0.2 years</font><font style="font-family:inherit;font-size:10pt;">, and (iii) risk-adjusted discount rate of  </font><font style="font-family:inherit;font-size:10pt;">8.5%</font><font style="font-family:inherit;font-size:10pt;">, which is comprised of the risk-free rate of </font><font style="font-family:inherit;font-size:10pt;">2.4%</font><font style="font-family:inherit;font-size:10pt;"> and a counterparty risk of </font><font style="font-family:inherit;font-size:10pt;">6.1%</font><font style="font-family:inherit;font-size:10pt;">.  The estimated fair value of the FDA Approval Milestone as of March 31, 2019 was </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">.  The significant assumptions used in estimating the fair value of the FDA Approval Milestone as of March 31, 2019 include (i) probability of milestone success at </font><font style="font-family:inherit;font-size:10pt;">22.5%</font><font style="font-family:inherit;font-size:10pt;">, (ii) expected time to milestone of </font><font style="font-family:inherit;font-size:10pt;">1.3 years</font><font style="font-family:inherit;font-size:10pt;">, and (iii) risk-adjusted discount rate of </font><font style="font-family:inherit;font-size:10pt;">8.4%</font><font style="font-family:inherit;font-size:10pt;">, which is comprised of the risk-free rate of </font><font style="font-family:inherit;font-size:10pt;">2.3%</font><font style="font-family:inherit;font-size:10pt;"> and a counterparty risk of </font><font style="font-family:inherit;font-size:10pt;">6.1%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;"> other changes in valuation techniques or inputs occurred during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;"> transfers of assets between Level&#160;1 and Level&#160;2 of the fair value measurement hierarchy occurred during the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829554704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses And Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract', window );"><strong>Accrued Liabilities and Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accrued Expenses and Other Current Liabilities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities as of March 31, 2019 and December 31, 2018 consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.07407407407408%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:68%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales returns and allowances</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,249,977</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,972,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicaid rebates</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,758,384</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,237,269</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum sales commitments, royalties payable, and purchase obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,808,083</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,662,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation and benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,679,572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,953,065</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,123,051</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278,132</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">938,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,112,378</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187,465</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235,721</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,128</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279,397</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accrued expenses and other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,815,097</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,731,373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829682656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deerfield Obligation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Deerfield Obligation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Deerfield Obligation </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In relation to the Company's acquisition of Avadel's pediatric products on February 16, 2018, the Company assumed an obligation that Avadel had to Deerfield CSF (the "Deerfield Obligation").  Beginning in July 2018 through October 2020, the Company is required to pay a quarterly payment of&#160;</font><font style="font-family:inherit;font-size:10pt;">$262,500</font><font style="font-family:inherit;font-size:10pt;">&#160;to Deerfield. In January 2021, a balloon payment of&#160;</font><font style="font-family:inherit;font-size:10pt;">$15,250,000</font><font style="font-family:inherit;font-size:10pt;">&#160;is due.  The difference between the gross value and fair value of these payments will be recorded as interest expense in the Company's condensed consolidated statements of operations through January 2021 using the effective interest method.  Interest expense for the three months ended March 31, 2019 was </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> and is included in interest expense, net on the accompanying condensed consolidated statements of operations. The amounts due within the next year are included in current portion of long-term debt on the Company's condensed consolidated balance sheets.  The amounts due in greater than one year are included in long-term debt, net of current portion, on the Company's condensed consolidated balance sheets.  The Deerfield Obligation was </font><font style="font-family:inherit;font-size:10pt;">$15.4 million</font><font style="font-family:inherit;font-size:10pt;"> as of March 31, 2019, of which </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> is recorded as a current liability.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829554704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_TemporaryEquityAndEquityDisclosureAbstract', window );"><strong>CAPITAL STRUCTURE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock', window );">Capital Structure</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital Structure </font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">According to the Company's amended and restated certificate of incorporation, the Company is authorized to issue </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> classes of stock, common stock and preferred stock.  At March 31, 2019, the total number of shares of capital stock the Company was authorized to issue was </font><font style="font-family:inherit;font-size:10pt;">205,000,000</font><font style="font-family:inherit;font-size:10pt;"> of which </font><font style="font-family:inherit;font-size:10pt;">200,000,000</font><font style="font-family:inherit;font-size:10pt;"> was common stock and </font><font style="font-family:inherit;font-size:10pt;">5,000,000</font><font style="font-family:inherit;font-size:10pt;"> was</font><font style="font-family:inherit;font-size:10pt;color:#ee2724;"> </font><font style="font-family:inherit;font-size:10pt;">preferred stock.  All shares of common and</font><font style="font-family:inherit;font-size:10pt;color:#ee2724;"> </font><font style="font-family:inherit;font-size:10pt;">preferred stock have a par value of </font><font style="font-family:inherit;font-size:10pt;">$0.001</font><font style="font-family:inherit;font-size:10pt;"> per share. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 26, 2018, the Company filed a Certificate of Designation of Preferences of Series B Non-Voting Convertible Preferred Stock ("Series B Convertible Preferred Stock" or "convertible preferred stock") of Cerecor Inc. (the &#8220;Certificate of Designation of the Series B Preferred Stock&#8221;) classifying and designating the rights, preferences and privileges of the Series B Convertible Preferred Stock.  The Certificate of Designation of the Series B Convertible Preferred Stock authorized </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;"> shares of convertible preferred stock.  The Series B Convertible Preferred Stock converts to shares of common stock on a 1-for-</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> ratio and has the same rights, preferences, and privileges as common stock other than it holds no voting rights.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Preferred Stock </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">December 2018 Armistice Private Placement</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 27, 2018, the Company entered into a series of transactions as part of a private placement with Armistice in order to generate cash to continue to develop our pipeline assets and for general corporate purposes.  The transactions are considered one transaction for accounting purposes.  As part of the transaction, the Company exchanged common stock warrants issued on April 27, 2017 to Armistice for the  purchase up to </font><font style="font-family:inherit;font-size:10pt;">14,285,714</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$0.40</font><font style="font-family:inherit;font-size:10pt;"> per share (the "original warrants") for like-kind warrants to purchase up to </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's newly designated Series B Convertible Preferred Stock with an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$2.00</font><font style="font-family:inherit;font-size:10pt;"> per share (the "exchanged warrants").  Armistice immediately exercised the exchanged warrants and acquired an aggregate of </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;"> shares of the convertible preferred stock.  Net proceeds of the transaction were approximately </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;"> for the year ended December 31, 2018. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In order to provide Armistice an incentive to exercise the exchanged warrants, the Company also entered into a securities purchase agreement with Armistice pursuant to which the Company issued warrants for </font><font style="font-family:inherit;font-size:10pt;">4,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock of the Company with a term of </font><font style="font-family:inherit;font-size:10pt;">5.5 years</font><font style="font-family:inherit;font-size:10pt;"> and an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$12.50</font><font style="font-family:inherit;font-size:10pt;"> per share (the "incentive warrants").  For accounting purposes, the Company calculated the fair value of the incentive warrants of </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;">, which was considered a deemed distribution to Armistice for the year ended December 31, 2018. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Voting</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the Company's convertible preferred stock are not entitled to vote. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Dividends</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The holders of convertible preferred stock are entitled to receive dividends, if any, as may be declared from time to time by the board of directors out of legally available funds.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidation</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event of the Company&#8217;s liquidation, dissolution or winding up, holders of the Company&#8217;s convertible preferred stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all debts and other liabilities.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rights and Preferences</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each share of convertible preferred stock converts to shares of common stock on a 1-for-</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> ratio.  There are no other preemptive or subscription rights and there are </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> redemption or sinking fund provisions applicable to the Company&#8217;s common stock.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Common Stock Offering</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 8, 2019, the Company closed on an underwritten public offering of common stock for </font><font style="font-family:inherit;font-size:10pt;">1,818,182</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock of the Company, at a price to the public of </font><font style="font-family:inherit;font-size:10pt;">$5.50</font><font style="font-family:inherit;font-size:10pt;"> per share.  Armistice participated in the offering by purchasing </font><font style="font-family:inherit;font-size:10pt;">363,637</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock of the Company from the underwriter at the public price.  The gross proceeds to the Company, before deducting underwriting discounts and commissions and offering expenses, were approximately </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;">.  The net proceeds were approximately </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">December 2018 Armistice Private Placement</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">As discussed in detail above, on December 27, 2018 the Company exchanged previously outstanding warrants for like-kind warrants for </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's convertible preferred stock with an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$2.00</font><font style="font-family:inherit;font-size:10pt;"> per share.  Armistice immediately exercised these warrants for </font><font style="font-family:inherit;font-size:10pt;">2,857,143</font><font style="font-family:inherit;font-size:10pt;"> shares of convertible preferred stock for net proceeds to the Company of </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;">.  The convertible preferred stock converts to common stock on a 1-for-</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> ratio (or to </font><font style="font-family:inherit;font-size:10pt;">14,285,714</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock in total).  Additionally, on December 27, 2018, in order to provide Armistice an incentive to exercise the exchanged warrants, the Company entered into a securities purchase agreement with Armistice pursuant to which the Company issued warrants for </font><font style="font-family:inherit;font-size:10pt;">4,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock of the Company with a term of </font><font style="font-family:inherit;font-size:10pt;">5.5 years</font><font style="font-family:inherit;font-size:10pt;"> and an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$12.50</font><font style="font-family:inherit;font-size:10pt;"> per share (the "incentive warrants").  See "December 2018 Armistice Private Placement" above for more details. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">August 2018 Armistice Private Placement</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August&#160;17, 2018, the Company entered into a securities purchase agreement with Armistice, pursuant to which the Company sold </font><font style="font-family:inherit;font-size:10pt;">1,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock, </font><font style="font-family:inherit;font-size:10pt;">$0.001</font><font style="font-family:inherit;font-size:10pt;"> par value per share for a purchase price of </font><font style="font-family:inherit;font-size:10pt;">$3.91</font><font style="font-family:inherit;font-size:10pt;"> per share, which was the closing price of shares of the Common Stock on August&#160;16, 2018. Net proceeds of this securities purchase agreement were approximately </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Ichorion Asset Acquisition</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 25, 2018, under the terms of the Ichorion Asset Acquisition noted above in Note 5, the Company issued </font><font style="font-family:inherit;font-size:10pt;">5.8 million</font><font style="font-family:inherit;font-size:10pt;"> common stock shares upon closing.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingently Issuable Shares</font></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the terms of TRx acquisition noted above in Note 5, the Company was required to issue common stock having an aggregate value as calculated in the TRx Purchase Agreement on the Closing Date of </font><font style="font-family:inherit;font-size:10pt;">$8.1 million</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;Equity Consideration&#8221;). &#160;Upon closing, the Company issued </font><font style="font-family:inherit;font-size:10pt;">5,184,920</font><font style="font-family:inherit;font-size:10pt;"> shares of its common stock.&#160; Pursuant to the TRx Purchase Agreement, the issuance of the remaining </font><font style="font-family:inherit;font-size:10pt;">2,349,968</font><font style="font-family:inherit;font-size:10pt;"> shares as a part of the Equity Consideration was subject to stockholder approval at the Company's 2018 Annual Stockholder's Meeting.  This approval was obtained in May 2018 and the remaining shares were issued to the TRx Sellers. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Voting</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock is entitled to </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> vote for each share held of record on all matters submitted to a vote of the stockholders, including the election of directors, and does not have cumulative voting rights. Accordingly, the holders of a majority of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing for election.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Dividends</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The holders of common stock are entitled to receive dividends, if any, as may be declared from time to time by the board of directors out of legally available funds.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidation</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event of the Company&#8217;s liquidation, dissolution or winding up, holders of the Company&#8217;s common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all debts and other liabilities.</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rights and Preferences</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the Company&#8217;s common stock have </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> preemptive, conversion or subscription rights, and there are </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> redemption or sinking fund provisions applicable to the Company&#8217;s common stock.</font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock Warrants</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the following common stock warrants were outstanding:&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:68%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number&#160;of&#160;shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise&#160;price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Expiration</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">underlying&#160;warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">per&#160;share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">date</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,328*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 2020</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,380*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 2022</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,000,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 2024</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,024,708</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Accounted for as a liability instrument (see Note 6)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Also include temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_StockholdersEquityAndTemporaryEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_TemporaryEquityAndEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>No definitions available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_TemporaryEquityAndEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6821276464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> 10. Stock-Based Compensation </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2016 Equity Incentive Plan</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 5, 2016, the Company&#8217;s board of directors adopted the 2016 Equity Incentive Plan (the &#8220;2016 Plan&#8221;) as the successor to the 2015 Omnibus Plan (the &#8220;2015 Plan&#8221;). The 2016 Plan was approved by the Company&#8217;s stockholders and became effective on May 18, 2016 (the &#8220;2016 Plan Effective Date&#8221;).</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon the 2016 Plan Effective Date, the 2016 Plan reserved and authorized up to </font><font style="font-family:inherit;font-size:10pt;">600,000</font><font style="font-family:inherit;font-size:10pt;"> additional shares of common stock for issuance, as well as </font><font style="font-family:inherit;font-size:10pt;">464,476</font><font style="font-family:inherit;font-size:10pt;"> unallocated shares remaining available for grant of new awards under the 2015 Plan. An Amended and Restated 2016 Equity Incentive Plan (the "2016 Amended Plan") was approved by the Company's stockholders in May 2018, which increased the share reserve by an additional&#160;</font><font style="font-family:inherit;font-size:10pt;">1.4 million</font><font style="font-family:inherit;font-size:10pt;"> shares. During the term of the 2016 Amended Plan, the share reserve will automatically increase on the first trading day in January of each calendar year, by an amount equal to </font><font style="font-family:inherit;font-size:10pt;">4%</font><font style="font-family:inherit;font-size:10pt;"> of the total number of outstanding shares of common stock of the Company on the last trading day in December of the prior calendar year. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">2.1 million</font><font style="font-family:inherit;font-size:10pt;"> shares available for future issuance under the 2016 Amended Plan.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Option grants to employees and directors typically expire after </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;"> years. Employee options with service based vesting conditions typically vest over </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> years.  Options granted to directors typically vest over </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years.  Directors may also elect to receive stock options in lieu of cash board compensation, which vest immediately.  For stock options granted to employees and non-employee directors, the estimated grant date fair market value of the Company&#8217;s stock-based awards is amortized ratably over the individuals&#8217; service periods, which is the period in which the awards vest.   Stock-based compensation expense includes expense related to stock options, restricted stock unit awards, and ESPP shares. The amount of stock-based compensation expense recognized for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> was as follows:&#160;</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87.03703703703704%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,376</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">489,953</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,382</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,364</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,945</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stock-based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">596,693</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock options with service-based vesting conditions</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">The Company has granted awards that contain service-based vesting conditions. The compensation cost for these options is recognized on a straight-line basis over the vesting periods.  A summary of option activity for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.22222222222221%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options&#160;Outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant date fair value of options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average remaining contractual term (in years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,746,597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.79</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,379</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334,624</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31,288</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,383</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,297</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,845,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.61</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,269,081</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.56</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.76</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&#8217;s common stock for those stock options that had exercise prices lower than the fair value of the Company&#8217;s common stock. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the aggregate intrinsic value of options outstanding and currently exercisable was </font><font style="font-family:inherit;font-size:10pt;">$8.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The total intrinsic value of options exercised during the three months ended March 31, 2019 was&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">.  The total grant date fair value of shares which vested during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#160;was&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">.  The per&#8209;share weighted&#8209;average grant date fair value of the options granted during the&#160;</font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> was estimated at&#160;</font><font style="font-family:inherit;font-size:10pt;">$2.49</font><font style="font-family:inherit;font-size:10pt;">. There were&#160;</font><font style="font-family:inherit;font-size:10pt;">302,901</font><font style="font-family:inherit;font-size:10pt;">&#160;options that vested during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> with a weighted average grant date fair value of&#160;</font><font style="font-family:inherit;font-size:10pt;">$2.09</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2019, there was </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to unvested service-based vesting conditions awards.  The unrecognized compensation cost is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">2.9</font><font style="font-family:inherit;font-size:10pt;"> years. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock options with market-based vesting conditions</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2018,&#160;the Company granted awards that vest upon the Company's common stock closing at or above </font><font style="font-family:inherit;font-size:10pt;">$12.50</font><font style="font-family:inherit;font-size:10pt;"> per share for </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> consecutive days.  A summary of option activity with market-based vesting conditions for the three months ended March 31, 2019 is as follows: </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:85%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options&#160;Outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average remaining contractual term (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate intrinsic value (1)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">800,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) The aggregate intrinsic value in the above table represents the total pre-tax amount that a participant would receive if the option had been exercised on the last day of the respective fiscal period. Options with a market value less than its exercise value are not included in the intrinsic value amount.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2019, there was </font><font style="font-family:inherit;font-size:10pt;">$805,068</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to unvested market-based vesting conditions awards. This compensation cost is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">1.8</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div><div style="line-height:120%;text-align:justify;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-based compensation assumptions</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows the assumptions used to compute stock-based compensation expense for stock options with service-based vesting conditions granted to employees and members of the board of directors under the Black-Scholes valuation model for the three months ended March 31, 2019.  There were no stock options granted with market-based vesting conditions for the three months ended March 31, 2019. </font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:65.55555555555556%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Service-based options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0 - 6.25 </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.23 - 2.59%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Units</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2018, the Company granted restricted stock units ("RSU") to certain employees.  The Company measures the fair value of the restricted units using the stock price at the date of the grant. The restricted shares vest annually over a </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;">-year period beginning on the first anniversary of the award. A summary of RSU grants activity for the three months ended March 31, 2019 is as follows:</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:69.62962962962963%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">RSUs outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average grant date fair value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested RSUs at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested RSUs at March 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The stock compensation expense related to RSUs for the three months ended March 31, 2019 was&#160;</font><font style="font-family:inherit;font-size:10pt;">$118,656</font><font style="font-family:inherit;font-size:10pt;">. At March 31, 2019, there was&#160;</font><font style="font-family:inherit;font-size:10pt;">$1,433,329</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to the RSU grants.  The compensation cost is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">3.0</font><font style="font-family:inherit;font-size:10pt;"> years. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Employee Stock Purchase Plan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 5, 2016, the Company&#8217;s board of directors approved the 2016 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was approved by the Company&#8217;s stockholders and became effective on May 18, 2016 (the &#8220;ESPP Effective Date&#8221;).</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the ESPP, eligible employees can purchase common stock through accumulated payroll deductions at such times as are established by the administrator. The ESPP is administered by the compensation committee of the Company&#8217;s board of directors. Under the ESPP, eligible employees may purchase stock at </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the lower of the fair market value of a share of the Company&#8217;s common stock (i) on the first day of an offering period or (ii) on the purchase date. Eligible employees may contribute up to </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> of their earnings during the offering period. The Company&#8217;s board of directors may establish a maximum number of shares of the Company&#8217;s common stock that may be purchased by any participant, or all participants in the aggregate, during each offering or offering period. Under the ESPP, a participant may not accrue rights to purchase more than </font><font style="font-family:inherit;font-size:10pt;">$25,000</font><font style="font-family:inherit;font-size:10pt;"> of the fair market value of the Company&#8217;s common stock for each calendar year in which such right is outstanding.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon the ESPP Effective Date, the Company reserved and authorized up to </font><font style="font-family:inherit;font-size:10pt;">500,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock for issuance under the ESPP. On January 1 of each calendar year, the aggregate number of shares that may be issued under the ESPP shall automatically increase by a number equal to the lesser of (i) </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> of the total number of shares of the Company&#8217;s capital stock outstanding on December 31 of the preceding calendar year, and (ii) </font><font style="font-family:inherit;font-size:10pt;">500,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock, or (iii) a number of shares of the Company&#8217;s common stock as determined by the Company&#8217;s board of directors or compensation committee. The number of shares increased by </font><font style="font-family:inherit;font-size:10pt;">408,042</font><font style="font-family:inherit;font-size:10pt;"> on January 1, 2019.  As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1,192,025</font><font style="font-family:inherit;font-size:10pt;"> shares remained available for issuance.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the guidance in ASC 718-50, the ability to purchase shares of the Company&#8217;s common stock at the lower of the offering date price or the purchase date price represents an option and, therefore, the ESPP is a compensatory plan under this guidance. Accordingly, stock-based compensation expense is determined based on the option&#8217;s grant-date fair value and is recognized over the requisite service period of the option. The Company used the Black-Scholes valuation model and recognized stock-based compensation expense of </font><font style="font-family:inherit;font-size:10pt;">$35,298</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, which is included in the table above with stock-based compensation from stock options.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Subsequent Equity Grants</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 1, 2019, the Company granted </font><font style="font-family:inherit;font-size:10pt;">1.8 million</font><font style="font-family:inherit;font-size:10pt;"> options with service-based vesting conditions at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$6.22</font><font style="font-family:inherit;font-size:10pt;"> per share to its employees as part of its annual stock option award.  One-quarter of the shares subject to the stock option will vest on the first anniversary of the grant date and the remaining three-quarters of the shares will vest in equal monthly installments over the following </font><font style="font-family:inherit;font-size:10pt;">36 months</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furthermore, on April 15, 2019, the Company granted </font><font style="font-family:inherit;font-size:10pt;">300,000</font><font style="font-family:inherit;font-size:10pt;"> options with service-based vesting conditions at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$5.17</font><font style="font-family:inherit;font-size:10pt;"> to its newly appointed Executive Chairman of the Board.  One-third of the shares subject to the stock option will vest on the first anniversary of the date of grant and the remaining two-thirds of the shares will vest in equal monthly installments over the following </font><font style="font-family:inherit;font-size:10pt;">24 months</font><font style="font-family:inherit;font-size:10pt;">, based on continuous service. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, the Company agreed to grant the Executive Chairman of the Board an option to purchase </font><font style="font-family:inherit;font-size:10pt;">300,000</font><font style="font-family:inherit;font-size:10pt;"> additional shares of Company common stock with market-based vesting conditions.  The exercise price will equal the market value on the date of the grant with one-third of the shares vesting upon the Company's common stock closing at or above </font><font style="font-family:inherit;font-size:10pt;">$8.00</font><font style="font-family:inherit;font-size:10pt;"> per share for </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> consecutive days, one-third of the shares vesting upon the Company's stock closing at or above </font><font style="font-family:inherit;font-size:10pt;">$10.50</font><font style="font-family:inherit;font-size:10pt;"> per share for </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> consecutive days, and one-third of these shares vesting upon the Company's stock closing at or above </font><font style="font-family:inherit;font-size:10pt;">$13.00</font><font style="font-family:inherit;font-size:10pt;"> per share for </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> consecutive days. The Company also agreed to grant the Executive Chairman of the Board </font><font style="font-family:inherit;font-size:10pt;">250,000</font><font style="font-family:inherit;font-size:10pt;"> RSUs, of which </font><font style="font-family:inherit;font-size:10pt;">50,000</font><font style="font-family:inherit;font-size:10pt;"> shares will vest immediately on the grant date and the remainder will vest in </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> equal annual increments based on continued service.  These </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> equity awards will be granted upon the Company having an adequate share reserve available for future issuance under the 2016 Amended Plan as a result of either an increase to the total share reserve subject to shareholder approval or as a result of an increase to the existing available share reserve due to future forfeitures and expirations.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829617872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision for income taxes was </font><font style="font-family:inherit;font-size:10pt;">$166,358</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended March 31, 2019 and is comprised of several components including current year state income tax related to one of the Company's wholly owned subsidiaries and current year amortization of tax-deductible goodwill that gives rise to indefinite lived deferred tax liability impacting the amount of valuation allowance required.  Additionally, discrete to the quarter, the Company recorded interest and penalties on the outstanding taxes payable to the IRS and various state authorities.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829636624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Leases</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Corporate Headquarter Lease</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">The Company identified </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> operating lease for its corporate headquarters located in Rockville, Maryland.  The annual base rent for the office space is </font><font style="font-family:inherit;font-size:10pt;">$161,671</font><font style="font-family:inherit;font-size:10pt;">, subject to annual </font><font style="font-family:inherit;font-size:10pt;">2.5%</font><font style="font-family:inherit;font-size:10pt;"> increases over the term of the lease.  The lease provides for a rent abatement for a period of </font><font style="font-family:inherit;font-size:10pt;">12 months</font><font style="font-family:inherit;font-size:10pt;"> following the Company's date of occupancy.  The lease has an initial term of </font><font style="font-family:inherit;font-size:10pt;">10 years</font><font style="font-family:inherit;font-size:10pt;"> from the date the Company makes its first annual fixed rent payment, which is expected to occur in January 2020. The Company has the option to extend the lease </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#160;times, each for a period of </font><font style="font-family:inherit;font-size:10pt;">five years</font><font style="font-family:inherit;font-size:10pt;">, and may terminate the lease as of the sixth anniversary of the first annual fixed rent payment, upon the payment of a termination fee.  As of the lease commencement date, it is not reasonably certain that the Company will exercise the renewal periods or early terminate the lease and therefore the end date of the lease for accounting purposes is January 31, 2030.  The remaining term of the lease at March 31, 2019 is </font><font style="font-family:inherit;font-size:10pt;">10.83 years</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplemental balance sheet information related to the lease is as follows: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment, net </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737,658</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,189,277</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The operating lease right-of-use asset is included in property and equipment and the lease liability is included in other long-term liabilities in our condensed consolidated balance sheets.  In order to determine the present value of lease payments, the Company utilized a discount rate of </font><font style="font-family:inherit;font-size:10pt;">7.7%</font><font style="font-family:inherit;font-size:10pt;">.  This rate was determined based on available information of the rate of interest the Company would pay to borrow on a collateralized basis at an amount equal to the lease payments in a similar economic environment over a similar term on the transition date. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of lease expense for the three months ended March 31, 2019 and 2018 were as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,606</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,559</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Includes short-term leases, which are immaterial. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because the corporate headquarter lease provides for a </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;">-month lease abatement, the cash paid for amounts included in the measurement of lease liabilities is </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended March 31, 2019. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows a maturity analysis of the operating lease liability as of March 31, 2019: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.14814814814815%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Undiscounted Cash Flows</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 1, 2019 through December 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">155,815</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173,748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">178,092</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,183,290</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,860,455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less implied interest </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(671,178</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,189,277</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6821262480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments And Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies </font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Litigation</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is party in various contractual disputes, litigation, and potential claims arising in the ordinary course of business.  The Company does not believe that the resolution of these matters will have a material adverse effect on our financial position or results of operations except as otherwise disclosed in this document. See below for further discussion of the Lachlan legal arbitration.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Purchase obligations</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has unconditional purchase obligations as a result of recent acquisitions that include agreements to purchase goods that are enforceable and legally binding and that specify all significant terms including: fixed or minimum quantities to be purchased; fixed, minimum or variable price provisions; and the approximate timing of the transaction. Purchase obligations exclude agreements that are cancelable at any time without penalty. The unconditional purchase obligations outstanding as of March 31, 2019 include the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lachlan Pharmaceuticals Minimum Obligations and Indemnity Receivable</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As discussed in Note 5, in November 2017, the Company acquired TRx and its wholly-owned subsidiaries, including Zylera.  The previous owners of TRx beneficially own more than </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of our outstanding common stock.  Zylera, which is now our wholly owned subsidiary, entered into an agreement with Lachlan Pharmaceuticals, an Irish company controlled by the previous owners of TRx (&#8220;Lachlan&#8221;), effective December 18, 2015 (the "Lachlan Agreement"). Pursuant to the Lachlan Agreement, Lachlan named Zylera as its exclusive distributor of Ulesfia in the United States and agreed to supply Ulesfia to Zylera exclusively for marketing and sale in the United States.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Lachlan Agreement requires Zylera to purchase a minimum of </font><font style="font-family:inherit;font-size:10pt;">20,000</font><font style="font-family:inherit;font-size:10pt;"> units per year, or approximately </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> worth of product, from Lachlan, unless and until there has been a &#8220;Market Change&#8221; involving a new successful competitive product. Zylera must pay Lachlan </font><font style="font-family:inherit;font-size:10pt;">$58.84</font><font style="font-family:inherit;font-size:10pt;"> per unit and handling fees that are equal to </font><font style="font-family:inherit;font-size:10pt;">$4.03</font><font style="font-family:inherit;font-size:10pt;"> per unit of fully packaged Ulesfia in 2019 and escalate at a rate of </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> annually.  The Lachlan Agreement also requires that Zylera make certain cumulative net sales milestone payments and royalty payments to Lachlan with a </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> annual minimum payment unless and until there has been a &#8220;Market Change&#8221; involving a new successful competitive product.  Lachlan is obligated to pay identical amounts to an unrelated third party from which it obtained rights to Ulesfia, with the payments ultimately flowing to Summers Laboratories, Inc. ("Summers Labs").  Because of the dispute described below, the Company has not made any payments to Lachlan under the Lachlan Agreement subsequent to the acquisition date.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 10, 2016, Zylera informed Lachlan that a Market Change had occurred due to the introduction of Arbor Pharmaceuticals' lice product, Sklice&#174;.&#160; On June 5, 2017, Lachlan and Zylera entered into joint legal representation along with other unrelated third parties in negotiation and arbitration of a dispute with Summers Labs regarding the existence of a Market Change and the concomitant obligations of the parties. The arbitration panel issued an interim ruling on October 23, 2018 that no Market Change had occurred up to and including the date of the hearing.  The arbitration panel issued a second interim ruling on December 26, 2018.  The second interim award rejected Summers Labs' request to accelerate future minimum royalties, however, it ruled in favor of Summers Labs that it is owed reimbursement for all reasonable costs and expenses, including legal fees, by Shionogi, as well as interest, as stipulated in the contract.  The arbitration panel issued a final award on March 1, 2019 that dictated the final amount of reimbursable costs and interest as contemplated in the second interim ruling.  The final award has no direct bearing on the Company as the Company was not a named defendant to the original claim by Summers Labs and a federal court denied Zylera's ability to be a counterclaimant in the matter.  Furthermore, the Company is not subject to the guarantee or interest provisions identified in the second ruling as these elements of the contractual relationship were not passed down to the Company&#8217;s agreement with Lachlan.  However, the Company has interpreted this ruling's impact on the Lachlan Agreement to mean that the minimum purchase obligation and minimum royalty provisions of the contract are active and due for any prior periods as well as going forward for any future periods.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recognized an&#160;</font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;"> liability for these minimum obligations in accrued liabilities as of March 31, 2019. Under the terms of the TRx Purchase Agreement, the former TRx owners are required to indemnify the Company for&#160;</font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#160;of all pre-acquisition losses related this arbitration, including legal costs, and possible minimum payments in excess of&#160;</font><font style="font-family:inherit;font-size:10pt;">$1 million</font><font style="font-family:inherit;font-size:10pt;">. Furthermore, the former TRx owners are required to indemnify the Company for&#160;</font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">&#160;of post-acquisition Ulesfia losses, which would include losses resulting from having to fund these minimum obligations. The Company has recorded an indemnity receivable of </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;"> in other receivables as of March 31, 2019, which the Company believes is fully collectible.  For the three months ended March 31, 2019, minimum obligations net of amounts recorded within the indemnity receivable of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#160;has been recorded in cost of product sales.  If the Company fails to make these minimum obligations timely then the Lachlan Agreement may be terminated by Lachlan, in which case the Company would no longer be able to sell the Ulesfia product, but it would also not be subject to future minimum obligations.  Lachlan has not requested payment for the minimum obligations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company expects a successful competitive product will enter the market in early 2021 and therefore the future minimum purchase obligations and royalty payments are expected only through 2020.  As of March 31, 2019, future minimum purchase obligations and future minimum royalty payments to Lachlan are as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q2 2019 - Q4 2019*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2020*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum Purchase Obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">942,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,265,378</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,208,372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum Royalties</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,250,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,250,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,192,994</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,265,378</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,458,372</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Per the TRx Purchase Agreement, the previous owners of TRx are required to indemnify the Company for </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of post-acquisition Ulesfia losses, which include the future minimum purchase obligations and future minimum royalties disclosed above. Thus, the Company's future net payouts related to the Ulesfia product should be significantly reduced as a result of the indemnification.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Karbinal Royalty Make-Whole Provision</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As discussed in Note 5, on February 16, 2018, in connection with the acquisition of Avadel's pediatric products, the Company entered into a supply and distribution agreement with TRIS Pharma (the "Karbinal Agreement").  As part of this agreement, the Company has an annual minimum sales commitment, which is based on a commercial year that spans from August 1 through July 31, of </font><font style="font-family:inherit;font-size:10pt;">70,000</font><font style="font-family:inherit;font-size:10pt;"> units through 2033.  The Company is required to pay TRIS a royalty make-whole payment of </font><font style="font-family:inherit;font-size:10pt;">$30</font><font style="font-family:inherit;font-size:10pt;"> for each unit under the </font><font style="font-family:inherit;font-size:10pt;">70,000</font><font style="font-family:inherit;font-size:10pt;"> units annual minimum sales commitment through 2033.  The annual payment is due in August of each year.  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> to TRIS in August 2018 related to the make-whole payment for the commercial year ended July 31, 2018.  As of March 31, 2019, the Company has accrued </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> in accrued expenses and other current liabilities related to the Karbinal royalty make whole for the commercial year ending July 31, 2019.  For the three months ended March 31, 2019, the make-whole provision of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> has been recorded in cost of product sales.  The future royalty make-whole payments are unknown as the amount owed to TRIS is dependent on the number of units sold.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Possible future milestone proceeds for out-licensed compound</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, the Company sold its worldwide rights to CERC-501 to Janssen Pharmaceuticals, Inc. (&#8220;Janssen&#8221;) in exchange for initial gross proceeds of </font><font style="font-family:inherit;font-size:10pt;">$25 million</font><font style="font-family:inherit;font-size:10pt;">.  There is a potential future </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> regulatory milestone payment to the Company. The terms of the agreement provide that Janssen will assume ongoing clinical trials and be responsible for any new development and commercialization of CERC-501.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6660469952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;).   Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows. The condensed consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> has been derived from audited financial statements at that date. The interim results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosure normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (&#8220;SEC&#8221;). Certain prior period amounts have been reclassified to conform to the current year presentation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company believes that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> audited consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassification</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2018, the Company concluded that going forward it would include change in fair value of contingent consideration within its own stand-alone line in operating expenses in the Company's statements of operations.  The Company has reclassified </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> from other expenses to operating expenses in the March 31, 2018 statement of operations to conform with current period presentation.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Significant Accounting Policies and Recent Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant Accounting Policies </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended March 31, 2019, there have been no significant changes to the Company&#8217;s summary of significant accounting policies contained in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on March 18, 2019 and amended on April 23, 2019, except for the recently adopted accounting standards described below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following significant accounting policy was updated in 2019 to reflect changes upon our adoption of ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;"> (Topic 842) ("ASU 2016-02").</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines if an arrangement is a lease at inception.  If an arrangement contains a lease, the Company performs a lease classification test to determine if the lease is an operating lease or a finance lease.  The Company has identified </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> operating lease for its corporate headquarters. Right-of-use ("ROU") assets represent the right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.  Operating lease liabilities are recognized on the commencement date of the lease based on the present value of the future lease payments over the lease term and are included in other long-term liabilities on our condensed consolidated balance sheet.  Right-of-use assets are valued at the initial measurement of the lease liability, plus any indirect costs or rent prepayments, and reduced by any lease incentives and any deferred lease payments.  Operating right-of-use assets are recorded in property and equipment, net on the condensed consolidated balance sheet and are amortized over the lease term.  To determine the present value of lease payments on lease commencement, we use the implicit rate when readily determinable, however as most leases do not provide an implicit rate, we use our incremental borrowing rate based on information available at commencement date. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Furthermore, the Company has elected the practical expedient to account for the lease and non-lease components as a single lease component for the leased property asset class.  Lease expense is recognized on a straight-line basis over the life of the lease and is included within general and administrative expenses. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adoption of ASC 842</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;"> (Topic 842) ("ASU 2016-02"). This guidance revises existing practice related to accounting for leases under ASC No. 840,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">&#160;(&#8220;ASC 840&#8221;) for both lessees and lessors. The new guidance in ASU 2016-02 requires lessees to recognize a right-of-use asset and a lease liability for nearly all leases (other than leases that meet the definition of a short-term lease). The lease liability will be equal to the present value of lease payments and the right-of-use asset will be based on the lease liability, subject to adjustment such as for initial direct costs. For income statement purposes, the new standard retains a dual model similar to ASC 840, requiring leases to be classified as either operating leases or finance leases. For lessees, operating leases will result in straight-line expense (similar to current accounting by lessees for operating leases under ASC 840) while finance leases will result in a front-loaded expense pattern (similar to current accounting by lessees for capital leases under ASC 840). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted the standard using the simplified transition method on its effective date of January 1, 2019 and therefore did not adjust prior comparative periods as permitted by the codification improvements issued by FASB in July 2018.  Additionally, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allows the Company to carryforward the historical lease classification.  As a result of the standard, the Company recorded a lease liability of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> and a right-of-use asset of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, which is equal to the initial measurement of the lease liability reduced by the unamortized balance of lease incentive received and deferred rent.  There was no material impact to our condensed consolidated income statement (see Note 12 below for more information). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Adopted Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532&#160;Disclosure Update and&#160;Simplification, to eliminate or modify certain disclosure rules that are redundant, outdated, or duplicative of GAAP or other regulatory requirements. Among other changes, the amendments provide that disclosure requirements related to the analysis of stockholders' equity are expanded for interim financial statements. An analysis of the changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement.  The Company has provided this disclosure beginning in the first quarter of 2019.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6821243376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company generates substantially all of its revenue from sales of prescription pharmaceutical products to its customers.  The following table presents net revenues disaggregated by type (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.07407407407408%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:68%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prescribed dietary supplements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prescription drugs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,029</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales force revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,411</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,483</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6644999072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Of Common Stock, Basic And Diluted (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of the computation of basic and diluted net loss per share of Common Stock</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted net loss per share of common stock and preferred stock for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, which includes both classes of participating securities:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.25925925925925%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Preferred stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Preferred stock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net&#160;loss&#160;per&#160;share,&#160;basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator: </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allocation of undistributed net loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,537,787</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,916,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,882,847</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,284,168</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,857,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,316,246</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and diluted net loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.13</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.67</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of anti-dilutive securities excluded from computation of diluted weighted shares outstanding</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following outstanding securities at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> have been excluded from the computation of diluted weighted shares outstanding, as they could have been anti-dilutive:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,345,305</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,909,384</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrants on common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,024,708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,986,659</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Underwriters' unit purchase option</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6774547504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract', window );"><strong>Business Combinations and Asset Acquisitions [Abstract] [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2017 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17, 2017 (as adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,068</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,068</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,872,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,872,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">495,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other receivables</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,764,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,764,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable Intangible Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Metafolin</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,465,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,987,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PAI sales and marketing agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,334,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,553,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Millipred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,714,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,056,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Ulesfia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">555,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(555,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets acquired</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,581,671</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,292,515</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,874,186</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of liabilities assumed:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192,706</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192,706</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,850,422</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,764,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,614,937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">839,773</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,840</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">918,613</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities assumed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,882,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,843,355</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,726,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,698,770</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449,160</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,147,930</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of consideration transferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,991,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,781,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,292,282</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,659,160</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,633,122</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition and as adjusted for measurement period adjustments identified during the second quarter of 2018: &#160; &#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (as adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,549,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,831,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">718,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">570,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">570,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,453,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,838,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,291,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(362,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(362,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of debt assumed</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,272,303</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197,303</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,075,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,875,165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44,835</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,920,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net liabilities assumed</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,145,468</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367,468</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,778,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consideration exchanged</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(240,999</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,386,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(608,467</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,778,001</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The final fair value of intangible assets both as disclosed in prior periods and as adjusted by measurement period adjustments identified during the third quarter of 2018 includes the following: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17,<br clear="none"/>2017 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17, 2017 (as adjusted)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Metafolin</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,465,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,987,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PAI sales and marketing agreement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,334,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,553,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Millipred</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,714,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,056,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired product marketing rights - Ulesfia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">555,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(555,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,068,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,528,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,596,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of intangible assets, both as of the date of acquisition and as adjusted by measurement period adjustments identified during the second quarter of 2018, includes the following: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At February 16,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 (as adjusted)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Product Marketing Rights - Karbinal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,221,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,200,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Product Marketing Rights - AcipHex</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,520,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">283,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,803,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Product Marketing Rights - Cefaclor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,291,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,320,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,611,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Developed Technology - Flexichamber</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,131,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,677,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired IPR&amp;D - LiquiTime formulations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">290,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(290,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indefinite</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,453,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,838,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,291,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock', window );">Schedule of Fair Value of Consideration Transferred</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary acquisition-date fair value of the consideration transferred at the date of acquisition both as disclosed in periods prior to the third quarter of 2018 and as adjusted for measurement period adjustments identified during the third quarter of 2018: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2017 (preliminary)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">At November 17, 2017 (as adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,900,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,900,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock (including contingently issuable shares)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,514,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,514,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,576,633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,366,633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total consideration transferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,991,052</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,210,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,781,052</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following supplemental unaudited pro forma information presents Cerecor&#8217;s financial results as if the acquisition of the Avadel pediatric products, which was completed on February 16, 2018, had occurred on January 1, 2018:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.48148148148148%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,187,775</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,928,446</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Basic and diluted net loss per share of common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Basic and diluted net loss per share of preferred stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combinations and Asset Acquisitions [Abstract] [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationsandAssetAcquisitionsAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Fair Value Of Consideration Transferred [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ScheduleOfFairValueOfConsiderationTransferredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6821238672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of assets and liabilities that are measured at fair value on a recurring basis</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents, for each of the fair value hierarchy levels required under ASC 820, the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis:</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;prices&#160;in</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant&#160;other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">active&#160;markets&#160;for</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">observable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">unobservable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">identical&#160;assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in money market funds*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,965,626</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,002,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrant liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unit purchase option liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,993</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;prices&#160;in</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant&#160;other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">active&#160;markets&#160;for</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">observable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">unobservable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">identical&#160;assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in money market funds*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,324,932</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,050,564</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrant liability**</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,950</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unit purchase option liability**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,216</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Investments in money market funds are reflected in cash and cash equivalents on the accompanying condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**Warrant liability and unit purchase option liability are reflected in accrued expenses and other current liabilities on the accompanying condensed consolidated balance sheets. </font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of changes in the fair value of the Level 3 valuation for the Warrant Liability and the Investor Rights Obligation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tables presented below are a summary of changes in the fair value of the Company&#8217;s Level&#160;3 valuations for the warrant liability, unit purchase option liability, and contingent consideration for the three months ended March 31, 2019 and 2018:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.62962962962963%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Warrant</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unit purchase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">option&#160;liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,950</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,216</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,050,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,060,730</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228,678</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228,678</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227,979</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,750</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,993</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,002,288</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,060,031</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.07407407407408%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Warrant liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unit purchase option liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Royalty Obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,991</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,576,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,611,809</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance of contingent consideration and royalty</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,875,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">240,744</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,115,909</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,846</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286,020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,590</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,837</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,651,081</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">304,230</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,013,738</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829671584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses And Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract', window );"><strong>Accrued Liabilities and Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock', window );">Schedule of accrued expenses and other current liabilities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities as of March 31, 2019 and December 31, 2018 consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.07407407407408%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:68%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales returns and allowances</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,249,977</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,972,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicaid rebates</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,758,384</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,237,269</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum sales commitments, royalties payable, and purchase obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,808,083</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,662,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation and benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,679,572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,953,065</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,123,051</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278,132</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">938,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,112,378</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187,465</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235,721</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,128</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279,397</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accrued expenses and other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,815,097</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,731,373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6821241936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_TemporaryEquityAndEquityDisclosureAbstract', window );"><strong>CAPITAL STRUCTURE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of outstanding common stock warrants</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the following common stock warrants were outstanding:&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:68%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number&#160;of&#160;shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise&#160;price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Expiration</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">underlying&#160;warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">per&#160;share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">date</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,328*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 2020</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,380*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 2022</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,000,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 2024</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,024,708</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Accounted for as a liability instrument (see Note 6)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_TemporaryEquityAndEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>No definitions available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_TemporaryEquityAndEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6659081360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of stock-based compensation expense</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amount of stock-based compensation expense recognized for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> was as follows:&#160;</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87.03703703703704%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,376</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">489,953</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,382</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,364</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,945</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stock-based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">596,693</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of option activity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of option activity with market-based vesting conditions for the three months ended March 31, 2019 is as follows: </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:85%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options&#160;Outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average remaining contractual term (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate intrinsic value (1)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">800,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) The aggregate intrinsic value in the above table represents the total pre-tax amount that a participant would receive if the option had been exercised on the last day of the respective fiscal period. Options with a market value less than its exercise value are not included in the intrinsic value amount.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of option activity for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.22222222222221%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options&#160;Outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant date fair value of options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average remaining contractual term (in years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,746,597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.79</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,379</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334,624</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31,288</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,383</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,297</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,845,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.61</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,269,081</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.56</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.76</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of fair value assumptions for options</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows the assumptions used to compute stock-based compensation expense for stock options with service-based vesting conditions granted to employees and members of the board of directors under the Black-Scholes valuation model for the three months ended March 31, 2019.  There were no stock options granted with market-based vesting conditions for the three months ended March 31, 2019. </font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:65.55555555555556%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Service-based options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0 - 6.25 </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.23 - 2.59%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Nonvested Restricted Stock Shares Activity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of RSU grants activity for the three months ended March 31, 2019 is as follows:</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:69.62962962962963%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">RSUs outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average grant date fair value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested RSUs at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested RSUs at March 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6819562144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Assets And Liabilities, Lessee</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplemental balance sheet information related to the lease is as follows: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment, net </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737,658</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,189,277</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of lease expense for the three months ended March 31, 2019 and 2018 were as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,606</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,559</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*Includes short-term leases, which are immaterial. </font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">he following table shows a maturity analysis of the operating lease liability as of March 31, 2019: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.14814814814815%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Undiscounted Cash Flows</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 1, 2019 through December 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">155,815</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173,748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">178,092</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,183,290</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,860,455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less implied interest </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(671,178</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,189,277</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829617584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments And Contingencies - (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentTextBlock', window );">Long-term Purchase Commitment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of March 31, 2019, future minimum purchase obligations and future minimum royalty payments to Lachlan are as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q2 2019 - Q4 2019*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2020*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum Purchase Obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">942,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,265,378</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,208,372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum Royalties</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,250,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,250,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,192,994</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,265,378</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,458,372</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6840510176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>product </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NumberOfMarketedMedicalDevices', window );">Number of marketed medical devices | product</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,454,048)<span></span>
</td>
<td class="num">$ (3,882,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operations</a></td>
<td class="num">(3,121,552)<span></span>
</td>
<td class="num">(280,423)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(105,672,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (98,218,070)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 16,121,388<span></span>
</td>
<td class="nump">$ 2,523,927<span></span>
</td>
<td class="nump">$ 10,646,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember', window );">Neurological Clinical and Preclinical Stage Compounds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NumberOfProductsInDevelopment', window );">Number of products in development | product</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_ThreePreclinicalTherapiesMember', window );">Three Preclinical Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NumberOfProductsInDevelopment', window );">Number of products in development | product</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember', window );">Preclinical Pediatric Orphan Rare Disease Compound</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NumberOfProductsInDevelopment', window );">Number of products in development | product</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common stock | Underwritten Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">1,818,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from sale of stock</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cerc_ArmisticeMember', window );">Armistice | Common stock | Underwritten Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">363,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_NumberOfMarketedMedicalDevices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Marketed Medical Devices</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_NumberOfMarketedMedicalDevices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_NumberOfProductsInDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Products In Development</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_NumberOfProductsInDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_NeurologicalClinicalAndPreclinicalStageCompoundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_ThreePreclinicalTherapiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_ThreePreclinicalTherapiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_PreclinicalPediatricOrphanRareDiseaseCompoundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cerc_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cerc_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cerc_ArmisticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cerc_ArmisticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838934288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>contract</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ScheduleOfSignificantAccountingLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustment', window );">Reclassification adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LesseeOperatingLeaseNumberOfContracts', window );">Number of operating leases | contract</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">$ 1,189,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="nump">$ 737,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ScheduleOfSignificantAccountingLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LesseeOperatingLeaseNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LesseeOperatingLeaseNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ScheduleOfSignificantAccountingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ScheduleOfSignificantAccountingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a reclassification adjustment made to prior period financial statement amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838770080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 5,411,443<span></span>
</td>
<td class="nump">$ 4,482,775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_PrescribedDietarySupplementsMember', window );">Prescribed dietary supplements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,791,000<span></span>
</td>
<td class="nump">2,231,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_PrescriptionDrugsMember', window );">Prescription drugs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,620,000<span></span>
</td>
<td class="nump">2,029,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_SalesForceRevenueMember', window );">Sales force revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 222,656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Net | Major Customer Number One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Net | Major Customer Number Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Net | Major Customer Number Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_PrescribedDietarySupplementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_PrescribedDietarySupplementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_PrescriptionDrugsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_PrescriptionDrugsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_SalesForceRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_SalesForceRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cerc_MajorCustomerNumberOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cerc_MajorCustomerNumberOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cerc_MajorCustomerNumberTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cerc_MajorCustomerNumberTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cerc_MajorCustomerNumberThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cerc_MajorCustomerNumberThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838645840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 27, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_StockholdersEquityNotePreferredStockConversionRatio', window );">Preferred stock conversion ratio</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock | Preferred Stock | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">2,857,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,857,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_StockholdersEquityNotePreferredStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity Note, Preferred Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_StockholdersEquityNotePreferredStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838881600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share  - Schedule of Earnings Per Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Basic and diluted loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Net loss</a></td>
<td class="num">$ (5,537,787)<span></span>
</td>
<td class="num">$ (3,882,847)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares (in shares)</a></td>
<td class="nump">41,284,168<span></span>
</td>
<td class="nump">31,316,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per share (in dollars per share)</a></td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Basic and diluted loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Net loss</a></td>
<td class="num">$ (1,916,261)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares (in shares)</a></td>
<td class="nump">2,857,143<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per share (in dollars per share)</a></td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6815121856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share  - Anti-dilutive Securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_EmployeeConsultantsAndDirectorsStockOptionsMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares)</a></td>
<td class="nump">4,345,305<span></span>
</td>
<td class="nump">3,909,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_WarrantCommonStockMember', window );">Warrants on common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares)</a></td>
<td class="nump">4,024,708<span></span>
</td>
<td class="nump">18,986,659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_RestrictedStockAwardsMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares)</a></td>
<td class="nump">345,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_UnderwritersUnitPurchaseOptionMember', window );">Underwriters' unit purchase option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares)</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_EmployeeConsultantsAndDirectorsStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_EmployeeConsultantsAndDirectorsStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_WarrantCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_WarrantCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_RestrictedStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_RestrictedStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_UnderwritersUnitPurchaseOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_UnderwritersUnitPurchaseOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6843653520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">39 Months Ended</th>
<th class="th" colspan="1">63 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 25, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 24, 2018 </div>
<div>USD ($) </div>
<div>therapy </div>
<div>milestone </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 16, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 17, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 17, 2018 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Fair value of debt assumed</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,075,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,411,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,411,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember', window );">Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payment to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Fair value of debt assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,075,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,778,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod', window );">Goodwill tax deductible period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember', window );">TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payment to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,366,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,633,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Unregistered shares of common stock issued or issuable as part of acquisition (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,534,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Shares issued for purchase of business (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,514,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued', window );">Shares issued upon closing (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,184,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares', window );">Contingent shares issuable as part of acquisition (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,349,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring | Level 3 | PAI sales and marketing agreement | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Fair value of sales and marketing agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetAcquisitionAxis=cerc_IchorionMember', window );">Ichorion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Consideration issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetAcquisitionContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Fair value of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetAcquisitionResearchAndDevelopmentInProcess', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NumberOfPreclinicalTherapies', window );">Number of preclinical therapies | therapy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetAcquisitionsTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones', window );">Number of contingent consideration milestones | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities', window );">Payment for asset acquisition contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetAcquisitionAxis=cerc_IchorionMember', window );">Ichorion | Assembled Workforce</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetAcquisitionResearchAndDevelopmentInProcess', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneOneMember', window );">Milestone One | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneOneMember', window );">Milestone One | Scenario, Forecast | Ichorion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities', window );">Payment for asset acquisition contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneTwoMember', window );">Milestone Two | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneTwoMember', window );">Milestone Two | Scenario, Forecast | Ichorion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities', window );">Payment for asset acquisition contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneThreeMember', window );">Milestone Three | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneThreeMember', window );">Milestone Three | Scenario, Forecast | Ichorion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities', window );">Payment for asset acquisition contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AssetAcquisitionContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Contingent Consideration, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AssetAcquisitionContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Number Of Contingent Consideration Milestones</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AssetAcquisitionNumberOfContingentConsiderationMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Cash And Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AssetAcquisitionResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Research And Development In Process</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AssetAcquisitionResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AssetAcquisitionsTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisitions, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AssetAcquisitionsTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued Or Issuable, Contingent Consideration, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Goodwill, Tax Deductible Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessAcquisitionGoodwillTaxDeductiblePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Number of Shares Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_NumberOfPreclinicalTherapies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Preclinical Therapies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_NumberOfPreclinicalTherapies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment For Asset Acquisition Contingent Consideration Liability, Operating Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_PaymentForAssetAcquisitionContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_TRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_PAISalesAndMarketingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_PAISalesAndMarketingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AssetAcquisitionAxis=cerc_IchorionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AssetAcquisitionAxis=cerc_IchorionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_AssembledWorkforceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_AssembledWorkforceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_MilestoneAxis=cerc_MilestoneOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_MilestoneAxis=cerc_MilestoneOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_MilestoneAxis=cerc_MilestoneTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_MilestoneAxis=cerc_MilestoneTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_MilestoneAxis=cerc_MilestoneThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_MilestoneAxis=cerc_MilestoneThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6841884976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Allocation of Purchase Price (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 16, 2018</div></th>
<th class="th"><div>Nov. 17, 2017</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Fair value of liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Fair value of debt assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (15,075,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,411,123<span></span>
</td>
<td class="nump">$ 16,411,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember', window );">Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">$ 718,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">18,291,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Fair value of liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="num">(362,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Fair value of debt assumed</a></td>
<td class="num">(15,075,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Fair value of contingent consideration</a></td>
<td class="num">(7,920,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets</a></td>
<td class="num">(3,778,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Fair value of consideration transferred</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,778,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,831,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(362,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt', window );">Fair value of debt assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,835)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities', window );">Total identifiable net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">367,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Fair value of consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(240,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (608,467)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember', window );">TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,872,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">495,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,764,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,596,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,874,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Fair value of liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,614,937)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">918,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,726,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,147,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Fair value of consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,781,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,633,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,764,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,528,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,292,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,764,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,843,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities', window );">Total identifiable net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">449,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Fair value of consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,210,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,659,160)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_PAISalesAndMarketingAgreementMember', window );">PAI sales and marketing agreement | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_MetafolinMember', window );">Metafolin | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,987,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,522,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_MillipredMember', window );">Millipred | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,056,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_UlesfiaMember', window );">Ulesfia | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (555,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">2,549,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">16,453,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Fair value of liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Fair value of debt assumed</a></td>
<td class="num">(15,272,303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Fair value of contingent consideration</a></td>
<td class="num">(7,875,165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets</a></td>
<td class="num">(4,145,468)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Fair value of consideration transferred</a></td>
<td class="nump">241,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 4,386,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,872,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">495,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,581,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Fair value of liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,850,422)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,882,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,698,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Fair value of consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,991,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,292,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | PAI sales and marketing agreement | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,334,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Metafolin | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,465,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Millipred | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,714,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Ulesfia | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Identifiable Intangible Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 555,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Accounting Incomplete, Adjustment, Other Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalAccountingIncompleteAdjustmentOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Contingent Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-term Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongtermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets (Liabilities)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses And Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_TRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_PAISalesAndMarketingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_PAISalesAndMarketingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_MetafolinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_MetafolinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_AcquiredProductMarketingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_AcquiredProductMarketingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_MillipredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_MillipredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_UlesfiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_UlesfiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6844373968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Intangible Assets Acquired (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 16, 2018</div></th>
<th class="th"><div>Nov. 17, 2017</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember', window );">Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">$ 18,291,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember', window );">TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,596,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,528,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_PAISalesAndMarketingAgreementMember', window );">PAI sales and marketing agreement | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_KarbinalMember', window );">Karbinal | Acquired product marketing rights | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_AcipHexMember', window );">AcipHex | Acquired product marketing rights | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">$ 2,803,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_CefaclorMember', window );">Cefaclor | Acquired product marketing rights | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">$ 7,611,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_FlexichamberMember', window );">Flexichamber | Acquired Developed Technology | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">$ 1,677,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_LiquiTimeProcessMember', window );">LiquiTime Process | In Process Research and Development | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (290,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_MetafolinMember', window );">Metafolin | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,987,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,522,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_MillipredMember', window );">Millipred | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,056,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cerc_UlesfiaMember', window );">Ulesfia | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (555,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">16,453,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | PAI sales and marketing agreement | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,334,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Karbinal | Acquired product marketing rights | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">6,221,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | AcipHex | Acquired product marketing rights | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">2,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Cefaclor | Acquired product marketing rights | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">6,291,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Flexichamber | Acquired Developed Technology | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">1,131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | LiquiTime Process | In Process Research and Development | Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="nump">$ 290,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Metafolin | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,465,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Millipred | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,714,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Ulesfia | Acquired product marketing rights | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable Intangible Assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 555,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_TRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_PAISalesAndMarketingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_PAISalesAndMarketingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_KarbinalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_KarbinalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_AcquiredProductMarketingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cerc_AcquiredProductMarketingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_AcipHexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_AcipHexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_CefaclorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_CefaclorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_FlexichamberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_FlexichamberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_LiquiTimeProcessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_LiquiTimeProcessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_MetafolinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_MetafolinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_MillipredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_MillipredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cerc_UlesfiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cerc_UlesfiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6845335552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Consideration Transferred (Details) - TRx - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">10 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 17, 2017</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">$ 18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock (including contingently issuable shares)</a></td>
<td class="nump">8,514,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="nump">1,366,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration transferred</a></td>
<td class="nump">28,781,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability', window );">Contingent payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,210,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Fair value of consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,210,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock (including contingently issuable shares)</a></td>
<td class="nump">8,514,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="nump">2,576,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration transferred</a></td>
<td class="nump">$ 29,991,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Contingent Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_TRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6826361648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Pro Forma Information (Details) - TRx<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total revenues, net | $</a></td>
<td class="nump">$ 6,187,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss | $</a></td>
<td class="num">$ (4,928,446)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted', window );">Diluted net loss per share (in dollars per share) | $ / shares</a></td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted', window );">Diluted net loss per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Pro Forma Earnings Per Share, Basic and Diluted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_TRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6827501600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Recurring basis - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">$ 13,965,626<span></span>
</td>
<td class="nump">$ 7,324,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities</a></td>
<td class="nump">9,002,288<span></span>
</td>
<td class="nump">9,050,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities</a></td>
<td class="nump">17,750<span></span>
</td>
<td class="nump">2,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Unit purchase option liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities</a></td>
<td class="nump">$ 39,993<span></span>
</td>
<td class="nump">$ 7,216<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_EquityUnitPurchaseOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_EquityUnitPurchaseOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6840920880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 16, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($) </div>
<div>class_of_stock</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 17, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber', window );">Number of changes in valuation techniques | class_of_stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount', window );">Amount of transfers of assets from level 2 to level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount', window );">Amount of transfers of assets from level 1 to level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of contingent consideration and royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,115,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=cerc_WarrantLiabilityMember', window );">Warrant liability | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=cerc_EquityUnitPurchaseOptionMember', window );">Equity Unit Purchase Option | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=cerc_RoyaltyPayableMember', window );">Royalty Payable | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of contingent consideration and royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 240,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility | Warrant liability | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility | Equity Unit Purchase Option | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price | Warrant liability | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price | Equity Unit Purchase Option | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate | Warrant liability | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate | Equity Unit Purchase Option | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price | Warrant liability | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price | Equity Unit Purchase Option | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember', window );">Avadel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementProductRoyaltyNet', window );">Product royalty net</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementRoyaltyObligation', window );">Royalty obligation (up to)</a></td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure', window );">Fair value of royalty obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember', window );">Avadel | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_RoyaltyObligationMeasurementInput', window );">Royalty obligation measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember', window );">Avadel | Measurement Input, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_RoyaltyObligationMeasurementInput', window );">Royalty obligation measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember', window );">Avadel | Measurement Input, Counterparty Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_RoyaltyObligationMeasurementInput', window );">Royalty obligation measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember', window );">TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,366,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneOneMember', window );">Milestone One | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationGrossProfit', window );">Business combination gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneTwoMember', window );">Milestone Two | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone', window );">Expected time to milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneTwoMember', window );">Milestone Two | TRx | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneTwoMember', window );">Milestone Two | TRx | Measurement Input, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneTwoMember', window );">Milestone Two | TRx | Measurement Input, Counterparty Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneTwoMember', window );">Milestone Two | TRx | Measurement Input, Probability Of Milestone Success</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneThreeMember', window );">Milestone Three | TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone', window );">Expected time to milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneThreeMember', window );">Milestone Three | TRx | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneThreeMember', window );">Milestone Three | TRx | Measurement Input, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneThreeMember', window );">Milestone Three | TRx | Measurement Input, Counterparty Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MilestoneAxis=cerc_MilestoneThreeMember', window );">Milestone Three | TRx | Measurement Input, Probability Of Milestone Success</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Level 3 Valuation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Expected Time To Milestone</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationContingentConsiderationExpectedTimeToMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationGrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Gross Profit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationGrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_FairValueMeasurementsChangesInValuationTechniquesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of changes in valuation techniques during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_FairValueMeasurementsChangesInValuationTechniquesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementProductRoyaltyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Product Royalty, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementProductRoyaltyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementRoyaltyObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Royalty Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementRoyaltyObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Royalty Obligation, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementRoyaltyObligationFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_RoyaltyObligationMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty Obligation, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_RoyaltyObligationMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_EquityUnitPurchaseOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_EquityUnitPurchaseOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_RoyaltyPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_RoyaltyPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_AvadelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCounterpartyCreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCounterpartyCreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_TRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_MilestoneAxis=cerc_MilestoneOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_MilestoneAxis=cerc_MilestoneOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_MilestoneAxis=cerc_MilestoneTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_MilestoneAxis=cerc_MilestoneTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=cerc_MeasurementInputProbabilityOfMilestoneSuccessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=cerc_MeasurementInputProbabilityOfMilestoneSuccessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_MilestoneAxis=cerc_MilestoneThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_MilestoneAxis=cerc_MilestoneThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838313200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Rollforward (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">$ 180,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,769<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">9,060,730<span></span>
</td>
<td class="nump">$ 11,013,738<span></span>
</td>
<td class="nump">2,611,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payment of contingent consideration</a></td>
<td class="num">(228,678)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of contingent consideration and royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,115,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">227,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">9,060,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,013,738<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=cerc_WarrantLiabilityMember', window );">Warrant liability | Recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">2,950<span></span>
</td>
<td class="nump">15,590<span></span>
</td>
<td class="nump">8,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">17,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=cerc_EquityUnitPurchaseOptionMember', window );">Unit purchase option liability | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">7,216<span></span>
</td>
<td class="nump">42,837<span></span>
</td>
<td class="nump">26,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">32,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">39,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,837<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=cerc_ContingentConsiderationMember', window );">Contingent consideration | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">9,050,564<span></span>
</td>
<td class="nump">10,651,081<span></span>
</td>
<td class="nump">2,576,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payment of contingent consideration</a></td>
<td class="num">(228,678)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of contingent consideration and royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,875,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">180,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 9,002,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,651,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=cerc_RoyaltyPayableMember', window );">Royalty Obligation | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">304,230<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of contingent consideration and royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">240,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 304,230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_EquityUnitPurchaseOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_EquityUnitPurchaseOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cerc_RoyaltyPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cerc_RoyaltyPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6821289552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses And Other Current Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract', window );"><strong>Accrued Liabilities and Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AccruedSalesReturnsAndAllowances', window );">Sales returns and allowances</a></td>
<td class="nump">$ 4,249,977<span></span>
</td>
<td class="nump">$ 3,972,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AccruedMedicaidRebates', window );">Medicaid rebates</a></td>
<td class="nump">2,758,384<span></span>
</td>
<td class="nump">2,237,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent', window );">Minimum sales commitments, royalties payable, and purchase obligations</a></td>
<td class="nump">10,808,083<span></span>
</td>
<td class="nump">9,662,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation and benefits</a></td>
<td class="nump">1,679,572<span></span>
</td>
<td class="nump">1,953,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AccruedResearchAndDevelopmentExpenses', window );">Research and development expenses</a></td>
<td class="nump">1,123,051<span></span>
</td>
<td class="nump">278,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Sales and marketing</a></td>
<td class="nump">938,437<span></span>
</td>
<td class="nump">1,112,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AccruedGeneralAndAdministrativeExpenses', window );">General and administrative</a></td>
<td class="nump">187,465<span></span>
</td>
<td class="nump">235,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent', window );">Other</a></td>
<td class="nump">70,128<span></span>
</td>
<td class="nump">279,397<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 21,815,097<span></span>
</td>
<td class="nump">$ 19,731,373<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AccruedGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for general and administrative expenses..</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AccruedGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AccruedLiabilitiesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet..</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AccruedLiabilitiesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AccruedMedicaidRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Medicaid Rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AccruedMedicaidRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AccruedResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for research and development.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AccruedResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AccruedSalesReturnsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Sales Returns And Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AccruedSalesReturnsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum Sales Commitments, Royalties Payable And Purchase Obligations, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_MinimumSalesCommitmentsRoyaltiesPayableAndPurchaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6844487296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deerfield Obligation  - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">28 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="num">$ (207,941)<span></span>
</td>
<td class="num">$ (100,402)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term debt, current portion</a></td>
<td class="nump">1,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,050,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cerc_DeerfieldObligationMember', window );">Deerfield Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Deerfield Obligation</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term debt, current portion</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember', window );">Scenario, Forecast | Deerfield Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Balloon payment to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cerc_DeerfieldObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cerc_DeerfieldObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6848989616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure - Common Stock (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 08, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 27, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 25, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 24, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 17, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 17, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>Vote </div>
<div>class_of_stock </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NumberOfClassOfStockAuthorized', window );">Number of classes of stock authorized to issue | class_of_stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_CapitalStockSharesAuthorized', window );">Number of shares of capital stock authorized to issue (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,975,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,818,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NumberofVotesPerShare', window );">Number of votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NumberOfPreemptiveConversionOrSubscriptionRights', window );">Number of preemptive, conversion or subscription rights | class_of_stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_NumberOfRedemptionOrSinkingFundProvisions', window );">Number of redemption or sinking fund provisions | class_of_stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_StockholdersEquityNotePreferredStockConversionRatio', window );">Preferred stock conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,285,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from issuance or sale of equity | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Series B Preferred Stock | Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,857,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,857,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,857,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cerc_BoughtDealMember', window );">Bought Deal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from sale of stock | $</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="nump">1,818,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cerc_BoughtDealMember', window );">Bought Deal | Armistice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="nump">363,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember', window );">TRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Unregistered shares of common stock issued or issuable as part of acquisition | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued', window );">Shares issued upon closing (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,184,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares', window );">Contingent shares issuable as part of acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,349,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_AssetAcquisitionAxis=cerc_IchorionMember', window );">Ichorion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Consideration issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_IncentiveWarrantsMember', window );">Incentive Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ClassOfWarrantOrRightDistributionAdjustment', window );">Distribution adjustment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued Or Issuable, Contingent Consideration, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Number of Shares Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableNumberofSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_CapitalStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of capital stock, including common stock and preferred stock, solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_CapitalStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ClassOfWarrantOrRightDistributionAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Distribution Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ClassOfWarrantOrRightDistributionAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_NumberOfClassOfStockAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of classes of stock permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_NumberOfClassOfStockAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_NumberOfPreemptiveConversionOrSubscriptionRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of preemptive, conversion or subscription rights held by common stock holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_NumberOfPreemptiveConversionOrSubscriptionRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_NumberOfRedemptionOrSinkingFundProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of redemption or sinking fund provisions applicable to the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_NumberOfRedemptionOrSinkingFundProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_NumberofVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of votes available to holders of the Preferred Stock for each share of Common Stock into which such share of Preferred Stock could be converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_NumberofVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_StockholdersEquityNotePreferredStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity Note, Preferred Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_StockholdersEquityNotePreferredStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cerc_BoughtDealMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cerc_BoughtDealMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cerc_ArmisticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cerc_ArmisticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cerc_TRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cerc_TRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_AssetAcquisitionAxis=cerc_IchorionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_AssetAcquisitionAxis=cerc_IchorionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_IncentiveWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cerc_IncentiveWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6826536176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital Structure - Warrants (Details) - Common Stock<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsExpirationOctober2020Member', window );">Common stock warrants, expiration date of October 2020</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Common Stock Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares)</a></td>
<td class="nump">22,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsExpirationMay2022Member', window );">Common stock warrants, expiration date of May 2022</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Common Stock Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares)</a></td>
<td class="nump">2,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsExpirationDateJune2024Member', window );">Common stock warrants, expiration date June 2024</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Common Stock Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares)</a></td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 12.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_WarrantCommonStockMember', window );">Warrants on common stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Common Stock Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares available under warrant (in shares)</a></td>
<td class="nump">4,024,708<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsExpirationOctober2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsExpirationOctober2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsExpirationMay2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsExpirationMay2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsExpirationDateJune2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cerc_CommonStockWarrantsExpirationDateJune2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_WarrantCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cerc_WarrantCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6849357136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 15, 2019 </div>
<div>installment </div>
<div>day </div>
<div>award </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 01, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 01, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 18, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 05, 2016 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent', window );">Annual share reserve increase (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 596,693<span></span>
</td>
<td class="nump">$ 242,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,376<span></span>
</td>
<td class="nump">11,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489,953<span></span>
</td>
<td class="nump">207,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,364<span></span>
</td>
<td class="nump">$ 23,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cerc_ServiceBasedOptionsMember', window );">Service Based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Option Activity, Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance, beginning of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,845,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,746,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercises in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,288)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance, end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,845,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,746,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,269,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Option Activity, Weighted-average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeitures (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">End of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Option Activity, Fair value of options granted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue', window );">Grant date fair value of options granted | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 334,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue', window );">Grant date fair value of options forfeited | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Option Activity, Weighted-average remaining contractual term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 7 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 9 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 9 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value of options outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value of options exercisable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested in period | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Per share weighted average fair value of options granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Options vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Options vested weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Fair value assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cerc_StockOptionsWithMarketBasedVestingConditionsMember', window );">Stock Options With Market Based Vesting Conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Option Activity, Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance, beginning of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance, end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Option Activity, Weighted-average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">End of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Option Activity, Weighted-average remaining contractual term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 11 months 27 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 2 months 27 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value of options outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 805,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor', window );">Market-based vesting condition share price floor (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod', window );">Market-based vesting condition number of consecutive days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Compensation not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,433,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Option Activity, Weighted-average remaining contractual term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>RSUs outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance of Non-vested RSAs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">445,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSAs vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance of Non-vested RSAs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">445,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested RSAs weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSAs vested in period weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Service Based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Fair value assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Service Based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Fair value assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.59%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cerc_The2016PlanMember', window );">2016 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease', window );">Increase in number of shares reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock remaining for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cerc_The2016PlanMember', window );">2016 Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cerc_The2015PlanMember', window );">2015 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock remaining for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cerc_EmployeeStockPurchasePlanESPPMember', window );">Employee Stock Purchase Plan (ESPP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock remaining for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,192,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of fair market value on the lower of first day or last day of the offering period at which employees may purchase stock under the ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum portion of earning an employee may contribute to the ESPP Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum', window );">Maximum annual amount of fair market value of the Company's common stock that a participant may accrue the rights to purchase | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear', window );">Automatic increase to shares authorized as percentage of outstanding stock at end of preceding year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease', window );">Increase in shares available (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=cerc_EmployeeMember', window );">Employee | 2016 Plan | Minimum | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=cerc_EmployeeMember', window );">Employee | 2016 Plan | Maximum | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember', window );">Director | 2016 Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Employee | Service Based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Option Activity, Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Option Activity, Weighted-average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Board of Directors Chairman | Service Based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Option Activity, Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Option Activity, Weighted-average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Board of Directors Chairman | Stock Options With Market Based Vesting Conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Option Activity, Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Board of Directors Chairman | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>RSUs outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSAs vested (in shares)</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments', window );">Number of vesting installments | installment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards', window );">Number of awards | award</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche One | Subsequent Event | Employee | Service Based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Option Activity, Weighted-average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent', window );">Share-based Compensation Arrangement By Share-based Payment Award, Awards Vesting, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche One | Subsequent Event | Board of Directors Chairman | Service Based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Option Activity, Weighted-average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent', window );">Share-based Compensation Arrangement By Share-based Payment Award, Awards Vesting, Percent</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche One | Subsequent Event | Board of Directors Chairman | Stock Options With Market Based Vesting Conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Option Activity, Weighted-average remaining contractual term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor', window );">Market-based vesting condition share price floor (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod', window );">Market-based vesting condition number of consecutive days | day</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Tranche Two | Subsequent Event | Employee | Service Based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Option Activity, Weighted-average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent', window );">Share-based Compensation Arrangement By Share-based Payment Award, Awards Vesting, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Tranche Two | Subsequent Event | Board of Directors Chairman | Service Based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Option Activity, Weighted-average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent', window );">Share-based Compensation Arrangement By Share-based Payment Award, Awards Vesting, Percent</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Tranche Two | Subsequent Event | Board of Directors Chairman | Stock Options With Market Based Vesting Conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Option Activity, Weighted-average remaining contractual term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor', window );">Market-based vesting condition share price floor (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod', window );">Market-based vesting condition number of consecutive days | day</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember', window );">Tranche Three | Subsequent Event | Board of Directors Chairman | Stock Options With Market Based Vesting Conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Option Activity, Weighted-average remaining contractual term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor', window );">Market-based vesting condition share price floor (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 13.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod', window );">Market-based vesting condition number of consecutive days | day</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Automatic Increase To Shares Authorized As Percentage Of Outstanding Stock At End Of Preceding Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseToSharesAuthorizedAsPercentageOfOutstandingStockAtEndOfPrecedingYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the increase in the number of shares reserved for issuance under the incentive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Options, Forfeitures In Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to share based compensation arrangement by share based payment award options grants in period fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percent, applied to total number of outstanding shares of common stock on the last trading day in December of the prior year, by which the share reserve automatically increases on the first day of January of each calendar year beginning in 2016.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareReserveIncreaseAsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement by Share Based Payment Award Fair Value Amount of Outstanding Stock Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAmountofOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensatin Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Number Of Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_SharebasedCompensatinArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Awards Vesting, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardsVestingPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Number Of Vesting Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Options Market-based Vesting Condition, Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Options, Market-based Vesting Condition, Share Price Floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsMarketbasedVestingConditionSharePriceFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based awards, other than options, awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other than shares newly issued, the number of additional shares issued (for example, a stock split) or canceled (for example, to correct a share issuance), during the period under the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cerc_ServiceBasedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cerc_ServiceBasedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cerc_StockOptionsWithMarketBasedVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cerc_StockOptionsWithMarketBasedVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cerc_The2016PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cerc_The2016PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cerc_EmployeeConsultantsAndDirectorsStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cerc_EmployeeConsultantsAndDirectorsStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cerc_The2015PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cerc_The2015PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cerc_EmployeeStockPurchasePlanESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cerc_EmployeeStockPurchasePlanESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=cerc_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=cerc_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6829684720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 166,358<span></span>
</td>
<td class="nump">$ 23,313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6840625856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases  - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>contract </div>
<div>renewal_option</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LesseeOperatingLeaseNumberOfContracts', window );">Number of operating leases | contract</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Annual base rent</a></td>
<td class="nump">$ 161,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent', window );">Annual increase in rent expense</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options | renewal_option</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LesseeOperatingLeaseRemainingLeaseTeam', window );">Remaining lease team</a></td>
<td class="text">10 years 9 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Discount rate</a></td>
<td class="nump">7.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LesseeOperatingLeaseRentAbatement', window );">Rent abatement period</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LesseeOperatingLeaseNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LesseeOperatingLeaseNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LesseeOperatingLeaseRemainingLeaseTeam">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Remaining Lease Team</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LesseeOperatingLeaseRemainingLeaseTeam</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LesseeOperatingLeaseRentAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Rent Abatement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LesseeOperatingLeaseRentAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_OperatingLeasesRentExpenseAnnualIncreasePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Leases, Rent Expense, Annual Increase, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_OperatingLeasesRentExpenseAnnualIncreasePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6641634256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Assets and Liabilities (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Property and equipment, net</a></td>
<td class="nump">$ 737,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Other long-term liabilities</a></td>
<td class="nump">$ 1,189,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6819690576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 54,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,559<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6840800272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Maturity (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">April 1, 2019 through December 31, 2019</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2020</a></td>
<td class="nump">155,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2021</a></td>
<td class="nump">169,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2022</a></td>
<td class="nump">173,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2023</a></td>
<td class="nump">178,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,183,290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">1,860,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less implied interest</a></td>
<td class="num">(671,178)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 1,189,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6827913024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments And Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 16, 2018 </div>
<div>unit </div>
<div>$ / unit</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2017 </div>
<div>USD ($) </div>
<div>unit </div>
<div>$ / unit</div>
</th>
<th class="th">
<div>Aug. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Oct. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest ownership percentage by Noncontrolling Owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,947,892<span></span>
</td>
<td class="nump">$ 863,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,411,443<span></span>
</td>
<td class="nump">$ 4,482,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_PotentialFutureRegulatoryMilestone', window );">Potential future regulatory milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_UlesfiaSupplyAgreementMember', window );">Ulesfia Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseObligationCurrent', window );">License obligation current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementIndemnityReceivable', window );">Indemnity receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cerc_TRISPharmaMember', window );">TRIS Pharma | Karbinal Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired', window );">Minimum quantity required | unit</a></td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementMakeWholePaymentPerUnit', window );">Make whole payment (in dollars per unit) | $ / unit</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementMakeWholePayment', window );">Make whole payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">432,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementAccruedMakeWholePayment', window );">Accrued make whole payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cerc_ZyleraMember', window );">Zylera | Ulesfia Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementPricePerUnit', window );">Price (in dollars per unit) | $ / unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit', window );">Management and handling fee (in dollars per unit) | $ / unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent', window );">Management and handling fee annual price increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cerc_ZyleraMember', window );">Zylera | Lachlan Pharmaceuticals | Ulesfia Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired', window );">Minimum quantity required | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Long-term purchase commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementMinimumRoyalty', window );">Minimum royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent', window );">Indemnification of post-acquisition losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cerc_LachlanPharmaceuticalsMember', window );">Lachlan Pharmaceuticals | Ulesfia Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent', window );">Indemnification of pre-acquisition losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent', window );">Indemnification of post-acquisition losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Lachlan Pharmaceuticals | Ulesfia Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments', window );">Threshold indemnification of legal costs and possible minimum payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementAccruedMakeWholePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Accrued Make Whole Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementAccruedMakeWholePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Indemnification Of Post-acquisition Losses, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Indemnification Of Pre-acquisition Losses, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementIndemnificationOfPreacquisitionLossesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementIndemnityReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Indemnity Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementIndemnityReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementMakeWholePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Make Whole Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementMakeWholePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementMakeWholePaymentPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Make Whole Payment Per Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementMakeWholePaymentPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementMinimumRoyalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Minimum Royalty</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementMinimumRoyalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementPricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Price Per Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementPricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Threshold Indemnification Of Legal Costs And Possible Minimum Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementThresholdIndemnificationOfLegalCostsAndPossibleMinimumPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Obligation, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management And Handling Fee, Related Party, Annual Price Increase, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ManagementAndHandlingFeeRelatedPartyAnnualPriceIncreasePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management And Handling Fee, Related Party, Price Per Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_ManagementAndHandlingFeeRelatedPartyPricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_PotentialFutureRegulatoryMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Future Regulatory Milestone</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_PotentialFutureRegulatoryMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of units of goods that must be purchased within the specified time period of the agreement to avoid penalties or unfavorable effects on pricing, among other adverse consequences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentMinimumQuantityRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_UlesfiaSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_UlesfiaSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cerc_TRISPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cerc_TRISPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_KarbinalAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_KarbinalAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cerc_ZyleraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cerc_ZyleraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cerc_LachlanPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cerc_LachlanPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cerc_LachlanPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cerc_LachlanPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6849056864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments And Contingencies - Minimum Future Obligations (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract', window );"><strong>Minimum Purchase Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear', window );">Q2 2019 - Q4 2019</a></td>
<td class="nump">$ 942,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">2020</a></td>
<td class="nump">1,265,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Total</a></td>
<td class="nump">2,208,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentFiscalYearMaturityAbstract', window );"><strong>Minimum Purchase Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear', window );">Q2 2019 - Q4 2019</a></td>
<td class="nump">2,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInSecondYear', window );">2020</a></td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInThirdYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInFourthYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Total</a></td>
<td class="nump">5,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationFiscalYearMaturityAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear', window );">Q2 2019 - Q4 2019</a></td>
<td class="nump">3,192,994<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondYear', window );">2020</a></td>
<td class="nump">4,265,378<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInThirdYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total</a></td>
<td class="nump">$ 7,458,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_UlesfiaSupplyAgreementMember', window );">Ulesfia Supply Agreement | Zylera | Lachlan Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationFiscalYearMaturityAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent', window );">Indemnification of post-acquisition losses</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Indemnification Of Post-acquisition Losses, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cerc_LicenseAgreementIndemnificationOfPostacquisitionLossesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cerc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation maturing in the remainder of the fiscal year following the latest fiscal year ended.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment maturing in the fourth fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment maturing in the second fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment maturing in the third fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other commitments maturing in the remainder of the fiscal year following the latest fiscal year ended.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the fourth fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the second fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the third fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the remainder of the fiscal year following the latest fiscal year ended. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_UlesfiaSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_UlesfiaSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cerc_ZyleraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cerc_ZyleraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cerc_LachlanPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cerc_LachlanPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>67
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O*NP[Z_;N'QM?!.L*?MU%_0502P,$%     @ #(*I3IE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M=V]R:W-H965T<R]S:&5E=#4N>&UL?9E;;]M&$(7_BJ!W19R9O9"&;2!24;1
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MKKO3!X33S= ^SQ]'UN<O-+?_ U!+ P04    "  ,@JE.:4P)&"X$  "S$@
M&    'AL+W=O<FMS:&5E=',O<VAE970V+GAM;(U8[V_B1A#]5Y"_<][?NXX
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M    >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL?5-A;YLP$/TKEG] G3BDJR)
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MC,>7C?TOC?& 4E8W.$(U?K#)D%#Z<-SCV0YC-AC>M.,/8M,WSOX"4$L#!!0
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M4V%OVR 0_2N('U 2DC519%MJ.DV;M$E1IZV?B7VV48'S ,?=OQ]@U_,V:U^
M.^Z]>W<<V8#VQ;4 GKQJ95Q.6^^[$V.N;$$+=X<=F'!3H]7"!],VS'461)5
M6C&^V=PS+:2A199\%UMDV'LE#5PL<;W6POX\@\(AIUOZYGB23>NC@Q59)QKX
M"OY;=['!8C-+)348)]$0"W5.'[:G\S[&IX#O$@:W.)-8R17Q)1J?JIQNHB!0
M4/K((,)V@T=0*A(%&3\F3CJGC,#E^8W]0ZH]U'(5#AY1/<O*MSD]4E)!+7KE
MGW#X"%,][RB9BO\,-U A/"H).4I4+JVD[)U'/;$$*5J\CKLT:1_&&WZ88.L
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M&V^11:7A$I3E6B$#;8GO=L?3(> CX">'R:[.*%1RT?HY&%^;$F<A(1!0NZ#
M_':%>Q B"/DT7I(F7D(&XOK\KOXEUNYKN3 +]UK\XHWK2YQCU$#+1N&>]/0
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M;#$4U"X</_FSF<9L,ASV\P]BRS<N_@)02P,$%     @ #(*I3CQ/^$JT 0
MT@,  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL?5-A;]L@$/TKB!]0
M$CMKH\BVU+2:.FF3HDY;/Q/[;*,"YP*.NW\_P*[K=M:^ '?<>_?N.+(!S;-M
M 1QY55+;G+;.=0?&;-F"XO8*.]#^ID:CN/.F:9CM#/ J@I1DR69SS107FA99
M])U,D6'OI-!P,L3V2G'SYP@2AYQNZ9OC432M"PY69!UOX">X7]W)>(O-+)50
MH*U 30S4.;W='HZ[$!\#?@L8[.),0B5GQ.=@?*MRN@F"0$+I @/WVP7N0,I
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MM0O'&W\VXYB-AL-N^D%L_L;%7U!+ P04    "  ,@JE. Q']8;0!  #2 P
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MV4QC-AE.]^D'D?D;E_\ 4$L#!!0    (  R"J4Z.@<-AM@$  -(#   9
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M[@RIJ1$)@@0UM&K]/#.Q)YYG["CKJH4G[HECTU#^=P4UZY<^]M\#S]6AE#J
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M2<\MU@Y,3,XQ&Y?.S+V0T)EK: 3",X&Y6R!R"D1&()H*I,%%)@,F,9C68,)
M_]P^L=,G=OC@BTT9,/'$Y\:F)$Z+Q&%Q4?!5<I4*QK,Y25.W4>HT2AU&X851
M>F64AFD2W]C<F=-GYO")W )SI\#\_T\'#MS?4O!Y43<6=%95<N>$X!O?+?Z\
MKAL+.BNLRPI-ND4#_& ZL? *=FRE_N(FT;';/YH&>!%?X<5ZZ$(?,L,5\H/R
M0]4*;\NDZF6FX^P9DZ"6&3RH4URJ6VN<U+"7>IBJ,1]:]S"1K+/7$AKOQOP?
M4$L#!!0    (  R"J4[!JWX&K@(  '(*   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;)56[8Z;,!!\%<0#''CY/B61DE15*[52=%7;WT[B).@ 4]M)
MKF]?VW <"4M%_@3;S,[N;!C8V96+5WEB3#EO95')N7M2JG[V/+D[L9+*)UZS
M2M\Y<%%2I;?BZ,E:,+JW067A@>_'7DGSREW,[-E&+&;\K(J\8AOAR'-94O%W
MQ0I^G;O$?3]XR8\G90Z\Q:RF1_:#J9_U1NB=U['L\Y)5,N>5(]AA[B[)\QK
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M !%!:H).K=1*T56]/CO)$M 9S-E.N/Y];<.A0*Q+\A![US/#[ )+VC'^)DH
MZ7S4M!%KMY2R72$D#B741#RQ%AIU4C!>$ZE"?D*BY4".AE13A#UOB6I2-6Z6
MFMR.9RD[2UHUL....-<UX?\V0%FW=A?N9^*E.I52)U"6MN0$OT'^:7=<16A4
M.58U-*)BC<.A6+O?%JL\T7@#>*V@$U=[1U>R9^Q-!S^.:]?3AH#"06H%HI8+
M;(%2+:1LO ^:[GA)3;S>?ZH_F]I5+7LB8,OHW^HHR[4;N\X1"G*F\H5UWV&H
M)W2=H?B?< &JX-J)NL:!46'^G<-92%8/*LI*33[ZM6K,VO4G2W^@V0EX(."1
M@+TO"?Y \!\E! ,AF!%07XKI34XDR5+..H?W=[<E^B%:K +5_8-.FF:;,]4>
MH;*7#,=1BBY::,!L>@R>8.(I9FO#)%-,;L$DWHA!RN=H%EO-8B/@3P06=@'?
M*N ;@>!*(/)FA?20T$ : PD]\YL5<Q\W\1-8_00W?G""[0*A52!\O"-+J\#2
MXL"?W?_E;:FSIMU%Y%\A)C8CJ\W(8C.P"\16@?CQ1B56@>3NH[-);FK$<1@M
M@ED_\_NXW@^Z>HGU%/Y%^*EJA+-G4LT#\]86C$E0FMZ3DBO5X!\#"H74VTCM
M>3_^^D"R=ICL:/R\9/\!4$L#!!0    (  R"J4X(?7CD> (  /@'   9
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MSLU<]LVG7VC1#HTU&+M[_@=02P,$%     @ #(*I3A%]:^00!0  ,!P  !D
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M":J$#E=7R@@% F1Q BUA@0_ !3<)"0,RN!V3,&6$ @& .$60 SX &=R/3U@
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MSIK,V:!Q1N=N%%9@IAM BTDH\ R@Q<3B%.%]8XC3-VF,006> 5B9&"N)\+8
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M9#^496,=3?;)E>)DT_W](;.'IKW5[K[JSS[ZAZ:\#.<ZT?UP:?4_4$L#!!0
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MB$"0!BJ30&4"" = DX;<!$*4,,S* "BA0YBBZLX2DR0020 %@;8D"@0!<[^
MO(Z%O*H0!S!-5"6)J@01"8BJF*BBG(1[6R=TG&!0D30030+1!% 5 -$X$$08
MD."=J6,=H@QBE.9A21X6\3 0X+!X(^SYP>&1CF7085.6QN%)'![A4![@\#@.
MHV45[&H=RQ"V>WKG]$"0KEP@XH& AJ4+1*$H@(B%]2N6(<KM:W^'Z$XMA8D#
M%!'!J+P@R" !/-RTA!)RBB&.2F-Q4^W=]?M=Z&/3C]FS,O;B\.7]H)21UBOX
M8),\V1M_Z;3R8%R3VK:>KKVI8]0P7^G%\EVQ^0=02P,$%     @ #(*I3O;L
M#VNC @  . D  !D   !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULC59=;YLP
M%/TKB/<5V]A (A*I25=MTB95K;8].XF3H )FMI-T_WZV<0D!)VT>@FW..?=<
M7_R1G[AXE7O&5/!6E;6<A7NEFFD4R?6>553>\8;5^LV6BXHJW16[2#:"T8TE
M566$ $BBBA9U.,_MV).8Y_R@RJ)F3R*0AZJBXM^"E?PT"V'X/O!<[/;*#$3S
MO*$[]L+4K^9)Z%[4J6R*BM6RX'4@V'86WL/I(\2&8!&_"W:2O79@4EEQ_FHZ
MWS>S$!A'K&1K922H?AS9DI6E4=(^_CK1L(MIB/WVN_JC35XGLZ*2+7GYI]BH
M_2S,PF##MO10JF=^^L9<0B0,7/8_V)&5&FZ<Z!AK7DK['ZP/4O'*J6@K%7UK
MGT5MGZ?V#<&.YB<@1T =0<>^18@=(3X3;D? CH#/A.0F@3@"^6R$Q!&2 2%J
M)\O._@-5=)X+?@I$^P$UU'RG<)KH^J[-H"VG?:<+(/7H<8[3+(^.1LAA%BT&
M]3#P$O$P1N!TTF$B[:"S@7PV%F@D@"Y#+,>(% ]<C"$X Y>8KS[,()M'CYDK
MR<3>.8TM/[Z(@?P"V"N K0#N"63#FK20Q$)J"_F"0#K!@UR6'AP$ (,K?HC7
M#QGYP>G 3PLAO3@0$*!_@[DE(S]#W(6?Q.LG&?F!:>(72+T"Z><KE'D%LH\K
ME(UF!('KB4Z\828W$VWC3,8S3_"-2!#X-P+P<9$=YJ)Z\%:H*WL.'(?*XBL2
MWOWB'J+/5Q#Z5RF,/2Z&6XH#]3-&"2)7$_:O9SA>T#@C@YT)CI<J),BW-J+>
MYEXQL;-'LPS6_% KLV_U1KOC_QZ9PV$POH#397N(GV7:.\5/*G9%+8,55_KH
ML0?$EG/%M%%PI[^UO;[&=)V2;95IIKHMVK.\[2C>N'M*U%V6YO\!4$L#!!0
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M,P 6!, " NS> ,P$<K/1T>NLO7M?X<)#:&=/% 0!"P+8!<^,Z'2=$JU,$.5
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M]6O=?HV;[V7_3K(_J(N=>=\:'%_Z3O\'4$L#!!0    (  R"J4XDZ"NK/0(
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MZ$I.C+WJQ;<J<SV=$! HI5; :CA# 81H(97&GUG372PU<3V_J'\QM:M:3EA
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M'_>FWB32Z$9\"_3WB?J8>,!;TS%[T2MV=^#NW.95O0V$P]PG*G3L&BVS.TS
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MI/.XT8(T-X^/]ZTO,N!2%"4(1O1%(5G!D='Q"J7I<]Y1MJ$OO\5S1 E'Q/I
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M)T=>7*:\^-W8_Q(.*9 8Y(>1I-(BLD*$A@PA187<KS.JV/H1A>8#Z'U42!N
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M>7"5E),_CI/Y[!EJM I&AWX7]B"PQXG-_:X94)*H9T][X.:2<_,3FT96@_6
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MOD&N; CMIXL+!4QQ09G@!DB2C:>:/#D<UU?-"ES9;$U.%4$POLTLZKM)^N8
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M8EW>?@CK4SH_[VG:,S>'@&^IFT!D8>Z!W"/_)CQ7]>'V'I1E>"$M8/1C55G
MSUQ2TDA6/33VJV? [1JL,<<-$%]0?8 I(VQ5ZE"R'(:<?DLK/V9: O7NF&\X
MEK2#^Y!MRHKLB3>X]X/^^;\?U66<0JBW^4I<T/0\L$,5#IVIC/I4ZDXM1(#$
MRF%')(_5?).305&UDX-2BZNM!A.D=(3)Y/LVAX.=N\W2A%8Y:$MJ'?6H,&=
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M ZUZ1/NMDJI7!2H!"Q2ID(SV&3]L:=RS+VS-&K4N"2X)G-6N4MO#>'Q&Q;+
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MC8$8V(4V3"SL@=B2YF(%I2:8>C9*KOOBB(ZAJ]C5K9N$8/?%^QPN#QP?9L>
MF%+%\2HE)NFWMP?_AJM\&?JMNW;_$R7>_&E7\H7*%QQCUF48[#:Y]I+\*7[
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M:.7/U5,&\JBXE"=U5-A^31'L2".$L@U]2W0(6 8][4WX[+*%B2/-$[1Q'\E
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M H1ADY9]E&' (>^ P[L#^F\G='P6..'\=OV9F,>Z*M+B.4!!QEQ'LZ.Q!I&
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M>1$6Y.M6J3E<N]:7AG??L(0\MA\'??D/4$L#!!0    (  R"J4XMGDXW^0$
M 'HA   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/%VLUNVD 4AN%;
M0;Z #.=G2%*%K++)MND-6#!@%+ MSU1-[KX.FSI2XJ\+]+$!(= Y[\:/K#$/
M/].Q+H>NS<VASXNWT['-ZZHII?\10MXTZ53GFZY/[?C-KAM.=1D_#OO0UYO7
M>I^"+I>K,$QG5(\/TYF+Y^VZ&IZW4BU^U<,^E745WH[A3S>\YB:EDL/Y36[&
M!>-/WOOT/^N[W>ZP24_=YO<IM>6+BG\+JO!UD,X'*3W(YH.,'N3S04X/BO-!
MD1ZTF@]:T8-NYX-NZ4%W\T%W]*#[^:![>I L@8Q+?A+"FJ^U *Z%[[4 L(4O
MM@"RA6^V +2%K[8 MH7OM@"XA2^W +J%;[< O(6OMP*]E:^W KWU"O?:Z&:;
MK[<"O96OMP*]E:^W KV5K[<"O96OMP*]E:^W KV5K[<"O96OMP&]C:^W ;V-
MK[<!O>T*9R7HL(2OMP&]C:^W ;V-K[<!O8VOMP&]C:^W ;V-K[<!O8VOMP.]
MG:^W [V=K[<#O9VOMP.]_0IGW>BPFZ^W [V=K[<#O9VOMP.]G:^W [V=K[<#
MO9VO=P1Z1[[>$>@=^7I'H'?DZQV!WI&O=P1ZQRL\JT0/*_EZQXG>N:F'M'TI
MPZ'=YTN7?!K^;<T$[ES>C^GR&>>IW^Z?*%W&+2F<7R]^B9^G?D2$3W^U>/P+
M4$L#!!0    (  R"J4YWOQ-;U@$  #4A   3    6T-O;G1E;G1?5'EP97-=
M+GAM;,W:74_",!0&X+]"=FM8Z<?\BGBCWJJ)_H&Z'=C"UC9M0?SW=A-,-)A@
M@.2]86RG.^?=:)XK;EX_'(71NFM-F&9UC.Z:L5#6U.F06T<F56;6=SJF4S]G
M3I<+/2<F)I-S5EH3R<1Q['MDMS?W--/+-H[NOJ[WK:>9=JYM2AT;:]C*5+^:
MCC<-<T_ML";4C0MG:4$V>EBG+B%=FV:I&C*VQX3?-_;GZ;ZG%7G?5/2O:'8V
M:TJJ;+GLTBUY<)YT%6JBV+5YJ+6GZB7ZQLPW>9^UCX^Z2XW9NF4_%N2GRQ$_
M6MH=8*@<<W),VX)VC1H*7Y_\H(';W5!:3V/G4]7'9L?CI4C/J1I8O_"8CTC]
MUJFHVFMX:GVZ'_;=^L7P?=<+_RX&-AP.>^O'RR% <DB0' HD1P&2XQPDQP5(
MCDN0'%<@.?@$)0B*J!R%5(YB*D=!E:.HRE%8Y2BN<A18.8JL D56@2*K0)%5
MH,@J4&05*+(*%%D%BJP"15:!(JM$D56BR"I19)4HLDH4626*K!)%5HDBJT21
M5:+(JE!D52BR*A19%8JL"D56A2*K0I%5H<BJ4&15*+(6*+(6*+(6*+(6*+(6
M*+(6)Y1U..:=;LQ?2=ZL76SGL^'?$K>?4$L! A0#%     @ #(*I3A\CSP/
M    $P(   L              ( !     %]R96QS+RYR96QS4$L! A0#%
M  @ #(*I3B?HAPZ"    L0   !               ( !Z0   &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    "  ,@JE.;&1[ON\    K @  $0
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M=#(N>&UL4$L! A0#%     @ #(*I3M[LFH5% @  R@<  !@
M ( !9A   'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (  R"
MJ4Z=_I+!_ ,   81   8              "  >$2  !X;"]W;W)K<VAE971S
M+W-H965T-"YX;6Q02P$"% ,4    "  ,@JE.[1PF@T0%  "M&0  &
M        @ $3%P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%
M  @ #(*I3FE,"1@N!   LQ(  !@              ( !C1P  'AL+W=O<FMS
M:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (  R"J4[6408AL $  -(#   8
M              "  ?$@  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"
M% ,4    "  ,@JE.;A"IQ;4!  #2 P  &               @ '7(@  >&PO
M=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ #(*I3M09062V 0
MT@,  !@              ( !PB0  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM
M;%!+ 0(4 Q0    (  R"J4Y2.>[XLP$  -(#   9              "  :XF
M  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ #(*I3J*'
MM]FU 0  T@,  !D              ( !F"@  'AL+W=O<FMS:&5E=',O<VAE
M970Q,2YX;6Q02P$"% ,4    "  ,@JE.Q-L3[[4!  #2 P  &0
M    @ &$*@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (
M  R"J4ZLM"N&M@$  -(#   9              "  7 L  !X;"]W;W)K<VAE
M971S+W-H965T,3,N>&UL4$L! A0#%     @ #(*I3EKWY::T 0  T@,  !D
M             ( !72X  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"
M% ,4    "  ,@JE.PGQ,GK,!  #2 P  &0              @ %(,   >&PO
M=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (  R"J4[4J4GLM@$
M -(#   9              "  3(R  !X;"]W;W)K<VAE971S+W-H965T,38N
M>&UL4$L! A0#%     @ #(*I3CQ/^$JT 0  T@,  !D              ( !
M'S0  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    "  ,@JE.
M Q']8;0!  #2 P  &0              @ $*-@  >&PO=V]R:W-H965T<R]S
M:&5E=#$X+GAM;%!+ 0(4 Q0    (  R"J4Z.@<-AM@$  -(#   9
M      "  ?4W  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%
M  @ #(*I3B&NY;O4 0  G 0  !D              ( !XCD  'AL+W=O<FMS
M:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  ,@JE. O'X,[<!  #2 P
M&0              @ 'M.P  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+
M 0(4 Q0    (  R"J4Z\SZ_*PP$  #<$   9              "  =L]  !X
M;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ #(*I3CCXZ-O=
M 0   04  !D              ( !U3\  'AL+W=O<FMS:&5E=',O<VAE970R
M,RYX;6Q02P$"% ,4    "  ,@JE.M@O]N\$!   W!   &0
M@ 'I00  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (  R"
MJ4XZED[?N $  -(#   9              "  >%#  !X;"]W;W)K<VAE971S
M+W-H965T,C4N>&UL4$L! A0#%     @ #(*I3JF_BU>W 0  T@,  !D
M         ( !T$4  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
M    "  ,@JE.@P:;J> !   !!0  &0              @ &^1P  >&PO=V]R
M:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (  R"J4YBMLB%TP$  )P$
M   9              "  =5)  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL
M4$L! A0#%     @ #(*I3E=)H*JX 0  T@,  !D              ( !WTL
M 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    "  ,@JE.^R68
M(28#  "!#   &0              @ '.30  >&PO=V]R:W-H965T<R]S:&5E
M=#,P+GAM;%!+ 0(4 Q0    (  R"J4Z:I.U>2@(  "<'   9
M  "  2M1  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @
M#(*I3L&K?@:N @  <@H  !D              ( !K%,  'AL+W=O<FMS:&5E
M=',O<VAE970S,BYX;6Q02P$"% ,4    "  ,@JE.,0A9F@P"  !J!@  &0
M            @ &15@  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4
M Q0    (  R"J4X(?7CD> (  /@'   9              "  =18  !X;"]W
M;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ #(*I3G+[?T=B @
MZ0<  !D              ( !@UL  'AL+W=O<FMS:&5E=',O<VAE970S-2YX
M;6Q02P$"% ,4    "  ,@JE.$7UKY! %   P'   &0              @ $<
M7@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (  R"J4XO
M+P8R'@@  ! R   9              "  6-C  !X;"]W;W)K<VAE971S+W-H
M965T,S<N>&UL4$L! A0#%     @ #(*I3C(#K$,=!0  VQ\  !D
M     ( !N&L  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  R"J4YVX"RA#00  &@2   9              "
M =A^  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ #(*I
M3A2<XW*/ @  8P@  !D              ( !'(,  'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6Q02P$"% ,4    "  ,@JE.]NP/:Z,"   X"0  &0
M        @ 'BA0  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0
M   (  R"J4[^,>AI6@4    >   9              "  ;R(  !X;"]W;W)K
M<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ #(*I3B3H*ZL] @  G@<
M !D              ( !38X  'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q0
M2P$"% ,4    "  ,@JE.X+/+ZHX)  #A/0  &0              @ '!D
M>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (  R"J4[!:@<0
MX0$  &<$   9              "  8::  !X;"]W;W)K<VAE971S+W-H965T
M-#DN>&UL4$L! A0#%     @ #(*I3L:HFPE# @  :P<  !D
M ( !GIP  'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    "  ,
M@JE.V_ATR[<!  #$ P  &0              @ $8GP  >&PO=V]R:W-H965T
M<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (  R"J4Y#;0#+Z $  *<$   9
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M["T! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  ,@JE.FOE1[JP$  "@)
M#P              @ %R, $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M#(*I3BV>3C?Y 0  >B$  !H              ( !2S4! 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ #(*I3G>_$UO6 0  -2$  !,
M             ( !?#<! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $
,0 !R$0  @SD!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>273</ContextCount>
  <ElementCount>350</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>99</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>16</UnitCount>
  <MyReports>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002000 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003000 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004000 - Statement - Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/Business</Role>
      <ShortName>Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - Basis of Presentation and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/BasisOfPresentationAndSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Revenue from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/RevenueFromContractsWithCustomers</Role>
      <ShortName>Revenue from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104100 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2106100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Accrued Expenses And Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses And Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Deerfield Obligation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/DeerfieldObligation</Role>
      <ShortName>Deerfield Obligation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2109100 - Disclosure - Capital Structure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CapitalStructure</Role>
      <ShortName>Capital Structure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Stock Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/StockBasedCompensation</Role>
      <ShortName>Stock Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - Commitments And Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments And Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/BasisOfPresentationAndSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Revenue from Contracts with Customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/RevenueFromContractsWithCustomersTables</Role>
      <ShortName>Revenue from Contracts with Customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/RevenueFromContractsWithCustomers</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Net Loss Per Share Of Common Stock, Basic And Diluted (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/NetLossPerShareOfCommonStockBasicAndDilutedTables</Role>
      <ShortName>Net Loss Per Share Of Common Stock, Basic And Diluted (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/Acquisitions</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/FairValueMeasurements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Accrued Expenses And Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses And Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2309301 - Disclosure - Capital Structure (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CapitalStructureTables</Role>
      <ShortName>Capital Structure (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/CapitalStructure</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2310301 - Disclosure - Stock Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/StockBasedCompensation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2312301 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/Leases</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2313301 - Disclosure - Commitments And Contingencies - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments And Contingencies - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2401401 - Disclosure - Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/BusinessDetails</Role>
      <ShortName>Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/Business</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2402402 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Revenue from Contracts with Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/RevenueFromContractsWithCustomersDetails</Role>
      <ShortName>Revenue from Contracts with Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/RevenueFromContractsWithCustomersTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2404402 - Disclosure - Net Loss Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/NetLossPerShareNarrativeDetails</Role>
      <ShortName>Net Loss Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2404403 - Disclosure - Net Loss Per Share  - Schedule of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/NetLossPerShareScheduleOfEarningsPerShareDetails</Role>
      <ShortName>Net Loss Per Share  - Schedule of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2404404 - Disclosure - Net Loss Per Share  - Anti-dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/NetLossPerShareAntiDilutiveSecuritiesDetails</Role>
      <ShortName>Net Loss Per Share  - Anti-dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Acquisitions - Schedule of Allocation of Purchase Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/AcquisitionsScheduleOfAllocationOfPurchasePriceDetails</Role>
      <ShortName>Acquisitions - Schedule of Allocation of Purchase Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2405404 - Disclosure - Acquisitions - Schedule of Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails</Role>
      <ShortName>Acquisitions - Schedule of Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2405405 - Disclosure - Acquisitions - Schedule of Consideration Transferred (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/AcquisitionsScheduleOfConsiderationTransferredDetails</Role>
      <ShortName>Acquisitions - Schedule of Consideration Transferred (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2405406 - Disclosure - Acquisitions - Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/AcquisitionsProFormaInformationDetails</Role>
      <ShortName>Acquisitions - Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2406404 - Disclosure - Fair Value Measurements - Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/FairValueMeasurementsRollforwardDetails</Role>
      <ShortName>Fair Value Measurements - Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Accrued Expenses And Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses And Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2408401 - Disclosure - Deerfield Obligation  - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/DeerfieldObligationNarrativeDetails</Role>
      <ShortName>Deerfield Obligation  - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - Capital Structure - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CapitalStructureCommonStockDetails</Role>
      <ShortName>Capital Structure - Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Capital Structure - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CapitalStructureWarrantsDetails</Role>
      <ShortName>Capital Structure - Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - Stock Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/StockBasedCompensationDetails</Role>
      <ShortName>Stock Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/StockBasedCompensationTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2411401 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/IncomeTaxes</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2412402 - Disclosure - Leases  - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases  - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - Leases - Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/LeasesAssetsAndLiabilitiesDetails</Role>
      <ShortName>Leases - Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2412404 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Leases - Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/LeasesLeaseMaturityDetails</Role>
      <ShortName>Leases - Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2413402 - Disclosure - Commitments And Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments And Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cerecor.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cerc-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2413403 - Disclosure - Commitments And Contingencies - Minimum Future Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerecor.com/role/CommitmentsAndContingenciesMinimumFutureObligationsDetails</Role>
      <ShortName>Commitments And Contingencies - Minimum Future Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cerc-20190331.xml</File>
    <File>cerc-20190331.xsd</File>
    <File>cerc-20190331_cal.xml</File>
    <File>cerc-20190331_def.xml</File>
    <File>cerc-20190331_lab.xml</File>
    <File>cerc-20190331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>72
<FILENAME>0001628280-19-006439-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-19-006439-xbrl.zip
M4$L#!!0    (  R"J4[F?HD^:HL! /@&&0 1    8V5R8RTR,#$Y,#,S,2YX
M;6SLO5E[&T>2*/I\SJ_P]?.EG?OB;\;GR[5',[8E2^KNT_>E/P@HDAB# +L
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M9?#@Z9^R/.W[8W4(G>UR?XQ>I LW+<KSV^!K*I<BG_/@Y6Z<=/GT?NA7)P]
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M];KNEW&!H>J;"M,L I^UB;PA"QQ7SK>4%]IO)U!_S:8=AEOR!30G,EKD@P6
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M19S@CRT!'N"TUD1D/\RO9>P+O@7<)T*XJ(69JO1TBQ/,X40;=[/9+?$DML<
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M1:6OI;:E6HMOA]I.8N&LE";@"J5K&-1Y*@T+ 5,0!EZ0:%Q40M2BA[PN>A(
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M0PC.$DNPXPZ%5(-&DGE 6P9:>O,+8XT4P7S9 J]>QK-6NLDG!J_ \& <U\H
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MM;2>214TM<19*U@I<X_HI)$Y*0-N%T@<!8*' 41*,_".8&X,&)"((K#O"T#
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M6P'N#-;:@*V>;'/%8]!K=RZ6$%654- @ZAF(2IP4X;.S<.QVA"61Q\&+IRH
MJI1+1DA"F(S.:^MB-<+(R\RT,T78,]VLTVLPZGQ"EK>8"\LY(UYQ0!J'_]/
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M#8J!><,ED4X7)<,) 3[%J.11$$4;')_OJPDU-TF(%(%&YASG D5P&BTKGE#
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MT&80=8"W4M% JJ7<? _TP- [(UP=#.0B4&]I""KQA[*:%""/)%UP+W$*L(_
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M)%+L>@?W=$D7IS;+N.6(RFBUC1BY$(.1O+@$%H3DGI?SR_D1D]ZNG8S.GAK
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M0?N/%4T-\WZ%U7SHM=HU%Z'?_1973GNU$3Z5HB *!P<(H4(SHA2600NYYA4
M/#[=M_+L^Y_1#VS9''W.5H\ JV63J7+*I7M@@X>'0;\ X&SB\.VQFQ=^J@<0
M_N>XGQ%$V)K9]&D6JIK.7T;!9.9).F,9_&0YW &@)UHK::0-.'K0D5P%;Z,"
M&<+6PQT+X&/R []BZ/_:>@+ DR,"GH.]%D6Z04<\,@&<+E\ WE+O9%S/<5@
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M?/G=_;!STQZAA]A/O[Y[MU.-"AE]8#X1&Y)S(LE9OMF;0*)<0SRY2KM#$=Y
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M \/&0HXL,:85-<C D*S47M?*!3?TXEZX]S*,(#>>8><]:%\2: 03EW@I#HZ
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M"%DU2%%@,BF3((J<8X1=G_6ZJ]5(YAQ0(BM!B@6_C4B-1;%12#[7"HK7HW;
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M96J3XSAG%BR@G0_HL[2>&.""8%GB<6"/A]W.N+@J+YK[Y7_00GT&!P73ON,
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M(G$,86)4@9<4\]H)Y8VYL#NP_OJ4/:5 8_6W(TQD+7':C:!4S<M>G(UD7>Q
M+5NJG7\QE)]JDY_;#]3LE&NY7JY7PF/P)*4)0-7LA5 91SC,0C/!W#KR"B6$
M5L^$NF]GGE,YKQ ??WCR]UA_'2MR!0?%$:/"^=<X/6?FIE@7ULYV9\H20QL@
M[B;$SXRJE1M(;-R95*:5WS>]L0N#_E5W+W)G&XA7&3R-[*EA+!L^'^OM)5F7
M96A".S\QH5<BW]D@SK)B\C1"78V'5+ DB4P49Z@HLJ ZS-R+P'S>G"6036B,
MP\AQ @X4\VO##X-QNP>NY;#;'W4[QZ1I]N? RC3N9&G(E$4B@K(*HB (28-/
M'O1+=O59HTVY(0=0HDG*@SFX+KHX=W']5?KI\BU$1JN#59&">.-43&/FXY%U
M2NL4"H[9;8[4:U!ODK++]^#KEQ,^MPK3S<L_7! J<JEPZ'$(4G-A1=(Q<)Y)
M]FO[.,J3\Z;!L[.&XE^)H<^[*'7C14/4G@JF=2*!:"%EBEA6G*,S/*:E2?_S
M^_:&U>,S8O'!OM=9\Q['0I<3436A!M,@5@8KLDI4.ZK7AN@OC/>GLX0NJNC@
M:#DAP11*FI5(\U6LUJS5GEQPW43"]7G1ML%XQG ?<?R2=$%YYF4V;CY4GL*?
M3AO//"F]F[X!/2ZX251*HBB/ L>."N)X7$R\]'IC01![(TXFZ$]ST3G]ZLHR
ML,/+%(_5+0DB&.<<,4EHZRTG-+GY7N2\M'MWKK>U@)BGB4J>38B?&54;U"J)
M!1JL]((*KVP,*KEYED0FM<Y%D@V;R:]-[>8S?5+:P*PAG.):.1>T6XP09$JO
M;<$W0G+21)+ZF5"U01F.F3GKO%#6":(RS8(NR.W4YJ6]SX_:AZ7[FM#.2^F^
M;!+UN*@OB8A#4*@5\[TV4IO-Z3[:8+IO3W(\"PX\ZA0LE< RY0B(._9>)I],
MX!),:!)!!6*#W+CGO:%ZK6?(FJ9SX5)S9DB*+D8EF<LYR;DEU4IOX0!MT%U\
M21QH['!H ]95>7 K>78Q)VS F/==2+9Q-?VS/QR3*DE<(#8M%?LPP)<J%R;N
MTZ=A\0DBB&UW%TT=EY4:"FV39N4X'2I)RIEA7YAS(98+8FM#<U7#-OMHXCP!
MARJR\O4XI,&(X#)R37%EF=<^.855+MX3+F*L;0HT3=\M'4V<9\JA1RF\I>4O
MW%'@$ N,*9ZEP!&],X67**N-3S0OBW%8*U[^Z<=^9XBS+V,Q^>^:[1KTW]K]
MIRE=2CS'(&V$F) 0D9/5LS6PWF3PT];='Q)#JLO03D"2@R@^.O0R>'^'X$1)
M/.T9-V#S9;8!R>V4F[=<*I?D)M//WY!#RFX:)4RC+%ES:?S5F<*C8TY&8HQ3
M-.#*.JX6_MCJ\.,E?^R0#$G#I&F4+5O3NILY\KSOX-E2-8637#$CK.7":4=#
M>3=K-$\L:;&Q=$B]88<HQ.;X<&;L?RDW]DLA=(XV4R<89=DY[[+4'F=*>:.$
M"GKCD$3YAAZ2_7]9,G$RR\D]=1H8$2PC*<&9%&Y>KFI7%XI6E71U&>J%&4UY
M^A7G/F9M,DU$>)^2QQ$1\[V;@? -C&G],>I^W^_V_N6[\? >?OU+C5X?=SN6
M'U?)!0Y^=S+]^_A:O)..):H6?8&-,> %4O"^G3&!QC"O5F4RB._^^HZ2U1%#
M31"E$4IOZP#$I<@GF<FV16M4ML@3XHG*W@A!+?'9!S.31ZH(#FY2O_'548 G
M(<'Y$;J!]KI%QBR3:*02P61B: ;S&.W\GHOP"(2638COTY!Y9_'V9)'Z1!>6
MJSS R=A._T?2-XB4*?'!>2L]UTDSN;A'#)Z6@FQ_%K$!&A^/?9/$WYR2WO3U
M[, 9F7L3'VQ7YE1I:X/0+CA.P[R\R5*.,Q8U$)_*!JE_!/K/D?J/<38RA&DF
M"ILXYS;C.&^>RGM%$[R+"L>\VM_8STQ?V'("C>1,EDG99#4-GCNFQ.+BB@-;
MRD.A?Z;D0OVG], Y"1*-L"86 E3CK5U,WI!2HJXROU'ZHD[%\L"5N8O0M#'>
M<!65A PA^4PC,U[P1+PJU1#5$*8*5=NMM_:N\ 38-T_AY2[8)RKHSHDD&K4,
MS!ANN2:!BGED!%9Y;;$\L[44></8-T_=,ZDLS@:O?SQ/0-P4F?=!SB(FD&ZV
MN;*8K):*G)XBC3!A?E>&&9.WUV&Q<@:PZQ0K?>WQB:=D>*N8)@P\?RXUE328
M.%^ECI[.VBD99O4JXB1TJ5&_:@?J-\RZ4F\VW_PS&::%D WZF/K:OOUGZ\ I
M&E2FC%&FHC:.*F.)5(YD1JQSZ[0$O%-9LRJU521.CN&[87%=#(=[#J>C$&R$
M')T32BL W@D;2B0E4<'R=7-R5^W,([ SZS8W-<4_DJTR/"K*<=D2:"#***(&
M/\G@R+H!!)SB7"6^*NI/BN%A_-,DRQBCCN"(&9&DQCL$(N%XNR =63?!HE'^
MG?#\!2<3NO])..J8TS[E$C4!_JA;=H*6"@AHD^?O< P/XU]T3"O'$I6X,<L2
MG9DND02'3QH9UR#)#&AML=IH_0@<U^Y/:XJ+BFL7-6. G0Q42B]51 0M_$'P
ML Y!P;3$MOZOB>%A7.2*@940T5D6G.><NR!*)!W.'?<-<!&AF"S,B_?#^2C_
MR6=<!S 938*WFF-A_LY_+>Z88&*ZW!'WYU8^L? I?NS<#."ANX9!"1^9"AP"
M0<&\Q&(3)TPR"@)TKBU=.U*V5G"U+SJ-TD"^9K(A(MB4!2BAH#Q1).%6K$A,
MBI9;8Y3WZUI"GX (OQ1?RC^MI<#*PK_CSOD>_NGB!.U:&+C:90O&6A 2C-9*
MA(1+%'!E($V&>2/6N5NTMJIW+^H\DIY;MW<VI39E,%R0Z"TUH I#M,&CVO11
M)OC5KQT:7-N\V2PU5@;J3H98%>.WUY7"HJ<G%'4.W *;G.0Q$PXJB2;+J0L0
MXNM,UG7TU>IV'XOUWB2LIN%FM^I/-<]%9K!)R1(: ?E,$K8"S*O0J*?KPQEC
M]J336M3V(,SDYNWD%DQ5?2X5)01PV3+CG>*$3BV8\R1XZ<5J=HV1/?5,#9=]
M\=^I:#95/FO#HH8CP!FG1CH?E%"H)A)GD=@8:I7/5DNK]L3D$!6Q'QH'J@%W
M-4E)MWOOVMVK'_NA?=<=KUO(6B5)2)HE1XS'0JI$-/>^) E8$L]CJG$72()S
MI9\)2;9JQBH9N PJ.*:8YY()RG'1:TD&G:+)JB89:#M.1(/'&(Z-7"8>W 07
M.?Q#0-$G")Y [4=M==2<\E7T]A3YAK3]H]%^BH.BC<XN\>BS@TA,1 A!*9)0
MY 0>QFI:]KN_OJ9+"?"71\6]SU9V#J)932' LQK\,D^R0LI1D;F7NB9\IR7<
MS:!W50Q'$]369A WX2&-($%FL'O9$O L-1&885%>> A-5[=T@R'4!JW'JIY8
M N (\/9D4VGB\<X/: 8O]AZ0B%A*LC??DDR,>R=3H)(JY;F6K,27R*"5JDD\
M4U(*);X.NH\ZVP3WKGL:LE#$6TV4826F#L*IH$F](XIS;BA77Q?5O1DIN-,Q
M>0Y\! ?.!2>C+-%C*=FPVGP\R<M_):G=-Z&TU,^F#2<*Q^02S8Q4#,+A$CV7
MM3=JIW%[8M3>%^-VMU]<I?80K^5W-.M!F$\USRP)SJCW@BH6RT/(3'8\U,T.
M;LF4K.:T/@I)\W>Z"3XO8F):@$IT6"!'<U(<<WF4$NY\I#4E(:1AX%8W#-Z3
M*<7(77+&6IHRR9$JP<IK$DU"D!;4Q1,HQ<,O28Y2BERKI"@'AS\PGKVD0K,2
M4V>3M[RV[MYP*W!KUM=%]0!&2O!]&"=:@3,OP/L/DZL@8E02PM:5HJ"K?LD3
MXW:(4G2&*_#VDTB&ZF -Q#2V1$^;C!L+3ZH4#T?M,*68C0\VB')E,]@VI2(W
M)7(I9B7J!NVU8D08VK1L;O04H\N9"IN")2+3'+BG\Q(P(T+=4R26:"T:M;G[
M7\4]7BF"/T]TM(+[K)U1DEJERFNY#%%2D/[$PO8D/F)0,EML2+2!)QM!TBPI
M<8PT"YGJ40R8!<,@Z/FZN.[-0_ :G(H&#+EE%">&RU :-B&RI<L)S\G$#;P\
M_KJX':(/,[CLG%C T8,'(DD@1I;H.4F,ES5KAA>.7Q>[PU2B,A3\1"I5TAD\
M?>N4*/&3%+RM'&IYO-<6A-,0W>A1M)O]1#! U()S+A4/&IP);X5<%"O[6HC%
M( C!O74-@_=D*A'7>=BDP25.WAO++<0DR ^(N902OF:BOA*BCU*)1A-#3=0A
M1\P>A^Q5*G$D68,G6*N[I<QHH0EO]& U7(ZQ%#=+#8B!W^N\#H0GXVCI9L#1
M\4ZN=AQ/*C$:58G-%V(L._C<2@A:0O(N$0.!G"^+:6P2P<58\X";5HF'8W>8
M2B0QFF3,I!"*!?B?=*5XBD0\J]_VO*8$-QK16F9_(Y;_Z%]U,07Y\7Z\ .JG
MP6CD>KU!IUV.MGG7'HZ[G>Y=&W7)KT7G?@@'K1CY]JC;6=>PLSX3&WKMT6A=
MW<#^V;P _%7>\90@!!!:D1A,4@$UL.:QYJ.]YL8P(RH<?RRV9T:Y0XX*S=*Y
M[ +/FBD"3@->]9;$BS1J5A,E\ERHMBGS_WAY _]0,4>E2SP'Q8(VR4])9DT(
M-8/_6N+\<O-LY.U@RATB;U98DXBD$%@09X-1QHKI896@P&K>*A8F*Z;H:8CW
MG^WA<-IW_Q[[ :IE=S\7[=']L,3\Q_[=_8[E?_.^ ?\P__%?N\6P/>S<//Q4
M?"Z6!X7,WU,^>E2^@:^45E4>^5.W_;'<=%ORH%+^7RKN?P#%9A7UD\J+E2>M
MHE*;>;+ZAJ5)#SL&VB2GK7?:*2+1+AD!#M.TJ4/DN#+/<-'4H=]4-? AC+@P
M<#<#2\8M%B3OZ,M1)E"B>39>R6B$U33-(A@#1W3]>F=RX=ZIN+=N9^_VK<,"
MRY9PP4_25!BM(]/S]0$TYO6M/(1Q?F'BJ9A8ZKD]%"BS*@JN2#"&XGU$%FH^
M?B&19#<I4/G&B OWIO#/__R$ED_[;*@'WXX0E3*$T3+'62X\^N0W,<Z\$1?=
MV3CC#K)X4@F<\&LT>.X2A_OC[/CYMA6W?DG[Q>(US[7#+5T(V&&3B9+)R8BM
M <PN=J\NW59<+-UIF;>OA?,1U"2U\#\!,4)R)"<V"Q&8<AM#A--;.!P7<8Z<
MVNZ35$DK969)9Q4DI4HGHDFT/(,O@=.$<L+9;K_IGU7<CXY(C^=.N_527DUY
M>4V,MD: 0#(E>00"SL21*$>>DF;3"[18=-BB)VN::)D^Z.VP?$RENZ&/'?+=
MS\7LFVH8&BDX4XKS' D$!)IY8ZQ@-H00DX6 #B>FJ9^/Q&]Y<L+2Z(K*Q\I<
M2SG/L(>)FJ=,"'N/S?>E_+OH$N52*<PQ*;P+\&LWSG/*J6*B4O=X')IG0:B#
MJFFL"DG$1 3+'JRDL\Q/:"4=<7S'>L7S(=+ITKV!9N8IYUP)=.^!7,%.*$29
MUG)=9[V@S A:K31]QH0ZZ#8!I$9D[55VG)CDE?#3D\=9LGY=$UZM__EX4J%V
M_+[L"D-%-C, W0),";Q8?,!K[@] #-\#1#8WFBPXGSTX+3ZK#*!;DR,$Y_!"
M\B %Q"KYW5__=V_\PU7W<VLT?N@5__+=-3SR]77[MMM[^/Y#][88M7XIOK3>
M#V[;_1_*OXVZ_U-\3\G=^(?O_O>G\0\K'^]U^\7KFQ+][RDC__P#PO>ZV[\"
M]GPOS-T?&Q^"KZ\#HMN_*8;=\=K/_7I_=]<K6=_NM3ZV>VTP*ZW135&,6]W^
M]6!X6PYS:0V+'N;46^-!:WQ3M'KE/HGNJ-4>M:X'O=[@R^C[%H+P%_R.&3Q_
M :SV0;!)?/!S'X>M#D X!-]_T"^^^\L<GF. *ZG?[G4_];_O%=>;O[3RC+OV
M%<KF:WS_]P085N4@_E[]DC[2N/?#[#/CP1T^^(_%@\<HL*U.T>M-WU,>-OQ]
M=-?NS'X_7/:^=*_&-]];\48L_=\___!Q,+PJAJ\[P-?VW:CX?O9#C10+$(?S
MGU#7(&#]?_D.XN<A"$;Y,YV_]R_CJ\6/P[5/F.(R 5"S?_YAZ4&++UC[T-7/
MTZ_[\:_\]=\2\CO$"0S)N-MI]Z82_'$P'@]N?U@ZJPS.7?4@5G^?O'_II6%Y
M@/&5G6!6M,-FA6*.4WZ+C[5O[W[X7U21[=IN+<7/A3H# .0:[,GW-]TKT)?-
MVH9CZ#,'5W^WG593M3FE!+W[HS4:]+I7K?\U:1<_BI9K->AZ6<)HL!@V(TWE
M;U\F]NGCH'<U><Z'FV%1M'Z&O]V,6@FLV57K9PSB6YR^VI>@ES-Z.:,G/*/\
M*YS1';3\VJ<60YJ+J%U$[6E$S;PP0[ J?].@338<A;]$JW!.I-K[U#[-J3QG
M4EVDZB)5#9/J*%W_L=WY_=-P<-^_PDS48/C]_^ITBN+Z^JRB@<=3\]UP< ?X
M/[3:_:M6\=_WW3O,Q;YJ]8OQ]H3J :?VC$AY=O[<D_MP&YEQ+A+Y3T]%O9UB
MN6]B9']BE4+;*+4TUZ^4W-OM/1G-SD5Z\','W[]<=-E%EUUTV5?791.A,XRR
M)Y.ZLY>@Q^JSYYWG8.2K!P\76KW F/0\:'61JXM<79(=3VA,WX[A;ZW> .''
M&NC>HCCO$A]<XH-+?'#>\0%]18U]Q;3^ZE0[%_FY9#LNVNQ\I/&BS2[9CK/)
M=OREK%M?^_XU/_]_?SFH;6/>Y^'O1]T^O"$,;C]V^V6O GY\=2G0Z)"&#X9K
M +QC-JKLLO31BSAK"\^"AI,W?#3$T?+76I'.TG*EK7Q]MBT;3=*O?/OW."NR
MV]E T=F>J58I=:T*@5\H?4_:D/2VW_JUN!N7#68+OX")5RTL+WM5MA_A^,1V
M_Z%55K055ZUN?SQX5=Z@C^X_CHK_OB]GFN)1']W?WDX:E^!CXV&[/X(3OM@K
M=GLW:6OZ^( ?;[4_#8NR%ZI\%ORMWQI<MVZ+X2<(6_^$C_CNY\DO;O;.[_X,
M'R[?WKZ%N'8)/'AU@<%<2CX [NV[XA[LQ^A5Y>_]SAL HA6+7OM+>XB[V(=W
M@^&D_:K\[IG!8F2+R,W?1'_X\ZO6E^[XIC5_\^A^^+G[&>PQMFVU6U]N!CV@
MTN!+OY@0;K+!$5&N8/%F 2*"7A*U"U9N MCU8%B^><L9*#^ R];QP>V[N^'@
MCR[RI/>PQ>T[1G+D&]."-_60"DT\;P'>I$MQA3!S_T'_@-*$?:3P#6!B7K7N
MVL/69^Q/;QC#?R)O"*$-(W<'XEPB^*H4BZO_NB^9A9Q-HW%W<GS^<S#\'05G
M.C<7WWE57..L4CA\)556#\:JW"QH6*55JUNN/L+G ='&,Q*W*_)SVWYH]0?C
MUL>B!0\ K=NZ[X^[O=:_M?OW**Z,,/*F!5PY4"Z[_4[O_@K718$OUP8LKG#4
MP*"LOT$Y*@! <"U:7P9#.$3W=]C[B#IB/DFX:>92V:CXHA@^E+V#1;?,NP&*
M:P7Y_RR+;VM0OK73'MV 1(S+=Q:]HE2;-=UPL6^'0HMGX;K=G2J(&4&7&##E
M4FFN)DW7R(=.;S#"(_@%3^D)U>@_,7(B-?H1]Y.V!OT5X9L@?8<39$HD"WS+
MW =HS4Q_:60'U]=XCDN3VRKFZNFJ.^I 6#4NSWVOC4(,=KL]_+T83^=_@#SW
M.O<3:W]?TO'3/:@+Y'WK[OYCKQR!.C';G^?CH\K'E2\/)TVXY3L@)GE3JK1V
M&:U,E-5PTF4_M72 #'Q[%ZWK=>-JPKS1)V(0$.W'=^_+W_&?^*IQV-^H1D$O
MS0DHJF57JRE;RTY$9I2;6Y"G*[0MOX.,=8J)0,T<QV'1P4P">JW=4=5M+2UT
M?R)X(+:3H4#XXN#N;C":].>W6Q^G03'*ZRPJQC=!/-K^-/%O051+ZX=? ;H%
MO;]Q&\QJ&SU"^-=,+TV4%,!3=#\CO/"4RB@ 4+4MS&?<X=M'72 !.#Y=U)O=
MZVYY8B9'!!S1FV[GIOQX:96K0C:SU0WS;XS=BDV[2D (T!B8^$&(P8T'75#"
M/_T\D.465<X ]0DHI3(?-&K]W@<G&SD0XM]&K3^%]#Z\-H2^:DU_8I/@9?H;
M__.R- "/YU[W))(9S77/C.A7P"5@R/37,F\R<\R&W='O$R K#LZK4I=A)JHU
M?K@#UP_8_ZFT1DMO&A:?4&<.P,VZ:X]OOK0?T*N IP,5[P9W^+=2MK!V&4 <
MW$),,W/Q<((B1,W_4[YEU1NL6\!EF4!)Z<(S(")!$U>>B$]]X$OI*KJ9QOVQ
M__K=<-!!67\/5"F[41&86''EBC_NBO[DE-2_9W*2D,)]$.?236KW(*B$0U.
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M%#$- AP4()G[ZT]F5N%&4A)%%2B K(Z>:9'$I2HK[Y7UI.E-?X:K[M@]O2&
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MRDE12ZXDDBVTO"@4Z7(I&WW!E4G,0L$\V:$*?DSX<B7;@$W7>(?%@:3)&I\
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M"'=AI>\K/_2"%$=*1;_P7QXFP=KRA4AEF>N"Q5P\)8O;%AHW;N?H#+$VQO;
MZ=M]?6W?S^$PUAGR20U>G>&4D^04HU$,?L\!+E'F^F#+NZ?NJ#:,4.WU:UJG
M;%Q[,!K:PYZV Y9-$8ACVI[6K?HKQW8=K6'WML"W*/5R4(7/R3&%8_>&1A68
M5,R3:"MQB.X]"VR2+B]=2V0 .@Q 1XWNX\2>3!R[.]#7\,4 =&A+B3R;/Y^D
M%/8F?_N]W>=3]DE^<BLXNQ8GVK"PTK-C>S0V>K:-0$A/QBXJ\(]P?W,1!7"'
M^/"OU$_65^'L.U^NHIC%:_G-;U'"KR683AH_"?]H/!IVKP<?G-''#_WK_L?!
M\/WP*L,_>O>Q_ZYV_"--RTT?M\Y!O&<K'R.3;TF<>@F01@NT#QZA\.?K"E+/
MN*^[>/80UGW&!'1B3>U>C*V1'T*6*\\#Q8/;_ HA"GNYLW#]L[#8DL-49H0.
M%7.1,(2&\E#MS4'Q210J/X3;47)0]NSR RP?GI FBPBAL&;X="P=V,$PAXPZ
MN8NT/ ?8@0E$^(6I4-V##2)>JH+ J:]BKA"XZ+N.95TEUJ_49;?GT%&@B9QX
M0D%[F-(I(7P@54C@7YX2&_G0,I'NV&XJX?=:9NAV!^BB[733#J(83.=NX</D
M-0VOJW=X2+BM)=3R:,UTA($^]T'*@>#<';E]]5@M@]O!\D%0YF=)8"!M6Z9@
M+=@MMYBU8B6\/2TO^E.WT^UN-X4YB"=6H#B(RAVM=M68T=)]GT/KFGOR**<[
M)/T]KAJNN1^@U;/>5TW=-1<P2)F+A8]?B,%XZ$F1^ 8OA+_>6;]%X>5_1;AK
M# \,*4I __]+SH_?9'W=17[' Y==6%%L77BE"S;X^N(UOAQ&RL$.6Y]"KV.]
MPKED=3%N]^W#T\"+\Y%LO#U_B//VM;24L#HX,=E=7CU'03]2="9L-4!)%VD^
M_5L@Z(TD4^5U#TP<5 YB:SYA[ \1NV1A]5@M>SP8V4Y_>T_G(+$O*]9[5UI1
M9*_YJL<(]">VM+;4AZB^+>=R'L67>JRC'E*0(TE\LV 2/U6 &[J+N>Q-[MHT
M_+)A0[)@H>4G%@9\P@HCZU;*IGPB$/6<%6V]L>(##-K 2;22Z'3Y&XPM?.^>
M92B,'2+]7L5+'X;AX9+XMZA6OP3,(_2(>N8X.6R*D]/T-T:[_ U"KR#,9E#7
MS!)2PZ-]PUP6\]#<D7H#YS4AZ&=2>[AXJVSQK#L_6916UP<#B?E$M  WU(<6
MKO:86. 7LJ _Q8@5S/@M#Z*5%:6QM?)7'.EE84R<2/.-4- WJI%M%NK#>U/X
M"^)F992J XT+%&N8%:Q8^7=Z(/.\**7*NO*3KHH9)M6';M#KAP=*_0:3$65]
M?\=BN .AJ3&"QA=;5T"G(*/Z"*=;4 C'@4_%$<#S!+?2%5ZAQ8XY?=L=#^R1
MT]?M(90(D=<^C]YNQKP)K!W0B<>>+]"3P EK#'CZFF+@/-Z13NL%^&@W?@B<
MEJTEN+>X3H'_![_\ R2T6&18J3H6KC;/KII:"_E=L,Y=:#2+^[AU).,U+JS;
MT97<V%S80F2+E46)+_35<LEG/I B6.?3FQ'1MF^5</4(?T^P^.#(WMS$_$;%
M",UG@X>=_-]X M]&'N<SL4,56G>@52VV@DM^^$M),#VK/^B,++@J@)?HF76F
M8==@NBV92LXMH<J<CDVBHS;'XU/)!0!NN05[7!(XC(I"!,[R;\D/R'7*;IFK
M6F 6B&C;;?'2F/J.%(J9@5SN=$_@"I'"<_'-,IM<W3D@ Y[+.S*2%I;LZTWA
MWA=:SZLI?M+:%A!KJ4T_#3H#$JMGIY#E1$BAUF=7'+<SJ,FP%#Q<,2P?=SN9
M52[V6."E 9E?_'J[%\OVPS721+.VM94<R?V/W/MFX&2 !,ZP-4P2^]-4EI+N
M<H2-FM:^?[Y'>"Y3Q<^C;FU;YOO5S>X[/NT6[O_((HYM]_H!#XO"TS!*T'SY
M22#W7&^CY#E;+H:?2^DF'QV-</;P.3G#T@\T%%L4;/T8(Y>9. :EC;9JEJV
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M0'R&TUM&,QZ 9P1,PZC<3K&!K58O#\IH]:9%:([!"<B.3VNP$:U2L%$)O=5
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M8RV;I,,7[HCWQ$W2AO7S>^;M0],.\"G1I>DTUK2=S;(^&IY[-T PZ,**3 =
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MMO0/)>6*!-R]>]F'/-O6).:V,W'MKCO0RM Q7S)B+W;+_(".TI=5JS'A1YO
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MT[5HNC(2W2ICLK<'O8KYG,=QMEFK'KKQ+9U&4,5C:EL1^UA C%E*M".2I;1
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MUD6-JH@"WD<)P"05.Y&C:?0;?:/9:Y%4:-AC*Q346FK5)AZ&W(\D"WP\3)G
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M3M((P"K >01@6Y.L91F]IK[2%01@!& $8 1@>]3 &D:G;1J-'A7()Q C$*L
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M%@:>?X]OFO#PFW  E<_57Q$3')X/HPY"S.)G4R!CX,R)P>PU4?!P.5(M&6\
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ML(*.99!D,(>ECC"Z]B2S<=%K:N2<9TKKD)ZW[KXO\73J*996RHBGFDK)L1#
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M/ EM4E $VHX"H^1P,CWR>1BG)DS&,9E"H[;)5:]OP>T%0\I\G!>Y6XC]*WC
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M15-OIEI2[%ZE1<SGC(E5CU)BP;[IY>18I$9:01VSJI(JDUF>;9(UF>4H9-F
M.EGZ\)"\ JO;PF(14C\G58FO89VNX(68[_D?(.@5W!5,1+A-TH)UW;SLF-WK
M*[,U' Q:YM#L#_K-0;_5Z/?[@V'_Z$KLIK1+F#RC7EK?/",@%=HM _]3#6LT
M2DRYM</>A29%B,WJA,MB5?*TV 3VG57)6@4&2%HDJ*3I@@:RU/)VWILY[2!C
M9VR2XGM>935)M4B!3*HZ:/,6(HXK56'U.YXEA<^F@KU2$!K$$G8>^7KW-)>Z
M,-E*#-JC2%&/))@)#^^PM2@.DL=1D'V1&-OJFR25H=^Z:'1;^;^>OCR9OIX\
MF7HGJC1K/?I:39["^2OAMSHRO]Y\N-UGXJIKGT9SHW)??PU4[NN[Q=S7'1P[
M)(,D@\>9V[#Y6="A15KGN2[Q(?'A"_APX[0/"N)XG&L_A?.>-(XK(BQHH7KX
M;5"+B(YY:W;,6XN(@TJ< =<CE,4TNGVS='+5@FMV\N01@!& $8 =$, LPVH2
M@!TN4/DH5=GD9,L)XSLJ!E&"H?I<#9*2G98E! 0;'4M;.'!59*%L?8@DXH@E
MPC(:EC8GW[%(!#F1'J?M%Q5<,@K"I$4-AH&0X54A!'K.>5Q>^99]0U?6"LBT
M])G^NQ*O*M))OI$ZB.C1B*!E-4OGK&,1+;+:W]X$V%]*L]9 R+/-GK8F:Y6*
M-VQ#I3ID$[:-EJG/U_H<9:K""^0'.4*@J85#OU(H5(_CH);1ZNG3'9\MS% '
M+M*H8#Z>%KVW@5$^V>X3&&#[3$RE4IE::3[J4OX6O!N&$BYUSY28^Z/RN3;*
M_7J5]D),4XVG3P:(J<:%TY6#M]?9 +_Z+B:!?8E4JMHT="<\A)EB5Z0@OANS
MAW'@"<Q-PZRQ"%X31T$HTQ:2<BJP15BDLJ-5^B(\*AWV[(*Q_SQR<](N2W5@
M6IL<5R#.W%_4?9MDL:5DR+/95&/4D#M9LT84(GG!WOL,839M\U;L5<I#_['<
MNXW7(.F7[,V2]M,1=[WL4A=?OJ[-TO6F_::,1^>?W.KQ\$[(*$_^RPB:MG#C
M4QCF=Q<;4L( 5^1GIR.X]M^U/.?E[=Z3X31U#0>91\NC+&T4 O:;)KV L<ON
MHC3\ S,_T1Q?*PES7MXTC73;5G>;9GL7,\2_V&/AQ)[X.!J E#NN%^/4O@@[
M!A* L+S[GI152!XZF<9)VOW'T3N04]"2Y"<1J@(?V^22-X:7C2O3&C:OVMUN
MP[R^MAK765F.?KM]N9]<\C)[3^>9OH4N.+"39&3%8F]:&%)A4XYBCY:.V^79
M&L5O7;3Y3D,:\WOL%"E\)E+.3.0J:9P]YT\4,<7,\/M#UFLBZ7!27!$#.P?"
MK;A#8GV0_.FXYYUGXO!F0\-NE[SKVB4RIYF@C8:^O.2NEKSD;N.4<FOK/?K:
M.^XI*[&"KK3Y<-NGEQF\@T>CRI)7.=XB^FB2O:-O?DDI^K095DD@J>LE9>$3
MJQUMHGV5-@(-H=!8,9@%RB]*^4<55E\K=.J-+0F:C;8N:E1%%/ ^BKTAJ=CM
M#,[H-_I&LT<=B73LL14*T2^3MO_A(;;AEDP5UY], JQT#ONQ+AZJ$!GK!45'
MVA_::%@MH]LHO_]X502L["V=!*P*A*N,@)D]H]_K&)UV^:WDCD7"R 1_F[?O
M88DUCD&(9(N3U;'WYH!5D0BRQ$DF7D@.K2GUQR(79(L_3MNOOB/"!_A5A/(?
M+(8MF$WCT!YS*5+W>"5UWU."I>,T&EH-K?U]C]U@(.DBZ2+IJG!;6OT9+NOS
M9Y8OO^32M0>^,TS2$!;[WFZ0)-/L=(;-=K,W[ VMWO7 O+JZ3)-D+GN==L,\
MIB29)%=!BDA508O&Z](Y;I&>*B4E2^S +"LOD!+[@B;)'4D/U_S@(DNO'(DP
MQ 00]=WH\4R_%;;<96HGEI)CL(6$5\D F\9,-2I-.R9RA"YWFK2$S7.@RLRJ
MV1M6;9CB_"2PUC0%J-^_L-K]PC]]"4&FGHR@5JO6*3GU;C5(DZ?)UV#R-3GP
MJ9?M1O0YZ2Z5Q$;$1I32N+F?A?*GZBQYE-!(W$7<1>FR56<YH@^))*7'$F,=
MEK%.INMTY=B0"/=2^7UID_E]$OG0HGY%^6/$I%5GTD^+H0'$I\2GE>13 E-B
MTLHSZ8Y@6A-W3DE1DNM)^9N(<K[%$+?\TU2$^0<5]&;DGU=BY,B*WS\F[$>T
M*T<?XA_B'^(?XA_BGVK2A_CGB)W-^]5.XXD(>0037DU%(&/T@,;H88W-RA&N
M,L0BCB..(XXCCB..JP[AB./VIB<?C3JL[AMX7F#/LY*!+;+>J86,9#);JVO6
M5X6/M#4X+V_.^LM?O&H;[6;7Z/:ZNF>?LWN->. U 04!!0'%.J PC;[9,:R.
M24!!0$% 04#Q&% TC5[/,GHMTB@(* @H""BH#B_5X=5#6_5QY?1S*/Q@XOKJ
M_),<M>2HK2SA*D,LXCCB..(XXCCBN.H0CCAN%\+1\>?;_RA]6#B,PVSYG4@*
M+].)9PFB^5PW]1>[(/9M@K=,P^JU#+.CK>-C5:3BI18XB<4)BX5E]-I=PVPU
M22I(*D@JTON:IM'$$^!6A\2"Q(+$@HXQZ!AC)]JN/\:XW*"=#CEB#NW!6B@O
MTIQ^9TX08T^7EU0$?'0UTK>I/C(KE4PJP,AZSZZ?I>VS7/L4C4L@90FQ,XT+
M4YO1\7)Z;A5P4PMFU1:-0PA*"$H(6DD$[6@+/"0$)00E!*T!4Q*"ZM5!K>K0
MDQ"4$)00E!"T1@A:@D=X=ZK6@OL.XF@^/$JF;:,M[!%=;<0D6M6I=%^E:$5\
M17Q%?$5\51=:$5\17Y49I_YCQ$%Q7WM]X>_"K#S7%^?I5$RK\?>WE=/$GQVL
MZ\-R1&]:/=T+\23YT[]_^C&6YW><3]]\L<?"B3WQ<?2.AS[PEOPDPB\86*&"
M+P:^,TQ"+VYPB6Y@Y)=>8'_[Y:]_^6G-(R93+Y@)\46$]ZXMLL<(YRJ83(4O
M546RO#;9Q]%G80=W/DS @;>Z 5PG(SE_"<B2C[3Z+$8_GUT/L>/C[^9_;X9G
MS'7@"VY'Y\UWS=Z5U6PTVL-6IWG=&38[9F\X;+V[&O3:[<:[LU^6%J-(QAMW
M(B3[33RPS\&$/^ZAV9#Q_HAEY(YFY2[OS5@P/@&C-L+*;JJ)R?DMDAB(E=.8
MB>_XMV#AG,!L%(0L@KLCU<-\$J@>Y@)[F*]62-YE9*I';@X#3=-@:WMT[O)L
M%0.DY4EKNSON-*0'+AG\&P7 SP_RS88 ^!0O+0'^4ZQ3>,S"/H*P7N0__%Q\
MCQ^$$^XM;#4F7C-_L$)B9@O/2Z_Y^:QQIC[#)F-GG[<7I@?7B<9O>MV+1K.;
M_VO]/7/&P+;I\:D4;[(_5B ]'V+1G3'?;OMK=\+-'2+) +NP#,^J(FN5H^1^
M\["W6[4>?:TF7Q/_VN.*T0MZ:QVM)5$=Z^'DVS#?*#7EUT1->:?4%*5A,% L
M=C Q2$9)1O=MX9<AHZNTW/PTZ] BO=8<(#XD/MP_'VZ<W$WY.H]S[6<AA=J2
M58:.N!=>,)W ZNF2\0J1L7+"KQT<'R5V5;A-7SC."Z)M*A-0T^X:S:ZVK./*
M+_Y./GB"&H(:@IH74\,TC59?7P))U1?_I5!3>Z?#RTGX3^&+D'M*+^3.Q/6Q
M_1"/W'MMV=H$RT=</J+5ZQO]-E4:(ID@F<C/K4'A[VE+0CH6F2#WS..T_<(]
M(=4>/.'A-Q'!*,E<JA &/>>6U4KDPV[H?:/9:6ECOEWI5A7!)&<&26>%I--J
M&OU6FZ23[']M0:I!!-;_8\&I9._LQS5;2DIW55AL?\G9=7+5MOL=H]/?7[FT
MJG #N58(:@AJ]JLUMBRC9Y5DU!TQU&R=]O9DSI;>A*OU65W7W W_S;U8#*04
MD1SXS@>7W[J>&[E"_BJXC$/A?/3AT7$8 KMBXIA<3!?;()/KNG]E#H?]RWZ_
M,QP.KMO7G<9U[]WE8'!UV1WVA\VCS.1*DH> 9BS)NYF&0L++I*&RM02WQYCE
MA5E;(U@$=H^KP,:N"#'L:L8\C+F2+!1_QBZL 0.C2H1L\.6*]:R&H>Y#1N#^
M;%Y_I?L6LY9P'95GT,M7$B[G$0,&8I-T31E\+KPW\!G'A+)DE=DM+O-J=\G-
M2;%ME/)3BW=P"=>1G%K3I*Y^ZZ*U\!]]25UF4TM65[M-B4UUO9TF?_"4MOD3
M.GLJ:4#I,D=D..;#-0][*%]^8L&F*?#U]AS7F,../FL2;;6<ALIJRS^FMAJF
M:,C\VZ]RB\  8M&CJ JT5Y[\/0XBX>1DFX:N+0H,Z-*)$#&:#D;[ J]Q1S!5
M(-2<=D$$#R &(P;3S&"T81*;E<1FW%:I$G.R)>&;A1US%!"B$:OI8+7@5HKP
M7AU#$4,10[V<H6)_>Y:B/9+X;%L^<_$D#&>:4RXYUB0<(_[2P5_^-"9F(F8Z
M #/1=G@4]; JQ8&O/F"H4$Y64UO'-6(\8KPM&,\BQB/&.P3C-3=F/,HI7\NF
MZ\D\T&IT58B*-1;V/1)Q?^RW3+BG_R)^)'XD?B1^/#01:\Z/-7%%E$G2]_Z]
MD)&*F6.NCWV3Q"PMJ,-&P$/R!S)HM,EPN>'!QY!#6MZ<2R@<VC3ZG;;1L;35
M*:[*<N)]E&].4$!0L!4+]"S3TL8#55E/P@+" L("P@(=6$"NYRU<SX4J%.1?
M(?]*90E7&6(1QQ''$<<1Q^DF''F)WU[!=S R 7?:@2]=1X14ZY2,0#("R0@D
MAQ!A 6$!80%A 6$!8<%SD^X;C89E6+V-&W2?"A*0:_AQVOZ'AR&'V[)JMC/R
ME=00=RO?&8;: I>LM56> \I6YPAO"&\(;PAO"&\(;PAO#AR]W#6Z[09!39GV
MZ7&9H5]]-V+3.+3'7 H63/$ 4+]-2M!,+K^C<OF1^Y^P@+" L("P@+" L("P
M(+NOV3?Z^GH95V4I-=I9C_</+5'B"F2B1H?4Z%#K[=3KK[:CK]7DJ=%A);2K
M(],^\^$>?:/#H;#%Y%:$+&UQN'&T5DV\Q#7F+6IQ2"T.JYT[MY\4.6IQ2(QV
M?(Q&+0Z)P:C%(;%9W=F,6AP2J^V)U:C%(3&45H:B%H?$9]3BD/BK]OQ%+0Z)
MF0[#3+0=4L,OW1Q(+0Z)\2K!>-3BD!CO((Q'+0Y+J3--+0ZK)^S4PHOXD?B1
M^)'X\>!$K#D_UL0502T.CT2&RPT,IARUI^:L/T>M:S2MEM%O6KHF7Y75Q/LH
M6Y60@)!@*Q:@S'7" L("P@+" O(\4X?#FH%P7=PKE2-<98A%'$<<1QQ''$<=
M#JG#8?UDDXQ ,@)/P@@D+" L("P@+" L("PX.2SH&XUVPVAW6H0$Y!K>E+8K
M'0Y_T!:34R$*'C_R5KX-#/4 *EEOJSP'E*W0$=X0WA#>$-X0WA#>$-X<%F\L
MHT\M#LLU4(_+#GVZQ:$^HY2PF;Q^1^7UHQ, P@+" L("P@+" L("PH(\@=0R
M.X0"CQI:C_<XW+0I89$;6K#T.B?ZP[.I\XR'@H5BY D[$@Y>8W,Y9MQWDC_$
MG[%[SSWU #"EHK%@W+:#"2S<#$:-L9: .E(X*NH2*UIQ?,XM][AO"R;'0D3R
MXDG"'HPX/ZR<6JIYQT_:D*L$ WJ$,?PIOD^1$E(]1/6\8'8<AJ+P E>\A(KL
M:?Y,__[IQUB>WW$^??/%'@LG]L3'$?8D4IV(DEI1 ]\II.ZD/8F<C_YG@0.&
M 5URZ<H;Y.P;$,-++["__?+7O_RTYL$N$$M\<.^%\]Z/N'_GPCWI2VQ@'7CL
M0'[B8?1Q=!E+6%TIKX+)K>NKV-SYPW':*/"?Q>CGL^NAU3#[OYO_O1F>,=>!
M+[@=G;]K6<U.HV,.KLR6V;OL7%F7O=Z[[M5URS*O>IWNV2]+O%1D@V?:9Z[#
MGT=9,:O@UIQ^+W;1_".6D3N:+?0';?4TL^P-,,X(B.>Q$:PHN\<E9<$(N#"C
M/4M*,#,8)4BQ9(XK;2^0":=.0S<(V10>'S@)F\(5W,&A([<!,N3MJ=++TI]3
M!%$5GT<N7.S$R">*DZ.Q&SKLSQA6&5@>1H,-U^!UMA<[0'6\9!1XH*+ #6^>
MYN%MZ-]8I#\U=-VNH:NEI:%KLU_KMIZM6H^^2:/?V]+7Q+>^; UF *I[(ZJ&
M97C$M*I8K7:B%='JY&A%>+6]/Z3*F^.>RC[6EL$J1Y^*@Q71A^A3:_I4#'^J
M11_:U(Z"J2I''^H8\GC'D$'$?@,4F-R*D)E= Q^[[IS.:IA=]FH:"L^=N#X/
M9]MTM"'Z/T[_7PO^_T^)_W^0^_^)R&4P.4NXN7 2HZT_TP&(NSD:ET_HKU*,
M8H]]<$?E]L&E#([ZI[[46$V@0FA$."(<85S--@>RK]]F(5)L&@9.;$=I9!X&
MUJC!2G;.?A41'X'65N-"AI7;6RE$^9A"E,V&T>JT#3!H=,V^*LOYF/^#6/U4
M6=UH6Q9Q.G'Z\7.Z:?1[76+UFNEW*TX]#9S09C,@U<;>Y[J[\,KDO4^#]TQR
M+\U1R:T-?A<*Y?4GJW>/?A9KGWZ6+8Y RJCCTFRV=(+YT==R.5$^,?O$)<0E
MSZ))N]TD/M&H,U9HNRY7F;3VH$L>E\JXD8_:]3QW"A?5UX:IKY98._AN&5U3
MJS)8%5'9YVY>NU5OMLAQ>6IKWC8:[0ZM>AWVOW+5KA:Y\/:ICWWUA!RY_+BM
M@VJ$$IR@^=UN:SUL/P7C^P2YY-6^V&054&ITMKM3XLKI,!'UFSAJ7U^UG"[D
M["L2;<._;H*(>T=A]E1#GWQ:=!?RN9K3[\P)8BQ ]Y*$KO2AJK;=2H9856BI
MKRW*IB3<,\5*B*#J&8U.3ZL*]ASM:L%*I>^O)*0DI!L+J=&V2$9)1DE&*RRC
M?:/=UWJ,04):36N@LO;H9ET&'JFD71QA&870EPIQ[Z\0^M,ET(UY#73X%8N0
M8TU]_)OC"8IT55E_7370I< 2_LM%T VJ@DY5T)]$ODI4XJ8JZ"<[>JJ"7BT/
M']&J3@4\B59$JZ.G%>'5]O9:E3?'>AUY$7VJ#E9$'Z)/K>E3,?RI%GUH4SL*
MIJH<?:A ]),%HJ_%;1CS<,;,CK&IKWBO8U0]/JD$.Y5@KR61ZR-A5!:>RL(?
MFTY9(\+56&^B(MU$."(<85S--@=R..0IWI_2%.]?YRG>G[,4[__EX2W8791Z
M4V&7356H<9(%A#N&99E4>X0X_>@Y_95>/E]%]1HQ@#8?"4E!S:0 \+[1(+RO
MF>971KWX!A6;VJ<E,K#=Z;_$=S*,]^B*.9T*,);1MK3"^BG4?SE%/NE117#B
MDN?1I-<@/M&I/59HNSX"M?+TM,<K,>(V\$U]K9GZ:HFU@V^P\?ODTSVU53>-
MIEX3@%:]!JO>-3HFR7HM=L!R%:\NN?.T*V1#<2^\8 I_W0A[[,.4[V:@C%U[
MXKMKC_GD5FA3R$Z$M.3/VW0S-YM:8?T4+/ 3Y)-V2V_%->*28^02T^ATM38)
M/P4^J>%V3?Z\*O#>7'U\_^FSTG?POT/0&S^X\ /6<F.C()S$'L?:>MODJIT0
M$<FEMW@BTR?7SJFM^2O-BWXR$8O'RQ(E-/JIR@*3OV\[>KWW'3%R?3<ZF>S<
M(^[H<WI4UD6X4CH4/+8:M:@WO[_6!<]R;?U[&G2,5EMO)-3.1*T%\Y7N=R%Y
M)WDOTU'::^ZYSU"M>8_$G<2]SN+>TQTI1_)^+'90M>)5=VYR]-./L3R_XWSZ
MYHL]%D[LB8^C:^4V^.#>"^?]O!W00'4#RLXN!O(3#Z./H\M8NKZ0\BJ88!T-
M/+"X ?ZZ] +[VR]__<M/JP__+.S@SH?Y.N_G+8"6GNT['UQ^ZWINY H)O\43
MX=S@I.:/AK7QD8\_B]'/9]=#JV'V?S?_>S,\8ZX#7W [.A^TKR[?736&_4%[
MT+Z\;/>&9JOWKM=L7/4:W:XU./ME:4&+BU-"?R<LK+XL>N7W=LI:);&DMQ"0
M<L)#N"[II%2H.UEH S7O])0T@$H:/>%Y%79Y\O*5P=]Q:1B/'FT,=9OVCG)<
M:7N!A(M=/VT')>'U;A"R*%!W1V,W7.G\M-)8:@0W[-19:NWC]3606K>Z&S#-
M FR=</\H4TO_J%:]>QC5N_M5I]:C;^_U]10$49'24D=&'VI10/0A^E!%Q4J!
M$M&'A([H0_0AT*X+T:I'GTJ$]I0@DJ?9,^0W8'?,C61FM[(]0[K4E8>Z\M23
MR$L2QA)NWJ4#3MTC0A]I<FLU-!^UG%1?@TH1L:Y=-8B(1$0B8BUMM3)MD>OY
M(;PZ2%\\?W]#]ALY38@^1)^JTZ?N9D.9:'7%Y5A%-=GXAP!D![C?TOBM"QVK
MQ95E[(J5KW.B+QK\!<'>U8GG-HU&IU<Z2:JR^'A?U5*F*T\TDIB2"PI4G@-(
M;$AL:*/9I\20Y^?MP+9A@2/)0F$+L EN/6$P7T3U]?E43OL_WK(_EM'K6D:[
MU=;%+561"@U;\?&N.A5[.LUU)VDGO^,.Y<#NA1\%X8S\C!72-(ZGA'2KWS:Z
MW2Z9/,0EY$XB3B$\J8/N<UPJSJ=03+GK,/%]*GR)]2E\AP41W,#L. PQYCB)
MJ"&?"OE4GG?A-EN&U3/)QCJA-2>/RFFN.\DZ^5.VI.U'I5?DAS44OU4E;>-X
M[""RF,EBWO18H-MI&6U3V[$ \0GQ"?$)^5;POJQ6JZHPF1>%94GEUAIG)E57
MQZ',$J(/>>3(.T.6^DLC*]/RU=,P<&([8A,>?A,1#):IP4IVSGX5$1\%GNN3
M%5\AA#H>G=ML&*U.FSILDW'V;(.AMF41GQ"?/)]@TN]UB5'(BM\J0F+PGDGN
MI:$1N1[$[T*ABK*1'4]VV 8.Q&:S1=WF3VW5S3ZM^:FMN='6V]WV6%:=_"TO
M]+>XGN=.X2+RMU1($SD>\ZAE=$VM*LK16T>GR2?-%CE;B$N>HUK;:+0[Q"?D
M:]&M!GWUA!RYG+PNY'5Y'H3:6L^/JB(F9'\_09Q7FA=]5=BWI< !.66G'BQ'
MQQ(4!$-.F1UH>Q-$W%LN*$_.EPHI),\U*M)*Y/1EJH7\RIL.?,Q@M'NFT>EJ
MR\;;F;";$ZG&H$DLNH-ST>I;6A,HB$.)0[6":-OH=5N&V>L0BU96\SR\<I2V
M?C)[TT.W?B):'5,.#-&*:'7<M")7PZ8][#R7W[J>&[D8="IE/-'8QZY"!*VN
MWZ%F[2B)<$2X4R)<34R'O;2^F/*9JB]P/%9#=83RZ ["S+YE=!O:'!Q5$89]
M>LMJM^9T^'F:ZTZR3E;H]DI%&(LGBT$73%.R2"NDBAQ/X'#+Z+4;1LNR2N>O
MJHC=/K>QX^&3)I7D(S[9@&H]HV.VC'Z3VF*0>V5C$@[%2(28B!#Q[W.=1UL;
M,%)L]$6GU ^/FGVCVVUJ0Z-GZ%,5B=KKYG5L/-/M&;V6ODPZ8IGC9YF^B8H/
MP0RYAS3G0ZP)3B!/4)44IJ.QW-I&KV<9_8:^K(9CM]Q.DT^:H!PUC6:;/$'$
M)T^J1$;7ZAA66U^ _['S"7F"4J7'+;;R\ 4U126'D+Z#^K;1Z?>,;I<,?#+P
MMS@G;?4-D#'B&>*9S:&F8YBMKM%O$MN07ZBDY!4[\"6H2R&/W,!G4<A]F9RE
MD9>H1EK4\5A]5M_H]TVCT=874+0K[:HBL%7:0X^'T5Z9AF4VM):\?"GMJ&;9
MZ;&A!:9DC_#NX,K?<>EX_PP"Y\'U//)X:=/5MI"Y)LB<$\3H?'R)[5F+NC)_
MVSL)]TRQ$LSZI+J6U2L)\M?0KA:LI$'/)2$E(=5F'G3:);ILGZ#=5F9 +?AO
M&QN!1)A$6-,^:QF=9M,P->:FT3Z[:%_]&.$1^]KK'_F[,,?B>&_<B9#L-_'
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MO5_KT7=J/?KV7E]/_L2C*'=;.?I4O!0IT8?H4U_Z$&@3:)/0$7V(/C6B3TU
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MH]G0UCST-*#GJ+G"['=U<D15%I?<-,\@0:/;IG"OO2@A%7)#[+593 3CQ'S
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M#EC3NK!:!#0$-$>TCVO3)?5+6W\?TD;,5MMFZ(<EG(9SE4;=S;U_AAQ,=BI
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MM;EY(6@6V@0PFX";6JKD!VS=D[84"F4@T0F@$T GL,VB-0\&7'F8*U#&$OV
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MSULN4%2/1-.=E;9//WSIB';"$_'_Z7]02P,$%     @ #(*I3LG;!* 5%@
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MGSN3<:C"GW'=C*=':G=+I480SXCH]PH+C]/<VW$_N,P_M)(5G0J%OO )H3]
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M-O=VX2Q_'WVLO]@'3*#>VZB.3HXQD^?LZ,R0HW-CC#H] VST*:5$8''Z)_*
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MF7?)OU[&Y]YUZNYZ27J#JMS5T.OWQK;>UKGS:65!#V8) SXNYGQOFB%C)>R
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M^37.\@C?-9,O-2BEQ]]_F^;SQ/-Z#!HU#.C(S^HOVP(>VU=2!6V(BI0C+$.
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MC-G_AK@1'+U%+X:Q5A[G>ES>U3P! F-N%::6,P< -=17YQ]3$ \PHUA$1D=
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M1H'X]";3#^_R61F.'1@0OG^S;G+@=&H\9B*\5A(%$19*:1E "8KP!B,:ULH
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M7E'FD>+4Z=6,(2.0PN:Z4&>O ,XI*DUQ.[.D^'Q9+&Z;B<ICWX0%I:]\H.T
M%E@"314%JSDC":1TS=\^=_:&X)RRTABX\PG+2=*12 XLE5QQPD69P=H#B5:S
MPLI:U")RM+.'!F<2AQ.1ZHO_+\)H&]E0M<=(J')6,DW*ZP')P\%*D \8^-(X
M-8P/,&M:EP945[B=27;F46RGYH,F2"@/A>!4(*6-0=KH<H=%W',M"1J@Y=2!
M!!R6L>[@/)/0U;>8#G=,D 74!4"])9)YR[DW=+4]$T:=@'U6>!ZJ\+2#[)P"
M4L=*.M@O 09#+8/VQC 65EJ $%O-E7*O&&A^4]_70^F>Q*,I8N>4CEJ6T>&.
M"3+4 174.Z<<<RQLF-ZN9LND"GK? ,VB\\A'8\C.)"#U)2*!Y66(M@KA,#14
M4A&D5O/A1G'08HOHZ\UU]R)P(D9]\;R**%VFTY;722>.E 3##YH22Z405YI:
M <,F28 "WCM%FZNLG1TK71I$W:)W7FG:I7>''?%4\ZC]X(DFQI' #N"1,Q"'
M[5>5-\08 @>8U@-,AM^97-22OP[!/:M(UC>=ZG1/J'5>0681(I@Z [S"<+6U
M!Q-2&]1<K#HSH,XJ5NW@.[_@U#&I:O1.5, .(64@Y,HZZ%#0_5;SED(@V*+V
M3V<GX/G%IBEZYY>:6J96G>X)M(IA+3C! A&H/+5^K4D&!;6L2C(\@^O\<M,8
MOK,*SJF2DF!N@L*I#$4!,XRQA&J]*(*%R;T$C46C,T/LK*)Q(E[-0SB'EQ$5
M0&>049@*!C&C0?*]7P=+ B.E'& !CR[,K]Z!3,^7&V?U?&)?"IP-3>T^'48*
M.)9?G>?3R;BL;:#3:3H;91]OLVQQUF]?I666]MML%=_;,R$?%^&_*YZ\OS;I
M_-9/\Z]]@_&4AO?W6;'.B[2'B.Z/NRTY;VOD/_J^<<*DYX0Y1 $76!,5+ <<
M-EV/#" &F%H'7<<S.Y;=Z'G#1#E.*?7E+H(P9T(*PS<S"NJL:9&X\N0-^6 R
MHS;,R",BD/:8JJC6XYRK(A\O1XOWQ2:/[H$'>[N:)@Z@8/(JKSAEQ&J+J(+5
M]!TW?;Z(/>G!7E,NYE'QZ/+9U8:\ISF2#SZSVML^\510K+#F+)BIMGRBHMUF
M3A@CSH;[_JX=B[[G=31P7@?CS\/P ^_I!L#O2,;7QS2HO9OTIAMB#C^>V]LA
M$64 (U9>.&P94X@26.UM6-,VN89C&TV1D,\[@*4=(WT>S*X-%378^'WS!'&H
M<%!9@N'FI8>04<LJ:BVMERFS'V]]5TQL#4I?3K&M:F&FZ3P8+A\7^>BO(UD<
M]_9)"!22![N<80*X#9)I]7:.#/?Z+*A/!2LV,+UY1)^0>33'W/>-$T,H1L8P
MX\,NPKCW$OMJ5@Y:-$Q=*R*W7GI 8T'T6@1@4#K7H/A^KBN0N[M\MJ)S[\F^
MMVVB, 46<F:HLD0S"J3%$A!@'18X'(W#T<UB,.:[VXUV</3VYBJ,E15%Z8ZL
MP^5=S1.+&0= *8L<(LH1K P*,X-EC@_L>'-'67?1%O$8'0&1OGA]_L(>P$M&
MH''.4P.AQ\QA4_DE-6*]&MWU)"6B<[5[P'J+2UY?5\QNW+?[\EYC7N=AWKX^
M"6,,$BN=,D9(1A%A4E9SQ-X.\+5+1*&(!4M_*D'<JG_:"DF-!8X1*A#4-MC)
MFUE2QF2O62=K!JJWYUC]HG^GP=/?0;(K+?(&CX-'QH%^"?/00080H 12K#ER
MHG*?$,MT<^N@NU=OT44A)D)]2</?LUF 81I(5N.[@'X)P6+R)3LN#T=Z)F$_
M=08IP<O4H9+[L BVIY_#3C:6B.X>ND67B+@8]>8GS*;34I69C?](B[^R)X@<
M<A3N[918"H3SR"MKH0-2<X](M0\"P9IGA>GN25MT28@&3U]"H.[R8C'YKTW,
MUIO9(IW=E%702P5W9\WZ>AT3ZQSDVE%B%/#E S##*@ I9RV$H;O';=&%(2I$
M?0F$3R?%?Z33\HXCG2^+E0I=FD!_SO+/\Z#VE-[T-[/[99D%8)3/1I/I9#7!
M\*]E403X=#J?S-].TL_A-XN'OP?HR]"_-[/2<LK&;V8N+6:AV2'9ZHV&!#&%
M $-($NX-)@XIN%V4"N'F;I'NRJ!&%].AHGTV2_D4"SGQUAKDR[2IB%K-16G\
M;U<QY<W?HW17!C6Z!+5%I7=.!]G,[[)22NOP^K%U0H#71@L/K?6"8\\0J:X1
M*6ZCXW2F[7;A!VD,2%^,?I?/\N?$;B2SAA/L:-_$&$^ =#P8>=Q1;H"#MIJS
MY:9Y6M_.%-V(0A ;GL:!+=MC2XW_<SE?1>_GU_](R[I/J\"/-[,O92'>XL/D
MYG8Q?WR^\C3"OZP--9^,-X'=^V)BXG\ID81H;YV'@#(5_E\("K<823[ S- 1
M^9X/"=M>\X2L@3MTYCRV2K #@"*'K<566>$]=I77@ &'FS]+Z\S7%E]&VN/2
M%W_?E,GU@Z@^F_=30-YEATZ=.MT3C)6GP'CF/5'(,*AHI3^S ,0 M8_N)*(#
MP,ZNG3312A+J"-/4(RRI]981R:#<+@=&FA\EG7E:^M!&3H2EL182I.Q1&];9
M=5YDG])O.VW(@^T3X1A1&G$+PC>0)M8&.WE#+V>T>>6ISCP1$=@8$Y+^-OJ2
MUD#A1M)T-@NP'][;=_9(@/#8<DT=1LR6>8(=U]7\"%;-(RTZ<QU$7+EQ0.EM
MRWXJHX>VZ:?M$N@I1S+\EQG@5U5@W78/DH@TCZX3%\#@-E#TQ=;*,WF5%1]O
MTR(K/9FC\EYW,ETNLD/A$D=Z)LYI+FTX>A""U#J,*:CV+NYX"U5-7@#KXX+3
M_>O_/8_.;\L*TO,WZPC1VWP:\)^[?RXGBX?G!%[0"W"M+./ &L6H-M13B2"1
M0B%IO$! 7> +<%*6Y4&.E>41- JF@V)F,R,6S,,^(YA/?0%>FQF'7X"?AD"?
M+\";"\%ZF9G\[CZ?K=)RU'R^M*M?0HS1Y1T[L-AI*Q2W3%< *<>:IW[J]XUX
M;3[O$Y<(X/1V,#\G]>A#EIWM$PRL((I:116P2DGML:OFY@5Q%_*8J1W?7I[-
M$9%Z7=)P'BFH^[)I $)P'N:W>^#$I*84$^\==%A [@06FSEQ2<T D]>VY,W1
M-TZG(7));YP(@% 3;WR Q"DLPLJPU<S*=*G#NS")R^L(H/06=C@>KT!.IU?I
M9/QF9M+[R2*='N7[P7X)"*J14)(C**@T4B-OMG,M R^'=S\25P!BHM/8(_YX
M+3M]>#.?+TO=M<X>7K]S0J4BP'$.B>6$&0V5JC1AKH(R/+P C#A\[@RB_AZE
M+,*\LW'E(#JZWG=W2(R%P%K(49@+D8JB,J)Z8SE+VJ*P=F=W7G$7>A18>KPP
M*;)TGMEL_><NA]J'?#KU>?$U+0XY74\<*?%&""A*LKQC"F" J:SPT, /*/-0
M!UZB;L'J[9%*Z3^>OU\NYHMT5KZ\/>0%>MDVP5XZ)+G1G")1%E,%=KL@&&P1
MKMF9 '3&M9=.H998]<;_O;[WG6[ EXV#TH.H%HH8;3"UPDI$'E</9\T+YG1F
M$_0F 6W!ZE4$2DTG&]ME^=[@*BLF^7@MP>^RKZM?'?8.UQD@T= X3ZCS'#KB
M;9D=S%>SAQXUC[?KS'KH551B WAF\5D%G;:0GN?]$T(EY&4.$6@%1D9:A"MH
MI0V+:'@FR9F%IQ5^C8W3@Y*\^N7[^U6.;S4;5U'([EOH.9GO# =H/VA".'+>
M*LFLPDIB20SBU<P#R .L/M&UY/0.:FQQ6LEV9&FJ-682X%26<EF:^80'HY\B
M5,U;&-(\54=G483G%*8N,.W/@UJ]EYA_RO<X_JK@F[*HP5T99;=Z(/%TPA^R
M=8&.;)/19(U+^<[S9BT"!WVQO5"0" :D9]8$C2(L:X^DUV1[-##=//=09V&2
M?1VMP^3 (.R"#]E\44Q&B\UEB"IQ?I<MWE\'S*^S25FBL;')4&?L!&-G&$;4
M&J8!!$Q 6EVS2:AD\XO'SF(_!V%-=(#M$ R-;L2Q]M )0!;X )CB &)I?4"/
M;1!3)9K#"T<=@GG2 ;3##EBWDM/RTD@YKI0-&C1EU16A$J1%358(+EU.V@#5
M=02SS;+B>I)-Q]\708Q?*&O'Q]Z5.G.9\,J6]U+3\Q7(LMGGP*6P:)=U8Z3W
M]$@XETH *QF&7KK 4DZ5!-!#:: @NE8L21]S/!8MO:-U0HB1S,&P"A@P%C)I
M+5K/39>Y;_N,AST8,MV:-WEL+"XC>/KC*)NEX1"K&S3]M'W"I1!<4N9HV,VL
M=D"P"EP (.WSSO2D8.E6S-T7,=T"F=ZTS@V)?\[F]]EH$G;F\='XV+U]$F6<
M@!I[)P)R"!H8SL9JCL)H=2$1T\WX]E(*(J/T.B5BV%'39Q:$\PI 4'FS43K?
M7[CK<(<$ >>X0QARR UEFECOMGB!%N^3NPN?:<^I/;QO!4U?C']^!AXY_K]O
MG&@A2;E$@ + 0$NHH5N0)$3-PV4ZKO44\^QO#<MYF/TNO<N.[O+[NB06^+ X
M$%=A/D0ZK+$U6W&V;. /I=JP["#W6R/T&F5AD ?^$$0@TIWR#O_*X9CYO1T2
M 0$1 &(+'4',."<8J0QEXH=8N*$]^'D'R)QG&:\=T9/15?JP]B'47,LO^B5A
M1IQ(XS0.2@_C!FJ.J[EJX7K5X)M(06S'3SM\!B$+G[+B;J[3Z33/9]6/<IV5
M%[]-Q>3 D DF6% OPS[*A->28^*V"!$+FN\CG071]BI!\:#K[TE&]\D*"5!!
MZP8R+"V#+$=0:[B9.8)0-[]+ZBR<-K;0= #3>78?DQ;%0UG6XBY?GG 0/>^6
M:"P<=H!2Y;G$R$"&JB,<A0-X@/5!NMU%6L'3ER"\S6<WY?Y6DFZ617%8$=G1
M.@%(&>D4 50S2X@FT-MJ7LCJYEZDSN);8[.]/2J=7R#GH[7A-!N[V6*R>'@S
MN\Z+NXYODG<5GMAW=]S5Y\Y]8_V8_WI5%"8PH"JD,<GF&T+'[Q]K;80&X00I
M7I3>.'[/'?4["8%*6.J08=A*SR2B2 C')=/AAY+54@B'B^>Q._5HWTBXQ\Q+
M"S18Y3@%B'*XP5%S1?K,3G+P)OY,TK.O4$W/N _ZUG\+BGYXLJ_Y(OOG,IN-
M'HY< M3HG1#G(?:$8\X18\0H3;=@"<7[K A_TJW &<1EG\!&0[<OM6_76;FE
M^ZAON4;O!"NK) G_@8AC0!15A%3S+JLD#OO*(2IG:]3CBH/>CR,]@[RD&+K0
M#$=8YMM-^6CL0IWNB1-,$ZT \,CX "2%6%8S)]0.,)(A*C]KR$I+R'H7%OVP
M_>N_3[(B?/_VX6U9C;F^PG-@@$0[(WU9M4X98Y7Q2CJPF;VAP70?:B3$H'2>
M> "?=2_Z?AJ-CK"]XR3>:,@D!%A8J0A&B%-785%>8E^,*A2%X74VJ\A0_MCB
M-71=:?A2=69I6A?G78$"Z^M+W_=*RLI($&-BJ/<0<B8L0]4\&8>]AOXT5Y,B
M\'&?M+3&[)RR@1O)!JXB9@#7I)PAPF%FC@%J*Z>=,90-L!KA^62C&69GT*&W
M1;O--)T?*[)PL%^"/0\0:N.LMH@0Q:G?[L2$6-I8/DZ_[K]<C;DUKKW+T&&P
M5NA\5T?^>1GYE[.NK_UT]>U$2B&\HD!R(H3RP&BD-YA;1LG 7T%%DJ=]4CHP
MU/\E\7U@/W0;X54)>J1 \CWUL>LF8-_1*5'< J*)"^02 SS 966X#>6*]?IR
M_%0E\/S<W)W$O3W,C05DD^IL.ZO#DK&[=8(UE\IKSBRB5&&OH:F6F0VF4/,0
MAN[M@F&)1!1\&\O".E'*GX$+5\M@%:7S;)T=[+!,'.Z5*!'L88^X001X1TH#
MRU2T&]Q"-CH+ 1ZH;$3%N2^-R:3SVV ME7^4]'])I\\,<#N9E\$T =D#FD_M
M,1**A5*2>L>5I8@@*BVN@HJ4Q@,L]#2,H*JN$!ZB7O[X#*R6G^.T$1/'."*&
M"RH4\]A0PX!_Y$"O=X87)8']X-UU"/5.;^-@$F/%X'39?P7]IVQT.YO\<YGU
M%GE\Z-,)%4 ZHC"3S'G+I5>02*Q-V*:,A*;6_=9%H=Y'?/*^SR9>,\4)+.T1
MY[3S7!*\09L#/9QZR\,1NPZBF"-Q9]"!S2NE^?WUQBQZ7WR8W-P>RVFRMT^"
M&90>!*4% :L$M%H9+ G4(&@RU%+<H]CV?CW17EI>ZHR18.[-$ME%[U&OZX%>
MB2X37P>KBR%K%5>2 *LW\]2.0C_L&X((_*LC$:VP>KVR,4A?^K!$(IH'?%L6
MLRKK<,S[O:=#..T]=-@IZR72VG*N@%]33+F'JM> \WK&713\\P[ :<S./R;3
M;+[(9]D>+>#[1HFBTGA3&H0"8PPTXL2$V6K/"9-&-M=6+R".-]JQWQK7]AS?
MNR'O:I9@@323SEH?1A04>POUACH.,:7#/)W;P+R34ZW0&!K/!G5JGHM5L5GT
M?I8=/A"_;YE@@[PA"'$. 2Z351BD5C0*CCS O883'SX)VT&\DT]-86C/JD]?
M\YJLVK9,J#.6A'T]3!0[3YTM+Q-7- I-)&J^IJ)[I#M@55,8(K J-*N[KIZT
M31##6#IB'+2&6,V)4^LM1"@$/&Y^@1#]NK0+=C4&HB]+42_GDUDVGZO1NEY6
MB?%A=]2>'HF"2ALDH$.08489<7B]=W!HF=;-M=(+B)6-[HR* _(YA:C\:Q#^
MHTZ'HWT3J1UCW"MI#'<><8HDVLS9.4GL,!7?:)RL(1DQ\/HQ9&50"O=P1222
M\J"^I.-L>EAI>-HF,41PCS %3!&J*.5E>LG5&0D@!7: H9@1L<[CH-*86Y\^
M?#O,JFV#Q#&#I6#0"^H<0Y(20-84K5X$-4\]T%E42$=\:@I)7[OMMF;(_]_>
MERZYD5M9_Y_'\ /8V)>)F2\"JT,1ZI9"DNV87PB*E9(XS6+*)$O=FJ?_@"23
MJHUD,C<B2VT[)+DJD0F<>P!<7-QEYVR7JJ5&M72U/1<6=;)=,"BE\20J*C(^
M<A(2:5DU5N92\<KV87.7)[V<OJK7)]1CT>I15\]NW,\^'S3W#AJL $/, L+C
M<L;W8[,"VTPMFCW+K1P.J9?%ABQ5MYQ(<!WAOXWO*M;K?379L]'8SST>&%7$
M*JZ3P[?$<8B&^=W6*R'EK'T2Y<'4OHX2*GL'933/@A_WI6=E_>39P"FUQDKC
M(,'&20J34VLU)D64]QGFW.]7T%T1&5UMW-^W[RI%-U09'[<)\8PB#>6>(>@,
MC:N@,#O+)S.I.''[.,S+DV6_('6Q(\PCNR)5W6SJ@73OX4"L0)8AA^.!3'G(
MF,/[/=08@C"8B)+87EK/>R!UA^BE$"!OO?":<K_2WE&LX_*H+]0+3[0*$%'!
MD3: >0X]\=) M]LCN<6*9ECKJ8NP'J_WO0$S%@'NQ0I5$:0?XM?/Z ['F@1%
M*%%QAE"O(?$*1)682QS_88RS4+2_5&0_H>K0$\K7Y-'9#>1XHX  BH Q09Q@
MG"C)L;*[45H M.!Y:Q+=A=> #9V0>JF\R%+!R(D.>=#@[7HQ+_Y9+N.2>3+O
MQT7M P1<"688HIQX[QE69'\^UQ*/;)5LIGOT(<@SW.@#JFO1Y/V7V;JH!G Q
M0QXW#7'#M5P3@R&AP&@'H0(5GE9(P4G[(B*#F;-&($='E*[%BY03(I6L>Q</
M;A<SXVGCH!E&%@+O#7,^KL$8*+B[#X;2 39FZLA\N-$9IVNQX]UB\YM?%T5=
M_;(52XZ_)" 4L>124<20E\3%I1/LUDX3CX>^?:*7P<I(CL"6WO"Z%FO<'_'$
MN-BTW&Z>:1WB_(CZ';#><F&U M"SO3NR0T"9]M[4@]6='($GW8&Z%D%,6@R+
M]=?9>OO=K(N;1<7YBYERZC4!2,NI8,(*F(ISTHBRW"VPR#O/V]M/+S>AY$.9
M'A%K'UKQ1*LN/^YSJ[WY= @A>'\WGQ>;,R&^+5X5D,* 4D*PT$(P3^(>O#-(
M"FVEP>V/O7P"O!@)M;'6E6&RGTNMM*)$ V:5XM!11=C>SBB!YNU5V,L9,GWC
M:Y]0CTZK%YD>6G 9)2>$<5A;$X^E6*,:<P]EYNZ'/?%I]#S1[5#_D_%C8)^E
MI?NE$KTG+;*7?-<(8ZT4,A0*HJ#P CMS0)'A#&_8,Y)?@WS7E^';F@N#Y+NF
MPBGA& !,,&,)<A&&NN_0LC&SS4R;&[WBW)HC[\KOL^7V^]O9]S3DT\QX[MD@
MXI%*2LH<]T K:[6$.[]D02B1L+VS]H3SG[?B0P_H7N%\.6B%6@Q2T)P@F"G#
MO;':6U'C2&6'-"SB8FZ]J!-G?YB/SKA1JXHR"*A'7,*X7\=M.0*/?(V%!";S
M5 -]"[Q3>=%V4/[<],K]_)4_JZ[,IGOE,E&KPJ2HOH(P6@CI$(8HY=YR C"Z
M'Z?""$V^:&UC.38H3-H.LVMRHUO16L<-BC.-2D M@MH33&T]3B*S+DXU.C?:
M8386-UZ7J\\?BO6M+3YN#[T_P8IGGT_%FITUAFD-4\UPBI&N5UZ# <XP>C;;
M,@9] #QR7-7#5,B_WB7DWWQZG["JX#2SY;*XT=_K[,;[!R\N.-#\S4%0@APQ
MA#$D* 64.EXOQ#85M,]X@<J-D..*8BSJUMV,,.[Z^2:NU]O9ZB9B^?A2_@1/
M+WE-<!J)>(:VD#)LL*!0@'I7L=CS]NX.PYNM<B/E@+CGP,"T ;1D76H:=0W@
M@4[YDK'W1D/!&#B,6)OVMVR#^7).DFDML&YM-'^]F,?3<J$^KXN*VF_7Y<W=
M?+NWX/Y:/+=*-6L8J'56 &69IA1+3@W9IX5EF'H!V[-E,(_.[-@R"-*]<67?
M@Q]%_IIRY4G#=#F@! ,*(4HXKRI2['SE&<'"R/;UG@9SY9P&5[HB/1Q7FA66
M;?VNX(6 3D&&&%3 "8.AVUTW,4HHY.TMDH,Y@4Z44=W![WKC^Z,O#53L9@V#
M=<1:P"F'#%J,%$AU(:H1, RCVC?B?=VDZ=,WTM>\1OG78OOER2WZYN$U^L,[
M]\.5^JO-)F)YX75+Y^\%2:BPW"'.J(>.8LK!SM^?">1!!Q5,_C0LSDE 8Y&_
M3BELRMN/BU4U#%.NMG$0*>]/N=HL(@EFNYK+^_&<H':+MP5@C%04\ B(],8C
MH>5>2Y%0*=X^#3,$/QUSA\>_]0;^3-?^OBXWFWC$^;0XNGN?;A5L//Z0")&A
M#!D/J.!DW_<(&$<=7#Y_GFN#_G'.>.VZP##;P]M#5',4Y=QCD\[JW',BQ0XW
MCKG"'6[ ?[Y;A/'ET>=:=Z2K[H^OQ7Q;W'Q8W!8?RD.XW@7+X64O#A1[S!#D
MA%.O@*9>[K.M,4T%[%);Y.>Y0KB**%J3\5F_!?-E%CNZ>;5Z!IC=S=PQ"K9\
M7;"6 L5C[XA$3EBBXD:R!]G%\U^'L)V?YT9A1 &,?OC>8;SSA?I05G_##^O9
M:O.I6&_4;0IU;W*F;O":H#!QQ&@*D(XS!0&JHLZ[1P)YWOYJ'_X\UQ4C ']-
M"L+]$% W"AY[39  ,*,L\0Y+HC6Q!-5P.^-\AWS /\\MR C _Z#@?_WM$>:Q
MW[]5OWCFY_MW/(#_]]]__VM<OXMYN?[KO+S]6P7]LVOYNW*Y_%2N?Y^M;VRQ
MG2V6FX>=*O[8%JN;XN8OHT^-5C(_"+CYW.GVG8  %IX@B[B'T",%!)&24"E
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M:WAC"@UK#;\,]ZRMX>_C2*O/[JL\[U3&T[;LHVV"YJFTI9/Q(&B- 4(H@@[
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MB[NN($IJ3C"4IO9/IIP0GKG1I;NTSKL#M(/HI1 @3R-*#G*_DKP;A& =?39
MJ8G1R@&1PA"(]\JI>DP8^#%5B?8N'XT%\UC&'>&8TJ6<,-"E,%1OF(B*EZ*<
M'S"R6K;?Z0<[R?8HZ!X0&4O6_UC=+%+(V,=TPJR5FW0,5,M**/'86;Z=K;>+
M^>+K+-46_''(KU2?$[SH^NJ@-35,:P#C,BJ]L9IY5".&(&MO#1GN8G>8$\C(
M2([%O7\5B\]?8N?5MV(]^US\>I? C3.P,H3<;3?;61SW+BO?/3/("<:U>V$
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M-4JC,>;NXZ;X]UVJ#_XM_M$@N^21%D%2ZZ"RFBI!?;J DCRMGDI"!QT58_K
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M<:HD85QQB&N_1Q8WY?99BJ_G-3PR58?&?"K+;@3R4['8WL5AOVIH=>WW:X'
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M$$>P#@6U0ZJ$"4$@!XRF"0H"F *4T3V= )+:'F!6PB78H=S),3!0&B&.O;/
MD<DZ/R<=.8\3 P=GPQ23&%Z"Q=@1J84"_U8T8H)L/60\H3BZ.4<HAS3*8D!
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MIH'4H?"ZG^T8?<>*%%YS'9,D$.C8'S4,'HO10:&.1PHX=.R5'A+5/)/#XLM
M3Z'1P)(9X-%$?6WGP5# Y(?J[[OJ<_50WC2UV.8XE(0@3D*((2'(!PF,0)C
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M8[ 526W_L5++GVGYM5S7C^(RA^7]IE[77[Y_[" VE!JD&*$@"_+ 1X@FD*(
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MR?Q3 ^TIZW1&?\P\5!@)FLQ+O5$A?4_EAHC.A7]JN,B*93,8.K(31VW[85+
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MQR=;]7\N"Z%A=;WY*,Z%;/C;SW_@EWK3C/_L.K?=$O1%PL*8(>IG/O7%_ >
M23#HXS2( I6\9SI5CA.BH_=VD#VTMGOI74YT+'Y8TJ]X2\*$]:@(TEE5H39U
MK=6>6QZ;FBT#[\DJ=&:DGR[N4\W"Q,XKMR'9]Z/7A#7EWW?E9OF]NW GRED0
MLB@)DP3$<41P!O<EIS@!6JV#07F.N7^DR]L+T[J(RXJYBLB>R%<U&&M9ZI:V
MIWV2X:@%EV=&2!L1G6*?-;>4J?9:N<,E/"&F&$7\/P%(0I]GZ#@:<_(,A8'2
M)10VRILLF[WR3KR.6E=\6;%:D7$3N:R;<&H;[)9XIUV3(9X%SV=&/!L1G2*>
M-;=,B-?NL\IA!V">QEF48=]G@##.5QB$:"PZ@E3I1 0K!;J?%!YZ=K<BCS8'
MF[JC^F1S:J85M#WI3%]F;[",<8ITT_9]OGC3#TF";X9^:714]W_]UZIL^._?
M?_]0?N7VBGPRRPEB:1X23 C%A&&4^T/A! *US7B6BIQNF'(OKA_:PO]AVFLU
M<EJYXSJ5R=H#B<K^NN["GG%,KA=KP_*9<<]24*?[LO8\,TKN7LH8$DQ&LB!&
M@1^F%.$H!""!^:@A19'24FB[)5^4A-9ZMP;.&V2#DYANDXRSZ>R>M$XU,32N
M@IF1TFYL,JFB)0>5N?E^\[C;MAVF@R%+]6,_#L(P(I"Q($CBE,9@+#%.@ER+
MDAKE.&9BI\4+-*FGXYLBXQQ;IM_1[85=>8.#E^[@OO1)!E\&[LX,5B:1G$*3
ML3LF( J'$E,_R2)1%@AY&7GL0YJ.)1(8*]U*85+.)" *S4$D[9L^B%Q89@M$
MX8Q %&J!2-7=^8)(.1()$.FYHS&*-JY#^4[$_HRN]QJRA"=B&<EI1D$4X02R
M?>\UBJC2]@>SDES#:%3D=9),A\ETK%0>'7/LHAJ?% UT/0[VTANYX2\#3V=&
M);-83@]V&3ND3*;SZ^.Z!7&_;NK;MFR^BG5Q'3K%/6:;)?^M;HO9<]5#'Q.A
M-&48^BB)TA0SGV0@&W33&$98BVX74SO=6-KM=^_%ZVXVF':Y*E:D[@]1N]J#
M=CH5ZY;DKOR6:0TN7M<S:U$N[\>I5NGRRN2/4"1UM_&NW&R?W)TR)/E8; ;*
MHIR7$A&?^2'TD[% '(=,^I1$LV(<MR4'<=[R6)W"67J&-I['_L0.JO'ZR+RG
M%S6].0Q@W46%0P>G<U/O7$%]5^7.##P;_RNMD4739G#RGZ5 :NL/E *X_U8T
M3;'9[MN)H:0P2Q!F61)3 "$.61:0L?-#:0R"Q=>RN:VEF*U9@LK+<2Q&^MT8
M='GK49@"871=DP#T!':ID7GTZ9!#:R!9US %%D]@G!Z$C_(XKRG7Q;;TMK7W
M1R^W%7]_Y+]Y7[2ER!OXL[SM[B=^Y.#M[R?L+NWYJR&J7[?G%*,-S9P!G$TC
MJ.T]6@HXSO^^XY__ZZ;:W@S/Q/7C<0.0)G'*0$) Y+,\$HL)R%@B"8'4!G8;
MY3C.I(6NPTM1=\JT.&UJIP2O)W12C=N],*_S<I3F]=IT"&YJI0+))[14C^C'
MMQL^<E[S3K78&\!)OKTOO<'XW=F'V!3GYSTZA75+SLX [[8BJ>T_=].?;O*A
MVI3OM^5#NX@"G%*8 Q*'%+$8 0C&Z=0<H#B:^H03>663#?1?>7T\W1+.X]QL
M#,GC[^F9TS,R@SU6T]2QXNC_[*I7?PV)A9KU?A-!>5U4/^ 1*?L:D9D+F+3F
M9S;N/VWL#HY+T:T!Z0MRB_:>ERO^$ WCUV+]9&GSX?RO!0Q3C!%D>8(I!!&
MB(9C^3@+E8[5LE>JXP:EKSG%JW3M62K'^,NXJ3CRS\5U+.[^<B3SRGOU2,&)
M;^65=? ,;^W7PCQ8ZB"NY[?[.G+.Q6J=Z]MU]:7K$[:+/$Y 1)(4ICAF(8$D
M]MF!R)K;<RUKF&CM(5?K;OF,DN?V%\6XLEL-H$<J9H%,30<M+5[1J9-YX-1Y
ME 8+3?1=E47MIVVQ[7;/7=\)W+-U_<?A8-D0!'X"<@H31E*&""4Q%/_U0X)\
M7JCDNVU4AKL7>"]+7,K394&=LHL=G7S.IC-OJ15WY_$JV@FE=O#TJ=X,L15%
MW33UUVI5KK+OO[;EZOWF^K%;5\#[E<MM];5[\?N%!SO^M>&;_$W?BP,XC+(
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M,J:=0:]5S^>!4KLAU0Z?4<6YEGO>N<L*#EI2/SR6F[8O+.9]!9:$?@S" .7
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MQVJ ZC0>K1B9V9RIM(5GJ&:_&N8!.P=QU:X?8",TM@IC_R#%+$C3!*8 9X2
MC&0BLP,)2S(4 :594H<RYCU'ZM)_+81>RGHSIK:SGQW5MUF>NR[J;I8@=A+H
M>3*[\U83U<]G- #U8<[; T8C%#.:)(S +G6.8IBG 3' L6I1LYL/-;5.BZ0N
M73/-0"\]#7K>*GGBZ7H\2ZII!W.>7&8>F=#I,'WADS#($/'S. Q3BJ@/0-R5
M"1.&8S\RA9-\2;.;]#0T3A]-;CRS1*9+S76>-4J12^H&SQ=+&K%(4$G7(1,H
M'<U-  )S'Z,$YSB/\YCG:HQVA<8(^Q0J36X:%C6[F4U3Z_2YY,@U2V"ZV(3F
M>:L4T:3A\7S9I!.,!)RT/=*DTR(( <DRBD'('X$ (QP!W)62$)SX(DF2G\%4
M_>SY35\JNZ-%'*O&F"'FHCB1YX>T8[,$AKSZ\X10=$'Z6,QZTXWV[XJUU.8I
M"DA Q$0 QB#!&:1IP-.FR,<^8SF&:O?16"[;<4JC@13K[LHAYY+&JB'I2.E\
M-WDJVGF&;*XJ9A[D<Q;=\[,TG;IH1L[7QNQY<O?ZL'T6D3Q"$/@,Y"0(>;*'
M0X[T,/!S/\ZR0"7_FD".XY3-<&)SBOHPP>_%JL(2D5^?[12]U+G,>)K[KHQN
M)Y4Z9YJ["5@*\ Z]-F+^\^D.2'.&@Y@"$(4P)S[#8= EZFF:9 284UVU0,?<
M5I\=M6.C 8Q=.F@'MY>>+Y6Q3966NJ[/F(?:(<D0S\PO<Z8=)DLP3Y0!P"0(
M$DSS( ?8[X<C49J"(+>$-/GRW!--<4[5BHFF0'/CGU6>76J65<(T+9JI6SYW
MF&E$),TR7;?,478TM1)0'(=9FD1A"J( ,TA9/XZ*,P0)8798IE"@>Y@ISL3:
ML=&49HX<M(JSB\W-RMBF!30-U^=.-)V0I)&F[9<1TQ9A0E+>IR400)J&88@"
MW/,S(RQAR#>&V)LES&_^5M,I TY9-<D&F&8 (57J2'LX8\S(QR##%45'Y*^N
M^5IN=B7C(8W%_JW:WI-=NZT?RN9P/"8!8MT)RQ")8D3B(,P)"C$"*$XPQO*7
MJ-@ISMTK-"CT1"5[HT;O#R[2&U5>;,I1TKTS+YMM_^?Q^EF/ZL6U*2Y<DWU%
M:=467[XT9<^!Z[M!37>]P>?RVS;C5OR^2/,D3U.:I6E ( L"Q"+(R\8QCL+$
M1X'*$@P[)3I>>/%4I)AB&F2JY0>6W)7#W_3&JL'OI*?#W2F>$.EU*B=&GY1S
M9\!GU_EY8,]R3+7+9U4.><NR62Y^KM8E!^NFQ-^J=@%SDJ$8)&%*XR#+LS
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M#U?H5\$\4G7[8<D-5ICZII6T?RS;DO_B/=ZL:/FU7->/HJE_O[EIZF79MHL
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MM&+.]AY4[25ES??ZN5BSK/U;\<RVV%"!_];??7F\I:S)]MLM_?0BAGZ2NQX
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M@*OKCCU32GR)I/>WOTSCUHY$6(TIIS>WJ.!')/W]&RU7M\6:O5E=/50;=L2
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M^JB.?#LT4:$]M:YI*KQ;LA_O!^N75VQ7S=\?V5HGG0VQZ_=CA\C/LR@-$?!
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MLP1K"?]J#-8Z9]OG"-9:&5(<K/5[T]2Z\S_:W9]PL\)_/I9+^L^;FOUHE(W
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MK#0H?H6LR"^FJL&+UW^>.&4%O2#P8@@@\D+7\X.0!,,-)CAQH=$32ZJQ:XZ
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M-[FN[YR> >?+IYI<HJ\FK+/ T!L(FR>;P$L&T^Z[^"[!VKEDRRL#>PEZ\V;
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M]8<7BJRWU;IF:R,+DB0>AE[LQQYT<9(%'NZV!\=1&'D@5Z?^,J-K#@CDL+F
MO?S9O@D/*D5,BGP5D4(W[QJ"QW@'@W.$/;L[5(89W6[1&'E$W:,H()U@3#I&
M36'_(X2M2?8)1;+I3(J<VSN.^V9Q/\=AGKL@ E[LY8$/71!VQVKC./ 2C[]K
MP_2AS-<QDN\A55'+$:?,LBH6E$Y)'/_K12V,BA\--,3LM'."<@P+'1H\S\.Y
M:*&.0 M"@T)C3IPM5,:1\/F>T7C_K';W?]_4MTVY?6)[[+K3"=]+1D^UKEIX
MWU]LWQXV?#]_:9I]V2S2,$IR@'T01\3#41 !MVLT%"<^<?G>;<R+4'.(82@*
M.ME8741![RA,]IC2?S85G;U=T&DWQ73S0O*@CUFG\KT>MM^?8L%M?/)R++E_
M4)N<L5'#*9^79ETY!\.<UK(KYV#;E3/,$\-;(K7XZ,*;['GGA!VOOV?FX-RA
MGAD]PE6XH'U3;<JFR>J'VVK38OC;MFZ:;]OZKJ)1,PMA&&.21;&?$3=*0-BO
M T(O!#[DKEHFCJ,YG@SHV+W% SSG)\/G/+8 !;+KJ8QR%"L&R103\P./(V17
M3HO-^6::2($:Q2"A<@7*!&+YJI/+#)PK313Q9D%=HLJ26OVL$JM(3@R:'3+D
M;)P@'Z++FUJ)5D@P H $&7O-#P@(TZ1#!@(  Z$6*2;P:(X.V;D*8ST@GKK1
MWHC3^.H+V_RE(@"-'/C"@A>UPLP;]A7P?J%",.E5.^H!HQ;7\SU#TW+],["&
M;?(WU4-Y4Q\:A2ZB@ 2Q[X$01 2Z*"*IASM0*$J\D/]UO'XHFF/"X2#!CN)R
M=K7S,"";EN&J=HA<-3&C+_3J_<%MS 3GICYV0[;+;=-JEQG=I[*\4>I&Z3)(
MC$R!2DF3E^PLIG09^TZ]I95CKJ![:B6PR>[I["^;+YL3C7NZH]>+/(]<".@$
M#5,?)WD(:8W8'ZK!).:[,U8K ,T!]MCU8-EAI755NQFN*[UV![@"PJW-%QQ1
MU@8WR+Z9&==&5*-[?WS9G.ZVU@&WP2T"4=0&]\C%3NX'Q5GMV]=DN_O2>2RW
M5;WZZ\1H*4G:N1BIVP<61$;M)M8&Y_2D5JA=\]6;NOUO[V9;;)H[&B7@ [N!
M:0&#$(<9BEP?T1GGNQ%,T #!)T"H>9/2@35'O0X%>YAW S#V/XH6N<,FD[/N
MVQ+3FK/[IS>IC>E$/PAN6C#M OF]"!W28Q=H2G?W3\\Y *:?:B'/VE/T(ID\
MFP94^L2.M3\]IEWNVZF2ORF2ZO40_-<04M>-,YB'! =IB%"8A_[0!A1GF C=
MOZET8%LDU3M*JFS;?"5^D)=4(RY0):G>45)]&R7U')F"DCK9)_9*ZG33."15
M$7^\DOJ#5E]MHGQ]1ZI-L5E6Q?I;W50L48:W#960Y6[A8^@%L>L'B$2^#T@8
M@8B61FZ<>AGR".%\A)6,I>_1/<!C<GD Z P(G=\'C(9[JO/0=N$A5<JZ'0^G
M6I-JC;-4L 5P_?!0;W[LZN6_?K1=:>%^=U]OJ_^4JT46)7X.<R\%*/12DOAA
MC/H1\R"!0A=?3!E'^]X3!LUI&+:K0_O> [P)'7NG<,NG;Z9H%9.UGM$?':,=
M,.>(S'#SW/,479 P%<3:H5Q*+'G=T%89.](ZU>[77BT\#^/ 32'P2."'D>L"
M#P^C>4DJM(].=HPY]*EJH2G4)EX^)75) Y73-:D[O3*[('4@1,1(D$U+A4C4
MBO=$2(H5:0$:M6A<9*$7A'D4Q@$=VDO3("1D&-+-,JX.6DH&FD.*1NVP%>J1
M$+V2HJ2+617*-,(VLSR-D(AHE RYE@J5E"GOJ94\/[R2]8W.BG*[+5?MJ-^*
M[?6VK317[0+0MW+; ED$"1W9S\+<0UD, Q*0*!L*2\^-/!'Q4C2D9AD[H!R4
M[+$8ND ]EMM.P%HI6]7K=;%MCC\55#55'N#3MQG(%U.Z(^^]V%&,[$Z5#F6_
M$8;B[$30K.SQD7=! !6S;X<4JC:JUCICI\CCBQ02A&GDT4&CS(]R$%%1#MUA
MP#CU8WE)%!K&M PJJBVG$"NC=-HXG:AN_<+7'#7F>8*X%4R*51M52\Z0BTHU
M@9LIZC1.&9/42^,\"!(WPZY+(N@B.(SJIIG0-:!3QYI)IY04GI-YEE<L712K
MD:W9"M!WJ!(4,!F2[54Q*6LXI$R>)5X]N][^+#;5?X8C(TV]KE;M_X";%474
M#)NR1Z] #Z]%F\-+4.AY7HCS/(BA&[E1$OL93O(\\I/0BV/,NRW #!A]S^P8
M?WN(ZVA!VY-K;,/+K05',V;;7*"$_ LJ8-:Y=FB%89OK.1\G,=WY6NSVV_+Z
M[OJQ/YC6+'R$,'%3$$:QFQ(OB%-,AH$ P4*]_R2^7G.V-!S1$TN#9&CBTUK-
M#(D)9P>&2>(1CO/[3?GGSD'T>?J782E\R\T%79M I!TB-<6 6MFD$MRLN+PO
M5_LU':K-EM!S>Y?O#6LNMT!Q&GM1@KP\0)'G(QPD* T#Z"59#")7:)5HRCB:
M!66 UEZ/S<"Q*[&[R[1_;P&>?VC44\JG.:;8%!.?"43JV>5YGJ5+FSL5<&N'
M'BFQY/563F7L<!U]_T(-W>RJIW*X0?*WLCU?Z$*$803H0-CS4P^&+H3]4 DA
M(>$^VBX[@&9-.L!R!EP"AZ&E2;LL/L;X$E.=MU0YOW>@.'5[&F<"!\1-<"=W
M %R&0[[SW6=L/J&_2BBRX'SV9!-JA5-&I+57O?]YO\O+8MV/@0D$<9X%:8J
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MY58Y%+J <Z6!GYZS"P\:&+9A'4*'6;7FF2EXBK,XG,AJ<_!#9[',Q7$:I#C
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MG0W?RESY: =%DL?+[/6C'1%M=.+[:.>'FA?3#H?9.S]4G@,S/4^DSWLI=8?
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MJ 8/G@B=EDZAS]AV?CHI6KO0*_(9;SS]6UVO_JC6ZV_TD;\OFO(([@BI67@
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M=GU7<8^^C_&C$>E2N4<<K)>[;G%Q@!Y([!J*Y7H8%/3_C".@6?P]C@;[J'K
M&AR!-8D6KKG7B"%G' .SR/*O_;O_1[6[?>\#N) QYG[<SWX<9,9U>-GP:O=H
M&W+T:'PK$'D:C!F$)U^>U?Y?95>A[-?EH[ >#=9%'"W2/$<\HDE(2($+"O;6
M$<5NPIB>S=F$, %;?KV1*PG5I-XV=/ECW7'8&H Z#UF:?+L*5_YX]Q6JQA=]
M%F'J"7U&(<IL .8>G@R]4@Y--JS9AR4J7L7_]; M!00T0$" 1"B'/,DC I-4
M_"/*<H1P6"0,T(2XB4T&AN<1H"1H^=4B5W)I,@2V,<HS^PX"U<5QI*)/B'<>
ML$Q&P%74\CP29J'+_8@X"% OF3**4A:$SSU4V;BF'*^L^;/:NOFQVI8?=N5=
MN\@@#Q,FK#$B(F7"0@K"(5(6(8^@]?9-=5/3!*:G7Z.#;9L:7*JM.$](HV:$
M>7O[IH07=/CFL(=S3Y;N/DY]EN>QUNS*&97]G*8<*679W==Y6V\$7RW[]X.8
MK>'M^FMY=U\WR^:Q_\FG>G=T3/FP]9V%81RG*8<1*7((8@H Z4XIYQG,BU"I
M?8MW$+Y%;GE?R3L(ONR:A]5.(--([KQRKY!JSX5V/5$\1AWT( .!.]@#'W\H
MH1_U45!KHS#Q*&FDXW,9+;/4_.M0#1+CL#X,B3P\V,H-@X-??PG*?NQD"]:F
M:N5)L^^!\%#::H/E;M=4UP^[[A39KNY*3/?B;XO(V%>:NC.'6R'A]78GP&[D
M<GVU%9]UV>XNQ._D]D7YLUK\S:8W4MZ6VU;NYZIDW]?R;[(;LMSD*.8-PE)0
MM>)YNV!3W54[@697BQ\OA6>KLNU;:A\FWQ>!>%K?%W;\P7*]KG9]$^;[9;7^
MI=H&JUXP+D8,@WY(X$TIMQB(OUT.VRG% U:"[(>-O,-VM-N15BY7M\%*1HNN
MP5<WMQ%PWO:K,["\DTW !MRON(XW;3VP)/C=?T_]F-A6\2S>W[<F3%-\$C.8
M/$WB9CVQU.A-JJZ6CUTSH:\U7@GS33GV=R[;?S1UVRYXRAG-Y.63608)11"$
MO.]4FN("YEJ'1ZR-><\YVMMID_[W&#F1]CLC<QZ)OSMW:D\OG?75'6\U.^^_
M^P]#.&T_M.U#N1;"('_3'3GC819SDF8<\U1\]0#%#(\(40Z45H?/@6O* OU?
M#TG(X4[YS:/(,WJP?3JD?M60MRL63-D^(07G&--YJ,99/'__1H2)V+?3HN$;
M>8+U</DT9(R@@N8%RF&4AP7G,1V1$ BT6LCZL.]=6_:WR=\/ 60.RG&2,VV%
M<#,"<U8"1QXJ??$NV?2098 %!!%&)"9%G,:,(Y@!OA>7"$14Y?Y3+X:UOF73
MRTSU+^DZ=T8 W(1\=?[G_"7;NF8>M'7Y.\-UQP?U.1(<$L51@@%A(:,1 TF2
ML0$T(8RDRHL(YX<ZWU@_R86DKU#V5N%N/F,U@_+>C,CP=QNI_1@I=SE^N&[+
M?S\(2^R';/[>35@(H6$L;X+/,2L8YC&/> XS&B<Y+H#:J5DK YZUX8 IZ$"9
M=<DRHTYMDX5WUC17$74)\]-]]Q523F135AS.(VNR<^%Y2UM[/I2RH-^V@I4_
MFFJW*[=7#]>;:G7Y721=0L^&G60@*M(\B>("$H0AB0%$40YS@!D*XP2H)S'6
MECSKS#&^H <8C @UUM3M"578WC IEWKJ<XI&DVW"]GQJ;$28E%>SW09V_*HE
MS^_1\%;NZXR^&:2N[GRI?;Q@&A+_J7P07M<WU6JY*<1_)'_%V_554ZZ&?_NR
M6][(2X7N19:[;@<DA;"?8)9& $00ISQ+<M '&PPH"97NX/5IWW,X.$8=C+"[
MK29'P(,.>;"'KJ%KOD9%(7K,8$#T8LKK8X%/CX5)L/$U*!HA: :#8Q:8/ V2
M6L0R8^VM..9Y#&80W7Q[6$_W1FM$PJ_B'2J/['Z]+9OE?=<JO0^^/$\R5##
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MCW2BKS.CGF/O$<YN:M\>(?UO_R6+0/KWKG*R>]13"G>DJVG)6?C64YOG5/?
MSG:R0)6Q$U+EG/1YB)E[MVK/+ZNQ(#X_%A$5.2(\(X!182R-:1*-Q6@2)EBK
ME8R%&<^B-Q[JV1P0:IZ%LJ%06]!\LF<L8><_&O4V0VJ294KK[$3*V)&W9<F.
M&]T##5?+1[D!>%P1BS@LT@RPD*0P3$, 4C@ND9.4IY')@05-$YX%:'_ZY[Z'
M978>09<VQ5F9?\8T9VDC60.B<ZUOO\K+J8F<'9'SD!E;)][8]6_%B8:\- _E
M^FFVU>VP._K1@E-<I)0C!@I:I"1E#(RV"R9P:*J- XO^Q4>"/+6O]R@QTI8F
M%Y0K*]7$;&L+5T?T\XE?O\GWHP+'OH3L?=I.ZYI#VF<C<RY]>JEZSAG3%,$/
MVU5]5WY=_MSG=HL\ R$#89BA'$84Q83'?+2'$JBU"\C<BO?U=(DHV$E(QMF6
M*8%:,N:9.S/I&NCK4)TO[WJ=GO<ERH+26<F2C1^O2Y$U,\JUIN$L)RVO=Z.E
M&&8HHC@'G&<Q@!D-03):XDFD5V<W>+[ODKJ ](OX>W?!6H!2/R[@CC_%"I-G
MZC1+2WO6:,?:6%WZ=;E[:,Z0);W"SJFRD@67\Y :*P^>%Y*LV5"5%_+05MNR
M;8OZ[KK:=MT$Y:GQ:GLC;(K?M96@K?OQF&D]CH!0'C*"$$AH'O((L9C'8V,Q
MD8;E6J<Y/<+P70K?PPQ6QS@M9<OGN*BIVTR&1$\$1]#!$6HAA8<Q*IZ.T1[Z
MF7(S<Y)/:.D$(S</R9W"T7KRK\)V+7(19CFG29H!S DIPBB-][LP"PR)UNDU
M@\=/LOG*NM!FPIOIPJ-3RNP7',^]RJBUNJC,W3PDR<:!=U<3-;DPF6(>;0IE
M*(MP1BB.* E#S!D/]\9H&!+36::&B8DGFIK;IIV2J3_E],2CW:SS<"QD3O-/
MI;WFEMS.1'\LG3@Q$37FQ.-<] A32#EGA$<)$[H(DX(6139B2F*D513SB^1L
M,U(7^N9YD+S-33V-SV33TP/^V<]0E=1VFB&<ARA/Y*O]5-688>6K&,OOI7C^
M8?GD*,F5!Z4C7M L@UBDN(3%1<KR:%Q#H6F*D=9-C):V/,OT"$\NK>ZGL2:M
M):TY5=/<*>G44]4]DX?%UN#)O'?R'@OO<'5"%EVQ/ _A<^;-\VL7G;*D="?X
MQVHE-WM=7F^J_K+'(ZW,>11S,36/DC@D(4(Q3L;CDS3)<*Q\(;B-$=]SY1Y:
M4.^Q*1;<[-D[K4^3$J=;?.LY.\!2RN,<TZ=Q[?=4-)K=^6U(I]IMWR=<?T6N
MG;$U@WN^G;A1.WZ+]-+*YUL!CTL5+&8H24%<$,C"+(24L-$@S*&2-CLPXUF=
M^QVQFWTQSGA9Q(9)M3QR(A+UE/K%CN+S3;C?YN=$VNB U'EDC"X<J9V_<,9+
MLHLXQ2QG\O$T2P'+8,[W>A>'/#-<BWWWN9,LPKI8?'V?(>U55Z?D&"^WGFV5
M56UY59FD>>B"$?*W%U0UO5?]\D^<1*>8LSS.XHAAB,*(<K#?'4SS(M$Z)65A
MQG,>\N7-[A>:Y\-MF%03C(E(U-./8U!_&1M<X-VNJ:X?=O+H1;"K@ZOE68^-
M&W6Z<,#V/(3(A2.U\S=13Z:*^NZNWG9F^Y[J40+B,&0D*7#&XCB/8#SN+680
M15J7$V@_W/MRJ,33]^7I)"GZ^W\-_Q:&(+A?-L$/"?'O@;!P$?;_'[2WXOMJ
M@^7#[K9NJO]7KH.EW,70K&X#""X"63KH3B'2<E7>78MIP_#3[.\!BB[2&%XD
M<?]?H/ B"]$%R/+QH57;RE-!W8'1AUV[$[^1>R44#5P$XAGWY6I7_2@WFOV$
M],=<34:]#K>>> XCW6&Y"#HT%\&'CO%I%?(Y)R=TT9B^>:BA.?S:T6ND?4M5
MOW)P9"D.<Y"(!!#%'%+ N7C^?A*8A$#KTG*3YWO6OSVD=R0P=B& T446IQ<
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MZM2%PR=KAM*A3IA+\7A&Q#OR84K;? 3$V(-7),2.#7T1Z26KMT42\=P<Q*"
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M539U?]YG\T6V4//IA^5M5II5609AO,_3+_DL7^;9(G1K_?;;,KO^^X_A/9.
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MEHO *D8M9)9);:@D5 H(-1.ZU3EV-T;1TPI2#^[Y0/3#LW];+QL'[*)37Y5
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ME71RB"EM@/3*;T=D>4PR(M31E8*WQ*2N 7^BT'"E5=?WD=]J.56 C(;8.,$
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MP7K,2 (I7<P%\Q'Z&>?D66O0ST>TDYB52 XLE5QQPD658=X#B=:CPLI:%!6
M>?HM@V*9SBZ12B>B/!1W7D2CMO)5&[\CH<I9R32ICJDD#\8 03Y@X*MM)L/X
MA:4>[--1[0OS,_%NT8F/VOZE"1+*0R$X%4AI8Y VNM+LB'NN)4$7YJ'VP)XC
M"8-[$\69"-O<,SW<,$$64!< ]99(YBWGWM#ULD 8=0)>=O7H_HD7!_<YR=7$
M&SW8+@$&0RV#M<HP%E9:@!!;CY5RKQB("8\9H2MZ'FJU1?N<S&KD@1YNF"!#
M'5#!G'7*,<>"HO9V/5HF5;!S+\S]/ ^W6L-])G(U9U,"JR-@;17"X=502460
M6H^'&\5!E&H:H<LY.'U.Q'>X?"N/@<ZK=!9Y/'KBFY+@8$-38:D4XDI3*V!0
MS@0HX+U3-,:\'^%2V*?CV2_RYV7B+A\E:.)3W=#XER>:&$>".(!'SD <U+ZJ
MXG$P! XPK8>M&-*[?NR-4XVXVZ-@SDKGYBYJD^8)M<XKR"Q"!%-G@%<8KI>4
MX*IK@V(H>;JC>MF4C(/^_*1KXKHV:)VH@!U"RD#(E770H6#KKL<MA4 PJI3@
MZ:OV=T"YMLB?GW&-7-HFS1-H%<-:<((%(E!Y:OVCY1P,\JIDU*".[7? N=;0
MGY5TI[(LP=P$ UL9B@)F&&,)U>.$"IX\]Q)<EL-[5EJ=B'7[BPGC2X4,H#/(
M*$P%@YC1,&N\?PSC!T9*>6'5E?IP<P<7PIG3+:W#]+^WK$J,BBJ,!PJO% \J
MP7D! BF,8!QCHQK%RP]]/^5SD(H.'_V]U?V4;>O$VZ!?H6!8(F,]U4 :MAD[
M]XRPRSKH[HD7S;,KM<1]&*T0)GE0<Q4LBV*63ZOZ3#J=I?-)]NDVRY;G4PN?
MPG#6FK?:>YF'#N7I+.C<M;)MH V:-$^<<!9*2+VC'B&O@UA(6.$!DT@@WNP(
MHI_15PD> U^/C_/;!Q/EH,52(\01)M1Q#!3=CHB!J$2*,5/[OLS7Y7O71D0_
M\[Q;B1<=PCR4F_+8R4VAI,;<>?%\H@! V'&MB>=:&6,D@O78 /9G6QT&H%!;
M*>\D2QRN@[FVZ:+*2E3]X8(Q^S6=K1?*I4G+\B$LE/^9SE:',CDV:I\HKR7R
M3$L..+!&&,)E/7:AH+QX3K4FPTMOMP>X!U-/DTEU\WSQ5!/DU^R@>MKU?(*9
MI4XJYG%PK2B5VGN^&9L,EMN%W>'JECU=('H^MNA\-LNFOBAK6[O>^EE\**_*
MXJ9,#][<;_?"A#*#-7.>,\<%9414*=(VZ'B@8O@VPK"!OOG6 ^1#$?+=_&O
MI"@?#FNMYX\E5%F+M;#KHH$(8NVLK4<B1%3UCA%NQG5+G@@@![MU56;W:3YU
M?]ZO]PKGTW4,UC<P'&!*@]9)57@22BTUMA88!"2'6]UL&8M)A!55_>7-&4[=
M@ST4R3YF8>CY9)E-8VWU$]^46,>-ITRIX"QK2Z%P!FWP4)+!LQ5!?W/DZQ?X
MLVPO--U62)CQ (;><UU=]P]N"/#U8JXXL3&'Z5$Q0T\D8OV2J-OMA!/Q'&XE
M+.ZS<OEP-4O#?)E/*W*O<QP?-I8.-4NP]\I YHWDS @N+7*F'JFU_&P!NV]G
M(ZI#>(>SLI?I_*:J;OR(0>CIMNI1513RC^! '+2^CS</:IP:8HDR&(>_, L9
M4?7(B087=G&E(R[U@.Q0G&K F^T(O+*"&TH]X1(KY F0]0&!8E;%['Z/L-QB
M1]QHB=Y8+.A?B_GDJ%73_"4)#8(P$B.L#!&*28:IW2[17,7L=K\-NSF:4+V!
M/:RM?-1(3ARD'EDB@K)T G*.+*L]"AW,NICSVI-+)NZVCL=.E59 #D6#]WGZ
M)9_ERSQ;%[->%I/?;XM9$,^B(G.C:VY-7Y%H*[E!!#CFPP(L@I,JMPC@\*MS
M'8R\]:/_G@1P!@HVCPS8WRA!1A+MA8;.AA%R:AFJ_4\-6+/ N7Z/<G%?-.N>
M"?NI%@?[T(=T5^E#=;K38&]H9X,$>6RX@ [HH/<Y@)#C>L-+<\\;U;A\H_$!
M7<A\S[%;%,@#4JBJLOWMW%IOSC_[T6%&'6]?A5X:;CUQT%C#-7<.UF,WP=:(
M(=C8%\=^"-8YY@/S[=U\4MQEG],_LR8[VOO:)%) X"  @@07Q!*J/?7U& G#
MEY94H#<J14,[F#FUB5NPV9?E<>+L>#JA6!!DE83>"PJQL "R>ER>H;-=T!G6
M@.J*/_$(#\4<O5KD\VRQ,,7=E^"D5*+;7D:HZC\N\B##30C_(TP/QPG6_J5)
M<'Z<)@0R*X%')'A%M':X@]J69PLM>#/4&PS[\[F*)[F("1#26Q9,3.6U-@!Q
MNMW]-PKKF'.5T_<]ASWJ[4.SQ0)\CB6QT5;Z[@:)(P(I466LLAH Y9T'V]%5
M50TO*[*W_\V$+E >\>+8B&I1[TV ]=YICY@+<PTS4U4PJ[%BE,28:N.V[OMA
MY)#"&(JX=B/#K0/S#,7#L2]'6B;(&RL$5D'=:T<-=Q+5_H_E7,7D1QQAE$+O
MY.L6[MB,$4^I*@ZJL6--$ND1]<$J0(P"#0BABM6GGY8)%5/==-Q&?+<DZ1CG
MH93/RRVW1DOB_D:)<]01QB$U&CL@ +;:U:/$$L>P:>R!"[WKG\Y@/X,WV,P-
M3"A73KIJ$%9PZ 0.WDH]#@I\S&;HV(,9ACP:/!'GH?C2*KKA %(V^":2"HJ<
MP@0@Z^%V_]=*PV*.;$0WRHB^639U!OMP&=CN[HKYNMM';Z2_>#1!#%( G&9&
M"4>I1)C6V\$.$Q1SC67L$0M=R/E5OK4H> >\FO<HED:<V?%T0H&$+.A60CVN
M:E6'T6Q7909@3"3P"+>C>F!*/*B#G0E/I^M8L71VE>;!0S3I?1[,AT,GPKM;
M),A1QKPTR"!NL3*N4LF;R: LC#E4&?N=E1X8U W*PX69+]-\GDU=6L[S^<U"
M32:KN]6L2JEEL^M\DA\.+S_6.!%*:P>5P4):;K1E6-0'"<Y)$F->=W1P_):X
MU3G@Y[.S3[*O$^&1](0*C)0W#D*M%:A')3&.26@1E8;V;=(H&N"QA*)'A* G
M% ,*(=9  U:5[F.0U:NZ9X;$N&IRY)0:TO'O OPGNITSJ^35&MO;;)E/GLRL
MBTPQ&?0)Q P@K#U%B >]P#>1'M#H8  WF1J]N]1!'!_*]7"F:S/]*BL_W081
M-?.R][5.&$=$.". AL)JZH)MMED_H?4\2BV,/:J[6V[L=\$[POX,VSCK;B[4
M:GD;9/'?V;09UUZV2@P5R :;7W)-H/0"$;8=)Q8JQB@>>V#W4!R+Q/QLW'JW
M6*Q.X]5CBP1"YS"0BD./$:$ <.CJ\4$ASY;R[>(XU0KOL_'IPVJY6*;S*N'!
M*:1ZUBPQ!&)B*6$XC!A*B8GW]4B!,6?+!W=QS&H/^GDVJ%M88,U>D& 1AHX,
ML5 ;IK#'GIH:4A@\AW-%B#Q1#KU)RO4"_WG(=X(I=KAA(GWP1@5FP@<]CC0/
MTTMOP61PV CPBR5;).SG)-E1FVQ_HX0328,S0ZE!U/+@TF "ZE$RB6(.Y$X/
M+[EP<K6"_)S$:F:<'6F9" DELQ@+8!P GBJ@53U>($W,%82.8DXNAV+M<3_;
M'N86H\6'ZRHCD9\5?XRB0LZV,Z=M6[YJEF $ 4?.4NZ-\-)8PVCUSRK'$G"H
M4>JJ?D;[:[:LNGM5%E_S@*]^^&U1!7-_N%]?&9C?J,DR__IX6VI]IV 5?K;Y
M99!@ URZ^4""%"8:*N^)P$0AQXCB-8(F*-!S;7KVKC4BR%2,0!)#+5YA<(]7
M$*J*@8?I^/1<PC$10"J-J^L$3H2U&-9C492+F+B2CK;2>PN&')H-K\G86@[#
MQ2_]UVKQ6.+N<_&Q*AH^R=>U/9YZ_KEH"&*3NE$]?"Y!Q@,9/!>KO" $6$9=
MK2P4\S:F.N[8-_+/S/ 1B'.XVWJ!",&R79>>SNYGV9HI\ZFZ*\IE_M_'ZCHW
M:9Y4IK!CU#H/$4.2:*58/7+AY A*\/46;GQ>)KVZ\->YL 8+\:H<))VNO8^[
MJF#%,6+N;I"PL"1Y'MPHA*%T"&@,83TZ3.#9;M0/D5UT3%3L1#QGN]&\J9FB
MLWEV?3"&]4C+Q /B*45<6T084-P'&.OQ>NEB=H='>)U^5 SL5C2M;S\_U[T?
MKK<5GGR:E^MCDR?,=M#LQ#<D3A*(.(.:>N!X5=)9DLV8M/$T)E/I""_0CX)N
M_8IHL/WE]66#_\CGX9]!<-GB8 F35P\GABBHL:5<24@,I8H\C8IJ.FR$]7>\
M[$:+IK6>V\'U#]?_2,LR?:Q"7TV*11#ZQ_SF=KEXRCBP3^NU?5^"& = F6#6
MNJJH5(!1V7J\DHB8$,RQW^@?!16'E-[X<C6I:H@WCR<FYK;ZZ[MY6!U6Z^WB
M(YE_X &=.U /$NUMD')5RH9[P+T-#J&K\=?2Q>3#B#IQON ),VX1#YK89=?^
MW^:,97OL<F"2-'Y' B3U&GBG%+#04DRPK(U_[1D_VZGW=T#SOH0T%%$#9F66
M+C*;/?[Y#*7-9=T&YPG-7Y(PI+P+KBJRCC"J."80U"@HX6*2HIU^T^P[M&=Z
M%]GYB/NZ6/E)E'W=/''**.L\MPACK@43&-0',D9I'V,^-#\)D(]DG6<W503+
MY][5:Q_,.$J^:/#/J"^K%>"IWX=" HXW3KCEUC#D$6:84<8<1G@[:DQB2L\U
MW_'_+B@7"?WY"%=OR!W.ZW:P7<(T0= 3:J4-?RKMPL?KL5H.A[DA]5W0K#WJ
MYV/859G=I_FT/G/8'#74)6*.ED9L]\($*(.(EQ1@S96V4@M7'^4:Y$U,>'CS
M[?[]G!S@^/TL!.U!-N=CKLWNJY#GMCQ]W3Q1%A'CC4!:(\B]D\20)S,$Q*00
M;WX6\%UHRFCPS^]Z; JVM?([-FT3X[6!#OC_O[TW77(CQ[*$_W^/,0_0C7TQ
M&QLSK#6R3RG))&65]2\81;HD=C+H*I*AE/KI!R#IC(V+D_"-E&J)5"H<[L"Y
M!\"]P%V@YHSK]7U:M4E8)K/*N@S]Q+]7T^,R_'OEW+/"6Q>R;_];@D4<2ZZ1
M@ I):[RR&%4XF+R%;X!GYWU1KQ'P>S9^G\V@Y*+WHK[@^59QG;<&HVR<J5)I
M0J.Q!J'3O+I@LY1FQ:LV%.]U6XME6Y+I,'BCY@EK(X%&04K&:$0<,",H,]08
M7!W/6NA$CDUSOL=<MXG5^@_[:$=(/5-UXVO08KS<F1\(!E$I@5: Q2FN"60<
M@8>M2N0<D@\RS7)W\7+M2J([9[R?VSLO-?[W_7115)X!Z[(]&QBWOSF:5^",
MUX2(/6$&@;C/ &V ]9KLD%!1J;K)BYNN6?3"6:\U ?5&U8AE!&CU\]UL-%]%
M/2=E[/QVPFVC_DL"-RGSIU$2<D:Q89@@M47!11'DF%B77O;TKA_T1M>FQ#0\
M_: 1'2":I!:HJ"0)091@G@G/*D<K%U6FG+"X*U5ENZ)J:T+JF:K;-"7MJ;)G
M?B"B)R%"C@+C6)SPAL<]JD(/>9/C;#W ^*8N5=EV)=%=WJ)R7!23I8]8;K+&
MQ;WBV/*ZOT'<4!3CT&LHB2-"0NQV;N'.Y15*'F"*D:XI\2)U40,RZ(-A*857
MRKB>O*!WV3%KDFUOV^ M8!XRB[CD1&$ F*HFM6,LZTA_@*;Z@'C7A#@Z-H)\
MN3CE?+\'R=-VT67O#5PX';4GI"4&'L)4?JK2P3VC,">[R*4.2S=-W@Z%U16Q
MWQ??MC;?V\^OR_F7C\7BSA:?CA=UVM\D6&=5'!(@5"J+O-?85+AZQW0WI9P&
M<L#4%2<;$L;PC)Y&#)N B9+"<<J,D)9@9IS>H2  S;D*'7I9J)Z)V9J0NJ)J
MZGWZ?SKR^CZ:%6M'_ C*=!S7E?6Y[7SR]"\>/?FNB *>O+PJ'L_N4VI0]V.\
MCNE[']<H]_ES<=2.[[8C@<7-B)'DC,L%P!@!IZK\+5YJF:-4G)]@XM&4N2)[
M?] 2NXKYT]9T"(18Y 3'$D9; E,O'4.[M8:K'-^#LS>$;VM)1P8N5K\8Q\\4
MPR].V2@2I0AV6%*A@31PYV;NM8 Y=PQG^[YN*.OF[=IY0R3L64+H+*7>_;=O
MLS52HUF%U*OYYW)Q-ZI;[J_>&^*$Q=@A(&74 04UAL!=1@%OA<NY!1B@XVLK
M!&P'ZN[<7#?)AE+ZH:C;'W5=??)D2.:F9X Y2!67Q"6_ALUX+)!(YX35#?!@
MOW$IOW _S4&W0Z?H!^_MZ3$7IF=/!N4)3NI 7&25\< "S%@UGKC^YBAH SR.
M;Y\M.>AVJ7>ED;\IY^/XQX<[_/EDSWF!G2['LW)YORAJ[&^YKP[.>TV!!,A(
M(S"#"%;G:!8P!G,.-0>81J8US:M#&71V=)X2F[W]_.>R6 ?FO?VT&DWGZ8RK
M,M%]^9 $YW4RXG?W \=.UR]_:] 2$0>$$D9*#Z&21.'=[/:TM]+$[7"U.UH]
M/W/O3$0])K]+N7B^S%,AME>3*(SIY^DZK&4=@EIYK$:D'Q=R7R[O[XI)$L?]
M(@GPT>]J7BUUVH_ D-,<"Z]02C^%M1#,;V4!C<KR;,KT-+VQ"3-DL7:IX\0!
M/3M74"LS6BQ^1N#7J31/*#(GVP<K4UD[SS0'7'GM. '5\@(),#G.+&=G$KOR
MLZ*FP>[N1O_9H=;%E#OS32'=W4&L(!"<>0HA1LA6>"BF<TRWY![QR["O7=R'
MPL.'A3R#@@\O"<)J#)U'PE"@J;"""%>A *G/\A\]6_N]8?9=#/D#\7HL</G@
MX?"T<QU6N-R<R>PZ52^5Z+X6(6HWU$AJ%4VEVS3" "()L$?:0P]UK;RA+5U,
M5'W]>"+YQM,'@W*<4NI%7,\0YDQ(8?AZ1 8@Z)Y7M;]V"S9;KL]O&'+ O'!?
M6"Y6CV@1_^TY)>)?);??R?UX]7;QH5A\GXX+]6.Z[[[TT*/! 02(4%YQRHC5
M%E$%JY$X;G(2Y Z0%I>*L6P4Q0[XD,H$;#NXM.7=:+JO5,31YX.G@F*%-6=$
M"DLA,MIMQX0QXEDZYW"8D2_2E]S(!O,T00[4$?D0%8GE^^)[,;\OMIWYH[C[
M5"SV2/]X@R (%QXK+QRVC"E$":SF!M:TO[*$K8D_1VIE"Y#FD<"7BW&Q[44-
M"KQ\/" .%6;2@ZB'I@-51BVK>FNIS2' V=>%WXO%I_+**) -:6>N+M6F:&:C
M953DU]%"!_2(DVT"@4+R=(:)"> V\MKJW1@9]CD^"4.\9<Y3*)J&L[,CUT?=
M/*A>''XX&$(Q,H89'U<NQKV7V%>C<M#>V'5: ])]?HJ:"VEG1'F(/SRX"QU\
M-BA,@86<&:HLT8P"::/51H!U6&!S:_Y-.4)]SH],*+N+/]Z*H!Y#]CT>+%Y7
M/5,6.424(UB9:-(3"#R*(/&<@XT!;C@-DJ0!-#M745Y/Y\6K^,=:NLGNX1!U
M+DZ80Q1P@351!%.\A8@88+H)Y[U:I>12'+N[#UDKV2GR/07<I8.^?TU77\W]
M<E7>%0OW8QO@D^[ X_\F'T<_CEZ,G/VV +QD!!KG/#40>LQ<N@K8X*(1Z_2L
MI$U;J0EJO+@4:1ONKFBX<TS:UC2HDTGH8)O &(/$2J>,$9)11)B4U1BQMS>6
M/*-!0C4%:7<J\G+U]O,_RG+R^/CA0SD[YMM]N%'05DAJ+'",4(&@MHA7-@5E
M3-[8B7X#TGZA.S<$;8?N $7\5KI0MG$QG97K-();/(Y[ !QN%YB'#C*  "60
M8LV1$]7!%[%,=^/"=S35>6MU<9KG5)-0=T6K?Q3S",,LI5N?W$WGTP3!:OJ]
M.$VL$RU#7-2=04IP)3&4W,?9M-N^'78Y1>>RM/$.4D<T3ZUFP>[,H"MFLXU_
M[!^CQ5_%(T2.&78'&P5+@7 >>64M=$!J[A&I5F8@6(Z+TOFI%:YPTVL,VJX(
MI.[*Q6KZ/VMAO?W\*HIM_F6Z\W,^0J+C#8-U#G+M*#$*>(X\-JP"D'*61:3S
MT]I<(9$:A;<K,OG1=+%V^/RC&"6W_+0Y)R/TSWGY:1D5P'2,\FK^[7Y=,'9=
M1WE:N=K?+Q81/CU:3I>[4)1_C*;S5%YYDUED';XR6LSC8\=XV5D? F(* 8:0
M)-P;3!Q2<#>A%<(Y!Z;ULQYTG4RL>:8/56"]'7><<\P1O+4&>8@,1]1J+M()
MSFXAH#RG9,+Y60]:SX74//MR$>V<)0]5Y^OPY.'I0(#71@L/K?6"8\\0J8ZO
M*<Y3[;(2P5_/0=C%8'9%DC?EO'S:V:HL;(U<[*?:!F,\ =+Q:&!S1[D!#MIJ
MS)8;?ENV08,$:AK:BSW:=ENMFOSW_7*51E=^_M=HL1C-USY;FWC+<K$.'UZ^
M_32;?ME(:CXYD$_VD#-<\U\*DA#MK?,04*;B_X6@<(>1Y#GTN[0X4+MI6YMC
M33DDR72V8Z::AQO@CNV4#T\%[ "@R&%KL556>(]==<3#@,,YM]L#O"IJGE_Y
MF':=*NK)N!\#4B]_U+'F 6/E*3">>4\4,@PJ6ED;+ +1K;[5[>EL>]1J ?G>
ME;-+E+) '6&:>H0EM=XR(AF4NWG%2,YNV%#::''-FMF9^%ZLD46Z/E@5NOA<
M+C:IL [I58>>#R)56-6(6Q"_@32Q%J&JOYS1;LO/7X-UUR2<W6U;VUQI6Y;J
M8EY\GIZ.RWW1(@#AL>6:.HR8-412QW4U/H*SD@P/.5EF_HK1#*"=[3F/^7UL
MGWG\7("><B3C3V: )P89Z79K7TH.E4&.\Q/*7<-:T@2,75&B.@U_5RP^?(T
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MO-_K@&F-8=T7X]R/8C&>+B_<(O>T#G%N17T66&^YL%H!Z-G6)] AH$R..^0
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MY]G#S=%2?5JN%J-QK7FUIUF0-FZ-#@,?_RLL<ES#N%-2*8!F+OZCSCP:;LS
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M<<\@&S^;;.5J-+LELIV)[B#X]>=\$LWP5 6JF+@?X_CHR>)@%[TO6,$AET8
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M9SPKE_?;VJ>[KK\O9BFIN2F7J^7#X-Z-?J[I5=-[)^?-P1&F,)+$(JYE.C,
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M*G.<,09XEM@5SR[%=T \.QH%?]%[ J-,6\FX=9IJ[#C"FDCB%00*&9#E^#/
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M,$9A:PS.X$\Y0.$,Y@*WYGB_CZ:SM #X<O&/V/:"7,G9GPP6:Z+BI@.]YMI
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M9K@TG"N!G?3(BQVR<>O.FA!9V5FO8P[T*X[K(GKV/M%^#P*')JXN4 B/L!*
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MMX>0"!",0<:<&J+Y,_0Y-00A7^6&]7ZZ_,LOBN3L640ZKKK<KO9].SCN(^P
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M8RTR,#$Y,#,S,2YX;6Q02P$"% ,4    "  ,@JE.R=L$H!46  !B P$ $0
M            @ &9BP$ 8V5R8RTR,#$Y,#,S,2YX<V102P$"% ,4    "  ,
M@JE.1,X_#+0B   >E0$ %0              @ '=H0$ 8V5R8RTR,#$Y,#,S
M,5]C86PN>&UL4$L! A0#%     @ #(*I3HSZ@P:P?   /T0& !4
M     ( !Q,0! &-E<F,M,C Q.3 S,S%?9&5F+GAM;%!+ 0(4 Q0    (  R"
MJ4YEX UYJ?0   =$#0 5              "  :=! @!C97)C+3(P,3DP,S,Q
M7VQA8BYX;6Q02P$"% ,4    "  ,@JE.9&#):::A  "6* @ %0
M    @ &#-@, 8V5R8RTR,#$Y,#,S,5]P<F4N>&UL4$L%!@     &  8 B@$
' %S8 P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
